drugbank-id,description
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Reteplase.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Reteplase.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Reteplase.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Reteplase.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Reteplase.
DB00374,The risk or severity of adverse effects can be increased when Reteplase is combined with Treprostinil.
DB03404,Hemin may increase the anticoagulant activities of Reteplase.
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Reteplase.
DB00624,Testosterone may increase the anticoagulant activities of Reteplase.
DB01420,Testosterone propionate may increase the anticoagulant activities of Reteplase.
DB01481,1-Testosterone may increase the anticoagulant activities of Reteplase.
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Reteplase.
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Reteplase.
DB01541,Boldenone may increase the anticoagulant activities of Reteplase.
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Reteplase.
DB01564,Calusterone may increase the anticoagulant activities of Reteplase.
DB01569,Formebolone may increase the anticoagulant activities of Reteplase.
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Reteplase.
DB02901,Stanolone may increase the anticoagulant activities of Reteplase.
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Reteplase.
DB08619,Testosterone succinate may increase the anticoagulant activities of Reteplase.
DB11429,Mibolerone may increase the anticoagulant activities of Reteplase.
DB13943,Testosterone cypionate may increase the anticoagulant activities of Reteplase.
DB13944,Testosterone enanthate may increase the anticoagulant activities of Reteplase.
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Reteplase.
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Reteplase.
DB13951,Stanolone acetate may increase the anticoagulant activities of Reteplase.
DB13958,Trestolone acetate may increase the anticoagulant activities of Reteplase.
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Reteplase."
DB14655,Drostanolone propionate may increase the anticoagulant activities of Reteplase.
DB11051,The risk or severity of adverse effects can be increased when Reteplase is combined with Azficel-T.
DB09568,The therapeutic efficacy of Reteplase can be increased when used in combination with Omega-3-carboxylic acids.
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Reteplase.
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Reteplase.
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Reteplase.
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Reteplase.
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Reteplase.
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Reteplase.
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Reteplase.
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Reteplase.
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase."
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Reteplase.
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Reteplase.
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Reteplase.
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Reteplase.
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Reteplase.
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Reteplase.
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Reteplase.
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Reteplase.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Reteplase."
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Reteplase.
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Reteplase.
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Reteplase.
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Reteplase.
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Reteplase.
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Reteplase.
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Reteplase.
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Reteplase.
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Reteplase.
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Reteplase.
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Reteplase.
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Reteplase.
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Reteplase.
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Reteplase.
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Reteplase.
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Reteplase.
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Reteplase.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Reteplase.
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Reteplase.
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Reteplase.
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Reteplase.
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Reteplase.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Reteplase.
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Reteplase.
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Reteplase.
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Reteplase.
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Reteplase.
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Reteplase.
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Reteplase.
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Reteplase.
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Reteplase.
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Reteplase.
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Reteplase.
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Reteplase.
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Reteplase.
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Reteplase.
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Reteplase.
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Reteplase.
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Reteplase.
DB00285,Venlafaxine may increase the antiplatelet activities of Reteplase.
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Reteplase.
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Reteplase.
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Reteplase.
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Reteplase.
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Reteplase.
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Reteplase.
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Reteplase.
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Reteplase.
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Reteplase.
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Reteplase.
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Reteplase.
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Reteplase.
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Reteplase.
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Reteplase.
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Reteplase.
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Reteplase.
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Reteplase.
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Reteplase."
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Reteplase.
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Reteplase.
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Reteplase.
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Reteplase.
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Reteplase.
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Reteplase.
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Reteplase.
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Reteplase.
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Reteplase.
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Reteplase.
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Reteplase.
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Reteplase.
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Reteplase.
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Reteplase.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Reteplase.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Reteplase.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Reteplase.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Reteplase.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Reteplase.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Reteplase.
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Reteplase.
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Reteplase.
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Reteplase.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Reteplase.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Reteplase.
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Reteplase.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Reteplase.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Reteplase.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Reteplase.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Reteplase.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Reteplase.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Reteplase.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Reteplase.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Reteplase.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Reteplase.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Reteplase.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Reteplase.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Reteplase.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Reteplase.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Reteplase.
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Reteplase.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Reteplase.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Reteplase.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Reteplase.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Reteplase.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Reteplase.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Reteplase.
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Reteplase.
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Reteplase.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Reteplase.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Reteplase.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Reteplase.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Reteplase.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Reteplase.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Reteplase.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Reteplase.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Reteplase.
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Reteplase.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Reteplase.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Reteplase.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Reteplase.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Reteplase.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Reteplase.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Reteplase.
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Reteplase.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Reteplase.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Reteplase.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Reteplase.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Reteplase.
DB00029,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.
DB14094,The risk or severity of bleeding can be increased when Reteplase is combined with Tocopherylquinone.
DB06679,The risk or severity of bleeding can be increased when Reteplase is combined with Amediplase.
DB03410,The risk or severity of bleeding can be increased when Reteplase is combined with 4-hydroxycoumarin.
DB08496,The risk or severity of bleeding can be increased when Reteplase is combined with (R)-warfarin.
DB14055,The risk or severity of bleeding can be increased when Reteplase is combined with (S)-Warfarin.
DB12364,The risk or severity of bleeding can be increased when Reteplase is combined with Betrixaban.
DB14598,The risk or severity of bleeding can be increased when Reteplase is combined with Edetate calcium disodium anhydrous.
DB11154,The risk or severity of bleeding can be increased when Reteplase is combined with Zinc citrate.
DB11166,The risk or severity of bleeding can be increased when Reteplase is combined with Antithrombin Alfa.
DB04665,The risk or severity of bleeding can be increased when Reteplase is combined with Coumarin.
DB14726,The risk or severity of bleeding can be increased when Reteplase is combined with Dabigatran.
DB06294,The risk or severity of bleeding can be increased when Reteplase is combined with Semuloparin.
DB12726,The risk or severity of bleeding can be increased when Reteplase is combined with Monteplase.
DB00177,The risk or severity of angioedema can be increased when Reteplase is combined with Valsartan.
DB00178,The risk or severity of angioedema can be increased when Reteplase is combined with Ramipril.
DB00230,The risk or severity of angioedema can be increased when Reteplase is combined with Pregabalin.
DB00492,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinopril.
DB00519,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolapril.
DB00542,The risk or severity of angioedema can be increased when Reteplase is combined with Benazepril.
DB00584,The risk or severity of angioedema can be increased when Reteplase is combined with Enalapril.
DB00678,The risk or severity of angioedema can be increased when Reteplase is combined with Losartan.
DB00691,The risk or severity of angioedema can be increased when Reteplase is combined with Moexipril.
DB00722,The risk or severity of angioedema can be increased when Reteplase is combined with Lisinopril.
DB00790,The risk or severity of angioedema can be increased when Reteplase is combined with Perindopril.
DB00876,The risk or severity of angioedema can be increased when Reteplase is combined with Eprosartan.
DB00877,The risk or severity of angioedema can be increased when Reteplase is combined with Sirolimus.
DB00881,The risk or severity of angioedema can be increased when Reteplase is combined with Quinapril.
DB00886,The risk or severity of angioedema can be increased when Reteplase is combined with Omapatrilat.
DB00966,The risk or severity of angioedema can be increased when Reteplase is combined with Telmisartan.
DB01050,The risk or severity of angioedema can be increased when Reteplase is combined with Ibuprofen.
DB01180,The risk or severity of angioedema can be increased when Reteplase is combined with Rescinnamine.
DB01197,The risk or severity of angioedema can be increased when Reteplase is combined with Captopril.
DB01261,The risk or severity of angioedema can be increased when Reteplase is combined with Sitagliptin.
DB01340,The risk or severity of angioedema can be increased when Reteplase is combined with Cilazapril.
DB01342,The risk or severity of angioedema can be increased when Reteplase is combined with Forasartan.
DB01347,The risk or severity of angioedema can be increased when Reteplase is combined with Saprisartan.
DB01348,The risk or severity of angioedema can be increased when Reteplase is combined with Spirapril.
DB04876,The risk or severity of angioedema can be increased when Reteplase is combined with Vildagliptin.
DB06011,The risk or severity of angioedema can be increased when Reteplase is combined with AMG-222.
DB06127,The risk or severity of angioedema can be increased when Reteplase is combined with Bisegliptin.
DB06196,The risk or severity of angioedema can be increased when Reteplase is combined with Icatibant.
DB06203,The risk or severity of angioedema can be increased when Reteplase is combined with Alogliptin.
DB06245,The risk or severity of angioedema can be increased when Reteplase is combined with Lanoteplase.
DB06287,The risk or severity of angioedema can be increased when Reteplase is combined with Temsirolimus.
DB06335,The risk or severity of angioedema can be increased when Reteplase is combined with Saxagliptin.
DB08382,The risk or severity of angioedema can be increased when Reteplase is combined with Gosogliptin.
DB08822,The risk or severity of angioedema can be increased when Reteplase is combined with Azilsartan medoxomil.
DB08836,The risk or severity of angioedema can be increased when Reteplase is combined with Temocapril.
DB08882,The risk or severity of angioedema can be increased when Reteplase is combined with Linagliptin.
DB09292,The risk or severity of angioedema can be increased when Reteplase is combined with Sacubitril.
DB09477,The risk or severity of angioedema can be increased when Reteplase is combined with Enalaprilat.
DB11723,The risk or severity of angioedema can be increased when Reteplase is combined with Dutogliptin.
DB11783,The risk or severity of angioedema can be increased when Reteplase is combined with Imidapril.
DB11950,The risk or severity of angioedema can be increased when Reteplase is combined with Teneligliptin.
DB11992,The risk or severity of angioedema can be increased when Reteplase is combined with Omarigliptin.
DB12268,The risk or severity of angioedema can be increased when Reteplase is combined with Carmegliptin.
DB12412,The risk or severity of angioedema can be increased when Reteplase is combined with Gemigliptin.
DB12417,The risk or severity of angioedema can be increased when Reteplase is combined with Anagliptin.
DB12625,The risk or severity of angioedema can be increased when Reteplase is combined with Evogliptin.
DB13166,The risk or severity of angioedema can be increased when Reteplase is combined with Zofenopril.
DB13312,The risk or severity of angioedema can be increased when Reteplase is combined with Delapril.
DB14125,The risk or severity of angioedema can be increased when Reteplase is combined with Benazeprilat.
DB14207,The risk or severity of angioedema can be increased when Reteplase is combined with Fosinoprilat.
DB14208,The risk or severity of angioedema can be increased when Reteplase is combined with Ramiprilat.
DB14209,The risk or severity of angioedema can be increased when Reteplase is combined with Trandolaprilat.
DB14210,The risk or severity of angioedema can be increased when Reteplase is combined with Moexiprilat.
DB14213,The risk or severity of angioedema can be increased when Reteplase is combined with Perindoprilat.
DB14217,The risk or severity of angioedema can be increased when Reteplase is combined with Quinaprilat.
DB14231,The risk or severity of angioedema can be increased when Reteplase is combined with Quinoline Yellow WS.
DB00203,The risk or severity of hemorrhage can be increased when Reteplase is combined with Sildenafil.
DB00008,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2a.
DB00011,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n1.
DB00018,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.
DB00022,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.
DB00033,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.
DB00034,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.
DB00056,The risk or severity of bleeding can be increased when Reteplase is combined with Gemtuzumab ozogamicin.
DB00068,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon beta-1b.
DB00069,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfacon-1.
DB00073,The risk or severity of bleeding can be increased when Reteplase is combined with Rituximab.
DB00078,The risk or severity of bleeding can be increased when Reteplase is combined with Ibritumomab tiuxetan.
DB00087,The risk or severity of bleeding can be increased when Reteplase is combined with Alemtuzumab.
DB00105,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2b.
DB00120,The risk or severity of bleeding can be increased when Reteplase is combined with Phenylalanine.
DB00188,The risk or severity of bleeding can be increased when Reteplase is combined with Bortezomib.
DB00242,The risk or severity of bleeding can be increased when Reteplase is combined with Cladribine.
DB00262,The risk or severity of bleeding can be increased when Reteplase is combined with Carmustine.
DB00276,The risk or severity of bleeding can be increased when Reteplase is combined with Amsacrine.
DB00291,The risk or severity of bleeding can be increased when Reteplase is combined with Chlorambucil.
DB00293,The risk or severity of bleeding can be increased when Reteplase is combined with Raltitrexed.
DB00305,The risk or severity of bleeding can be increased when Reteplase is combined with Mitomycin.
DB00307,The risk or severity of bleeding can be increased when Reteplase is combined with Bexarotene.
DB00309,The risk or severity of bleeding can be increased when Reteplase is combined with Vindesine.
DB00322,The risk or severity of bleeding can be increased when Reteplase is combined with Floxuridine.
DB00352,The risk or severity of bleeding can be increased when Reteplase is combined with Tioguanine.
DB00361,The risk or severity of bleeding can be increased when Reteplase is combined with Vinorelbine.
DB00380,The risk or severity of bleeding can be increased when Reteplase is combined with Dexrazoxane.
DB00398,The risk or severity of bleeding can be increased when Reteplase is combined with Sorafenib.
DB00428,The risk or severity of bleeding can be increased when Reteplase is combined with Streptozocin.
DB00441,The risk or severity of bleeding can be increased when Reteplase is combined with Gemcitabine.
DB00444,The risk or severity of bleeding can be increased when Reteplase is combined with Teniposide.
DB00445,The risk or severity of bleeding can be increased when Reteplase is combined with Epirubicin.
DB00446,The risk or severity of bleeding can be increased when Reteplase is combined with Chloramphenicol.
DB00480,The risk or severity of bleeding can be increased when Reteplase is combined with Lenalidomide.
DB00488,The risk or severity of bleeding can be increased when Reteplase is combined with Altretamine.
DB00495,The risk or severity of bleeding can be increased when Reteplase is combined with Zidovudine.
DB00515,The risk or severity of bleeding can be increased when Reteplase is combined with Cisplatin.
DB00526,The risk or severity of bleeding can be increased when Reteplase is combined with Oxaliplatin.
DB00531,The risk or severity of bleeding can be increased when Reteplase is combined with Cyclophosphamide.
DB00544,The risk or severity of bleeding can be increased when Reteplase is combined with Fluorouracil.
DB00552,The risk or severity of bleeding can be increased when Reteplase is combined with Pentostatin.
DB00563,The risk or severity of bleeding can be increased when Reteplase is combined with Methotrexate.
DB00564,The risk or severity of bleeding can be increased when Reteplase is combined with Carbamazepine.
DB00570,The risk or severity of bleeding can be increased when Reteplase is combined with Vinblastine.
DB00619,The risk or severity of bleeding can be increased when Reteplase is combined with Imatinib.
DB00631,The risk or severity of bleeding can be increased when Reteplase is combined with Clofarabine.
DB00642,The risk or severity of bleeding can be increased when Reteplase is combined with Pemetrexed.
DB00694,The risk or severity of bleeding can be increased when Reteplase is combined with Daunorubicin.
DB00762,The risk or severity of bleeding can be increased when Reteplase is combined with Irinotecan.
DB00773,The risk or severity of bleeding can be increased when Reteplase is combined with Etoposide.
DB00851,The risk or severity of bleeding can be increased when Reteplase is combined with Dacarbazine.
DB00853,The risk or severity of bleeding can be increased when Reteplase is combined with Temozolomide.
DB00859,The risk or severity of bleeding can be increased when Reteplase is combined with Penicillamine.
DB00864,The risk or severity of bleeding can be increased when Reteplase is combined with Tacrolimus.
DB00888,The risk or severity of bleeding can be increased when Reteplase is combined with Mechlorethamine.
DB00928,The risk or severity of bleeding can be increased when Reteplase is combined with Azacitidine.
DB00958,The risk or severity of bleeding can be increased when Reteplase is combined with Carboplatin.
DB00970,The risk or severity of bleeding can be increased when Reteplase is combined with Dactinomycin.
DB00987,The risk or severity of bleeding can be increased when Reteplase is combined with Cytarabine.
DB00997,The risk or severity of bleeding can be increased when Reteplase is combined with Doxorubicin.
DB01005,The risk or severity of bleeding can be increased when Reteplase is combined with Hydroxyurea.
DB01008,The risk or severity of bleeding can be increased when Reteplase is combined with Busulfan.
DB01030,The risk or severity of bleeding can be increased when Reteplase is combined with Topotecan.
DB01033,The risk or severity of bleeding can be increased when Reteplase is combined with Mercaptopurine.
DB01041,The risk or severity of bleeding can be increased when Reteplase is combined with Thalidomide.
DB01042,The risk or severity of bleeding can be increased when Reteplase is combined with Melphalan.
DB01073,The risk or severity of bleeding can be increased when Reteplase is combined with Fludarabine.
DB01099,The risk or severity of bleeding can be increased when Reteplase is combined with Flucytosine.
DB01101,The risk or severity of bleeding can be increased when Reteplase is combined with Capecitabine.
DB01169,The risk or severity of bleeding can be increased when Reteplase is combined with Arsenic trioxide.
DB01177,The risk or severity of bleeding can be increased when Reteplase is combined with Idarubicin.
DB01204,The risk or severity of bleeding can be increased when Reteplase is combined with Mitoxantrone.
DB01206,The risk or severity of bleeding can be increased when Reteplase is combined with Lomustine.
DB01229,The risk or severity of bleeding can be increased when Reteplase is combined with Paclitaxel.
DB01248,The risk or severity of bleeding can be increased when Reteplase is combined with Docetaxel.
DB01262,The risk or severity of bleeding can be increased when Reteplase is combined with Decitabine.
DB01280,The risk or severity of bleeding can be increased when Reteplase is combined with Nelarabine.
DB01590,The risk or severity of bleeding can be increased when Reteplase is combined with Everolimus.
DB02546,The risk or severity of bleeding can be increased when Reteplase is combined with Vorinostat.
DB04572,The risk or severity of bleeding can be increased when Reteplase is combined with Thiotepa.
DB04845,The risk or severity of bleeding can be increased when Reteplase is combined with Ixabepilone.
DB04868,The risk or severity of bleeding can be increased when Reteplase is combined with Nilotinib.
DB05015,The risk or severity of bleeding can be increased when Reteplase is combined with Belinostat.
DB05109,The risk or severity of bleeding can be increased when Reteplase is combined with Trabectedin.
DB05258,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa.
DB05472,The risk or severity of bleeding can be increased when Reteplase is combined with omega interferon.
DB05773,The risk or severity of bleeding can be increased when Reteplase is combined with Trastuzumab emtansine.
DB06616,The risk or severity of bleeding can be increased when Reteplase is combined with Bosutinib.
DB06769,The risk or severity of bleeding can be increased when Reteplase is combined with Bendamustine.
DB06772,The risk or severity of bleeding can be increased when Reteplase is combined with Cabazitaxel.
DB08871,The risk or severity of bleeding can be increased when Reteplase is combined with Eribulin.
DB08877,The risk or severity of bleeding can be increased when Reteplase is combined with Ruxolitinib.
DB08889,The risk or severity of bleeding can be increased when Reteplase is combined with Carfilzomib.
DB08895,The risk or severity of bleeding can be increased when Reteplase is combined with Tofacitinib.
DB08901,The risk or severity of bleeding can be increased when Reteplase is combined with Ponatinib.
DB08910,The risk or severity of bleeding can be increased when Reteplase is combined with Pomalidomide.
DB09042,The risk or severity of bleeding can be increased when Reteplase is combined with Tedizolid phosphate.
DB09052,The risk or severity of bleeding can be increased when Reteplase is combined with Blinatumomab.
DB09073,The risk or severity of bleeding can be increased when Reteplase is combined with Palbociclib.
DB09074,The risk or severity of bleeding can be increased when Reteplase is combined with Olaparib.
DB09077,The risk or severity of bleeding can be increased when Reteplase is combined with Dinutuximab.
DB09122,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon beta-1a.
DB12814,The risk or severity of bleeding can be increased when Reteplase is combined with Cepeginterferon alfa-2B.
DB00229,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotiam.
DB00267,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmenoxime.
DB00274,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefmetazole.
DB00430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpiramide.
DB00438,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftazidime.
DB00447,The therapeutic efficacy of Reteplase can be decreased when used in combination with Loracarbef.
DB00456,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefalotin.
DB00493,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotaxime.
DB00535,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefdinir.
DB00567,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephalexin.
DB00671,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefixime.
DB00689,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephaloglycin.
DB00833,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaclor.
DB00923,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceforanide.
DB01066,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefditoren.
DB01112,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefuroxime.
DB01139,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefapirin.
DB01140,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefadroxil.
DB01150,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefprozil.
DB01212,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftriaxone.
DB01326,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole.
DB01327,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazolin.
DB01328,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefonicid.
DB01329,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoperazone.
DB01330,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefotetan.
DB01331,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefoxitin.
DB01332,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftizoxime.
DB01333,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefradine.
DB01413,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefepime.
DB01414,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefacetrile.
DB01415,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftibuten.
DB01416,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpodoxime.
DB04570,The therapeutic efficacy of Reteplase can be decreased when used in combination with Latamoxef.
DB04918,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftobiprole.
DB06590,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftaroline fosamil.
DB09008,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefaloridine.
DB09050,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftolozane.
DB09062,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefminox.
DB11367,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefroxadine.
DB11935,The therapeutic efficacy of Reteplase can be decreased when used in combination with Flomoxef.
DB13266,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefatrizine.
DB13461,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefcapene.
DB13470,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefodizime.
DB13499,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefsulodin.
DB13504,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefetamet.
DB13638,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefbuperazone.
DB13667,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefozopran.
DB13682,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefpirome.
DB13778,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefazedone.
DB13821,The therapeutic efficacy of Reteplase can be decreased when used in combination with Ceftezole.
DB14725,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefamandole nafate.
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Reteplase.
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Reteplase.
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Reteplase.
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Reteplase.
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Reteplase.
DB00727,The therapeutic efficacy of Reteplase can be decreased when used in combination with Nitroglycerin.
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Reteplase.
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Reteplase.
DB00620,The therapeutic efficacy of Reteplase can be decreased when used in combination with Triamcinolone.
DB09079,The risk or severity of bleeding can be increased when Reteplase is combined with Nintedanib.
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Reteplase.
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Reteplase.
DB00232,The therapeutic efficacy of Reteplase can be decreased when used in combination with Methyclothiazide.
DB00436,The therapeutic efficacy of Reteplase can be decreased when used in combination with Bendroflumethiazide.
DB00562,The therapeutic efficacy of Reteplase can be decreased when used in combination with Benzthiazide.
DB00606,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclothiazide.
DB00774,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydroflumethiazide.
DB00880,The therapeutic efficacy of Reteplase can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Reteplase can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Reteplase can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Reteplase can be decreased when used in combination with Polythiazide.
DB13430,The therapeutic efficacy of Reteplase can be decreased when used in combination with Mebutizide.
DB13532,The therapeutic efficacy of Reteplase can be decreased when used in combination with Cyclopenthiazide.
DB00480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenalidomide.
DB01041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thalidomide.
DB08910,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pomalidomide.
DB00002,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cetuximab.
DB00004,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Denileukin diftitox.
DB00007,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Leuprolide.
DB00008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Peginterferon alfa-2a.
DB00014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Goserelin.
DB00023,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.
DB00041,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.
DB00056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pegaspargase.
DB00072,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab.
DB00073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rituximab.
DB00081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tositumomab.
DB00087,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alemtuzumab.
DB00104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Octreotide.
DB00105,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Interferon alfa-2b.
DB00112,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bevacizumab.
DB00179,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masoprocol.
DB00188,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bortezomib.
DB00236,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pipobroman.
DB00242,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cladribine.
DB00248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabergoline.
DB00261,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anagrelide.
DB00262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmustine.
DB00269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorotrianisene.
DB00276,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amsacrine.
DB00282,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pamidronic acid.
DB00290,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bleomycin.
DB00291,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Chlorambucil.
DB00293,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Raltitrexed.
DB00305,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitomycin.
DB00307,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bexarotene.
DB00313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valproic acid.
DB00317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gefitinib.
DB00322,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Floxuridine.
DB00351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Megestrol acetate.
DB00352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tioguanine.
DB00357,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminoglutethimide.
DB00385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Valrubicin.
DB00398,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sorafenib.
DB00428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Streptozocin.
DB00432,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trifluridine.
DB00441,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gemcitabine.
DB00444,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Teniposide.
DB00445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epirubicin.
DB00488,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Altretamine.
DB00499,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flutamide.
DB00515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cisplatin.
DB00523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin.
DB00526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxaliplatin.
DB00530,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erlotinib.
DB00539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toremifene.
DB00544,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fluorouracil.
DB00552,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pentostatin.
DB00563,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methotrexate.
DB00603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Medroxyprogesterone acetate.
DB00619,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Imatinib.
DB00631,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Clofarabine.
DB00635,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone.
DB00642,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemetrexed.
DB00648,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitotane.
DB00665,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilutamide.
DB00675,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tamoxifen.
DB00694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daunorubicin.
DB00707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfimer sodium.
DB00755,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretinoin.
DB00762,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irinotecan.
DB00773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoposide.
DB00791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Uracil mustard.
DB00851,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacarbazine.
DB00853,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temozolomide.
DB00855,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aminolevulinic acid.
DB00860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisolone.
DB00888,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mechlorethamine.
DB00894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Testolactone.
DB00928,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Azacitidine.
DB00947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fulvestrant.
DB00958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboplatin.
DB00959,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone.
DB00970,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactinomycin.
DB00987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cytarabine.
DB00990,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exemestane.
DB00997,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxorubicin.
DB01005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyurea.
DB01006,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Letrozole.
DB01008,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Busulfan.
DB01030,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Topotecan.
DB01033,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mercaptopurine.
DB01042,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Melphalan.
DB01073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fludarabine.
DB01101,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capecitabine.
DB01108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trilostane.
DB01128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bicalutamide.
DB01157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trimetrexate.
DB01168,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Procarbazine.
DB01169,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Arsenic trioxide.
DB01177,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idarubicin.
DB01181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ifosfamide.
DB01196,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Estramustine.
DB01204,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoxantrone.
DB01206,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lomustine.
DB01217,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anastrozole.
DB01229,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel.
DB01234,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexamethasone.
DB01248,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Docetaxel.
DB01254,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dasatinib.
DB01259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lapatinib.
DB01262,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Decitabine.
DB01268,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sunitinib.
DB01269,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panitumumab.
DB01280,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nelarabine.
DB01590,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Everolimus.
DB01645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Genistein.
DB01667,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 8-azaguanine.
DB01873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epothilone D.
DB01933,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-Hydroxystaurosporine.
DB02109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hadacidin.
DB02342,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-Methoxyestradiol.
DB02424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Geldanamycin.
DB02546,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorinostat.
DB02640,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fumagillin.
DB03010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Patupilone.
DB03172,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tubercidin.
DB03459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparfosic acid.
DB03496,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alvocidib.
DB03509,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide.
DB03523,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brequinar.
DB03695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Piritrexim.
DB03825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rhodamine 6G.
DB03880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Batimastat.
DB03946,"The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 3,4-Dihydroxybenzoic Acid."
DB04106,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fotemustine.
DB04222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sparsomycin.
DB04253,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretazicar.
DB04258,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seocalcitol.
DB04331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Monastrol.
DB04440,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nebularine.
DB04468,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afimoxifene.
DB04572,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thiotepa.
DB04576,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fleroxacin.
DB04655,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Metoprine.
DB04690,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Camptothecin.
DB04786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Suramin.
DB04827,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Urethane.
DB04839,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cyproterone acetate.
DB04845,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixabepilone.
DB04849,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cediranib.
DB04858,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tirapazamine.
DB04865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Omacetaxine mepesuccinate.
DB04866,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Halofuginone.
DB04868,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nilotinib.
DB04894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vapreotide.
DB04900,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Thymalfasin.
DB04901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Galiximab.
DB04907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sitimagene ceradenovec.
DB04950,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranpirnase.
DB04951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirfenidone.
DB04958,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epratuzumab.
DB04960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tipifarnib.
DB04961,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Troxacitabine.
DB04964,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oregovomab.
DB04975,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Banoxantrone.
DB04977,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plitidepsin.
DB04996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Satraplatin.
DB05015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belinostat.
DB05022,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amonafide.
DB05076,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fenretinide.
DB05088,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrathiomolybdate.
DB05097,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Labetuzumab.
DB05109,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trabectedin.
DB05129,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elsamitrucin.
DB05136,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bavituximab.
DB05223,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pracinostat.
DB05239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cobimetinib.
DB05260,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gallium nitrate.
DB05265,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecabet.
DB05294,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vandetanib.
DB05374,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rindopepimut.
DB05424,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Canertinib.
DB05428,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Motexafin gadolinium.
DB05482,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 7-ethyl-10-hydroxycamptothecin.
DB05524,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pelitinib.
DB05540,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alanosine.
DB05578,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ramucirumab.
DB05595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Farletuzumab.
DB05656,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veltuzumab.
DB05668,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palifosfamide.
DB05697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AP 12009.
DB05773,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab emtansine.
DB05779,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oglufanide.
DB05786,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Irofulven.
DB05812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abiraterone.
DB05889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Inotuzumab ozogamicin.
DB05903,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KOS-1584.
DB05916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CT-011.
DB05974,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Transcrocetinate.
DB05996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glembatumumab vedotin.
DB06013,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldoxorubicin.
DB06021,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AV-412.
DB06040,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Filanesib.
DB06043,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaratumab.
DB06159,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rubitecan.
DB06160,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Garenoxacin.
DB06163,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plevitrexed.
DB06171,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel trevatide.
DB06176,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Romidepsin.
DB06181,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with IMO-2055.
DB06186,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ipilimumab.
DB06192,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimotuzumab.
DB06193,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pixantrone.
DB06195,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Seliciclib.
DB06199,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atrasentan.
DB06233,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ridaforolimus.
DB06235,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vadimezan.
DB06246,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exisulind.
DB06263,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Amrubicin.
DB06266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lonidamine.
DB06272,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Maxacalcitol.
DB06287,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temsirolimus.
DB06317,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Elotuzumab.
DB06334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tucidinostat.
DB06365,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sapacitabine.
DB06366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pertuzumab.
DB06370,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indisulam.
DB06420,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Annamycin.
DB06423,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostatin.
DB06433,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tezacitabine.
DB06436,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semaxanib.
DB06445,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Diethylnorspermine.
DB06461,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Squalamine.
DB06478,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Porfiromycin.
DB06517,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with MLN576.
DB06589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pazopanib.
DB06595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Midostaurin.
DB06603,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Panobinostat.
DB06607,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Catumaxomab.
DB06616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bosutinib.
DB06626,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Axitinib.
DB06647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volociximab.
DB06650,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ofatumumab.
DB06699,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Degarelix.
DB06710,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methyltestosterone.
DB06719,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buserelin.
DB06748,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ginsenoside C.
DB06769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bendamustine.
DB06772,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabazitaxel.
DB06789,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hydroxyprogesterone caproate.
DB06791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lanreotide.
DB06810,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Plicamycin.
DB06813,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pralatrexate.
DB06825,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptorelin.
DB07232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Veliparib.
DB07931,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hexestrol.
DB08313,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nocodazole.
DB08437,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Puromycin.
DB08486,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efaproxiral.
DB08633,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with TNP-470.
DB08828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vismodegib.
DB08865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crizotinib.
DB08870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin.
DB08871,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Eribulin.
DB08875,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cabozantinib.
DB08877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ruxolitinib.
DB08881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vemurafenib.
DB08886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Erwinia chrysanthemi.
DB08889,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carfilzomib.
DB08896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Regorafenib.
DB08899,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enzalutamide.
DB08901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ponatinib.
DB08905,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Formestane.
DB08911,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trametinib.
DB08912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dabrafenib.
DB08913,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Radium Ra 223 dichloride.
DB08916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Afatinib.
DB08935,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Obinutuzumab.
DB08972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Flumequine.
DB09010,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carmofur.
DB09031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Miltefosine.
DB09035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nivolumab.
DB09036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Siltuximab.
DB09037,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pembrolizumab.
DB09052,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Blinatumomab.
DB09053,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ibrutinib.
DB09054,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Idelalisib.
DB09063,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ceritinib.
DB09073,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Palbociclib.
DB09074,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olaparib.
DB09077,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dinutuximab.
DB09078,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lenvatinib.
DB09079,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nintedanib.
DB09123,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dienogest.
DB09143,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sonidegib.
DB09239,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niguldipine.
DB09256,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tegafur.
DB09274,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Artesunate.
DB09298,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Silibinin.
DB09330,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Osimertinib.
DB09331,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daratumumab.
DB09559,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Necitumumab.
DB09570,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ixazomib.
DB11363,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alectinib.
DB11366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Roquinimex.
DB11526,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Masitinib.
DB11581,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Venetoclax.
DB11595,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Atezolizumab.
DB11616,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pirarubicin.
DB11617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aclarubicin.
DB11618,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zorubicin.
DB11630,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Temoporfin.
DB11646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Conatumumab.
DB11651,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dactolisib.
DB11662,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rabusertib.
DB11669,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ortataxel.
DB11678,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Treosulfan.
DB11688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 2-chloroethyl-3-sarcosinamide-1-nitrosourea.
DB11694,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ilorasertib.
DB11714,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Durvalumab.
DB11716,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Misonidazole.
DB11717,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epacadostat.
DB11718,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Encorafenib.
DB11727,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Endostar.
DB11730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ribociclib.
DB11737,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Icotinib.
DB11752,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bryostatin 1.
DB11760,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talazoparib.
DB11771,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tremelimumab.
DB11793,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Niraparib.
DB11795,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with GSK-2636771.
DB11800,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tivozanib.
DB11805,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Saracatinib.
DB11812,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talaporfin.
DB11828,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Neratinib.
DB11830,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mocetinostat.
DB11832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Crenolanib.
DB11841,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entinostat.
DB11880,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acridine Carboxamide.
DB11886,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Infigratinib.
DB11891,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-907.
DB11894,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Efatutazone.
DB11901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apalutamide.
DB11907,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rociletinib.
DB11918,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Guadecitabine.
DB11919,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 6-O-benzylguanine.
DB11945,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Avelumab.
DB11960,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboxyamidotriazole.
DB11963,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacomitinib.
DB11967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binimetinib.
DB11972,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rilotumumab.
DB11973,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tesevatinib.
DB11978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Glasdegib.
DB11986,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Entrectinib.
DB11999,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vosaroxin.
DB12001,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abemaciclib.
DB12015,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib.
DB12025,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triptolide.
DB12028,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Broxuridine.
DB12036,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Naquotinib.
DB12056,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trebananib.
DB12081,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Anecortave.
DB12082,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vesnarinone.
DB12083,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mafosfamide.
DB12085,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with LCL-161.
DB12089,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorvotuzumab mertansine.
DB12108,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taselisib.
DB12124,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Namitecan.
DB12130,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lorlatinib.
DB12141,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gilteritinib.
DB12142,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Duligotuzumab.
DB12146,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rigosertib.
DB12147,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Erdafitinib.
DB12156,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cordycepin.
DB12174,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CUDC-101.
DB12182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Binetrakin.
DB12185,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Exatecan.
DB12202,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zalutumumab.
DB12222,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lurtotecan.
DB12232,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-7000.
DB12257,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Platinum.
DB12259,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with CG-200745.
DB12266,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Epofolate.
DB12267,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brigatinib.
DB12279,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with OBP-801.
DB12332,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rucaparib.
DB12340,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Navitoclax.
DB12352,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bizelesin.
DB12376,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ricolinostat.
DB12379,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indirubin.
DB12381,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Merestinib.
DB12382,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with R-306465.
DB12385,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 10-hydroxycamptothecin.
DB12391,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sagopilone.
DB12422,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sulforaphane.
DB12459,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Belotecan.
DB12473,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Taurolidine.
DB12480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Betulinic Acid.
DB12483,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Copanlisib.
DB12498,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mogamulizumab.
DB12515,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with 9-aminocamptothecin.
DB12525,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Molgramostim.
DB12539,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oltipraz.
DB12549,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pyrazoloacridine.
DB12565,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Abexinostat.
DB12577,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fosbretabulin.
DB12589,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dacetuzumab.
DB12593,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Apaziquone.
DB12596,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin.
DB12617,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mizoribine.
DB12637,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Onapristone.
DB12638,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with PU-H71.
DB12645,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Givinostat.
DB12671,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Beloranib.
DB12677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Soblidotin.
DB12681,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Salirasib.
DB12688,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Moxetumomab Pasudotox.
DB12692,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Gusperimus.
DB12695,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Phenethyl Isothiocyanate.
DB12697,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylselenocysteine.
DB12701,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Intetumumab.
DB12730,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dolastatin 10.
DB12736,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etanidazole.
DB12769,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lometrexol.
DB12797,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ecromeximab.
DB12832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednimustine.
DB12870,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Buthionine Sulfoximine.
DB12873,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dianhydrogalactitol.
DB12881,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Indole-3-carbinol.
DB12901,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Fiacitabine.
DB12902,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trofosfamide.
DB12912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nolatrexed.
DB12916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitolactol.
DB12920,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pinometostat.
DB12947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Doxifluridine.
DB12948,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Didox.
DB12967,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoguazone.
DB12978,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pexidartinib.
DB12987,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Penclomedine.
DB12991,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Deoxyspergualin.
DB12996,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Acteoside.
DB13005,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rebastinib.
DB13014,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Hypericin.
DB13046,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tocladesine.
DB13066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Liarozole.
DB13069,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nimustine.
DB13104,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with X-396.
DB13128,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Sizofiran.
DB13145,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nedaplatin.
DB13164,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Olmutinib.
DB13182,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Daidzein.
DB13243,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tiazofurine.
DB13304,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Triaziquone.
DB13318,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Demecolcine.
DB13334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mannosulfan.
DB13339,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etoglucid.
DB13375,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Edrecolomab.
DB13480,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lentinan.
DB13543,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitobronitol.
DB13627,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oxolinic acid.
DB13647,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Semustine.
DB13677,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Carboquone.
DB13767,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Vorozole.
DB13809,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Paclitaxel poliglumex.
DB13811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Oblimersen.
DB13832,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ranimustine.
DB13874,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Enasidenib.
DB13877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Iniparib.
DB13896,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talimogene laherparepvec.
DB13912,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Coumermycin A1.
DB13916,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Toyocamycin.
DB14031,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tretamine.
DB14066,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tetrandrine.
DB14067,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dofequidar.
DB14068,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dexniguldipine.
DB14568,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ivosidenib.
DB14644,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Methylprednisolone hemisuccinate.
DB14646,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Prednisone acetate.
DB14680,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Combretastatin A4.
DB14707,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Cemiplimab.
DB14723,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Larotrectinib.
DB14731,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tagraxofusp.
DB14765,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Rivoceranib.
DB14792,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with AZD-5991.
DB14844,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with ONC-201.
DB14860,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Ensartinib.
DB14865,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Human interleukin-2.
DB14877,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Lintuzumab.
DB14947,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Bermekimab.
DB14951,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Etirinotecan pegol.
DB15035,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Zanubrutinib.
DB15057,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with NUC-1031.
DB15157,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Voruciclib.
DB15215,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with KRN-5500.
DB15289,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Perillyl alcohol.
DB15321,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tefinostat.
DB15334,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Biochanin A.
DB15351,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Dihematoporphyrin ether.
DB15366,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with SOR-C13.
DB15383,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pidilizumab.
DB15419,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Nanatinostat.
DB15466,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Tallimustine.
DB12062,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Volasertib.
DB14811,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Isatuximab.
DB15102,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemigatinib.
DB11791,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Capmatinib.
DB15685,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Selpercatinib.
DB00531,The risk or severity of pulmonary toxicity can be increased when Erythropoietin is combined with Cyclophosphamide.
DB00984,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone phenpropionate.
DB08804,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone decanoate.
DB13169,The therapeutic efficacy of Erythropoietin can be increased when used in combination with Nandrolone.
DB00178,The serum concentration of Erythropoietin can be decreased when it is combined with Ramipril.
DB00492,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinopril.
DB00519,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolapril.
DB00542,The serum concentration of Erythropoietin can be decreased when it is combined with Benazepril.
DB00584,The serum concentration of Erythropoietin can be decreased when it is combined with Enalapril.
DB00691,The serum concentration of Erythropoietin can be decreased when it is combined with Moexipril.
DB00722,The serum concentration of Erythropoietin can be decreased when it is combined with Lisinopril.
DB00790,The serum concentration of Erythropoietin can be decreased when it is combined with Perindopril.
DB00881,The serum concentration of Erythropoietin can be decreased when it is combined with Quinapril.
DB00886,The serum concentration of Erythropoietin can be decreased when it is combined with Omapatrilat.
DB01180,The serum concentration of Erythropoietin can be decreased when it is combined with Rescinnamine.
DB01197,The serum concentration of Erythropoietin can be decreased when it is combined with Captopril.
DB01340,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazapril.
DB01348,The serum concentration of Erythropoietin can be decreased when it is combined with Spirapril.
DB08836,The serum concentration of Erythropoietin can be decreased when it is combined with Temocapril.
DB09477,The serum concentration of Erythropoietin can be decreased when it is combined with Enalaprilat.
DB11783,The serum concentration of Erythropoietin can be decreased when it is combined with Imidapril.
DB13166,The serum concentration of Erythropoietin can be decreased when it is combined with Zofenopril.
DB13312,The serum concentration of Erythropoietin can be decreased when it is combined with Delapril.
DB14125,The serum concentration of Erythropoietin can be decreased when it is combined with Benazeprilat.
DB14207,The serum concentration of Erythropoietin can be decreased when it is combined with Fosinoprilat.
DB14208,The serum concentration of Erythropoietin can be decreased when it is combined with Ramiprilat.
DB14209,The serum concentration of Erythropoietin can be decreased when it is combined with Trandolaprilat.
DB14210,The serum concentration of Erythropoietin can be decreased when it is combined with Moexiprilat.
DB14213,The serum concentration of Erythropoietin can be decreased when it is combined with Perindoprilat.
DB14217,The serum concentration of Erythropoietin can be decreased when it is combined with Quinaprilat.
DB14231,The serum concentration of Erythropoietin can be decreased when it is combined with Quinoline Yellow WS.
DB15565,The serum concentration of Erythropoietin can be decreased when it is combined with Cilazaprilat.
DB00309,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vindesine.
DB00361,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinorelbine.
DB00541,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincristine.
DB00570,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinblastine.
DB05168,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vintafolide.
DB11641,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vinflunine.
DB13374,The risk or severity of peripheral neuropathy can be increased when Erythropoietin is combined with Vincamine.
DB00215,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Citalopram.
DB00472,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fluoxetine.
DB00656,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Trazodone.
DB01104,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sertraline.
DB01175,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Escitalopram.
DB04832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Zimelidine.
DB04884,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dapoxetine.
DB06731,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Seproxetine.
DB08953,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Indalpine.
DB12693,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ritanserin.
DB13233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alaproclate.
DB00715,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Paroxetine.
DB00399,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Zoledronic acid.
DB00630,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Alendronic acid.
DB00710,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Ibandronate.
DB00720,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Clodronic acid.
DB00884,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Risedronic acid.
DB01077,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Etidronic acid.
DB06255,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Incadronic acid.
DB00282,The risk or severity of hypocalcemia can be increased when Pamidronic acid is combined with Salmon calcitonin.
DB01133,The risk or severity of hypocalcemia can be increased when Salmon calcitonin is combined with Tiludronic acid.
DB01356,Salmon calcitonin may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy.
DB14507,Salmon calcitonin may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy.
DB14509,Salmon calcitonin may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy.
DB14506,Salmon calcitonin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
DB00091,Cyclosporine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00159,Icosapent may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00229,Cefotiam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00244,Mesalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00267,Cefmenoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00274,Cefmetazole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00300,Tenofovir disoproxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00328,Indomethacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00369,Cidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00384,Triamterene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00430,Cefpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00438,Ceftazidime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00447,Loracarbef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00456,Cefalotin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00461,Nabumetone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00465,Ketorolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00469,Tenoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00482,Celecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00493,Cefotaxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00500,Tolmetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00529,Foscarnet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00533,Rofecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00554,Piroxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00563,Methotrexate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00567,Cephalexin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00573,Fenoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00577,Valaciclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00580,Valdecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00586,Diclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00605,Sulindac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00626,Bacitracin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00681,Amphotericin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00689,Cephaloglycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00712,Flurbiprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00718,Adefovir dipivoxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00738,Pentamidine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00742,Mannitol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00749,Etodolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00784,Mefenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00787,Acyclovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00788,Naproxen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00795,Sulfasalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00812,Phenylbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00814,Meloxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00821,Carprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00833,Cefaclor may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00861,Diflunisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00864,Tacrolimus may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00903,Etacrynic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00923,Ceforanide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00936,Salicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00939,Meclofenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00945,Acetylsalicylic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00958,Carboplatin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00991,Oxaprozin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00999,Hydrochlorothiazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01009,Ketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01014,Balsalazide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01050,Ibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01066,Cefditoren may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01072,Atazanavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01111,Colistimethate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01112,Cefuroxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01139,Cefapirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01140,Cefadroxil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01150,Cefprozil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01212,Ceftriaxone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01250,Olsalazine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01283,Lumiracoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01326,Cefamandole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01327,Cefazolin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01328,Cefonicid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01329,Cefoperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01330,Cefotetan may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01331,Cefoxitin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01332,Ceftizoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01333,Cefradine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01397,Magnesium salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01399,Salsalate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01413,Cefepime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01414,Cefacetrile may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01415,Ceftibuten may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01416,Cefpodoxime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01419,Antrafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01424,Aminophenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01435,Antipyrine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01600,Tiaprofenic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01601,Lopinavir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01628,Etoricoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB03450,Cephalothin Group may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB03585,Oxyphenbutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04552,Niflumic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04570,Latamoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04743,Nimesulide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04812,Benoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04817,Metamizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04828,Zomepirac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04918,Ceftobiprole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB05095,Cimicoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB06590,Ceftaroline fosamil may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB06725,Lornoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB06736,Aceclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB06737,Zaltoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB07402,Azapropazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB07477,Felbinac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08439,Parecoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08797,Salicylamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08940,Kebuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08942,Isoxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08951,Indoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08955,Ibuproxam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08976,Floctafenine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08981,Fenbufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08984,Etofenamate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08991,Epirizole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09008,Cefaloridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09062,Cefminox may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09084,Benzydamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09212,Loxoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09213,Dexibuprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09214,Dexketoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09215,Droxicam may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09216,Tolfenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09217,Firocoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09218,Clonixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09285,Morniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09288,Propacetamol may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09295,Talniflumate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB09299,Tenofovir alafenamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11367,Cefroxadine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11455,Robenacoxib may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11466,Tepoxalin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11518,Flunixin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11935,Flomoxef may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB12151,Brincidofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB12445,Nitroaspirin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB12545,Indobufen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13001,Tinoridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13167,Alclofenac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13217,Fentiazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13232,Suxibuzone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13266,Cefatrizine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13286,Bumadizone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13314,Alminoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13317,Flunoxaprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13364,Feprazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13371,Difenpiramide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13407,Nifenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13432,Lonazolac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13461,Cefcapene may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13470,Cefodizime may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13481,Tenidap may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13499,Cefsulodin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13501,Bendazac may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13504,Cefetamet may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13514,Pranoprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13524,Propyphenazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13527,Proglumetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13538,Guacetisal may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13544,Ethenzamide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13612,Carbaspirin calcium may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13629,Mofebutazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13638,Cefbuperazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13649,Proquazone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13657,Benorilate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13667,Cefozopran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13682,Cefpirome may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13722,Pirprofen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13778,Cefazedone may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13783,Acemetacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13821,Ceftezole may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13860,Imidazole salicylate may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13868,Adefovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB14059,SC-236 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB14060,NS-398 may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB14126,Tenofovir may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB14713,Inotersen may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01438,Phenazopyridine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB15066,Givosiran may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00007,Leuprolide may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00014,Goserelin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00035,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00080,Salmon calcitonin may decrease the excretion rate of Daptomycin which could result in a higher serum level.
DB00081,Salmon calcitonin may decrease the excretion rate of Tositumomab which could result in a higher serum level.
DB00115,Salmon calcitonin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.
DB00158,Salmon calcitonin may decrease the excretion rate of Folic acid which could result in a higher serum level.
DB00165,Salmon calcitonin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
DB00176,Salmon calcitonin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
DB00181,Salmon calcitonin may decrease the excretion rate of Baclofen which could result in a higher serum level.
DB00185,Salmon calcitonin may decrease the excretion rate of Cevimeline which could result in a higher serum level.
DB00186,Salmon calcitonin may decrease the excretion rate of Lorazepam which could result in a higher serum level.
DB00190,Salmon calcitonin may decrease the excretion rate of Carbidopa which could result in a higher serum level.
DB00193,Salmon calcitonin may decrease the excretion rate of Tramadol which could result in a higher serum level.
DB00196,Salmon calcitonin may decrease the excretion rate of Fluconazole which could result in a higher serum level.
DB00198,Salmon calcitonin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
DB00200,Salmon calcitonin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
DB00206,Salmon calcitonin may decrease the excretion rate of Reserpine which could result in a higher serum level.
DB00208,Salmon calcitonin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.
DB00213,Salmon calcitonin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
DB00225,Salmon calcitonin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
DB00230,Salmon calcitonin may decrease the excretion rate of Pregabalin which could result in a higher serum level.
DB00231,Salmon calcitonin may decrease the excretion rate of Temazepam which could result in a higher serum level.
DB00235,Salmon calcitonin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00237,Salmon calcitonin may decrease the excretion rate of Butabarbital which could result in a higher serum level.
DB00243,Salmon calcitonin may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245,Salmon calcitonin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254,Salmon calcitonin may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262,Salmon calcitonin may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00264,Salmon calcitonin may decrease the excretion rate of Metoprolol which could result in a higher serum level.
DB00270,Salmon calcitonin may decrease the excretion rate of Isradipine which could result in a higher serum level.
DB00271,Salmon calcitonin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00273,Salmon calcitonin may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00279,Salmon calcitonin may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00280,Salmon calcitonin may decrease the excretion rate of Disopyramide which could result in a higher serum level.
DB00284,Salmon calcitonin may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00285,Salmon calcitonin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
DB00286,Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289,Salmon calcitonin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00290,Salmon calcitonin may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00292,Salmon calcitonin may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294,Salmon calcitonin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296,Salmon calcitonin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303,Salmon calcitonin may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308,Salmon calcitonin may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00312,Salmon calcitonin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.
DB00316,Salmon calcitonin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
DB00319,Salmon calcitonin may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322,Salmon calcitonin may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00323,Salmon calcitonin may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00325,Salmon calcitonin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.
DB00327,Salmon calcitonin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
DB00330,Salmon calcitonin may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331,Salmon calcitonin may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00333,Salmon calcitonin may decrease the excretion rate of Methadone which could result in a higher serum level.
DB00339,Salmon calcitonin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341,Salmon calcitonin may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349,Salmon calcitonin may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351,Salmon calcitonin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355,Salmon calcitonin may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00356,Salmon calcitonin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
DB00359,Salmon calcitonin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00363,Salmon calcitonin may decrease the excretion rate of Clozapine which could result in a higher serum level.
DB00364,Salmon calcitonin may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00372,Salmon calcitonin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00373,Salmon calcitonin may decrease the excretion rate of Timolol which could result in a higher serum level.
DB00377,Salmon calcitonin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00380,Salmon calcitonin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00401,Salmon calcitonin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
DB00402,Salmon calcitonin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
DB00404,Salmon calcitonin may decrease the excretion rate of Alprazolam which could result in a higher serum level.
DB00412,Salmon calcitonin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
DB00413,Salmon calcitonin may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415,Salmon calcitonin may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00418,Salmon calcitonin may decrease the excretion rate of Secobarbital which could result in a higher serum level.
DB00422,Salmon calcitonin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00432,Salmon calcitonin may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435,Salmon calcitonin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437,Salmon calcitonin may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00440,Salmon calcitonin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441,Salmon calcitonin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00476,Salmon calcitonin may decrease the excretion rate of Duloxetine which could result in a higher serum level.
DB00477,Salmon calcitonin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
DB00480,Salmon calcitonin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00490,Salmon calcitonin may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00492,Salmon calcitonin may decrease the excretion rate of Fosinopril which could result in a higher serum level.
DB00499,Salmon calcitonin may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00501,Salmon calcitonin may decrease the excretion rate of Cimetidine which could result in a higher serum level.
DB00502,Salmon calcitonin may decrease the excretion rate of Haloperidol which could result in a higher serum level.
DB00535,Salmon calcitonin may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537,Salmon calcitonin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548,Salmon calcitonin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553,Salmon calcitonin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00555,Salmon calcitonin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
DB00558,Salmon calcitonin may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00569,Salmon calcitonin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
DB00571,Salmon calcitonin may decrease the excretion rate of Propranolol which could result in a higher serum level.
DB00583,Salmon calcitonin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00591,Salmon calcitonin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.
DB00597,Salmon calcitonin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00603,Salmon calcitonin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608,Salmon calcitonin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00612,Salmon calcitonin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
DB00624,Salmon calcitonin may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628,Salmon calcitonin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00631,Salmon calcitonin may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00633,Salmon calcitonin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00635,Salmon calcitonin may decrease the excretion rate of Prednisone which could result in a higher serum level.
DB00651,Salmon calcitonin may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00657,Salmon calcitonin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.
DB00660,Salmon calcitonin may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00661,Salmon calcitonin may decrease the excretion rate of Verapamil which could result in a higher serum level.
DB00665,Salmon calcitonin may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669,Salmon calcitonin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00683,Salmon calcitonin may decrease the excretion rate of Midazolam which could result in a higher serum level.
DB00688,Salmon calcitonin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00690,Salmon calcitonin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00692,Salmon calcitonin may decrease the excretion rate of Phentolamine which could result in a higher serum level.
DB00698,Salmon calcitonin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706,Salmon calcitonin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709,Salmon calcitonin may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713,Salmon calcitonin may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716,Salmon calcitonin may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00722,Salmon calcitonin may decrease the excretion rate of Lisinopril which could result in a higher serum level.
DB00730,Salmon calcitonin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731,Salmon calcitonin may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733,Salmon calcitonin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743,Salmon calcitonin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759,Salmon calcitonin may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760,Salmon calcitonin may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761,Salmon calcitonin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00763,Salmon calcitonin may decrease the excretion rate of Methimazole which could result in a higher serum level.
DB00775,Salmon calcitonin may decrease the excretion rate of Tirofiban which could result in a higher serum level.
DB00780,Salmon calcitonin may decrease the excretion rate of Phenelzine which could result in a higher serum level.
DB00782,Salmon calcitonin may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783,Salmon calcitonin may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00789,Salmon calcitonin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00790,Salmon calcitonin may decrease the excretion rate of Perindopril which could result in a higher serum level.
DB00800,Salmon calcitonin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.
DB00804,Salmon calcitonin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00806,Salmon calcitonin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
DB00811,Salmon calcitonin may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00820,Salmon calcitonin may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB00828,Salmon calcitonin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00842,Salmon calcitonin may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00851,Salmon calcitonin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853,Salmon calcitonin may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00863,Salmon calcitonin may decrease the excretion rate of Ranitidine which could result in a higher serum level.
DB00894,Salmon calcitonin may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00897,Salmon calcitonin may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB00900,Salmon calcitonin may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911,Salmon calcitonin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915,Salmon calcitonin may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918,Salmon calcitonin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00928,Salmon calcitonin may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00934,Salmon calcitonin may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951,Salmon calcitonin may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953,Salmon calcitonin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00960,Salmon calcitonin may decrease the excretion rate of Pindolol which could result in a higher serum level.
DB00961,Salmon calcitonin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962,Salmon calcitonin may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00968,Salmon calcitonin may decrease the excretion rate of Methyldopa which could result in a higher serum level.
DB00980,Salmon calcitonin may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00993,Salmon calcitonin may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995,Salmon calcitonin may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001,Salmon calcitonin may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002,Salmon calcitonin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004,Salmon calcitonin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010,Salmon calcitonin may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011,Salmon calcitonin may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01015,Salmon calcitonin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.
DB01018,Salmon calcitonin may decrease the excretion rate of Guanfacine which could result in a higher serum level.
DB01020,Salmon calcitonin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022,Salmon calcitonin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024,Salmon calcitonin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030,Salmon calcitonin may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01032,Salmon calcitonin may decrease the excretion rate of Probenecid which could result in a higher serum level.
DB01036,Salmon calcitonin may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01039,Salmon calcitonin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01043,Salmon calcitonin may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046,Salmon calcitonin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048,Salmon calcitonin may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060,Salmon calcitonin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01068,Salmon calcitonin may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01069,Salmon calcitonin may decrease the excretion rate of Promethazine which could result in a higher serum level.
DB01093,Salmon calcitonin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01099,Salmon calcitonin may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101,Salmon calcitonin may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01105,Salmon calcitonin may decrease the excretion rate of Sibutramine which could result in a higher serum level.
DB01115,Salmon calcitonin may decrease the excretion rate of Nifedipine which could result in a higher serum level.
DB01129,Salmon calcitonin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01135,Salmon calcitonin may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137,Salmon calcitonin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01148,Salmon calcitonin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01149,Salmon calcitonin may decrease the excretion rate of Nefazodone which could result in a higher serum level.
DB01156,Salmon calcitonin may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157,Salmon calcitonin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01166,Salmon calcitonin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
DB01169,Salmon calcitonin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
DB01170,Salmon calcitonin may decrease the excretion rate of Guanethidine which could result in a higher serum level.
DB01181,Salmon calcitonin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01183,Salmon calcitonin may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01203,Salmon calcitonin may decrease the excretion rate of Nadolol which could result in a higher serum level.
DB01205,Salmon calcitonin may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01213,Salmon calcitonin may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215,Salmon calcitonin may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221,Salmon calcitonin may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01222,Salmon calcitonin may decrease the excretion rate of Budesonide which could result in a higher serum level.
DB01224,Salmon calcitonin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
DB01240,Salmon calcitonin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.
DB01241,Salmon calcitonin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249,Salmon calcitonin may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01261,Salmon calcitonin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01267,Salmon calcitonin may decrease the excretion rate of Paliperidone which could result in a higher serum level.
DB01273,Salmon calcitonin may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274,Salmon calcitonin may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01275,Salmon calcitonin may decrease the excretion rate of Hydralazine which could result in a higher serum level.
DB01359,Salmon calcitonin may decrease the excretion rate of Penbutolol which could result in a higher serum level.
DB01367,Salmon calcitonin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
DB01394,Salmon calcitonin may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01409,Salmon calcitonin may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01420,Salmon calcitonin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427,Salmon calcitonin may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428,Salmon calcitonin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431,Salmon calcitonin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550,Salmon calcitonin may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558,Salmon calcitonin may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563,Salmon calcitonin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01587,Salmon calcitonin may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610,Salmon calcitonin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638,Salmon calcitonin may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01656,Salmon calcitonin may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685,Salmon calcitonin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574,Salmon calcitonin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871,Salmon calcitonin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895,Salmon calcitonin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04896,Salmon calcitonin may decrease the excretion rate of Milnacipran which could result in a higher serum level.
DB04920,Salmon calcitonin may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB04948,Salmon calcitonin may decrease the excretion rate of Lofexidine which could result in a higher serum level.
DB04953,Salmon calcitonin may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018,Salmon calcitonin may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541,Salmon calcitonin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB05676,Salmon calcitonin may decrease the excretion rate of Apremilast which could result in a higher serum level.
DB06154,Salmon calcitonin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186,Salmon calcitonin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196,Salmon calcitonin may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203,Salmon calcitonin may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06209,Salmon calcitonin may decrease the excretion rate of Prasugrel which could result in a higher serum level.
DB06211,Salmon calcitonin may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06228,Salmon calcitonin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
DB06230,Salmon calcitonin may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262,Salmon calcitonin may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282,Salmon calcitonin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06335,Salmon calcitonin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06402,Salmon calcitonin may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06480,Salmon calcitonin may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB06623,Salmon calcitonin may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637,Salmon calcitonin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06695,Salmon calcitonin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
DB06700,Salmon calcitonin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
DB06702,Salmon calcitonin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705,Salmon calcitonin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710,Salmon calcitonin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767,Salmon calcitonin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782,Salmon calcitonin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796,Salmon calcitonin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800,Salmon calcitonin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809,Salmon calcitonin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06813,Salmon calcitonin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
DB06823,Salmon calcitonin may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824,Salmon calcitonin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824,Salmon calcitonin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826,Salmon calcitonin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840,Salmon calcitonin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872,Salmon calcitonin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08893,Salmon calcitonin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08894,Salmon calcitonin may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08897,Salmon calcitonin may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899,Salmon calcitonin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900,Salmon calcitonin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08904,Salmon calcitonin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
DB08905,Salmon calcitonin may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08909,Salmon calcitonin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08910,Salmon calcitonin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
DB08911,Salmon calcitonin may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08918,Salmon calcitonin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
DB08932,Salmon calcitonin may decrease the excretion rate of Macitentan which could result in a higher serum level.
DB08934,Salmon calcitonin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB08964,Salmon calcitonin may decrease the excretion rate of Gemeprost which could result in a higher serum level.
DB09027,Salmon calcitonin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050,Salmon calcitonin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066,Salmon calcitonin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068,Salmon calcitonin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09071,Salmon calcitonin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
DB09075,Salmon calcitonin may decrease the excretion rate of Edoxaban which could result in a higher serum level.
DB09081,Salmon calcitonin may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09082,Salmon calcitonin may decrease the excretion rate of Vilanterol which could result in a higher serum level.
DB09089,Salmon calcitonin may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB09091,Salmon calcitonin may decrease the excretion rate of Tixocortol which could result in a higher serum level.
DB09103,Salmon calcitonin may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09104,Salmon calcitonin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09106,Salmon calcitonin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111,Salmon calcitonin may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118,Salmon calcitonin may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121,Salmon calcitonin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123,Salmon calcitonin may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129,Salmon calcitonin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132,Salmon calcitonin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133,Salmon calcitonin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134,Salmon calcitonin may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135,Salmon calcitonin may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136,Salmon calcitonin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148,Salmon calcitonin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149,Salmon calcitonin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156,Salmon calcitonin may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165,Salmon calcitonin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185,Salmon calcitonin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194,Salmon calcitonin may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195,Salmon calcitonin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09204,Salmon calcitonin may decrease the excretion rate of Arotinolol which could result in a higher serum level.
DB09205,Salmon calcitonin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209,Salmon calcitonin may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210,Salmon calcitonin may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219,Salmon calcitonin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09220,Salmon calcitonin may decrease the excretion rate of Nicorandil which could result in a higher serum level.
DB09223,Salmon calcitonin may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224,Salmon calcitonin may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09241,Salmon calcitonin may decrease the excretion rate of Methylene blue which could result in a higher serum level.
DB09244,Salmon calcitonin may decrease the excretion rate of Pirlindole which could result in a higher serum level.
DB09245,Salmon calcitonin may decrease the excretion rate of Toloxatone which could result in a higher serum level.
DB09255,Salmon calcitonin may decrease the excretion rate of Dextran which could result in a higher serum level.
DB09256,Salmon calcitonin may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257,Salmon calcitonin may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262,Salmon calcitonin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264,Salmon calcitonin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265,Salmon calcitonin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09268,Salmon calcitonin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276,Salmon calcitonin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277,Salmon calcitonin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09281,Salmon calcitonin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09292,Salmon calcitonin may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301,Salmon calcitonin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level."
DB09318,"Salmon calcitonin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level."
DB09320,Salmon calcitonin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324,Salmon calcitonin may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325,Salmon calcitonin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329,"Salmon calcitonin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level."
DB09344,Salmon calcitonin may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357,Salmon calcitonin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394,Salmon calcitonin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395,Salmon calcitonin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407,Salmon calcitonin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418,Salmon calcitonin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09472,Salmon calcitonin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09477,Salmon calcitonin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.
DB09481,Salmon calcitonin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB09488,Salmon calcitonin may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496,Salmon calcitonin may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502,Salmon calcitonin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546,Salmon calcitonin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570,Salmon calcitonin may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077,Salmon calcitonin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090,Salmon calcitonin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098,Salmon calcitonin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102,Salmon calcitonin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114,Salmon calcitonin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127,Salmon calcitonin may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11130,Salmon calcitonin may decrease the excretion rate of Opium which could result in a higher serum level.
DB11135,Salmon calcitonin may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136,Salmon calcitonin may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145,Salmon calcitonin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156,Salmon calcitonin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164,Salmon calcitonin may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251,Salmon calcitonin may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278,Salmon calcitonin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328,Salmon calcitonin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338,Salmon calcitonin may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358,Salmon calcitonin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364,Salmon calcitonin may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11560,Salmon calcitonin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577,Salmon calcitonin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587,Salmon calcitonin may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11598,Salmon calcitonin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
DB11642,Salmon calcitonin may decrease the excretion rate of Pitolisant which could result in a higher serum level.
DB11691,Salmon calcitonin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699,Salmon calcitonin may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11817,Salmon calcitonin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901,Salmon calcitonin may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915,Salmon calcitonin may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943,Salmon calcitonin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989,Salmon calcitonin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007,Salmon calcitonin may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107,Salmon calcitonin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12161,Salmon calcitonin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12278,Salmon calcitonin may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783,Salmon calcitonin may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025,Salmon calcitonin may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139,Salmon calcitonin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156,Salmon calcitonin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178,Salmon calcitonin may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185,Salmon calcitonin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191,Salmon calcitonin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269,Salmon calcitonin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293,Salmon calcitonin may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595,Salmon calcitonin may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873,Salmon calcitonin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884,Salmon calcitonin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909,Salmon calcitonin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943,Salmon calcitonin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944,Salmon calcitonin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13946,Salmon calcitonin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
DB13952,Salmon calcitonin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954,Salmon calcitonin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955,Salmon calcitonin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956,Salmon calcitonin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967,Salmon calcitonin may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14006,Salmon calcitonin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007,Salmon calcitonin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498,Salmon calcitonin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499,Salmon calcitonin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526,Salmon calcitonin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527,Salmon calcitonin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528,Salmon calcitonin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529,Salmon calcitonin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530,Salmon calcitonin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB14754,Salmon calcitonin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
DB06815,Salmon calcitonin may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121,Salmon calcitonin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB15593,Salmon calcitonin may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00318,Salmon calcitonin may decrease the excretion rate of Codeine which could result in a higher serum level.
DB00454,Salmon calcitonin may decrease the excretion rate of Meperidine which could result in a higher serum level.
DB00813,Salmon calcitonin may decrease the excretion rate of Fentanyl which could result in a higher serum level.
DB00879,Salmon calcitonin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB00452,Framycetin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00479,Amikacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00684,Tobramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00798,Gentamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00955,Netilmicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00994,Neomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01082,Streptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01172,Kanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB01421,Paromomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB03615,Ribostamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04263,Geneticin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04626,Apramycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04729,Gentamicin C1a may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB04808,Neamine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB06696,Arbekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB08437,Puromycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11512,Dihydrostreptomycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB11520,Hygromycin B may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB12604,Sisomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13270,Dibekacin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13274,Micronomicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13540,Isepamicin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB13673,Bekanamycin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
DB00552,Salmon calcitonin may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145,Salmon calcitonin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00314,Salmon calcitonin may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00390,Salmon calcitonin may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB00512,Salmon calcitonin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00515,Salmon calcitonin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
DB00564,Salmon calcitonin may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
DB00642,Salmon calcitonin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB00682,Salmon calcitonin may decrease the excretion rate of Warfarin which could result in a higher serum level.
DB00908,Salmon calcitonin may decrease the excretion rate of Quinidine which could result in a higher serum level.
DB00982,Salmon calcitonin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB01035,Salmon calcitonin may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615,Salmon calcitonin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB00524,Salmon calcitonin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00695,Salmon calcitonin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00808,Salmon calcitonin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00887,Salmon calcitonin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB00909,Salmon calcitonin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08907,Salmon calcitonin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB09338,Salmon calcitonin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB00214,Torasemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00232,Methyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00310,Chlorthalidone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00311,Ethoxzolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00421,Spironolactone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00436,Bendroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00562,Benzthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00594,Amiloride may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00606,Cyclothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00700,Eplerenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00703,Methazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00774,Hydroflumethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00819,Acetazolamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00872,Conivaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00880,Chlorothiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01021,Trichlormethiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01119,Diazoxide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01144,Diclofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01324,Polythiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01325,Quinethazone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01395,Drospirenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB01412,Theobromine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB02925,Piretanide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB04831,Tienilic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB05034,Ularitide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB06212,Tolvaptan may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB06292,Dapagliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB06370,Indisulam may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB08961,Azosemide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB09015,Canrenoic acid may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB09125,Potassium citrate may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB09235,Efonidipine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB09401,Isosorbide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB11827,Ertugliflozin may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB12221,Canrenone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB12670,Rolofylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB12704,Spiradoline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB12766,Cicletanine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13284,Meticrane may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13316,Ibopamine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13405,Mefruside may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13430,Mebutizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13532,Cyclopenthiazide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13617,Clorexolone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13663,Clofenamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13708,Fenquizone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13792,Clopamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13801,Muzolimine may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13803,Xipamide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB13989,Epitizide may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB14018,Bromotheophylline may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB14500,Potassium may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy.
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Salmon calcitonin.
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Salmon calcitonin.
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Salmon calcitonin.
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Salmon calcitonin.
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Salmon calcitonin.
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Salmon calcitonin.
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Salmon calcitonin.
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Salmon calcitonin.
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Salmon calcitonin.
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Salmon calcitonin.
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Salmon calcitonin.
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Salmon calcitonin.
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Salmon calcitonin.
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Salmon calcitonin.
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Salmon calcitonin.
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Salmon calcitonin.
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Salmon calcitonin.
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Salmon calcitonin.
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Salmon calcitonin.
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Salmon calcitonin.
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Salmon calcitonin.
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Salmon calcitonin.
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Salmon calcitonin.
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Salmon calcitonin.
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Salmon calcitonin."
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Salmon calcitonin."
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Salmon calcitonin.
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Salmon calcitonin.
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Salmon calcitonin.
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Salmon calcitonin.
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Salmon calcitonin.
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Salmon calcitonin.
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Salmon calcitonin.
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Salmon calcitonin.
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Salmon calcitonin.
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Salmon calcitonin.
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Salmon calcitonin.
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Salmon calcitonin.
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Salmon calcitonin.
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Salmon calcitonin.
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Salmon calcitonin.
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Salmon calcitonin.
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Salmon calcitonin.
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Salmon calcitonin.
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Salmon calcitonin.
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Salmon calcitonin.
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Salmon calcitonin.
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Salmon calcitonin."
DB00182,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Amphetamine.
DB00598,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Labetalol.
DB00841,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dobutamine.
DB00871,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Terbutaline.
DB00988,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Dopamine.
DB01577,The risk or severity of adverse effects can be increased when Salmon calcitonin is combined with Metamfetamine.
DB01193,The risk or severity of adverse effects can be increased when Acebutolol is combined with Salmon calcitonin.
DB04846,The risk or severity of adverse effects can be increased when Celiprolol is combined with Salmon calcitonin.
DB12752,The risk or severity of adverse effects can be increased when Bucindolol is combined with Salmon calcitonin.
DB13757,The risk or severity of adverse effects can be increased when Epanolol is combined with Salmon calcitonin.
DB00317,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gefitinib.
DB00530,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erlotinib.
DB00619,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Imatinib.
DB01254,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dasatinib.
DB01259,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lapatinib.
DB01268,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Sunitinib.
DB01645,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Genistein.
DB02058,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.
DB02424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Geldanamycin.
DB02567,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with PD173955.
DB03758,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radicicol.
DB04849,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cediranib.
DB04868,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nilotinib.
DB04879,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vatalanib.
DB05294,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vandetanib.
DB05424,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Canertinib.
DB05465,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tandutinib.
DB05575,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Motesanib.
DB05928,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dovitinib.
DB06302,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Glesatinib.
DB06469,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lestaurtinib.
DB06589,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pazopanib.
DB06595,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Midostaurin.
DB06616,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Bosutinib.
DB06626,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Axitinib.
DB08399,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Piceatannol.
DB08865,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crizotinib.
DB08875,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Cabozantinib.
DB08881,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Vemurafenib.
DB08896,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Regorafenib.
DB08901,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ponatinib.
DB08916,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Afatinib.
DB09053,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ibrutinib.
DB09063,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ceritinib.
DB09078,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lenvatinib.
DB09079,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Nintedanib.
DB09330,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Osimertinib.
DB11363,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Alectinib.
DB11689,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selumetinib.
DB11697,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pacritinib.
DB11703,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Acalabrutinib.
DB11737,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Icotinib.
DB11805,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Saracatinib.
DB11828,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Neratinib.
DB11832,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Crenolanib.
DB11904,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Flumatinib.
DB11963,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Dacomitinib.
DB11973,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tesevatinib.
DB11986,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Entrectinib.
DB12010,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fostamatinib.
DB12048,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Savolitinib.
DB12141,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Gilteritinib.
DB12147,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erdafitinib.
DB12267,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Brigatinib.
DB12307,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Foretinib.
DB12323,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Radotinib.
DB14723,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Larotrectinib.
DB00398,The therapeutic efficacy of Sorafenib can be decreased when used in combination with Salmon calcitonin.
DB08877,The therapeutic efficacy of Ruxolitinib can be decreased when used in combination with Salmon calcitonin.
DB12978,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Pexidartinib.
DB12500,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Fedratinib.
DB11652,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Tucatinib.
DB11791,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Capmatinib.
DB15685,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Selpercatinib.
DB05258,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Interferon alfa.
DB00041,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.
DB00227,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Lovastatin.
DB00609,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Ethionamide.
DB00850,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine.
DB14651,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Perphenazine enanthate.
DB00829,The therapeutic efficacy of Diazepam can be decreased when used in combination with Salmon calcitonin.
DB01233,The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Salmon calcitonin.
DB00233,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aminosalicylic acid.
DB11085,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Resorcinol.
DB00672,The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Salmon calcitonin.
DB00839,The therapeutic efficacy of Tolazamide can be decreased when used in combination with Salmon calcitonin.
DB01067,The therapeutic efficacy of Glipizide can be decreased when used in combination with Salmon calcitonin.
DB01124,The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Salmon calcitonin.
DB00222,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Salmon calcitonin.
DB00414,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Salmon calcitonin.
DB01016,The therapeutic efficacy of Glyburide can be decreased when used in combination with Salmon calcitonin.
DB01120,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Salmon calcitonin.
DB01251,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Salmon calcitonin.
DB01289,The therapeutic efficacy of Glisoxepide can be decreased when used in combination with Salmon calcitonin.
DB08962,The therapeutic efficacy of Glibornuride can be decreased when used in combination with Salmon calcitonin.
DB13406,The therapeutic efficacy of Carbutamide can be decreased when used in combination with Salmon calcitonin.
DB13675,The therapeutic efficacy of Metahexamide can be decreased when used in combination with Salmon calcitonin.
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Desipramine.
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Clomipramine.
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dimetacrine.
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Nortriptyline.
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptyline.
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Protriptyline.
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine.
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amoxapine.
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Trimipramine.
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Doxepin.
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amineptine.
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Butriptyline.
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dosulepin.
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Tianeptine.
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Oxaprotiline.
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Opipramol.
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Amitriptylinoxide.
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Dibenzepin.
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Quinupramine.
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Melitracen.
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Lofepramine.
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Iprindole.
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Salmon calcitonin is combined with Imipramine oxide.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-n3.
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-n3.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-n3.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-n3.
DB00022,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.
DB00026,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.
DB00033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant."
DB00051,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.
DB00056,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pegaspargase.
DB00065,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Infliximab.
DB00068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon beta-1b.
DB00069,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfacon-1.
DB00073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antithymocyte immunoglobulin (rabbit).
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2b.
DB00111,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Phenylalanine.
DB00180,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flunisolide.
DB00188,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bortezomib.
DB00242,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cladribine.
DB00262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carmustine.
DB00276,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitomycin.
DB00307,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bexarotene.
DB00309,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vindesine.
DB00322,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Floxuridine.
DB00328,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Indomethacin.
DB00352,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tioguanine.
DB00361,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinorelbine.
DB00380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexrazoxane.
DB00394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Beclomethasone dipropionate.
DB00398,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sorafenib.
DB00428,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gemcitabine.
DB00443,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Betamethasone.
DB00444,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teniposide.
DB00445,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Altretamine.
DB00495,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Zidovudine.
DB00515,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Oxaliplatin.
DB00531,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cyclophosphamide.
DB00541,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vincristine.
DB00544,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluorouracil.
DB00550,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Propylthiouracil.
DB00552,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pentostatin.
DB00563,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methotrexate.
DB00564,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carbamazepine.
DB00570,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vinblastine.
DB00588,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone propionate.
DB00591,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocinolone acetonide.
DB00601,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Linezolid.
DB00619,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Imatinib.
DB00620,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triamcinolone.
DB00631,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clofarabine.
DB00635,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisone.
DB00642,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pemetrexed.
DB00687,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludrocortisone.
DB00688,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolate mofetil.
DB00694,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Daunorubicin.
DB00755,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tretinoin.
DB00762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Irinotecan.
DB00763,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methimazole.
DB00764,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone.
DB00773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Etoposide.
DB00795,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sulfasalazine.
DB00851,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dacarbazine.
DB00853,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Penicillamine.
DB00860,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednisolone.
DB00877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirolimus.
DB00888,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carboplatin.
DB00959,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Methylprednisolone.
DB00970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dactinomycin.
DB00987,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cytarabine.
DB00993,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Azathioprine.
DB00997,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxorubicin.
DB01005,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxyurea.
DB01008,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Busulfan.
DB01024,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Topotecan.
DB01033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mercaptopurine.
DB01041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thalidomide.
DB01042,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Flucytosine.
DB01101,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Capecitabine.
DB01108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trilostane.
DB01168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Arsenic trioxide.
DB01177,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idarubicin.
DB01181,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ifosfamide.
DB01196,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Estramustine.
DB01204,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Lomustine.
DB01222,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Budesonide.
DB01229,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paclitaxel.
DB01234,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone.
DB01248,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Docetaxel.
DB01254,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dasatinib.
DB01257,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Decitabine.
DB01268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sunitinib.
DB01280,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nelarabine.
DB01281,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abatacept.
DB01285,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Corticotropin.
DB01380,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortisone acetate.
DB01384,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Paramethasone.
DB01394,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Colchicine.
DB01410,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ciclesonide.
DB01423,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Stepronin.
DB01590,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Everolimus.
DB01611,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydroxychloroquine.
DB01816,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brequinar.
DB04572,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Thiotepa.
DB04630,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldosterone.
DB04845,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixabepilone.
DB04868,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Nilotinib.
DB04951,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirfenidone.
DB04956,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Afelimomab.
DB05015,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belinostat.
DB05109,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trabectedin.
DB05258,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with omega interferon.
DB05676,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Apremilast.
DB05773,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trastuzumab emtansine.
DB06168,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Canakinumab.
DB06273,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tocilizumab.
DB06287,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Temsirolimus.
DB06372,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rilonacept.
DB06589,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pazopanib.
DB06603,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Panobinostat.
DB06612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mepolizumab.
DB06616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bosutinib.
DB06662,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Abetimus.
DB06674,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Golimumab.
DB06681,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belatacept.
DB06769,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bendamustine.
DB06772,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cabazitaxel.
DB06813,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Wortmannin.
DB08870,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brentuximab vedotin.
DB08871,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Eribulin.
DB08877,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ruxolitinib.
DB08879,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Carfilzomib.
DB08901,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ponatinib.
DB08904,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Certolizumab pegol.
DB08906,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone furoate.
DB08908,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dimethyl fumarate.
DB08910,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pomalidomide.
DB08935,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Obinutuzumab.
DB08970,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednidene.
DB08971,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortolone.
DB09029,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vedolizumab.
DB09036,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Blinatumomab.
DB09053,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ibrutinib.
DB09054,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Idelalisib.
DB09073,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Palbociclib.
DB09074,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Olaparib.
DB09077,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dinutuximab.
DB09082,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Vilanterol.
DB09091,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Antilymphocyte immunoglobulin (horse).
DB09378,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluprednisolone.
DB09383,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Meprednisone.
DB11466,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tepoxalin.
DB11487,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Dexamethasone isonicotinate.
DB11529,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Melengestrol.
DB11569,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peficitinib.
DB11750,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Clobetasol.
DB11767,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Sirukumab.
DB11817,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Baricitinib.
DB11834,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Guselkumab.
DB11921,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deflazacort.
DB11988,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ocrelizumab.
DB12025,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Triptolide.
DB12371,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Siponimod.
DB12612,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Acteoside.
DB13003,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cortivazol.
DB13014,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13208,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Prednylidene.
DB13223,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Formocortal.
DB13728,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Halometasone.
DB13843,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Cloprednol.
DB13856,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluclorolone.
DB13867,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Fluticasone.
DB14066,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Tetrandrine.
DB14219,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Monomethyl fumarate.
DB14512,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Mometasone furoate.
DB14538,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone aceponate.
DB14539,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone acetate.
DB14545,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Hydrocortisone succinate.
DB14724,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Bleselumab.
DB00108,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-n3.
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon alfa-n3.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-n3.
DB00041,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.
DB00363,The risk or severity of neutropenia can be increased when Interferon alfa-n3 is combined with Clozapine.
DB00333,The serum concentration of Methadone can be increased when it is combined with Interferon alfa-n3.
DB00811,The risk or severity of anemia can be increased when Interferon alfa-n3 is combined with Ribavirin.
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-n3.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-n3.
DB01265,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Telbivudine.
DB01097,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Leflunomide.
DB08895,Interferon alfa-n3 may increase the immunosuppressive activities of Tofacitinib.
DB00072,Trastuzumab may increase the neutropenic activities of Interferon alfa-n3.
DB08868,Interferon alfa-n3 may increase the immunosuppressive activities of Fingolimod.
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon alfa-n3.
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon alfa-n3.
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon alfa-n3.
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-n3.
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-n3.
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon alfa-n3.
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon alfa-n3.
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-n3.
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-n3."
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon alfa-n3.
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-n3.
DB02377,The metabolism of Guanine can be decreased when combined with Interferon alfa-n3.
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-n3.
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon alfa-n3.
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-n3.
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-n3.
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon alfa-n3.
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-n3.
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-n3.
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon alfa-n3.
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon alfa-n3.
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-n3.
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon alfa-n3.
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon alfa-n3.
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon alfa-n3.
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-n3.
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon alfa-n3.
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-n3.
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon alfa-n3.
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-n3.
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon alfa-n3.
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon alfa-n3.
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-n3.
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon alfa-n3.
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-n3.
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon alfa-n3.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-n3.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-n3.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-n3.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-n3.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-n3.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-n3.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-n3.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-n3.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-n3.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-n3."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-n3.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-n3."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-n3.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-n3.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-n3.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-n3.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-n3.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-n3.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-n3.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-n3.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-n3.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-n3.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-n3.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-n3.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-n3.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-n3."
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-n3.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-n3.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-n3.
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-n3.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-n3.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-n3.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-n3.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-n3.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-n3.
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-n3.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-n3.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-n3.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-n3.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-n3.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-n3.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-n3.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-n3.
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-n3.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-n3.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-n3.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-n3.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-n3.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-n3.
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-n3.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-n3.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-n3.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-n3.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-n3.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-n3.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-n3.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-n3.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-n3.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-n3.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-n3.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-n3.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-n3.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-n3.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-n3.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-n3.
DB13200,Interferon alfa-n3 may increase the myelosuppressive activities of Lipegfilgrastim.
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-n3.
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-n3.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-n3.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-n3.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-n3.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-n3.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-n3.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-n3.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-n3.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-n3.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-n3.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-n3.
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-n3.
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon alfa-n3.
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon alfa-n3.
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon alfa-n3.
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon alfa-n3.
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon alfa-n3.
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-n3.
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-n3.
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-n3.
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon alfa-n3.
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-n3.
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-n3.
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-n3.
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon alfa-n3.
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon alfa-n3.
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon alfa-n3.
DB00420,The metabolism of Promazine can be decreased when combined with Interferon alfa-n3.
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon alfa-n3.
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon alfa-n3.
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon alfa-n3.
DB00468,The metabolism of Quinine can be decreased when combined with Interferon alfa-n3.
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-n3.
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon alfa-n3.
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-n3.
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon alfa-n3.
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon alfa-n3.
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon alfa-n3.
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-n3.
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-n3.
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon alfa-n3.
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon alfa-n3.
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon alfa-n3.
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon alfa-n3.
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon alfa-n3.
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-n3.
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon alfa-n3.
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon alfa-n3.
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-n3.
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon alfa-n3.
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon alfa-n3.
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon alfa-n3.
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-n3.
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon alfa-n3.
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon alfa-n3.
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon alfa-n3.
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon alfa-n3.
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon alfa-n3.
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon alfa-n3.
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-n3.
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon alfa-n3.
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-n3.
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-n3.
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-n3.
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon alfa-n3.
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon alfa-n3.
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon alfa-n3.
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon alfa-n3.
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon alfa-n3.
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon alfa-n3.
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon alfa-n3.
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon alfa-n3.
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon alfa-n3.
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon alfa-n3.
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon alfa-n3.
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-n3.
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon alfa-n3.
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-n3.
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-n3.
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon alfa-n3.
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon alfa-n3.
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon alfa-n3.
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-n3.
DB01645,The metabolism of Genistein can be decreased when combined with Interferon alfa-n3.
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon alfa-n3.
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon alfa-n3.
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-n3.
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon alfa-n3.
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-n3.
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon alfa-n3.
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon alfa-n3.
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-n3.
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon alfa-n3.
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon alfa-n3.
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-n3.
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon alfa-n3.
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon alfa-n3.
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-n3.
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon alfa-n3.
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-n3.
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon alfa-n3.
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-n3.
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon alfa-n3.
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon alfa-n3.
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon alfa-n3.
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon alfa-n3.
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon alfa-n3.
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-n3.
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-n3.
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon alfa-n3.
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-n3.
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-n3.
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-n3.
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-n3.
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-n3.
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-n3.
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon alfa-n3.
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon alfa-n3.
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon alfa-n3.
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-n3.
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon alfa-n3.
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon alfa-n3.
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon alfa-n3.
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-n3.
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-n3.
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon alfa-n3.
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon alfa-n3.
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-n3.
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-n3.
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon alfa-n3.
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-n3.
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon alfa-n3.
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon alfa-n3.
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon alfa-n3.
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon alfa-n3.
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon alfa-n3.
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon alfa-n3.
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon alfa-n3.
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon alfa-n3.
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-n3.
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon alfa-n3.
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon alfa-n3.
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon alfa-n3.
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-n3.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-n3.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-n3.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-n3.
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-n3.
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-n3.
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-n3.
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-n3.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-n3.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-n3.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-n3.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-n3.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-n3.
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-n3.
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-n3.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-n3.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-n3.
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-n3.
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-n3.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-n3.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-n3.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-n3.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-n3.
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-n3.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-n3.
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-n3.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-n3.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-n3.
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-n3.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-n3.
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-n3.
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-n3.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-n3.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-n3.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-n3.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-n3.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-n3.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-n3.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-n3.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-n3.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-n3.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-n3.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-n3.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-n3.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-n3.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-n3.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-n3.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-n3.
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-n3.
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-n3.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-n3.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-n3.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-n3.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-n3.
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-n3.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-n3.
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-n3.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-n3.
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-n3.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-n3.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-n3.
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-n3.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-n3.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-n3.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-n3.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-n3.
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-n3.
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-n3.
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-n3.
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-n3.
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-n3.
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-n3.
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-n3.
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-n3.
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-n3.
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-n3.
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-n3.
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-n3.
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-n3.
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-n3.
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-n3.
DB09042,The risk or severity of myelosuppression can be increased when Interferon alfa-n3 is combined with Tedizolid phosphate.
DB00091,Interferon alfa-n3 may increase the immunosuppressive activities of Cyclosporine.
DB00268,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Ropinirole.
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-n3.
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-n3.
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-n3.
DB01601,The serum concentration of Interferon alfa-n3 can be increased when it is combined with Lopinavir.
DB12530,The risk or severity of infection can be increased when Interferon alfa-n3 is combined with Inebilizumab.
DB00531,The risk or severity of pulmonary toxicity can be increased when Pegfilgrastim is combined with Cyclophosphamide.
DB01030,The risk or severity of neutropenia can be increased when Pegfilgrastim is combined with Topotecan.
DB00008,The therapeutic efficacy of Pegfilgrastim can be decreased when used in combination with Peginterferon alfa-2a.
DB00022,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.
DB00059,The therapeutic efficacy of Pegaspargase can be decreased when used in combination with Pegfilgrastim.
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Pegfilgrastim.
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Pegfilgrastim.
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Pegfilgrastim.
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Pegfilgrastim.
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Pegfilgrastim.
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Pegfilgrastim.
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Pegfilgrastim.
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Pegfilgrastim.
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Pegfilgrastim.
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Pegfilgrastim.
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Pegfilgrastim.
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Pegfilgrastim.
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Pegfilgrastim.
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Pegfilgrastim.
DB08904,The therapeutic efficacy of Certolizumab pegol can be decreased when used in combination with Pegfilgrastim.
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Pegfilgrastim.
DB09122,The therapeutic efficacy of Peginterferon beta-1a can be decreased when used in combination with Pegfilgrastim.
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Pegfilgrastim.
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Pegfilgrastim.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Pegfilgrastim."
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Pegfilgrastim.
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Pegfilgrastim.
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Pegfilgrastim.
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Pegfilgrastim.
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Pegfilgrastim.
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Pegfilgrastim.
DB12814,The therapeutic efficacy of Cepeginterferon alfa-2B can be decreased when used in combination with Pegfilgrastim.
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Pegfilgrastim.
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Pegfilgrastim.
DB13200,The therapeutic efficacy of Lipegfilgrastim can be decreased when used in combination with Pegfilgrastim.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Pegfilgrastim.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Pegfilgrastim.
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Pegfilgrastim.
DB00309,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vindesine.
DB00361,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinorelbine.
DB00541,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincristine.
DB00570,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinblastine.
DB05168,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vintafolide.
DB11641,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vinflunine.
DB13374,The risk or severity of peripheral neuropathy can be increased when Pegfilgrastim is combined with Vincamine.
DB00290,The risk or severity of adverse effects can be increased when Sargramostim is combined with Bleomycin.
DB00531,The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Sargramostim.
DB00309,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vindesine.
DB00361,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinorelbine.
DB00541,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincristine.
DB00570,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinblastine.
DB05168,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vintafolide.
DB11641,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vinflunine.
DB13374,The risk or severity of peripheral neuropathy can be increased when Sargramostim is combined with Vincamine.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Peginterferon alfa-2b.
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Peginterferon alfa-2b.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Peginterferon alfa-2b.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Peginterferon alfa-2b.
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Peginterferon alfa-2b.
DB00026,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.
DB00033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.
DB00034,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant."
DB00051,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.
DB00056,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pegaspargase.
DB00065,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Infliximab.
DB00068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon beta-1b.
DB00069,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfacon-1.
DB00073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antithymocyte immunoglobulin (rabbit).
DB00105,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2b.
DB00111,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Phenylalanine.
DB00180,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flunisolide.
DB00242,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cladribine.
DB00276,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitomycin.
DB00307,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bexarotene.
DB00309,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vindesine.
DB00322,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Floxuridine.
DB00328,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Indomethacin.
DB00352,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tioguanine.
DB00361,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinorelbine.
DB00380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexrazoxane.
DB00394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Beclomethasone dipropionate.
DB00428,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gemcitabine.
DB00443,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Betamethasone.
DB00444,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teniposide.
DB00445,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Altretamine.
DB00515,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Oxaliplatin.
DB00531,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cyclophosphamide.
DB00541,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vincristine.
DB00550,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Propylthiouracil.
DB00552,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pentostatin.
DB00563,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methotrexate.
DB00570,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vinblastine.
DB00588,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone propionate.
DB00591,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocinolone acetonide.
DB00601,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Linezolid.
DB00620,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triamcinolone.
DB00631,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clofarabine.
DB00635,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisone.
DB00687,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludrocortisone.
DB00688,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolate mofetil.
DB00694,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Daunorubicin.
DB00755,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tretinoin.
DB00762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Irinotecan.
DB00763,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methimazole.
DB00764,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone.
DB00795,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sulfasalazine.
DB00853,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Penicillamine.
DB00860,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednisolone.
DB00877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirolimus.
DB00888,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carboplatin.
DB00959,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Methylprednisolone.
DB00970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dactinomycin.
DB00987,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cytarabine.
DB00997,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxorubicin.
DB01005,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxyurea.
DB01008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Busulfan.
DB01024,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Topotecan.
DB01033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mercaptopurine.
DB01041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thalidomide.
DB01042,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Flucytosine.
DB01108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trilostane.
DB01168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Arsenic trioxide.
DB01177,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idarubicin.
DB01181,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ifosfamide.
DB01196,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Estramustine.
DB01204,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Lomustine.
DB01222,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Budesonide.
DB01229,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paclitaxel.
DB01234,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone.
DB01248,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Docetaxel.
DB01257,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Decitabine.
DB01268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sunitinib.
DB01280,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nelarabine.
DB01281,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abatacept.
DB01285,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Corticotropin.
DB01380,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortisone acetate.
DB01384,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Paramethasone.
DB01394,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Colchicine.
DB01410,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ciclesonide.
DB01423,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Stepronin.
DB01590,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Everolimus.
DB01611,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydroxychloroquine.
DB01816,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brequinar.
DB04572,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Thiotepa.
DB04630,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldosterone.
DB04845,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixabepilone.
DB04868,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Nilotinib.
DB04956,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Afelimomab.
DB05258,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with omega interferon.
DB05773,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trastuzumab emtansine.
DB06168,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Canakinumab.
DB06273,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tocilizumab.
DB06287,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Temsirolimus.
DB06372,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rilonacept.
DB06603,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Panobinostat.
DB06612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mepolizumab.
DB06616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bosutinib.
DB06662,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Abetimus.
DB06674,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Golimumab.
DB06681,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belatacept.
DB06772,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cabazitaxel.
DB06813,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Wortmannin.
DB08870,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brentuximab vedotin.
DB08871,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Eribulin.
DB08877,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ruxolitinib.
DB08879,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Carfilzomib.
DB08901,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ponatinib.
DB08904,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Certolizumab pegol.
DB08906,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone furoate.
DB08908,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dimethyl fumarate.
DB08935,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Obinutuzumab.
DB08970,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednidene.
DB08971,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortolone.
DB09029,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vedolizumab.
DB09036,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Blinatumomab.
DB09053,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ibrutinib.
DB09054,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Idelalisib.
DB09073,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Palbociclib.
DB09074,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Olaparib.
DB09077,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dinutuximab.
DB09082,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Vilanterol.
DB09091,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Antilymphocyte immunoglobulin (horse).
DB09378,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluprednisolone.
DB09383,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Meprednisone.
DB11466,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tepoxalin.
DB11487,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Dexamethasone isonicotinate.
DB11529,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Melengestrol.
DB11569,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Peficitinib.
DB11750,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Clobetasol.
DB11767,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Sirukumab.
DB11817,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Baricitinib.
DB11834,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Guselkumab.
DB11921,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deflazacort.
DB11988,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ocrelizumab.
DB12025,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Triptolide.
DB12612,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Acteoside.
DB13003,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cortivazol.
DB13014,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13208,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Prednylidene.
DB13223,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Formocortal.
DB13728,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Halometasone.
DB13843,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Cloprednol.
DB13856,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluclorolone.
DB13867,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Fluticasone.
DB14066,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Tetrandrine.
DB14219,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Monomethyl fumarate.
DB14512,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Mometasone furoate.
DB14538,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone aceponate.
DB14539,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone acetate.
DB14545,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Hydrocortisone succinate.
DB14724,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Bleselumab.
DB12371,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Siponimod.
DB00108,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa-2b.
DB01656,Roflumilast may increase the immunosuppressive activities of Peginterferon alfa-2b.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Peginterferon alfa-2b.
DB00041,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.
DB00363,The risk or severity of neutropenia can be increased when Peginterferon alfa-2b is combined with Clozapine.
DB00333,The serum concentration of Methadone can be increased when it is combined with Peginterferon alfa-2b.
DB00495,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Zidovudine.
DB00472,The serum concentration of Fluoxetine can be decreased when it is combined with Peginterferon alfa-2b.
DB01265,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Telbivudine.
DB00675,The serum concentration of Tamoxifen can be increased when it is combined with Peginterferon alfa-2b.
DB00972,The serum concentration of Azelastine can be increased when it is combined with Peginterferon alfa-2b.
DB00176,The serum concentration of Fluvoxamine can be increased when it is combined with Peginterferon alfa-2b.
DB00184,The serum concentration of Nicotine can be increased when it is combined with Peginterferon alfa-2b.
DB00188,The serum concentration of Bortezomib can be increased when it is combined with Peginterferon alfa-2b.
DB00195,The serum concentration of Betaxolol can be increased when it is combined with Peginterferon alfa-2b.
DB00201,The serum concentration of Caffeine can be increased when it is combined with Peginterferon alfa-2b.
DB00261,The serum concentration of Anagrelide can be increased when it is combined with Peginterferon alfa-2b.
DB00262,The serum concentration of Carmustine can be increased when it is combined with Peginterferon alfa-2b.
DB00277,The serum concentration of Theophylline can be increased when it is combined with Peginterferon alfa-2b.
DB00280,The serum concentration of Disopyramide can be increased when it is combined with Peginterferon alfa-2b.
DB00281,The serum concentration of Lidocaine can be increased when it is combined with Peginterferon alfa-2b.
DB00286,The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.
DB00296,The serum concentration of Ropivacaine can be increased when it is combined with Peginterferon alfa-2b.
DB00316,The serum concentration of Acetaminophen can be increased when it is combined with Peginterferon alfa-2b.
DB00334,The serum concentration of Olanzapine can be increased when it is combined with Peginterferon alfa-2b.
DB00356,The serum concentration of Chlorzoxazone can be increased when it is combined with Peginterferon alfa-2b.
DB00365,The serum concentration of Grepafloxacin can be increased when it is combined with Peginterferon alfa-2b.
DB00370,The serum concentration of Mirtazapine can be increased when it is combined with Peginterferon alfa-2b.
DB00379,The serum concentration of Mexiletine can be increased when it is combined with Peginterferon alfa-2b.
DB00382,The serum concentration of Tacrine can be increased when it is combined with Peginterferon alfa-2b.
DB00384,The serum concentration of Triamterene can be increased when it is combined with Peginterferon alfa-2b.
DB00398,The serum concentration of Sorafenib can be increased when it is combined with Peginterferon alfa-2b.
DB00420,The serum concentration of Promazine can be increased when it is combined with Peginterferon alfa-2b.
DB00425,The serum concentration of Zolpidem can be increased when it is combined with Peginterferon alfa-2b.
DB00442,The serum concentration of Entecavir can be increased when it is combined with Peginterferon alfa-2b.
DB00458,The serum concentration of Imipramine can be increased when it is combined with Peginterferon alfa-2b.
DB00461,The serum concentration of Nabumetone can be increased when it is combined with Peginterferon alfa-2b.
DB00468,The serum concentration of Quinine can be increased when it is combined with Peginterferon alfa-2b.
DB00476,The serum concentration of Duloxetine can be increased when it is combined with Peginterferon alfa-2b.
DB00477,The serum concentration of Chlorpromazine can be increased when it is combined with Peginterferon alfa-2b.
DB00499,The serum concentration of Flutamide can be increased when it is combined with Peginterferon alfa-2b.
DB00518,The serum concentration of Albendazole can be increased when it is combined with Peginterferon alfa-2b.
DB00530,The serum concentration of Erlotinib can be increased when it is combined with Peginterferon alfa-2b.
DB00532,The serum concentration of Mephenytoin can be increased when it is combined with Peginterferon alfa-2b.
DB00533,The serum concentration of Rofecoxib can be increased when it is combined with Peginterferon alfa-2b.
DB00540,The serum concentration of Nortriptyline can be increased when it is combined with Peginterferon alfa-2b.
DB00544,The serum concentration of Fluorouracil can be increased when it is combined with Peginterferon alfa-2b.
DB00564,The serum concentration of Carbamazepine can be increased when it is combined with Peginterferon alfa-2b.
DB00568,The serum concentration of Cinnarizine can be increased when it is combined with Peginterferon alfa-2b.
DB00571,The serum concentration of Propranolol can be increased when it is combined with Peginterferon alfa-2b.
DB00575,The serum concentration of Clonidine can be increased when it is combined with Peginterferon alfa-2b.
DB00586,The serum concentration of Diclofenac can be increased when it is combined with Peginterferon alfa-2b.
DB00619,The serum concentration of Imatinib can be increased when it is combined with Peginterferon alfa-2b.
DB00629,The serum concentration of Guanabenz can be increased when it is combined with Peginterferon alfa-2b.
DB00642,The serum concentration of Pemetrexed can be increased when it is combined with Peginterferon alfa-2b.
DB00661,The serum concentration of Verapamil can be increased when it is combined with Peginterferon alfa-2b.
DB00682,The serum concentration of Warfarin can be increased when it is combined with Peginterferon alfa-2b.
DB00697,The serum concentration of Tizanidine can be increased when it is combined with Peginterferon alfa-2b.
DB00715,The serum concentration of Paroxetine can be increased when it is combined with Peginterferon alfa-2b.
DB00730,The serum concentration of Thiabendazole can be increased when it is combined with Peginterferon alfa-2b.
DB00740,The serum concentration of Riluzole can be increased when it is combined with Peginterferon alfa-2b.
DB00744,The serum concentration of Zileuton can be increased when it is combined with Peginterferon alfa-2b.
DB00758,The serum concentration of Clopidogrel can be increased when it is combined with Peginterferon alfa-2b.
DB00773,The serum concentration of Etoposide can be increased when it is combined with Peginterferon alfa-2b.
DB00783,The serum concentration of Estradiol can be increased when it is combined with Peginterferon alfa-2b.
DB00787,The serum concentration of Acyclovir can be increased when it is combined with Peginterferon alfa-2b.
DB00788,The serum concentration of Naproxen can be increased when it is combined with Peginterferon alfa-2b.
DB00806,The serum concentration of Pentoxifylline can be increased when it is combined with Peginterferon alfa-2b.
DB00831,The serum concentration of Trifluoperazine can be increased when it is combined with Peginterferon alfa-2b.
DB00850,The serum concentration of Perphenazine can be increased when it is combined with Peginterferon alfa-2b.
DB00851,The serum concentration of Dacarbazine can be increased when it is combined with Peginterferon alfa-2b.
DB00857,The serum concentration of Terbinafine can be increased when it is combined with Peginterferon alfa-2b.
DB00863,The serum concentration of Ranitidine can be increased when it is combined with Peginterferon alfa-2b.
DB00898,The serum concentration of Ethanol can be increased when it is combined with Peginterferon alfa-2b.
DB00924,The serum concentration of Cyclobenzaprine can be increased when it is combined with Peginterferon alfa-2b.
DB00934,The serum concentration of Maprotiline can be increased when it is combined with Peginterferon alfa-2b.
DB00969,The serum concentration of Alosetron can be increased when it is combined with Peginterferon alfa-2b.
DB00978,The serum concentration of Lomefloxacin can be increased when it is combined with Peginterferon alfa-2b.
DB00980,The serum concentration of Ramelteon can be increased when it is combined with Peginterferon alfa-2b.
DB00993,The serum concentration of Azathioprine can be increased when it is combined with Peginterferon alfa-2b.
DB00998,The serum concentration of Frovatriptan can be increased when it is combined with Peginterferon alfa-2b.
DB01002,The serum concentration of Levobupivacaine can be increased when it is combined with Peginterferon alfa-2b.
DB01012,The serum concentration of Cinacalcet can be increased when it is combined with Peginterferon alfa-2b.
DB01037,The serum concentration of Selegiline can be increased when it is combined with Peginterferon alfa-2b.
DB01056,The serum concentration of Tocainide can be increased when it is combined with Peginterferon alfa-2b.
DB01058,The serum concentration of Praziquantel can be increased when it is combined with Peginterferon alfa-2b.
DB01065,The serum concentration of Melatonin can be increased when it is combined with Peginterferon alfa-2b.
DB01087,The serum concentration of Primaquine can be increased when it is combined with Peginterferon alfa-2b.
DB01094,The serum concentration of Hesperetin can be increased when it is combined with Peginterferon alfa-2b.
DB01100,The serum concentration of Pimozide can be increased when it is combined with Peginterferon alfa-2b.
DB01115,The serum concentration of Nifedipine can be increased when it is combined with Peginterferon alfa-2b.
DB01136,The serum concentration of Carvedilol can be increased when it is combined with Peginterferon alfa-2b.
DB01142,The serum concentration of Doxepin can be increased when it is combined with Peginterferon alfa-2b.
DB01151,The serum concentration of Desipramine can be increased when it is combined with Peginterferon alfa-2b.
DB01166,The serum concentration of Cilostazol can be increased when it is combined with Peginterferon alfa-2b.
DB01182,The serum concentration of Propafenone can be increased when it is combined with Peginterferon alfa-2b.
DB01184,The serum concentration of Domperidone can be increased when it is combined with Peginterferon alfa-2b.
DB01191,The serum concentration of Dexfenfluramine can be increased when it is combined with Peginterferon alfa-2b.
DB01223,The serum concentration of Aminophylline can be increased when it is combined with Peginterferon alfa-2b.
DB01242,The serum concentration of Clomipramine can be increased when it is combined with Peginterferon alfa-2b.
DB01254,The serum concentration of Dasatinib can be increased when it is combined with Peginterferon alfa-2b.
DB01303,The serum concentration of Oxtriphylline can be increased when it is combined with Peginterferon alfa-2b.
DB01367,The serum concentration of Rasagiline can be increased when it is combined with Peginterferon alfa-2b.
DB01405,The serum concentration of Temafloxacin can be increased when it is combined with Peginterferon alfa-2b.
DB01412,The serum concentration of Theobromine can be increased when it is combined with Peginterferon alfa-2b.
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Peginterferon alfa-2b.
DB01424,The serum concentration of Aminophenazone can be increased when it is combined with Peginterferon alfa-2b.
DB01435,The serum concentration of Antipyrine can be increased when it is combined with Peginterferon alfa-2b.
DB01482,The serum concentration of Fenethylline can be increased when it is combined with Peginterferon alfa-2b.
DB01558,The serum concentration of Bromazepam can be increased when it is combined with Peginterferon alfa-2b.
DB01623,The serum concentration of Thiothixene can be increased when it is combined with Peginterferon alfa-2b.
DB01628,The serum concentration of Etoricoxib can be increased when it is combined with Peginterferon alfa-2b.
DB01645,The serum concentration of Genistein can be increased when it is combined with Peginterferon alfa-2b.
DB01667,The serum concentration of 8-azaguanine can be increased when it is combined with Peginterferon alfa-2b.
DB02134,The serum concentration of Xanthine can be increased when it is combined with Peginterferon alfa-2b.
DB02489,The serum concentration of 9-Methylguanine can be increased when it is combined with Peginterferon alfa-2b.
DB02568,The serum concentration of Peldesine can be increased when it is combined with Peginterferon alfa-2b.
DB02709,The serum concentration of Resveratrol can be increased when it is combined with Peginterferon alfa-2b.
DB03783,The serum concentration of Phenacetin can be increased when it is combined with Peginterferon alfa-2b.
DB04076,The serum concentration of Hypoxanthine can be increased when it is combined with Peginterferon alfa-2b.
DB04356,The serum concentration of 9-Deazaguanine can be increased when it is combined with Peginterferon alfa-2b.
DB04574,The serum concentration of Estrone sulfate can be increased when it is combined with Peginterferon alfa-2b.
DB04841,The serum concentration of Flunarizine can be increased when it is combined with Peginterferon alfa-2b.
DB04871,The serum concentration of Lorcaserin can be increased when it is combined with Peginterferon alfa-2b.
DB04948,The serum concentration of Lofexidine can be increased when it is combined with Peginterferon alfa-2b.
DB04951,The serum concentration of Pirfenidone can be increased when it is combined with Peginterferon alfa-2b.
DB05676,The serum concentration of Apremilast can be increased when it is combined with Peginterferon alfa-2b.
DB06148,The serum concentration of Mianserin can be increased when it is combined with Peginterferon alfa-2b.
DB06210,The serum concentration of Eltrombopag can be increased when it is combined with Peginterferon alfa-2b.
DB06216,The serum concentration of Asenapine can be increased when it is combined with Peginterferon alfa-2b.
DB06235,The serum concentration of Vadimezan can be increased when it is combined with Peginterferon alfa-2b.
DB06292,The serum concentration of Dapagliflozin can be increased when it is combined with Peginterferon alfa-2b.
DB06479,The serum concentration of Propentofylline can be increased when it is combined with Peginterferon alfa-2b.
DB06589,The serum concentration of Pazopanib can be increased when it is combined with Peginterferon alfa-2b.
DB06594,The serum concentration of Agomelatine can be increased when it is combined with Peginterferon alfa-2b.
DB06626,The serum concentration of Axitinib can be increased when it is combined with Peginterferon alfa-2b.
DB06769,The serum concentration of Bendamustine can be increased when it is combined with Peginterferon alfa-2b.
DB06770,The serum concentration of Benzyl alcohol can be increased when it is combined with Peginterferon alfa-2b.
DB06774,The serum concentration of Capsaicin can be increased when it is combined with Peginterferon alfa-2b.
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Peginterferon alfa-2b.
DB08883,The serum concentration of Perampanel can be increased when it is combined with Peginterferon alfa-2b.
DB08910,The serum concentration of Pomalidomide can be increased when it is combined with Peginterferon alfa-2b.
DB09071,The serum concentration of Tasimelteon can be increased when it is combined with Peginterferon alfa-2b.
DB09118,The serum concentration of Stiripentol can be increased when it is combined with Peginterferon alfa-2b.
DB09225,The serum concentration of Zotepine can be increased when it is combined with Peginterferon alfa-2b.
DB09256,The serum concentration of Tegafur can be increased when it is combined with Peginterferon alfa-2b.
DB09273,The serum concentration of Doxofylline can be increased when it is combined with Peginterferon alfa-2b.
DB09288,The serum concentration of Propacetamol can be increased when it is combined with Peginterferon alfa-2b.
DB09290,The serum concentration of Ramosetron can be increased when it is combined with Peginterferon alfa-2b.
DB11919,The serum concentration of 6-O-benzylguanine can be increased when it is combined with Peginterferon alfa-2b.
DB11967,The serum concentration of Binimetinib can be increased when it is combined with Peginterferon alfa-2b.
DB12026,The serum concentration of Voxilaprevir can be increased when it is combined with Peginterferon alfa-2b.
DB12245,The serum concentration of Triclabendazole can be increased when it is combined with Peginterferon alfa-2b.
DB12332,The serum concentration of Rucaparib can be increased when it is combined with Peginterferon alfa-2b.
DB12406,The serum concentration of Lisofylline can be increased when it is combined with Peginterferon alfa-2b.
DB12531,The serum concentration of Lobucavir can be increased when it is combined with Peginterferon alfa-2b.
DB12926,The serum concentration of Cafedrine can be increased when it is combined with Peginterferon alfa-2b.
DB12927,The serum concentration of Theodrenaline can be increased when it is combined with Peginterferon alfa-2b.
DB12945,The serum concentration of Dihydralazine can be increased when it is combined with Peginterferon alfa-2b.
DB13203,The serum concentration of Bamifylline can be increased when it is combined with Peginterferon alfa-2b.
DB13449,The serum concentration of Proxyphylline can be increased when it is combined with Peginterferon alfa-2b.
DB13573,The serum concentration of Acefylline can be increased when it is combined with Peginterferon alfa-2b.
DB13592,The serum concentration of Etamiphylline can be increased when it is combined with Peginterferon alfa-2b.
DB13634,The serum concentration of Pentifylline can be increased when it is combined with Peginterferon alfa-2b.
DB13812,The serum concentration of Bufylline can be increased when it is combined with Peginterferon alfa-2b.
DB13874,The serum concentration of Enasidenib can be increased when it is combined with Peginterferon alfa-2b.
DB13952,The serum concentration of Estradiol acetate can be increased when it is combined with Peginterferon alfa-2b.
DB13953,The serum concentration of Estradiol benzoate can be increased when it is combined with Peginterferon alfa-2b.
DB13954,The serum concentration of Estradiol cypionate can be increased when it is combined with Peginterferon alfa-2b.
DB13955,The serum concentration of Estradiol dienanthate can be increased when it is combined with Peginterferon alfa-2b.
DB13956,The serum concentration of Estradiol valerate can be increased when it is combined with Peginterferon alfa-2b.
DB14018,The serum concentration of Bromotheophylline can be increased when it is combined with Peginterferon alfa-2b.
DB14132,The serum concentration of 8-chlorotheophylline can be increased when it is combined with Peginterferon alfa-2b.
DB01195,The serum concentration of Flecainide can be increased when it is combined with Peginterferon alfa-2b.
DB01233,The serum concentration of Metoclopramide can be increased when it is combined with Peginterferon alfa-2b.
DB11757,The serum concentration of Istradefylline can be increased when it is combined with Peginterferon alfa-2b.
DB00625,The serum concentration of Efavirenz can be increased when it is combined with Peginterferon alfa-2b.
DB04889,The serum concentration of Bicifadine can be increased when it is combined with Peginterferon alfa-2b.
DB05708,The serum concentration of GTS-21 can be increased when it is combined with Peginterferon alfa-2b.
DB00977,The serum concentration of Ethinylestradiol can be increased when it is combined with Peginterferon alfa-2b.
DB11689,The serum concentration of Selumetinib can be increased when it is combined with Peginterferon alfa-2b.
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Peginterferon alfa-2b.
DB00289,The metabolism of Atomoxetine can be decreased when combined with Peginterferon alfa-2b.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Peginterferon alfa-2b.
DB04817,The risk or severity of myelosuppression can be increased when Metamizole is combined with Peginterferon alfa-2b.
DB01097,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Leflunomide.
DB08895,Peginterferon alfa-2b may increase the immunosuppressive activities of Tofacitinib.
DB00072,Trastuzumab may increase the neutropenic activities of Peginterferon alfa-2b.
DB00019,The therapeutic efficacy of Peginterferon alfa-2b can be decreased when used in combination with Pegfilgrastim.
DB00061,The therapeutic efficacy of Pegademase can be decreased when used in combination with Peginterferon alfa-2b.
DB00082,The therapeutic efficacy of Pegvisomant can be decreased when used in combination with Peginterferon alfa-2b.
DB01839,The therapeutic efficacy of Propylene glycol can be decreased when used in combination with Peginterferon alfa-2b.
DB03394,The therapeutic efficacy of Heptaethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.
DB04895,The therapeutic efficacy of Pegaptanib can be decreased when used in combination with Peginterferon alfa-2b.
DB05202,The therapeutic efficacy of Egaptivon pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB05321,The therapeutic efficacy of PEG-uricase can be decreased when used in combination with Peginterferon alfa-2b.
DB05860,The therapeutic efficacy of Peginterferon alfacon-1 can be decreased when used in combination with Peginterferon alfa-2b.
DB06022,The therapeutic efficacy of GlycoPEG-GCSF can be decreased when used in combination with Peginterferon alfa-2b.
DB06293,The therapeutic efficacy of Pegnivacogin can be decreased when used in combination with Peginterferon alfa-2b.
DB06325,The therapeutic efficacy of Pegpleranib can be decreased when used in combination with Peginterferon alfa-2b.
DB06611,The therapeutic efficacy of Pegsunercept can be decreased when used in combination with Peginterferon alfa-2b.
DB06811,The therapeutic efficacy of Polidocanol can be decreased when used in combination with Peginterferon alfa-2b.
DB08894,The therapeutic efficacy of Peginesatide can be decreased when used in combination with Peginterferon alfa-2b.
DB09107,The therapeutic efficacy of Methoxy polyethylene glycol-epoetin beta can be decreased when used in combination with Peginterferon alfa-2b.
DB09208,The therapeutic efficacy of Pegloticase can be decreased when used in combination with Peginterferon alfa-2b.
DB09287,The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Peginterferon alfa-2b.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Peginterferon alfa-2b."
DB11077,The therapeutic efficacy of Polyethylene glycol 400 can be decreased when used in combination with Peginterferon alfa-2b.
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Peginterferon alfa-2b.
DB11661,The therapeutic efficacy of Eptacog alfa pegol (activated) can be decreased when used in combination with Peginterferon alfa-2b.
DB11707,The therapeutic efficacy of Olaptesed Pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB12258,The therapeutic efficacy of Abicipar Pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB12578,The therapeutic efficacy of Lexaptepid Pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB12839,The therapeutic efficacy of Pegvaliase can be decreased when used in combination with Peginterferon alfa-2b.
DB12842,The therapeutic efficacy of Pegamotecan can be decreased when used in combination with Peginterferon alfa-2b.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Peginterferon alfa-2b.
DB14712,The therapeutic efficacy of Elapegademase can be decreased when used in combination with Peginterferon alfa-2b.
DB08868,Peginterferon alfa-2b may increase the immunosuppressive activities of Fingolimod.
DB00864,Tacrolimus may increase the immunosuppressive activities of Peginterferon alfa-2b.
DB00651,The metabolism of Dyphylline can be decreased when combined with Peginterferon alfa-2b.
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Peginterferon alfa-2b."
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Peginterferon alfa-2b.
DB02377,The metabolism of Guanine can be decreased when combined with Peginterferon alfa-2b.
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Peginterferon alfa-2b.
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Peginterferon alfa-2b.
DB08844,The metabolism of Uric acid can be decreased when combined with Peginterferon alfa-2b.
DB14029,The metabolism of Furafylline can be decreased when combined with Peginterferon alfa-2b.
DB15122,The metabolism of PCS-499 can be decreased when combined with Peginterferon alfa-2b.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Peginterferon alfa-2b.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Peginterferon alfa-2b.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Peginterferon alfa-2b.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Peginterferon alfa-2b.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Peginterferon alfa-2b.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Peginterferon alfa-2b.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Peginterferon alfa-2b.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Peginterferon alfa-2b.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Peginterferon alfa-2b.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Peginterferon alfa-2b."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Peginterferon alfa-2b.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Peginterferon alfa-2b."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Peginterferon alfa-2b.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Peginterferon alfa-2b.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Peginterferon alfa-2b.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Peginterferon alfa-2b.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Peginterferon alfa-2b.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Peginterferon alfa-2b.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Peginterferon alfa-2b.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Peginterferon alfa-2b.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Peginterferon alfa-2b.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Peginterferon alfa-2b.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Peginterferon alfa-2b."
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Peginterferon alfa-2b.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Peginterferon alfa-2b.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Peginterferon alfa-2b.
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Peginterferon alfa-2b.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Peginterferon alfa-2b.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Peginterferon alfa-2b.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Peginterferon alfa-2b.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Peginterferon alfa-2b.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Peginterferon alfa-2b.
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Peginterferon alfa-2b.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Peginterferon alfa-2b.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Peginterferon alfa-2b.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Peginterferon alfa-2b.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Peginterferon alfa-2b.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Peginterferon alfa-2b.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Peginterferon alfa-2b.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Peginterferon alfa-2b.
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Peginterferon alfa-2b.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Peginterferon alfa-2b.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Peginterferon alfa-2b.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Peginterferon alfa-2b.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Peginterferon alfa-2b.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Peginterferon alfa-2b.
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Peginterferon alfa-2b.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Peginterferon alfa-2b.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Peginterferon alfa-2b.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Peginterferon alfa-2b.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Peginterferon alfa-2b.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Peginterferon alfa-2b.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Peginterferon alfa-2b.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Peginterferon alfa-2b.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Peginterferon alfa-2b.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Peginterferon alfa-2b.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Peginterferon alfa-2b.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Peginterferon alfa-2b.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Peginterferon alfa-2b.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Peginterferon alfa-2b.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Peginterferon alfa-2b.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Peginterferon alfa-2b.
DB13200,Peginterferon alfa-2b may increase the myelosuppressive activities of Lipegfilgrastim.
DB10318,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Varicella Zoster Vaccine (Live/attenuated).
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Peginterferon alfa-2b.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Peginterferon alfa-2b.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Peginterferon alfa-2b.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Peginterferon alfa-2b.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Peginterferon alfa-2b.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Peginterferon alfa-2b.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Peginterferon alfa-2b.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Peginterferon alfa-2b.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Peginterferon alfa-2b.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Peginterferon alfa-2b.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Peginterferon alfa-2b.
DB01238,The metabolism of Aripiprazole can be decreased when combined with Peginterferon alfa-2b.
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Peginterferon alfa-2b.
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.
DB00757,The metabolism of Dolasetron can be decreased when combined with Peginterferon alfa-2b.
DB00182,The metabolism of Amphetamine can be decreased when combined with Peginterferon alfa-2b.
DB00185,The metabolism of Cevimeline can be decreased when combined with Peginterferon alfa-2b.
DB00187,The metabolism of Esmolol can be decreased when combined with Peginterferon alfa-2b.
DB00215,The metabolism of Citalopram can be decreased when combined with Peginterferon alfa-2b.
DB00243,The metabolism of Ranolazine can be decreased when combined with Peginterferon alfa-2b.
DB00245,The metabolism of Benzatropine can be decreased when combined with Peginterferon alfa-2b.
DB00264,The metabolism of Metoprolol can be decreased when combined with Peginterferon alfa-2b.
DB00297,The metabolism of Bupivacaine can be decreased when combined with Peginterferon alfa-2b.
DB00317,The metabolism of Gefitinib can be decreased when combined with Peginterferon alfa-2b.
DB00318,The metabolism of Codeine can be decreased when combined with Peginterferon alfa-2b.
DB00335,The metabolism of Atenolol can be decreased when combined with Peginterferon alfa-2b.
DB00342,The metabolism of Terfenadine can be decreased when combined with Peginterferon alfa-2b.
DB00377,The metabolism of Palonosetron can be decreased when combined with Peginterferon alfa-2b.
DB00409,The metabolism of Remoxipride can be decreased when combined with Peginterferon alfa-2b.
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Peginterferon alfa-2b.
DB00490,The metabolism of Buspirone can be decreased when combined with Peginterferon alfa-2b.
DB00496,The metabolism of Darifenacin can be decreased when combined with Peginterferon alfa-2b.
DB00497,The metabolism of Oxycodone can be decreased when combined with Peginterferon alfa-2b.
DB00503,The metabolism of Ritonavir can be decreased when combined with Peginterferon alfa-2b.
DB00589,The metabolism of Lisuride can be decreased when combined with Peginterferon alfa-2b.
DB00592,The metabolism of Piperazine can be decreased when combined with Peginterferon alfa-2b.
DB00608,The metabolism of Chloroquine can be decreased when combined with Peginterferon alfa-2b.
DB00637,The metabolism of Astemizole can be decreased when combined with Peginterferon alfa-2b.
DB00641,The metabolism of Simvastatin can be decreased when combined with Peginterferon alfa-2b.
DB00647,The metabolism of Dextropropoxyphene can be decreased when combined with Peginterferon alfa-2b.
DB00656,The metabolism of Trazodone can be decreased when combined with Peginterferon alfa-2b.
DB00674,The metabolism of Galantamine can be decreased when combined with Peginterferon alfa-2b.
DB00679,The metabolism of Thioridazine can be decreased when combined with Peginterferon alfa-2b.
DB00699,The metabolism of Nicergoline can be decreased when combined with Peginterferon alfa-2b.
DB00705,The metabolism of Delavirdine can be decreased when combined with Peginterferon alfa-2b.
DB00706,The metabolism of Tamsulosin can be decreased when combined with Peginterferon alfa-2b.
DB00734,The metabolism of Risperidone can be decreased when combined with Peginterferon alfa-2b.
DB00737,The metabolism of Meclizine can be decreased when combined with Peginterferon alfa-2b.
DB00738,The metabolism of Pentamidine can be decreased when combined with Peginterferon alfa-2b.
DB00805,The metabolism of Minaprine can be decreased when combined with Peginterferon alfa-2b.
DB00836,The metabolism of Loperamide can be decreased when combined with Peginterferon alfa-2b.
DB00866,The metabolism of Alprenolol can be decreased when combined with Peginterferon alfa-2b.
DB00914,The metabolism of Phenformin can be decreased when combined with Peginterferon alfa-2b.
DB00918,The metabolism of Almotriptan can be decreased when combined with Peginterferon alfa-2b.
DB00932,The metabolism of Tipranavir can be decreased when combined with Peginterferon alfa-2b.
DB00933,The metabolism of Mesoridazine can be decreased when combined with Peginterferon alfa-2b.
DB00956,The metabolism of Hydrocodone can be decreased when combined with Peginterferon alfa-2b.
DB00960,The metabolism of Pindolol can be decreased when combined with Peginterferon alfa-2b.
DB01069,The metabolism of Promethazine can be decreased when combined with Peginterferon alfa-2b.
DB01071,The metabolism of Mequitazine can be decreased when combined with Peginterferon alfa-2b.
DB01074,The metabolism of Perhexiline can be decreased when combined with Peginterferon alfa-2b.
DB01079,The metabolism of Tegaserod can be decreased when combined with Peginterferon alfa-2b.
DB01114,The metabolism of Chlorpheniramine can be decreased when combined with Peginterferon alfa-2b.
DB01149,The metabolism of Nefazodone can be decreased when combined with Peginterferon alfa-2b.
DB01175,The metabolism of Escitalopram can be decreased when combined with Peginterferon alfa-2b.
DB01192,The metabolism of Oxymorphone can be decreased when combined with Peginterferon alfa-2b.
DB01193,The metabolism of Acebutolol can be decreased when combined with Peginterferon alfa-2b.
DB01203,The metabolism of Nadolol can be decreased when combined with Peginterferon alfa-2b.
DB01224,The metabolism of Quetiapine can be decreased when combined with Peginterferon alfa-2b.
DB01228,The metabolism of Encainide can be decreased when combined with Peginterferon alfa-2b.
DB01244,The metabolism of Bepridil can be decreased when combined with Peginterferon alfa-2b.
DB01255,The metabolism of Lisdexamfetamine can be decreased when combined with Peginterferon alfa-2b.
DB01267,The metabolism of Paliperidone can be decreased when combined with Peginterferon alfa-2b.
DB01295,The metabolism of Bevantolol can be decreased when combined with Peginterferon alfa-2b.
DB01297,The metabolism of Practolol can be decreased when combined with Peginterferon alfa-2b.
DB01359,The metabolism of Penbutolol can be decreased when combined with Peginterferon alfa-2b.
DB01392,The metabolism of Yohimbine can be decreased when combined with Peginterferon alfa-2b.
DB01403,The metabolism of Methotrimeprazine can be decreased when combined with Peginterferon alfa-2b.
DB01409,The metabolism of Tiotropium can be decreased when combined with Peginterferon alfa-2b.
DB01429,The metabolism of Aprindine can be decreased when combined with Peginterferon alfa-2b.
DB01454,The metabolism of Midomafetamine can be decreased when combined with Peginterferon alfa-2b.
DB01466,The metabolism of Ethylmorphine can be decreased when combined with Peginterferon alfa-2b.
DB01472,The metabolism of 4-Methoxyamphetamine can be decreased when combined with Peginterferon alfa-2b.
DB01551,The metabolism of Dihydrocodeine can be decreased when combined with Peginterferon alfa-2b.
DB01576,The metabolism of Dextroamphetamine can be decreased when combined with Peginterferon alfa-2b.
DB01577,The metabolism of Metamfetamine can be decreased when combined with Peginterferon alfa-2b.
DB01580,The metabolism of Oxprenolol can be decreased when combined with Peginterferon alfa-2b.
DB01591,The metabolism of Solifenacin can be decreased when combined with Peginterferon alfa-2b.
DB01621,The metabolism of Pipotiazine can be decreased when combined with Peginterferon alfa-2b.
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Peginterferon alfa-2b.
DB02703,The metabolism of Fusidic acid can be decreased when combined with Peginterferon alfa-2b.
DB04829,The metabolism of Lysergic acid diethylamide can be decreased when combined with Peginterferon alfa-2b.
DB04840,The metabolism of Debrisoquine can be decreased when combined with Peginterferon alfa-2b.
DB04844,The metabolism of Tetrabenazine can be decreased when combined with Peginterferon alfa-2b.
DB04846,The metabolism of Celiprolol can be decreased when combined with Peginterferon alfa-2b.
DB04861,The metabolism of Nebivolol can be decreased when combined with Peginterferon alfa-2b.
DB04884,The metabolism of Dapoxetine can be decreased when combined with Peginterferon alfa-2b.
DB04920,The metabolism of Clevidipine can be decreased when combined with Peginterferon alfa-2b.
DB04946,The metabolism of Iloperidone can be decreased when combined with Peginterferon alfa-2b.
DB05271,The metabolism of Rotigotine can be decreased when combined with Peginterferon alfa-2b.
DB06016,The metabolism of Cariprazine can be decreased when combined with Peginterferon alfa-2b.
DB06144,The metabolism of Sertindole can be decreased when combined with Peginterferon alfa-2b.
DB06203,The metabolism of Alogliptin can be decreased when combined with Peginterferon alfa-2b.
DB06217,The metabolism of Vernakalant can be decreased when combined with Peginterferon alfa-2b.
DB06506,The metabolism of Repinotan can be decreased when combined with Peginterferon alfa-2b.
DB06608,The metabolism of Tafenoquine can be decreased when combined with Peginterferon alfa-2b.
DB06678,The metabolism of Esmirtazapine can be decreased when combined with Peginterferon alfa-2b.
DB06684,The metabolism of Vilazodone can be decreased when combined with Peginterferon alfa-2b.
DB06702,The metabolism of Fesoterodine can be decreased when combined with Peginterferon alfa-2b.
DB06726,The metabolism of Bufuralol can be decreased when combined with Peginterferon alfa-2b.
DB06727,The metabolism of Sparteine can be decreased when combined with Peginterferon alfa-2b.
DB06735,The metabolism of Enclomiphene can be decreased when combined with Peginterferon alfa-2b.
DB08807,The metabolism of Bopindolol can be decreased when combined with Peginterferon alfa-2b.
DB08808,The metabolism of Bupranolol can be decreased when combined with Peginterferon alfa-2b.
DB08893,The metabolism of Mirabegron can be decreased when combined with Peginterferon alfa-2b.
DB08918,The metabolism of Levomilnacipran can be decreased when combined with Peginterferon alfa-2b.
DB08922,The metabolism of Perospirone can be decreased when combined with Peginterferon alfa-2b.
DB08952,The metabolism of Indenolol can be decreased when combined with Peginterferon alfa-2b.
DB09013,The metabolism of Befunolol can be decreased when combined with Peginterferon alfa-2b.
DB09039,The metabolism of Eliglustat can be decreased when combined with Peginterferon alfa-2b.
DB09076,The metabolism of Umeclidinium can be decreased when combined with Peginterferon alfa-2b.
DB09128,The metabolism of Brexpiprazole can be decreased when combined with Peginterferon alfa-2b.
DB09183,The metabolism of Dasabuvir can be decreased when combined with Peginterferon alfa-2b.
DB09195,The metabolism of Lorpiprazole can be decreased when combined with Peginterferon alfa-2b.
DB09204,The metabolism of Arotinolol can be decreased when combined with Peginterferon alfa-2b.
DB09351,The metabolism of Levobetaxolol can be decreased when combined with Peginterferon alfa-2b.
DB09555,The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Peginterferon alfa-2b.
DB11130,The metabolism of Opium can be decreased when combined with Peginterferon alfa-2b.
DB11770,The metabolism of Talinolol can be decreased when combined with Peginterferon alfa-2b.
DB11785,The metabolism of Anisodamine can be decreased when combined with Peginterferon alfa-2b.
DB11855,The metabolism of Revefenacin can be decreased when combined with Peginterferon alfa-2b.
DB11915,The metabolism of Valbenazine can be decreased when combined with Peginterferon alfa-2b.
DB11979,The metabolism of Elagolix can be decreased when combined with Peginterferon alfa-2b.
DB12070,The metabolism of Letermovir can be decreased when combined with Peginterferon alfa-2b.
DB12161,The metabolism of Deutetrabenazine can be decreased when combined with Peginterferon alfa-2b.
DB12212,The metabolism of Landiolol can be decreased when combined with Peginterferon alfa-2b.
DB12752,The metabolism of Bucindolol can be decreased when combined with Peginterferon alfa-2b.
DB13293,The metabolism of Ipecac can be decreased when combined with Peginterferon alfa-2b.
DB13443,The metabolism of Esatenolol can be decreased when combined with Peginterferon alfa-2b.
DB13508,The metabolism of Cloranolol can be decreased when combined with Peginterferon alfa-2b.
DB13530,The metabolism of Mepindolol can be decreased when combined with Peginterferon alfa-2b.
DB13679,The metabolism of Dexchlorpheniramine can be decreased when combined with Peginterferon alfa-2b.
DB13757,The metabolism of Epanolol can be decreased when combined with Peginterferon alfa-2b.
DB13775,The metabolism of Tertatolol can be decreased when combined with Peginterferon alfa-2b.
DB09173,The metabolism of Butyrfentanyl can be decreased when combined with Peginterferon alfa-2b.
DB00598,The metabolism of Labetalol can be decreased when combined with Peginterferon alfa-2b.
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be decreased when combined with Peginterferon alfa-2b."
DB11642,The metabolism of Pitolisant can be decreased when combined with Peginterferon alfa-2b.
DB00344,The metabolism of Protriptyline can be decreased when combined with Peginterferon alfa-2b.
DB00454,The metabolism of Meperidine can be decreased when combined with Peginterferon alfa-2b.
DB00543,The metabolism of Amoxapine can be decreased when combined with Peginterferon alfa-2b.
DB12930,The metabolism of Opipramol can be decreased when combined with Peginterferon alfa-2b.
DB05109,The metabolism of Trabectedin can be decreased when combined with Peginterferon alfa-2b.
DB11963,The metabolism of Dacomitinib can be decreased when combined with Peginterferon alfa-2b.
DB00489,The metabolism of Sotalol can be decreased when combined with Peginterferon alfa-2b.
DB01035,The metabolism of Procainamide can be decreased when combined with Peginterferon alfa-2b.
DB09167,The metabolism of Dosulepin can be decreased when combined with Peginterferon alfa-2b.
DB11718,The metabolism of Encorafenib can be decreased when combined with Peginterferon alfa-2b.
DB01118,The metabolism of Amiodarone can be decreased when combined with Peginterferon alfa-2b.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Peginterferon alfa-2b.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Peginterferon alfa-2b.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Peginterferon alfa-2b.
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Peginterferon alfa-2b.
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Peginterferon alfa-2b.
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Peginterferon alfa-2b.
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Peginterferon alfa-2b.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Peginterferon alfa-2b.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Peginterferon alfa-2b.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Peginterferon alfa-2b.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Peginterferon alfa-2b.
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Peginterferon alfa-2b.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Peginterferon alfa-2b.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Peginterferon alfa-2b.
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Peginterferon alfa-2b.
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Peginterferon alfa-2b.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Peginterferon alfa-2b.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Peginterferon alfa-2b.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Peginterferon alfa-2b.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Peginterferon alfa-2b.
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Peginterferon alfa-2b.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Peginterferon alfa-2b.
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Peginterferon alfa-2b.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Peginterferon alfa-2b.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Peginterferon alfa-2b.
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Peginterferon alfa-2b.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Peginterferon alfa-2b.
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Peginterferon alfa-2b.
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon alfa-2b.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Peginterferon alfa-2b.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Peginterferon alfa-2b.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Peginterferon alfa-2b.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Peginterferon alfa-2b.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Peginterferon alfa-2b.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Peginterferon alfa-2b.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Peginterferon alfa-2b.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Peginterferon alfa-2b.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Peginterferon alfa-2b.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Peginterferon alfa-2b.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Peginterferon alfa-2b.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Peginterferon alfa-2b.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Peginterferon alfa-2b.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Peginterferon alfa-2b.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Peginterferon alfa-2b.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Peginterferon alfa-2b.
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Peginterferon alfa-2b.
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Peginterferon alfa-2b.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Peginterferon alfa-2b.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Peginterferon alfa-2b.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Peginterferon alfa-2b.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Peginterferon alfa-2b.
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Peginterferon alfa-2b.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Peginterferon alfa-2b.
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Peginterferon alfa-2b.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Peginterferon alfa-2b.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Peginterferon alfa-2b.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Peginterferon alfa-2b.
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Peginterferon alfa-2b.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Peginterferon alfa-2b.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Peginterferon alfa-2b.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Peginterferon alfa-2b.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Peginterferon alfa-2b.
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Peginterferon alfa-2b.
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Peginterferon alfa-2b.
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Peginterferon alfa-2b.
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Peginterferon alfa-2b.
DB00177,The metabolism of Valsartan can be increased when combined with Peginterferon alfa-2b.
DB00197,The metabolism of Troglitazone can be increased when combined with Peginterferon alfa-2b.
DB00203,The metabolism of Sildenafil can be increased when combined with Peginterferon alfa-2b.
DB00214,The metabolism of Torasemide can be increased when combined with Peginterferon alfa-2b.
DB00216,The metabolism of Eletriptan can be increased when combined with Peginterferon alfa-2b.
DB00222,The metabolism of Glimepiride can be increased when combined with Peginterferon alfa-2b.
DB00238,The metabolism of Nevirapine can be increased when combined with Peginterferon alfa-2b.
DB00250,The metabolism of Dapsone can be increased when combined with Peginterferon alfa-2b.
DB00285,The metabolism of Venlafaxine can be increased when combined with Peginterferon alfa-2b.
DB00304,The metabolism of Desogestrel can be increased when combined with Peginterferon alfa-2b.
DB00327,The metabolism of Hydromorphone can be increased when combined with Peginterferon alfa-2b.
DB00338,The metabolism of Omeprazole can be increased when combined with Peginterferon alfa-2b.
DB00343,The metabolism of Diltiazem can be increased when combined with Peginterferon alfa-2b.
DB00347,The metabolism of Trimethadione can be increased when combined with Peginterferon alfa-2b.
DB00374,The metabolism of Treprostinil can be increased when combined with Peginterferon alfa-2b.
DB00396,The metabolism of Progesterone can be increased when combined with Peginterferon alfa-2b.
DB00404,The metabolism of Alprazolam can be increased when combined with Peginterferon alfa-2b.
DB00412,The metabolism of Rosiglitazone can be increased when combined with Peginterferon alfa-2b.
DB00414,The metabolism of Acetohexamide can be increased when combined with Peginterferon alfa-2b.
DB00440,The metabolism of Trimethoprim can be increased when combined with Peginterferon alfa-2b.
DB00448,The metabolism of Lansoprazole can be increased when combined with Peginterferon alfa-2b.
DB00469,The metabolism of Tenoxicam can be increased when combined with Peginterferon alfa-2b.
DB00470,The metabolism of Dronabinol can be increased when combined with Peginterferon alfa-2b.
DB00471,The metabolism of Montelukast can be increased when combined with Peginterferon alfa-2b.
DB00482,The metabolism of Celecoxib can be increased when combined with Peginterferon alfa-2b.
DB00514,The metabolism of Dextromethorphan can be increased when combined with Peginterferon alfa-2b.
DB00549,The metabolism of Zafirlukast can be increased when combined with Peginterferon alfa-2b.
DB00554,The metabolism of Piroxicam can be increased when combined with Peginterferon alfa-2b.
DB00559,The metabolism of Bosentan can be increased when combined with Peginterferon alfa-2b.
DB00580,The metabolism of Valdecoxib can be increased when combined with Peginterferon alfa-2b.
DB00582,The metabolism of Voriconazole can be increased when combined with Peginterferon alfa-2b.
DB00590,The metabolism of Doxazosin can be increased when combined with Peginterferon alfa-2b.
DB00617,The metabolism of Paramethadione can be increased when combined with Peginterferon alfa-2b.
DB00624,The metabolism of Testosterone can be increased when combined with Peginterferon alfa-2b.
DB00672,The metabolism of Chlorpropamide can be increased when combined with Peginterferon alfa-2b.
DB00678,The metabolism of Losartan can be increased when combined with Peginterferon alfa-2b.
DB00701,The metabolism of Amprenavir can be increased when combined with Peginterferon alfa-2b.
DB00712,The metabolism of Flurbiprofen can be increased when combined with Peginterferon alfa-2b.
DB00731,The metabolism of Nateglinide can be increased when combined with Peginterferon alfa-2b.
DB00749,The metabolism of Etodolac can be increased when combined with Peginterferon alfa-2b.
DB00784,The metabolism of Mefenamic acid can be increased when combined with Peginterferon alfa-2b.
DB00794,The metabolism of Primidone can be increased when combined with Peginterferon alfa-2b.
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Peginterferon alfa-2b.
DB00812,The metabolism of Phenylbutazone can be increased when combined with Peginterferon alfa-2b.
DB00814,The metabolism of Meloxicam can be increased when combined with Peginterferon alfa-2b.
DB00818,The metabolism of Propofol can be increased when combined with Peginterferon alfa-2b.
DB00829,The metabolism of Diazepam can be increased when combined with Peginterferon alfa-2b.
DB00839,The metabolism of Tolazamide can be increased when combined with Peginterferon alfa-2b.
DB00843,The metabolism of Donepezil can be increased when combined with Peginterferon alfa-2b.
DB00904,The metabolism of Ondansetron can be increased when combined with Peginterferon alfa-2b.
DB00921,The metabolism of Buprenorphine can be increased when combined with Peginterferon alfa-2b.
DB00936,The metabolism of Salicylic acid can be increased when combined with Peginterferon alfa-2b.
DB00983,The metabolism of Formoterol can be increased when combined with Peginterferon alfa-2b.
DB01016,The metabolism of Glyburide can be increased when combined with Peginterferon alfa-2b.
DB01028,The metabolism of Methoxyflurane can be increased when combined with Peginterferon alfa-2b.
DB01029,The metabolism of Irbesartan can be increased when combined with Peginterferon alfa-2b.
DB01036,The metabolism of Tolterodine can be increased when combined with Peginterferon alfa-2b.
DB01050,The metabolism of Ibuprofen can be increased when combined with Peginterferon alfa-2b.
DB01067,The metabolism of Glipizide can be increased when combined with Peginterferon alfa-2b.
DB01072,The metabolism of Atazanavir can be increased when combined with Peginterferon alfa-2b.
DB01075,The metabolism of Diphenhydramine can be increased when combined with Peginterferon alfa-2b.
DB01095,The metabolism of Fluvastatin can be increased when combined with Peginterferon alfa-2b.
DB01098,The metabolism of Rosuvastatin can be increased when combined with Peginterferon alfa-2b.
DB01104,The metabolism of Sertraline can be increased when combined with Peginterferon alfa-2b.
DB01120,The metabolism of Gliclazide can be increased when combined with Peginterferon alfa-2b.
DB01124,The metabolism of Tolbutamide can be increased when combined with Peginterferon alfa-2b.
DB01131,The metabolism of Proguanil can be increased when combined with Peginterferon alfa-2b.
DB01154,The metabolism of Thiamylal can be increased when combined with Peginterferon alfa-2b.
DB01156,The metabolism of Bupropion can be increased when combined with Peginterferon alfa-2b.
DB01159,The metabolism of Halothane can be increased when combined with Peginterferon alfa-2b.
DB01171,The metabolism of Moclobemide can be increased when combined with Peginterferon alfa-2b.
DB01174,The metabolism of Phenobarbital can be increased when combined with Peginterferon alfa-2b.
DB01198,The metabolism of Zopiclone can be increased when combined with Peginterferon alfa-2b.
DB01221,The metabolism of Ketamine can be increased when combined with Peginterferon alfa-2b.
DB01251,The metabolism of Gliquidone can be increased when combined with Peginterferon alfa-2b.
DB01274,The metabolism of Arformoterol can be increased when combined with Peginterferon alfa-2b.
DB01283,The metabolism of Lumiracoxib can be increased when combined with Peginterferon alfa-2b.
DB01289,The metabolism of Glisoxepide can be increased when combined with Peginterferon alfa-2b.
DB01355,The metabolism of Hexobarbital can be increased when combined with Peginterferon alfa-2b.
DB01357,The metabolism of Mestranol can be increased when combined with Peginterferon alfa-2b.
DB01544,The metabolism of Flunitrazepam can be increased when combined with Peginterferon alfa-2b.
DB01589,The metabolism of Quazepam can be increased when combined with Peginterferon alfa-2b.
DB03756,The metabolism of Doconexent can be increased when combined with Peginterferon alfa-2b.
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Peginterferon alfa-2b.
DB04725,The metabolism of Licofelone can be increased when combined with Peginterferon alfa-2b.
DB04938,The metabolism of Ospemifene can be increased when combined with Peginterferon alfa-2b.
DB05541,The metabolism of Brivaracetam can be increased when combined with Peginterferon alfa-2b.
DB06204,The metabolism of Tapentadol can be increased when combined with Peginterferon alfa-2b.
DB06218,The metabolism of Lacosamide can be increased when combined with Peginterferon alfa-2b.
DB06268,The metabolism of Sitaxentan can be increased when combined with Peginterferon alfa-2b.
DB06370,The metabolism of Indisulam can be increased when combined with Peginterferon alfa-2b.
DB06414,The metabolism of Etravirine can be increased when combined with Peginterferon alfa-2b.
DB06652,The metabolism of Vicriviroc can be increased when combined with Peginterferon alfa-2b.
DB06697,The metabolism of Artemether can be increased when combined with Peginterferon alfa-2b.
DB06725,The metabolism of Lornoxicam can be increased when combined with Peginterferon alfa-2b.
DB06737,The metabolism of Zaltoprofen can be increased when combined with Peginterferon alfa-2b.
DB06738,The metabolism of Ketobemidone can be increased when combined with Peginterferon alfa-2b.
DB06739,The metabolism of Seratrodast can be increased when combined with Peginterferon alfa-2b.
DB06803,The metabolism of Niclosamide can be increased when combined with Peginterferon alfa-2b.
DB08439,The metabolism of Parecoxib can be increased when combined with Peginterferon alfa-2b.
DB08828,The metabolism of Vismodegib can be increased when combined with Peginterferon alfa-2b.
DB08860,The metabolism of Pitavastatin can be increased when combined with Peginterferon alfa-2b.
DB08875,The metabolism of Cabozantinib can be increased when combined with Peginterferon alfa-2b.
DB08899,The metabolism of Enzalutamide can be increased when combined with Peginterferon alfa-2b.
DB08962,The metabolism of Glibornuride can be increased when combined with Peginterferon alfa-2b.
DB09048,The metabolism of Netupitant can be increased when combined with Peginterferon alfa-2b.
DB09061,The metabolism of Cannabidiol can be increased when combined with Peginterferon alfa-2b.
DB09068,The metabolism of Vortioxetine can be increased when combined with Peginterferon alfa-2b.
DB09080,The metabolism of Olodaterol can be increased when combined with Peginterferon alfa-2b.
DB11560,The metabolism of Lesinurad can be increased when combined with Peginterferon alfa-2b.
DB11586,The metabolism of Asunaprevir can be increased when combined with Peginterferon alfa-2b.
DB11614,The metabolism of Rupatadine can be increased when combined with Peginterferon alfa-2b.
DB11823,The metabolism of Esketamine can be increased when combined with Peginterferon alfa-2b.
DB12474,The metabolism of Lynestrenol can be increased when combined with Peginterferon alfa-2b.
DB13406,The metabolism of Carbutamide can be increased when combined with Peginterferon alfa-2b.
DB13675,The metabolism of Metahexamide can be increased when combined with Peginterferon alfa-2b.
DB13919,The metabolism of Candesartan can be increased when combined with Peginterferon alfa-2b.
DB13941,The metabolism of Piperaquine can be increased when combined with Peginterferon alfa-2b.
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Peginterferon alfa-2b.
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Peginterferon alfa-2b.
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Peginterferon alfa-2b.
DB14009,The metabolism of Medical Cannabis can be increased when combined with Peginterferon alfa-2b.
DB14011,The metabolism of Nabiximols can be increased when combined with Peginterferon alfa-2b.
DB09213,The metabolism of Dexibuprofen can be increased when combined with Peginterferon alfa-2b.
DB00465,The metabolism of Ketorolac can be increased when combined with Peginterferon alfa-2b.
DB14975,The metabolism of Voxelotor can be increased when combined with Peginterferon alfa-2b.
DB15233,The metabolism of Avapritinib can be increased when combined with Peginterferon alfa-2b.
DB00726,The metabolism of Trimipramine can be increased when combined with Peginterferon alfa-2b.
DB01101,The metabolism of Capecitabine can be increased when combined with Peginterferon alfa-2b.
DB05015,The metabolism of Belinostat can be increased when combined with Peginterferon alfa-2b.
DB00252,The metabolism of Phenytoin can be increased when combined with Peginterferon alfa-2b.
DB00266,The metabolism of Dicoumarol can be increased when combined with Peginterferon alfa-2b.
DB00313,The metabolism of Valproic acid can be increased when combined with Peginterferon alfa-2b.
DB00908,The metabolism of Quinidine can be increased when combined with Peginterferon alfa-2b.
DB00946,The metabolism of Phenprocoumon can be increased when combined with Peginterferon alfa-2b.
DB01320,The metabolism of Fosphenytoin can be increased when combined with Peginterferon alfa-2b.
DB13136,The metabolism of Fluindione can be increased when combined with Peginterferon alfa-2b.
DB12147,The metabolism of Erdafitinib can be increased when combined with Peginterferon alfa-2b.
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Peginterferon alfa-2b.
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Peginterferon alfa-2b.
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Peginterferon alfa-2b.
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Peginterferon alfa-2b.
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Peginterferon alfa-2b.
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Peginterferon alfa-2b.
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Peginterferon alfa-2b.
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Peginterferon alfa-2b.
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Peginterferon alfa-2b.
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Peginterferon alfa-2b.
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Peginterferon alfa-2b.
DB09042,The risk or severity of myelosuppression can be increased when Peginterferon alfa-2b is combined with Tedizolid phosphate.
DB00091,Peginterferon alfa-2b may increase the immunosuppressive activities of Cyclosporine.
DB00268,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Ropinirole.
DB00321,The metabolism of Amitriptyline can be decreased when combined with Peginterferon alfa-2b.
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Peginterferon alfa-2b.
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Peginterferon alfa-2b.
DB00373,The metabolism of Timolol can be decreased when combined with Peginterferon alfa-2b.
DB00193,The metabolism of Tramadol can be decreased when combined with Peginterferon alfa-2b.
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Peginterferon alfa-2b.
DB01601,The serum concentration of Peginterferon alfa-2b can be increased when it is combined with Lopinavir.
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Peginterferon alfa-2b.
DB12530,The risk or severity of infection can be increased when Peginterferon alfa-2b is combined with Inebilizumab.
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Asparaginase Escherichia coli.
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Asparaginase Escherichia coli.
DB08894,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Asparaginase Escherichia coli.
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Asparaginase Escherichia coli.
DB01234,The serum concentration of Dexamethasone can be increased when it is combined with Asparaginase Escherichia coli.
DB00563,The therapeutic efficacy of Methotrexate can be decreased when used in combination with Asparaginase Escherichia coli.
DB00619,The risk or severity of liver damage can be increased when Asparaginase Escherichia coli is combined with Imatinib.
DB00252,The therapeutic efficacy of Phenytoin can be increased when used in combination with Asparaginase Escherichia coli.
DB00279,The therapeutic efficacy of Liothyronine can be increased when used in combination with Asparaginase Escherichia coli.
DB00451,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Asparaginase Escherichia coli.
DB00532,The therapeutic efficacy of Mephenytoin can be increased when used in combination with Asparaginase Escherichia coli.
DB00564,The therapeutic efficacy of Carbamazepine can be increased when used in combination with Asparaginase Escherichia coli.
DB00695,The therapeutic efficacy of Furosemide can be increased when used in combination with Asparaginase Escherichia coli.
DB00698,The therapeutic efficacy of Nitrofurantoin can be increased when used in combination with Asparaginase Escherichia coli.
DB00754,The therapeutic efficacy of Ethotoin can be increased when used in combination with Asparaginase Escherichia coli.
DB00939,The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Escherichia coli.
DB01109,The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Escherichia coli.
DB01219,The therapeutic efficacy of Dantrolene can be increased when used in combination with Asparaginase Escherichia coli.
DB01320,The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Asparaginase Escherichia coli.
DB01583,The therapeutic efficacy of Liotrix can be increased when used in combination with Asparaginase Escherichia coli.
DB08899,The therapeutic efficacy of Enzalutamide can be increased when used in combination with Asparaginase Escherichia coli.
DB08984,The therapeutic efficacy of Etofenamate can be increased when used in combination with Asparaginase Escherichia coli.
DB12425,The therapeutic efficacy of Liothyronine I-131 can be increased when used in combination with Asparaginase Escherichia coli.
DB13396,The therapeutic efficacy of Neocitrullamon can be increased when used in combination with Asparaginase Escherichia coli.
DB01344,Tolevamer can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00255,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diethylstilbestrol.
DB00269,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Chlorotrianisene.
DB00286,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Conjugated estrogens.
DB00783,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol.
DB00977,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethinylestradiol.
DB01357,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mestranol.
DB04573,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estriol.
DB04574,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estrone sulfate.
DB04575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Quinestrol.
DB07931,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Hexestrol.
DB09070,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tibolone.
DB09317,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, A."
DB09318,"The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Synthetic Conjugated Estrogens, B."
DB09369,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Polyestradiol phosphate.
DB09381,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esterified estrogens.
DB11478,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zeranol.
DB11674,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Equol.
DB12487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Promestriene.
DB13143,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methallenestril.
DB13386,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epimestrol.
DB13418,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Moxestrol.
DB13952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol acetate.
DB13953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol benzoate.
DB13954,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol cypionate.
DB13956,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Estradiol valerate.
DB15334,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Biochanin A.
DB15335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Formononetin.
DB00176,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluvoxamine.
DB00215,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Citalopram.
DB00472,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluoxetine.
DB00476,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Duloxetine.
DB00656,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Trazodone.
DB00715,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paroxetine.
DB01104,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sertraline.
DB01105,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sibutramine.
DB01149,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nefazodone.
DB01175,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Escitalopram.
DB04832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Zimelidine.
DB04884,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dapoxetine.
DB04896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Milnacipran.
DB06700,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Desvenlafaxine.
DB06731,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Seproxetine.
DB08918,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levomilnacipran.
DB08953,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indalpine.
DB12693,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ritanserin.
DB13233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alaproclate.
DB00930,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Colesevelam.
DB00258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium acetate.
DB00326,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glucoheptonate.
DB01164,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium chloride.
DB01373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium.
DB06724,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium carbonate.
DB11093,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium citrate.
DB11126,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium gluconate.
DB11348,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium Phosphate.
DB13142,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium glubionate anhydrous.
DB13231,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate.
DB13365,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium lactate gluconate.
DB13590,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium pangamate.
DB13800,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium levulinate.
DB14577,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium cation.
DB14684,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Calcium polycarbophil.
DB06792,Lanthanum carbonate can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB09210,"The risk or severity of confusion, irritability, and sleep disorders can be increased when Thyrotropin alfa is combined with Piracetam."
DB00331,The therapeutic efficacy of Metformin can be decreased when used in combination with Thyrotropin alfa.
DB00067,Thyrotropin alfa may increase the vasoconstricting activities of Vasopressin.
DB00093,Thyrotropin alfa may increase the vasoconstricting activities of Felypressin.
DB00247,Thyrotropin alfa may increase the vasoconstricting activities of Methysergide.
DB00320,Thyrotropin alfa may increase the vasoconstricting activities of Dihydroergotamine.
DB00669,Thyrotropin alfa may increase the vasoconstricting activities of Sumatriptan.
DB00696,Thyrotropin alfa may increase the vasoconstricting activities of Ergotamine.
DB00907,Thyrotropin alfa may increase the vasoconstricting activities of Cocaine.
DB00952,Thyrotropin alfa may increase the vasoconstricting activities of Naratriptan.
DB02234,Thyrotropin alfa may increase the vasoconstricting activities of S-Ethylisothiourea.
DB02638,Thyrotropin alfa may increase the vasoconstricting activities of Terlipressin.
DB02860,Thyrotropin alfa may increase the vasoconstricting activities of Calyculin A.
DB06694,Thyrotropin alfa may increase the vasoconstricting activities of Xylometazoline.
DB06707,Thyrotropin alfa may increase the vasoconstricting activities of Levonordefrin.
DB06711,Thyrotropin alfa may increase the vasoconstricting activities of Naphazoline.
DB09202,Thyrotropin alfa may increase the vasoconstricting activities of Cirazoline.
DB11842,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensin II.
DB13251,Thyrotropin alfa may increase the vasoconstricting activities of Octopamine.
DB13394,Thyrotropin alfa may increase the vasoconstricting activities of Adrenalone.
DB13464,Thyrotropin alfa may increase the vasoconstricting activities of Ornipressin.
DB13517,Thyrotropin alfa may increase the vasoconstricting activities of Angiotensinamide.
DB14642,Thyrotropin alfa may increase the vasoconstricting activities of Lypressin.
DB00233,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aminosalicylic acid.
DB00244,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Mesalazine.
DB00795,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Sulfasalazine.
DB00861,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Diflunisal.
DB00936,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Salicylic acid.
DB00945,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Acetylsalicylic acid.
DB01014,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Balsalazide.
DB01250,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Olsalazine.
DB01294,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Bismuth subsalicylate.
DB06251,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Dersalazine.
DB06807,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Phenyl aminosalicylate.
DB09543,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Methyl salicylate.
DB12445,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Nitroaspirin.
DB13509,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Aloxiprin.
DB13538,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Guacetisal.
DB13612,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Carbaspirin calcium.
DB14006,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Choline salicylate.
DB14026,The therapeutic efficacy of Thyrotropin alfa can be increased when used in combination with Thiosalicylic acid.
DB00187,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esmolol.
DB00195,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betaxolol.
DB00264,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoprolol.
DB00335,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Atenolol.
DB00373,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Timolol.
DB00489,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sotalol.
DB00571,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propranolol.
DB00598,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Labetalol.
DB00612,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bisoprolol.
DB00866,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alprenolol.
DB00960,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pindolol.
DB01136,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Carvedilol.
DB01182,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Propafenone.
DB01193,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acebutolol.
DB01203,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nadolol.
DB01295,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bevantolol.
DB01297,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Practolol.
DB01359,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Penbutolol.
DB01580,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Oxprenolol.
DB03322,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexpropranolol.
DB04846,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Celiprolol.
DB04861,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nebivolol.
DB06726,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bufuralol.
DB08807,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bopindolol.
DB08808,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bupranolol.
DB08952,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Indenolol.
DB09013,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Befunolol.
DB09204,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Arotinolol.
DB09351,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Levobetaxolol.
DB11770,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Talinolol.
DB11785,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Anisodamine.
DB12212,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Landiolol.
DB12752,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bucindolol.
DB13443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Esatenolol.
DB13508,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloranolol.
DB13530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mepindolol.
DB13757,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Epanolol.
DB13775,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tertatolol.
DB00394,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Beclomethasone dipropionate.
DB00443,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone.
DB00620,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Triamcinolone.
DB00635,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone.
DB00764,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone.
DB01380,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone acetate.
DB01384,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Paramethasone.
DB01410,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ciclesonide.
DB08906,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone furoate.
DB08970,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene.
DB08971,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluocortolone.
DB09383,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Meprednisone.
DB11487,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dexamethasone isonicotinate.
DB11750,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clobetasol.
DB11921,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Deflazacort.
DB13003,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortivazol.
DB13208,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednylidene.
DB13728,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Halometasone.
DB13843,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cloprednol.
DB13867,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluticasone.
DB14512,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Mometasone furoate.
DB14631,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone phosphate.
DB14633,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisolone hemisuccinate.
DB14634,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fluprednidene acetate.
DB14644,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Methylprednisolone hemisuccinate.
DB14646,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Prednisone acetate.
DB14652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Clocortolone acetate.
DB14659,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Melengestrol acetate.
DB14669,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Betamethasone phosphate.
DB14681,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cortisone.
DB01118,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Amiodarone.
DB00182,The risk or severity of adverse effects can be increased when Amphetamine is combined with Thyrotropin alfa.
DB00191,The risk or severity of adverse effects can be increased when Phentermine is combined with Thyrotropin alfa.
DB00211,The risk or severity of adverse effects can be increased when Midodrine is combined with Thyrotropin alfa.
DB00368,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Thyrotropin alfa.
DB00388,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Thyrotropin alfa.
DB00397,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Thyrotropin alfa.
DB00610,The risk or severity of adverse effects can be increased when Metaraminol is combined with Thyrotropin alfa.
DB00668,The risk or severity of adverse effects can be increased when Epinephrine is combined with Thyrotropin alfa.
DB00723,The risk or severity of adverse effects can be increased when Methoxamine is combined with Thyrotropin alfa.
DB00816,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Thyrotropin alfa.
DB00830,The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Thyrotropin alfa.
DB00841,The risk or severity of adverse effects can be increased when Dobutamine is combined with Thyrotropin alfa.
DB00852,The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Thyrotropin alfa.
DB00865,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Thyrotropin alfa.
DB00867,The risk or severity of adverse effects can be increased when Ritodrine is combined with Thyrotropin alfa.
DB00871,The risk or severity of adverse effects can be increased when Terbutaline is combined with Thyrotropin alfa.
DB00935,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Thyrotropin alfa.
DB00937,The risk or severity of adverse effects can be increased when Diethylpropion is combined with Thyrotropin alfa.
DB00988,The risk or severity of adverse effects can be increased when Dopamine is combined with Thyrotropin alfa.
DB01064,The risk or severity of adverse effects can be increased when Isoprenaline is combined with Thyrotropin alfa.
DB01255,The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Thyrotropin alfa.
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Thyrotropin alfa.
DB01364,The risk or severity of adverse effects can be increased when Ephedrine is combined with Thyrotropin alfa.
DB01365,The risk or severity of adverse effects can be increased when Mephentermine is combined with Thyrotropin alfa.
DB01366,The risk or severity of adverse effects can be increased when Procaterol is combined with Thyrotropin alfa.
DB01407,The risk or severity of adverse effects can be increased when Clenbuterol is combined with Thyrotropin alfa.
DB01442,The risk or severity of adverse effects can be increased when MMDA is combined with Thyrotropin alfa.
DB01454,The risk or severity of adverse effects can be increased when Midomafetamine is combined with Thyrotropin alfa.
DB01467,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Thyrotropin alfa."
DB01484,"The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Thyrotropin alfa."
DB01509,The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Thyrotropin alfa.
DB01556,The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Thyrotropin alfa.
DB01566,The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Thyrotropin alfa.
DB01576,The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Thyrotropin alfa.
DB01577,The risk or severity of adverse effects can be increased when Metamfetamine is combined with Thyrotropin alfa.
DB06152,The risk or severity of adverse effects can be increased when Nylidrin is combined with Thyrotropin alfa.
DB06764,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Thyrotropin alfa.
DB08841,The risk or severity of adverse effects can be increased when Tyramine is combined with Thyrotropin alfa.
DB08941,The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Thyrotropin alfa.
DB08985,The risk or severity of adverse effects can be increased when Etilefrine is combined with Thyrotropin alfa.
DB09203,The risk or severity of adverse effects can be increased when Synephrine is combined with Thyrotropin alfa.
DB09480,The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Thyrotropin alfa.
DB11124,The risk or severity of adverse effects can be increased when Racepinephrine is combined with Thyrotropin alfa.
DB12080,The risk or severity of adverse effects can be increased when Ritobegron is combined with Thyrotropin alfa.
DB13064,The risk or severity of adverse effects can be increased when Tramazoline is combined with Thyrotropin alfa.
DB13108,The risk or severity of adverse effects can be increased when Mephedrone is combined with Thyrotropin alfa.
DB13341,The risk or severity of adverse effects can be increased when Fenozolone is combined with Thyrotropin alfa.
DB13624,The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Thyrotropin alfa.
DB13692,The risk or severity of adverse effects can be increased when Tretoquinol is combined with Thyrotropin alfa.
DB13703,The risk or severity of adverse effects can be increased when Gepefrine is combined with Thyrotropin alfa.
DB13777,The risk or severity of adverse effects can be increased when Prenalterol is combined with Thyrotropin alfa.
DB13852,The risk or severity of adverse effects can be increased when Mefenorex is combined with Thyrotropin alfa.
DB13940,"The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Thyrotropin alfa."
DB00317,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gefitinib.
DB00398,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sorafenib.
DB00530,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erlotinib.
DB00619,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Imatinib.
DB01254,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dasatinib.
DB01259,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lapatinib.
DB01268,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sunitinib.
DB01645,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Genistein.
DB02058,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone.
DB02424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Geldanamycin.
DB02567,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with PD173955.
DB03758,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radicicol.
DB04849,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cediranib.
DB04868,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nilotinib.
DB04879,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vatalanib.
DB05294,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vandetanib.
DB05424,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Canertinib.
DB05465,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tandutinib.
DB05575,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Motesanib.
DB05928,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dovitinib.
DB06302,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Glesatinib.
DB06469,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lestaurtinib.
DB06589,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pazopanib.
DB06595,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Midostaurin.
DB06616,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Bosutinib.
DB06626,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Axitinib.
DB08399,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Piceatannol.
DB08865,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crizotinib.
DB08875,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Cabozantinib.
DB08877,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ruxolitinib.
DB08881,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Vemurafenib.
DB08896,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Regorafenib.
DB08901,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ponatinib.
DB08916,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Afatinib.
DB09053,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ibrutinib.
DB09063,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ceritinib.
DB09078,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lenvatinib.
DB09079,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Nintedanib.
DB09330,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Osimertinib.
DB11363,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Alectinib.
DB11689,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selumetinib.
DB11697,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pacritinib.
DB11703,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Acalabrutinib.
DB11737,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Icotinib.
DB11805,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Saracatinib.
DB11828,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Neratinib.
DB11832,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Crenolanib.
DB11904,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Flumatinib.
DB11963,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Dacomitinib.
DB11973,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tesevatinib.
DB11986,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Entrectinib.
DB12010,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fostamatinib.
DB12048,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Savolitinib.
DB12141,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Gilteritinib.
DB12147,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erdafitinib.
DB12267,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Brigatinib.
DB12307,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Foretinib.
DB12323,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Radotinib.
DB14723,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Larotrectinib.
DB12978,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Pexidartinib.
DB12500,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Fedratinib.
DB11652,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Tucatinib.
DB11791,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Capmatinib.
DB15685,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Selpercatinib.
DB05258,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Interferon alfa.
DB00041,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.
DB00227,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Lovastatin.
DB00609,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Ethionamide.
DB00829,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Diazepam.
DB00850,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine.
DB01233,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Metoclopramide.
DB14651,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Perphenazine enanthate.
DB11085,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Resorcinol.
DB00201,Thyrotropin alfa may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.
DB00277,Thyrotropin alfa may increase the excretion rate of Theophylline which could result in a lower serum level and potentially a reduction in efficacy.
DB00651,Thyrotropin alfa may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.
DB00806,Thyrotropin alfa may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.
DB01033,Thyrotropin alfa may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.
DB01223,Thyrotropin alfa may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.
DB01303,Thyrotropin alfa may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.
DB01412,Thyrotropin alfa may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.
DB01482,Thyrotropin alfa may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.
DB01667,Thyrotropin alfa may increase the excretion rate of 8-azaguanine which could result in a lower serum level and potentially a reduction in efficacy.
DB01978,"Thyrotropin alfa may increase the excretion rate of 7,9-Dimethylguanine which could result in a lower serum level and potentially a reduction in efficacy."
DB02134,Thyrotropin alfa may increase the excretion rate of Xanthine which could result in a lower serum level and potentially a reduction in efficacy.
DB02245,Thyrotropin alfa may increase the excretion rate of 7-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.
DB02377,Thyrotropin alfa may increase the excretion rate of Guanine which could result in a lower serum level and potentially a reduction in efficacy.
DB02489,Thyrotropin alfa may increase the excretion rate of 9-Methylguanine which could result in a lower serum level and potentially a reduction in efficacy.
DB02568,Thyrotropin alfa may increase the excretion rate of Peldesine which could result in a lower serum level and potentially a reduction in efficacy.
DB04076,Thyrotropin alfa may increase the excretion rate of Hypoxanthine which could result in a lower serum level and potentially a reduction in efficacy.
DB04356,Thyrotropin alfa may increase the excretion rate of 9-Deazaguanine which could result in a lower serum level and potentially a reduction in efficacy.
DB06479,Thyrotropin alfa may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.
DB06575,Thyrotropin alfa may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.
DB07954,Thyrotropin alfa may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.
DB08844,Thyrotropin alfa may increase the excretion rate of Uric acid which could result in a lower serum level and potentially a reduction in efficacy.
DB09273,Thyrotropin alfa may increase the excretion rate of Doxofylline which could result in a lower serum level and potentially a reduction in efficacy.
DB11919,Thyrotropin alfa may increase the excretion rate of 6-O-benzylguanine which could result in a lower serum level and potentially a reduction in efficacy.
DB12406,Thyrotropin alfa may increase the excretion rate of Lisofylline which could result in a lower serum level and potentially a reduction in efficacy.
DB12531,Thyrotropin alfa may increase the excretion rate of Lobucavir which could result in a lower serum level and potentially a reduction in efficacy.
DB12926,Thyrotropin alfa may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.
DB12927,Thyrotropin alfa may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.
DB13203,Thyrotropin alfa may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.
DB13449,Thyrotropin alfa may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.
DB13573,Thyrotropin alfa may increase the excretion rate of Acefylline which could result in a lower serum level and potentially a reduction in efficacy.
DB13592,Thyrotropin alfa may increase the excretion rate of Etamiphylline which could result in a lower serum level and potentially a reduction in efficacy.
DB13634,Thyrotropin alfa may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.
DB13812,Thyrotropin alfa may increase the excretion rate of Bufylline which could result in a lower serum level and potentially a reduction in efficacy.
DB14018,Thyrotropin alfa may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
DB14029,Thyrotropin alfa may increase the excretion rate of Furafylline which could result in a lower serum level and potentially a reduction in efficacy.
DB14132,Thyrotropin alfa may increase the excretion rate of 8-chlorotheophylline which could result in a lower serum level and potentially a reduction in efficacy.
DB15122,Thyrotropin alfa may increase the excretion rate of PCS-499 which could result in a lower serum level and potentially a reduction in efficacy.
DB01432,Cholestyramine can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00375,Colestipol can cause a decrease in the absorption of Thyrotropin alfa resulting in a reduced serum concentration and potentially a decrease in efficacy.
DB00658,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Sevelamer.
DB00390,The serum concentration of Digoxin can be decreased when it is combined with Thyrotropin alfa.
DB13401,The serum concentration of Metildigoxin can be decreased when it is combined with Thyrotropin alfa.
DB13691,The serum concentration of Acetyldigoxin can be decreased when it is combined with Thyrotropin alfa.
DB00266,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Dicoumarol.
DB00498,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenindione.
DB00682,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Warfarin.
DB00946,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Phenprocoumon.
DB01418,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Acenocoumarol.
DB03410,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with 4-hydroxycoumarin.
DB04665,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Coumarin.
DB08496,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (R)-warfarin.
DB08794,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Ethyl biscoumacetate.
DB13136,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Fluindione.
DB13275,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Clorindione.
DB13347,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Diphenadione.
DB13451,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with Tioclomarol.
DB14055,The risk or severity of bleeding can be increased when Thyrotropin alfa is combined with (S)-Warfarin.
DB00222,Thyrotropin alfa may decrease the hypoglycemic activities of Glimepiride.
DB00414,Thyrotropin alfa may decrease the hypoglycemic activities of Acetohexamide.
DB00672,Thyrotropin alfa may decrease the hypoglycemic activities of Chlorpropamide.
DB00839,Thyrotropin alfa may decrease the hypoglycemic activities of Tolazamide.
DB01016,Thyrotropin alfa may decrease the hypoglycemic activities of Glyburide.
DB01067,Thyrotropin alfa may decrease the hypoglycemic activities of Glipizide.
DB01120,Thyrotropin alfa may decrease the hypoglycemic activities of Gliclazide.
DB01124,Thyrotropin alfa may decrease the hypoglycemic activities of Tolbutamide.
DB01251,Thyrotropin alfa may decrease the hypoglycemic activities of Gliquidone.
DB01289,Thyrotropin alfa may decrease the hypoglycemic activities of Glisoxepide.
DB08962,Thyrotropin alfa may decrease the hypoglycemic activities of Glibornuride.
DB13406,Thyrotropin alfa may decrease the hypoglycemic activities of Carbutamide.
DB13675,Thyrotropin alfa may decrease the hypoglycemic activities of Metahexamide.
DB00030,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.
DB00046,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.
DB00047,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.
DB00071,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin pork.
DB00197,Thyrotropin alfa may decrease the hypoglycemic activities of Troglitazone.
DB00263,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfisoxazole.
DB00280,Thyrotropin alfa may decrease the hypoglycemic activities of Disopyramide.
DB00284,Thyrotropin alfa may decrease the hypoglycemic activities of Acarbose.
DB00359,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfadiazine.
DB00412,Thyrotropin alfa may decrease the hypoglycemic activities of Rosiglitazone.
DB00468,Thyrotropin alfa may decrease the hypoglycemic activities of Quinine.
DB00491,Thyrotropin alfa may decrease the hypoglycemic activities of Miglitol.
DB00731,Thyrotropin alfa may decrease the hypoglycemic activities of Nateglinide.
DB00738,Thyrotropin alfa may decrease the hypoglycemic activities of Pentamidine.
DB00834,Thyrotropin alfa may decrease the hypoglycemic activities of Mifepristone.
DB00912,Thyrotropin alfa may decrease the hypoglycemic activities of Repaglinide.
DB00914,Thyrotropin alfa may decrease the hypoglycemic activities of Phenformin.
DB01015,Thyrotropin alfa may decrease the hypoglycemic activities of Sulfamethoxazole.
DB01132,Thyrotropin alfa may decrease the hypoglycemic activities of Pioglitazone.
DB01200,Thyrotropin alfa may decrease the hypoglycemic activities of Bromocriptine.
DB01252,Thyrotropin alfa may decrease the hypoglycemic activities of Mitiglinide.
DB01261,Thyrotropin alfa may decrease the hypoglycemic activities of Sitagliptin.
DB01276,Thyrotropin alfa may decrease the hypoglycemic activities of Exenatide.
DB01277,Thyrotropin alfa may decrease the hypoglycemic activities of Mecasermin.
DB01278,Thyrotropin alfa may decrease the hypoglycemic activities of Pramlintide.
DB01306,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin aspart.
DB01307,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin detemir.
DB01309,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glulisine.
DB01382,Thyrotropin alfa may decrease the hypoglycemic activities of Glymidine.
DB01700,Thyrotropin alfa may decrease the hypoglycemic activities of AICA ribonucleotide.
DB04830,Thyrotropin alfa may decrease the hypoglycemic activities of Buformin.
DB04876,Thyrotropin alfa may decrease the hypoglycemic activities of Vildagliptin.
DB04878,Thyrotropin alfa may decrease the hypoglycemic activities of Voglibose.
DB05115,Thyrotropin alfa may decrease the hypoglycemic activities of NN344.
DB05819,Thyrotropin alfa may decrease the hypoglycemic activities of NBI-6024.
DB06011,Thyrotropin alfa may decrease the hypoglycemic activities of AMG-222.
DB06127,Thyrotropin alfa may decrease the hypoglycemic activities of Bisegliptin.
DB06203,Thyrotropin alfa may decrease the hypoglycemic activities of Alogliptin.
DB06292,Thyrotropin alfa may decrease the hypoglycemic activities of Dapagliflozin.
DB06335,Thyrotropin alfa may decrease the hypoglycemic activities of Saxagliptin.
DB06655,Thyrotropin alfa may decrease the hypoglycemic activities of Liraglutide.
DB08382,Thyrotropin alfa may decrease the hypoglycemic activities of Gosogliptin.
DB08882,Thyrotropin alfa may decrease the hypoglycemic activities of Linagliptin.
DB08907,Thyrotropin alfa may decrease the hypoglycemic activities of Canagliflozin.
DB09022,Thyrotropin alfa may decrease the hypoglycemic activities of Benfluorex.
DB09038,Thyrotropin alfa may decrease the hypoglycemic activities of Empagliflozin.
DB09043,Thyrotropin alfa may decrease the hypoglycemic activities of Albiglutide.
DB09045,Thyrotropin alfa may decrease the hypoglycemic activities of Dulaglutide.
DB09198,Thyrotropin alfa may decrease the hypoglycemic activities of Lobeglitazone.
DB09199,Thyrotropin alfa may decrease the hypoglycemic activities of Netoglitazone.
DB09200,Thyrotropin alfa may decrease the hypoglycemic activities of Rivoglitazone.
DB09201,Thyrotropin alfa may decrease the hypoglycemic activities of Ciglitazone.
DB09265,Thyrotropin alfa may decrease the hypoglycemic activities of Lixisenatide.
DB09456,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin beef.
DB09564,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin degludec.
DB11567,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin peglispro.
DB11568,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin tregopil.
DB11698,Thyrotropin alfa may decrease the hypoglycemic activities of Ipragliflozin.
DB11723,Thyrotropin alfa may decrease the hypoglycemic activities of Dutogliptin.
DB11780,Thyrotropin alfa may decrease the hypoglycemic activities of Allicin.
DB11824,Thyrotropin alfa may decrease the hypoglycemic activities of Tofogliflozin.
DB11827,Thyrotropin alfa may decrease the hypoglycemic activities of Ertugliflozin.
DB11898,"Thyrotropin alfa may decrease the hypoglycemic activities of 2,4-thiazolidinedione."
DB11950,Thyrotropin alfa may decrease the hypoglycemic activities of Teneligliptin.
DB11992,Thyrotropin alfa may decrease the hypoglycemic activities of Omarigliptin.
DB12268,Thyrotropin alfa may decrease the hypoglycemic activities of Carmegliptin.
DB12412,Thyrotropin alfa may decrease the hypoglycemic activities of Gemigliptin.
DB12417,Thyrotropin alfa may decrease the hypoglycemic activities of Anagliptin.
DB12625,Thyrotropin alfa may decrease the hypoglycemic activities of Evogliptin.
DB12713,Thyrotropin alfa may decrease the hypoglycemic activities of Sotagliflozin.
DB12781,Thyrotropin alfa may decrease the hypoglycemic activities of Balaglitazone.
DB12935,Thyrotropin alfa may decrease the hypoglycemic activities of Remogliflozin etabonate.
DB13446,Thyrotropin alfa may decrease the hypoglycemic activities of Guar gum.
DB13928,Thyrotropin alfa may decrease the hypoglycemic activities of Semaglutide.
DB14027,Thyrotropin alfa may decrease the hypoglycemic activities of Taspoglutide.
DB14035,Thyrotropin alfa may decrease the hypoglycemic activities of Englitazone.
DB15171,Thyrotropin alfa may decrease the hypoglycemic activities of Tirzepatide.
DB15217,Thyrotropin alfa may decrease the hypoglycemic activities of Gastric inhibitory polypeptide.
DB00540,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Nortriptyline.
DB00321,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptyline.
DB00344,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Protriptyline.
DB00458,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine.
DB00543,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amoxapine.
DB00726,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Trimipramine.
DB01142,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Doxepin.
DB01151,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Desipramine.
DB01242,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Clomipramine.
DB04836,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amineptine.
DB08996,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dimetacrine.
DB09016,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Butriptyline.
DB09167,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dosulepin.
DB09289,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Tianeptine.
DB09307,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Oxaprotiline.
DB12930,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Opipramol.
DB13114,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Amitriptylinoxide.
DB13225,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Dibenzepin.
DB13246,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Quinupramine.
DB13384,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Melitracen.
DB13411,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Lofepramine.
DB13496,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Iprindole.
DB13782,The risk or severity of Cardiac Arrhythmia can be increased when Thyrotropin alfa is combined with Imipramine oxide.
DB00513,"The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Antihemophilic factor, human recombinant."
DB00058,"Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB00170,"Menadione may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB00302,"Tranexamic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB06692,"Aprotinin may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB11091,"Hydrogen peroxide may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB13244,"Aminomethylbenzoic acid may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB13729,"Camostat may increase the thrombogenic activities of Antihemophilic factor, human recombinant."
DB12726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Monteplase."
DB00001,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Lepirudin."
DB00006,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bivalirudin."
DB00009,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Alteplase."
DB00013,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Urokinase."
DB00015,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reteplase."
DB00029,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase."
DB00031,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase."
DB00054,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab."
DB00055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Drotrecogin alfa."
DB00086,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Streptokinase."
DB00266,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dicoumarol."
DB00278,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Argatroban."
DB00407,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ardeparin."
DB00498,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenindione."
DB00569,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fondaparinux."
DB00682,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Warfarin."
DB00686,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Pentosan polysulfate."
DB00945,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acetylsalicylic acid."
DB00946,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Phenprocoumon."
DB00975,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dipyridamole."
DB01088,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Iloprost."
DB01109,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Heparin."
DB01225,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Enoxaparin."
DB01240,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Epoprostenol."
DB01418,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Acenocoumarol."
DB03410,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with 4-hydroxycoumarin."
DB04665,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Coumarin."
DB04898,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ximelagatran."
DB04925,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desmoteplase."
DB04932,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Defibrotide."
DB05099,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ancrod."
DB05229,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Beraprost."
DB05254,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fibrinolysin."
DB06209,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Prasugrel."
DB06228,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Rivaroxaban."
DB06271,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sulodexide."
DB06406,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Idraparinux."
DB06441,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Cangrelor."
DB06543,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Astaxanthin."
DB06605,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Apixaban."
DB06635,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Otamixaban."
DB06679,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Amediplase."
DB06695,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran etexilate."
DB06754,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Danaparoid."
DB06779,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dalteparin."
DB06822,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tinzaparin."
DB07767,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ferulic acid."
DB08496,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (R)-warfarin."
DB08794,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ethyl biscoumacetate."
DB08813,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nadroparin."
DB08814,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Triflusal."
DB08816,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ticagrelor."
DB08994,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Ditazole."
DB09030,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Vorapaxar."
DB09075,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edoxaban."
DB09125,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Potassium citrate."
DB09154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Sodium citrate."
DB09255,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dextran."
DB09258,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Bemiparin."
DB09259,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Reviparin."
DB09260,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Parnaparin."
DB09261,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Certoparin."
DB11095,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Desirudin."
DB11154,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Zinc citrate."
DB11166,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin Alfa."
DB11312,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein C."
DB11598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Antithrombin III human."
DB11984,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Letaxaban."
DB12289,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Darexaban."
DB12364,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Betrixaban."
DB12598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Nafamostat."
DB12831,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Gabexate."
DB13136,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Fluindione."
DB13149,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Protein S human."
DB13199,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Brinase."
DB13275,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Clorindione."
DB13347,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Diphenadione."
DB13451,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tioclomarol."
DB13616,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Melagatran."
DB13646,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Saruplase."
DB14055,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with (S)-Warfarin."
DB14094,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tocopherylquinone."
DB14598,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Edetate calcium disodium anhydrous."
DB14726,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Dabigatran."
DB06294,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Semuloparin."
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Anakinra.
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.
DB00065,The risk or severity of adverse effects can be increased when Infliximab is combined with Anakinra.
DB04956,The risk or severity of adverse effects can be increased when Afelimomab is combined with Anakinra.
DB06674,The risk or severity of adverse effects can be increased when Golimumab is combined with Anakinra.
DB08904,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Anakinra.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Anakinra.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Anakinra.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Anakinra.
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Anakinra.
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Anakinra.
DB00033,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.
DB00034,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.
DB00056,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Anakinra is combined with Pegaspargase.
DB00068,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon beta-1b.
DB00069,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfacon-1.
DB00073,The risk or severity of adverse effects can be increased when Anakinra is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Anakinra is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Anakinra is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Anakinra is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Anakinra is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Anakinra is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Anakinra is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Anakinra is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Anakinra is combined with Antithymocyte immunoglobulin (rabbit).
DB00105,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2b.
DB00111,The risk or severity of adverse effects can be increased when Anakinra is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Anakinra is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Anakinra is combined with Phenylalanine.
DB00242,The risk or severity of adverse effects can be increased when Anakinra is combined with Cladribine.
DB00276,The risk or severity of adverse effects can be increased when Anakinra is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Anakinra is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Anakinra is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitomycin.
DB00322,The risk or severity of adverse effects can be increased when Anakinra is combined with Floxuridine.
DB00352,The risk or severity of adverse effects can be increased when Anakinra is combined with Tioguanine.
DB00380,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexrazoxane.
DB00428,The risk or severity of adverse effects can be increased when Anakinra is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Anakinra is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Anakinra is combined with Gemcitabine.
DB00445,The risk or severity of adverse effects can be increased when Anakinra is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Anakinra is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Anakinra is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Anakinra is combined with Altretamine.
DB00515,The risk or severity of adverse effects can be increased when Anakinra is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Anakinra is combined with Oxaliplatin.
DB00550,The risk or severity of adverse effects can be increased when Anakinra is combined with Propylthiouracil.
DB00552,The risk or severity of adverse effects can be increased when Anakinra is combined with Pentostatin.
DB00601,The risk or severity of adverse effects can be increased when Anakinra is combined with Linezolid.
DB00631,The risk or severity of adverse effects can be increased when Anakinra is combined with Clofarabine.
DB00763,The risk or severity of adverse effects can be increased when Anakinra is combined with Methimazole.
DB00795,The risk or severity of adverse effects can be increased when Anakinra is combined with Sulfasalazine.
DB00853,The risk or severity of adverse effects can be increased when Anakinra is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Anakinra is combined with Penicillamine.
DB00888,The risk or severity of adverse effects can be increased when Anakinra is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Anakinra is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Anakinra is combined with Carboplatin.
DB00970,The risk or severity of adverse effects can be increased when Anakinra is combined with Dactinomycin.
DB01005,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxyurea.
DB01024,The risk or severity of adverse effects can be increased when Anakinra is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Anakinra is combined with Topotecan.
DB01033,The risk or severity of adverse effects can be increased when Anakinra is combined with Mercaptopurine.
DB01042,The risk or severity of adverse effects can be increased when Anakinra is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Anakinra is combined with Flucytosine.
DB01168,The risk or severity of adverse effects can be increased when Anakinra is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Anakinra is combined with Arsenic trioxide.
DB01204,The risk or severity of adverse effects can be increased when Anakinra is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Anakinra is combined with Lomustine.
DB01257,The risk or severity of adverse effects can be increased when Anakinra is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Anakinra is combined with Decitabine.
DB01280,The risk or severity of adverse effects can be increased when Anakinra is combined with Nelarabine.
DB01423,The risk or severity of adverse effects can be increased when Anakinra is combined with Stepronin.
DB01816,The risk or severity of adverse effects can be increased when Anakinra is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Anakinra is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Anakinra is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Anakinra is combined with Brequinar.
DB05258,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Anakinra is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Anakinra is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Anakinra is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Anakinra is combined with omega interferon.
DB06273,The risk or severity of adverse effects can be increased when Anakinra is combined with Tocilizumab.
DB06372,The risk or severity of adverse effects can be increased when Anakinra is combined with Rilonacept.
DB06612,The risk or severity of adverse effects can be increased when Anakinra is combined with Mepolizumab.
DB06662,The risk or severity of adverse effects can be increased when Anakinra is combined with Abetimus.
DB06681,The risk or severity of adverse effects can be increased when Anakinra is combined with Belatacept.
DB06813,The risk or severity of adverse effects can be increased when Anakinra is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Anakinra is combined with Wortmannin.
DB08871,The risk or severity of adverse effects can be increased when Anakinra is combined with Eribulin.
DB08879,The risk or severity of adverse effects can be increased when Anakinra is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Anakinra is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Anakinra is combined with Carfilzomib.
DB08908,The risk or severity of adverse effects can be increased when Anakinra is combined with Dimethyl fumarate.
DB08935,The risk or severity of adverse effects can be increased when Anakinra is combined with Obinutuzumab.
DB09029,The risk or severity of adverse effects can be increased when Anakinra is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Anakinra is combined with Vedolizumab.
DB09036,The risk or severity of adverse effects can be increased when Anakinra is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Anakinra is combined with Blinatumomab.
DB09077,The risk or severity of adverse effects can be increased when Anakinra is combined with Dinutuximab.
DB09091,The risk or severity of adverse effects can be increased when Anakinra is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Anakinra is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Anakinra is combined with Antilymphocyte immunoglobulin (horse).
DB11466,The risk or severity of adverse effects can be increased when Anakinra is combined with Tepoxalin.
DB11569,The risk or severity of adverse effects can be increased when Anakinra is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Anakinra is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Anakinra is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Anakinra is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Anakinra is combined with Peficitinib.
DB11767,The risk or severity of adverse effects can be increased when Anakinra is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Anakinra is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Anakinra is combined with Sirukumab.
DB11834,The risk or severity of adverse effects can be increased when Anakinra is combined with Guselkumab.
DB11988,The risk or severity of adverse effects can be increased when Anakinra is combined with Ocrelizumab.
DB12025,The risk or severity of adverse effects can be increased when Anakinra is combined with Triptolide.
DB12612,The risk or severity of adverse effects can be increased when Anakinra is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Anakinra is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Anakinra is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Anakinra is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Anakinra is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Anakinra is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Anakinra is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Anakinra is combined with Acteoside.
DB13003,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortivazol.
DB13014,The risk or severity of adverse effects can be increased when Anakinra is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Anakinra is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13223,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Anakinra is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Anakinra is combined with Formocortal.
DB13728,The risk or severity of adverse effects can be increased when Anakinra is combined with Halometasone.
DB13843,The risk or severity of adverse effects can be increased when Anakinra is combined with Cloprednol.
DB13856,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluclorolone.
DB14219,The risk or severity of adverse effects can be increased when Anakinra is combined with Monomethyl fumarate.
DB14724,The risk or severity of adverse effects can be increased when Anakinra is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Anakinra is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Anakinra is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Anakinra is combined with Bleselumab.
DB00180,The risk or severity of adverse effects can be increased when Anakinra is combined with Flunisolide.
DB00394,The risk or severity of adverse effects can be increased when Anakinra is combined with Beclomethasone dipropionate.
DB00443,The risk or severity of adverse effects can be increased when Anakinra is combined with Betamethasone.
DB00591,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocinolone acetonide.
DB00635,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisone.
DB00687,The risk or severity of adverse effects can be increased when Anakinra is combined with Fludrocortisone.
DB00764,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone.
DB00860,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednisolone.
DB00959,The risk or severity of adverse effects can be increased when Anakinra is combined with Methylprednisolone.
DB01196,The risk or severity of adverse effects can be increased when Anakinra is combined with Estramustine.
DB01285,The risk or severity of adverse effects can be increased when Anakinra is combined with Corticotropin.
DB01380,The risk or severity of adverse effects can be increased when Anakinra is combined with Cortisone acetate.
DB01384,The risk or severity of adverse effects can be increased when Anakinra is combined with Paramethasone.
DB01611,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydroxychloroquine.
DB04630,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldosterone.
DB08970,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednidene.
DB08971,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluocortolone.
DB09082,The risk or severity of adverse effects can be increased when Anakinra is combined with Vilanterol.
DB09378,The risk or severity of adverse effects can be increased when Anakinra is combined with Fluprednisolone.
DB09383,The risk or severity of adverse effects can be increased when Anakinra is combined with Meprednisone.
DB11487,The risk or severity of adverse effects can be increased when Anakinra is combined with Dexamethasone isonicotinate.
DB11529,The risk or severity of adverse effects can be increased when Anakinra is combined with Melengestrol.
DB11750,The risk or severity of adverse effects can be increased when Anakinra is combined with Clobetasol.
DB11817,The risk or severity of adverse effects can be increased when Anakinra is combined with Baricitinib.
DB11921,The risk or severity of adverse effects can be increased when Anakinra is combined with Deflazacort.
DB13208,The risk or severity of adverse effects can be increased when Anakinra is combined with Prednylidene.
DB14066,The risk or severity of adverse effects can be increased when Anakinra is combined with Tetrandrine.
DB14512,The risk or severity of adverse effects can be increased when Anakinra is combined with Mometasone furoate.
DB14545,The risk or severity of adverse effects can be increased when Anakinra is combined with Hydrocortisone succinate.
DB01222,The risk or severity of adverse effects can be increased when Anakinra is combined with Budesonide.
DB01394,The risk or severity of adverse effects can be increased when Anakinra is combined with Colchicine.
DB00108,The risk or severity of adverse effects can be increased when Anakinra is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Anakinra.
DB01656,Anakinra may increase the immunosuppressive activities of Roflumilast.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Anakinra.
DB01281,The risk or severity of adverse effects can be increased when Anakinra is combined with Abatacept.
DB06168,Anakinra may increase the immunosuppressive activities of Canakinumab.
DB08895,The risk or severity of adverse effects can be increased when Anakinra is combined with Tofacitinib.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Anakinra.
DB01097,The risk or severity of adverse effects can be increased when Anakinra is combined with Leflunomide.
DB00072,Trastuzumab may increase the neutropenic activities of Anakinra.
DB08868,Anakinra may increase the immunosuppressive activities of Fingolimod.
DB00864,Tacrolimus may increase the immunosuppressive activities of Anakinra.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Anakinra.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Anakinra.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Anakinra.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Anakinra.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Anakinra.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Anakinra.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Anakinra.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Anakinra.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Anakinra.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Anakinra."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Anakinra.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Anakinra."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Anakinra.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Anakinra.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Anakinra.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Anakinra.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Anakinra.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Anakinra.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Anakinra.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Anakinra.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Anakinra.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Anakinra.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Anakinra.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Anakinra.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Anakinra.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Anakinra.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Anakinra.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Anakinra.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Anakinra."
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Anakinra.
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Anakinra.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Anakinra.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Anakinra.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Anakinra.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Anakinra.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Anakinra.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Anakinra.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Anakinra.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Anakinra.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Anakinra.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Anakinra.
DB00201,The metabolism of Caffeine can be increased when combined with Anakinra.
DB00176,The metabolism of Fluvoxamine can be increased when combined with Anakinra.
DB00195,The metabolism of Betaxolol can be increased when combined with Anakinra.
DB00261,The metabolism of Anagrelide can be increased when combined with Anakinra.
DB00262,The metabolism of Carmustine can be increased when combined with Anakinra.
DB00268,The metabolism of Ropinirole can be increased when combined with Anakinra.
DB00280,The metabolism of Disopyramide can be increased when combined with Anakinra.
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Anakinra.
DB00296,The metabolism of Ropivacaine can be increased when combined with Anakinra.
DB00315,The metabolism of Zolmitriptan can be increased when combined with Anakinra.
DB00316,The metabolism of Acetaminophen can be increased when combined with Anakinra.
DB00334,The metabolism of Olanzapine can be increased when combined with Anakinra.
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Anakinra.
DB00365,The metabolism of Grepafloxacin can be increased when combined with Anakinra.
DB00370,The metabolism of Mirtazapine can be increased when combined with Anakinra.
DB00379,The metabolism of Mexiletine can be increased when combined with Anakinra.
DB00382,The metabolism of Tacrine can be increased when combined with Anakinra.
DB00384,The metabolism of Triamterene can be increased when combined with Anakinra.
DB00442,The metabolism of Entecavir can be increased when combined with Anakinra.
DB00477,The metabolism of Chlorpromazine can be increased when combined with Anakinra.
DB00518,The metabolism of Albendazole can be increased when combined with Anakinra.
DB00544,The metabolism of Fluorouracil can be increased when combined with Anakinra.
DB00629,The metabolism of Guanabenz can be increased when combined with Anakinra.
DB00642,The metabolism of Pemetrexed can be increased when combined with Anakinra.
DB00730,The metabolism of Thiabendazole can be increased when combined with Anakinra.
DB00740,The metabolism of Riluzole can be increased when combined with Anakinra.
DB00787,The metabolism of Acyclovir can be increased when combined with Anakinra.
DB00806,The metabolism of Pentoxifylline can be increased when combined with Anakinra.
DB00831,The metabolism of Trifluoperazine can be increased when combined with Anakinra.
DB00863,The metabolism of Ranitidine can be increased when combined with Anakinra.
DB00898,The metabolism of Ethanol can be increased when combined with Anakinra.
DB00934,The metabolism of Maprotiline can be increased when combined with Anakinra.
DB00978,The metabolism of Lomefloxacin can be increased when combined with Anakinra.
DB00993,The metabolism of Azathioprine can be increased when combined with Anakinra.
DB00998,The metabolism of Frovatriptan can be increased when combined with Anakinra.
DB01002,The metabolism of Levobupivacaine can be increased when combined with Anakinra.
DB01012,The metabolism of Cinacalcet can be increased when combined with Anakinra.
DB01056,The metabolism of Tocainide can be increased when combined with Anakinra.
DB01087,The metabolism of Primaquine can be increased when combined with Anakinra.
DB01094,The metabolism of Hesperetin can be increased when combined with Anakinra.
DB01182,The metabolism of Propafenone can be increased when combined with Anakinra.
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Anakinra.
DB01303,The metabolism of Oxtriphylline can be increased when combined with Anakinra.
DB01367,The metabolism of Rasagiline can be increased when combined with Anakinra.
DB01405,The metabolism of Temafloxacin can be increased when combined with Anakinra.
DB01412,The metabolism of Theobromine can be increased when combined with Anakinra.
DB01482,The metabolism of Fenethylline can be increased when combined with Anakinra.
DB01558,The metabolism of Bromazepam can be increased when combined with Anakinra.
DB01623,The metabolism of Thiothixene can be increased when combined with Anakinra.
DB01645,The metabolism of Genistein can be increased when combined with Anakinra.
DB01667,The metabolism of 8-azaguanine can be increased when combined with Anakinra.
DB02134,The metabolism of Xanthine can be increased when combined with Anakinra.
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Anakinra.
DB02568,The metabolism of Peldesine can be increased when combined with Anakinra.
DB02709,The metabolism of Resveratrol can be increased when combined with Anakinra.
DB04076,The metabolism of Hypoxanthine can be increased when combined with Anakinra.
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Anakinra.
DB04871,The metabolism of Lorcaserin can be increased when combined with Anakinra.
DB04948,The metabolism of Lofexidine can be increased when combined with Anakinra.
DB04951,The metabolism of Pirfenidone can be increased when combined with Anakinra.
DB06148,The metabolism of Mianserin can be increased when combined with Anakinra.
DB06210,The metabolism of Eltrombopag can be increased when combined with Anakinra.
DB06216,The metabolism of Asenapine can be increased when combined with Anakinra.
DB06235,The metabolism of Vadimezan can be increased when combined with Anakinra.
DB06479,The metabolism of Propentofylline can be increased when combined with Anakinra.
DB06594,The metabolism of Agomelatine can be increased when combined with Anakinra.
DB06769,The metabolism of Bendamustine can be increased when combined with Anakinra.
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Anakinra.
DB06774,The metabolism of Capsaicin can be increased when combined with Anakinra.
DB08496,The metabolism of (R)-warfarin can be increased when combined with Anakinra.
DB09071,The metabolism of Tasimelteon can be increased when combined with Anakinra.
DB09118,The metabolism of Stiripentol can be increased when combined with Anakinra.
DB09225,The metabolism of Zotepine can be increased when combined with Anakinra.
DB09273,The metabolism of Doxofylline can be increased when combined with Anakinra.
DB09290,The metabolism of Ramosetron can be increased when combined with Anakinra.
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Anakinra.
DB11967,The metabolism of Binimetinib can be increased when combined with Anakinra.
DB12026,The metabolism of Voxilaprevir can be increased when combined with Anakinra.
DB12245,The metabolism of Triclabendazole can be increased when combined with Anakinra.
DB12332,The metabolism of Rucaparib can be increased when combined with Anakinra.
DB12406,The metabolism of Lisofylline can be increased when combined with Anakinra.
DB12531,The metabolism of Lobucavir can be increased when combined with Anakinra.
DB12926,The metabolism of Cafedrine can be increased when combined with Anakinra.
DB12927,The metabolism of Theodrenaline can be increased when combined with Anakinra.
DB12945,The metabolism of Dihydralazine can be increased when combined with Anakinra.
DB13203,The metabolism of Bamifylline can be increased when combined with Anakinra.
DB13449,The metabolism of Proxyphylline can be increased when combined with Anakinra.
DB13573,The metabolism of Acefylline can be increased when combined with Anakinra.
DB13592,The metabolism of Etamiphylline can be increased when combined with Anakinra.
DB13634,The metabolism of Pentifylline can be increased when combined with Anakinra.
DB13812,The metabolism of Bufylline can be increased when combined with Anakinra.
DB14018,The metabolism of Bromotheophylline can be increased when combined with Anakinra.
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Anakinra.
DB11757,The metabolism of Istradefylline can be increased when combined with Anakinra.
DB04889,The metabolism of Bicifadine can be increased when combined with Anakinra.
DB05708,The metabolism of GTS-21 can be increased when combined with Anakinra.
DB00977,The metabolism of Ethinylestradiol can be increased when combined with Anakinra.
DB00425,The metabolism of Zolpidem can be increased when combined with Anakinra.
DB00458,The metabolism of Imipramine can be increased when combined with Anakinra.
DB00532,The metabolism of Mephenytoin can be increased when combined with Anakinra.
DB00540,The metabolism of Nortriptyline can be increased when combined with Anakinra.
DB00575,The metabolism of Clonidine can be increased when combined with Anakinra.
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Anakinra.
DB01242,The metabolism of Clomipramine can be increased when combined with Anakinra.
DB11689,The metabolism of Selumetinib can be increased when combined with Anakinra.
DB00277,The metabolism of Theophylline can be increased when combined with Anakinra.
DB00564,The metabolism of Carbamazepine can be increased when combined with Anakinra.
DB00682,The metabolism of Warfarin can be increased when combined with Anakinra.
DB00697,The metabolism of Tizanidine can be increased when combined with Anakinra.
DB01100,The metabolism of Pimozide can be increased when combined with Anakinra.
DB01223,The metabolism of Aminophylline can be increased when combined with Anakinra.
DB01418,The metabolism of Acenocoumarol can be increased when combined with Anakinra.
DB09256,The metabolism of Tegafur can be increased when combined with Anakinra.
DB00851,The metabolism of Dacarbazine can be increased when combined with Anakinra.
DB08910,The metabolism of Pomalidomide can be increased when combined with Anakinra.
DB00238,The metabolism of Nevirapine can be increased when combined with Anakinra.
DB00471,The metabolism of Montelukast can be increased when combined with Anakinra.
DB00690,The metabolism of Flurazepam can be increased when combined with Anakinra.
DB00916,The metabolism of Metronidazole can be increased when combined with Anakinra.
DB00983,The metabolism of Formoterol can be increased when combined with Anakinra.
DB01006,The metabolism of Letrozole can be increased when combined with Anakinra.
DB01028,The metabolism of Methoxyflurane can be increased when combined with Anakinra.
DB01159,The metabolism of Halothane can be increased when combined with Anakinra.
DB01236,The metabolism of Sevoflurane can be increased when combined with Anakinra.
DB01274,The metabolism of Arformoterol can be increased when combined with Anakinra.
DB01544,The metabolism of Flunitrazepam can be increased when combined with Anakinra.
DB06292,The metabolism of Dapagliflozin can be increased when combined with Anakinra.
DB06470,The metabolism of Clomethiazole can be increased when combined with Anakinra.
DB09068,The metabolism of Vortioxetine can be increased when combined with Anakinra.
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Anakinra.
DB11586,The metabolism of Asunaprevir can be increased when combined with Anakinra.
DB04977,The metabolism of Plitidepsin can be increased when combined with Anakinra.
DB06119,The metabolism of Cenobamate can be increased when combined with Anakinra.
DB00193,The metabolism of Tramadol can be increased when combined with Anakinra.
DB00333,The metabolism of Methadone can be increased when combined with Anakinra.
DB00349,The metabolism of Clobazam can be increased when combined with Anakinra.
DB00625,The metabolism of Efavirenz can be increased when combined with Anakinra.
DB00753,The metabolism of Isoflurane can be increased when combined with Anakinra.
DB00818,The metabolism of Propofol can be increased when combined with Anakinra.
DB00835,The metabolism of Brompheniramine can be increased when combined with Anakinra.
DB00836,The metabolism of Loperamide can be increased when combined with Anakinra.
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Anakinra.
DB00865,The metabolism of Benzphetamine can be increased when combined with Anakinra.
DB01069,The metabolism of Promethazine can be increased when combined with Anakinra.
DB01074,The metabolism of Perhexiline can be increased when combined with Anakinra.
DB01221,The metabolism of Ketamine can be increased when combined with Anakinra.
DB01466,The metabolism of Ethylmorphine can be increased when combined with Anakinra.
DB01559,The metabolism of Clotiazepam can be increased when combined with Anakinra.
DB04938,The metabolism of Ospemifene can be increased when combined with Anakinra.
DB04975,The metabolism of Banoxantrone can be increased when combined with Anakinra.
DB05541,The metabolism of Brivaracetam can be increased when combined with Anakinra.
DB06176,The metabolism of Romidepsin can be increased when combined with Anakinra.
DB06209,The metabolism of Prasugrel can be increased when combined with Anakinra.
DB06697,The metabolism of Artemether can be increased when combined with Anakinra.
DB06710,The metabolism of Methyltestosterone can be increased when combined with Anakinra.
DB06738,The metabolism of Ketobemidone can be increased when combined with Anakinra.
DB06739,The metabolism of Seratrodast can be increased when combined with Anakinra.
DB11613,The metabolism of Velpatasvir can be increased when combined with Anakinra.
DB13132,The metabolism of Artemisinin can be increased when combined with Anakinra.
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Anakinra.
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Anakinra.
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Anakinra.
DB01156,The metabolism of Bupropion can be increased when combined with Anakinra.
DB00956,The metabolism of Hydrocodone can be increased when combined with Anakinra.
DB14975,The metabolism of Voxelotor can be increased when combined with Anakinra.
DB11837,The metabolism of Osilodrostat can be increased when combined with Anakinra.
DB13384,The metabolism of Melitracen can be increased when combined with Anakinra.
DB13411,The metabolism of Lofepramine can be increased when combined with Anakinra.
DB00714,The metabolism of Apomorphine can be increased when combined with Anakinra.
DB09167,The metabolism of Dosulepin can be increased when combined with Anakinra.
DB00213,The metabolism of Pantoprazole can be increased when combined with Anakinra.
DB00215,The metabolism of Citalopram can be increased when combined with Anakinra.
DB00312,The metabolism of Pentobarbital can be increased when combined with Anakinra.
DB00338,The metabolism of Omeprazole can be increased when combined with Anakinra.
DB00347,The metabolism of Trimethadione can be increased when combined with Anakinra.
DB00395,The metabolism of Carisoprodol can be increased when combined with Anakinra.
DB00448,The metabolism of Lansoprazole can be increased when combined with Anakinra.
DB00474,The metabolism of Methohexital can be increased when combined with Anakinra.
DB00582,The metabolism of Voriconazole can be increased when combined with Anakinra.
DB00679,The metabolism of Thioridazine can be increased when combined with Anakinra.
DB00736,The metabolism of Esomeprazole can be increased when combined with Anakinra.
DB00794,The metabolism of Primidone can be increased when combined with Anakinra.
DB00909,The metabolism of Zonisamide can be increased when combined with Anakinra.
DB01129,The metabolism of Rabeprazole can be increased when combined with Anakinra.
DB01131,The metabolism of Proguanil can be increased when combined with Anakinra.
DB01175,The metabolism of Escitalopram can be increased when combined with Anakinra.
DB01259,The metabolism of Lapatinib can be increased when combined with Anakinra.
DB01323,The metabolism of St. John's Wort can be increased when combined with Anakinra.
DB01355,The metabolism of Hexobarbital can be increased when combined with Anakinra.
DB01483,The metabolism of Barbital can be increased when combined with Anakinra.
DB05246,The metabolism of Methsuximide can be increased when combined with Anakinra.
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Anakinra.
DB06218,The metabolism of Lacosamide can be increased when combined with Anakinra.
DB06414,The metabolism of Etravirine can be increased when combined with Anakinra.
DB06605,The metabolism of Apixaban can be increased when combined with Anakinra.
DB09166,The metabolism of Etizolam can be increased when combined with Anakinra.
DB12130,The metabolism of Lorlatinib can be increased when combined with Anakinra.
DB12474,The metabolism of Lynestrenol can be increased when combined with Anakinra.
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Anakinra.
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Anakinra.
DB00715,The metabolism of Paroxetine can be increased when combined with Anakinra.
DB12500,The metabolism of Fedratinib can be increased when combined with Anakinra.
DB04861,The metabolism of Nebivolol can be increased when combined with Anakinra.
DB06684,The metabolism of Vilazodone can be increased when combined with Anakinra.
DB01104,The metabolism of Sertraline can be increased when combined with Anakinra.
DB11823,The metabolism of Esketamine can be increased when combined with Anakinra.
DB00252,The metabolism of Phenytoin can be increased when combined with Anakinra.
DB00599,The metabolism of Thiopental can be increased when combined with Anakinra.
DB01174,The metabolism of Phenobarbital can be increased when combined with Anakinra.
DB01320,The metabolism of Fosphenytoin can be increased when combined with Anakinra.
DB00613,The metabolism of Amodiaquine can be increased when combined with Anakinra.
DB00799,The metabolism of Tazarotene can be increased when combined with Anakinra.
DB05229,The metabolism of Beraprost can be increased when combined with Anakinra.
DB06510,The metabolism of Muraglitazar can be increased when combined with Anakinra.
DB09296,The metabolism of Ombitasvir can be increased when combined with Anakinra.
DB01217,The metabolism of Anastrozole can be increased when combined with Anakinra.
DB00255,The metabolism of Diethylstilbestrol can be increased when combined with Anakinra.
DB00295,The metabolism of Morphine can be increased when combined with Anakinra.
DB00359,The metabolism of Sulfadiazine can be increased when combined with Anakinra.
DB00402,The metabolism of Eszopiclone can be increased when combined with Anakinra.
DB00622,The metabolism of Nicardipine can be increased when combined with Anakinra.
DB00912,The metabolism of Repaglinide can be increased when combined with Anakinra.
DB01261,The metabolism of Sitagliptin can be increased when combined with Anakinra.
DB06670,The metabolism of Odanacatib can be increased when combined with Anakinra.
DB08502,The metabolism of Capravirine can be increased when combined with Anakinra.
DB08931,The metabolism of Riociguat can be increased when combined with Anakinra.
DB09198,The metabolism of Lobeglitazone can be increased when combined with Anakinra.
DB09199,The metabolism of Netoglitazone can be increased when combined with Anakinra.
DB09200,The metabolism of Rivoglitazone can be increased when combined with Anakinra.
DB09201,The metabolism of Ciglitazone can be increased when combined with Anakinra.
DB11362,The metabolism of Selexipag can be increased when combined with Anakinra.
DB11901,The metabolism of Apalutamide can be increased when combined with Anakinra.
DB11978,The metabolism of Glasdegib can be increased when combined with Anakinra.
DB12781,The metabolism of Balaglitazone can be increased when combined with Anakinra.
DB01132,The metabolism of Pioglitazone can be increased when combined with Anakinra.
DB11652,The metabolism of Tucatinib can be increased when combined with Anakinra.
DB00946,The metabolism of Phenprocoumon can be increased when combined with Anakinra.
DB01229,The metabolism of Paclitaxel can be increased when combined with Anakinra.
DB00177,The metabolism of Valsartan can be increased when combined with Anakinra.
DB00184,The metabolism of Nicotine can be increased when combined with Anakinra.
DB00197,The metabolism of Troglitazone can be increased when combined with Anakinra.
DB00214,The metabolism of Torasemide can be increased when combined with Anakinra.
DB00222,The metabolism of Glimepiride can be increased when combined with Anakinra.
DB00285,The metabolism of Venlafaxine can be increased when combined with Anakinra.
DB00304,The metabolism of Desogestrel can be increased when combined with Anakinra.
DB00307,The metabolism of Bexarotene can be increased when combined with Anakinra.
DB00327,The metabolism of Hydromorphone can be increased when combined with Anakinra.
DB00328,The metabolism of Indomethacin can be increased when combined with Anakinra.
DB00343,The metabolism of Diltiazem can be increased when combined with Anakinra.
DB00374,The metabolism of Treprostinil can be increased when combined with Anakinra.
DB00412,The metabolism of Rosiglitazone can be increased when combined with Anakinra.
DB00414,The metabolism of Acetohexamide can be increased when combined with Anakinra.
DB00420,The metabolism of Promazine can be increased when combined with Anakinra.
DB00440,The metabolism of Trimethoprim can be increased when combined with Anakinra.
DB00461,The metabolism of Nabumetone can be increased when combined with Anakinra.
DB00468,The metabolism of Quinine can be increased when combined with Anakinra.
DB00469,The metabolism of Tenoxicam can be increased when combined with Anakinra.
DB00472,The metabolism of Fluoxetine can be increased when combined with Anakinra.
DB00476,The metabolism of Duloxetine can be increased when combined with Anakinra.
DB00482,The metabolism of Celecoxib can be increased when combined with Anakinra.
DB00495,The metabolism of Zidovudine can be increased when combined with Anakinra.
DB00502,The metabolism of Haloperidol can be increased when combined with Anakinra.
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Anakinra.
DB00533,The metabolism of Rofecoxib can be increased when combined with Anakinra.
DB00549,The metabolism of Zafirlukast can be increased when combined with Anakinra.
DB00554,The metabolism of Piroxicam can be increased when combined with Anakinra.
DB00559,The metabolism of Bosentan can be increased when combined with Anakinra.
DB00568,The metabolism of Cinnarizine can be increased when combined with Anakinra.
DB00580,The metabolism of Valdecoxib can be increased when combined with Anakinra.
DB00586,The metabolism of Diclofenac can be increased when combined with Anakinra.
DB00617,The metabolism of Paramethadione can be increased when combined with Anakinra.
DB00661,The metabolism of Verapamil can be increased when combined with Anakinra.
DB00672,The metabolism of Chlorpropamide can be increased when combined with Anakinra.
DB00678,The metabolism of Losartan can be increased when combined with Anakinra.
DB00701,The metabolism of Amprenavir can be increased when combined with Anakinra.
DB00712,The metabolism of Flurbiprofen can be increased when combined with Anakinra.
DB00731,The metabolism of Nateglinide can be increased when combined with Anakinra.
DB00744,The metabolism of Zileuton can be increased when combined with Anakinra.
DB00749,The metabolism of Etodolac can be increased when combined with Anakinra.
DB00755,The metabolism of Tretinoin can be increased when combined with Anakinra.
DB00758,The metabolism of Clopidogrel can be increased when combined with Anakinra.
DB00783,The metabolism of Estradiol can be increased when combined with Anakinra.
DB00784,The metabolism of Mefenamic acid can be increased when combined with Anakinra.
DB00788,The metabolism of Naproxen can be increased when combined with Anakinra.
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Anakinra.
DB00812,The metabolism of Phenylbutazone can be increased when combined with Anakinra.
DB00814,The metabolism of Meloxicam can be increased when combined with Anakinra.
DB00839,The metabolism of Tolazamide can be increased when combined with Anakinra.
DB00843,The metabolism of Donepezil can be increased when combined with Anakinra.
DB00857,The metabolism of Terbinafine can be increased when combined with Anakinra.
DB00904,The metabolism of Ondansetron can be increased when combined with Anakinra.
DB00921,The metabolism of Buprenorphine can be increased when combined with Anakinra.
DB00936,The metabolism of Salicylic acid can be increased when combined with Anakinra.
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Anakinra.
DB00969,The metabolism of Alosetron can be increased when combined with Anakinra.
DB00972,The metabolism of Azelastine can be increased when combined with Anakinra.
DB00980,The metabolism of Ramelteon can be increased when combined with Anakinra.
DB01016,The metabolism of Glyburide can be increased when combined with Anakinra.
DB01029,The metabolism of Irbesartan can be increased when combined with Anakinra.
DB01036,The metabolism of Tolterodine can be increased when combined with Anakinra.
DB01037,The metabolism of Selegiline can be increased when combined with Anakinra.
DB01041,The metabolism of Thalidomide can be increased when combined with Anakinra.
DB01050,The metabolism of Ibuprofen can be increased when combined with Anakinra.
DB01065,The metabolism of Melatonin can be increased when combined with Anakinra.
DB01067,The metabolism of Glipizide can be increased when combined with Anakinra.
DB01072,The metabolism of Atazanavir can be increased when combined with Anakinra.
DB01075,The metabolism of Diphenhydramine can be increased when combined with Anakinra.
DB01095,The metabolism of Fluvastatin can be increased when combined with Anakinra.
DB01098,The metabolism of Rosuvastatin can be increased when combined with Anakinra.
DB01120,The metabolism of Gliclazide can be increased when combined with Anakinra.
DB01124,The metabolism of Tolbutamide can be increased when combined with Anakinra.
DB01136,The metabolism of Carvedilol can be increased when combined with Anakinra.
DB01154,The metabolism of Thiamylal can be increased when combined with Anakinra.
DB01171,The metabolism of Moclobemide can be increased when combined with Anakinra.
DB01177,The metabolism of Idarubicin can be increased when combined with Anakinra.
DB01198,The metabolism of Zopiclone can be increased when combined with Anakinra.
DB01251,The metabolism of Gliquidone can be increased when combined with Anakinra.
DB01283,The metabolism of Lumiracoxib can be increased when combined with Anakinra.
DB01289,The metabolism of Glisoxepide can be increased when combined with Anakinra.
DB01357,The metabolism of Mestranol can be increased when combined with Anakinra.
DB01424,The metabolism of Aminophenazone can be increased when combined with Anakinra.
DB01435,The metabolism of Antipyrine can be increased when combined with Anakinra.
DB01589,The metabolism of Quazepam can be increased when combined with Anakinra.
DB01628,The metabolism of Etoricoxib can be increased when combined with Anakinra.
DB03756,The metabolism of Doconexent can be increased when combined with Anakinra.
DB03783,The metabolism of Phenacetin can be increased when combined with Anakinra.
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Anakinra.
DB04574,The metabolism of Estrone sulfate can be increased when combined with Anakinra.
DB04665,The metabolism of Coumarin can be increased when combined with Anakinra.
DB04725,The metabolism of Licofelone can be increased when combined with Anakinra.
DB04841,The metabolism of Flunarizine can be increased when combined with Anakinra.
DB04898,The metabolism of Ximelagatran can be increased when combined with Anakinra.
DB06204,The metabolism of Tapentadol can be increased when combined with Anakinra.
DB06268,The metabolism of Sitaxentan can be increased when combined with Anakinra.
DB06370,The metabolism of Indisulam can be increased when combined with Anakinra.
DB06652,The metabolism of Vicriviroc can be increased when combined with Anakinra.
DB06725,The metabolism of Lornoxicam can be increased when combined with Anakinra.
DB06737,The metabolism of Zaltoprofen can be increased when combined with Anakinra.
DB06803,The metabolism of Niclosamide can be increased when combined with Anakinra.
DB07615,The metabolism of Tranilast can be increased when combined with Anakinra.
DB08439,The metabolism of Parecoxib can be increased when combined with Anakinra.
DB08828,The metabolism of Vismodegib can be increased when combined with Anakinra.
DB08860,The metabolism of Pitavastatin can be increased when combined with Anakinra.
DB08875,The metabolism of Cabozantinib can be increased when combined with Anakinra.
DB08899,The metabolism of Enzalutamide can be increased when combined with Anakinra.
DB08962,The metabolism of Glibornuride can be increased when combined with Anakinra.
DB09048,The metabolism of Netupitant can be increased when combined with Anakinra.
DB09061,The metabolism of Cannabidiol can be increased when combined with Anakinra.
DB09080,The metabolism of Olodaterol can be increased when combined with Anakinra.
DB09288,The metabolism of Propacetamol can be increased when combined with Anakinra.
DB11560,The metabolism of Lesinurad can be increased when combined with Anakinra.
DB11614,The metabolism of Rupatadine can be increased when combined with Anakinra.
DB13406,The metabolism of Carbutamide can be increased when combined with Anakinra.
DB13675,The metabolism of Metahexamide can be increased when combined with Anakinra.
DB13919,The metabolism of Candesartan can be increased when combined with Anakinra.
DB13941,The metabolism of Piperaquine can be increased when combined with Anakinra.
DB13952,The metabolism of Estradiol acetate can be increased when combined with Anakinra.
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Anakinra.
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Anakinra.
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Anakinra.
DB13956,The metabolism of Estradiol valerate can be increased when combined with Anakinra.
DB14009,The metabolism of Medical Cannabis can be increased when combined with Anakinra.
DB14011,The metabolism of Nabiximols can be increased when combined with Anakinra.
DB00829,The metabolism of Diazepam can be increased when combined with Anakinra.
DB00514,The metabolism of Dextromethorphan can be increased when combined with Anakinra.
DB00470,The metabolism of Dronabinol can be increased when combined with Anakinra.
DB09213,The metabolism of Dexibuprofen can be increased when combined with Anakinra.
DB00465,The metabolism of Ketorolac can be increased when combined with Anakinra.
DB15233,The metabolism of Avapritinib can be increased when combined with Anakinra.
DB00321,The metabolism of Amitriptyline can be increased when combined with Anakinra.
DB01142,The metabolism of Doxepin can be increased when combined with Anakinra.
DB00216,The metabolism of Eletriptan can be increased when combined with Anakinra.
DB00404,The metabolism of Alprazolam can be increased when combined with Anakinra.
DB00726,The metabolism of Trimipramine can be increased when combined with Anakinra.
DB01101,The metabolism of Capecitabine can be increased when combined with Anakinra.
DB00266,The metabolism of Dicoumarol can be increased when combined with Anakinra.
DB00313,The metabolism of Valproic acid can be increased when combined with Anakinra.
DB00908,The metabolism of Quinidine can be increased when combined with Anakinra.
DB13136,The metabolism of Fluindione can be increased when combined with Anakinra.
DB01224,The metabolism of Quetiapine can be increased when combined with Anakinra.
DB00182,The metabolism of Amphetamine can be increased when combined with Anakinra.
DB00187,The metabolism of Esmolol can be increased when combined with Anakinra.
DB00245,The metabolism of Benzatropine can be increased when combined with Anakinra.
DB00289,The metabolism of Atomoxetine can be increased when combined with Anakinra.
DB00335,The metabolism of Atenolol can be increased when combined with Anakinra.
DB00373,The metabolism of Timolol can be increased when combined with Anakinra.
DB00409,The metabolism of Remoxipride can be increased when combined with Anakinra.
DB00592,The metabolism of Piperazine can be increased when combined with Anakinra.
DB00699,The metabolism of Nicergoline can be increased when combined with Anakinra.
DB00737,The metabolism of Meclizine can be increased when combined with Anakinra.
DB00805,The metabolism of Minaprine can be increased when combined with Anakinra.
DB00866,The metabolism of Alprenolol can be increased when combined with Anakinra.
DB00914,The metabolism of Phenformin can be increased when combined with Anakinra.
DB00933,The metabolism of Mesoridazine can be increased when combined with Anakinra.
DB00960,The metabolism of Pindolol can be increased when combined with Anakinra.
DB01071,The metabolism of Mequitazine can be increased when combined with Anakinra.
DB01079,The metabolism of Tegaserod can be increased when combined with Anakinra.
DB01193,The metabolism of Acebutolol can be increased when combined with Anakinra.
DB01203,The metabolism of Nadolol can be increased when combined with Anakinra.
DB01228,The metabolism of Encainide can be increased when combined with Anakinra.
DB01233,The metabolism of Metoclopramide can be increased when combined with Anakinra.
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Anakinra.
DB01295,The metabolism of Bevantolol can be increased when combined with Anakinra.
DB01297,The metabolism of Practolol can be increased when combined with Anakinra.
DB01359,The metabolism of Penbutolol can be increased when combined with Anakinra.
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Anakinra.
DB01429,The metabolism of Aprindine can be increased when combined with Anakinra.
DB01454,The metabolism of Midomafetamine can be increased when combined with Anakinra.
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Anakinra.
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Anakinra.
DB01577,The metabolism of Metamfetamine can be increased when combined with Anakinra.
DB01580,The metabolism of Oxprenolol can be increased when combined with Anakinra.
DB04840,The metabolism of Debrisoquine can be increased when combined with Anakinra.
DB04844,The metabolism of Tetrabenazine can be increased when combined with Anakinra.
DB04846,The metabolism of Celiprolol can be increased when combined with Anakinra.
DB06217,The metabolism of Vernakalant can be increased when combined with Anakinra.
DB06506,The metabolism of Repinotan can be increased when combined with Anakinra.
DB06608,The metabolism of Tafenoquine can be increased when combined with Anakinra.
DB06678,The metabolism of Esmirtazapine can be increased when combined with Anakinra.
DB06726,The metabolism of Bufuralol can be increased when combined with Anakinra.
DB06727,The metabolism of Sparteine can be increased when combined with Anakinra.
DB06735,The metabolism of Enclomiphene can be increased when combined with Anakinra.
DB08807,The metabolism of Bopindolol can be increased when combined with Anakinra.
DB08808,The metabolism of Bupranolol can be increased when combined with Anakinra.
DB08952,The metabolism of Indenolol can be increased when combined with Anakinra.
DB09013,The metabolism of Befunolol can be increased when combined with Anakinra.
DB09076,The metabolism of Umeclidinium can be increased when combined with Anakinra.
DB09204,The metabolism of Arotinolol can be increased when combined with Anakinra.
DB09351,The metabolism of Levobetaxolol can be increased when combined with Anakinra.
DB11770,The metabolism of Talinolol can be increased when combined with Anakinra.
DB11785,The metabolism of Anisodamine can be increased when combined with Anakinra.
DB11855,The metabolism of Revefenacin can be increased when combined with Anakinra.
DB11979,The metabolism of Elagolix can be increased when combined with Anakinra.
DB12070,The metabolism of Letermovir can be increased when combined with Anakinra.
DB12212,The metabolism of Landiolol can be increased when combined with Anakinra.
DB12752,The metabolism of Bucindolol can be increased when combined with Anakinra.
DB13443,The metabolism of Esatenolol can be increased when combined with Anakinra.
DB13508,The metabolism of Cloranolol can be increased when combined with Anakinra.
DB13530,The metabolism of Mepindolol can be increased when combined with Anakinra.
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Anakinra.
DB13757,The metabolism of Epanolol can be increased when combined with Anakinra.
DB13775,The metabolism of Tertatolol can be increased when combined with Anakinra.
DB00850,The metabolism of Perphenazine can be increased when combined with Anakinra.
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Anakinra.
DB00281,The metabolism of Lidocaine can be increased when combined with Anakinra.
DB00598,The metabolism of Labetalol can be increased when combined with Anakinra.
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Anakinra."
DB01410,The metabolism of Ciclesonide can be increased when combined with Anakinra.
DB00918,The metabolism of Almotriptan can be increased when combined with Anakinra.
DB08918,The metabolism of Levomilnacipran can be increased when combined with Anakinra.
DB08922,The metabolism of Perospirone can be increased when combined with Anakinra.
DB09183,The metabolism of Dasabuvir can be increased when combined with Anakinra.
DB00185,The metabolism of Cevimeline can be increased when combined with Anakinra.
DB00243,The metabolism of Ranolazine can be increased when combined with Anakinra.
DB00297,The metabolism of Bupivacaine can be increased when combined with Anakinra.
DB00318,The metabolism of Codeine can be increased when combined with Anakinra.
DB00377,The metabolism of Palonosetron can be increased when combined with Anakinra.
DB00589,The metabolism of Lisuride can be increased when combined with Anakinra.
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Anakinra.
DB00674,The metabolism of Galantamine can be increased when combined with Anakinra.
DB00705,The metabolism of Delavirdine can be increased when combined with Anakinra.
DB00706,The metabolism of Tamsulosin can be increased when combined with Anakinra.
DB00757,The metabolism of Dolasetron can be increased when combined with Anakinra.
DB01149,The metabolism of Nefazodone can be increased when combined with Anakinra.
DB01192,The metabolism of Oxymorphone can be increased when combined with Anakinra.
DB01244,The metabolism of Bepridil can be increased when combined with Anakinra.
DB01392,The metabolism of Yohimbine can be increased when combined with Anakinra.
DB01409,The metabolism of Tiotropium can be increased when combined with Anakinra.
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Anakinra.
DB01591,The metabolism of Solifenacin can be increased when combined with Anakinra.
DB01621,The metabolism of Pipotiazine can be increased when combined with Anakinra.
DB02703,The metabolism of Fusidic acid can be increased when combined with Anakinra.
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Anakinra.
DB04884,The metabolism of Dapoxetine can be increased when combined with Anakinra.
DB04905,The metabolism of Tesmilifene can be increased when combined with Anakinra.
DB04920,The metabolism of Clevidipine can be increased when combined with Anakinra.
DB05271,The metabolism of Rotigotine can be increased when combined with Anakinra.
DB06016,The metabolism of Cariprazine can be increased when combined with Anakinra.
DB06144,The metabolism of Sertindole can be increased when combined with Anakinra.
DB06203,The metabolism of Alogliptin can be increased when combined with Anakinra.
DB06702,The metabolism of Fesoterodine can be increased when combined with Anakinra.
DB08893,The metabolism of Mirabegron can be increased when combined with Anakinra.
DB09128,The metabolism of Brexpiprazole can be increased when combined with Anakinra.
DB09195,The metabolism of Lorpiprazole can be increased when combined with Anakinra.
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Anakinra.
DB11130,The metabolism of Opium can be increased when combined with Anakinra.
DB11642,The metabolism of Pitolisant can be increased when combined with Anakinra.
DB13293,The metabolism of Ipecac can be increased when combined with Anakinra.
DB00344,The metabolism of Protriptyline can be increased when combined with Anakinra.
DB00496,The metabolism of Darifenacin can be increased when combined with Anakinra.
DB00543,The metabolism of Amoxapine can be increased when combined with Anakinra.
DB00932,The metabolism of Tipranavir can be increased when combined with Anakinra.
DB09039,The metabolism of Eliglustat can be increased when combined with Anakinra.
DB12930,The metabolism of Opipramol can be increased when combined with Anakinra.
DB00489,The metabolism of Sotalol can be increased when combined with Anakinra.
DB01035,The metabolism of Procainamide can be increased when combined with Anakinra.
DB01195,The metabolism of Flecainide can be increased when combined with Anakinra.
DB00228,The metabolism of Enflurane can be increased when combined with Anakinra.
DB06712,The metabolism of Nilvadipine can be increased when combined with Anakinra.
DB06728,The metabolism of Aniline can be increased when combined with Anakinra.
DB00949,The metabolism of Felbamate can be increased when combined with Anakinra.
DB00593,The metabolism of Ethosuximide can be increased when combined with Anakinra.
DB00186,The metabolism of Lorazepam can be increased when combined with Anakinra.
DB00191,The metabolism of Phentermine can be increased when combined with Anakinra.
DB00207,The metabolism of Azithromycin can be increased when combined with Anakinra.
DB00208,The metabolism of Ticlopidine can be increased when combined with Anakinra.
DB00264,The metabolism of Metoprolol can be increased when combined with Anakinra.
DB00426,The metabolism of Famciclovir can be increased when combined with Anakinra.
DB00433,The metabolism of Prochlorperazine can be increased when combined with Anakinra.
DB00567,The metabolism of Cephalexin can be increased when combined with Anakinra.
DB00590,The metabolism of Doxazosin can be increased when combined with Anakinra.
DB01039,The metabolism of Fenofibrate can be increased when combined with Anakinra.
DB01395,The metabolism of Drospirenone can be increased when combined with Anakinra.
DB01411,The metabolism of Pranlukast can be increased when combined with Anakinra.
DB01431,The metabolism of Allylestrenol can be increased when combined with Anakinra.
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Anakinra.
DB06201,The metabolism of Rufinamide can be increased when combined with Anakinra.
DB06480,The metabolism of Prucalopride can be increased when combined with Anakinra.
DB08882,The metabolism of Linagliptin can be increased when combined with Anakinra.
DB09030,The metabolism of Vorapaxar can be increased when combined with Anakinra.
DB09034,The metabolism of Suvorexant can be increased when combined with Anakinra.
DB09079,The metabolism of Nintedanib can be increased when combined with Anakinra.
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Anakinra.
DB09330,The metabolism of Osimertinib can be increased when combined with Anakinra.
DB11094,The metabolism of Vitamin D can be increased when combined with Anakinra.
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Anakinra.
DB11730,The metabolism of Ribociclib can be increased when combined with Anakinra.
DB11952,The metabolism of Duvelisib can be increased when combined with Anakinra.
DB12141,The metabolism of Gilteritinib can be increased when combined with Anakinra.
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Anakinra.
DB12952,The metabolism of Methylprednisone can be increased when combined with Anakinra.
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Anakinra.
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Anakinra.
DB14126,The metabolism of Tenofovir can be increased when combined with Anakinra.
DB15444,The metabolism of Elexacaftor can be increased when combined with Anakinra.
DB06717,The metabolism of Fosaprepitant can be increased when combined with Anakinra.
DB12825,The metabolism of Lefamulin can be increased when combined with Anakinra.
DB12887,The metabolism of Tazemetostat can be increased when combined with Anakinra.
DB00454,The metabolism of Meperidine can be increased when combined with Anakinra.
DB01151,The metabolism of Desipramine can be increased when combined with Anakinra.
DB12371,The metabolism of Siponimod can be increased when combined with Anakinra.
DB00247,The metabolism of Methysergide can be increased when combined with Anakinra.
DB08827,The metabolism of Lomitapide can be increased when combined with Anakinra.
DB11742,The metabolism of Ebastine can be increased when combined with Anakinra.
DB05015,The metabolism of Belinostat can be increased when combined with Anakinra.
DB01118,The metabolism of Amiodarone can be increased when combined with Anakinra.
DB00675,The metabolism of Tamoxifen can be increased when combined with Anakinra.
DB00204,The metabolism of Dofetilide can be increased when combined with Anakinra.
DB00342,The metabolism of Terfenadine can be increased when combined with Anakinra.
DB00451,The metabolism of Levothyroxine can be increased when combined with Anakinra.
DB00604,The metabolism of Cisapride can be increased when combined with Anakinra.
DB00877,The metabolism of Sirolimus can be increased when combined with Anakinra.
DB01008,The metabolism of Busulfan can be increased when combined with Anakinra.
DB01254,The metabolism of Dasatinib can be increased when combined with Anakinra.
DB01396,The metabolism of Digitoxin can be increased when combined with Anakinra.
DB01590,The metabolism of Everolimus can be increased when combined with Anakinra.
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Anakinra.
DB04855,The metabolism of Dronedarone can be increased when combined with Anakinra.
DB06287,The metabolism of Temsirolimus can be increased when combined with Anakinra.
DB09053,The metabolism of Ibrutinib can be increased when combined with Anakinra.
DB09289,The metabolism of Tianeptine can be increased when combined with Anakinra.
DB11633,The metabolism of Isavuconazole can be increased when combined with Anakinra.
DB13275,The metabolism of Clorindione can be increased when combined with Anakinra.
DB00398,The metabolism of Sorafenib can be increased when combined with Anakinra.
DB00444,The metabolism of Teniposide can be increased when combined with Anakinra.
DB00530,The metabolism of Erlotinib can be increased when combined with Anakinra.
DB00541,The metabolism of Vincristine can be increased when combined with Anakinra.
DB00619,The metabolism of Imatinib can be increased when combined with Anakinra.
DB00773,The metabolism of Etoposide can be increased when combined with Anakinra.
DB01248,The metabolism of Docetaxel can be increased when combined with Anakinra.
DB01268,The metabolism of Sunitinib can be increased when combined with Anakinra.
DB06626,The metabolism of Axitinib can be increased when combined with Anakinra.
DB08865,The metabolism of Crizotinib can be increased when combined with Anakinra.
DB08901,The metabolism of Ponatinib can be increased when combined with Anakinra.
DB12483,The metabolism of Copanlisib can be increased when combined with Anakinra.
DB00188,The metabolism of Bortezomib can be increased when combined with Anakinra.
DB00363,The metabolism of Clozapine can be increased when combined with Anakinra.
DB01181,The metabolism of Ifosfamide can be increased when combined with Anakinra.
DB05109,The metabolism of Trabectedin can be increased when combined with Anakinra.
DB12147,The metabolism of Erdafitinib can be increased when combined with Anakinra.
DB13874,The metabolism of Enasidenib can be increased when combined with Anakinra.
DB06589,The metabolism of Pazopanib can be increased when combined with Anakinra.
DB05239,The metabolism of Cobimetinib can be increased when combined with Anakinra.
DB09063,The metabolism of Ceritinib can be increased when combined with Anakinra.
DB11963,The metabolism of Dacomitinib can be increased when combined with Anakinra.
DB12015,The metabolism of Alpelisib can be increased when combined with Anakinra.
DB00309,The metabolism of Vindesine can be increased when combined with Anakinra.
DB00361,The metabolism of Vinorelbine can be increased when combined with Anakinra.
DB00570,The metabolism of Vinblastine can be increased when combined with Anakinra.
DB00694,The metabolism of Daunorubicin can be increased when combined with Anakinra.
DB00987,The metabolism of Cytarabine can be increased when combined with Anakinra.
DB00997,The metabolism of Doxorubicin can be increased when combined with Anakinra.
DB01108,The metabolism of Trilostane can be increased when combined with Anakinra.
DB04572,The metabolism of Thiotepa can be increased when combined with Anakinra.
DB04845,The metabolism of Ixabepilone can be increased when combined with Anakinra.
DB04868,The metabolism of Nilotinib can be increased when combined with Anakinra.
DB06603,The metabolism of Panobinostat can be increased when combined with Anakinra.
DB06616,The metabolism of Bosutinib can be increased when combined with Anakinra.
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Anakinra.
DB08877,The metabolism of Ruxolitinib can be increased when combined with Anakinra.
DB09073,The metabolism of Palbociclib can be increased when combined with Anakinra.
DB08912,The metabolism of Dabrafenib can be increased when combined with Anakinra.
DB12267,The metabolism of Brigatinib can be increased when combined with Anakinra.
DB11718,The metabolism of Encorafenib can be increased when combined with Anakinra.
DB00563,The metabolism of Methotrexate can be increased when combined with Anakinra.
DB05294,The metabolism of Vandetanib can be increased when combined with Anakinra.
DB05812,The metabolism of Abiraterone can be increased when combined with Anakinra.
DB08881,The metabolism of Vemurafenib can be increased when combined with Anakinra.
DB11363,The metabolism of Alectinib can be increased when combined with Anakinra.
DB11581,The metabolism of Venetoclax can be increased when combined with Anakinra.
DB11641,The metabolism of Vinflunine can be increased when combined with Anakinra.
DB11703,The metabolism of Acalabrutinib can be increased when combined with Anakinra.
DB15035,The metabolism of Zanubrutinib can be increased when combined with Anakinra.
DB00248,The metabolism of Cabergoline can be increased when combined with Anakinra.
DB06595,The metabolism of Midostaurin can be increased when combined with Anakinra.
DB09143,The metabolism of Sonidegib can be increased when combined with Anakinra.
DB11828,The metabolism of Neratinib can be increased when combined with Anakinra.
DB11986,The metabolism of Entrectinib can be increased when combined with Anakinra.
DB12978,The metabolism of Pexidartinib can be increased when combined with Anakinra.
DB14568,The metabolism of Ivosidenib can be increased when combined with Anakinra.
DB09054,The metabolism of Idelalisib can be increased when combined with Anakinra.
DB09570,The metabolism of Ixazomib can be increased when combined with Anakinra.
DB00199,The metabolism of Erythromycin can be increased when combined with Anakinra.
DB00246,The metabolism of Ziprasidone can be increased when combined with Anakinra.
DB00439,The metabolism of Cerivastatin can be increased when combined with Anakinra.
DB00499,The metabolism of Flutamide can be increased when combined with Anakinra.
DB00528,The metabolism of Lercanidipine can be increased when combined with Anakinra.
DB00571,The metabolism of Propranolol can be increased when combined with Anakinra.
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Anakinra.
DB00608,The metabolism of Chloroquine can be increased when combined with Anakinra.
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Anakinra.
DB00717,The metabolism of Norethisterone can be increased when combined with Anakinra.
DB00738,The metabolism of Pentamidine can be increased when combined with Anakinra.
DB00741,The metabolism of Hydrocortisone can be increased when combined with Anakinra.
DB00762,The metabolism of Irinotecan can be increased when combined with Anakinra.
DB00822,The metabolism of Disulfiram can be increased when combined with Anakinra.
DB00834,The metabolism of Mifepristone can be increased when combined with Anakinra.
DB00938,The metabolism of Salmeterol can be increased when combined with Anakinra.
DB00962,The metabolism of Zaleplon can be increased when combined with Anakinra.
DB00976,The metabolism of Telithromycin can be increased when combined with Anakinra.
DB01054,The metabolism of Nitrendipine can be increased when combined with Anakinra.
DB01058,The metabolism of Praziquantel can be increased when combined with Anakinra.
DB01062,The metabolism of Oxybutynin can be increased when combined with Anakinra.
DB01076,The metabolism of Atorvastatin can be increased when combined with Anakinra.
DB01103,The metabolism of Quinacrine can be increased when combined with Anakinra.
DB01115,The metabolism of Nifedipine can be increased when combined with Anakinra.
DB01126,The metabolism of Dutasteride can be increased when combined with Anakinra.
DB01166,The metabolism of Cilostazol can be increased when combined with Anakinra.
DB01184,The metabolism of Domperidone can be increased when combined with Anakinra.
DB01211,The metabolism of Clarithromycin can be increased when combined with Anakinra.
DB01216,The metabolism of Finasteride can be increased when combined with Anakinra.
DB01218,The metabolism of Halofantrine can be increased when combined with Anakinra.
DB05521,The metabolism of Telaprevir can be increased when combined with Anakinra.
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Anakinra.
DB06267,The metabolism of Udenafil can be increased when combined with Anakinra.
DB06335,The metabolism of Saxagliptin can be increased when combined with Anakinra.
DB06403,The metabolism of Ambrisentan can be increased when combined with Anakinra.
DB06419,The metabolism of Cethromycin can be increased when combined with Anakinra.
DB06772,The metabolism of Cabazitaxel can be increased when combined with Anakinra.
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Anakinra.
DB08820,The metabolism of Ivacaftor can be increased when combined with Anakinra.
DB08873,The metabolism of Boceprevir can be increased when combined with Anakinra.
DB08883,The metabolism of Perampanel can be increased when combined with Anakinra.
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Anakinra.
DB09065,The metabolism of Cobicistat can be increased when combined with Anakinra.
DB09074,The metabolism of Olaparib can be increased when combined with Anakinra.
DB09102,The metabolism of Daclatasvir can be increased when combined with Anakinra.
DB09231,The metabolism of Benidipine can be increased when combined with Anakinra.
DB09297,The metabolism of Paritaprevir can be increased when combined with Anakinra.
DB11574,The metabolism of Elbasvir can be increased when combined with Anakinra.
DB11712,The metabolism of Tezacaftor can be increased when combined with Anakinra.
DB11737,The metabolism of Icotinib can be increased when combined with Anakinra.
DB12301,The metabolism of Doravirine can be increased when combined with Anakinra.
DB13867,The metabolism of Fluticasone can be increased when combined with Anakinra.
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Anakinra.
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Anakinra.
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Anakinra.
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Anakinra.
DB00396,The metabolism of Progesterone can be increased when combined with Anakinra.
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Anakinra.
DB04957,The metabolism of Azimilide can be increased when combined with Anakinra.
DB00250,The metabolism of Dapsone can be increased when combined with Anakinra.
DB00317,The metabolism of Gefitinib can be increased when combined with Anakinra.
DB00367,The metabolism of Levonorgestrel can be increased when combined with Anakinra.
DB00497,The metabolism of Oxycodone can be increased when combined with Anakinra.
DB00620,The metabolism of Triamcinolone can be increased when combined with Anakinra.
DB00624,The metabolism of Testosterone can be increased when combined with Anakinra.
DB00656,The metabolism of Trazodone can be increased when combined with Anakinra.
DB00734,The metabolism of Risperidone can be increased when combined with Anakinra.
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Anakinra.
DB01238,The metabolism of Aripiprazole can be increased when combined with Anakinra.
DB01267,The metabolism of Paliperidone can be increased when combined with Anakinra.
DB04946,The metabolism of Iloperidone can be increased when combined with Anakinra.
DB11915,The metabolism of Valbenazine can be increased when combined with Anakinra.
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Anakinra.
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Anakinra.
DB01234,The metabolism of Dexamethasone can be increased when combined with Anakinra.
DB09237,The metabolism of Levamlodipine can be increased when combined with Anakinra.
DB11951,The metabolism of Lemborexant can be increased when combined with Anakinra.
DB00557,The metabolism of Hydroxyzine can be increased when combined with Anakinra.
DB00203,The metabolism of Sildenafil can be increased when combined with Anakinra.
DB00227,The metabolism of Lovastatin can be increased when combined with Anakinra.
DB00490,The metabolism of Buspirone can be increased when combined with Anakinra.
DB00641,The metabolism of Simvastatin can be increased when combined with Anakinra.
DB00673,The metabolism of Aprepitant can be increased when combined with Anakinra.
DB00820,The metabolism of Tadalafil can be increased when combined with Anakinra.
DB00862,The metabolism of Vardenafil can be increased when combined with Anakinra.
DB01190,The metabolism of Clindamycin can be increased when combined with Anakinra.
DB00503,The metabolism of Ritonavir can be increased when combined with Anakinra.
DB00224,The metabolism of Indinavir can be increased when combined with Anakinra.
DB00401,The metabolism of Nisoldipine can be increased when combined with Anakinra.
DB00637,The metabolism of Astemizole can be increased when combined with Anakinra.
DB00683,The metabolism of Midazolam can be increased when combined with Anakinra.
DB00700,The metabolism of Eplerenone can be increased when combined with Anakinra.
DB00802,The metabolism of Alfentanil can be increased when combined with Anakinra.
DB00813,The metabolism of Fentanyl can be increased when combined with Anakinra.
DB00897,The metabolism of Triazolam can be increased when combined with Anakinra.
DB01023,The metabolism of Felodipine can be increased when combined with Anakinra.
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Anakinra.
DB01232,The metabolism of Saquinavir can be increased when combined with Anakinra.
DB06228,The metabolism of Rivaroxaban can be increased when combined with Anakinra.
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Anakinra.
DB00091,Anakinra may increase the immunosuppressive activities of Cyclosporine.
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Anakinra.
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Anakinra.
DB01601,The serum concentration of Anakinra can be increased when it is combined with Lopinavir.
DB12530,The risk or severity of infection can be increased when Anakinra is combined with Inebilizumab.
DB12768,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Gramicidin D.
DB00266,The risk or severity of bleeding can be increased when Gramicidin D is combined with Dicoumarol.
DB00498,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenindione.
DB00682,The risk or severity of bleeding can be increased when Gramicidin D is combined with Warfarin.
DB00946,The risk or severity of bleeding can be increased when Gramicidin D is combined with Phenprocoumon.
DB01418,The risk or severity of bleeding can be increased when Gramicidin D is combined with Acenocoumarol.
DB03410,The risk or severity of bleeding can be increased when Gramicidin D is combined with 4-hydroxycoumarin.
DB04665,The risk or severity of bleeding can be increased when Gramicidin D is combined with Coumarin.
DB08496,The risk or severity of bleeding can be increased when Gramicidin D is combined with (R)-warfarin.
DB08794,The risk or severity of bleeding can be increased when Gramicidin D is combined with Ethyl biscoumacetate.
DB13136,The risk or severity of bleeding can be increased when Gramicidin D is combined with Fluindione.
DB13275,The risk or severity of bleeding can be increased when Gramicidin D is combined with Clorindione.
DB13347,The risk or severity of bleeding can be increased when Gramicidin D is combined with Diphenadione.
DB13451,The risk or severity of bleeding can be increased when Gramicidin D is combined with Tioclomarol.
DB14055,The risk or severity of bleeding can be increased when Gramicidin D is combined with (S)-Warfarin.
DB14443,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Gramicidin D.
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB00269,Chlorotrianisene may increase the thrombogenic activities of Human immunoglobulin G.
DB00286,Conjugated estrogens may increase the thrombogenic activities of Human immunoglobulin G.
DB00655,Estrone may increase the thrombogenic activities of Human immunoglobulin G.
DB00783,Estradiol may increase the thrombogenic activities of Human immunoglobulin G.
DB00890,Dienestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB00977,Ethinylestradiol may increase the thrombogenic activities of Human immunoglobulin G.
DB01357,Mestranol may increase the thrombogenic activities of Human immunoglobulin G.
DB04573,Estriol may increase the thrombogenic activities of Human immunoglobulin G.
DB04574,Estrone sulfate may increase the thrombogenic activities of Human immunoglobulin G.
DB04575,Quinestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB07931,Hexestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB09070,Tibolone may increase the thrombogenic activities of Human immunoglobulin G.
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Human immunoglobulin G."
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Human immunoglobulin G."
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Human immunoglobulin G.
DB09381,Esterified estrogens may increase the thrombogenic activities of Human immunoglobulin G.
DB11478,Zeranol may increase the thrombogenic activities of Human immunoglobulin G.
DB11674,Equol may increase the thrombogenic activities of Human immunoglobulin G.
DB12487,Promestriene may increase the thrombogenic activities of Human immunoglobulin G.
DB13143,Methallenestril may increase the thrombogenic activities of Human immunoglobulin G.
DB13386,Epimestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB13418,Moxestrol may increase the thrombogenic activities of Human immunoglobulin G.
DB13952,Estradiol acetate may increase the thrombogenic activities of Human immunoglobulin G.
DB13953,Estradiol benzoate may increase the thrombogenic activities of Human immunoglobulin G.
DB13954,Estradiol cypionate may increase the thrombogenic activities of Human immunoglobulin G.
DB13956,Estradiol valerate may increase the thrombogenic activities of Human immunoglobulin G.
DB15334,Biochanin A may increase the thrombogenic activities of Human immunoglobulin G.
DB15335,Formononetin may increase the thrombogenic activities of Human immunoglobulin G.
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Human immunoglobulin G.
DB00043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.
DB00051,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.
DB00054,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.
DB00056,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gemtuzumab ozogamicin.
DB00057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indium In-111 satumomab pendetide.
DB00065,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Infliximab.
DB00072,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab.
DB00073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Muromonab.
DB00076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Digoxin Immune Fab (Ovine).
DB00078,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alemtuzumab.
DB00089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Capromab pendetide.
DB00095,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antithymocyte immunoglobulin (rabbit).
DB00108,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Natalizumab.
DB00110,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Palivizumab.
DB00111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab.
DB00113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Technetium Tc-99m arcitumomab.
DB01257,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eculizumab.
DB01269,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Panitumumab.
DB01270,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ranibizumab.
DB04901,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galiximab.
DB04949,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pexelizumab.
DB04956,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Afelimomab.
DB04958,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Epratuzumab.
DB04962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bectumomab.
DB04964,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Oregovomab.
DB04988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IGN311.
DB05006,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adecatumumab.
DB05097,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab.
DB05101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Matuzumab.
DB05111,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fontolizumab.
DB05136,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bavituximab.
DB05139,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CR002.
DB05209,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozrolimupab.
DB05304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Girentuximab.
DB05336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obiltoxaximab.
DB05405,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XTL-001.
DB05437,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with NAV 1800.
DB05459,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Briakinumab.
DB05496,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Otelixizumab.
DB05545,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AMG 108.
DB05550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Iratumumab.
DB05555,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Enokizumab.
DB05578,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ramucirumab.
DB05595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Farletuzumab.
DB05656,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Veltuzumab.
DB05679,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ustekinumab.
DB05773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab emtansine.
DB05793,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with PRO-542.
DB05797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TNX-901.
DB05889,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inotuzumab ozogamicin.
DB05892,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with RI 624.
DB05915,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with MYO-029.
DB05916,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with CT-011.
DB05941,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Leronlimab.
DB05996,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Glembatumumab vedotin.
DB06043,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olaratumab.
DB06049,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IPH 2101.
DB06050,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with TB-402.
DB06081,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Caplacizumab.
DB06101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with IMC-1C11.
DB06116,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eldelumab.
DB06162,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumiliximab.
DB06168,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Canakinumab.
DB06186,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipilimumab.
DB06192,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nimotuzumab.
DB06241,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clenoliximab.
DB06273,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tocilizumab.
DB06304,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with BIIB015.
DB06305,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sonepcizumab.
DB06310,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Motavizumab.
DB06317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Elotuzumab.
DB06318,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AVE9633.
DB06322,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carotuximab.
DB06324,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with XmAb 2513.
DB06342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Coltuximab ravtansine.
DB06343,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teprotumumab.
DB06360,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lucatumumab.
DB06366,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pertuzumab.
DB06371,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siplizumab.
DB06467,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apolizumab.
DB06474,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sibrotuzumab.
DB06550,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bivatuzumab.
DB06557,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lerdelimumab.
DB06599,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lexatumumab.
DB06602,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Reslizumab.
DB06606,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Teplizumab.
DB06607,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Catumaxomab.
DB06612,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mepolizumab.
DB06643,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Denosumab.
DB06647,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Volociximab.
DB06650,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ofatumumab.
DB06674,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Golimumab.
DB08870,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin.
DB08879,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Belimumab.
DB08902,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Raxibacumab.
DB08904,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Certolizumab pegol.
DB08935,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Obinutuzumab.
DB09029,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vedolizumab.
DB09035,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nivolumab.
DB09036,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Siltuximab.
DB09037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pembrolizumab.
DB09045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dulaglutide.
DB09052,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blinatumomab.
DB09057,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anthrax immune globulin human.
DB09077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dinutuximab.
DB09105,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asfotase alfa.
DB09264,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Idarucizumab.
DB09302,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Alirocumab.
DB09303,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evolocumab.
DB09312,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Antilymphocyte immunoglobulin (horse).
DB09331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Daratumumab.
DB09559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Necitumumab.
DB11569,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ravulizumab.
DB11595,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Atezolizumab.
DB11604,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tetanus Immune Globulin.
DB11608,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eftrenonacog alfa.
DB11621,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human Varicella-Zoster Immune Globulin.
DB11646,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Conatumumab.
DB11657,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tabalumab.
DB11680,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ficlatuzumab.
DB11685,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Figitumumab.
DB11714,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Durvalumab.
DB11715,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bapineuzumab.
DB11731,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab mafodotin.
DB11746,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Onartuzumab.
DB11756,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Solanezumab.
DB11767,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sarilumab.
DB11771,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tremelimumab.
DB11776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sirukumab.
DB11826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lampalizumab.
DB11834,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Guselkumab.
DB11840,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalotuzumab.
DB11849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emibetuzumab.
DB11850,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ublituximab.
DB11856,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ligelizumab.
DB11857,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Seribantumab.
DB11862,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Landogrozumab.
DB11866,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Romosozumab.
DB11884,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vadastuximab Talirine.
DB11914,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lebrikizumab.
DB11930,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Varlilumab.
DB11945,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Avelumab.
DB11959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crenezumab.
DB11972,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rilotumumab.
DB11976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anifrolumab.
DB11988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ocrelizumab.
DB12023,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Benralizumab.
DB12034,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gantenerumab.
DB12053,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Visilizumab.
DB12077,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Urelumab.
DB12089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorvotuzumab mertansine.
DB12090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Patritumab.
DB12102,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fulranumab.
DB12104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tarextumab.
DB12118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sotatercept.
DB12119,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gevokizumab.
DB12142,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Duligotuzumab.
DB12152,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Simtuzumab.
DB12157,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fasinumab.
DB12159,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dupilumab.
DB12169,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tralokinumab.
DB12189,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etrolizumab.
DB12202,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zalutumumab.
DB12205,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ganitumab.
DB12213,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Etaracizumab.
DB12240,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Polatuzumab vedotin.
DB12246,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inclacumab.
DB12250,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cixutumumab.
DB12261,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ascrinvacumab.
DB12274,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Aducanumab.
DB12281,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Luspatercept.
DB12296,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GS-5745.
DB12317,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vanucizumab.
DB12331,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Labetuzumab govitecan.
DB12335,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tanezumab.
DB12342,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ensituximab.
DB12344,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fezakinumab.
DB12363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dusigitumab.
DB12396,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fresolimumab.
DB12413,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Indusatumab vedotin.
DB12456,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bococizumab.
DB12489,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mirvetuximab Soravtansine.
DB12498,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mogamulizumab.
DB12520,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Plozalizumab.
DB12530,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inebilizumab.
DB12534,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mavrilimumab.
DB12560,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Blosozumab.
DB12584,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimagrumab.
DB12589,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dacetuzumab.
DB12609,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tovetumab.
DB12683,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lumretuzumab.
DB12698,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ibalizumab.
DB12701,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Intetumumab.
DB12718,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Carlumab.
DB12734,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Demcizumab.
DB12773,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sifalimumab.
DB12775,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abituzumab.
DB12797,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ecromeximab.
DB12807,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naptumomab Estafenatox.
DB12815,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Crotedumab.
DB12820,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Concizumab.
DB12826,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Depatuxizumab.
DB12844,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rontalizumab.
DB12845,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Amatuximab.
DB12849,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Clazakizumab.
DB12891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ozanezumab.
DB12893,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sacituzumab govitecan.
DB12917,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bimekizumab.
DB12943,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Milatuzumab.
DB12976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Robatumumab.
DB13017,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rovalpituzumab Tesirine.
DB13037,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Namilumab.
DB13045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Racotumomab.
DB13073,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tregalizumab.
DB13127,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Olokizumab.
DB13140,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bezlotoxumab.
DB13375,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Edrecolomab.
DB13535,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nebacumab.
DB13886,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Human cytomegalovirus immune globulin.
DB13923,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emicizumab.
DB13976,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sulesomab.
DB13979,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Besilesomab.
DB14004,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tildrakizumab.
DB14012,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Burosumab.
DB14039,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Erenumab.
DB14040,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Eptinezumab.
DB14041,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fremanezumab.
DB14042,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Galcanezumab.
DB14211,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Fanolesomab.
DB14580,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lecanemab.
DB14597,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lanadelumab.
DB14707,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Cemiplimab.
DB14724,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Risankizumab.
DB14776,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Camrelizumab.
DB14778,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Setrusumab.
DB14784,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gancotamab.
DB14809,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Anetumab ravtansine.
DB14811,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Isatuximab.
DB14824,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Icrucumab.
DB14843,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Codrituzumab.
DB14864,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brolucizumab.
DB14871,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Xentuzumab.
DB14877,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lintuzumab.
DB14891,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vobarilizumab.
DB14897,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Parsatuzumab.
DB14905,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Emactuzumab.
DB14907,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bevacizumab zirconium Zr-89.
DB14908,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Refanezumab.
DB14919,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Rozanolixizumab.
DB14947,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bermekimab.
DB14952,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pamrevlumab.
DB14959,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Opicinumab.
DB14962,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab deruxtecan.
DB14967,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Margetuximab.
DB14988,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Dalantercept.
DB14997,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pateclizumab.
DB15014,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gremubamab.
DB15022,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Apomab.
DB15044,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tafasitamab.
DB15045,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipafricept.
DB15076,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abrilumab.
DB15089,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Frovocimab.
DB15090,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tezepelumab.
DB15101,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tigatuzumab.
DB15104,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Telisotuzumab vedotin.
DB15113,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Utomilumab.
DB15118,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zolbetuximab.
DB15135,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ponezumab.
DB15160,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Asunercept.
DB15172,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Suvratoxumab.
DB15225,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mitazalimab.
DB15252,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Nemolizumab.
DB15253,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Bleselumab.
DB15277,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Gedivumab.
DB15336,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Valanafusp alfa.
DB15349,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Sofituzumab vedotin.
DB15354,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Evinacumab.
DB15363,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Istiratumab.
DB15383,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pidilizumab.
DB15397,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with GMA-161.
DB15409,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ladiratuzumab vedotin.
DB15415,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tomaralimab.
DB15428,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Vesencumab.
DB15432,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pinatuzumab vedotin.
DB15441,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lulizumab pegol.
DB15443,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Lorukafusp alfa.
DB15453,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Naratuximab emtansine.
DB15559,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Zenocutuzumab.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Human immunoglobulin G."
DB06605,Apixaban may increase the anticoagulant activities of Anistreplase.
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Anistreplase.
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Anistreplase.
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Anistreplase is combined with Deferasirox.
DB01586,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Ursodeoxycholic acid.
DB02123,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycochenodeoxycholic Acid.
DB02659,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Cholic Acid.
DB02691,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Glycocholic acid.
DB03619,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Deoxycholic acid.
DB04348,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurocholic acid.
DB05990,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Obeticholic acid.
DB06777,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Chenodeoxycholic acid.
DB08833,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Taurochenodeoxycholic acid.
DB08834,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Tauroursodeoxycholic acid.
DB08857,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Bamet-UD2.
DB11622,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Dehydrocholic acid.
DB11789,The risk or severity of bleeding and bruising can be increased when Anistreplase is combined with Hyodeoxycholic Acid.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Anistreplase.
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Anistreplase.
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Obinutuzumab.
DB06228,Anistreplase may increase the anticoagulant activities of Rivaroxaban.
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Sugammadex.
DB09070,Tibolone may increase the anticoagulant activities of Anistreplase.
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Anistreplase.
DB00013,Urokinase may increase the anticoagulant activities of Anistreplase.
DB00163,Vitamin E may increase the anticoagulant activities of Anistreplase.
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Anistreplase.
DB06692,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Aprotinin.
DB01381,The therapeutic efficacy of Anistreplase can be increased when used in combination with Ginkgo biloba.
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Anistreplase.
DB00468,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinine.
DB00908,The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinidine.
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Anistreplase.
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Anistreplase.
DB00806,The therapeutic efficacy of Anistreplase can be increased when used in combination with Pentoxifylline.
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Anistreplase.
DB00583,The therapeutic efficacy of Anistreplase can be increased when used in combination with Levocarnitine.
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Anistreplase.
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Anistreplase.
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Anistreplase.
DB00783,Estradiol may decrease the anticoagulant activities of Anistreplase.
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Anistreplase.
DB01357,Mestranol may decrease the anticoagulant activities of Anistreplase.
DB04573,Estriol may decrease the anticoagulant activities of Anistreplase.
DB04574,Estrone sulfate may decrease the anticoagulant activities of Anistreplase.
DB04575,Quinestrol may decrease the anticoagulant activities of Anistreplase.
DB07931,Hexestrol may decrease the anticoagulant activities of Anistreplase.
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Anistreplase."
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Anistreplase."
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Anistreplase.
DB09381,Esterified estrogens may decrease the anticoagulant activities of Anistreplase.
DB11478,Zeranol may decrease the anticoagulant activities of Anistreplase.
DB11674,Equol may decrease the anticoagulant activities of Anistreplase.
DB12487,Promestriene may decrease the anticoagulant activities of Anistreplase.
DB13143,Methallenestril may decrease the anticoagulant activities of Anistreplase.
DB13386,Epimestrol may decrease the anticoagulant activities of Anistreplase.
DB13418,Moxestrol may decrease the anticoagulant activities of Anistreplase.
DB13952,Estradiol acetate may decrease the anticoagulant activities of Anistreplase.
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Anistreplase.
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Anistreplase.
DB13956,Estradiol valerate may decrease the anticoagulant activities of Anistreplase.
DB15334,Biochanin A may decrease the anticoagulant activities of Anistreplase.
DB15335,Formononetin may decrease the anticoagulant activities of Anistreplase.
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Anistreplase.
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Anistreplase.
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Anistreplase.
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Anistreplase.
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Anistreplase.
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Anistreplase.
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Anistreplase.
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Anistreplase.
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Anistreplase.
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Anistreplase.
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Anistreplase.
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Anistreplase.
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Anistreplase.
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Anistreplase.
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Anistreplase.
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Anistreplase.
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Anistreplase.
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Anistreplase.
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Anistreplase.
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Anistreplase.
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Anistreplase.
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Anistreplase.
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Anistreplase.
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Anistreplase.
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Anistreplase.
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Anistreplase.
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Anistreplase.
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Anistreplase.
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Anistreplase.
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Anistreplase.
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Anistreplase.
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Anistreplase.
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Anistreplase.
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Anistreplase.
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Anistreplase.
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Anistreplase.
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Anistreplase.
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Anistreplase.
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Anistreplase.
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Anistreplase.
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Anistreplase.
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Anistreplase.
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Anistreplase.
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Anistreplase.
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Anistreplase.
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Anistreplase.
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Anistreplase.
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Anistreplase.
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Anistreplase.
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Anistreplase.
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Anistreplase.
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Anistreplase.
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Anistreplase.
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Anistreplase.
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Anistreplase.
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Anistreplase.
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Anistreplase.
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Anistreplase.
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Anistreplase.
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Anistreplase.
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Anistreplase.
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Anistreplase.
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Anistreplase.
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Anistreplase.
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Anistreplase.
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Anistreplase.
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Anistreplase.
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Anistreplase.
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Anistreplase.
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Anistreplase.
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Anistreplase.
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Anistreplase.
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Anistreplase.
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Anistreplase.
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Anistreplase.
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Anistreplase.
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Anistreplase.
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Anistreplase.
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Anistreplase.
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Anistreplase.
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Anistreplase.
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Anistreplase.
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Anistreplase.
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Anistreplase.
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Anistreplase.
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Anistreplase.
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Anistreplase.
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Anistreplase.
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Anistreplase.
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Anistreplase.
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Anistreplase.
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Anistreplase.
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Anistreplase.
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Anistreplase.
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Anistreplase.
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Anistreplase.
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Anistreplase.
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Anistreplase.
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Anistreplase.
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Anistreplase.
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Anistreplase.
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Anistreplase.
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Anistreplase.
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Anistreplase.
DB04865,The risk or severity of bleeding can be increased when Anistreplase is combined with Omacetaxine mepesuccinate.
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Anistreplase.
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Anistreplase is combined with Tositumomab.
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Anistreplase.
DB00048,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.
DB00389,Carbimazole may increase the anticoagulant activities of Anistreplase.
DB00550,Propylthiouracil may increase the anticoagulant activities of Anistreplase.
DB00763,Methimazole may increase the anticoagulant activities of Anistreplase.
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Anistreplase."
DB06715,Potassium Iodide may increase the anticoagulant activities of Anistreplase.
DB07637,Dibromotyrosine may increase the anticoagulant activities of Anistreplase.
DB09418,Potassium perchlorate may increase the anticoagulant activities of Anistreplase.
DB13644,Methylthiouracil may increase the anticoagulant activities of Anistreplase.
DB13804,Benzylthiouracil may increase the anticoagulant activities of Anistreplase.
DB00834,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mifepristone.
DB04066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with p-Coumaric acid.
DB04682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
DB05830,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trestolone.
DB06266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Lonidamine.
DB08867,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ulipristal.
DB09401,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Isosorbide.
DB11507,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cloprostenol.
DB12025,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triptolide.
DB13044,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Gossypol.
DB13310,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ormeloxifene.
DB00294,Etonogestrel may decrease the anticoagulant activities of Anistreplase.
DB00304,Desogestrel may decrease the anticoagulant activities of Anistreplase.
DB00351,Megestrol acetate may decrease the anticoagulant activities of Anistreplase.
DB00367,Levonorgestrel may decrease the anticoagulant activities of Anistreplase.
DB00378,Dydrogesterone may decrease the anticoagulant activities of Anistreplase.
DB00396,Progesterone may decrease the anticoagulant activities of Anistreplase.
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Anistreplase.
DB00717,Norethisterone may decrease the anticoagulant activities of Anistreplase.
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Anistreplase.
DB00957,Norgestimate may decrease the anticoagulant activities of Anistreplase.
DB01395,Drospirenone may decrease the anticoagulant activities of Anistreplase.
DB01431,Allylestrenol may decrease the anticoagulant activities of Anistreplase.
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Anistreplase.
DB06713,Norelgestromin may decrease the anticoagulant activities of Anistreplase.
DB06730,Gestodene may decrease the anticoagulant activities of Anistreplase.
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Anistreplase.
DB09123,Dienogest may decrease the anticoagulant activities of Anistreplase.
DB09124,Medrogestone may decrease the anticoagulant activities of Anistreplase.
DB09371,Norethynodrel may decrease the anticoagulant activities of Anistreplase.
DB09389,Norgestrel may decrease the anticoagulant activities of Anistreplase.
DB11372,Altrenogest may decrease the anticoagulant activities of Anistreplase.
DB11619,Gestrinone may decrease the anticoagulant activities of Anistreplase.
DB11636,Nomegestrol may decrease the anticoagulant activities of Anistreplase.
DB12474,Lynestrenol may decrease the anticoagulant activities of Anistreplase.
DB13230,Gestonorone may decrease the anticoagulant activities of Anistreplase.
DB13528,Chlormadinone may decrease the anticoagulant activities of Anistreplase.
DB13533,Methylestrenolone may decrease the anticoagulant activities of Anistreplase.
DB13563,Norgestrienone may decrease the anticoagulant activities of Anistreplase.
DB13602,Promegestone may decrease the anticoagulant activities of Anistreplase.
DB13685,Quingestanol may decrease the anticoagulant activities of Anistreplase.
DB13857,Demegestone may decrease the anticoagulant activities of Anistreplase.
DB13866,Etynodiol may decrease the anticoagulant activities of Anistreplase.
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Anistreplase.
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Anistreplase.
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Anistreplase.
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Anistreplase.
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Anistreplase.
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Anistreplase.
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Anistreplase.
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Anistreplase.
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Anistreplase.
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Anistreplase.
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Anistreplase.
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Anistreplase.
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Anistreplase.
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Anistreplase.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Anistreplase.
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Anistreplase.
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Anistreplase.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Anistreplase.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Anistreplase.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Anistreplase.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Anistreplase.
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Anistreplase.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Anistreplase.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Anistreplase.
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Anistreplase.
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Anistreplase.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Anistreplase.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Anistreplase.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Anistreplase.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Anistreplase.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Anistreplase.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Anistreplase.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Anistreplase.
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Anistreplase.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Anistreplase.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Anistreplase.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Anistreplase.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Anistreplase.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Anistreplase.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Anistreplase.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Anistreplase.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Anistreplase.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Anistreplase.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Anistreplase.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Anistreplase.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Anistreplase.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Anistreplase.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Anistreplase.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Anistreplase.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Anistreplase.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Anistreplase.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Anistreplase.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Anistreplase.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Anistreplase.
DB00374,The risk or severity of adverse effects can be increased when Anistreplase is combined with Treprostinil.
DB03404,Hemin may increase the anticoagulant activities of Anistreplase.
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Anistreplase.
DB00624,Testosterone may increase the anticoagulant activities of Anistreplase.
DB01420,Testosterone propionate may increase the anticoagulant activities of Anistreplase.
DB01481,1-Testosterone may increase the anticoagulant activities of Anistreplase.
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Anistreplase.
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Anistreplase.
DB01541,Boldenone may increase the anticoagulant activities of Anistreplase.
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Anistreplase.
DB01564,Calusterone may increase the anticoagulant activities of Anistreplase.
DB01569,Formebolone may increase the anticoagulant activities of Anistreplase.
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Anistreplase.
DB02901,Stanolone may increase the anticoagulant activities of Anistreplase.
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Anistreplase.
DB08619,Testosterone succinate may increase the anticoagulant activities of Anistreplase.
DB11429,Mibolerone may increase the anticoagulant activities of Anistreplase.
DB13943,Testosterone cypionate may increase the anticoagulant activities of Anistreplase.
DB13944,Testosterone enanthate may increase the anticoagulant activities of Anistreplase.
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Anistreplase.
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Anistreplase.
DB13951,Stanolone acetate may increase the anticoagulant activities of Anistreplase.
DB13958,Trestolone acetate may increase the anticoagulant activities of Anistreplase.
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Anistreplase."
DB14655,Drostanolone propionate may increase the anticoagulant activities of Anistreplase.
DB11051,The risk or severity of adverse effects can be increased when Anistreplase is combined with Azficel-T.
DB09568,The therapeutic efficacy of Anistreplase can be increased when used in combination with Omega-3-carboxylic acids.
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Anistreplase.
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Anistreplase.
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Anistreplase.
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Anistreplase.
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Anistreplase.
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Anistreplase.
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Anistreplase.
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Anistreplase.
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Anistreplase."
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Anistreplase.
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Anistreplase.
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Anistreplase.
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Anistreplase.
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Anistreplase.
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Anistreplase.
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Anistreplase.
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Anistreplase.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Anistreplase."
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Anistreplase.
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Anistreplase.
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Anistreplase.
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Anistreplase.
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Anistreplase.
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Anistreplase.
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Anistreplase.
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Anistreplase.
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Anistreplase.
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Anistreplase.
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Anistreplase.
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Anistreplase.
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Anistreplase.
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Anistreplase.
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Anistreplase.
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Anistreplase.
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Anistreplase.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Anistreplase.
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Anistreplase.
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Anistreplase.
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Anistreplase.
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Anistreplase.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Anistreplase.
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Anistreplase.
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Anistreplase.
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Anistreplase.
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Anistreplase.
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Anistreplase.
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Anistreplase.
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Anistreplase.
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Anistreplase.
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Anistreplase.
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Anistreplase.
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Anistreplase.
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Anistreplase.
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Anistreplase.
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Anistreplase.
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Anistreplase.
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Anistreplase.
DB00285,Venlafaxine may increase the antiplatelet activities of Anistreplase.
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Anistreplase.
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Anistreplase.
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Anistreplase.
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Anistreplase.
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Anistreplase.
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Anistreplase.
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Anistreplase.
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Anistreplase.
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Anistreplase.
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Anistreplase.
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Anistreplase.
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Anistreplase.
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Anistreplase.
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Anistreplase.
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Anistreplase.
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Anistreplase.
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Anistreplase.
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Anistreplase."
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Anistreplase.
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Anistreplase.
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Anistreplase.
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Anistreplase.
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Anistreplase.
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Anistreplase.
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Anistreplase.
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Anistreplase.
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Anistreplase.
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Anistreplase.
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Anistreplase.
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Anistreplase.
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Anistreplase.
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Anistreplase.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Anistreplase.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Anistreplase.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Anistreplase.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Anistreplase.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Anistreplase.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Anistreplase.
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Anistreplase.
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Anistreplase.
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Anistreplase.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Anistreplase.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Anistreplase.
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Anistreplase.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Anistreplase.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Anistreplase.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Anistreplase.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Anistreplase.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Anistreplase.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Anistreplase.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Anistreplase.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Anistreplase.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Anistreplase.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Anistreplase.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Anistreplase.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Anistreplase.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Anistreplase.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Anistreplase.
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Anistreplase.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Anistreplase.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Anistreplase.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Anistreplase.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Anistreplase.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Anistreplase.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Anistreplase.
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Anistreplase.
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Anistreplase.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Anistreplase.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Anistreplase.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Anistreplase.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Anistreplase.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Anistreplase.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Anistreplase.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Anistreplase.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Anistreplase.
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Anistreplase.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Anistreplase.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Anistreplase.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Anistreplase.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Anistreplase.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Anistreplase.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Anistreplase.
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Anistreplase.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Anistreplase.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Anistreplase.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Anistreplase.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Anistreplase.
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Anistreplase.
DB14094,The risk or severity of bleeding can be increased when Anistreplase is combined with Tocopherylquinone.
DB06679,The risk or severity of bleeding can be increased when Anistreplase is combined with Amediplase.
DB03410,The risk or severity of bleeding can be increased when Anistreplase is combined with 4-hydroxycoumarin.
DB08496,The risk or severity of bleeding can be increased when Anistreplase is combined with (R)-warfarin.
DB14055,The risk or severity of bleeding can be increased when Anistreplase is combined with (S)-Warfarin.
DB12364,The risk or severity of bleeding can be increased when Anistreplase is combined with Betrixaban.
DB14598,The risk or severity of bleeding can be increased when Anistreplase is combined with Edetate calcium disodium anhydrous.
DB11154,The risk or severity of bleeding can be increased when Anistreplase is combined with Zinc citrate.
DB11166,The risk or severity of bleeding can be increased when Anistreplase is combined with Antithrombin Alfa.
DB04665,The risk or severity of bleeding can be increased when Anistreplase is combined with Coumarin.
DB14726,The risk or severity of bleeding can be increased when Anistreplase is combined with Dabigatran.
DB06294,The risk or severity of bleeding can be increased when Anistreplase is combined with Semuloparin.
DB12726,The risk or severity of bleeding can be increased when Anistreplase is combined with Monteplase.
DB00177,The risk or severity of angioedema can be increased when Anistreplase is combined with Valsartan.
DB00178,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramipril.
DB00230,The risk or severity of angioedema can be increased when Anistreplase is combined with Pregabalin.
DB00492,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinopril.
DB00519,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolapril.
DB00542,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazepril.
DB00584,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalapril.
DB00678,The risk or severity of angioedema can be increased when Anistreplase is combined with Losartan.
DB00691,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexipril.
DB00722,The risk or severity of angioedema can be increased when Anistreplase is combined with Lisinopril.
DB00790,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindopril.
DB00876,The risk or severity of angioedema can be increased when Anistreplase is combined with Eprosartan.
DB00877,The risk or severity of angioedema can be increased when Anistreplase is combined with Sirolimus.
DB00881,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinapril.
DB00886,The risk or severity of angioedema can be increased when Anistreplase is combined with Omapatrilat.
DB00966,The risk or severity of angioedema can be increased when Anistreplase is combined with Telmisartan.
DB01050,The risk or severity of angioedema can be increased when Anistreplase is combined with Ibuprofen.
DB01180,The risk or severity of angioedema can be increased when Anistreplase is combined with Rescinnamine.
DB01197,The risk or severity of angioedema can be increased when Anistreplase is combined with Captopril.
DB01261,The risk or severity of angioedema can be increased when Anistreplase is combined with Sitagliptin.
DB01340,The risk or severity of angioedema can be increased when Anistreplase is combined with Cilazapril.
DB01342,The risk or severity of angioedema can be increased when Anistreplase is combined with Forasartan.
DB01347,The risk or severity of angioedema can be increased when Anistreplase is combined with Saprisartan.
DB01348,The risk or severity of angioedema can be increased when Anistreplase is combined with Spirapril.
DB04876,The risk or severity of angioedema can be increased when Anistreplase is combined with Vildagliptin.
DB06011,The risk or severity of angioedema can be increased when Anistreplase is combined with AMG-222.
DB06127,The risk or severity of angioedema can be increased when Anistreplase is combined with Bisegliptin.
DB06196,The risk or severity of angioedema can be increased when Anistreplase is combined with Icatibant.
DB06203,The risk or severity of angioedema can be increased when Anistreplase is combined with Alogliptin.
DB06245,The risk or severity of angioedema can be increased when Anistreplase is combined with Lanoteplase.
DB06287,The risk or severity of angioedema can be increased when Anistreplase is combined with Temsirolimus.
DB06335,The risk or severity of angioedema can be increased when Anistreplase is combined with Saxagliptin.
DB08382,The risk or severity of angioedema can be increased when Anistreplase is combined with Gosogliptin.
DB08822,The risk or severity of angioedema can be increased when Anistreplase is combined with Azilsartan medoxomil.
DB08836,The risk or severity of angioedema can be increased when Anistreplase is combined with Temocapril.
DB08882,The risk or severity of angioedema can be increased when Anistreplase is combined with Linagliptin.
DB09292,The risk or severity of angioedema can be increased when Anistreplase is combined with Sacubitril.
DB09477,The risk or severity of angioedema can be increased when Anistreplase is combined with Enalaprilat.
DB11723,The risk or severity of angioedema can be increased when Anistreplase is combined with Dutogliptin.
DB11783,The risk or severity of angioedema can be increased when Anistreplase is combined with Imidapril.
DB11950,The risk or severity of angioedema can be increased when Anistreplase is combined with Teneligliptin.
DB11992,The risk or severity of angioedema can be increased when Anistreplase is combined with Omarigliptin.
DB12268,The risk or severity of angioedema can be increased when Anistreplase is combined with Carmegliptin.
DB12412,The risk or severity of angioedema can be increased when Anistreplase is combined with Gemigliptin.
DB12417,The risk or severity of angioedema can be increased when Anistreplase is combined with Anagliptin.
DB12625,The risk or severity of angioedema can be increased when Anistreplase is combined with Evogliptin.
DB13166,The risk or severity of angioedema can be increased when Anistreplase is combined with Zofenopril.
DB13312,The risk or severity of angioedema can be increased when Anistreplase is combined with Delapril.
DB14125,The risk or severity of angioedema can be increased when Anistreplase is combined with Benazeprilat.
DB14207,The risk or severity of angioedema can be increased when Anistreplase is combined with Fosinoprilat.
DB14208,The risk or severity of angioedema can be increased when Anistreplase is combined with Ramiprilat.
DB14209,The risk or severity of angioedema can be increased when Anistreplase is combined with Trandolaprilat.
DB14210,The risk or severity of angioedema can be increased when Anistreplase is combined with Moexiprilat.
DB14213,The risk or severity of angioedema can be increased when Anistreplase is combined with Perindoprilat.
DB14217,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinaprilat.
DB14231,The risk or severity of angioedema can be increased when Anistreplase is combined with Quinoline Yellow WS.
DB00203,The risk or severity of hemorrhage can be increased when Anistreplase is combined with Sildenafil.
DB00008,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2a.
DB00011,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n1.
DB00018,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-n3.
DB00022,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon alfa-2b.
DB00033,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.
DB00034,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.
DB00056,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemtuzumab ozogamicin.
DB00068,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon beta-1b.
DB00069,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfacon-1.
DB00073,The risk or severity of bleeding can be increased when Anistreplase is combined with Rituximab.
DB00078,The risk or severity of bleeding can be increased when Anistreplase is combined with Ibritumomab tiuxetan.
DB00087,The risk or severity of bleeding can be increased when Anistreplase is combined with Alemtuzumab.
DB00105,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2b.
DB00120,The risk or severity of bleeding can be increased when Anistreplase is combined with Phenylalanine.
DB00188,The risk or severity of bleeding can be increased when Anistreplase is combined with Bortezomib.
DB00242,The risk or severity of bleeding can be increased when Anistreplase is combined with Cladribine.
DB00262,The risk or severity of bleeding can be increased when Anistreplase is combined with Carmustine.
DB00276,The risk or severity of bleeding can be increased when Anistreplase is combined with Amsacrine.
DB00291,The risk or severity of bleeding can be increased when Anistreplase is combined with Chlorambucil.
DB00293,The risk or severity of bleeding can be increased when Anistreplase is combined with Raltitrexed.
DB00305,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitomycin.
DB00307,The risk or severity of bleeding can be increased when Anistreplase is combined with Bexarotene.
DB00309,The risk or severity of bleeding can be increased when Anistreplase is combined with Vindesine.
DB00322,The risk or severity of bleeding can be increased when Anistreplase is combined with Floxuridine.
DB00352,The risk or severity of bleeding can be increased when Anistreplase is combined with Tioguanine.
DB00361,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinorelbine.
DB00380,The risk or severity of bleeding can be increased when Anistreplase is combined with Dexrazoxane.
DB00398,The risk or severity of bleeding can be increased when Anistreplase is combined with Sorafenib.
DB00428,The risk or severity of bleeding can be increased when Anistreplase is combined with Streptozocin.
DB00441,The risk or severity of bleeding can be increased when Anistreplase is combined with Gemcitabine.
DB00444,The risk or severity of bleeding can be increased when Anistreplase is combined with Teniposide.
DB00445,The risk or severity of bleeding can be increased when Anistreplase is combined with Epirubicin.
DB00446,The risk or severity of bleeding can be increased when Anistreplase is combined with Chloramphenicol.
DB00480,The risk or severity of bleeding can be increased when Anistreplase is combined with Lenalidomide.
DB00488,The risk or severity of bleeding can be increased when Anistreplase is combined with Altretamine.
DB00495,The risk or severity of bleeding can be increased when Anistreplase is combined with Zidovudine.
DB00515,The risk or severity of bleeding can be increased when Anistreplase is combined with Cisplatin.
DB00526,The risk or severity of bleeding can be increased when Anistreplase is combined with Oxaliplatin.
DB00531,The risk or severity of bleeding can be increased when Anistreplase is combined with Cyclophosphamide.
DB00544,The risk or severity of bleeding can be increased when Anistreplase is combined with Fluorouracil.
DB00552,The risk or severity of bleeding can be increased when Anistreplase is combined with Pentostatin.
DB00563,The risk or severity of bleeding can be increased when Anistreplase is combined with Methotrexate.
DB00564,The risk or severity of bleeding can be increased when Anistreplase is combined with Carbamazepine.
DB00570,The risk or severity of bleeding can be increased when Anistreplase is combined with Vinblastine.
DB00619,The risk or severity of bleeding can be increased when Anistreplase is combined with Imatinib.
DB00631,The risk or severity of bleeding can be increased when Anistreplase is combined with Clofarabine.
DB00642,The risk or severity of bleeding can be increased when Anistreplase is combined with Pemetrexed.
DB00694,The risk or severity of bleeding can be increased when Anistreplase is combined with Daunorubicin.
DB00762,The risk or severity of bleeding can be increased when Anistreplase is combined with Irinotecan.
DB00773,The risk or severity of bleeding can be increased when Anistreplase is combined with Etoposide.
DB00851,The risk or severity of bleeding can be increased when Anistreplase is combined with Dacarbazine.
DB00853,The risk or severity of bleeding can be increased when Anistreplase is combined with Temozolomide.
DB00859,The risk or severity of bleeding can be increased when Anistreplase is combined with Penicillamine.
DB00864,The risk or severity of bleeding can be increased when Anistreplase is combined with Tacrolimus.
DB00888,The risk or severity of bleeding can be increased when Anistreplase is combined with Mechlorethamine.
DB00928,The risk or severity of bleeding can be increased when Anistreplase is combined with Azacitidine.
DB00958,The risk or severity of bleeding can be increased when Anistreplase is combined with Carboplatin.
DB00970,The risk or severity of bleeding can be increased when Anistreplase is combined with Dactinomycin.
DB00987,The risk or severity of bleeding can be increased when Anistreplase is combined with Cytarabine.
DB00997,The risk or severity of bleeding can be increased when Anistreplase is combined with Doxorubicin.
DB01005,The risk or severity of bleeding can be increased when Anistreplase is combined with Hydroxyurea.
DB01008,The risk or severity of bleeding can be increased when Anistreplase is combined with Busulfan.
DB01030,The risk or severity of bleeding can be increased when Anistreplase is combined with Topotecan.
DB01033,The risk or severity of bleeding can be increased when Anistreplase is combined with Mercaptopurine.
DB01041,The risk or severity of bleeding can be increased when Anistreplase is combined with Thalidomide.
DB01042,The risk or severity of bleeding can be increased when Anistreplase is combined with Melphalan.
DB01073,The risk or severity of bleeding can be increased when Anistreplase is combined with Fludarabine.
DB01099,The risk or severity of bleeding can be increased when Anistreplase is combined with Flucytosine.
DB01101,The risk or severity of bleeding can be increased when Anistreplase is combined with Capecitabine.
DB01169,The risk or severity of bleeding can be increased when Anistreplase is combined with Arsenic trioxide.
DB01177,The risk or severity of bleeding can be increased when Anistreplase is combined with Idarubicin.
DB01204,The risk or severity of bleeding can be increased when Anistreplase is combined with Mitoxantrone.
DB01206,The risk or severity of bleeding can be increased when Anistreplase is combined with Lomustine.
DB01229,The risk or severity of bleeding can be increased when Anistreplase is combined with Paclitaxel.
DB01248,The risk or severity of bleeding can be increased when Anistreplase is combined with Docetaxel.
DB01262,The risk or severity of bleeding can be increased when Anistreplase is combined with Decitabine.
DB01280,The risk or severity of bleeding can be increased when Anistreplase is combined with Nelarabine.
DB01590,The risk or severity of bleeding can be increased when Anistreplase is combined with Everolimus.
DB02546,The risk or severity of bleeding can be increased when Anistreplase is combined with Vorinostat.
DB04572,The risk or severity of bleeding can be increased when Anistreplase is combined with Thiotepa.
DB04845,The risk or severity of bleeding can be increased when Anistreplase is combined with Ixabepilone.
DB04868,The risk or severity of bleeding can be increased when Anistreplase is combined with Nilotinib.
DB05015,The risk or severity of bleeding can be increased when Anistreplase is combined with Belinostat.
DB05109,The risk or severity of bleeding can be increased when Anistreplase is combined with Trabectedin.
DB05258,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa.
DB05472,The risk or severity of bleeding can be increased when Anistreplase is combined with omega interferon.
DB05773,The risk or severity of bleeding can be increased when Anistreplase is combined with Trastuzumab emtansine.
DB06616,The risk or severity of bleeding can be increased when Anistreplase is combined with Bosutinib.
DB06769,The risk or severity of bleeding can be increased when Anistreplase is combined with Bendamustine.
DB06772,The risk or severity of bleeding can be increased when Anistreplase is combined with Cabazitaxel.
DB08871,The risk or severity of bleeding can be increased when Anistreplase is combined with Eribulin.
DB08877,The risk or severity of bleeding can be increased when Anistreplase is combined with Ruxolitinib.
DB08889,The risk or severity of bleeding can be increased when Anistreplase is combined with Carfilzomib.
DB08895,The risk or severity of bleeding can be increased when Anistreplase is combined with Tofacitinib.
DB08901,The risk or severity of bleeding can be increased when Anistreplase is combined with Ponatinib.
DB08910,The risk or severity of bleeding can be increased when Anistreplase is combined with Pomalidomide.
DB09042,The risk or severity of bleeding can be increased when Anistreplase is combined with Tedizolid phosphate.
DB09052,The risk or severity of bleeding can be increased when Anistreplase is combined with Blinatumomab.
DB09073,The risk or severity of bleeding can be increased when Anistreplase is combined with Palbociclib.
DB09074,The risk or severity of bleeding can be increased when Anistreplase is combined with Olaparib.
DB09077,The risk or severity of bleeding can be increased when Anistreplase is combined with Dinutuximab.
DB09122,The risk or severity of bleeding can be increased when Anistreplase is combined with Peginterferon beta-1a.
DB12814,The risk or severity of bleeding can be increased when Anistreplase is combined with Cepeginterferon alfa-2B.
DB00229,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotiam.
DB00267,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmenoxime.
DB00274,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefmetazole.
DB00430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpiramide.
DB00438,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftazidime.
DB00447,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Loracarbef.
DB00456,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefalotin.
DB00493,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotaxime.
DB00535,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefdinir.
DB00567,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephalexin.
DB00671,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefixime.
DB00689,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephaloglycin.
DB00833,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaclor.
DB00923,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceforanide.
DB01066,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefditoren.
DB01112,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefuroxime.
DB01139,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefapirin.
DB01140,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefadroxil.
DB01150,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefprozil.
DB01212,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftriaxone.
DB01326,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole.
DB01327,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazolin.
DB01328,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefonicid.
DB01329,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoperazone.
DB01330,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefotetan.
DB01331,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefoxitin.
DB01332,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftizoxime.
DB01333,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefradine.
DB01413,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefepime.
DB01414,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefacetrile.
DB01415,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftibuten.
DB01416,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpodoxime.
DB04570,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Latamoxef.
DB04918,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftobiprole.
DB06590,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftaroline fosamil.
DB09008,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefaloridine.
DB09050,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftolozane.
DB09062,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefminox.
DB11367,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefroxadine.
DB11935,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Flomoxef.
DB13266,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefatrizine.
DB13461,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefcapene.
DB13470,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefodizime.
DB13499,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefsulodin.
DB13504,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefetamet.
DB13638,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefbuperazone.
DB13667,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefozopran.
DB13682,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefpirome.
DB13778,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefazedone.
DB13821,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Ceftezole.
DB14725,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefamandole nafate.
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Anistreplase.
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Anistreplase.
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Anistreplase.
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Anistreplase.
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Anistreplase.
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Anistreplase.
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Anistreplase.
DB00620,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Triamcinolone.
DB09079,The risk or severity of bleeding can be increased when Anistreplase is combined with Nintedanib.
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Anistreplase.
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Anistreplase.
DB00232,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Methyclothiazide.
DB00436,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Bendroflumethiazide.
DB00562,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Benzthiazide.
DB00606,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclothiazide.
DB00774,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydroflumethiazide.
DB00880,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Polythiazide.
DB13430,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Mebutizide.
DB13532,The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cyclopenthiazide.
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin human.
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin human.
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin human.
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin human.
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin human.
DB00412,The risk or severity of congestive heart failure can be increased when Insulin human is combined with Rosiglitazone.
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin human.
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin human.
DB00187,Esmolol may increase the hypoglycemic activities of Insulin human.
DB00218,The therapeutic efficacy of Insulin human can be increased when used in combination with Moxifloxacin.
DB00365,The therapeutic efficacy of Insulin human can be increased when used in combination with Grepafloxacin.
DB00467,The therapeutic efficacy of Insulin human can be increased when used in combination with Enoxacin.
DB00487,The therapeutic efficacy of Insulin human can be increased when used in combination with Pefloxacin.
DB00537,The therapeutic efficacy of Insulin human can be increased when used in combination with Ciprofloxacin.
DB00685,The therapeutic efficacy of Insulin human can be increased when used in combination with Trovafloxacin.
DB00779,The therapeutic efficacy of Insulin human can be increased when used in combination with Nalidixic acid.
DB00817,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosoxacin.
DB00827,The therapeutic efficacy of Insulin human can be increased when used in combination with Cinoxacin.
DB00978,The therapeutic efficacy of Insulin human can be increased when used in combination with Lomefloxacin.
DB01044,The therapeutic efficacy of Insulin human can be increased when used in combination with Gatifloxacin.
DB01059,The therapeutic efficacy of Insulin human can be increased when used in combination with Norfloxacin.
DB01137,The therapeutic efficacy of Insulin human can be increased when used in combination with Levofloxacin.
DB01155,The therapeutic efficacy of Insulin human can be increased when used in combination with Gemifloxacin.
DB01165,The therapeutic efficacy of Insulin human can be increased when used in combination with Ofloxacin.
DB01208,The therapeutic efficacy of Insulin human can be increased when used in combination with Sparfloxacin.
DB01405,The therapeutic efficacy of Insulin human can be increased when used in combination with Temafloxacin.
DB04576,The therapeutic efficacy of Insulin human can be increased when used in combination with Fleroxacin.
DB05488,The therapeutic efficacy of Insulin human can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
DB06160,The therapeutic efficacy of Insulin human can be increased when used in combination with Garenoxacin.
DB06600,The therapeutic efficacy of Insulin human can be increased when used in combination with Nemonoxacin.
DB08972,The therapeutic efficacy of Insulin human can be increased when used in combination with Flumequine.
DB11404,The therapeutic efficacy of Insulin human can be increased when used in combination with Enrofloxacin.
DB11443,The therapeutic efficacy of Insulin human can be increased when used in combination with Orbifloxacin.
DB11491,The therapeutic efficacy of Insulin human can be increased when used in combination with Sarafloxacin.
DB11511,The therapeutic efficacy of Insulin human can be increased when used in combination with Difloxacin.
DB11774,The therapeutic efficacy of Insulin human can be increased when used in combination with Pazufloxacin.
DB11892,The therapeutic efficacy of Insulin human can be increased when used in combination with Prulifloxacin.
DB11943,The therapeutic efficacy of Insulin human can be increased when used in combination with Delafloxacin.
DB13261,The therapeutic efficacy of Insulin human can be increased when used in combination with Sitafloxacin.
DB13627,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxolinic acid.
DB13772,The therapeutic efficacy of Insulin human can be increased when used in combination with Rufloxacin.
DB13823,The therapeutic efficacy of Insulin human can be increased when used in combination with Pipemidic acid.
DB00232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methyclothiazide.
DB00310,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorthalidone.
DB00436,The therapeutic efficacy of Insulin human can be decreased when used in combination with Bendroflumethiazide.
DB00524,The therapeutic efficacy of Insulin human can be decreased when used in combination with Metolazone.
DB00562,The therapeutic efficacy of Insulin human can be decreased when used in combination with Benzthiazide.
DB00774,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroflumethiazide.
DB00808,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indapamide.
DB00880,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Insulin human can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Insulin human can be decreased when used in combination with Polythiazide.
DB01325,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quinethazone.
DB13532,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyclopenthiazide.
DB13989,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epitizide.
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin human.
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin human.
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin human.
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin human.
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin human.
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin human.
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin human.
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin human.
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin human.
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin human.
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin human.
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin human.
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin human.
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin human.
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin human.
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin human.
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin human.
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin human.
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin human.
DB00007,The therapeutic efficacy of Insulin human can be decreased when used in combination with Leuprolide.
DB00014,The therapeutic efficacy of Insulin human can be decreased when used in combination with Goserelin.
DB00104,The therapeutic efficacy of Insulin human can be decreased when used in combination with Octreotide.
DB00220,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nelfinavir.
DB00224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Indinavir.
DB00246,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ziprasidone.
DB00294,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etonogestrel.
DB00304,The therapeutic efficacy of Insulin human can be decreased when used in combination with Desogestrel.
DB00334,The therapeutic efficacy of Insulin human can be decreased when used in combination with Olanzapine.
DB00351,The therapeutic efficacy of Insulin human can be decreased when used in combination with Megestrol acetate.
DB00363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Clozapine.
DB00367,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levonorgestrel.
DB00396,The therapeutic efficacy of Insulin human can be decreased when used in combination with Progesterone.
DB00477,The therapeutic efficacy of Insulin human can be decreased when used in combination with Chlorpromazine.
DB00502,The therapeutic efficacy of Insulin human can be decreased when used in combination with Haloperidol.
DB00503,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ritonavir.
DB00592,The therapeutic efficacy of Insulin human can be decreased when used in combination with Piperazine.
DB00603,The therapeutic efficacy of Insulin human can be decreased when used in combination with Medroxyprogesterone acetate.
DB00627,The therapeutic efficacy of Insulin human can be decreased when used in combination with Niacin.
DB00668,The therapeutic efficacy of Insulin human can be decreased when used in combination with Epinephrine.
DB00717,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norethisterone.
DB00734,The therapeutic efficacy of Insulin human can be decreased when used in combination with Risperidone.
DB00738,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pentamidine.
DB00823,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethynodiol diacetate.
DB00852,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pseudoephedrine.
DB00864,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tacrolimus.
DB00877,The therapeutic efficacy of Insulin human can be decreased when used in combination with Sirolimus.
DB00903,The therapeutic efficacy of Insulin human can be decreased when used in combination with Etacrynic acid.
DB00932,The therapeutic efficacy of Insulin human can be decreased when used in combination with Tipranavir.
DB00957,The therapeutic efficacy of Insulin human can be decreased when used in combination with Norgestimate.
DB00977,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ethinylestradiol.
DB01072,The therapeutic efficacy of Insulin human can be decreased when used in combination with Atazanavir.
DB01169,The therapeutic efficacy of Insulin human can be decreased when used in combination with Arsenic trioxide.
DB01224,The therapeutic efficacy of Insulin human can be decreased when used in combination with Quetiapine.
DB01232,The therapeutic efficacy of Insulin human can be decreased when used in combination with Saquinavir.
DB01238,The therapeutic efficacy of Insulin human can be decreased when used in combination with Aripiprazole.
DB01267,The therapeutic efficacy of Insulin human can be decreased when used in combination with Paliperidone.
DB01319,The therapeutic efficacy of Insulin human can be decreased when used in combination with Fosamprenavir.
DB01323,The therapeutic efficacy of Insulin human can be decreased when used in combination with St. John's Wort.
DB01357,The therapeutic efficacy of Insulin human can be decreased when used in combination with Mestranol.
DB01363,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ephedra sinica root.
DB01395,The therapeutic efficacy of Insulin human can be decreased when used in combination with Drospirenone.
DB01403,The therapeutic efficacy of Insulin human can be decreased when used in combination with Methotrimeprazine.
DB01406,The therapeutic efficacy of Insulin human can be decreased when used in combination with Danazol.
DB01590,The therapeutic efficacy of Insulin human can be decreased when used in combination with Everolimus.
DB01601,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lopinavir.
DB01621,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pipotiazine.
DB02546,The therapeutic efficacy of Insulin human can be decreased when used in combination with Vorinostat.
DB04574,The therapeutic efficacy of Insulin human can be decreased when used in combination with Estrone sulfate.
DB04839,The therapeutic efficacy of Insulin human can be decreased when used in combination with Cyproterone acetate.
DB04868,The therapeutic efficacy of Insulin human can be decreased when used in combination with Nilotinib.
DB04946,The therapeutic efficacy of Insulin human can be decreased when used in combination with Iloperidone.
DB06216,The therapeutic efficacy of Insulin human can be decreased when used in combination with Asenapine.
DB06287,The therapeutic efficacy of Insulin human can be decreased when used in combination with Temsirolimus.
DB06663,The therapeutic efficacy of Insulin human can be decreased when used in combination with Pasireotide.
DB06719,The therapeutic efficacy of Insulin human can be decreased when used in combination with Buserelin.
DB06788,The therapeutic efficacy of Insulin human can be decreased when used in combination with Histrelin.
DB06789,The therapeutic efficacy of Insulin human can be decreased when used in combination with Hydroxyprogesterone caproate.
DB06791,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lanreotide.
DB06825,The therapeutic efficacy of Insulin human can be decreased when used in combination with Triptorelin.
DB08815,The therapeutic efficacy of Insulin human can be decreased when used in combination with Lurasidone.
DB08912,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dabrafenib.
DB09009,The therapeutic efficacy of Insulin human can be decreased when used in combination with Articaine.
DB09063,The therapeutic efficacy of Insulin human can be decreased when used in combination with Ceritinib.
DB09123,The therapeutic efficacy of Insulin human can be decreased when used in combination with Dienogest.
DB09128,The therapeutic efficacy of Insulin human can be decreased when used in combination with Brexpiprazole.
DB06343,The therapeutic efficacy of Insulin human can be decreased when used in combination with Teprotumumab.
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin human.
DB00624,Testosterone may increase the hypoglycemic activities of Insulin human.
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin human.
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin human.
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin human.
DB02901,Stanolone may increase the hypoglycemic activities of Insulin human.
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin human.
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin human.
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin human.
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin human.
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin human.
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin human.
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin human.
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin human.
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin human.
DB00215,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Citalopram.
DB00230,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Pregabalin.
DB00285,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Venlafaxine.
DB00328,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indomethacin.
DB01104,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sertraline.
DB01149,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nefazodone.
DB01175,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Escitalopram.
DB04832,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Zimelidine.
DB04884,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Dapoxetine.
DB04896,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Milnacipran.
DB06700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Desvenlafaxine.
DB08918,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Levomilnacipran.
DB08953,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Indalpine.
DB09270,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ubidecarenone.
DB12693,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ritanserin.
DB13233,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Alaproclate.
DB13358,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Cibenzoline.
DB14025,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Clinafloxacin.
DB09038,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Empagliflozin.
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin human.
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin human.
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin human.
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin human.
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin human.
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin human.
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin human.
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin human.
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin human.
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin human.
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin human.
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin human.
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin human.
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin human.
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin human.
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin human.
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin human.
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin human.
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin human.
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin human.
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin human.
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin human.
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin human.
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin human.
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin human.
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin human.
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin human.
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin human.
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin human.
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin human.
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin human.
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin human.
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin human.
DB01276,Exenatide may increase the hypoglycemic activities of Insulin human.
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin human.
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin human.
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin human.
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin human.
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin human.
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin human.
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin human.
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin human.
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin human.
DB01626,Pargyline may increase the hypoglycemic activities of Insulin human.
DB00805,Minaprine may increase the hypoglycemic activities of Insulin human.
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin human.
DB04820,Nialamide may increase the hypoglycemic activities of Insulin human.
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin human.
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin human.
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin human.
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin human.
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin human.
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin human.
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin human.
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin human.
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin human.
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin human.
DB09253,Safrazine may increase the hypoglycemic activities of Insulin human.
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin human.
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin human.
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin human."
DB13875,Harmaline may increase the hypoglycemic activities of Insulin human.
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin human.
DB00721,Procaine may increase the hypoglycemic activities of Insulin human.
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin human.
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin human.
DB00601,Linezolid may increase the hypoglycemic activities of Insulin human.
DB06654,Safinamide may increase the hypoglycemic activities of Insulin human.
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin human.
DB11827,The therapeutic efficacy of Insulin human can be increased when used in combination with Ertugliflozin.
DB00203,The therapeutic efficacy of Insulin human can be increased when used in combination with Sildenafil.
DB00214,The therapeutic efficacy of Insulin human can be increased when used in combination with Torasemide.
DB00263,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfisoxazole.
DB00311,The therapeutic efficacy of Insulin human can be increased when used in combination with Ethoxzolamide.
DB00359,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadiazine.
DB00482,The therapeutic efficacy of Insulin human can be increased when used in combination with Celecoxib.
DB00559,The therapeutic efficacy of Insulin human can be increased when used in combination with Bosentan.
DB00576,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethizole.
DB00606,The therapeutic efficacy of Insulin human can be increased when used in combination with Cyclothiazide.
DB00664,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametopyrazine.
DB00669,The therapeutic efficacy of Insulin human can be increased when used in combination with Sumatriptan.
DB00695,The therapeutic efficacy of Insulin human can be increased when used in combination with Furosemide.
DB00706,The therapeutic efficacy of Insulin human can be increased when used in combination with Tamsulosin.
DB00819,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetazolamide.
DB00887,The therapeutic efficacy of Insulin human can be increased when used in combination with Bumetanide.
DB00891,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfapyridine.
DB00909,The therapeutic efficacy of Insulin human can be increased when used in combination with Zonisamide.
DB01015,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxazole.
DB01032,The therapeutic efficacy of Insulin human can be increased when used in combination with Probenecid.
DB01098,The therapeutic efficacy of Insulin human can be increased when used in combination with Rosuvastatin.
DB01119,The therapeutic efficacy of Insulin human can be increased when used in combination with Diazoxide.
DB01144,The therapeutic efficacy of Insulin human can be increased when used in combination with Diclofenamide.
DB01264,The therapeutic efficacy of Insulin human can be increased when used in combination with Darunavir.
DB01298,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfacytine.
DB01299,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadoxine.
DB01382,The therapeutic efficacy of Insulin human can be increased when used in combination with Glymidine.
DB01581,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamerazine.
DB01582,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethazine.
DB02925,The therapeutic efficacy of Insulin human can be increased when used in combination with Piretanide.
DB04707,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxyfasudil.
DB06150,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadimethoxine.
DB06290,The therapeutic efficacy of Insulin human can be increased when used in combination with Simeprevir.
DB06729,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaphenazole.
DB06821,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfameter.
DB07996,The therapeutic efficacy of Insulin human can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.
DB08162,The therapeutic efficacy of Insulin human can be increased when used in combination with Fasudil.
DB08798,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamoxole.
DB08881,The therapeutic efficacy of Insulin human can be increased when used in combination with Vemurafenib.
DB08961,The therapeutic efficacy of Insulin human can be increased when used in combination with Azosemide.
DB11389,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorsulon.
DB11461,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfachlorpyridazine.
DB11462,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaethoxypyridazine.
DB11463,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfanitran.
DB11464,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaquinoxaline.
DB12051,The therapeutic efficacy of Insulin human can be increased when used in combination with Setrobuvir.
DB12921,The therapeutic efficacy of Insulin human can be increased when used in combination with Chlorsulfaquinoxaline.
DB13214,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfadicramide.
DB13248,The therapeutic efficacy of Insulin human can be increased when used in combination with Phthalylsulfathiazole.
DB13283,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaisodimidine.
DB13284,The therapeutic efficacy of Insulin human can be increased when used in combination with Meticrane.
DB13320,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaperin.
DB13405,The therapeutic efficacy of Insulin human can be increased when used in combination with Mefruside.
DB13430,The therapeutic efficacy of Insulin human can be increased when used in combination with Mebutizide.
DB13485,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfametomidine.
DB13547,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfatolamide.
DB13556,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamazone.
DB13580,The therapeutic efficacy of Insulin human can be increased when used in combination with Succinylsulfathiazole.
DB13617,The therapeutic efficacy of Insulin human can be increased when used in combination with Clorexolone.
DB13663,The therapeutic efficacy of Insulin human can be increased when used in combination with Clofenamide.
DB13699,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfathiourea.
DB13708,The therapeutic efficacy of Insulin human can be increased when used in combination with Fenquizone.
DB13726,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfaguanidine.
DB13773,The therapeutic efficacy of Insulin human can be increased when used in combination with Sulfamethoxypyridazine.
DB13792,The therapeutic efficacy of Insulin human can be increased when used in combination with Clopamide.
DB13803,The therapeutic efficacy of Insulin human can be increased when used in combination with Xipamide.
DB14033,The therapeutic efficacy of Insulin human can be increased when used in combination with Acetyl sulfisoxazole.
DB14708,The therapeutic efficacy of Insulin human can be increased when used in combination with Tosylchloramide.
DB00703,The therapeutic efficacy of Insulin human can be increased when used in combination with Methazolamide.
DB06370,The therapeutic efficacy of Insulin human can be increased when used in combination with Indisulam.
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin human.
DB00184,The metabolism of Nicotine can be increased when combined with Insulin human.
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin human.
DB00201,The metabolism of Caffeine can be increased when combined with Insulin human.
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin human.
DB00262,The metabolism of Carmustine can be increased when combined with Insulin human.
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin human.
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin human.
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin human.
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin human.
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin human.
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin human.
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin human.
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin human.
DB00382,The metabolism of Tacrine can be increased when combined with Insulin human.
DB00384,The metabolism of Triamterene can be increased when combined with Insulin human.
DB00420,The metabolism of Promazine can be increased when combined with Insulin human.
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin human.
DB00442,The metabolism of Entecavir can be increased when combined with Insulin human.
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin human.
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin human.
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin human.
DB00499,The metabolism of Flutamide can be increased when combined with Insulin human.
DB00518,The metabolism of Albendazole can be increased when combined with Insulin human.
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin human.
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin human.
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin human.
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin human.
DB00619,The metabolism of Imatinib can be increased when combined with Insulin human.
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin human.
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin human.
DB00661,The metabolism of Verapamil can be increased when combined with Insulin human.
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin human.
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin human.
DB00740,The metabolism of Riluzole can be increased when combined with Insulin human.
DB00744,The metabolism of Zileuton can be increased when combined with Insulin human.
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin human.
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin human.
DB00788,The metabolism of Naproxen can be increased when combined with Insulin human.
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin human.
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin human.
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin human.
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin human.
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin human.
DB00898,The metabolism of Ethanol can be increased when combined with Insulin human.
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin human.
DB00969,The metabolism of Alosetron can be increased when combined with Insulin human.
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin human.
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin human.
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin human.
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin human.
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin human.
DB01037,The metabolism of Selegiline can be increased when combined with Insulin human.
DB01056,The metabolism of Tocainide can be increased when combined with Insulin human.
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin human.
DB01065,The metabolism of Melatonin can be increased when combined with Insulin human.
DB01087,The metabolism of Primaquine can be increased when combined with Insulin human.
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin human.
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin human.
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin human.
DB01184,The metabolism of Domperidone can be increased when combined with Insulin human.
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin human.
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin human.
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin human.
DB01412,The metabolism of Theobromine can be increased when combined with Insulin human.
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin human.
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin human.
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin human.
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin human.
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin human.
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin human.
DB01645,The metabolism of Genistein can be increased when combined with Insulin human.
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin human.
DB02134,The metabolism of Xanthine can be increased when combined with Insulin human.
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin human.
DB02568,The metabolism of Peldesine can be increased when combined with Insulin human.
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin human.
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin human.
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin human.
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin human.
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin human.
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin human.
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin human.
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin human.
DB05676,The metabolism of Apremilast can be increased when combined with Insulin human.
DB06148,The metabolism of Mianserin can be increased when combined with Insulin human.
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin human.
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin human.
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin human.
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin human.
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin human.
DB06626,The metabolism of Axitinib can be increased when combined with Insulin human.
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin human.
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin human.
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin human.
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin human.
DB08883,The metabolism of Perampanel can be increased when combined with Insulin human.
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin human.
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin human.
DB09225,The metabolism of Zotepine can be increased when combined with Insulin human.
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin human.
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin human.
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin human.
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin human.
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin human.
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin human.
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin human.
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin human.
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin human.
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin human.
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin human.
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin human.
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin human.
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin human.
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin human.
DB13573,The metabolism of Acefylline can be increased when combined with Insulin human.
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin human.
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin human.
DB13812,The metabolism of Bufylline can be increased when combined with Insulin human.
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin human.
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin human.
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin human.
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin human.
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin human.
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin human.
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin human.
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin human.
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin human.
DB00972,The metabolism of Azelastine can be increased when combined with Insulin human.
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin human.
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin human.
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin human.
DB01195,The metabolism of Flecainide can be increased when combined with Insulin human.
DB00783,The metabolism of Estradiol can be increased when combined with Insulin human.
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin human.
DB00458,The metabolism of Imipramine can be increased when combined with Insulin human.
DB01142,The metabolism of Doxepin can be increased when combined with Insulin human.
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin human.
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin human.
DB00575,The metabolism of Clonidine can be increased when combined with Insulin human.
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin human.
DB01151,The metabolism of Desipramine can be increased when combined with Insulin human.
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin human.
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin human.
DB00277,The metabolism of Theophylline can be increased when combined with Insulin human.
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin human.
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin human.
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin human.
DB00682,The metabolism of Warfarin can be increased when combined with Insulin human.
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin human.
DB00773,The metabolism of Etoposide can be increased when combined with Insulin human.
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin human.
DB01100,The metabolism of Pimozide can be increased when combined with Insulin human.
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin human.
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin human.
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin human.
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin human.
DB09256,The metabolism of Tegafur can be increased when combined with Insulin human.
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin human.
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin human.
DB00046,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.
DB00047,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.
DB00071,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin pork.
DB00197,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Troglitazone.
DB00222,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glimepiride.
DB00280,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Disopyramide.
DB00284,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acarbose.
DB00414,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Acetohexamide.
DB00468,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Quinine.
DB00491,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Miglitol.
DB00672,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Chlorpropamide.
DB00731,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Nateglinide.
DB00834,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mifepristone.
DB00839,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolazamide.
DB00912,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Repaglinide.
DB00914,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Phenformin.
DB01016,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glyburide.
DB01067,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glipizide.
DB01120,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliclazide.
DB01124,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tolbutamide.
DB01200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Bromocriptine.
DB01251,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gliquidone.
DB01252,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mitiglinide.
DB01268,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sunitinib.
DB01277,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Mecasermin.
DB01289,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glisoxepide.
DB01306,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin aspart.
DB01307,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin detemir.
DB01309,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glulisine.
DB01700,The risk or severity of hypoglycemia can be increased when Insulin human is combined with AICA ribonucleotide.
DB04830,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Buformin.
DB04878,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Voglibose.
DB05115,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NN344.
DB05819,The risk or severity of hypoglycemia can be increased when Insulin human is combined with NBI-6024.
DB08962,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Glibornuride.
DB09022,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Benfluorex.
DB09198,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Lobeglitazone.
DB09199,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Netoglitazone.
DB09200,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Rivoglitazone.
DB09201,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ciglitazone.
DB09456,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin beef.
DB09564,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin degludec.
DB11567,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin peglispro.
DB11568,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin tregopil.
DB11698,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Ipragliflozin.
DB11780,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Allicin.
DB11824,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tofogliflozin.
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin human is combined with 2,4-thiazolidinedione."
DB12713,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Sotagliflozin.
DB12781,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Balaglitazone.
DB12935,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Remogliflozin etabonate.
DB13406,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Carbutamide.
DB13446,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Guar gum.
DB13675,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Metahexamide.
DB14035,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Englitazone.
DB15171,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Tirzepatide.
DB15217,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Gastric inhibitory polypeptide.
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin human.
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin human.
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin human.
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin human.
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin human.
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin human.
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin human.
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin human.
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin human.
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin human.
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin human.
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin human.
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin human.
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin human.
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin human.
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin human.
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin human.
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin human.
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin human.
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin human.
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin human.
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin human.
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin human.
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin human.
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin human.
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin human.
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin human.
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin human.
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin human.
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin human.
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin human.
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin human.
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin human.
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin human.
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin human.
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin human.
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin human.
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin human.
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin human.
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin human.
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin human.
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin human.
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin human.
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin human.
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin human.
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin human.
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin human.
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin human.
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin human.
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin human.
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin human.
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin human.
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin human.
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin human.
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin human.
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin human.
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin human.
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin human.
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin human.
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin human.
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin human.
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin human.
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin human.
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin human.
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin human.
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin human.
DB00191,The therapeutic efficacy of Insulin human can be increased when used in combination with Phentermine.
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin human.
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin human.
DB00279,The therapeutic efficacy of Insulin human can be decreased when used in combination with Liothyronine.
DB00331,The risk or severity of adverse effects can be increased when Insulin human is combined with Metformin.
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin human.
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin human.
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin human.
DB00181,The therapeutic efficacy of Insulin human can be decreased when used in combination with Baclofen.
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin human.
DB00196,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Fluconazole.
DB00040,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.
DB00264,The therapeutic efficacy of Insulin human can be increased when used in combination with Metoprolol.
DB00335,The therapeutic efficacy of Insulin human can be increased when used in combination with Atenolol.
DB00373,The therapeutic efficacy of Insulin human can be increased when used in combination with Timolol.
DB00598,The therapeutic efficacy of Insulin human can be increased when used in combination with Labetalol.
DB00612,The therapeutic efficacy of Insulin human can be increased when used in combination with Bisoprolol.
DB00866,The therapeutic efficacy of Insulin human can be increased when used in combination with Alprenolol.
DB00960,The therapeutic efficacy of Insulin human can be increased when used in combination with Pindolol.
DB01193,The therapeutic efficacy of Insulin human can be increased when used in combination with Acebutolol.
DB01203,The therapeutic efficacy of Insulin human can be increased when used in combination with Nadolol.
DB01295,The therapeutic efficacy of Insulin human can be increased when used in combination with Bevantolol.
DB01297,The therapeutic efficacy of Insulin human can be increased when used in combination with Practolol.
DB01359,The therapeutic efficacy of Insulin human can be increased when used in combination with Penbutolol.
DB01580,The therapeutic efficacy of Insulin human can be increased when used in combination with Oxprenolol.
DB03322,The therapeutic efficacy of Insulin human can be increased when used in combination with Dexpropranolol.
DB04846,The therapeutic efficacy of Insulin human can be increased when used in combination with Celiprolol.
DB04861,The therapeutic efficacy of Insulin human can be increased when used in combination with Nebivolol.
DB06726,The therapeutic efficacy of Insulin human can be increased when used in combination with Bufuralol.
DB08807,The therapeutic efficacy of Insulin human can be increased when used in combination with Bopindolol.
DB08808,The therapeutic efficacy of Insulin human can be increased when used in combination with Bupranolol.
DB08952,The therapeutic efficacy of Insulin human can be increased when used in combination with Indenolol.
DB09013,The therapeutic efficacy of Insulin human can be increased when used in combination with Befunolol.
DB09204,The therapeutic efficacy of Insulin human can be increased when used in combination with Arotinolol.
DB09351,The therapeutic efficacy of Insulin human can be increased when used in combination with Levobetaxolol.
DB11770,The therapeutic efficacy of Insulin human can be increased when used in combination with Talinolol.
DB11785,The therapeutic efficacy of Insulin human can be increased when used in combination with Anisodamine.
DB12212,The therapeutic efficacy of Insulin human can be increased when used in combination with Landiolol.
DB12752,The therapeutic efficacy of Insulin human can be increased when used in combination with Bucindolol.
DB13443,The therapeutic efficacy of Insulin human can be increased when used in combination with Esatenolol.
DB13508,The therapeutic efficacy of Insulin human can be increased when used in combination with Cloranolol.
DB13530,The therapeutic efficacy of Insulin human can be increased when used in combination with Mepindolol.
DB13757,The therapeutic efficacy of Insulin human can be increased when used in combination with Epanolol.
DB13775,The therapeutic efficacy of Insulin human can be increased when used in combination with Tertatolol.
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin human.
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin human.
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin human.
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin human.
DB01611,The therapeutic efficacy of Insulin human can be increased when used in combination with Hydroxychloroquine.
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin human.
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin human.
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin human.
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin human.
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin human.
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin human.
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin human.
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin human.
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin human.
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin human.
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin human.
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin human.
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin human.
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin human.
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin human.
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin human.
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin human.
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin human.
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin human.
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin human.
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin human.
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin human.
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin human.
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin human.
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin human.
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin human.
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin human.
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin human.
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin human.
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin human.
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin human.
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin human.
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin human.
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin human.
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin human.
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin human.
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin human.
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin human.
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin human.
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin human.
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin human.
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin human.
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin human.
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin human.
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin human.
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin human.
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin human.
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin human.
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin human.
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin human.
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin human.
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin human.
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin human.
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin human.
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin human.
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin human.
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin human.
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin human.
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin human.
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin human.
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin human.
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin human.
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin human.
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin human.
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin human.
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin human.
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin human.
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin human.
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin human.
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin human.
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin human.
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin human.
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin human.
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin human.
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin human.
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin human.
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin human.
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin human.
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin human.
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin human.
DB00451,The therapeutic efficacy of Insulin human can be decreased when used in combination with Levothyroxine.
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin human.
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin human.
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin human.
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin human."
DB06605,Apixaban may increase the anticoagulant activities of Tenecteplase.
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Tenecteplase.
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Tenecteplase.
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Tenecteplase is combined with Deferasirox.
DB01586,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Ursodeoxycholic acid.
DB02123,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycochenodeoxycholic Acid.
DB02659,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Cholic Acid.
DB02691,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Glycocholic acid.
DB03619,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Deoxycholic acid.
DB04348,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurocholic acid.
DB05990,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Obeticholic acid.
DB06777,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Chenodeoxycholic acid.
DB08833,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Taurochenodeoxycholic acid.
DB08834,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Tauroursodeoxycholic acid.
DB08857,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Bamet-UD2.
DB11622,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Dehydrocholic acid.
DB11789,The risk or severity of bleeding and bruising can be increased when Tenecteplase is combined with Hyodeoxycholic Acid.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Tenecteplase.
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Tenecteplase.
DB08935,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Obinutuzumab.
DB06228,Tenecteplase may increase the anticoagulant activities of Rivaroxaban.
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Sugammadex.
DB09070,Tibolone may increase the anticoagulant activities of Tenecteplase.
DB00932,The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Tenecteplase.
DB00013,Urokinase may increase the anticoagulant activities of Tenecteplase.
DB00163,Vitamin E may increase the anticoagulant activities of Tenecteplase.
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tenecteplase.
DB06692,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Aprotinin.
DB01381,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Ginkgo biloba.
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Tenecteplase.
DB00468,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinine.
DB00908,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinidine.
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Tenecteplase.
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Tenecteplase.
DB00806,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Pentoxifylline.
DB00686,Pentosan polysulfate may increase the anticoagulant activities of Tenecteplase.
DB00583,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Levocarnitine.
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Tenecteplase.
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Tenecteplase.
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Tenecteplase.
DB00783,Estradiol may decrease the anticoagulant activities of Tenecteplase.
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Tenecteplase.
DB01357,Mestranol may decrease the anticoagulant activities of Tenecteplase.
DB04573,Estriol may decrease the anticoagulant activities of Tenecteplase.
DB04574,Estrone sulfate may decrease the anticoagulant activities of Tenecteplase.
DB04575,Quinestrol may decrease the anticoagulant activities of Tenecteplase.
DB07931,Hexestrol may decrease the anticoagulant activities of Tenecteplase.
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Tenecteplase."
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Tenecteplase."
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Tenecteplase.
DB09381,Esterified estrogens may decrease the anticoagulant activities of Tenecteplase.
DB11478,Zeranol may decrease the anticoagulant activities of Tenecteplase.
DB11674,Equol may decrease the anticoagulant activities of Tenecteplase.
DB12487,Promestriene may decrease the anticoagulant activities of Tenecteplase.
DB13143,Methallenestril may decrease the anticoagulant activities of Tenecteplase.
DB13386,Epimestrol may decrease the anticoagulant activities of Tenecteplase.
DB13418,Moxestrol may decrease the anticoagulant activities of Tenecteplase.
DB13952,Estradiol acetate may decrease the anticoagulant activities of Tenecteplase.
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Tenecteplase.
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Tenecteplase.
DB13956,Estradiol valerate may decrease the anticoagulant activities of Tenecteplase.
DB15334,Biochanin A may decrease the anticoagulant activities of Tenecteplase.
DB15335,Formononetin may decrease the anticoagulant activities of Tenecteplase.
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Tenecteplase.
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Tenecteplase.
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Tenecteplase.
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Tenecteplase.
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Tenecteplase.
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Tenecteplase.
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Tenecteplase.
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Tenecteplase.
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Tenecteplase.
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Tenecteplase.
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Tenecteplase.
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Tenecteplase.
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Tenecteplase.
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Tenecteplase.
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Tenecteplase.
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Tenecteplase.
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Tenecteplase.
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Tenecteplase.
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Tenecteplase.
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Tenecteplase.
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Tenecteplase.
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Tenecteplase.
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Tenecteplase.
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Tenecteplase.
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Tenecteplase.
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Tenecteplase.
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Tenecteplase.
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Tenecteplase.
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Tenecteplase.
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Tenecteplase.
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Tenecteplase.
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Tenecteplase.
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Tenecteplase.
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Tenecteplase.
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Tenecteplase.
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Tenecteplase.
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Tenecteplase.
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Tenecteplase.
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Tenecteplase.
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tenecteplase.
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Tenecteplase.
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Tenecteplase.
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Tenecteplase.
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Tenecteplase.
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Tenecteplase.
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Tenecteplase.
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Tenecteplase.
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Tenecteplase.
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Tenecteplase.
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Tenecteplase.
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Tenecteplase.
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Tenecteplase.
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Tenecteplase.
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Tenecteplase.
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Tenecteplase.
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Tenecteplase.
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Tenecteplase.
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Tenecteplase.
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Tenecteplase.
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Tenecteplase.
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Tenecteplase.
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Tenecteplase.
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Tenecteplase.
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Tenecteplase.
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Tenecteplase.
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Tenecteplase.
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Tenecteplase.
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Tenecteplase.
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Tenecteplase.
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Tenecteplase.
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Tenecteplase.
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Tenecteplase.
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Tenecteplase.
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Tenecteplase.
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Tenecteplase.
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Tenecteplase.
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Tenecteplase.
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Tenecteplase.
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Tenecteplase.
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Tenecteplase.
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Tenecteplase.
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Tenecteplase.
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Tenecteplase.
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Tenecteplase.
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Tenecteplase.
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Tenecteplase.
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Tenecteplase.
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Tenecteplase.
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Tenecteplase.
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Tenecteplase.
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Tenecteplase.
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Tenecteplase.
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Tenecteplase.
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Tenecteplase.
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Tenecteplase.
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Tenecteplase.
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Tenecteplase.
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Tenecteplase.
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Tenecteplase.
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Tenecteplase.
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Tenecteplase.
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Tenecteplase.
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Tenecteplase.
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Tenecteplase.
DB04865,The risk or severity of bleeding can be increased when Tenecteplase is combined with Omacetaxine mepesuccinate.
DB11133,Omega-3 fatty acids may increase the anticoagulant activities of Tenecteplase.
DB00081,The risk or severity of bleeding and hemorrhage can be increased when Tenecteplase is combined with Tositumomab.
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Tenecteplase.
DB00048,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.
DB00389,Carbimazole may increase the anticoagulant activities of Tenecteplase.
DB00550,Propylthiouracil may increase the anticoagulant activities of Tenecteplase.
DB00763,Methimazole may increase the anticoagulant activities of Tenecteplase.
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Tenecteplase."
DB06715,Potassium Iodide may increase the anticoagulant activities of Tenecteplase.
DB07637,Dibromotyrosine may increase the anticoagulant activities of Tenecteplase.
DB09418,Potassium perchlorate may increase the anticoagulant activities of Tenecteplase.
DB13644,Methylthiouracil may increase the anticoagulant activities of Tenecteplase.
DB13804,Benzylthiouracil may increase the anticoagulant activities of Tenecteplase.
DB00834,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mifepristone.
DB04066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with p-Coumaric acid.
DB04682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
DB05830,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trestolone.
DB06266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Lonidamine.
DB08867,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ulipristal.
DB09401,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Isosorbide.
DB11507,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cloprostenol.
DB12025,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triptolide.
DB13044,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Gossypol.
DB13310,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ormeloxifene.
DB00294,Etonogestrel may decrease the anticoagulant activities of Tenecteplase.
DB00304,Desogestrel may decrease the anticoagulant activities of Tenecteplase.
DB00351,Megestrol acetate may decrease the anticoagulant activities of Tenecteplase.
DB00367,Levonorgestrel may decrease the anticoagulant activities of Tenecteplase.
DB00378,Dydrogesterone may decrease the anticoagulant activities of Tenecteplase.
DB00396,Progesterone may decrease the anticoagulant activities of Tenecteplase.
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Tenecteplase.
DB00717,Norethisterone may decrease the anticoagulant activities of Tenecteplase.
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Tenecteplase.
DB00957,Norgestimate may decrease the anticoagulant activities of Tenecteplase.
DB01395,Drospirenone may decrease the anticoagulant activities of Tenecteplase.
DB01431,Allylestrenol may decrease the anticoagulant activities of Tenecteplase.
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Tenecteplase.
DB06713,Norelgestromin may decrease the anticoagulant activities of Tenecteplase.
DB06730,Gestodene may decrease the anticoagulant activities of Tenecteplase.
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Tenecteplase.
DB09123,Dienogest may decrease the anticoagulant activities of Tenecteplase.
DB09124,Medrogestone may decrease the anticoagulant activities of Tenecteplase.
DB09371,Norethynodrel may decrease the anticoagulant activities of Tenecteplase.
DB09389,Norgestrel may decrease the anticoagulant activities of Tenecteplase.
DB11372,Altrenogest may decrease the anticoagulant activities of Tenecteplase.
DB11619,Gestrinone may decrease the anticoagulant activities of Tenecteplase.
DB11636,Nomegestrol may decrease the anticoagulant activities of Tenecteplase.
DB12474,Lynestrenol may decrease the anticoagulant activities of Tenecteplase.
DB13230,Gestonorone may decrease the anticoagulant activities of Tenecteplase.
DB13528,Chlormadinone may decrease the anticoagulant activities of Tenecteplase.
DB13533,Methylestrenolone may decrease the anticoagulant activities of Tenecteplase.
DB13563,Norgestrienone may decrease the anticoagulant activities of Tenecteplase.
DB13602,Promegestone may decrease the anticoagulant activities of Tenecteplase.
DB13685,Quingestanol may decrease the anticoagulant activities of Tenecteplase.
DB13857,Demegestone may decrease the anticoagulant activities of Tenecteplase.
DB13866,Etynodiol may decrease the anticoagulant activities of Tenecteplase.
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Tenecteplase.
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Tenecteplase.
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Tenecteplase.
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Tenecteplase.
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Tenecteplase.
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Tenecteplase.
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Tenecteplase.
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Tenecteplase.
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Tenecteplase.
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Tenecteplase.
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Tenecteplase.
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Tenecteplase.
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Tenecteplase.
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Tenecteplase.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Tenecteplase.
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Tenecteplase.
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Tenecteplase.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Tenecteplase.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Tenecteplase.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Tenecteplase.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Tenecteplase.
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Tenecteplase.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Tenecteplase.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Tenecteplase.
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Tenecteplase.
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Tenecteplase.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Tenecteplase.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Tenecteplase.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Tenecteplase.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Tenecteplase.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Tenecteplase.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Tenecteplase.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Tenecteplase.
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Tenecteplase.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Tenecteplase.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Tenecteplase.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Tenecteplase.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Tenecteplase.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Tenecteplase.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Tenecteplase.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Tenecteplase.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Tenecteplase.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Tenecteplase.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Tenecteplase.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Tenecteplase.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Tenecteplase.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Tenecteplase.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Tenecteplase.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Tenecteplase.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Tenecteplase.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Tenecteplase.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Tenecteplase.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Tenecteplase.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Tenecteplase.
DB00374,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Treprostinil.
DB03404,Hemin may increase the anticoagulant activities of Tenecteplase.
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Tenecteplase.
DB00624,Testosterone may increase the anticoagulant activities of Tenecteplase.
DB01420,Testosterone propionate may increase the anticoagulant activities of Tenecteplase.
DB01481,1-Testosterone may increase the anticoagulant activities of Tenecteplase.
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Tenecteplase.
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Tenecteplase.
DB01541,Boldenone may increase the anticoagulant activities of Tenecteplase.
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Tenecteplase.
DB01564,Calusterone may increase the anticoagulant activities of Tenecteplase.
DB01569,Formebolone may increase the anticoagulant activities of Tenecteplase.
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Tenecteplase.
DB02901,Stanolone may increase the anticoagulant activities of Tenecteplase.
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Tenecteplase.
DB08619,Testosterone succinate may increase the anticoagulant activities of Tenecteplase.
DB11429,Mibolerone may increase the anticoagulant activities of Tenecteplase.
DB13943,Testosterone cypionate may increase the anticoagulant activities of Tenecteplase.
DB13944,Testosterone enanthate may increase the anticoagulant activities of Tenecteplase.
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Tenecteplase.
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Tenecteplase.
DB13951,Stanolone acetate may increase the anticoagulant activities of Tenecteplase.
DB13958,Trestolone acetate may increase the anticoagulant activities of Tenecteplase.
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Tenecteplase."
DB14655,Drostanolone propionate may increase the anticoagulant activities of Tenecteplase.
DB11051,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Azficel-T.
DB09568,The therapeutic efficacy of Tenecteplase can be increased when used in combination with Omega-3-carboxylic acids.
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Tenecteplase.
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Tenecteplase.
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Tenecteplase.
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Tenecteplase.
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Tenecteplase.
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Tenecteplase.
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Tenecteplase.
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Tenecteplase.
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Tenecteplase."
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Tenecteplase.
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Tenecteplase.
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Tenecteplase.
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Tenecteplase.
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Tenecteplase.
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Tenecteplase.
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Tenecteplase.
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Tenecteplase.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Tenecteplase."
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Tenecteplase.
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Tenecteplase.
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Tenecteplase.
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Tenecteplase.
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Tenecteplase.
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Tenecteplase.
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Tenecteplase.
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Tenecteplase.
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Tenecteplase.
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Tenecteplase.
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Tenecteplase.
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Tenecteplase.
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Tenecteplase.
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Tenecteplase.
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Tenecteplase.
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Tenecteplase.
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Tenecteplase.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Tenecteplase.
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Tenecteplase.
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Tenecteplase.
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Tenecteplase.
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Tenecteplase.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Tenecteplase.
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Tenecteplase.
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Tenecteplase.
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Tenecteplase.
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Tenecteplase.
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Tenecteplase.
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Tenecteplase.
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Tenecteplase.
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Tenecteplase.
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Tenecteplase.
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Tenecteplase.
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Tenecteplase.
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Tenecteplase.
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Tenecteplase.
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Tenecteplase.
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Tenecteplase.
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Tenecteplase.
DB00285,Venlafaxine may increase the antiplatelet activities of Tenecteplase.
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Tenecteplase.
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Tenecteplase.
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Tenecteplase.
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Tenecteplase.
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Tenecteplase.
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Tenecteplase.
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Tenecteplase.
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Tenecteplase.
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Tenecteplase.
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Tenecteplase.
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Tenecteplase.
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Tenecteplase.
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Tenecteplase.
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Tenecteplase.
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Tenecteplase.
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Tenecteplase.
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Tenecteplase.
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Tenecteplase."
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Tenecteplase.
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Tenecteplase.
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Tenecteplase.
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Tenecteplase.
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Tenecteplase.
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Tenecteplase.
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Tenecteplase.
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Tenecteplase.
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Tenecteplase.
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Tenecteplase.
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Tenecteplase.
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Tenecteplase.
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Tenecteplase.
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Tenecteplase.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Tenecteplase.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Tenecteplase.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Tenecteplase.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Tenecteplase.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Tenecteplase.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Tenecteplase.
DB00682,The risk or severity of bleeding can be increased when Warfarin is combined with Tenecteplase.
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Tenecteplase.
DB00974,The risk or severity of bleeding can be increased when Edetic acid is combined with Tenecteplase.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Tenecteplase.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Tenecteplase.
DB01418,The risk or severity of bleeding can be increased when Acenocoumarol is combined with Tenecteplase.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tenecteplase.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Tenecteplase.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Tenecteplase.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Tenecteplase.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Tenecteplase.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Tenecteplase.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Tenecteplase.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Tenecteplase.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Tenecteplase.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Tenecteplase.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Tenecteplase.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Tenecteplase.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Tenecteplase.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Tenecteplase.
DB11268,The risk or severity of bleeding can be increased when Protocatechualdehyde is combined with Tenecteplase.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Tenecteplase.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Tenecteplase.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Tenecteplase.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Tenecteplase.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Tenecteplase.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Tenecteplase.
DB13124,The risk or severity of bleeding can be increased when Troxerutin is combined with Tenecteplase.
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Tenecteplase.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Tenecteplase.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Tenecteplase.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Tenecteplase.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Tenecteplase.
DB00055,The risk or severity of bleeding can be increased when Tenecteplase is combined with Drotrecogin alfa.
DB06822,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tinzaparin.
DB13199,The risk or severity of bleeding can be increased when Tenecteplase is combined with Brinase.
DB13646,The risk or severity of bleeding can be increased when Tenecteplase is combined with Saruplase.
DB00086,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptokinase.
DB04925,The risk or severity of bleeding can be increased when Tenecteplase is combined with Desmoteplase.
DB05254,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fibrinolysin.
DB06543,The risk or severity of bleeding can be increased when Tenecteplase is combined with Astaxanthin.
DB08994,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ditazole.
DB09258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bemiparin.
DB09260,The risk or severity of bleeding can be increased when Tenecteplase is combined with Parnaparin.
DB13275,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clorindione.
DB13347,The risk or severity of bleeding can be increased when Tenecteplase is combined with Diphenadione.
DB13451,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioclomarol.
DB00001,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lepirudin.
DB00009,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alteplase.
DB00015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Reteplase.
DB00029,The risk or severity of bleeding can be increased when Tenecteplase is combined with Anistreplase.
DB14094,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tocopherylquinone.
DB06679,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amediplase.
DB03410,The risk or severity of bleeding can be increased when Tenecteplase is combined with 4-hydroxycoumarin.
DB08496,The risk or severity of bleeding can be increased when Tenecteplase is combined with (R)-warfarin.
DB14055,The risk or severity of bleeding can be increased when Tenecteplase is combined with (S)-Warfarin.
DB12364,The risk or severity of bleeding can be increased when Tenecteplase is combined with Betrixaban.
DB14598,The risk or severity of bleeding can be increased when Tenecteplase is combined with Edetate calcium disodium anhydrous.
DB11154,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zinc citrate.
DB11166,The risk or severity of bleeding can be increased when Tenecteplase is combined with Antithrombin Alfa.
DB04665,The risk or severity of bleeding can be increased when Tenecteplase is combined with Coumarin.
DB14726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dabigatran.
DB06294,The risk or severity of bleeding can be increased when Tenecteplase is combined with Semuloparin.
DB12726,The risk or severity of bleeding can be increased when Tenecteplase is combined with Monteplase.
DB00177,The risk or severity of angioedema can be increased when Tenecteplase is combined with Valsartan.
DB00178,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramipril.
DB00230,The risk or severity of angioedema can be increased when Tenecteplase is combined with Pregabalin.
DB00492,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinopril.
DB00519,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolapril.
DB00542,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazepril.
DB00584,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalapril.
DB00678,The risk or severity of angioedema can be increased when Tenecteplase is combined with Losartan.
DB00691,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexipril.
DB00722,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lisinopril.
DB00790,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindopril.
DB00876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Eprosartan.
DB00877,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sirolimus.
DB00881,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinapril.
DB00886,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omapatrilat.
DB00966,The risk or severity of angioedema can be increased when Tenecteplase is combined with Telmisartan.
DB01050,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ibuprofen.
DB01180,The risk or severity of angioedema can be increased when Tenecteplase is combined with Rescinnamine.
DB01197,The risk or severity of angioedema can be increased when Tenecteplase is combined with Captopril.
DB01261,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sitagliptin.
DB01340,The risk or severity of angioedema can be increased when Tenecteplase is combined with Cilazapril.
DB01342,The risk or severity of angioedema can be increased when Tenecteplase is combined with Forasartan.
DB01347,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saprisartan.
DB01348,The risk or severity of angioedema can be increased when Tenecteplase is combined with Spirapril.
DB04876,The risk or severity of angioedema can be increased when Tenecteplase is combined with Vildagliptin.
DB06011,The risk or severity of angioedema can be increased when Tenecteplase is combined with AMG-222.
DB06127,The risk or severity of angioedema can be increased when Tenecteplase is combined with Bisegliptin.
DB06196,The risk or severity of angioedema can be increased when Tenecteplase is combined with Icatibant.
DB06203,The risk or severity of angioedema can be increased when Tenecteplase is combined with Alogliptin.
DB06245,The risk or severity of angioedema can be increased when Tenecteplase is combined with Lanoteplase.
DB06287,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temsirolimus.
DB06335,The risk or severity of angioedema can be increased when Tenecteplase is combined with Saxagliptin.
DB08382,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gosogliptin.
DB08822,The risk or severity of angioedema can be increased when Tenecteplase is combined with Azilsartan medoxomil.
DB08836,The risk or severity of angioedema can be increased when Tenecteplase is combined with Temocapril.
DB08882,The risk or severity of angioedema can be increased when Tenecteplase is combined with Linagliptin.
DB09292,The risk or severity of angioedema can be increased when Tenecteplase is combined with Sacubitril.
DB09477,The risk or severity of angioedema can be increased when Tenecteplase is combined with Enalaprilat.
DB11723,The risk or severity of angioedema can be increased when Tenecteplase is combined with Dutogliptin.
DB11783,The risk or severity of angioedema can be increased when Tenecteplase is combined with Imidapril.
DB11950,The risk or severity of angioedema can be increased when Tenecteplase is combined with Teneligliptin.
DB11992,The risk or severity of angioedema can be increased when Tenecteplase is combined with Omarigliptin.
DB12268,The risk or severity of angioedema can be increased when Tenecteplase is combined with Carmegliptin.
DB12412,The risk or severity of angioedema can be increased when Tenecteplase is combined with Gemigliptin.
DB12417,The risk or severity of angioedema can be increased when Tenecteplase is combined with Anagliptin.
DB12625,The risk or severity of angioedema can be increased when Tenecteplase is combined with Evogliptin.
DB13166,The risk or severity of angioedema can be increased when Tenecteplase is combined with Zofenopril.
DB13312,The risk or severity of angioedema can be increased when Tenecteplase is combined with Delapril.
DB14125,The risk or severity of angioedema can be increased when Tenecteplase is combined with Benazeprilat.
DB14207,The risk or severity of angioedema can be increased when Tenecteplase is combined with Fosinoprilat.
DB14208,The risk or severity of angioedema can be increased when Tenecteplase is combined with Ramiprilat.
DB14209,The risk or severity of angioedema can be increased when Tenecteplase is combined with Trandolaprilat.
DB14210,The risk or severity of angioedema can be increased when Tenecteplase is combined with Moexiprilat.
DB14213,The risk or severity of angioedema can be increased when Tenecteplase is combined with Perindoprilat.
DB14217,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinaprilat.
DB14231,The risk or severity of angioedema can be increased when Tenecteplase is combined with Quinoline Yellow WS.
DB00203,The risk or severity of hemorrhage can be increased when Tenecteplase is combined with Sildenafil.
DB00008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2a.
DB00011,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n1.
DB00018,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-n3.
DB00022,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon alfa-2b.
DB00033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.
DB00034,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.
DB00056,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemtuzumab ozogamicin.
DB00068,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon beta-1b.
DB00069,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfacon-1.
DB00073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Rituximab.
DB00078,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ibritumomab tiuxetan.
DB00087,The risk or severity of bleeding can be increased when Tenecteplase is combined with Alemtuzumab.
DB00105,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2b.
DB00120,The risk or severity of bleeding can be increased when Tenecteplase is combined with Phenylalanine.
DB00188,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bortezomib.
DB00242,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cladribine.
DB00262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carmustine.
DB00276,The risk or severity of bleeding can be increased when Tenecteplase is combined with Amsacrine.
DB00291,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chlorambucil.
DB00293,The risk or severity of bleeding can be increased when Tenecteplase is combined with Raltitrexed.
DB00305,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitomycin.
DB00307,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bexarotene.
DB00309,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vindesine.
DB00322,The risk or severity of bleeding can be increased when Tenecteplase is combined with Floxuridine.
DB00352,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tioguanine.
DB00361,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinorelbine.
DB00380,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dexrazoxane.
DB00398,The risk or severity of bleeding can be increased when Tenecteplase is combined with Sorafenib.
DB00428,The risk or severity of bleeding can be increased when Tenecteplase is combined with Streptozocin.
DB00441,The risk or severity of bleeding can be increased when Tenecteplase is combined with Gemcitabine.
DB00444,The risk or severity of bleeding can be increased when Tenecteplase is combined with Teniposide.
DB00445,The risk or severity of bleeding can be increased when Tenecteplase is combined with Epirubicin.
DB00446,The risk or severity of bleeding can be increased when Tenecteplase is combined with Chloramphenicol.
DB00480,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lenalidomide.
DB00488,The risk or severity of bleeding can be increased when Tenecteplase is combined with Altretamine.
DB00495,The risk or severity of bleeding can be increased when Tenecteplase is combined with Zidovudine.
DB00515,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cisplatin.
DB00526,The risk or severity of bleeding can be increased when Tenecteplase is combined with Oxaliplatin.
DB00531,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cyclophosphamide.
DB00544,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fluorouracil.
DB00552,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pentostatin.
DB00563,The risk or severity of bleeding can be increased when Tenecteplase is combined with Methotrexate.
DB00564,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carbamazepine.
DB00570,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vinblastine.
DB00619,The risk or severity of bleeding can be increased when Tenecteplase is combined with Imatinib.
DB00631,The risk or severity of bleeding can be increased when Tenecteplase is combined with Clofarabine.
DB00642,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pemetrexed.
DB00694,The risk or severity of bleeding can be increased when Tenecteplase is combined with Daunorubicin.
DB00762,The risk or severity of bleeding can be increased when Tenecteplase is combined with Irinotecan.
DB00773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Etoposide.
DB00851,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dacarbazine.
DB00853,The risk or severity of bleeding can be increased when Tenecteplase is combined with Temozolomide.
DB00859,The risk or severity of bleeding can be increased when Tenecteplase is combined with Penicillamine.
DB00864,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tacrolimus.
DB00888,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mechlorethamine.
DB00928,The risk or severity of bleeding can be increased when Tenecteplase is combined with Azacitidine.
DB00958,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carboplatin.
DB00970,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dactinomycin.
DB00987,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cytarabine.
DB00997,The risk or severity of bleeding can be increased when Tenecteplase is combined with Doxorubicin.
DB01005,The risk or severity of bleeding can be increased when Tenecteplase is combined with Hydroxyurea.
DB01008,The risk or severity of bleeding can be increased when Tenecteplase is combined with Busulfan.
DB01030,The risk or severity of bleeding can be increased when Tenecteplase is combined with Topotecan.
DB01033,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mercaptopurine.
DB01041,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thalidomide.
DB01042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Melphalan.
DB01073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Fludarabine.
DB01099,The risk or severity of bleeding can be increased when Tenecteplase is combined with Flucytosine.
DB01101,The risk or severity of bleeding can be increased when Tenecteplase is combined with Capecitabine.
DB01169,The risk or severity of bleeding can be increased when Tenecteplase is combined with Arsenic trioxide.
DB01177,The risk or severity of bleeding can be increased when Tenecteplase is combined with Idarubicin.
DB01204,The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitoxantrone.
DB01206,The risk or severity of bleeding can be increased when Tenecteplase is combined with Lomustine.
DB01229,The risk or severity of bleeding can be increased when Tenecteplase is combined with Paclitaxel.
DB01248,The risk or severity of bleeding can be increased when Tenecteplase is combined with Docetaxel.
DB01262,The risk or severity of bleeding can be increased when Tenecteplase is combined with Decitabine.
DB01280,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nelarabine.
DB01590,The risk or severity of bleeding can be increased when Tenecteplase is combined with Everolimus.
DB02546,The risk or severity of bleeding can be increased when Tenecteplase is combined with Vorinostat.
DB04572,The risk or severity of bleeding can be increased when Tenecteplase is combined with Thiotepa.
DB04845,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ixabepilone.
DB04868,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nilotinib.
DB05015,The risk or severity of bleeding can be increased when Tenecteplase is combined with Belinostat.
DB05109,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trabectedin.
DB05258,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa.
DB05472,The risk or severity of bleeding can be increased when Tenecteplase is combined with omega interferon.
DB05773,The risk or severity of bleeding can be increased when Tenecteplase is combined with Trastuzumab emtansine.
DB06616,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bosutinib.
DB06769,The risk or severity of bleeding can be increased when Tenecteplase is combined with Bendamustine.
DB06772,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cabazitaxel.
DB08871,The risk or severity of bleeding can be increased when Tenecteplase is combined with Eribulin.
DB08877,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ruxolitinib.
DB08889,The risk or severity of bleeding can be increased when Tenecteplase is combined with Carfilzomib.
DB08895,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tofacitinib.
DB08901,The risk or severity of bleeding can be increased when Tenecteplase is combined with Ponatinib.
DB08910,The risk or severity of bleeding can be increased when Tenecteplase is combined with Pomalidomide.
DB09042,The risk or severity of bleeding can be increased when Tenecteplase is combined with Tedizolid phosphate.
DB09052,The risk or severity of bleeding can be increased when Tenecteplase is combined with Blinatumomab.
DB09073,The risk or severity of bleeding can be increased when Tenecteplase is combined with Palbociclib.
DB09074,The risk or severity of bleeding can be increased when Tenecteplase is combined with Olaparib.
DB09077,The risk or severity of bleeding can be increased when Tenecteplase is combined with Dinutuximab.
DB09122,The risk or severity of bleeding can be increased when Tenecteplase is combined with Peginterferon beta-1a.
DB12814,The risk or severity of bleeding can be increased when Tenecteplase is combined with Cepeginterferon alfa-2B.
DB00229,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotiam.
DB00267,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmenoxime.
DB00274,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefmetazole.
DB00430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpiramide.
DB00438,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftazidime.
DB00447,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Loracarbef.
DB00456,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefalotin.
DB00493,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotaxime.
DB00535,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefdinir.
DB00567,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephalexin.
DB00671,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefixime.
DB00689,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephaloglycin.
DB00833,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaclor.
DB00923,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceforanide.
DB01066,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefditoren.
DB01112,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefuroxime.
DB01139,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefapirin.
DB01140,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefadroxil.
DB01150,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefprozil.
DB01212,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftriaxone.
DB01326,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole.
DB01327,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazolin.
DB01328,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefonicid.
DB01329,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoperazone.
DB01330,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefotetan.
DB01331,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefoxitin.
DB01332,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftizoxime.
DB01333,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefradine.
DB01413,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefepime.
DB01414,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefacetrile.
DB01415,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftibuten.
DB01416,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpodoxime.
DB04570,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Latamoxef.
DB04918,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftobiprole.
DB06590,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftaroline fosamil.
DB09008,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefaloridine.
DB09050,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftolozane.
DB09062,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefminox.
DB11367,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefroxadine.
DB11935,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Flomoxef.
DB13266,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefatrizine.
DB13461,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefcapene.
DB13470,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefodizime.
DB13499,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefsulodin.
DB13504,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefetamet.
DB13638,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefbuperazone.
DB13667,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefozopran.
DB13682,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefpirome.
DB13778,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazedone.
DB13821,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Ceftezole.
DB14725,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefamandole nafate.
DB00254,The risk or severity of bleeding can be increased when Doxycycline is combined with Tenecteplase.
DB00207,The risk or severity of adverse effects can be increased when Azithromycin is combined with Tenecteplase.
DB09539,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tenecteplase.
DB00945,Acetylsalicylic acid may increase the anticoagulant activities of Tenecteplase.
DB01606,The risk or severity of bleeding can be increased when Tazobactam is combined with Tenecteplase.
DB00727,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Nitroglycerin.
DB00199,The risk or severity of bleeding can be increased when Erythromycin is combined with Tenecteplase.
DB00656,The risk or severity of bleeding can be increased when Trazodone is combined with Tenecteplase.
DB00620,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Triamcinolone.
DB09079,The risk or severity of bleeding can be increased when Tenecteplase is combined with Nintedanib.
DB01175,The risk or severity of bleeding can be increased when Escitalopram is combined with Tenecteplase.
DB01104,The risk or severity of bleeding can be increased when Sertraline is combined with Tenecteplase.
DB00232,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Methyclothiazide.
DB00436,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Bendroflumethiazide.
DB00562,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Benzthiazide.
DB00606,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclothiazide.
DB00774,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydroflumethiazide.
DB00880,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Polythiazide.
DB13430,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Mebutizide.
DB13532,The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cyclopenthiazide.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon gamma-1b.
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon gamma-1b.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon gamma-1b.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon gamma-1b.
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon gamma-1b.
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon gamma-1b.
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon gamma-1b.
DB00034,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.
DB00051,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.
DB00056,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pegaspargase.
DB00065,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Infliximab.
DB00068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon beta-1b.
DB00069,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfacon-1.
DB00073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antithymocyte immunoglobulin (rabbit).
DB00105,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2b.
DB00111,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Phenylalanine.
DB00180,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flunisolide.
DB00188,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bortezomib.
DB00242,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cladribine.
DB00262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carmustine.
DB00276,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitomycin.
DB00307,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bexarotene.
DB00309,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vindesine.
DB00322,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Floxuridine.
DB00328,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Indomethacin.
DB00352,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tioguanine.
DB00361,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinorelbine.
DB00380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexrazoxane.
DB00394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Beclomethasone dipropionate.
DB00398,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sorafenib.
DB00428,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gemcitabine.
DB00443,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Betamethasone.
DB00444,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teniposide.
DB00445,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Altretamine.
DB00495,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Zidovudine.
DB00515,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Oxaliplatin.
DB00531,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cyclophosphamide.
DB00541,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vincristine.
DB00544,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluorouracil.
DB00550,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Propylthiouracil.
DB00552,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pentostatin.
DB00563,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methotrexate.
DB00564,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carbamazepine.
DB00570,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vinblastine.
DB00588,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone propionate.
DB00591,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocinolone acetonide.
DB00601,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Linezolid.
DB00619,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Imatinib.
DB00620,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triamcinolone.
DB00631,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clofarabine.
DB00635,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisone.
DB00642,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pemetrexed.
DB00687,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludrocortisone.
DB00688,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolate mofetil.
DB00694,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Daunorubicin.
DB00755,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tretinoin.
DB00762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Irinotecan.
DB00763,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methimazole.
DB00764,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone.
DB00773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Etoposide.
DB00795,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sulfasalazine.
DB00851,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dacarbazine.
DB00853,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Penicillamine.
DB00860,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednisolone.
DB00877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirolimus.
DB00888,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carboplatin.
DB00959,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Methylprednisolone.
DB00970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dactinomycin.
DB00987,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cytarabine.
DB00993,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azathioprine.
DB00997,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxorubicin.
DB01005,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxyurea.
DB01008,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Busulfan.
DB01024,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Topotecan.
DB01033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mercaptopurine.
DB01041,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thalidomide.
DB01042,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Flucytosine.
DB01101,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Capecitabine.
DB01108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trilostane.
DB01168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Arsenic trioxide.
DB01177,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idarubicin.
DB01181,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ifosfamide.
DB01196,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Estramustine.
DB01204,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Lomustine.
DB01222,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Budesonide.
DB01229,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paclitaxel.
DB01234,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone.
DB01248,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Docetaxel.
DB01254,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dasatinib.
DB01257,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Decitabine.
DB01268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sunitinib.
DB01280,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nelarabine.
DB01281,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abatacept.
DB01285,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Corticotropin.
DB01380,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortisone acetate.
DB01384,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Paramethasone.
DB01394,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Colchicine.
DB01410,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ciclesonide.
DB01423,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Stepronin.
DB01590,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Everolimus.
DB01611,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydroxychloroquine.
DB01816,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brequinar.
DB04572,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Thiotepa.
DB04630,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldosterone.
DB04845,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixabepilone.
DB04868,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Nilotinib.
DB04951,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirfenidone.
DB04956,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Afelimomab.
DB05015,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belinostat.
DB05109,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trabectedin.
DB05258,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with omega interferon.
DB05676,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Apremilast.
DB05773,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trastuzumab emtansine.
DB06168,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Canakinumab.
DB06273,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tocilizumab.
DB06287,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Temsirolimus.
DB06372,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rilonacept.
DB06589,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pazopanib.
DB06603,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Panobinostat.
DB06612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mepolizumab.
DB06616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bosutinib.
DB06662,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Abetimus.
DB06674,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Golimumab.
DB06681,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belatacept.
DB06769,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bendamustine.
DB06772,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cabazitaxel.
DB06813,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Wortmannin.
DB08870,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brentuximab vedotin.
DB08871,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Eribulin.
DB08877,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ruxolitinib.
DB08879,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Carfilzomib.
DB08901,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ponatinib.
DB08904,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Certolizumab pegol.
DB08906,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone furoate.
DB08908,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dimethyl fumarate.
DB08910,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pomalidomide.
DB08935,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Obinutuzumab.
DB08970,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednidene.
DB08971,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortolone.
DB09029,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vedolizumab.
DB09036,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Blinatumomab.
DB09053,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ibrutinib.
DB09054,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Idelalisib.
DB09073,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Palbociclib.
DB09074,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Olaparib.
DB09077,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dinutuximab.
DB09082,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Vilanterol.
DB09091,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Antilymphocyte immunoglobulin (horse).
DB09378,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluprednisolone.
DB09383,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Meprednisone.
DB11466,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tepoxalin.
DB11487,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Dexamethasone isonicotinate.
DB11529,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Melengestrol.
DB11569,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Peficitinib.
DB11750,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Clobetasol.
DB11767,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Sirukumab.
DB11817,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Baricitinib.
DB11834,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Guselkumab.
DB11921,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deflazacort.
DB11988,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ocrelizumab.
DB12025,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Triptolide.
DB12371,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Siponimod.
DB12612,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Acteoside.
DB13003,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cortivazol.
DB13014,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13208,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Prednylidene.
DB13223,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Formocortal.
DB13728,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Halometasone.
DB13843,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Cloprednol.
DB13856,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluclorolone.
DB13867,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Fluticasone.
DB14066,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Tetrandrine.
DB14219,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Monomethyl fumarate.
DB14512,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Mometasone furoate.
DB14538,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone aceponate.
DB14539,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone acetate.
DB14545,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Hydrocortisone succinate.
DB14724,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Bleselumab.
DB00108,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon gamma-1b.
DB01656,Roflumilast may increase the immunosuppressive activities of Interferon gamma-1b.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon gamma-1b.
DB00363,The risk or severity of neutropenia can be increased when Interferon gamma-1b is combined with Clozapine.
DB00315,The metabolism of Zolmitriptan can be decreased when combined with Interferon gamma-1b.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon gamma-1b.
DB01097,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Leflunomide.
DB08895,Interferon gamma-1b may increase the immunosuppressive activities of Tofacitinib.
DB00072,Trastuzumab may increase the neutropenic activities of Interferon gamma-1b.
DB08868,Interferon gamma-1b may increase the immunosuppressive activities of Fingolimod.
DB00864,Tacrolimus may increase the immunosuppressive activities of Interferon gamma-1b.
DB00201,The metabolism of Caffeine can be decreased when combined with Interferon gamma-1b.
DB00651,The metabolism of Dyphylline can be decreased when combined with Interferon gamma-1b.
DB00806,The metabolism of Pentoxifylline can be decreased when combined with Interferon gamma-1b.
DB01303,The metabolism of Oxtriphylline can be decreased when combined with Interferon gamma-1b.
DB01412,The metabolism of Theobromine can be decreased when combined with Interferon gamma-1b.
DB01482,The metabolism of Fenethylline can be decreased when combined with Interferon gamma-1b.
DB01667,The metabolism of 8-azaguanine can be decreased when combined with Interferon gamma-1b.
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon gamma-1b."
DB02134,The metabolism of Xanthine can be decreased when combined with Interferon gamma-1b.
DB02245,The metabolism of 7-Deazaguanine can be decreased when combined with Interferon gamma-1b.
DB02377,The metabolism of Guanine can be decreased when combined with Interferon gamma-1b.
DB02489,The metabolism of 9-Methylguanine can be decreased when combined with Interferon gamma-1b.
DB02568,The metabolism of Peldesine can be decreased when combined with Interferon gamma-1b.
DB04076,The metabolism of Hypoxanthine can be decreased when combined with Interferon gamma-1b.
DB04356,The metabolism of 9-Deazaguanine can be decreased when combined with Interferon gamma-1b.
DB06479,The metabolism of Propentofylline can be decreased when combined with Interferon gamma-1b.
DB06575,The metabolism of Valomaciclovir can be decreased when combined with Interferon gamma-1b.
DB07954,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon gamma-1b.
DB08844,The metabolism of Uric acid can be decreased when combined with Interferon gamma-1b.
DB09273,The metabolism of Doxofylline can be decreased when combined with Interferon gamma-1b.
DB11919,The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon gamma-1b.
DB12406,The metabolism of Lisofylline can be decreased when combined with Interferon gamma-1b.
DB12531,The metabolism of Lobucavir can be decreased when combined with Interferon gamma-1b.
DB12926,The metabolism of Cafedrine can be decreased when combined with Interferon gamma-1b.
DB12927,The metabolism of Theodrenaline can be decreased when combined with Interferon gamma-1b.
DB13203,The metabolism of Bamifylline can be decreased when combined with Interferon gamma-1b.
DB13449,The metabolism of Proxyphylline can be decreased when combined with Interferon gamma-1b.
DB13573,The metabolism of Acefylline can be decreased when combined with Interferon gamma-1b.
DB13592,The metabolism of Etamiphylline can be decreased when combined with Interferon gamma-1b.
DB13634,The metabolism of Pentifylline can be decreased when combined with Interferon gamma-1b.
DB13812,The metabolism of Bufylline can be decreased when combined with Interferon gamma-1b.
DB14018,The metabolism of Bromotheophylline can be decreased when combined with Interferon gamma-1b.
DB14029,The metabolism of Furafylline can be decreased when combined with Interferon gamma-1b.
DB14132,The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon gamma-1b.
DB15122,The metabolism of PCS-499 can be decreased when combined with Interferon gamma-1b.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon gamma-1b.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon gamma-1b.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon gamma-1b.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon gamma-1b.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon gamma-1b.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon gamma-1b.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon gamma-1b.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon gamma-1b.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon gamma-1b.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon gamma-1b."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon gamma-1b.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon gamma-1b."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon gamma-1b.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon gamma-1b.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon gamma-1b.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon gamma-1b.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon gamma-1b.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon gamma-1b.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon gamma-1b.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon gamma-1b.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon gamma-1b.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon gamma-1b.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon gamma-1b.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon gamma-1b.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon gamma-1b.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon gamma-1b."
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon gamma-1b.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon gamma-1b.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon gamma-1b.
DB00945,The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon gamma-1b.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon gamma-1b.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Interferon gamma-1b.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon gamma-1b.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon gamma-1b.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon gamma-1b.
DB01240,The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon gamma-1b.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon gamma-1b.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon gamma-1b.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon gamma-1b.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Interferon gamma-1b.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon gamma-1b.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon gamma-1b.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon gamma-1b.
DB06209,The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon gamma-1b.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon gamma-1b.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Interferon gamma-1b.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Interferon gamma-1b.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon gamma-1b.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon gamma-1b.
DB09030,The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon gamma-1b.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Interferon gamma-1b.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon gamma-1b.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon gamma-1b.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon gamma-1b.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon gamma-1b.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon gamma-1b.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Interferon gamma-1b.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon gamma-1b.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon gamma-1b.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon gamma-1b.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Interferon gamma-1b.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon gamma-1b.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon gamma-1b.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon gamma-1b.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon gamma-1b.
DB13200,Interferon gamma-1b may increase the myelosuppressive activities of Lipegfilgrastim.
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon gamma-1b.
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon gamma-1b.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon gamma-1b.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon gamma-1b.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon gamma-1b.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon gamma-1b.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon gamma-1b.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon gamma-1b.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Interferon gamma-1b.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon gamma-1b.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon gamma-1b.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon gamma-1b.
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.
DB00176,The metabolism of Fluvoxamine can be decreased when combined with Interferon gamma-1b.
DB00184,The metabolism of Nicotine can be decreased when combined with Interferon gamma-1b.
DB00195,The metabolism of Betaxolol can be decreased when combined with Interferon gamma-1b.
DB00261,The metabolism of Anagrelide can be decreased when combined with Interferon gamma-1b.
DB00280,The metabolism of Disopyramide can be decreased when combined with Interferon gamma-1b.
DB00281,The metabolism of Lidocaine can be decreased when combined with Interferon gamma-1b.
DB00286,The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.
DB00296,The metabolism of Ropivacaine can be decreased when combined with Interferon gamma-1b.
DB00316,The metabolism of Acetaminophen can be decreased when combined with Interferon gamma-1b.
DB00334,The metabolism of Olanzapine can be decreased when combined with Interferon gamma-1b.
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Interferon gamma-1b.
DB00365,The metabolism of Grepafloxacin can be decreased when combined with Interferon gamma-1b.
DB00370,The metabolism of Mirtazapine can be decreased when combined with Interferon gamma-1b.
DB00379,The metabolism of Mexiletine can be decreased when combined with Interferon gamma-1b.
DB00382,The metabolism of Tacrine can be decreased when combined with Interferon gamma-1b.
DB00384,The metabolism of Triamterene can be decreased when combined with Interferon gamma-1b.
DB00420,The metabolism of Promazine can be decreased when combined with Interferon gamma-1b.
DB00425,The metabolism of Zolpidem can be decreased when combined with Interferon gamma-1b.
DB00442,The metabolism of Entecavir can be decreased when combined with Interferon gamma-1b.
DB00461,The metabolism of Nabumetone can be decreased when combined with Interferon gamma-1b.
DB00468,The metabolism of Quinine can be decreased when combined with Interferon gamma-1b.
DB00472,The metabolism of Fluoxetine can be decreased when combined with Interferon gamma-1b.
DB00476,The metabolism of Duloxetine can be decreased when combined with Interferon gamma-1b.
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Interferon gamma-1b.
DB00499,The metabolism of Flutamide can be decreased when combined with Interferon gamma-1b.
DB00502,The metabolism of Haloperidol can be decreased when combined with Interferon gamma-1b.
DB00518,The metabolism of Albendazole can be decreased when combined with Interferon gamma-1b.
DB00533,The metabolism of Rofecoxib can be decreased when combined with Interferon gamma-1b.
DB00568,The metabolism of Cinnarizine can be decreased when combined with Interferon gamma-1b.
DB00571,The metabolism of Propranolol can be decreased when combined with Interferon gamma-1b.
DB00586,The metabolism of Diclofenac can be decreased when combined with Interferon gamma-1b.
DB00629,The metabolism of Guanabenz can be decreased when combined with Interferon gamma-1b.
DB00661,The metabolism of Verapamil can be decreased when combined with Interferon gamma-1b.
DB00715,The metabolism of Paroxetine can be decreased when combined with Interferon gamma-1b.
DB00730,The metabolism of Thiabendazole can be decreased when combined with Interferon gamma-1b.
DB00740,The metabolism of Riluzole can be decreased when combined with Interferon gamma-1b.
DB00744,The metabolism of Zileuton can be decreased when combined with Interferon gamma-1b.
DB00758,The metabolism of Clopidogrel can be decreased when combined with Interferon gamma-1b.
DB00783,The metabolism of Estradiol can be decreased when combined with Interferon gamma-1b.
DB00787,The metabolism of Acyclovir can be decreased when combined with Interferon gamma-1b.
DB00788,The metabolism of Naproxen can be decreased when combined with Interferon gamma-1b.
DB00831,The metabolism of Trifluoperazine can be decreased when combined with Interferon gamma-1b.
DB00850,The metabolism of Perphenazine can be decreased when combined with Interferon gamma-1b.
DB00857,The metabolism of Terbinafine can be decreased when combined with Interferon gamma-1b.
DB00863,The metabolism of Ranitidine can be decreased when combined with Interferon gamma-1b.
DB00898,The metabolism of Ethanol can be decreased when combined with Interferon gamma-1b.
DB00934,The metabolism of Maprotiline can be decreased when combined with Interferon gamma-1b.
DB00969,The metabolism of Alosetron can be decreased when combined with Interferon gamma-1b.
DB00978,The metabolism of Lomefloxacin can be decreased when combined with Interferon gamma-1b.
DB00980,The metabolism of Ramelteon can be decreased when combined with Interferon gamma-1b.
DB00998,The metabolism of Frovatriptan can be decreased when combined with Interferon gamma-1b.
DB01002,The metabolism of Levobupivacaine can be decreased when combined with Interferon gamma-1b.
DB01012,The metabolism of Cinacalcet can be decreased when combined with Interferon gamma-1b.
DB01037,The metabolism of Selegiline can be decreased when combined with Interferon gamma-1b.
DB01056,The metabolism of Tocainide can be decreased when combined with Interferon gamma-1b.
DB01058,The metabolism of Praziquantel can be decreased when combined with Interferon gamma-1b.
DB01065,The metabolism of Melatonin can be decreased when combined with Interferon gamma-1b.
DB01087,The metabolism of Primaquine can be decreased when combined with Interferon gamma-1b.
DB01094,The metabolism of Hesperetin can be decreased when combined with Interferon gamma-1b.
DB01115,The metabolism of Nifedipine can be decreased when combined with Interferon gamma-1b.
DB01136,The metabolism of Carvedilol can be decreased when combined with Interferon gamma-1b.
DB01166,The metabolism of Cilostazol can be decreased when combined with Interferon gamma-1b.
DB01182,The metabolism of Propafenone can be decreased when combined with Interferon gamma-1b.
DB01184,The metabolism of Domperidone can be decreased when combined with Interferon gamma-1b.
DB01191,The metabolism of Dexfenfluramine can be decreased when combined with Interferon gamma-1b.
DB01367,The metabolism of Rasagiline can be decreased when combined with Interferon gamma-1b.
DB01405,The metabolism of Temafloxacin can be decreased when combined with Interferon gamma-1b.
DB01424,The metabolism of Aminophenazone can be decreased when combined with Interferon gamma-1b.
DB01435,The metabolism of Antipyrine can be decreased when combined with Interferon gamma-1b.
DB01558,The metabolism of Bromazepam can be decreased when combined with Interferon gamma-1b.
DB01623,The metabolism of Thiothixene can be decreased when combined with Interferon gamma-1b.
DB01628,The metabolism of Etoricoxib can be decreased when combined with Interferon gamma-1b.
DB01645,The metabolism of Genistein can be decreased when combined with Interferon gamma-1b.
DB02709,The metabolism of Resveratrol can be decreased when combined with Interferon gamma-1b.
DB03783,The metabolism of Phenacetin can be decreased when combined with Interferon gamma-1b.
DB04574,The metabolism of Estrone sulfate can be decreased when combined with Interferon gamma-1b.
DB04841,The metabolism of Flunarizine can be decreased when combined with Interferon gamma-1b.
DB04871,The metabolism of Lorcaserin can be decreased when combined with Interferon gamma-1b.
DB04948,The metabolism of Lofexidine can be decreased when combined with Interferon gamma-1b.
DB06148,The metabolism of Mianserin can be decreased when combined with Interferon gamma-1b.
DB06210,The metabolism of Eltrombopag can be decreased when combined with Interferon gamma-1b.
DB06216,The metabolism of Asenapine can be decreased when combined with Interferon gamma-1b.
DB06235,The metabolism of Vadimezan can be decreased when combined with Interferon gamma-1b.
DB06292,The metabolism of Dapagliflozin can be decreased when combined with Interferon gamma-1b.
DB06594,The metabolism of Agomelatine can be decreased when combined with Interferon gamma-1b.
DB06626,The metabolism of Axitinib can be decreased when combined with Interferon gamma-1b.
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Interferon gamma-1b.
DB06774,The metabolism of Capsaicin can be decreased when combined with Interferon gamma-1b.
DB08496,The metabolism of (R)-warfarin can be decreased when combined with Interferon gamma-1b.
DB08883,The metabolism of Perampanel can be decreased when combined with Interferon gamma-1b.
DB09071,The metabolism of Tasimelteon can be decreased when combined with Interferon gamma-1b.
DB09118,The metabolism of Stiripentol can be decreased when combined with Interferon gamma-1b.
DB09225,The metabolism of Zotepine can be decreased when combined with Interferon gamma-1b.
DB09288,The metabolism of Propacetamol can be decreased when combined with Interferon gamma-1b.
DB09290,The metabolism of Ramosetron can be decreased when combined with Interferon gamma-1b.
DB11967,The metabolism of Binimetinib can be decreased when combined with Interferon gamma-1b.
DB12026,The metabolism of Voxilaprevir can be decreased when combined with Interferon gamma-1b.
DB12245,The metabolism of Triclabendazole can be decreased when combined with Interferon gamma-1b.
DB12332,The metabolism of Rucaparib can be decreased when combined with Interferon gamma-1b.
DB12945,The metabolism of Dihydralazine can be decreased when combined with Interferon gamma-1b.
DB13952,The metabolism of Estradiol acetate can be decreased when combined with Interferon gamma-1b.
DB13953,The metabolism of Estradiol benzoate can be decreased when combined with Interferon gamma-1b.
DB13954,The metabolism of Estradiol cypionate can be decreased when combined with Interferon gamma-1b.
DB13955,The metabolism of Estradiol dienanthate can be decreased when combined with Interferon gamma-1b.
DB13956,The metabolism of Estradiol valerate can be decreased when combined with Interferon gamma-1b.
DB11757,The metabolism of Istradefylline can be decreased when combined with Interferon gamma-1b.
DB00972,The metabolism of Azelastine can be decreased when combined with Interferon gamma-1b.
DB00625,The metabolism of Efavirenz can be decreased when combined with Interferon gamma-1b.
DB01233,The metabolism of Metoclopramide can be decreased when combined with Interferon gamma-1b.
DB04889,The metabolism of Bicifadine can be decreased when combined with Interferon gamma-1b.
DB05708,The metabolism of GTS-21 can be decreased when combined with Interferon gamma-1b.
DB01195,The metabolism of Flecainide can be decreased when combined with Interferon gamma-1b.
DB00977,The metabolism of Ethinylestradiol can be decreased when combined with Interferon gamma-1b.
DB00321,The metabolism of Amitriptyline can be decreased when combined with Interferon gamma-1b.
DB00458,The metabolism of Imipramine can be decreased when combined with Interferon gamma-1b.
DB01142,The metabolism of Doxepin can be decreased when combined with Interferon gamma-1b.
DB00532,The metabolism of Mephenytoin can be decreased when combined with Interferon gamma-1b.
DB00540,The metabolism of Nortriptyline can be decreased when combined with Interferon gamma-1b.
DB00575,The metabolism of Clonidine can be decreased when combined with Interferon gamma-1b.
DB00924,The metabolism of Cyclobenzaprine can be decreased when combined with Interferon gamma-1b.
DB01151,The metabolism of Desipramine can be decreased when combined with Interferon gamma-1b.
DB01242,The metabolism of Clomipramine can be decreased when combined with Interferon gamma-1b.
DB11689,The metabolism of Selumetinib can be decreased when combined with Interferon gamma-1b.
DB00277,The metabolism of Theophylline can be decreased when combined with Interferon gamma-1b.
DB00682,The metabolism of Warfarin can be decreased when combined with Interferon gamma-1b.
DB00697,The metabolism of Tizanidine can be decreased when combined with Interferon gamma-1b.
DB01100,The metabolism of Pimozide can be decreased when combined with Interferon gamma-1b.
DB01223,The metabolism of Aminophylline can be decreased when combined with Interferon gamma-1b.
DB01418,The metabolism of Acenocoumarol can be decreased when combined with Interferon gamma-1b.
DB00530,The metabolism of Erlotinib can be decreased when combined with Interferon gamma-1b.
DB09256,The metabolism of Tegafur can be decreased when combined with Interferon gamma-1b.
DB13874,The metabolism of Enasidenib can be decreased when combined with Interferon gamma-1b.
DB00675,The metabolism of Tamoxifen can be decreased when combined with Interferon gamma-1b.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon gamma-1b.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon gamma-1b.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Interferon gamma-1b.
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Interferon gamma-1b.
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Interferon gamma-1b.
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon gamma-1b.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon gamma-1b.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon gamma-1b.
DB00086,The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon gamma-1b.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon gamma-1b.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Interferon gamma-1b.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon gamma-1b.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Interferon gamma-1b.
DB00569,The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon gamma-1b.
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon gamma-1b.
DB00946,The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon gamma-1b.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Interferon gamma-1b.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon gamma-1b.
DB03410,The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon gamma-1b.
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Interferon gamma-1b.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon gamma-1b.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon gamma-1b.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Interferon gamma-1b.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon gamma-1b.
DB06228,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon gamma-1b.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon gamma-1b.
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon gamma-1b.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon gamma-1b.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon gamma-1b.
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Interferon gamma-1b.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon gamma-1b.
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Interferon gamma-1b.
DB06695,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon gamma-1b.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon gamma-1b.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon gamma-1b.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon gamma-1b.
DB07767,The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon gamma-1b.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon gamma-1b.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon gamma-1b.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Interferon gamma-1b.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon gamma-1b.
DB09125,The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon gamma-1b.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon gamma-1b.
DB09255,The risk or severity of bleeding can be increased when Dextran is combined with Interferon gamma-1b.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon gamma-1b.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Interferon gamma-1b.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon gamma-1b.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Interferon gamma-1b.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Interferon gamma-1b.
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon gamma-1b.
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon gamma-1b.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Interferon gamma-1b.
DB11598,The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon gamma-1b.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon gamma-1b.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Interferon gamma-1b.
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon gamma-1b.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon gamma-1b.
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Interferon gamma-1b.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Interferon gamma-1b.
DB13136,The risk or severity of bleeding can be increased when Fluindione is combined with Interferon gamma-1b.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Interferon gamma-1b.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Interferon gamma-1b.
DB13275,The risk or severity of bleeding can be increased when Clorindione is combined with Interferon gamma-1b.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon gamma-1b.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon gamma-1b.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Interferon gamma-1b.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Interferon gamma-1b.
DB14055,The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon gamma-1b.
DB14094,The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon gamma-1b.
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon gamma-1b.
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon gamma-1b.
DB00232,The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon gamma-1b.
DB00436,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon gamma-1b.
DB00562,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon gamma-1b.
DB00606,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon gamma-1b.
DB00774,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon gamma-1b.
DB00880,The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon gamma-1b.
DB00999,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon gamma-1b.
DB01021,The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon gamma-1b.
DB01324,The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon gamma-1b.
DB13430,The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon gamma-1b.
DB13532,The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon gamma-1b.
DB09042,The risk or severity of myelosuppression can be increased when Interferon gamma-1b is combined with Tedizolid phosphate.
DB00091,Interferon gamma-1b may increase the immunosuppressive activities of Cyclosporine.
DB00268,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Ropinirole.
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon gamma-1b.
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon gamma-1b.
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Interferon gamma-1b.
DB01601,The serum concentration of Interferon gamma-1b can be increased when it is combined with Lopinavir.
DB12530,The risk or severity of infection can be increased when Interferon gamma-1b is combined with Inebilizumab.
DB06643,"The risk or severity of adverse effects can be increased when Denosumab is combined with Interferon alfa-2a, Recombinant."
DB00005,"The risk or severity of adverse effects can be increased when Etanercept is combined with Interferon alfa-2a, Recombinant."
DB00008,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Interferon alfa-2a, Recombinant."
DB00011,"The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Interferon alfa-2a, Recombinant."
DB00018,"The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Interferon alfa-2a, Recombinant."
DB00022,"The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Interferon alfa-2a, Recombinant."
DB00026,"The risk or severity of adverse effects can be increased when Anakinra is combined with Interferon alfa-2a, Recombinant."
DB00033,"The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Interferon alfa-2a, Recombinant."
DB00051,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab."
DB00056,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemtuzumab ozogamicin."
DB00059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pegaspargase."
DB00065,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Infliximab."
DB00068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon beta-1b."
DB00069,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfacon-1."
DB00073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rituximab."
DB00074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Basiliximab."
DB00075,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Muromonab."
DB00078,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibritumomab tiuxetan."
DB00081,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tositumomab."
DB00087,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alemtuzumab."
DB00092,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Alefacept."
DB00095,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Efalizumab."
DB00098,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antithymocyte immunoglobulin (rabbit)."
DB00105,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa-2b."
DB00111,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daclizumab."
DB00112,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bevacizumab."
DB00120,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Phenylalanine."
DB00180,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flunisolide."
DB00188,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bortezomib."
DB00242,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cladribine."
DB00262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carmustine."
DB00276,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Amsacrine."
DB00290,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleomycin."
DB00291,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chlorambucil."
DB00293,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Raltitrexed."
DB00305,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitomycin."
DB00307,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bexarotene."
DB00309,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vindesine."
DB00322,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Floxuridine."
DB00328,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Indomethacin."
DB00352,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tioguanine."
DB00361,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinorelbine."
DB00380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexrazoxane."
DB00394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Beclomethasone dipropionate."
DB00398,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sorafenib."
DB00428,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Streptozocin."
DB00432,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trifluridine."
DB00441,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gemcitabine."
DB00443,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Betamethasone."
DB00444,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teniposide."
DB00445,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Epirubicin."
DB00446,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Chloramphenicol."
DB00480,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lenalidomide."
DB00488,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Altretamine."
DB00495,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Zidovudine."
DB00515,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cisplatin."
DB00526,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Oxaliplatin."
DB00531,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cyclophosphamide."
DB00541,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vincristine."
DB00544,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluorouracil."
DB00550,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Propylthiouracil."
DB00552,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pentostatin."
DB00563,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methotrexate."
DB00564,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carbamazepine."
DB00570,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vinblastine."
DB00588,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone propionate."
DB00591,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocinolone acetonide."
DB00601,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Linezolid."
DB00619,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Imatinib."
DB00620,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triamcinolone."
DB00631,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clofarabine."
DB00635,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisone."
DB00642,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pemetrexed."
DB00687,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludrocortisone."
DB00688,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolate mofetil."
DB00694,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Daunorubicin."
DB00755,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tretinoin."
DB00762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Irinotecan."
DB00763,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methimazole."
DB00764,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone."
DB00773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Etoposide."
DB00795,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sulfasalazine."
DB00851,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dacarbazine."
DB00853,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temozolomide."
DB00859,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Penicillamine."
DB00860,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednisolone."
DB00877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirolimus."
DB00888,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mechlorethamine."
DB00928,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azacitidine."
DB00958,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carboplatin."
DB00959,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Methylprednisolone."
DB00970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dactinomycin."
DB00987,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cytarabine."
DB00993,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Azathioprine."
DB00997,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxorubicin."
DB01005,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxyurea."
DB01008,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Busulfan."
DB01024,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mycophenolic acid."
DB01030,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Topotecan."
DB01033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mercaptopurine."
DB01041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thalidomide."
DB01042,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melphalan."
DB01073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fludarabine."
DB01099,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Flucytosine."
DB01101,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Capecitabine."
DB01108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trilostane."
DB01168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Procarbazine."
DB01169,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Arsenic trioxide."
DB01177,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idarubicin."
DB01181,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ifosfamide."
DB01196,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Estramustine."
DB01204,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mitoxantrone."
DB01206,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Lomustine."
DB01222,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Budesonide."
DB01229,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paclitaxel."
DB01234,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone."
DB01248,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Docetaxel."
DB01254,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dasatinib."
DB01257,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eculizumab."
DB01262,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Decitabine."
DB01268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sunitinib."
DB01280,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nelarabine."
DB01281,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abatacept."
DB01285,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Corticotropin."
DB01380,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortisone acetate."
DB01384,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Paramethasone."
DB01394,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Colchicine."
DB01410,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ciclesonide."
DB01423,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Stepronin."
DB01590,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Everolimus."
DB01611,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydroxychloroquine."
DB01816,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Castanospermine."
DB02546,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vorinostat."
DB02806,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 2-Methoxyethanol."
DB03523,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brequinar."
DB04572,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Thiotepa."
DB04630,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldosterone."
DB04845,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixabepilone."
DB04868,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Nilotinib."
DB04951,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirfenidone."
DB04956,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Afelimomab."
DB05015,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belinostat."
DB05109,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trabectedin."
DB05258,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Interferon alfa."
DB05259,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Glatiramer."
DB05260,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gallium nitrate."
DB05459,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Briakinumab."
DB05472,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with omega interferon."
DB05676,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Apremilast."
DB05773,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trastuzumab emtansine."
DB06168,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Canakinumab."
DB06273,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tocilizumab."
DB06287,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Temsirolimus."
DB06372,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rilonacept."
DB06589,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pazopanib."
DB06603,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Panobinostat."
DB06612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mepolizumab."
DB06616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bosutinib."
DB06662,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Abetimus."
DB06674,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Golimumab."
DB06681,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belatacept."
DB06769,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bendamustine."
DB06772,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cabazitaxel."
DB06813,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pralatrexate."
DB08059,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Wortmannin."
DB08870,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brentuximab vedotin."
DB08871,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Eribulin."
DB08877,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ruxolitinib."
DB08879,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Belimumab."
DB08880,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Teriflunomide."
DB08889,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Carfilzomib."
DB08901,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ponatinib."
DB08904,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Certolizumab pegol."
DB08906,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone furoate."
DB08908,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dimethyl fumarate."
DB08910,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pomalidomide."
DB08935,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Obinutuzumab."
DB08970,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednidene."
DB08971,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortolone."
DB09029,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Secukinumab."
DB09033,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vedolizumab."
DB09036,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siltuximab."
DB09052,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Blinatumomab."
DB09053,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ibrutinib."
DB09054,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Idelalisib."
DB09073,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Palbociclib."
DB09074,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Olaparib."
DB09077,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dinutuximab."
DB09082,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Vilanterol."
DB09091,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tixocortol."
DB09122,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peginterferon beta-1a."
DB09312,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Antilymphocyte immunoglobulin (horse)."
DB09378,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluprednisolone."
DB09383,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Meprednisone."
DB11466,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tepoxalin."
DB11487,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Dexamethasone isonicotinate."
DB11529,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Melengestrol."
DB11569,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ixekizumab."
DB11580,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ravulizumab."
DB11616,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Pirarubicin."
DB11693,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Voclosporin."
DB11708,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Peficitinib."
DB11750,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Clobetasol."
DB11767,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sarilumab."
DB11776,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Brodalumab."
DB11803,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Sirukumab."
DB11817,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Baricitinib."
DB11834,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Guselkumab."
DB11921,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deflazacort."
DB11988,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ocrelizumab."
DB12025,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Triptolide."
DB12371,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Siponimod."
DB12612,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ozanimod."
DB12617,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mizoribine."
DB12692,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Gusperimus."
DB12814,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cepeginterferon alfa-2B."
DB12902,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Trofosfamide."
DB12947,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Doxifluridine."
DB12991,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Deoxyspergualin."
DB12996,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Acteoside."
DB13003,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cortivazol."
DB13014,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hypericin."
DB13068,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A."
DB13208,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Prednylidene."
DB13223,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluocortin."
DB13241,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Begelomab."
DB13491,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluperolone."
DB13664,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Formocortal."
DB13728,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Halometasone."
DB13843,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Cloprednol."
DB13856,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluclorolone."
DB13867,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Fluticasone."
DB14066,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Tetrandrine."
DB14219,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Monomethyl fumarate."
DB14512,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Mometasone furoate."
DB14538,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone aceponate."
DB14539,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone acetate."
DB14545,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Hydrocortisone succinate."
DB14724,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Emapalumab."
DB14762,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Risankizumab."
DB14919,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Rozanolixizumab."
DB15253,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Bleselumab."
DB00108,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Natalizumab."
DB00337,"The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa-2a, Recombinant."
DB01656,"Roflumilast may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant."
DB06688,"The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB00041,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin."
DB00363,"The risk or severity of neutropenia can be increased when Interferon alfa-2a, Recombinant is combined with Clozapine."
DB00333,"The serum concentration of Methadone can be increased when it is combined with Interferon alfa-2a, Recombinant."
DB00811,"The risk or severity of anemia can be increased when Interferon alfa-2a, Recombinant is combined with Ribavirin."
DB00315,"The metabolism of Zolmitriptan can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01015,"The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Interferon alfa-2a, Recombinant."
DB01265,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Telbivudine."
DB01097,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Leflunomide."
DB08895,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Tofacitinib."
DB00072,"Trastuzumab may increase the neutropenic activities of Interferon alfa-2a, Recombinant."
DB08868,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Fingolimod."
DB00864,"Tacrolimus may increase the immunosuppressive activities of Interferon alfa-2a, Recombinant."
DB00201,"The metabolism of Caffeine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00651,"The metabolism of Dyphylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00806,"The metabolism of Pentoxifylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01303,"The metabolism of Oxtriphylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01412,"The metabolism of Theobromine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01482,"The metabolism of Fenethylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01667,"The metabolism of 8-azaguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01978,"The metabolism of 7,9-Dimethylguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02134,"The metabolism of Xanthine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02245,"The metabolism of 7-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02377,"The metabolism of Guanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02489,"The metabolism of 9-Methylguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02568,"The metabolism of Peldesine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04076,"The metabolism of Hypoxanthine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04356,"The metabolism of 9-Deazaguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06479,"The metabolism of Propentofylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06575,"The metabolism of Valomaciclovir can be decreased when combined with Interferon alfa-2a, Recombinant."
DB07954,"The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB08844,"The metabolism of Uric acid can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09273,"The metabolism of Doxofylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB11919,"The metabolism of 6-O-benzylguanine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12406,"The metabolism of Lisofylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12531,"The metabolism of Lobucavir can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12926,"The metabolism of Cafedrine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12927,"The metabolism of Theodrenaline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13203,"The metabolism of Bamifylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13449,"The metabolism of Proxyphylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13573,"The metabolism of Acefylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13592,"The metabolism of Etamiphylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13634,"The metabolism of Pentifylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13812,"The metabolism of Bufylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB14018,"The metabolism of Bromotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB14029,"The metabolism of Furafylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB14132,"The metabolism of 8-chlorotheophylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB15122,"The metabolism of PCS-499 can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04914,"The therapeutic efficacy of G17DT can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB05144,"The therapeutic efficacy of PEV3A can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB05325,"The therapeutic efficacy of INGN 225 can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB05374,"The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB05440,"The therapeutic efficacy of SRP 299 can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB05942,"The therapeutic efficacy of GI-5005 can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB06400,"The therapeutic efficacy of Vitespen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB06584,"The therapeutic efficacy of TG4010 can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB09057,"The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10076,"The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10276,"The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10342,"The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10583,"The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10584,"The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10600,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10769,"The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10794,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10803,"The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10989,"The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB10990,"The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11038,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11040,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11041,"The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11044,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11603,"The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB11627,"The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB12568,"The therapeutic efficacy of Tecemotide can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14022,"The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14384,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14385,"The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14394,"The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14445,"The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14449,"The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14619,"The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14620,"The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB14711,"The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB15274,"The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB15461,"The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB13924,"The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB15483,"The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB00054,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant."
DB00063,"The risk or severity of bleeding can be increased when Eptifibatide is combined with Interferon alfa-2a, Recombinant."
DB00208,"The risk or severity of bleeding can be increased when Ticlopidine is combined with Interferon alfa-2a, Recombinant."
DB00775,"The risk or severity of bleeding can be increased when Tirofiban is combined with Interferon alfa-2a, Recombinant."
DB00945,"The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Interferon alfa-2a, Recombinant."
DB00975,"The risk or severity of bleeding can be increased when Dipyridamole is combined with Interferon alfa-2a, Recombinant."
DB01088,"The risk or severity of bleeding can be increased when Iloprost is combined with Interferon alfa-2a, Recombinant."
DB01138,"The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Interferon alfa-2a, Recombinant."
DB01207,"The risk or severity of bleeding can be increased when Ridogrel is combined with Interferon alfa-2a, Recombinant."
DB01236,"The risk or severity of bleeding can be increased when Sevoflurane is combined with Interferon alfa-2a, Recombinant."
DB01240,"The risk or severity of bleeding can be increased when Epoprostenol is combined with Interferon alfa-2a, Recombinant."
DB04743,"The risk or severity of bleeding can be increased when Nimesulide is combined with Interferon alfa-2a, Recombinant."
DB04905,"The risk or severity of bleeding can be increased when Tesmilifene is combined with Interferon alfa-2a, Recombinant."
DB04932,"The risk or severity of bleeding can be increased when Defibrotide is combined with Interferon alfa-2a, Recombinant."
DB05229,"The risk or severity of bleeding can be increased when Beraprost is combined with Interferon alfa-2a, Recombinant."
DB05266,"The risk or severity of bleeding can be increased when Ibudilast is combined with Interferon alfa-2a, Recombinant."
DB05767,"The risk or severity of bleeding can be increased when Andrographolide is combined with Interferon alfa-2a, Recombinant."
DB06081,"The risk or severity of bleeding can be increased when Caplacizumab is combined with Interferon alfa-2a, Recombinant."
DB06209,"The risk or severity of bleeding can be increased when Prasugrel is combined with Interferon alfa-2a, Recombinant."
DB06441,"The risk or severity of bleeding can be increased when Cangrelor is combined with Interferon alfa-2a, Recombinant."
DB07615,"The risk or severity of bleeding can be increased when Tranilast is combined with Interferon alfa-2a, Recombinant."
DB08814,"The risk or severity of bleeding can be increased when Triflusal is combined with Interferon alfa-2a, Recombinant."
DB08816,"The risk or severity of bleeding can be increased when Ticagrelor is combined with Interferon alfa-2a, Recombinant."
DB08887,"The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Interferon alfa-2a, Recombinant."
DB09030,"The risk or severity of bleeding can be increased when Vorapaxar is combined with Interferon alfa-2a, Recombinant."
DB09283,"The risk or severity of bleeding can be increased when Trapidil is combined with Interferon alfa-2a, Recombinant."
DB12092,"The risk or severity of bleeding can be increased when Naftopidil is combined with Interferon alfa-2a, Recombinant."
DB12163,"The risk or severity of bleeding can be increased when Sarpogrelate is combined with Interferon alfa-2a, Recombinant."
DB12321,"The risk or severity of bleeding can be increased when Ifetroban is combined with Interferon alfa-2a, Recombinant."
DB12445,"The risk or severity of bleeding can be increased when Nitroaspirin is combined with Interferon alfa-2a, Recombinant."
DB12465,"The risk or severity of bleeding can be increased when Ketanserin is combined with Interferon alfa-2a, Recombinant."
DB12545,"The risk or severity of bleeding can be increased when Indobufen is combined with Interferon alfa-2a, Recombinant."
DB12749,"The risk or severity of bleeding can be increased when Butylphthalide is combined with Interferon alfa-2a, Recombinant."
DB12771,"The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Interferon alfa-2a, Recombinant."
DB13036,"The risk or severity of bleeding can be increased when Ramatroban is combined with Interferon alfa-2a, Recombinant."
DB13327,"The risk or severity of bleeding can be increased when Picotamide is combined with Interferon alfa-2a, Recombinant."
DB13367,"The risk or severity of bleeding can be increased when Cloricromen is combined with Interferon alfa-2a, Recombinant."
DB13400,"The risk or severity of bleeding can be increased when Linsidomine is combined with Interferon alfa-2a, Recombinant."
DB13510,"The risk or severity of bleeding can be increased when Buflomedil is combined with Interferon alfa-2a, Recombinant."
DB13929,"The risk or severity of bleeding can be increased when Relcovaptan is combined with Interferon alfa-2a, Recombinant."
DB13200,"Interferon alfa-2a, Recombinant may increase the myelosuppressive activities of Lipegfilgrastim."
DB10317,"The risk or severity of infection can be increased when Rubella virus vaccine is combined with Interferon alfa-2a, Recombinant."
DB10318,"The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Interferon alfa-2a, Recombinant."
DB10343,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Interferon alfa-2a, Recombinant."
DB10804,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Interferon alfa-2a, Recombinant."
DB10805,"The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Interferon alfa-2a, Recombinant."
DB11003,"The risk or severity of infection can be increased when Anthrax vaccine is combined with Interferon alfa-2a, Recombinant."
DB11050,"The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Interferon alfa-2a, Recombinant."
DB12386,"The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Interferon alfa-2a, Recombinant."
DB12768,"The risk or severity of infection can be increased when BCG vaccine is combined with Interferon alfa-2a, Recombinant."
DB14409,"The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Interferon alfa-2a, Recombinant."
DB14443,"The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Interferon alfa-2a, Recombinant."
DB14685,"The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Interferon alfa-2a, Recombinant."
DB00039,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB00176,"The metabolism of Fluvoxamine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00184,"The metabolism of Nicotine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00195,"The metabolism of Betaxolol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00261,"The metabolism of Anagrelide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00280,"The metabolism of Disopyramide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00281,"The metabolism of Lidocaine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00286,"The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00296,"The metabolism of Ropivacaine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00316,"The metabolism of Acetaminophen can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00334,"The metabolism of Olanzapine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00356,"The metabolism of Chlorzoxazone can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00365,"The metabolism of Grepafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00370,"The metabolism of Mirtazapine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00379,"The metabolism of Mexiletine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00382,"The metabolism of Tacrine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00384,"The metabolism of Triamterene can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00420,"The metabolism of Promazine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00425,"The metabolism of Zolpidem can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00442,"The metabolism of Entecavir can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00461,"The metabolism of Nabumetone can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00468,"The metabolism of Quinine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00472,"The metabolism of Fluoxetine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00476,"The metabolism of Duloxetine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00477,"The metabolism of Chlorpromazine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00499,"The metabolism of Flutamide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00502,"The metabolism of Haloperidol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00518,"The metabolism of Albendazole can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00533,"The metabolism of Rofecoxib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00568,"The metabolism of Cinnarizine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00571,"The metabolism of Propranolol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00586,"The metabolism of Diclofenac can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00629,"The metabolism of Guanabenz can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00661,"The metabolism of Verapamil can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00715,"The metabolism of Paroxetine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00730,"The metabolism of Thiabendazole can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00740,"The metabolism of Riluzole can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00744,"The metabolism of Zileuton can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00758,"The metabolism of Clopidogrel can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00783,"The metabolism of Estradiol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00787,"The metabolism of Acyclovir can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00788,"The metabolism of Naproxen can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00831,"The metabolism of Trifluoperazine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00850,"The metabolism of Perphenazine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00857,"The metabolism of Terbinafine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00863,"The metabolism of Ranitidine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00898,"The metabolism of Ethanol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00934,"The metabolism of Maprotiline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00969,"The metabolism of Alosetron can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00978,"The metabolism of Lomefloxacin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00980,"The metabolism of Ramelteon can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00998,"The metabolism of Frovatriptan can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01002,"The metabolism of Levobupivacaine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01012,"The metabolism of Cinacalcet can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01037,"The metabolism of Selegiline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01056,"The metabolism of Tocainide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01058,"The metabolism of Praziquantel can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01065,"The metabolism of Melatonin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01087,"The metabolism of Primaquine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01094,"The metabolism of Hesperetin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01115,"The metabolism of Nifedipine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01136,"The metabolism of Carvedilol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01166,"The metabolism of Cilostazol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01182,"The metabolism of Propafenone can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01184,"The metabolism of Domperidone can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01191,"The metabolism of Dexfenfluramine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01367,"The metabolism of Rasagiline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01405,"The metabolism of Temafloxacin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01424,"The metabolism of Aminophenazone can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01435,"The metabolism of Antipyrine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01558,"The metabolism of Bromazepam can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01623,"The metabolism of Thiothixene can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01628,"The metabolism of Etoricoxib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01645,"The metabolism of Genistein can be decreased when combined with Interferon alfa-2a, Recombinant."
DB02709,"The metabolism of Resveratrol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB03783,"The metabolism of Phenacetin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04574,"The metabolism of Estrone sulfate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04841,"The metabolism of Flunarizine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04871,"The metabolism of Lorcaserin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04948,"The metabolism of Lofexidine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06148,"The metabolism of Mianserin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06210,"The metabolism of Eltrombopag can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06216,"The metabolism of Asenapine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06235,"The metabolism of Vadimezan can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06292,"The metabolism of Dapagliflozin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06594,"The metabolism of Agomelatine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06626,"The metabolism of Axitinib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06770,"The metabolism of Benzyl alcohol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB06774,"The metabolism of Capsaicin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB08496,"The metabolism of (R)-warfarin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB08883,"The metabolism of Perampanel can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09071,"The metabolism of Tasimelteon can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09118,"The metabolism of Stiripentol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09225,"The metabolism of Zotepine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09288,"The metabolism of Propacetamol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09290,"The metabolism of Ramosetron can be decreased when combined with Interferon alfa-2a, Recombinant."
DB11967,"The metabolism of Binimetinib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12026,"The metabolism of Voxilaprevir can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12245,"The metabolism of Triclabendazole can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12332,"The metabolism of Rucaparib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB12945,"The metabolism of Dihydralazine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13952,"The metabolism of Estradiol acetate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13953,"The metabolism of Estradiol benzoate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13954,"The metabolism of Estradiol cypionate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13955,"The metabolism of Estradiol dienanthate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13956,"The metabolism of Estradiol valerate can be decreased when combined with Interferon alfa-2a, Recombinant."
DB11757,"The metabolism of Istradefylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00972,"The metabolism of Azelastine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00625,"The metabolism of Efavirenz can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01233,"The metabolism of Metoclopramide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB04889,"The metabolism of Bicifadine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB05708,"The metabolism of GTS-21 can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01195,"The metabolism of Flecainide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00977,"The metabolism of Ethinylestradiol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00321,"The metabolism of Amitriptyline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00458,"The metabolism of Imipramine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01142,"The metabolism of Doxepin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00532,"The metabolism of Mephenytoin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00540,"The metabolism of Nortriptyline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00575,"The metabolism of Clonidine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00924,"The metabolism of Cyclobenzaprine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01151,"The metabolism of Desipramine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01242,"The metabolism of Clomipramine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB11689,"The metabolism of Selumetinib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00277,"The metabolism of Theophylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00682,"The metabolism of Warfarin can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00697,"The metabolism of Tizanidine can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01100,"The metabolism of Pimozide can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01223,"The metabolism of Aminophylline can be decreased when combined with Interferon alfa-2a, Recombinant."
DB01418,"The metabolism of Acenocoumarol can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00530,"The metabolism of Erlotinib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB09256,"The metabolism of Tegafur can be decreased when combined with Interferon alfa-2a, Recombinant."
DB13874,"The metabolism of Enasidenib can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00675,"The metabolism of Tamoxifen can be decreased when combined with Interferon alfa-2a, Recombinant."
DB00001,"The risk or severity of bleeding can be increased when Lepirudin is combined with Interferon alfa-2a, Recombinant."
DB00006,"The risk or severity of bleeding can be increased when Bivalirudin is combined with Interferon alfa-2a, Recombinant."
DB00009,"The risk or severity of bleeding can be increased when Alteplase is combined with Interferon alfa-2a, Recombinant."
DB00013,"The risk or severity of bleeding can be increased when Urokinase is combined with Interferon alfa-2a, Recombinant."
DB00015,"The risk or severity of bleeding can be increased when Reteplase is combined with Interferon alfa-2a, Recombinant."
DB00029,"The risk or severity of bleeding can be increased when Anistreplase is combined with Interferon alfa-2a, Recombinant."
DB00031,"The risk or severity of bleeding can be increased when Tenecteplase is combined with Interferon alfa-2a, Recombinant."
DB00055,"The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Interferon alfa-2a, Recombinant."
DB00086,"The risk or severity of bleeding can be increased when Streptokinase is combined with Interferon alfa-2a, Recombinant."
DB00266,"The risk or severity of bleeding can be increased when Dicoumarol is combined with Interferon alfa-2a, Recombinant."
DB00278,"The risk or severity of bleeding can be increased when Argatroban is combined with Interferon alfa-2a, Recombinant."
DB00407,"The risk or severity of bleeding can be increased when Ardeparin is combined with Interferon alfa-2a, Recombinant."
DB00498,"The risk or severity of bleeding can be increased when Phenindione is combined with Interferon alfa-2a, Recombinant."
DB00569,"The risk or severity of bleeding can be increased when Fondaparinux is combined with Interferon alfa-2a, Recombinant."
DB00686,"The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Interferon alfa-2a, Recombinant."
DB00946,"The risk or severity of bleeding can be increased when Phenprocoumon is combined with Interferon alfa-2a, Recombinant."
DB01109,"The risk or severity of bleeding can be increased when Heparin is combined with Interferon alfa-2a, Recombinant."
DB01225,"The risk or severity of bleeding can be increased when Enoxaparin is combined with Interferon alfa-2a, Recombinant."
DB03410,"The risk or severity of bleeding can be increased when 4-hydroxycoumarin is combined with Interferon alfa-2a, Recombinant."
DB04665,"The risk or severity of bleeding can be increased when Coumarin is combined with Interferon alfa-2a, Recombinant."
DB04898,"The risk or severity of bleeding can be increased when Ximelagatran is combined with Interferon alfa-2a, Recombinant."
DB04925,"The risk or severity of bleeding can be increased when Desmoteplase is combined with Interferon alfa-2a, Recombinant."
DB05099,"The risk or severity of bleeding can be increased when Ancrod is combined with Interferon alfa-2a, Recombinant."
DB05254,"The risk or severity of bleeding can be increased when Fibrinolysin is combined with Interferon alfa-2a, Recombinant."
DB06228,"The risk or severity of bleeding can be increased when Rivaroxaban is combined with Interferon alfa-2a, Recombinant."
DB06271,"The risk or severity of bleeding can be increased when Sulodexide is combined with Interferon alfa-2a, Recombinant."
DB06294,"The risk or severity of bleeding can be increased when Semuloparin is combined with Interferon alfa-2a, Recombinant."
DB06406,"The risk or severity of bleeding can be increased when Idraparinux is combined with Interferon alfa-2a, Recombinant."
DB06543,"The risk or severity of bleeding can be increased when Astaxanthin is combined with Interferon alfa-2a, Recombinant."
DB06605,"The risk or severity of bleeding can be increased when Apixaban is combined with Interferon alfa-2a, Recombinant."
DB06635,"The risk or severity of bleeding can be increased when Otamixaban is combined with Interferon alfa-2a, Recombinant."
DB06679,"The risk or severity of bleeding can be increased when Amediplase is combined with Interferon alfa-2a, Recombinant."
DB06695,"The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Interferon alfa-2a, Recombinant."
DB06754,"The risk or severity of bleeding can be increased when Danaparoid is combined with Interferon alfa-2a, Recombinant."
DB06779,"The risk or severity of bleeding can be increased when Dalteparin is combined with Interferon alfa-2a, Recombinant."
DB06822,"The risk or severity of bleeding can be increased when Tinzaparin is combined with Interferon alfa-2a, Recombinant."
DB07767,"The risk or severity of bleeding can be increased when Ferulic acid is combined with Interferon alfa-2a, Recombinant."
DB08794,"The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Interferon alfa-2a, Recombinant."
DB08813,"The risk or severity of bleeding can be increased when Nadroparin is combined with Interferon alfa-2a, Recombinant."
DB08994,"The risk or severity of bleeding can be increased when Ditazole is combined with Interferon alfa-2a, Recombinant."
DB09075,"The risk or severity of bleeding can be increased when Edoxaban is combined with Interferon alfa-2a, Recombinant."
DB09125,"The risk or severity of bleeding can be increased when Potassium citrate is combined with Interferon alfa-2a, Recombinant."
DB09154,"The risk or severity of bleeding can be increased when Sodium citrate is combined with Interferon alfa-2a, Recombinant."
DB09255,"The risk or severity of bleeding can be increased when Dextran is combined with Interferon alfa-2a, Recombinant."
DB09258,"The risk or severity of bleeding can be increased when Bemiparin is combined with Interferon alfa-2a, Recombinant."
DB09259,"The risk or severity of bleeding can be increased when Reviparin is combined with Interferon alfa-2a, Recombinant."
DB09260,"The risk or severity of bleeding can be increased when Parnaparin is combined with Interferon alfa-2a, Recombinant."
DB09261,"The risk or severity of bleeding can be increased when Certoparin is combined with Interferon alfa-2a, Recombinant."
DB11095,"The risk or severity of bleeding can be increased when Desirudin is combined with Interferon alfa-2a, Recombinant."
DB11154,"The risk or severity of bleeding can be increased when Zinc citrate is combined with Interferon alfa-2a, Recombinant."
DB11166,"The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Interferon alfa-2a, Recombinant."
DB11312,"The risk or severity of bleeding can be increased when Protein C is combined with Interferon alfa-2a, Recombinant."
DB11598,"The risk or severity of bleeding can be increased when Antithrombin III human is combined with Interferon alfa-2a, Recombinant."
DB11984,"The risk or severity of bleeding can be increased when Letaxaban is combined with Interferon alfa-2a, Recombinant."
DB12289,"The risk or severity of bleeding can be increased when Darexaban is combined with Interferon alfa-2a, Recombinant."
DB12364,"The risk or severity of bleeding can be increased when Betrixaban is combined with Interferon alfa-2a, Recombinant."
DB12598,"The risk or severity of bleeding can be increased when Nafamostat is combined with Interferon alfa-2a, Recombinant."
DB12726,"The risk or severity of bleeding can be increased when Monteplase is combined with Interferon alfa-2a, Recombinant."
DB12831,"The risk or severity of bleeding can be increased when Gabexate is combined with Interferon alfa-2a, Recombinant."
DB13136,"The risk or severity of bleeding can be increased when Fluindione is combined with Interferon alfa-2a, Recombinant."
DB13149,"The risk or severity of bleeding can be increased when Protein S human is combined with Interferon alfa-2a, Recombinant."
DB13199,"The risk or severity of bleeding can be increased when Brinase is combined with Interferon alfa-2a, Recombinant."
DB13275,"The risk or severity of bleeding can be increased when Clorindione is combined with Interferon alfa-2a, Recombinant."
DB13347,"The risk or severity of bleeding can be increased when Diphenadione is combined with Interferon alfa-2a, Recombinant."
DB13451,"The risk or severity of bleeding can be increased when Tioclomarol is combined with Interferon alfa-2a, Recombinant."
DB13616,"The risk or severity of bleeding can be increased when Melagatran is combined with Interferon alfa-2a, Recombinant."
DB13646,"The risk or severity of bleeding can be increased when Saruplase is combined with Interferon alfa-2a, Recombinant."
DB14055,"The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Interferon alfa-2a, Recombinant."
DB14094,"The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Interferon alfa-2a, Recombinant."
DB14598,"The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Interferon alfa-2a, Recombinant."
DB14726,"The risk or severity of bleeding can be increased when Dabigatran is combined with Interferon alfa-2a, Recombinant."
DB00232,"The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Interferon alfa-2a, Recombinant."
DB00436,"The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Interferon alfa-2a, Recombinant."
DB00562,"The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Interferon alfa-2a, Recombinant."
DB00606,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Interferon alfa-2a, Recombinant."
DB00774,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Interferon alfa-2a, Recombinant."
DB00880,"The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Interferon alfa-2a, Recombinant."
DB00999,"The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Interferon alfa-2a, Recombinant."
DB01021,"The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Interferon alfa-2a, Recombinant."
DB01324,"The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Interferon alfa-2a, Recombinant."
DB13430,"The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Interferon alfa-2a, Recombinant."
DB13532,"The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Interferon alfa-2a, Recombinant."
DB09042,"The risk or severity of myelosuppression can be increased when Interferon alfa-2a, Recombinant is combined with Tedizolid phosphate."
DB00091,"Interferon alfa-2a, Recombinant may increase the immunosuppressive activities of Cyclosporine."
DB00268,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Ropinirole."
DB00115,"The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB00437,"The risk or severity of adverse effects can be increased when Allopurinol is combined with Interferon alfa-2a, Recombinant."
DB14513,"The serum concentration of Magnesium can be decreased when it is combined with Interferon alfa-2a, Recombinant."
DB01601,"The serum concentration of Interferon alfa-2a, Recombinant can be increased when it is combined with Lopinavir."
DB12530,"The risk or severity of infection can be increased when Interferon alfa-2a, Recombinant is combined with Inebilizumab."
DB00564,The risk or severity of adverse effects can be increased when Carbamazepine is combined with Desmopressin.
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Desmopressin.
DB00618,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Demeclocycline.
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Desmopressin.
DB01356,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium cation.
DB14507,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium citrate.
DB14509,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Lithium carbonate.
DB14506,The therapeutic efficacy of Lithium hydroxide can be decreased when used in combination with Desmopressin.
DB06212,The therapeutic efficacy of Desmopressin can be decreased when used in combination with Tolvaptan.
DB00176,The risk or severity of hyponatremia can be increased when Fluvoxamine is combined with Desmopressin.
DB00215,The risk or severity of hyponatremia can be increased when Citalopram is combined with Desmopressin.
DB00472,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Desmopressin.
DB00476,The risk or severity of hyponatremia can be increased when Duloxetine is combined with Desmopressin.
DB00656,The risk or severity of hyponatremia can be increased when Trazodone is combined with Desmopressin.
DB00715,The risk or severity of hyponatremia can be increased when Paroxetine is combined with Desmopressin.
DB01104,The risk or severity of hyponatremia can be increased when Sertraline is combined with Desmopressin.
DB01105,The risk or severity of hyponatremia can be increased when Sibutramine is combined with Desmopressin.
DB01149,The risk or severity of hyponatremia can be increased when Nefazodone is combined with Desmopressin.
DB01175,The risk or severity of hyponatremia can be increased when Escitalopram is combined with Desmopressin.
DB04832,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Desmopressin.
DB04884,The risk or severity of hyponatremia can be increased when Dapoxetine is combined with Desmopressin.
DB04896,The risk or severity of hyponatremia can be increased when Milnacipran is combined with Desmopressin.
DB06700,The risk or severity of hyponatremia can be increased when Desvenlafaxine is combined with Desmopressin.
DB06731,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Desmopressin.
DB08918,The risk or severity of hyponatremia can be increased when Levomilnacipran is combined with Desmopressin.
DB08953,The risk or severity of hyponatremia can be increased when Indalpine is combined with Desmopressin.
DB12693,The risk or severity of hyponatremia can be increased when Ritanserin is combined with Desmopressin.
DB13233,The risk or severity of hyponatremia can be increased when Alaproclate is combined with Desmopressin.
DB00177,Desmopressin may decrease the antihypertensive activities of Valsartan.
DB00178,Desmopressin may decrease the antihypertensive activities of Ramipril.
DB00187,Desmopressin may decrease the antihypertensive activities of Esmolol.
DB00195,Desmopressin may decrease the antihypertensive activities of Betaxolol.
DB00212,Desmopressin may decrease the antihypertensive activities of Remikiren.
DB00226,Desmopressin may decrease the antihypertensive activities of Guanadrel.
DB00275,Desmopressin may decrease the antihypertensive activities of Olmesartan.
DB00335,Desmopressin may decrease the antihypertensive activities of Atenolol.
DB00343,Desmopressin may decrease the antihypertensive activities of Diltiazem.
DB00350,Desmopressin may decrease the antihypertensive activities of Minoxidil.
DB00374,Desmopressin may decrease the antihypertensive activities of Treprostinil.
DB00381,Desmopressin may decrease the antihypertensive activities of Amlodipine.
DB00393,Desmopressin may decrease the antihypertensive activities of Nimodipine.
DB00457,Desmopressin may decrease the antihypertensive activities of Prazosin.
DB00519,Desmopressin may decrease the antihypertensive activities of Trandolapril.
DB00528,Desmopressin may decrease the antihypertensive activities of Lercanidipine.
DB00542,Desmopressin may decrease the antihypertensive activities of Benazepril.
DB00559,Desmopressin may decrease the antihypertensive activities of Bosentan.
DB00584,Desmopressin may decrease the antihypertensive activities of Enalapril.
DB00590,Desmopressin may decrease the antihypertensive activities of Doxazosin.
DB00616,Desmopressin may decrease the antihypertensive activities of Candoxatril.
DB00622,Desmopressin may decrease the antihypertensive activities of Nicardipine.
DB00678,Desmopressin may decrease the antihypertensive activities of Losartan.
DB00691,Desmopressin may decrease the antihypertensive activities of Moexipril.
DB00727,Desmopressin may decrease the antihypertensive activities of Nitroglycerin.
DB00765,Desmopressin may decrease the antihypertensive activities of Metyrosine.
DB00785,Desmopressin may decrease the antihypertensive activities of Cryptenamine.
DB00796,Desmopressin may decrease the antihypertensive activities of Candesartan cilexetil.
DB00866,Desmopressin may decrease the antihypertensive activities of Alprenolol.
DB00876,Desmopressin may decrease the antihypertensive activities of Eprosartan.
DB00881,Desmopressin may decrease the antihypertensive activities of Quinapril.
DB00966,Desmopressin may decrease the antihypertensive activities of Telmisartan.
DB01023,Desmopressin may decrease the antihypertensive activities of Felodipine.
DB01029,Desmopressin may decrease the antihypertensive activities of Irbesartan.
DB01054,Desmopressin may decrease the antihypertensive activities of Nitrendipine.
DB01089,Desmopressin may decrease the antihypertensive activities of Deserpidine.
DB01090,Desmopressin may decrease the antihypertensive activities of Pentolinium.
DB01116,Desmopressin may decrease the antihypertensive activities of Trimethaphan.
DB01136,Desmopressin may decrease the antihypertensive activities of Carvedilol.
DB01158,Desmopressin may decrease the antihypertensive activities of Bretylium.
DB01162,Desmopressin may decrease the antihypertensive activities of Terazosin.
DB01193,Desmopressin may decrease the antihypertensive activities of Acebutolol.
DB01197,Desmopressin may decrease the antihypertensive activities of Captopril.
DB01244,Desmopressin may decrease the antihypertensive activities of Bepridil.
DB01295,Desmopressin may decrease the antihypertensive activities of Bevantolol.
DB01297,Desmopressin may decrease the antihypertensive activities of Practolol.
DB01340,Desmopressin may decrease the antihypertensive activities of Cilazapril.
DB01347,Desmopressin may decrease the antihypertensive activities of Saprisartan.
DB01348,Desmopressin may decrease the antihypertensive activities of Spirapril.
DB01388,Desmopressin may decrease the antihypertensive activities of Mibefradil.
DB01580,Desmopressin may decrease the antihypertensive activities of Oxprenolol.
DB03322,Desmopressin may decrease the antihypertensive activities of Dexpropranolol.
DB04840,Desmopressin may decrease the antihypertensive activities of Debrisoquine.
DB04846,Desmopressin may decrease the antihypertensive activities of Celiprolol.
DB04861,Desmopressin may decrease the antihypertensive activities of Nebivolol.
DB06268,Desmopressin may decrease the antihypertensive activities of Sitaxentan.
DB06403,Desmopressin may decrease the antihypertensive activities of Ambrisentan.
DB06445,Desmopressin may decrease the antihypertensive activities of Diethylnorspermine.
DB06712,Desmopressin may decrease the antihypertensive activities of Nilvadipine.
DB06762,Desmopressin may decrease the antihypertensive activities of Pinacidil.
DB07767,Desmopressin may decrease the antihypertensive activities of Ferulic acid.
DB08808,Desmopressin may decrease the antihypertensive activities of Bupranolol.
DB08836,Desmopressin may decrease the antihypertensive activities of Temocapril.
DB08931,Desmopressin may decrease the antihypertensive activities of Riociguat.
DB08952,Desmopressin may decrease the antihypertensive activities of Indenolol.
DB08960,Desmopressin may decrease the antihypertensive activities of Hexamethonium.
DB09026,Desmopressin may decrease the antihypertensive activities of Aliskiren.
DB09206,Desmopressin may decrease the antihypertensive activities of Trimazosin.
DB09236,Desmopressin may decrease the antihypertensive activities of Lacidipine.
DB09238,Desmopressin may decrease the antihypertensive activities of Manidipine.
DB09239,Desmopressin may decrease the antihypertensive activities of Niguldipine.
DB09363,Desmopressin may decrease the antihypertensive activities of Rauwolfia serpentina root.
DB11362,Desmopressin may decrease the antihypertensive activities of Selexipag.
DB11720,Desmopressin may decrease the antihypertensive activities of Angiotensin 1-7.
DB11770,Desmopressin may decrease the antihypertensive activities of Talinolol.
DB11783,Desmopressin may decrease the antihypertensive activities of Imidapril.
DB12054,Desmopressin may decrease the antihypertensive activities of BQ-123.
DB12093,Desmopressin may decrease the antihypertensive activities of Tetrahydropalmatine.
DB12212,Desmopressin may decrease the antihypertensive activities of Landiolol.
DB12465,Desmopressin may decrease the antihypertensive activities of Ketanserin.
DB12945,Desmopressin may decrease the antihypertensive activities of Dihydralazine.
DB13166,Desmopressin may decrease the antihypertensive activities of Zofenopril.
DB13211,Desmopressin may decrease the antihypertensive activities of Guanoxan.
DB13312,Desmopressin may decrease the antihypertensive activities of Delapril.
DB13374,Desmopressin may decrease the antihypertensive activities of Vincamine.
DB13400,Desmopressin may decrease the antihypertensive activities of Linsidomine.
DB13410,Desmopressin may decrease the antihypertensive activities of Guanoxabenz.
DB13429,Desmopressin may decrease the antihypertensive activities of Tolonidine.
DB13435,Desmopressin may decrease the antihypertensive activities of Endralazine.
DB13443,Desmopressin may decrease the antihypertensive activities of Esatenolol.
DB13452,Desmopressin may decrease the antihypertensive activities of Cadralazine.
DB13508,Desmopressin may decrease the antihypertensive activities of Cloranolol.
DB13575,Desmopressin may decrease the antihypertensive activities of Bietaserpine.
DB13604,Desmopressin may decrease the antihypertensive activities of Guanazodine.
DB13631,Desmopressin may decrease the antihypertensive activities of Methoserpidine.
DB13757,Desmopressin may decrease the antihypertensive activities of Epanolol.
DB13779,Desmopressin may decrease the antihypertensive activities of Guanoclor.
DB13919,Desmopressin may decrease the antihypertensive activities of Candesartan.
DB14068,Desmopressin may decrease the antihypertensive activities of Dexniguldipine.
DB14094,Desmopressin may decrease the antihypertensive activities of Tocopherylquinone.
DB14125,Desmopressin may decrease the antihypertensive activities of Benazeprilat.
DB14207,Desmopressin may decrease the antihypertensive activities of Fosinoprilat.
DB14208,Desmopressin may decrease the antihypertensive activities of Ramiprilat.
DB14213,Desmopressin may decrease the antihypertensive activities of Perindoprilat.
DB14217,Desmopressin may decrease the antihypertensive activities of Quinaprilat.
DB00193,The risk or severity of hyponatremia can be increased when Tramadol is combined with Desmopressin.
DB00295,The risk or severity of hyponatremia can be increased when Morphine is combined with Desmopressin.
DB00318,The risk or severity of hyponatremia can be increased when Codeine is combined with Desmopressin.
DB00327,The risk or severity of hyponatremia can be increased when Hydromorphone is combined with Desmopressin.
DB00333,The risk or severity of hyponatremia can be increased when Methadone is combined with Desmopressin.
DB00454,The risk or severity of hyponatremia can be increased when Meperidine is combined with Desmopressin.
DB00497,The risk or severity of hyponatremia can be increased when Oxycodone is combined with Desmopressin.
DB00611,The risk or severity of hyponatremia can be increased when Butorphanol is combined with Desmopressin.
DB00647,The risk or severity of hyponatremia can be increased when Dextropropoxyphene is combined with Desmopressin.
DB00652,The risk or severity of hyponatremia can be increased when Pentazocine is combined with Desmopressin.
DB00704,The risk or severity of hyponatremia can be increased when Naltrexone is combined with Desmopressin.
DB00708,The risk or severity of hyponatremia can be increased when Sufentanil is combined with Desmopressin.
DB00802,The risk or severity of hyponatremia can be increased when Alfentanil is combined with Desmopressin.
DB00813,The risk or severity of hyponatremia can be increased when Fentanyl is combined with Desmopressin.
DB00844,The risk or severity of hyponatremia can be increased when Nalbuphine is combined with Desmopressin.
DB00854,The risk or severity of hyponatremia can be increased when Levorphanol is combined with Desmopressin.
DB00899,The risk or severity of hyponatremia can be increased when Remifentanil is combined with Desmopressin.
DB00921,The risk or severity of hyponatremia can be increased when Buprenorphine is combined with Desmopressin.
DB00956,The risk or severity of hyponatremia can be increased when Hydrocodone is combined with Desmopressin.
DB01081,The risk or severity of hyponatremia can be increased when Diphenoxylate is combined with Desmopressin.
DB01192,The risk or severity of hyponatremia can be increased when Oxymorphone is combined with Desmopressin.
DB01209,The risk or severity of hyponatremia can be increased when Dezocine is combined with Desmopressin.
DB01227,The risk or severity of hyponatremia can be increased when Levacetylmethadol is combined with Desmopressin.
DB01433,The risk or severity of hyponatremia can be increased when Methadyl acetate is combined with Desmopressin.
DB01450,The risk or severity of hyponatremia can be increased when Dihydroetorphine is combined with Desmopressin.
DB01452,The risk or severity of hyponatremia can be increased when Diamorphine is combined with Desmopressin.
DB01459,The risk or severity of hyponatremia can be increased when Bezitramide is combined with Desmopressin.
DB01466,The risk or severity of hyponatremia can be increased when Ethylmorphine is combined with Desmopressin.
DB01497,The risk or severity of hyponatremia can be increased when Etorphine is combined with Desmopressin.
DB01529,The risk or severity of hyponatremia can be increased when Dextromoramide is combined with Desmopressin.
DB01531,The risk or severity of hyponatremia can be increased when Desomorphine is combined with Desmopressin.
DB01535,The risk or severity of hyponatremia can be increased when Carfentanil is combined with Desmopressin.
DB01551,The risk or severity of hyponatremia can be increased when Dihydrocodeine is combined with Desmopressin.
DB01555,The risk or severity of hyponatremia can be increased when Alphacetylmethadol is combined with Desmopressin.
DB01565,The risk or severity of hyponatremia can be increased when Dihydromorphine is combined with Desmopressin.
DB06204,The risk or severity of hyponatremia can be increased when Tapentadol is combined with Desmopressin.
DB06738,The risk or severity of hyponatremia can be increased when Ketobemidone is combined with Desmopressin.
DB08861,The risk or severity of hyponatremia can be increased when DPDPE is combined with Desmopressin.
DB09174,The risk or severity of hyponatremia can be increased when Lofentanil is combined with Desmopressin.
DB09272,The risk or severity of hyponatremia can be increased when Eluxadoline is combined with Desmopressin.
DB11130,The risk or severity of hyponatremia can be increased when Opium is combined with Desmopressin.
DB11609,The risk or severity of hyponatremia can be increased when Normethadone is combined with Desmopressin.
DB12492,The risk or severity of hyponatremia can be increased when Piritramide is combined with Desmopressin.
DB13160,The risk or severity of hyponatremia can be increased when Alphaprodine is combined with Desmopressin.
DB13454,The risk or severity of hyponatremia can be increased when Nicomorphine is combined with Desmopressin.
DB13478,The risk or severity of hyponatremia can be increased when Meptazinol is combined with Desmopressin.
DB13605,The risk or severity of hyponatremia can be increased when Phenoperidine is combined with Desmopressin.
DB13606,The risk or severity of hyponatremia can be increased when Phenazocine is combined with Desmopressin.
DB13787,The risk or severity of hyponatremia can be increased when Tilidine is combined with Desmopressin.
DB15360,"The risk or severity of hyponatremia can be increased when Carfentanil, C-11 is combined with Desmopressin."
DB15465,The risk or severity of hyponatremia can be increased when Benzhydrocodone is combined with Desmopressin.
DB00191,The risk or severity of hypertension can be increased when Desmopressin is combined with Phentermine.
DB00211,The risk or severity of hypertension can be increased when Desmopressin is combined with Midodrine.
DB00216,The risk or severity of hypertension can be increased when Desmopressin is combined with Eletriptan.
DB00217,The risk or severity of hypertension can be increased when Desmopressin is combined with Bethanidine.
DB00221,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoetharine.
DB00246,The risk or severity of hypertension can be increased when Desmopressin is combined with Ziprasidone.
DB00247,The risk or severity of hypertension can be increased when Desmopressin is combined with Methysergide.
DB00248,The risk or severity of hypertension can be increased when Desmopressin is combined with Cabergoline.
DB00315,The risk or severity of hypertension can be increased when Desmopressin is combined with Zolmitriptan.
DB00320,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergotamine.
DB00353,The risk or severity of hypertension can be increased when Desmopressin is combined with Methylergometrine.
DB00368,The risk or severity of hypertension can be increased when Desmopressin is combined with Norepinephrine.
DB00370,The risk or severity of hypertension can be increased when Desmopressin is combined with Mirtazapine.
DB00388,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylephrine.
DB00397,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenylpropanolamine.
DB00420,The risk or severity of hypertension can be increased when Desmopressin is combined with Promazine.
DB00450,The risk or severity of hypertension can be increased when Desmopressin is combined with Droperidol.
DB00561,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxapram.
DB00572,The risk or severity of hypertension can be increased when Desmopressin is combined with Atropine.
DB00575,The risk or severity of hypertension can be increased when Desmopressin is combined with Clonidine.
DB00589,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisuride.
DB00601,The risk or severity of hypertension can be increased when Desmopressin is combined with Linezolid.
DB00610,The risk or severity of hypertension can be increased when Desmopressin is combined with Metaraminol.
DB00614,The risk or severity of hypertension can be increased when Desmopressin is combined with Furazolidone.
DB00629,The risk or severity of hypertension can be increased when Desmopressin is combined with Guanabenz.
DB00668,The risk or severity of hypertension can be increased when Desmopressin is combined with Epinephrine.
DB00679,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioridazine.
DB00696,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergotamine.
DB00699,The risk or severity of hypertension can be increased when Desmopressin is combined with Nicergoline.
DB00723,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxamine.
DB00734,The risk or severity of hypertension can be increased when Desmopressin is combined with Risperidone.
DB00752,The risk or severity of hypertension can be increased when Desmopressin is combined with Tranylcypromine.
DB00753,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoflurane.
DB00777,The risk or severity of hypertension can be increased when Desmopressin is combined with Propiomazine.
DB00797,The risk or severity of hypertension can be increased when Desmopressin is combined with Tolazoline.
DB00805,The risk or severity of hypertension can be increased when Desmopressin is combined with Minaprine.
DB00816,The risk or severity of hypertension can be increased when Desmopressin is combined with Orciprenaline.
DB00818,The risk or severity of hypertension can be increased when Desmopressin is combined with Propofol.
DB00830,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenmetrazine.
DB00831,The risk or severity of hypertension can be increased when Desmopressin is combined with Trifluoperazine.
DB00852,The risk or severity of hypertension can be increased when Desmopressin is combined with Pseudoephedrine.
DB00865,The risk or severity of hypertension can be increased when Desmopressin is combined with Benzphetamine.
DB00867,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritodrine.
DB00875,The risk or severity of hypertension can be increased when Desmopressin is combined with Flupentixol.
DB00886,The risk or severity of hypertension can be increased when Desmopressin is combined with Omapatrilat.
DB00901,The risk or severity of hypertension can be increased when Desmopressin is combined with Bitolterol.
DB00925,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxybenzamine.
DB00935,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxymetazoline.
DB00937,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethylpropion.
DB00938,The risk or severity of hypertension can be increased when Desmopressin is combined with Salmeterol.
DB00952,The risk or severity of hypertension can be increased when Desmopressin is combined with Naratriptan.
DB00983,The risk or severity of hypertension can be increased when Desmopressin is combined with Formoterol.
DB00998,The risk or severity of hypertension can be increased when Desmopressin is combined with Frovatriptan.
DB01028,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyflurane.
DB01037,The risk or severity of hypertension can be increased when Desmopressin is combined with Selegiline.
DB01049,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergoloid mesylate.
DB01064,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoprenaline.
DB01102,The risk or severity of hypertension can be increased when Desmopressin is combined with Arbutamine.
DB01126,The risk or severity of hypertension can be increased when Desmopressin is combined with Dutasteride.
DB01159,The risk or severity of hypertension can be increased when Desmopressin is combined with Halothane.
DB01171,The risk or severity of hypertension can be increased when Desmopressin is combined with Moclobemide.
DB01180,The risk or severity of hypertension can be increased when Desmopressin is combined with Rescinnamine.
DB01182,The risk or severity of hypertension can be increased when Desmopressin is combined with Propafenone.
DB01186,The risk or severity of hypertension can be increased when Desmopressin is combined with Pergolide.
DB01189,The risk or severity of hypertension can be increased when Desmopressin is combined with Desflurane.
DB01200,The risk or severity of hypertension can be increased when Desmopressin is combined with Bromocriptine.
DB01216,The risk or severity of hypertension can be increased when Desmopressin is combined with Finasteride.
DB01236,The risk or severity of hypertension can be increased when Desmopressin is combined with Sevoflurane.
DB01238,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole.
DB01247,The risk or severity of hypertension can be increased when Desmopressin is combined with Isocarboxazid.
DB01253,The risk or severity of hypertension can be increased when Desmopressin is combined with Ergometrine.
DB01255,The risk or severity of hypertension can be increased when Desmopressin is combined with Lisdexamfetamine.
DB01288,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenoterol.
DB01291,The risk or severity of hypertension can be increased when Desmopressin is combined with Pirbuterol.
DB01363,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedra sinica root.
DB01364,The risk or severity of hypertension can be increased when Desmopressin is combined with Ephedrine.
DB01365,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephentermine.
DB01366,The risk or severity of hypertension can be increased when Desmopressin is combined with Procaterol.
DB01392,The risk or severity of hypertension can be increased when Desmopressin is combined with Yohimbine.
DB01403,The risk or severity of hypertension can be increased when Desmopressin is combined with Methotrimeprazine.
DB01407,The risk or severity of hypertension can be increased when Desmopressin is combined with Clenbuterol.
DB01408,The risk or severity of hypertension can be increased when Desmopressin is combined with Bambuterol.
DB01442,The risk or severity of hypertension can be increased when Desmopressin is combined with MMDA.
DB01454,The risk or severity of hypertension can be increased when Desmopressin is combined with Midomafetamine.
DB01467,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine."
DB01472,The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.
DB01484,"The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine."
DB01509,The risk or severity of hypertension can be increased when Desmopressin is combined with Tenamfetamine.
DB01556,The risk or severity of hypertension can be increased when Desmopressin is combined with Chlorphentermine.
DB01576,The risk or severity of hypertension can be increased when Desmopressin is combined with Dextroamphetamine.
DB01579,The risk or severity of hypertension can be increased when Desmopressin is combined with Phendimetrazine.
DB01591,The risk or severity of hypertension can be increased when Desmopressin is combined with Solifenacin.
DB01608,The risk or severity of hypertension can be increased when Desmopressin is combined with Periciazine.
DB01614,The risk or severity of hypertension can be increased when Desmopressin is combined with Acepromazine.
DB01622,The risk or severity of hypertension can be increased when Desmopressin is combined with Thioproperazine.
DB01624,The risk or severity of hypertension can be increased when Desmopressin is combined with Zuclopenthixol.
DB01626,The risk or severity of hypertension can be increased when Desmopressin is combined with Pargyline.
DB02032,The risk or severity of hypertension can be increased when Desmopressin is combined with Epicaptopril.
DB04017,The risk or severity of hypertension can be increased when Desmopressin is combined with Clorgiline.
DB04581,The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.
DB04818,The risk or severity of hypertension can be increased when Desmopressin is combined with Iproniazid.
DB04820,The risk or severity of hypertension can be increased when Desmopressin is combined with Nialamide.
DB04829,The risk or severity of hypertension can be increased when Desmopressin is combined with Lysergic acid diethylamide.
DB04855,The risk or severity of hypertension can be increased when Desmopressin is combined with Dronedarone.
DB04908,The risk or severity of hypertension can be increased when Desmopressin is combined with Flibanserin.
DB04946,The risk or severity of hypertension can be increased when Desmopressin is combined with Iloperidone.
DB05039,The risk or severity of hypertension can be increased when Desmopressin is combined with Indacaterol.
DB05271,The risk or severity of hypertension can be increased when Desmopressin is combined with Rotigotine.
DB05395,The risk or severity of hypertension can be increased when Desmopressin is combined with Amibegron.
DB05562,The risk or severity of hypertension can be increased when Desmopressin is combined with Naluzotan.
DB06016,The risk or severity of hypertension can be increased when Desmopressin is combined with Cariprazine.
DB06148,The risk or severity of hypertension can be increased when Desmopressin is combined with Mianserin.
DB06152,The risk or severity of hypertension can be increased when Desmopressin is combined with Nylidrin.
DB06153,The risk or severity of hypertension can be increased when Desmopressin is combined with Pizotifen.
DB06190,The risk or severity of hypertension can be increased when Desmopressin is combined with Solabegron.
DB06216,The risk or severity of hypertension can be increased when Desmopressin is combined with Asenapine.
DB06654,The risk or severity of hypertension can be increased when Desmopressin is combined with Safinamide.
DB06678,The risk or severity of hypertension can be increased when Desmopressin is combined with Esmirtazapine.
DB06684,The risk or severity of hypertension can be increased when Desmopressin is combined with Vilazodone.
DB06690,The risk or severity of hypertension can be increased when Desmopressin is combined with Nitrous oxide.
DB06694,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylometazoline.
DB06701,The risk or severity of hypertension can be increased when Desmopressin is combined with Dexmethylphenidate.
DB06706,The risk or severity of hypertension can be increased when Desmopressin is combined with Isometheptene.
DB06707,The risk or severity of hypertension can be increased when Desmopressin is combined with Levonordefrin.
DB06711,The risk or severity of hypertension can be increased when Desmopressin is combined with Naphazoline.
DB06763,The risk or severity of hypertension can be increased when Desmopressin is combined with Saralasin.
DB06764,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetryzoline.
DB08810,The risk or severity of hypertension can be increased when Desmopressin is combined with Cinitapride.
DB08815,The risk or severity of hypertension can be increased when Desmopressin is combined with Lurasidone.
DB08841,The risk or severity of hypertension can be increased when Desmopressin is combined with Tyramine.
DB08925,The risk or severity of hypertension can be increased when Desmopressin is combined with Adrafinil.
DB08941,The risk or severity of hypertension can be increased when Desmopressin is combined with Isoxsuprine.
DB08950,The risk or severity of hypertension can be increased when Desmopressin is combined with Indoramin.
DB08954,The risk or severity of hypertension can be increased when Desmopressin is combined with Ifenprodil.
DB08957,The risk or severity of hypertension can be increased when Desmopressin is combined with Hexoprenaline.
DB08985,The risk or severity of hypertension can be increased when Desmopressin is combined with Etilefrine.
DB09061,The risk or severity of hypertension can be increased when Desmopressin is combined with Cannabidiol.
DB09080,The risk or severity of hypertension can be increased when Desmopressin is combined with Olodaterol.
DB09128,The risk or severity of hypertension can be increased when Desmopressin is combined with Brexpiprazole.
DB09202,The risk or severity of hypertension can be increased when Desmopressin is combined with Cirazoline.
DB09203,The risk or severity of hypertension can be increased when Desmopressin is combined with Synephrine.
DB09242,The risk or severity of hypertension can be increased when Desmopressin is combined with Moxonidine.
DB09243,The risk or severity of hypertension can be increased when Desmopressin is combined with Hydracarbazine.
DB09246,The risk or severity of hypertension can be increased when Desmopressin is combined with Benmoxin.
DB09248,The risk or severity of hypertension can be increased when Desmopressin is combined with Mebanazine.
DB09249,The risk or severity of hypertension can be increased when Desmopressin is combined with Octamoxin.
DB09250,The risk or severity of hypertension can be increased when Desmopressin is combined with Pheniprazine.
DB09251,The risk or severity of hypertension can be increased when Desmopressin is combined with Phenoxypropazine.
DB09252,The risk or severity of hypertension can be increased when Desmopressin is combined with Pivhydrazine.
DB09253,The risk or severity of hypertension can be increased when Desmopressin is combined with Safrazine.
DB09254,The risk or severity of hypertension can be increased when Desmopressin is combined with Caroxazone.
DB09273,The risk or severity of hypertension can be increased when Desmopressin is combined with Doxofylline.
DB09480,The risk or severity of hypertension can be increased when Desmopressin is combined with Iofetamine I-123.
DB11124,The risk or severity of hypertension can be increased when Desmopressin is combined with Racepinephrine.
DB11273,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocornine.
DB11373,The risk or severity of hypertension can be increased when Desmopressin is combined with Amitraz.
DB11428,The risk or severity of hypertension can be increased when Desmopressin is combined with Medetomidine.
DB11477,The risk or severity of hypertension can be increased when Desmopressin is combined with Xylazine.
DB11481,The risk or severity of hypertension can be increased when Desmopressin is combined with Atipamezole.
DB11541,The risk or severity of hypertension can be increased when Desmopressin is combined with Ractopamine.
DB11543,The risk or severity of hypertension can be increased when Desmopressin is combined with Romifidine.
DB11556,The risk or severity of hypertension can be increased when Desmopressin is combined with Detomidine.
DB11738,The risk or severity of hypertension can be increased when Desmopressin is combined with Rilmenidine.
DB11755,The risk or severity of hypertension can be increased when Desmopressin is combined with Tetrahydrocannabivarin.
DB11785,The risk or severity of hypertension can be increased when Desmopressin is combined with Anisodamine.
DB11871,The risk or severity of hypertension can be increased when Desmopressin is combined with PF-00610355.
DB12080,The risk or severity of hypertension can be increased when Desmopressin is combined with Ritobegron.
DB12092,The risk or severity of hypertension can be increased when Desmopressin is combined with Naftopidil.
DB12100,The risk or severity of hypertension can be increased when Desmopressin is combined with Abediterol.
DB12248,The risk or severity of hypertension can be increased when Desmopressin is combined with Tulobuterol.
DB12313,The risk or severity of hypertension can be increased when Desmopressin is combined with Dopexamine.
DB12361,The risk or severity of hypertension can be increased when Desmopressin is combined with Piclozotan.
DB12371,The risk or severity of hypertension can be increased when Desmopressin is combined with Siponimod.
DB12551,The risk or severity of hypertension can be increased when Desmopressin is combined with Idazoxan.
DB12661,The risk or severity of hypertension can be increased when Desmopressin is combined with Urapidil.
DB12779,The risk or severity of hypertension can be increased when Desmopressin is combined with Higenamine.
DB12846,The risk or severity of hypertension can be increased when Desmopressin is combined with Reproterol.
DB12927,The risk or severity of hypertension can be increased when Desmopressin is combined with Theodrenaline.
DB13064,The risk or severity of hypertension can be increased when Desmopressin is combined with Tramazoline.
DB13108,The risk or severity of hypertension can be increased when Desmopressin is combined with Mephedrone.
DB13251,The risk or severity of hypertension can be increased when Desmopressin is combined with Octopamine.
DB13323,The risk or severity of hypertension can be increased when Desmopressin is combined with Trichloroethylene.
DB13341,The risk or severity of hypertension can be increased when Desmopressin is combined with Fenozolone.
DB13345,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocristine.
DB13378,The risk or severity of hypertension can be increased when Desmopressin is combined with Norfenefrine.
DB13385,The risk or severity of hypertension can be increased when Desmopressin is combined with Dihydroergocryptine.
DB13398,The risk or severity of hypertension can be increased when Desmopressin is combined with Oxyfedrine.
DB13399,The risk or severity of hypertension can be increased when Desmopressin is combined with Terguride.
DB13453,The risk or severity of hypertension can be increased when Desmopressin is combined with Xenon.
DB13510,The risk or severity of hypertension can be increased when Desmopressin is combined with Buflomedil.
DB13520,The risk or severity of hypertension can be increased when Desmopressin is combined with Metergoline.
DB13559,The risk or severity of hypertension can be increased when Desmopressin is combined with Rimiterol.
DB13598,The risk or severity of hypertension can be increased when Desmopressin is combined with Diethyl ether.
DB13624,The risk or severity of hypertension can be increased when Desmopressin is combined with Methoxyphenamine.
DB13692,The risk or severity of hypertension can be increased when Desmopressin is combined with Tretoquinol.
DB13703,The risk or severity of hypertension can be increased when Desmopressin is combined with Gepefrine.
DB13777,The risk or severity of hypertension can be increased when Desmopressin is combined with Prenalterol.
DB13781,The risk or severity of hypertension can be increased when Desmopressin is combined with Xamoterol.
DB13852,The risk or severity of hypertension can be increased when Desmopressin is combined with Mefenorex.
DB13875,The risk or severity of hypertension can be increased when Desmopressin is combined with Harmaline.
DB13917,The risk or severity of hypertension can be increased when Desmopressin is combined with Deoxyepinephrine.
DB13940,"The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine."
DB14010,"The risk or severity of hypertension can be increased when Desmopressin is combined with 5-methoxy-N,N-dimethyltryptamine."
DB14185,The risk or severity of hypertension can be increased when Desmopressin is combined with Aripiprazole lauroxil.
DB14231,The risk or severity of hypertension can be increased when Desmopressin is combined with Quinoline Yellow WS.
DB15685,The risk or severity of hypertension can be increased when Desmopressin is combined with Selpercatinib.
DB00321,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptyline is combined with Desmopressin.
DB00344,The risk or severity of hyponatremia and water intoxication can be increased when Protriptyline is combined with Desmopressin.
DB00458,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine is combined with Desmopressin.
DB00540,The risk or severity of hyponatremia and water intoxication can be increased when Nortriptyline is combined with Desmopressin.
DB00543,The risk or severity of hyponatremia and water intoxication can be increased when Amoxapine is combined with Desmopressin.
DB00726,The risk or severity of hyponatremia and water intoxication can be increased when Trimipramine is combined with Desmopressin.
DB01142,The risk or severity of hyponatremia and water intoxication can be increased when Doxepin is combined with Desmopressin.
DB01151,The risk or severity of hyponatremia and water intoxication can be increased when Desipramine is combined with Desmopressin.
DB01242,The risk or severity of hyponatremia and water intoxication can be increased when Clomipramine is combined with Desmopressin.
DB04836,The risk or severity of hyponatremia and water intoxication can be increased when Amineptine is combined with Desmopressin.
DB08996,The risk or severity of hyponatremia and water intoxication can be increased when Dimetacrine is combined with Desmopressin.
DB09016,The risk or severity of hyponatremia and water intoxication can be increased when Butriptyline is combined with Desmopressin.
DB09167,The risk or severity of hyponatremia and water intoxication can be increased when Dosulepin is combined with Desmopressin.
DB09289,The risk or severity of hyponatremia and water intoxication can be increased when Tianeptine is combined with Desmopressin.
DB09307,The risk or severity of hyponatremia and water intoxication can be increased when Oxaprotiline is combined with Desmopressin.
DB12930,The risk or severity of hyponatremia and water intoxication can be increased when Opipramol is combined with Desmopressin.
DB13114,The risk or severity of hyponatremia and water intoxication can be increased when Amitriptylinoxide is combined with Desmopressin.
DB13225,The risk or severity of hyponatremia and water intoxication can be increased when Dibenzepin is combined with Desmopressin.
DB13246,The risk or severity of hyponatremia and water intoxication can be increased when Quinupramine is combined with Desmopressin.
DB13384,The risk or severity of hyponatremia and water intoxication can be increased when Melitracen is combined with Desmopressin.
DB13411,The risk or severity of hyponatremia and water intoxication can be increased when Lofepramine is combined with Desmopressin.
DB13496,The risk or severity of hyponatremia and water intoxication can be increased when Iprindole is combined with Desmopressin.
DB13782,The risk or severity of hyponatremia and water intoxication can be increased when Imipramine oxide is combined with Desmopressin.
DB00159,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Icosapent is combined with Desmopressin."
DB00244,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mesalazine is combined with Desmopressin."
DB00328,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indomethacin is combined with Desmopressin."
DB00461,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nabumetone is combined with Desmopressin."
DB00465,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketorolac is combined with Desmopressin."
DB00469,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenoxicam is combined with Desmopressin."
DB00482,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Celecoxib is combined with Desmopressin."
DB00500,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolmetin is combined with Desmopressin."
DB00533,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Rofecoxib is combined with Desmopressin."
DB00554,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Piroxicam is combined with Desmopressin."
DB00573,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenoprofen is combined with Desmopressin."
DB00580,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Valdecoxib is combined with Desmopressin."
DB00586,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diclofenac is combined with Desmopressin."
DB00605,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulindac is combined with Desmopressin."
DB00712,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen is combined with Desmopressin."
DB00749,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etodolac is combined with Desmopressin."
DB00784,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mefenamic acid is combined with Desmopressin."
DB00788,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Naproxen is combined with Desmopressin."
DB00795,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Sulfasalazine is combined with Desmopressin."
DB00812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Phenylbutazone is combined with Desmopressin."
DB00814,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meloxicam is combined with Desmopressin."
DB00821,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carprofen is combined with Desmopressin."
DB00861,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Diflunisal is combined with Desmopressin."
DB00936,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylic acid is combined with Desmopressin."
DB00939,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meclofenamic acid is combined with Desmopressin."
DB00945,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acetylsalicylic acid is combined with Desmopressin."
DB00991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxaprozin is combined with Desmopressin."
DB01009,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ketoprofen is combined with Desmopressin."
DB01014,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Balsalazide is combined with Desmopressin."
DB01050,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuprofen is combined with Desmopressin."
DB01250,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Olsalazine is combined with Desmopressin."
DB01283,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lumiracoxib is combined with Desmopressin."
DB01397,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Magnesium salicylate is combined with Desmopressin."
DB01399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salsalate is combined with Desmopressin."
DB01401,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Choline magnesium trisalicylate is combined with Desmopressin."
DB01419,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antrafenine is combined with Desmopressin."
DB01424,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aminophenazone is combined with Desmopressin."
DB01435,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Antipyrine is combined with Desmopressin."
DB01600,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tiaprofenic acid is combined with Desmopressin."
DB01628,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etoricoxib is combined with Desmopressin."
DB02224,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Taxifolin is combined with Desmopressin."
DB03585,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Oxyphenbutazone is combined with Desmopressin."
DB04552,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Niflumic acid is combined with Desmopressin."
DB04725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Licofelone is combined with Desmopressin."
DB04743,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nimesulide is combined with Desmopressin."
DB04812,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benoxaprofen is combined with Desmopressin."
DB04817,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Metamizole is combined with Desmopressin."
DB04828,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zomepirac is combined with Desmopressin."
DB05095,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Cimicoxib is combined with Desmopressin."
DB06725,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lornoxicam is combined with Desmopressin."
DB06736,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Aceclofenac is combined with Desmopressin."
DB06737,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Zaltoprofen is combined with Desmopressin."
DB07402,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Azapropazone is combined with Desmopressin."
DB07477,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Felbinac is combined with Desmopressin."
DB08439,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Parecoxib is combined with Desmopressin."
DB08797,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Salicylamide is combined with Desmopressin."
DB08940,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Kebuzone is combined with Desmopressin."
DB08942,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Isoxicam is combined with Desmopressin."
DB08951,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indoprofen is combined with Desmopressin."
DB08955,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ibuproxam is combined with Desmopressin."
DB08976,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Floctafenine is combined with Desmopressin."
DB08981,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fenbufen is combined with Desmopressin."
DB08984,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Etofenamate is combined with Desmopressin."
DB08991,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Epirizole is combined with Desmopressin."
DB09084,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benzydamine is combined with Desmopressin."
DB09212,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Loxoprofen is combined with Desmopressin."
DB09213,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexibuprofen is combined with Desmopressin."
DB09214,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Dexketoprofen is combined with Desmopressin."
DB09215,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Droxicam is combined with Desmopressin."
DB09216,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tolfenamic acid is combined with Desmopressin."
DB09217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Firocoxib is combined with Desmopressin."
DB09218,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Clonixin is combined with Desmopressin."
DB09285,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Morniflumate is combined with Desmopressin."
DB09288,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propacetamol is combined with Desmopressin."
DB09295,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Talniflumate is combined with Desmopressin."
DB11455,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Robenacoxib is combined with Desmopressin."
DB11466,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tepoxalin is combined with Desmopressin."
DB11518,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunixin is combined with Desmopressin."
DB12399,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Polmacoxib is combined with Desmopressin."
DB12445,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nitroaspirin is combined with Desmopressin."
DB12480,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Betulinic Acid is combined with Desmopressin."
DB12545,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Indobufen is combined with Desmopressin."
DB12610,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ebselen is combined with Desmopressin."
DB13001,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tinoridine is combined with Desmopressin."
DB13167,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alclofenac is combined with Desmopressin."
DB13217,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Fentiazac is combined with Desmopressin."
DB13232,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Suxibuzone is combined with Desmopressin."
DB13286,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bumadizone is combined with Desmopressin."
DB13314,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Alminoprofen is combined with Desmopressin."
DB13317,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flunoxaprofen is combined with Desmopressin."
DB13364,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Feprazone is combined with Desmopressin."
DB13371,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Difenpiramide is combined with Desmopressin."
DB13407,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Nifenazone is combined with Desmopressin."
DB13432,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Lonazolac is combined with Desmopressin."
DB13481,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Tenidap is combined with Desmopressin."
DB13501,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Bendazac is combined with Desmopressin."
DB13514,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pranoprofen is combined with Desmopressin."
DB13524,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Propyphenazone is combined with Desmopressin."
DB13527,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proglumetacin is combined with Desmopressin."
DB13538,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Guacetisal is combined with Desmopressin."
DB13544,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Ethenzamide is combined with Desmopressin."
DB13612,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Carbaspirin calcium is combined with Desmopressin."
DB13629,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Mofebutazone is combined with Desmopressin."
DB13649,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Proquazone is combined with Desmopressin."
DB13657,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Benorilate is combined with Desmopressin."
DB13722,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Pirprofen is combined with Desmopressin."
DB13783,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Acemetacin is combined with Desmopressin."
DB13860,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Imidazole salicylate is combined with Desmopressin."
DB14059,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when SC-236 is combined with Desmopressin."
DB14060,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when NS-398 is combined with Desmopressin."
DB14938,"The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Flurbiprofen axetil is combined with Desmopressin."
DB00091,Cyclosporine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00229,Cefotiam may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00267,Cefmenoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00274,Cefmetazole may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00282,Pamidronic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00300,Tenofovir disoproxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00369,Cidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00384,Triamterene may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00430,Cefpiramide may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00438,Ceftazidime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00447,Loracarbef may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00456,Cefalotin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00493,Cefotaxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00529,Foscarnet may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00563,Methotrexate may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00567,Cephalexin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00577,Valaciclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00626,Bacitracin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00681,Amphotericin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00689,Cephaloglycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00718,Adefovir dipivoxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00738,Pentamidine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00742,Mannitol may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00787,Acyclovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00833,Cefaclor may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00864,Tacrolimus may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00903,Etacrynic acid may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00923,Ceforanide may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00958,Carboplatin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00999,Hydrochlorothiazide may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01066,Cefditoren may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01072,Atazanavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01111,Colistimethate may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01112,Cefuroxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01139,Cefapirin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01140,Cefadroxil may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01150,Cefprozil may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01212,Ceftriaxone may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01326,Cefamandole may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01327,Cefazolin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01328,Cefonicid may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01329,Cefoperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01330,Cefotetan may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01331,Cefoxitin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01332,Ceftizoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01333,Cefradine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01413,Cefepime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01414,Cefacetrile may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01415,Ceftibuten may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01416,Cefpodoxime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01601,Lopinavir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB03450,Cephalothin Group may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04570,Latamoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04918,Ceftobiprole may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB06590,Ceftaroline fosamil may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB09008,Cefaloridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB09062,Cefminox may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB09299,Tenofovir alafenamide may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB11367,Cefroxadine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB11935,Flomoxef may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB12151,Brincidofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13266,Cefatrizine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13461,Cefcapene may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13470,Cefodizime may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13499,Cefsulodin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13504,Cefetamet may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13638,Cefbuperazone may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13667,Cefozopran may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13682,Cefpirome may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13778,Cefazedone may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13821,Ceftezole may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13868,Adefovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB14126,Tenofovir may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB14713,Inotersen may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01438,Phenazopyridine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB15066,Givosiran may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00007,Leuprolide may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00014,Goserelin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00017,Salmon calcitonin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00041,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00080,Desmopressin may decrease the excretion rate of Daptomycin which could result in a higher serum level.
DB00081,Desmopressin may decrease the excretion rate of Tositumomab which could result in a higher serum level.
DB00115,Desmopressin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.
DB00158,Desmopressin may decrease the excretion rate of Folic acid which could result in a higher serum level.
DB00165,Desmopressin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
DB00181,Desmopressin may decrease the excretion rate of Baclofen which could result in a higher serum level.
DB00182,Desmopressin may decrease the excretion rate of Amphetamine which could result in a higher serum level.
DB00185,Desmopressin may decrease the excretion rate of Cevimeline which could result in a higher serum level.
DB00186,Desmopressin may decrease the excretion rate of Lorazepam which could result in a higher serum level.
DB00190,Desmopressin may decrease the excretion rate of Carbidopa which could result in a higher serum level.
DB00196,Desmopressin may decrease the excretion rate of Fluconazole which could result in a higher serum level.
DB00198,Desmopressin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
DB00200,Desmopressin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
DB00206,Desmopressin may decrease the excretion rate of Reserpine which could result in a higher serum level.
DB00208,Desmopressin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.
DB00213,Desmopressin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
DB00225,Desmopressin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
DB00230,Desmopressin may decrease the excretion rate of Pregabalin which could result in a higher serum level.
DB00231,Desmopressin may decrease the excretion rate of Temazepam which could result in a higher serum level.
DB00235,Desmopressin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00237,Desmopressin may decrease the excretion rate of Butabarbital which could result in a higher serum level.
DB00243,Desmopressin may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245,Desmopressin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254,Desmopressin may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00262,Desmopressin may decrease the excretion rate of Carmustine which could result in a higher serum level.
DB00264,Desmopressin may decrease the excretion rate of Metoprolol which could result in a higher serum level.
DB00270,Desmopressin may decrease the excretion rate of Isradipine which could result in a higher serum level.
DB00271,Desmopressin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.
DB00273,Desmopressin may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00279,Desmopressin may decrease the excretion rate of Liothyronine which could result in a higher serum level.
DB00280,Desmopressin may decrease the excretion rate of Disopyramide which could result in a higher serum level.
DB00284,Desmopressin may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00285,Desmopressin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
DB00286,Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289,Desmopressin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00290,Desmopressin may decrease the excretion rate of Bleomycin which could result in a higher serum level.
DB00292,Desmopressin may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294,Desmopressin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296,Desmopressin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303,Desmopressin may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308,Desmopressin may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00312,Desmopressin may decrease the excretion rate of Pentobarbital which could result in a higher serum level.
DB00316,Desmopressin may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
DB00319,Desmopressin may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00322,Desmopressin may decrease the excretion rate of Floxuridine which could result in a higher serum level.
DB00323,Desmopressin may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00325,Desmopressin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.
DB00330,Desmopressin may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331,Desmopressin may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00339,Desmopressin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341,Desmopressin may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349,Desmopressin may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351,Desmopressin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355,Desmopressin may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00356,Desmopressin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
DB00359,Desmopressin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00363,Desmopressin may decrease the excretion rate of Clozapine which could result in a higher serum level.
DB00364,Desmopressin may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00372,Desmopressin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00373,Desmopressin may decrease the excretion rate of Timolol which could result in a higher serum level.
DB00377,Desmopressin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00380,Desmopressin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
DB00398,Desmopressin may decrease the excretion rate of Sorafenib which could result in a higher serum level.
DB00401,Desmopressin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
DB00402,Desmopressin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
DB00404,Desmopressin may decrease the excretion rate of Alprazolam which could result in a higher serum level.
DB00412,Desmopressin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
DB00413,Desmopressin may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415,Desmopressin may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00418,Desmopressin may decrease the excretion rate of Secobarbital which could result in a higher serum level.
DB00422,Desmopressin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00432,Desmopressin may decrease the excretion rate of Trifluridine which could result in a higher serum level.
DB00435,Desmopressin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00437,Desmopressin may decrease the excretion rate of Allopurinol which could result in a higher serum level.
DB00440,Desmopressin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00441,Desmopressin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
DB00480,Desmopressin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
DB00490,Desmopressin may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00492,Desmopressin may decrease the excretion rate of Fosinopril which could result in a higher serum level.
DB00499,Desmopressin may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00501,Desmopressin may decrease the excretion rate of Cimetidine which could result in a higher serum level.
DB00502,Desmopressin may decrease the excretion rate of Haloperidol which could result in a higher serum level.
DB00535,Desmopressin may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537,Desmopressin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548,Desmopressin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553,Desmopressin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00558,Desmopressin may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00569,Desmopressin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
DB00571,Desmopressin may decrease the excretion rate of Propranolol which could result in a higher serum level.
DB00583,Desmopressin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00591,Desmopressin may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.
DB00597,Desmopressin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00598,Desmopressin may decrease the excretion rate of Labetalol which could result in a higher serum level.
DB00603,Desmopressin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608,Desmopressin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00612,Desmopressin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
DB00624,Desmopressin may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628,Desmopressin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00631,Desmopressin may decrease the excretion rate of Clofarabine which could result in a higher serum level.
DB00633,Desmopressin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00635,Desmopressin may decrease the excretion rate of Prednisone which could result in a higher serum level.
DB00651,Desmopressin may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00657,Desmopressin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.
DB00660,Desmopressin may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00661,Desmopressin may decrease the excretion rate of Verapamil which could result in a higher serum level.
DB00665,Desmopressin may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669,Desmopressin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00672,Desmopressin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
DB00683,Desmopressin may decrease the excretion rate of Midazolam which could result in a higher serum level.
DB00688,Desmopressin may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level.
DB00690,Desmopressin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00692,Desmopressin may decrease the excretion rate of Phentolamine which could result in a higher serum level.
DB00698,Desmopressin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706,Desmopressin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709,Desmopressin may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713,Desmopressin may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716,Desmopressin may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00722,Desmopressin may decrease the excretion rate of Lisinopril which could result in a higher serum level.
DB00730,Desmopressin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731,Desmopressin may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733,Desmopressin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743,Desmopressin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759,Desmopressin may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760,Desmopressin may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761,Desmopressin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00763,Desmopressin may decrease the excretion rate of Methimazole which could result in a higher serum level.
DB00775,Desmopressin may decrease the excretion rate of Tirofiban which could result in a higher serum level.
DB00780,Desmopressin may decrease the excretion rate of Phenelzine which could result in a higher serum level.
DB00782,Desmopressin may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783,Desmopressin may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00789,Desmopressin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00790,Desmopressin may decrease the excretion rate of Perindopril which could result in a higher serum level.
DB00800,Desmopressin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.
DB00804,Desmopressin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00806,Desmopressin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
DB00811,Desmopressin may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00820,Desmopressin may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB00828,Desmopressin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00829,Desmopressin may decrease the excretion rate of Diazepam which could result in a higher serum level.
DB00839,Desmopressin may decrease the excretion rate of Tolazamide which could result in a higher serum level.
DB00841,Desmopressin may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00842,Desmopressin may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00851,Desmopressin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
DB00853,Desmopressin may decrease the excretion rate of Temozolomide which could result in a higher serum level.
DB00863,Desmopressin may decrease the excretion rate of Ranitidine which could result in a higher serum level.
DB00871,Desmopressin may decrease the excretion rate of Terbutaline which could result in a higher serum level.
DB00894,Desmopressin may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00897,Desmopressin may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB00900,Desmopressin may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911,Desmopressin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915,Desmopressin may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918,Desmopressin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00928,Desmopressin may decrease the excretion rate of Azacitidine which could result in a higher serum level.
DB00934,Desmopressin may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951,Desmopressin may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953,Desmopressin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00960,Desmopressin may decrease the excretion rate of Pindolol which could result in a higher serum level.
DB00961,Desmopressin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962,Desmopressin may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00968,Desmopressin may decrease the excretion rate of Methyldopa which could result in a higher serum level.
DB00980,Desmopressin may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00988,Desmopressin may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00993,Desmopressin may decrease the excretion rate of Azathioprine which could result in a higher serum level.
DB00995,Desmopressin may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001,Desmopressin may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002,Desmopressin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004,Desmopressin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010,Desmopressin may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011,Desmopressin may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01015,Desmopressin may decrease the excretion rate of Sulfamethoxazole which could result in a higher serum level.
DB01018,Desmopressin may decrease the excretion rate of Guanfacine which could result in a higher serum level.
DB01020,Desmopressin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022,Desmopressin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01024,Desmopressin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
DB01030,Desmopressin may decrease the excretion rate of Topotecan which could result in a higher serum level.
DB01032,Desmopressin may decrease the excretion rate of Probenecid which could result in a higher serum level.
DB01036,Desmopressin may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01039,Desmopressin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
DB01043,Desmopressin may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046,Desmopressin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048,Desmopressin may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060,Desmopressin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01067,Desmopressin may decrease the excretion rate of Glipizide which could result in a higher serum level.
DB01068,Desmopressin may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01069,Desmopressin may decrease the excretion rate of Promethazine which could result in a higher serum level.
DB01093,Desmopressin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01099,Desmopressin may decrease the excretion rate of Flucytosine which could result in a higher serum level.
DB01101,Desmopressin may decrease the excretion rate of Capecitabine which could result in a higher serum level.
DB01115,Desmopressin may decrease the excretion rate of Nifedipine which could result in a higher serum level.
DB01124,Desmopressin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
DB01129,Desmopressin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01133,Desmopressin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.
DB01135,Desmopressin may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137,Desmopressin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01148,Desmopressin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01156,Desmopressin may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157,Desmopressin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01166,Desmopressin may decrease the excretion rate of Cilostazol which could result in a higher serum level.
DB01169,Desmopressin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
DB01170,Desmopressin may decrease the excretion rate of Guanethidine which could result in a higher serum level.
DB01181,Desmopressin may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
DB01203,Desmopressin may decrease the excretion rate of Nadolol which could result in a higher serum level.
DB01205,Desmopressin may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01213,Desmopressin may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215,Desmopressin may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221,Desmopressin may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01222,Desmopressin may decrease the excretion rate of Budesonide which could result in a higher serum level.
DB01224,Desmopressin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
DB01233,Desmopressin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
DB01240,Desmopressin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.
DB01241,Desmopressin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01249,Desmopressin may decrease the excretion rate of Iodixanol which could result in a higher serum level.
DB01261,Desmopressin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01267,Desmopressin may decrease the excretion rate of Paliperidone which could result in a higher serum level.
DB01273,Desmopressin may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274,Desmopressin may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01275,Desmopressin may decrease the excretion rate of Hydralazine which could result in a higher serum level.
DB01359,Desmopressin may decrease the excretion rate of Penbutolol which could result in a higher serum level.
DB01367,Desmopressin may decrease the excretion rate of Rasagiline which could result in a higher serum level.
DB01394,Desmopressin may decrease the excretion rate of Colchicine which could result in a higher serum level.
DB01409,Desmopressin may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01420,Desmopressin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427,Desmopressin may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428,Desmopressin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01431,Desmopressin may decrease the excretion rate of Allylestrenol which could result in a higher serum level.
DB01550,Desmopressin may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558,Desmopressin may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563,Desmopressin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01577,Desmopressin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
DB01587,Desmopressin may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610,Desmopressin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638,Desmopressin may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01656,Desmopressin may decrease the excretion rate of Roflumilast which could result in a higher serum level.
DB01685,Desmopressin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574,Desmopressin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871,Desmopressin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895,Desmopressin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04920,Desmopressin may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB04948,Desmopressin may decrease the excretion rate of Lofexidine which could result in a higher serum level.
DB04953,Desmopressin may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018,Desmopressin may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541,Desmopressin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB05676,Desmopressin may decrease the excretion rate of Apremilast which could result in a higher serum level.
DB06154,Desmopressin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186,Desmopressin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196,Desmopressin may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203,Desmopressin may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06209,Desmopressin may decrease the excretion rate of Prasugrel which could result in a higher serum level.
DB06211,Desmopressin may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06228,Desmopressin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
DB06230,Desmopressin may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262,Desmopressin may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282,Desmopressin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06335,Desmopressin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06402,Desmopressin may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06480,Desmopressin may decrease the excretion rate of Prucalopride which could result in a higher serum level.
DB06623,Desmopressin may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637,Desmopressin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06695,Desmopressin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
DB06702,Desmopressin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705,Desmopressin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710,Desmopressin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767,Desmopressin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782,Desmopressin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796,Desmopressin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800,Desmopressin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809,Desmopressin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06813,Desmopressin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
DB06823,Desmopressin may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824,Desmopressin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824,Desmopressin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826,Desmopressin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840,Desmopressin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872,Desmopressin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08877,Desmopressin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
DB08893,Desmopressin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08894,Desmopressin may decrease the excretion rate of Peginesatide which could result in a higher serum level.
DB08897,Desmopressin may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899,Desmopressin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900,Desmopressin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08904,Desmopressin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
DB08905,Desmopressin may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08909,Desmopressin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08910,Desmopressin may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
DB08911,Desmopressin may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08932,Desmopressin may decrease the excretion rate of Macitentan which could result in a higher serum level.
DB08934,Desmopressin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB08964,Desmopressin may decrease the excretion rate of Gemeprost which could result in a higher serum level.
DB09027,Desmopressin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050,Desmopressin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066,Desmopressin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068,Desmopressin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09071,Desmopressin may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
DB09075,Desmopressin may decrease the excretion rate of Edoxaban which could result in a higher serum level.
DB09081,Desmopressin may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09082,Desmopressin may decrease the excretion rate of Vilanterol which could result in a higher serum level.
DB09089,Desmopressin may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB09091,Desmopressin may decrease the excretion rate of Tixocortol which could result in a higher serum level.
DB09103,Desmopressin may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09104,Desmopressin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09106,Desmopressin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111,Desmopressin may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118,Desmopressin may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121,Desmopressin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123,Desmopressin may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129,Desmopressin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132,Desmopressin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133,Desmopressin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09134,Desmopressin may decrease the excretion rate of Ioversol which could result in a higher serum level.
DB09135,Desmopressin may decrease the excretion rate of Ioxilan which could result in a higher serum level.
DB09136,Desmopressin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137,Desmopressin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139,Desmopressin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148,Desmopressin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149,Desmopressin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09156,Desmopressin may decrease the excretion rate of Iopromide which could result in a higher serum level.
DB09163,Desmopressin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165,Desmopressin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185,Desmopressin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194,Desmopressin may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195,Desmopressin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09204,Desmopressin may decrease the excretion rate of Arotinolol which could result in a higher serum level.
DB09205,Desmopressin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209,Desmopressin may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210,Desmopressin may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219,Desmopressin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09220,Desmopressin may decrease the excretion rate of Nicorandil which could result in a higher serum level.
DB09223,Desmopressin may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224,Desmopressin may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09241,Desmopressin may decrease the excretion rate of Methylene blue which could result in a higher serum level.
DB09244,Desmopressin may decrease the excretion rate of Pirlindole which could result in a higher serum level.
DB09245,Desmopressin may decrease the excretion rate of Toloxatone which could result in a higher serum level.
DB09255,Desmopressin may decrease the excretion rate of Dextran which could result in a higher serum level.
DB09256,Desmopressin may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257,Desmopressin may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262,Desmopressin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264,Desmopressin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265,Desmopressin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09268,Desmopressin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276,Desmopressin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277,Desmopressin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09281,Desmopressin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09292,Desmopressin may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301,Desmopressin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level."
DB09318,"Desmopressin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level."
DB09320,Desmopressin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324,Desmopressin may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325,Desmopressin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329,"Desmopressin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level."
DB09344,Desmopressin may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357,Desmopressin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394,Desmopressin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395,Desmopressin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407,Desmopressin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09418,Desmopressin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.
DB09472,Desmopressin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09477,Desmopressin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.
DB09481,Desmopressin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB09488,Desmopressin may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496,Desmopressin may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502,Desmopressin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546,Desmopressin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB09570,Desmopressin may decrease the excretion rate of Ixazomib which could result in a higher serum level.
DB11077,Desmopressin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090,Desmopressin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098,Desmopressin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102,Desmopressin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114,Desmopressin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127,Desmopressin may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11135,Desmopressin may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136,Desmopressin may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145,Desmopressin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156,Desmopressin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164,Desmopressin may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251,Desmopressin may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278,Desmopressin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328,Desmopressin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338,Desmopressin may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358,Desmopressin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364,Desmopressin may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11560,Desmopressin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577,Desmopressin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587,Desmopressin may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11598,Desmopressin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
DB11642,Desmopressin may decrease the excretion rate of Pitolisant which could result in a higher serum level.
DB11691,Desmopressin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699,Desmopressin may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11817,Desmopressin may decrease the excretion rate of Baricitinib which could result in a higher serum level.
DB11901,Desmopressin may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915,Desmopressin may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943,Desmopressin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989,Desmopressin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007,Desmopressin may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107,Desmopressin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12161,Desmopressin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12278,Desmopressin may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783,Desmopressin may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025,Desmopressin may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139,Desmopressin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156,Desmopressin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178,Desmopressin may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185,Desmopressin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191,Desmopressin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269,Desmopressin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293,Desmopressin may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595,Desmopressin may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873,Desmopressin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884,Desmopressin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909,Desmopressin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943,Desmopressin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944,Desmopressin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13952,Desmopressin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954,Desmopressin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955,Desmopressin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956,Desmopressin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967,Desmopressin may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14006,Desmopressin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007,Desmopressin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498,Desmopressin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499,Desmopressin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526,Desmopressin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527,Desmopressin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528,Desmopressin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529,Desmopressin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530,Desmopressin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB06815,Desmopressin may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121,Desmopressin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB01183,Desmopressin may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB11085,Desmopressin may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB15593,Desmopressin may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00879,Desmopressin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB00452,Framycetin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00479,Amikacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00684,Tobramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00798,Gentamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00955,Netilmicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00994,Neomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01082,Streptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01172,Kanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB01421,Paromomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB03615,Ribostamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04263,Geneticin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04626,Apramycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04729,Gentamicin C1a may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB04808,Neamine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB06696,Arbekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB08437,Puromycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB11512,Dihydrostreptomycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB11520,Hygromycin B may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB12604,Sisomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13270,Dibekacin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13274,Micronomicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13540,Isepamicin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB13673,Bekanamycin may decrease the excretion rate of Desmopressin which could result in a higher serum level.
DB00552,Desmopressin may decrease the excretion rate of Pentostatin which could result in a higher serum level.
DB13145,Desmopressin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00314,Desmopressin may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00390,Desmopressin may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB00512,Desmopressin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00515,Desmopressin may decrease the excretion rate of Cisplatin which could result in a higher serum level.
DB00642,Desmopressin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
DB00682,Desmopressin may decrease the excretion rate of Warfarin which could result in a higher serum level.
DB00908,Desmopressin may decrease the excretion rate of Quinidine which could result in a higher serum level.
DB00982,Desmopressin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB01035,Desmopressin may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615,Desmopressin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB13316,Desmopressin may increase the excretion rate of Ibopamine which could result in a lower serum level and potentially a reduction in efficacy.
DB00524,Desmopressin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00695,Desmopressin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00808,Desmopressin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00887,Desmopressin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB00909,Desmopressin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08907,Desmopressin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB09338,Desmopressin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB00214,Torasemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00232,Methyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00310,Chlorthalidone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00311,Ethoxzolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00421,Spironolactone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00436,Bendroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00562,Benzthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00594,Amiloride may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00606,Cyclothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00700,Eplerenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00703,Methazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00774,Hydroflumethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00819,Acetazolamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00872,Conivaptan may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB00880,Chlorothiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01021,Trichlormethiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01119,Diazoxide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01144,Diclofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01324,Polythiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01325,Quinethazone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01395,Drospirenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB01412,Theobromine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB02925,Piretanide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB04831,Tienilic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB05034,Ularitide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB06292,Dapagliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB06370,Indisulam may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB08961,Azosemide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB09015,Canrenoic acid may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB09125,Potassium citrate may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB09235,Efonidipine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB09401,Isosorbide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB11827,Ertugliflozin may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB12221,Canrenone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB12670,Rolofylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB12704,Spiradoline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB12766,Cicletanine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13284,Meticrane may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13405,Mefruside may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13430,Mebutizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13532,Cyclopenthiazide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13617,Clorexolone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13663,Clofenamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13708,Fenquizone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13792,Clopamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13801,Muzolimine may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13803,Xipamide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB13989,Epitizide may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB14018,Bromotheophylline may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB14500,Potassium may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy.
DB11823,The risk or severity of hypertension can be increased when Esketamine is combined with Desmopressin.
DB14754,The risk or severity of hypertension can be increased when Solriamfetol is combined with Desmopressin.
DB13946,Testosterone undecanoate may increase the hypertensive activities of Desmopressin.
DB09310,Catridecacog may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB00513,The risk or severity of adverse effects can be increased when Aminocaproic acid is combined with Coagulation factor VIIa Recombinant Human.
DB00058,Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB00170,Menadione may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB00302,Tranexamic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB06692,Aprotinin may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB11091,Hydrogen peroxide may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB13244,Aminomethylbenzoic acid may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB13729,Camostat may increase the thrombogenic activities of Coagulation factor VIIa Recombinant Human.
DB12726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Monteplase.
DB00001,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Lepirudin.
DB00006,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bivalirudin.
DB00009,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Alteplase.
DB00013,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Urokinase.
DB00015,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reteplase.
DB00029,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Anistreplase.
DB00031,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tenecteplase.
DB00054,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.
DB00055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Drotrecogin alfa.
DB00086,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Streptokinase.
DB00266,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dicoumarol.
DB00278,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Argatroban.
DB00407,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ardeparin.
DB00498,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenindione.
DB00569,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fondaparinux.
DB00682,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Warfarin.
DB00686,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Pentosan polysulfate.
DB00945,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acetylsalicylic acid.
DB00946,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Phenprocoumon.
DB00975,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dipyridamole.
DB01088,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Iloprost.
DB01109,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Heparin.
DB01225,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Enoxaparin.
DB01240,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Epoprostenol.
DB01418,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Acenocoumarol.
DB03410,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with 4-hydroxycoumarin.
DB04665,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Coumarin.
DB04898,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ximelagatran.
DB04925,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desmoteplase.
DB04932,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Defibrotide.
DB05099,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ancrod.
DB05229,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Beraprost.
DB05254,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fibrinolysin.
DB06209,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Prasugrel.
DB06228,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Rivaroxaban.
DB06271,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sulodexide.
DB06406,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Idraparinux.
DB06441,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Cangrelor.
DB06543,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Astaxanthin.
DB06605,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Apixaban.
DB06635,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Otamixaban.
DB06679,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Amediplase.
DB06695,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran etexilate.
DB06754,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Danaparoid.
DB06779,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dalteparin.
DB06822,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tinzaparin.
DB07767,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ferulic acid.
DB08496,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (R)-warfarin.
DB08794,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ethyl biscoumacetate.
DB08813,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nadroparin.
DB08814,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Triflusal.
DB08816,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ticagrelor.
DB08994,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Ditazole.
DB09030,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Vorapaxar.
DB09075,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edoxaban.
DB09125,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Potassium citrate.
DB09154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Sodium citrate.
DB09255,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dextran.
DB09258,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Bemiparin.
DB09259,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Reviparin.
DB09260,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Parnaparin.
DB09261,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Certoparin.
DB11095,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Desirudin.
DB11154,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Zinc citrate.
DB11166,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin Alfa.
DB11312,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein C.
DB11598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Antithrombin III human.
DB11984,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Letaxaban.
DB12289,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Darexaban.
DB12364,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Betrixaban.
DB12598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Nafamostat.
DB12831,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Gabexate.
DB13136,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Fluindione.
DB13149,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Protein S human.
DB13199,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Brinase.
DB13275,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Clorindione.
DB13347,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Diphenadione.
DB13451,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tioclomarol.
DB13616,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Melagatran.
DB13646,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Saruplase.
DB14055,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with (S)-Warfarin.
DB14094,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Tocopherylquinone.
DB14598,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Edetate calcium disodium anhydrous.
DB14726,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Dabigatran.
DB06294,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Semuloparin.
DB00407,The serum concentration of Palifermin can be increased when it is combined with Ardeparin.
DB01109,The serum concentration of Palifermin can be increased when it is combined with Heparin.
DB01225,The serum concentration of Palifermin can be increased when it is combined with Enoxaparin.
DB06271,The serum concentration of Palifermin can be increased when it is combined with Sulodexide.
DB06294,The serum concentration of Palifermin can be increased when it is combined with Semuloparin.
DB06754,The serum concentration of Palifermin can be increased when it is combined with Danaparoid.
DB06779,The serum concentration of Palifermin can be increased when it is combined with Dalteparin.
DB06822,The serum concentration of Palifermin can be increased when it is combined with Tinzaparin.
DB08813,The serum concentration of Palifermin can be increased when it is combined with Nadroparin.
DB09258,The serum concentration of Palifermin can be increased when it is combined with Bemiparin.
DB09259,The serum concentration of Palifermin can be increased when it is combined with Reviparin.
DB09260,The serum concentration of Palifermin can be increased when it is combined with Parnaparin.
DB09261,The serum concentration of Palifermin can be increased when it is combined with Certoparin.
DB00008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2a.
DB00011,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n1.
DB00018,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-n3.
DB00022,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon alfa-2b.
DB00033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon gamma-1b.
DB00034,"The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2a, Recombinant."
DB00041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.
DB00056,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemtuzumab ozogamicin.
DB00068,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon beta-1b.
DB00069,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfacon-1.
DB00073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Rituximab.
DB00078,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibritumomab tiuxetan.
DB00081,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tositumomab.
DB00087,The therapeutic efficacy of Palifermin can be decreased when used in combination with Alemtuzumab.
DB00105,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa-2b.
DB00120,The therapeutic efficacy of Palifermin can be decreased when used in combination with Phenylalanine.
DB00188,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bortezomib.
DB00242,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cladribine.
DB00262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carmustine.
DB00276,The therapeutic efficacy of Palifermin can be decreased when used in combination with Amsacrine.
DB00291,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chlorambucil.
DB00293,The therapeutic efficacy of Palifermin can be decreased when used in combination with Raltitrexed.
DB00305,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitomycin.
DB00307,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bexarotene.
DB00309,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vindesine.
DB00322,The therapeutic efficacy of Palifermin can be decreased when used in combination with Floxuridine.
DB00328,The therapeutic efficacy of Palifermin can be decreased when used in combination with Indomethacin.
DB00352,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tioguanine.
DB00361,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinorelbine.
DB00380,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dexrazoxane.
DB00398,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sorafenib.
DB00428,The therapeutic efficacy of Palifermin can be decreased when used in combination with Streptozocin.
DB00441,The therapeutic efficacy of Palifermin can be decreased when used in combination with Gemcitabine.
DB00444,The therapeutic efficacy of Palifermin can be decreased when used in combination with Teniposide.
DB00445,The therapeutic efficacy of Palifermin can be decreased when used in combination with Epirubicin.
DB00446,The therapeutic efficacy of Palifermin can be decreased when used in combination with Chloramphenicol.
DB00480,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lenalidomide.
DB00488,The therapeutic efficacy of Palifermin can be decreased when used in combination with Altretamine.
DB00495,The therapeutic efficacy of Palifermin can be decreased when used in combination with Zidovudine.
DB00515,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cisplatin.
DB00526,The therapeutic efficacy of Palifermin can be decreased when used in combination with Oxaliplatin.
DB00531,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cyclophosphamide.
DB00544,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fluorouracil.
DB00550,The therapeutic efficacy of Palifermin can be decreased when used in combination with Propylthiouracil.
DB00552,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pentostatin.
DB00563,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methotrexate.
DB00564,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carbamazepine.
DB00570,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vinblastine.
DB00601,The therapeutic efficacy of Palifermin can be decreased when used in combination with Linezolid.
DB00619,The therapeutic efficacy of Palifermin can be decreased when used in combination with Imatinib.
DB00631,The therapeutic efficacy of Palifermin can be decreased when used in combination with Clofarabine.
DB00642,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pemetrexed.
DB00694,The therapeutic efficacy of Palifermin can be decreased when used in combination with Daunorubicin.
DB00762,The therapeutic efficacy of Palifermin can be decreased when used in combination with Irinotecan.
DB00763,The therapeutic efficacy of Palifermin can be decreased when used in combination with Methimazole.
DB00773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Etoposide.
DB00851,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dacarbazine.
DB00853,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temozolomide.
DB00859,The therapeutic efficacy of Palifermin can be decreased when used in combination with Penicillamine.
DB00864,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tacrolimus.
DB00877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Sirolimus.
DB00888,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mechlorethamine.
DB00928,The therapeutic efficacy of Palifermin can be decreased when used in combination with Azacitidine.
DB00958,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carboplatin.
DB00970,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dactinomycin.
DB00987,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cytarabine.
DB00997,The therapeutic efficacy of Palifermin can be decreased when used in combination with Doxorubicin.
DB01005,The therapeutic efficacy of Palifermin can be decreased when used in combination with Hydroxyurea.
DB01008,The therapeutic efficacy of Palifermin can be decreased when used in combination with Busulfan.
DB01030,The therapeutic efficacy of Palifermin can be decreased when used in combination with Topotecan.
DB01033,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mercaptopurine.
DB01041,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thalidomide.
DB01042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Melphalan.
DB01073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Fludarabine.
DB01099,The therapeutic efficacy of Palifermin can be decreased when used in combination with Flucytosine.
DB01101,The therapeutic efficacy of Palifermin can be decreased when used in combination with Capecitabine.
DB01168,The therapeutic efficacy of Palifermin can be decreased when used in combination with Procarbazine.
DB01169,The therapeutic efficacy of Palifermin can be decreased when used in combination with Arsenic trioxide.
DB01177,The therapeutic efficacy of Palifermin can be decreased when used in combination with Idarubicin.
DB01181,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ifosfamide.
DB01204,The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitoxantrone.
DB01206,The therapeutic efficacy of Palifermin can be decreased when used in combination with Lomustine.
DB01229,The therapeutic efficacy of Palifermin can be decreased when used in combination with Paclitaxel.
DB01248,The therapeutic efficacy of Palifermin can be decreased when used in combination with Docetaxel.
DB01254,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dasatinib.
DB01262,The therapeutic efficacy of Palifermin can be decreased when used in combination with Decitabine.
DB01280,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nelarabine.
DB01590,The therapeutic efficacy of Palifermin can be decreased when used in combination with Everolimus.
DB02546,The therapeutic efficacy of Palifermin can be decreased when used in combination with Vorinostat.
DB04572,The therapeutic efficacy of Palifermin can be decreased when used in combination with Thiotepa.
DB04845,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ixabepilone.
DB04868,The therapeutic efficacy of Palifermin can be decreased when used in combination with Nilotinib.
DB05015,The therapeutic efficacy of Palifermin can be decreased when used in combination with Belinostat.
DB05109,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trabectedin.
DB05258,The therapeutic efficacy of Palifermin can be decreased when used in combination with Interferon alfa.
DB05472,The therapeutic efficacy of Palifermin can be decreased when used in combination with omega interferon.
DB05773,The therapeutic efficacy of Palifermin can be decreased when used in combination with Trastuzumab emtansine.
DB06287,The therapeutic efficacy of Palifermin can be decreased when used in combination with Temsirolimus.
DB06616,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bosutinib.
DB06769,The therapeutic efficacy of Palifermin can be decreased when used in combination with Bendamustine.
DB06772,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cabazitaxel.
DB08871,The therapeutic efficacy of Palifermin can be decreased when used in combination with Eribulin.
DB08877,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ruxolitinib.
DB08889,The therapeutic efficacy of Palifermin can be decreased when used in combination with Carfilzomib.
DB08895,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tofacitinib.
DB08901,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ponatinib.
DB08910,The therapeutic efficacy of Palifermin can be decreased when used in combination with Pomalidomide.
DB08935,The therapeutic efficacy of Palifermin can be decreased when used in combination with Obinutuzumab.
DB09042,The therapeutic efficacy of Palifermin can be decreased when used in combination with Tedizolid phosphate.
DB09052,The therapeutic efficacy of Palifermin can be decreased when used in combination with Blinatumomab.
DB09053,The therapeutic efficacy of Palifermin can be decreased when used in combination with Ibrutinib.
DB09073,The therapeutic efficacy of Palifermin can be decreased when used in combination with Palbociclib.
DB09074,The therapeutic efficacy of Palifermin can be decreased when used in combination with Olaparib.
DB09077,The therapeutic efficacy of Palifermin can be decreased when used in combination with Dinutuximab.
DB09122,The therapeutic efficacy of Palifermin can be decreased when used in combination with Peginterferon beta-1a.
DB12814,The therapeutic efficacy of Palifermin can be decreased when used in combination with Cepeginterferon alfa-2B.
DB00193,Tramadol may increase the gastrointestinal motility reducing activities of Glucagon.
DB00209,Trospium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00219,Oxyphenonium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00245,Benzatropine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00246,Ziprasidone may increase the gastrointestinal motility reducing activities of Glucagon.
DB00280,Disopyramide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00321,Amitriptyline may increase the gastrointestinal motility reducing activities of Glucagon.
DB00332,Ipratropium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00334,Olanzapine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00340,Metixene may increase the gastrointestinal motility reducing activities of Glucagon.
DB00342,Terfenadine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00354,Buclizine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00363,Clozapine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00366,Doxylamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00376,Trihexyphenidyl may increase the gastrointestinal motility reducing activities of Glucagon.
DB00383,Oxyphencyclimine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00387,Procyclidine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00392,Profenamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00420,Promazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00424,Hyoscyamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00434,Cyproheptadine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00458,Imipramine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00462,Methscopolamine bromide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00477,Chlorpromazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00483,Gallamine triethiodide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00496,Darifenacin may increase the gastrointestinal motility reducing activities of Glucagon.
DB00505,Tridihexethyl may increase the gastrointestinal motility reducing activities of Glucagon.
DB00508,Triflupromazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00517,Anisotropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00540,Nortriptyline may increase the gastrointestinal motility reducing activities of Glucagon.
DB00543,Amoxapine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00555,Lamotrigine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00572,Atropine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00622,Nicardipine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00670,Pirenzepine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00715,Paroxetine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00725,Homatropine methylbromide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00728,Rocuronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00747,Scopolamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00767,Benzquinamide may increase the gastrointestinal motility reducing activities of Glucagon.
DB00771,Clidinium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00777,Propiomazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00782,Propantheline may increase the gastrointestinal motility reducing activities of Glucagon.
DB00804,Dicyclomine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00810,Biperiden may increase the gastrointestinal motility reducing activities of Glucagon.
DB00835,Brompheniramine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00875,Flupentixol may increase the gastrointestinal motility reducing activities of Glucagon.
DB00907,Cocaine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00908,Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00934,Maprotiline may increase the gastrointestinal motility reducing activities of Glucagon.
DB00940,Methantheline may increase the gastrointestinal motility reducing activities of Glucagon.
DB00942,Cycrimine may increase the gastrointestinal motility reducing activities of Glucagon.
DB00986,Glycopyrronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01036,Tolterodine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01062,Oxybutynin may increase the gastrointestinal motility reducing activities of Glucagon.
DB01069,Promethazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01075,Diphenhydramine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01135,Doxacurium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01142,Doxepin may increase the gastrointestinal motility reducing activities of Glucagon.
DB01148,Flavoxate may increase the gastrointestinal motility reducing activities of Glucagon.
DB01151,Desipramine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01173,Orphenadrine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01175,Escitalopram may increase the gastrointestinal motility reducing activities of Glucagon.
DB01224,Quetiapine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01226,Mivacurium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01231,Diphenidol may increase the gastrointestinal motility reducing activities of Glucagon.
DB01238,Aripiprazole may increase the gastrointestinal motility reducing activities of Glucagon.
DB01239,Chlorprothixene may increase the gastrointestinal motility reducing activities of Glucagon.
DB01336,Metocurine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01337,Pancuronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01338,Pipecuronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01403,Methotrimeprazine may increase the gastrointestinal motility reducing activities of Glucagon.
DB01409,Tiotropium may increase the gastrointestinal motility reducing activities of Glucagon.
DB01591,Solifenacin may increase the gastrointestinal motility reducing activities of Glucagon.
DB01625,Isopropamide may increase the gastrointestinal motility reducing activities of Glucagon.
DB04834,Rapacuronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB04843,Mepenzolate may increase the gastrointestinal motility reducing activities of Glucagon.
DB06153,Pizotifen may increase the gastrointestinal motility reducing activities of Glucagon.
DB06702,Fesoterodine may increase the gastrointestinal motility reducing activities of Glucagon.
DB06787,Hexocyclium may increase the gastrointestinal motility reducing activities of Glucagon.
DB08801,Dimetindene may increase the gastrointestinal motility reducing activities of Glucagon.
DB08897,Aclidinium may increase the gastrointestinal motility reducing activities of Glucagon.
DB08997,Dexetimide may increase the gastrointestinal motility reducing activities of Glucagon.
DB09007,Chlorphenoxamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB09023,Benactyzine may increase the gastrointestinal motility reducing activities of Glucagon.
DB09076,Umeclidinium may increase the gastrointestinal motility reducing activities of Glucagon.
DB09089,Trimebutine may increase the gastrointestinal motility reducing activities of Glucagon.
DB09167,Dosulepin may increase the gastrointestinal motility reducing activities of Glucagon.
DB09262,Imidafenacin may increase the gastrointestinal motility reducing activities of Glucagon.
DB09300,Butylscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB11235,Thonzylamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB11315,Methscopolamine may increase the gastrointestinal motility reducing activities of Glucagon.
DB11855,Revefenacin may increase the gastrointestinal motility reducing activities of Glucagon.
DB12086,Oxitropium may increase the gastrointestinal motility reducing activities of Glucagon.
DB12278,Propiverine may increase the gastrointestinal motility reducing activities of Glucagon.
DB12526,Batefenterol may increase the gastrointestinal motility reducing activities of Glucagon.
DB12554,Mebeverine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13252,Tropatepine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13254,Prifinium may increase the gastrointestinal motility reducing activities of Glucagon.
DB13351,Piperidolate may increase the gastrointestinal motility reducing activities of Glucagon.
DB13369,Benzilone may increase the gastrointestinal motility reducing activities of Glucagon.
DB13380,Difemerine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13413,Phenglutarimide may increase the gastrointestinal motility reducing activities of Glucagon.
DB13448,Mazaticol may increase the gastrointestinal motility reducing activities of Glucagon.
DB13468,Etybenzatropine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13500,Otilonium may increase the gastrointestinal motility reducing activities of Glucagon.
DB13505,Emepronium may increase the gastrointestinal motility reducing activities of Glucagon.
DB13507,Poldine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13542,Bevonium may increase the gastrointestinal motility reducing activities of Glucagon.
DB13581,Rociverine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13619,Bornaprine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13636,Etanautine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13666,Tiemonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.
DB13678,Dihexyverine may increase the gastrointestinal motility reducing activities of Glucagon.
DB13695,Penthienate may increase the gastrointestinal motility reducing activities of Glucagon.
DB13720,Diphemanil may increase the gastrointestinal motility reducing activities of Glucagon.
DB13738,Camylofin may increase the gastrointestinal motility reducing activities of Glucagon.
DB13759,Fenpiverinium may increase the gastrointestinal motility reducing activities of Glucagon.
DB13769,Emetonium iodide may increase the gastrointestinal motility reducing activities of Glucagon.
DB13844,Pipenzolate may increase the gastrointestinal motility reducing activities of Glucagon.
DB13850,Timepidium may increase the gastrointestinal motility reducing activities of Glucagon.
DB00328,The therapeutic efficacy of Glucagon can be decreased when used in combination with Indomethacin.
DB00266,The therapeutic efficacy of Dicoumarol can be increased when used in combination with Glucagon.
DB00498,The therapeutic efficacy of Phenindione can be increased when used in combination with Glucagon.
DB00682,The therapeutic efficacy of Warfarin can be increased when used in combination with Glucagon.
DB00946,The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Glucagon.
DB01418,The therapeutic efficacy of Acenocoumarol can be increased when used in combination with Glucagon.
DB03410,The therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Glucagon.
DB04665,The therapeutic efficacy of Coumarin can be increased when used in combination with Glucagon.
DB08496,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Glucagon.
DB08794,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Glucagon.
DB13136,The therapeutic efficacy of Fluindione can be increased when used in combination with Glucagon.
DB13275,The therapeutic efficacy of Clorindione can be increased when used in combination with Glucagon.
DB13347,The therapeutic efficacy of Diphenadione can be increased when used in combination with Glucagon.
DB13451,The therapeutic efficacy of Tioclomarol can be increased when used in combination with Glucagon.
DB14055,The therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Glucagon.
DB00187,The therapeutic efficacy of Esmolol can be decreased when used in combination with Glucagon.
DB00195,The therapeutic efficacy of Betaxolol can be decreased when used in combination with Glucagon.
DB00264,The therapeutic efficacy of Metoprolol can be decreased when used in combination with Glucagon.
DB00335,The therapeutic efficacy of Atenolol can be decreased when used in combination with Glucagon.
DB00373,The therapeutic efficacy of Timolol can be decreased when used in combination with Glucagon.
DB00489,The therapeutic efficacy of Sotalol can be decreased when used in combination with Glucagon.
DB00571,The therapeutic efficacy of Propranolol can be decreased when used in combination with Glucagon.
DB00598,The therapeutic efficacy of Labetalol can be decreased when used in combination with Glucagon.
DB00612,The therapeutic efficacy of Bisoprolol can be decreased when used in combination with Glucagon.
DB00866,The therapeutic efficacy of Alprenolol can be decreased when used in combination with Glucagon.
DB00960,The therapeutic efficacy of Pindolol can be decreased when used in combination with Glucagon.
DB01136,The therapeutic efficacy of Carvedilol can be decreased when used in combination with Glucagon.
DB01182,The therapeutic efficacy of Propafenone can be decreased when used in combination with Glucagon.
DB01193,The therapeutic efficacy of Acebutolol can be decreased when used in combination with Glucagon.
DB01203,The therapeutic efficacy of Nadolol can be decreased when used in combination with Glucagon.
DB01295,The therapeutic efficacy of Bevantolol can be decreased when used in combination with Glucagon.
DB01297,The therapeutic efficacy of Practolol can be decreased when used in combination with Glucagon.
DB01359,The therapeutic efficacy of Penbutolol can be decreased when used in combination with Glucagon.
DB01580,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Glucagon.
DB03322,The therapeutic efficacy of Dexpropranolol can be decreased when used in combination with Glucagon.
DB04846,The therapeutic efficacy of Celiprolol can be decreased when used in combination with Glucagon.
DB04861,The therapeutic efficacy of Nebivolol can be decreased when used in combination with Glucagon.
DB06726,The therapeutic efficacy of Bufuralol can be decreased when used in combination with Glucagon.
DB08807,The therapeutic efficacy of Bopindolol can be decreased when used in combination with Glucagon.
DB08808,The therapeutic efficacy of Bupranolol can be decreased when used in combination with Glucagon.
DB08952,The therapeutic efficacy of Indenolol can be decreased when used in combination with Glucagon.
DB09013,The therapeutic efficacy of Befunolol can be decreased when used in combination with Glucagon.
DB09204,The therapeutic efficacy of Arotinolol can be decreased when used in combination with Glucagon.
DB09351,The therapeutic efficacy of Levobetaxolol can be decreased when used in combination with Glucagon.
DB11770,The therapeutic efficacy of Talinolol can be decreased when used in combination with Glucagon.
DB11785,The therapeutic efficacy of Anisodamine can be decreased when used in combination with Glucagon.
DB12212,The therapeutic efficacy of Landiolol can be decreased when used in combination with Glucagon.
DB12752,The therapeutic efficacy of Bucindolol can be decreased when used in combination with Glucagon.
DB13443,The therapeutic efficacy of Esatenolol can be decreased when used in combination with Glucagon.
DB13508,The therapeutic efficacy of Cloranolol can be decreased when used in combination with Glucagon.
DB13530,The therapeutic efficacy of Mepindolol can be decreased when used in combination with Glucagon.
DB13757,The therapeutic efficacy of Epanolol can be decreased when used in combination with Glucagon.
DB13775,The therapeutic efficacy of Tertatolol can be decreased when used in combination with Glucagon.
DB00030,The therapeutic efficacy of Insulin human can be decreased when used in combination with Glucagon.
DB00046,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.
DB00047,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.
DB00071,The therapeutic efficacy of Insulin pork can be decreased when used in combination with Glucagon.
DB01306,The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Glucagon.
DB01307,The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Glucagon.
DB01309,The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Glucagon.
DB05115,The therapeutic efficacy of NN344 can be decreased when used in combination with Glucagon.
DB09456,The therapeutic efficacy of Insulin beef can be decreased when used in combination with Glucagon.
DB09564,The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Glucagon.
DB11567,The therapeutic efficacy of Insulin peglispro can be decreased when used in combination with Glucagon.
DB11568,The therapeutic efficacy of Insulin tregopil can be decreased when used in combination with Glucagon.
DB11564,The therapeutic efficacy of Insulin argine can be decreased when used in combination with Glucagon.
DB14513,The serum concentration of Magnesium can be increased when it is combined with Glucagon.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Aldesleukin.
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Aldesleukin.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Aldesleukin.
DB00026,The risk or severity of adverse effects can be increased when Anakinra is combined with Aldesleukin.
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Aldesleukin.
DB00051,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.
DB00056,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pegaspargase.
DB00065,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Infliximab.
DB00068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon beta-1b.
DB00073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antithymocyte immunoglobulin (rabbit).
DB00111,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenylalanine.
DB00180,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flunisolide.
DB00242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cladribine.
DB00262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carmustine.
DB00276,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitomycin.
DB00307,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bexarotene.
DB00322,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Floxuridine.
DB00328,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indomethacin.
DB00352,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tioguanine.
DB00380,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexrazoxane.
DB00428,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gemcitabine.
DB00445,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Altretamine.
DB00495,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Zidovudine.
DB00515,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxaliplatin.
DB00531,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cyclophosphamide.
DB00544,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluorouracil.
DB00552,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pentostatin.
DB00588,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluticasone propionate.
DB00591,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocinolone acetonide.
DB00601,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Linezolid.
DB00631,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clofarabine.
DB00642,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pemetrexed.
DB00687,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludrocortisone.
DB00688,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolate mofetil.
DB00755,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tretinoin.
DB00762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irinotecan.
DB00795,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sulfasalazine.
DB00851,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dacarbazine.
DB00853,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Penicillamine.
DB00860,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prednisolone.
DB00888,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carboplatin.
DB00959,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Methylprednisolone.
DB00970,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dactinomycin.
DB00993,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azathioprine.
DB01005,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxyurea.
DB01024,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Topotecan.
DB01033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mercaptopurine.
DB01041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thalidomide.
DB01042,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Flucytosine.
DB01101,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Capecitabine.
DB01168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Arsenic trioxide.
DB01177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Idarubicin.
DB01196,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Estramustine.
DB01204,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lomustine.
DB01234,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dexamethasone.
DB01257,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Decitabine.
DB01280,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nelarabine.
DB01281,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abatacept.
DB01285,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Corticotropin.
DB01423,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Stepronin.
DB01611,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydroxychloroquine.
DB01816,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brequinar.
DB04630,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aldosterone.
DB04951,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirfenidone.
DB04956,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Afelimomab.
DB05258,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Aldesleukin is combined with omega interferon.
DB05676,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apremilast.
DB05773,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trastuzumab emtansine.
DB06168,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Canakinumab.
DB06273,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tocilizumab.
DB06372,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rilonacept.
DB06612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mepolizumab.
DB06662,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Abetimus.
DB06674,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Golimumab.
DB06681,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belatacept.
DB06769,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bendamustine.
DB06772,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cabazitaxel.
DB06813,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Wortmannin.
DB08871,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eribulin.
DB08879,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carfilzomib.
DB08904,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Certolizumab pegol.
DB08908,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dimethyl fumarate.
DB08910,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pomalidomide.
DB08935,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Obinutuzumab.
DB09029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vedolizumab.
DB09036,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Blinatumomab.
DB09074,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olaparib.
DB09077,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Dinutuximab.
DB09082,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Vilanterol.
DB09091,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Antilymphocyte immunoglobulin (horse).
DB09378,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluprednisolone.
DB11466,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tepoxalin.
DB11529,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Melengestrol.
DB11569,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Peficitinib.
DB11767,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sirukumab.
DB11817,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Baricitinib.
DB11834,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Guselkumab.
DB12025,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Triptolide.
DB12612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acteoside.
DB13014,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Aldesleukin is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13223,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Formocortal.
DB13856,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fluclorolone.
DB14066,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tetrandrine.
DB14219,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Monomethyl fumarate.
DB14538,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone aceponate.
DB14539,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone acetate.
DB14545,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Hydrocortisone succinate.
DB14724,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bleselumab.
DB01222,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Budesonide.
DB12371,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Siponimod.
DB00108,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aldesleukin.
DB01656,Roflumilast may increase the immunosuppressive activities of Aldesleukin.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Aldesleukin.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Aldesleukin.
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Aldesleukin.
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Aldesleukin.
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Aldesleukin."
DB00069,The risk or severity of adverse effects can be increased when Interferon alfacon-1 is combined with Aldesleukin.
DB00105,The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Aldesleukin.
DB00363,The risk or severity of neutropenia can be increased when Aldesleukin is combined with Clozapine.
DB08894,The risk or severity of Thrombosis can be increased when Aldesleukin is combined with Peginesatide.
DB00012,The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Aldesleukin.
DB00016,The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Aldesleukin.
DB09107,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Aldesleukin.
DB00476,The risk or severity of orthostatic hypotension and syncope can be increased when Aldesleukin is combined with Duloxetine.
DB01235,The risk or severity of hypotension and orthostatic hypotension can be increased when Aldesleukin is combined with Levodopa.
DB00734,Aldesleukin may increase the hypotensive activities of Risperidone.
DB09039,The metabolism of Eliglustat can be decreased when combined with Aldesleukin.
DB09053,The metabolism of Ibrutinib can be decreased when combined with Aldesleukin.
DB01166,The metabolism of Cilostazol can be decreased when combined with Aldesleukin.
DB01394,The metabolism of Colchicine can be decreased when combined with Aldesleukin.
DB00813,The metabolism of Fentanyl can be decreased when combined with Aldesleukin.
DB04946,The metabolism of Iloperidone can be decreased when combined with Aldesleukin.
DB01256,The metabolism of Retapamulin can be decreased when combined with Aldesleukin.
DB08895,The metabolism of Tofacitinib can be decreased when combined with Aldesleukin.
DB00862,The metabolism of Vardenafil can be decreased when combined with Aldesleukin.
DB00402,The metabolism of Eszopiclone can be decreased when combined with Aldesleukin.
DB01198,The metabolism of Zopiclone can be decreased when combined with Aldesleukin.
DB00394,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Beclomethasone dipropionate.
DB00443,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone.
DB00620,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Triamcinolone.
DB00635,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone.
DB00764,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone.
DB01380,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone acetate.
DB01384,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Paramethasone.
DB01410,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Ciclesonide.
DB08906,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone furoate.
DB08970,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene.
DB08971,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluocortolone.
DB09383,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Meprednisone.
DB11487,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Dexamethasone isonicotinate.
DB11750,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clobetasol.
DB11921,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Deflazacort.
DB13003,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortivazol.
DB13208,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednylidene.
DB13728,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Halometasone.
DB13843,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cloprednol.
DB13867,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluticasone.
DB14512,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Mometasone furoate.
DB14631,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone phosphate.
DB14633,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisolone hemisuccinate.
DB14634,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Fluprednidene acetate.
DB14644,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Methylprednisolone hemisuccinate.
DB14646,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Prednisone acetate.
DB14652,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Clocortolone acetate.
DB14659,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Melengestrol acetate.
DB14669,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Betamethasone phosphate.
DB14681,The therapeutic efficacy of Aldesleukin can be decreased when used in combination with Cortisone.
DB00227,The metabolism of Lovastatin can be decreased when combined with Aldesleukin.
DB00271,The risk of a hypersensitivity reaction to Diatrizoate is increased when it is combined with Aldesleukin.
DB00965,The risk of a hypersensitivity reaction to Ethiodized oil is increased when it is combined with Aldesleukin.
DB01249,The risk of a hypersensitivity reaction to Iodixanol is increased when it is combined with Aldesleukin.
DB01362,The risk of a hypersensitivity reaction to Iohexol is increased when it is combined with Aldesleukin.
DB04711,The risk of a hypersensitivity reaction to Iodipamide is increased when it is combined with Aldesleukin.
DB08947,The risk of a hypersensitivity reaction to Iopamidol is increased when it is combined with Aldesleukin.
DB09134,The risk of a hypersensitivity reaction to Ioversol is increased when it is combined with Aldesleukin.
DB09135,The risk of a hypersensitivity reaction to Ioxilan is increased when it is combined with Aldesleukin.
DB09156,The risk of a hypersensitivity reaction to Iopromide is increased when it is combined with Aldesleukin.
DB00346,The metabolism of Alfuzosin can be decreased when combined with Aldesleukin.
DB00404,The metabolism of Alprazolam can be decreased when combined with Aldesleukin.
DB00682,The serum concentration of Warfarin can be increased when it is combined with Aldesleukin.
DB01418,The serum concentration of Acenocoumarol can be increased when it is combined with Aldesleukin.
DB08496,The serum concentration of (R)-warfarin can be increased when it is combined with Aldesleukin.
DB08735,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Aldesleukin."
DB08736,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Aldesleukin."
DB14055,The serum concentration of (S)-Warfarin can be increased when it is combined with Aldesleukin.
DB00683,The serum concentration of Midazolam can be increased when it is combined with Aldesleukin.
DB00864,The serum concentration of Tacrolimus can be increased when it is combined with Aldesleukin.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Aldesleukin.
DB01076,The metabolism of Atorvastatin can be decreased when combined with Aldesleukin.
DB01097,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Leflunomide.
DB00072,Trastuzumab may increase the neutropenic activities of Aldesleukin.
DB08868,Aldesleukin may increase the immunosuppressive activities of Fingolimod.
DB09220,Nicorandil may increase the hypotensive activities of Aldesleukin.
DB00614,Furazolidone may increase the orthostatic hypotensive activities of Aldesleukin.
DB00721,Procaine may increase the orthostatic hypotensive activities of Aldesleukin.
DB00752,Tranylcypromine may increase the orthostatic hypotensive activities of Aldesleukin.
DB00780,Phenelzine may increase the orthostatic hypotensive activities of Aldesleukin.
DB00805,Minaprine may increase the orthostatic hypotensive activities of Aldesleukin.
DB01037,Selegiline may increase the orthostatic hypotensive activities of Aldesleukin.
DB01171,Moclobemide may increase the orthostatic hypotensive activities of Aldesleukin.
DB01247,Isocarboxazid may increase the orthostatic hypotensive activities of Aldesleukin.
DB01367,Rasagiline may increase the orthostatic hypotensive activities of Aldesleukin.
DB01626,Pargyline may increase the orthostatic hypotensive activities of Aldesleukin.
DB04017,Clorgiline may increase the orthostatic hypotensive activities of Aldesleukin.
DB04818,Iproniazid may increase the orthostatic hypotensive activities of Aldesleukin.
DB04820,Nialamide may increase the orthostatic hypotensive activities of Aldesleukin.
DB06654,Safinamide may increase the orthostatic hypotensive activities of Aldesleukin.
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Aldesleukin."
DB09241,Methylene blue may increase the orthostatic hypotensive activities of Aldesleukin.
DB09243,Hydracarbazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09244,Pirlindole may increase the orthostatic hypotensive activities of Aldesleukin.
DB09245,Toloxatone may increase the orthostatic hypotensive activities of Aldesleukin.
DB09246,Benmoxin may increase the orthostatic hypotensive activities of Aldesleukin.
DB09248,Mebanazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09249,Octamoxin may increase the orthostatic hypotensive activities of Aldesleukin.
DB09250,Pheniprazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09251,Phenoxypropazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09252,Pivhydrazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09253,Safrazine may increase the orthostatic hypotensive activities of Aldesleukin.
DB09254,Caroxazone may increase the orthostatic hypotensive activities of Aldesleukin.
DB13875,Harmaline may increase the orthostatic hypotensive activities of Aldesleukin.
DB13876,Brofaromine may increase the orthostatic hypotensive activities of Aldesleukin.
DB00182,Aldesleukin may increase the orthostatic hypotensive activities of Amphetamine.
DB00241,Butalbital may increase the hypotensive activities of Aldesleukin.
DB00312,Pentobarbital may increase the hypotensive activities of Aldesleukin.
DB00418,Secobarbital may increase the hypotensive activities of Aldesleukin.
DB00474,Methohexital may increase the hypotensive activities of Aldesleukin.
DB00599,Thiopental may increase the hypotensive activities of Aldesleukin.
DB00794,Primidone may increase the hypotensive activities of Aldesleukin.
DB00849,Methylphenobarbital may increase the hypotensive activities of Aldesleukin.
DB01154,Thiamylal may increase the hypotensive activities of Aldesleukin.
DB01174,Phenobarbital may increase the hypotensive activities of Aldesleukin.
DB01351,Amobarbital may increase the hypotensive activities of Aldesleukin.
DB01355,Hexobarbital may increase the hypotensive activities of Aldesleukin.
DB01483,Barbital may increase the hypotensive activities of Aldesleukin.
DB09001,Barbexaclone may increase the hypotensive activities of Aldesleukin.
DB00237,Aldesleukin may increase the hypotensive activities of Butabarbital.
DB00086,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Streptokinase.
DB00268,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ropinirole.
DB00334,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olanzapine.
DB00486,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nabilone.
DB00489,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sotalol.
DB00679,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Thioridazine.
DB00697,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tizanidine.
DB00714,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Apomorphine.
DB00818,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Propofol.
DB00899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Remifentanil.
DB00922,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Levosimendan.
DB01113,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Papaverine.
DB01143,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amifostine.
DB01189,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Desflurane.
DB01282,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Carbetocin.
DB01612,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amyl Nitrite.
DB04899,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nesiritide.
DB08822,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azilsartan medoxomil.
DB08941,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isoxsuprine.
DB09112,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrous acid.
DB09279,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Fimasartan.
DB09286,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Pipamperone.
DB00177,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Valsartan.
DB00178,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Ramipril.
DB00187,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Esmolol.
DB00195,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Betaxolol.
DB00275,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Olmesartan.
DB00335,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol.
DB00350,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Minoxidil.
DB00457,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Prazosin.
DB00519,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Trandolapril.
DB00542,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Benazepril.
DB00691,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moexipril.
DB00727,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitroglycerin.
DB00796,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Candesartan cilexetil.
DB00797,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Tolazoline.
DB00876,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eprosartan.
DB00881,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Quinapril.
DB00925,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Phenoxybenzamine.
DB00966,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Telmisartan.
DB01029,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Irbesartan.
DB01158,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bretylium.
DB01162,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Terazosin.
DB01193,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Acebutolol.
DB01197,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Captopril.
DB01340,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilazapril.
DB01580,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Oxprenolol.
DB08950,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Indoramin.
DB09242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Moxonidine.
DB11783,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Imidapril.
DB00584,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Enalapril.
DB00343,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Diltiazem.
DB00381,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Amlodipine.
DB00393,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nimodipine.
DB00528,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Lercanidipine.
DB00622,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nicardipine.
DB00678,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Losartan.
DB01054,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nitrendipine.
DB01244,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bepridil.
DB04861,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nebivolol.
DB08931,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Riociguat.
DB09026,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Aliskiren.
DB00295,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Morphine.
DB00297,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bupivacaine.
DB00708,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Sufentanil.
DB00883,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide dinitrate.
DB05271,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Rotigotine.
DB09227,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Barnidipine.
DB09232,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Cilnidipine.
DB00401,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Nisoldipine.
DB00575,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clonidine.
DB01023,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Felodipine.
DB01200,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Bromocriptine.
DB01242,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Clomipramine.
DB09038,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Empagliflozin.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Aldesleukin.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Aldesleukin.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Aldesleukin.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Aldesleukin.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Aldesleukin.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Aldesleukin.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Aldesleukin.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Aldesleukin.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Aldesleukin.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Aldesleukin."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Aldesleukin.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Aldesleukin."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Aldesleukin.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Aldesleukin.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Aldesleukin.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Aldesleukin.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Aldesleukin.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Aldesleukin.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Aldesleukin.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Aldesleukin.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Aldesleukin.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Aldesleukin.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Aldesleukin.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Aldesleukin.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Aldesleukin.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Aldesleukin.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Aldesleukin."
DB00054,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Aldesleukin.
DB00261,The risk or severity of bleeding can be increased when Anagrelide is combined with Aldesleukin.
DB00975,The risk or severity of bleeding can be increased when Dipyridamole is combined with Aldesleukin.
DB01088,The risk or severity of bleeding can be increased when Iloprost is combined with Aldesleukin.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Aldesleukin.
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Aldesleukin.
DB04932,The risk or severity of bleeding can be increased when Defibrotide is combined with Aldesleukin.
DB05229,The risk or severity of bleeding can be increased when Beraprost is combined with Aldesleukin.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Aldesleukin.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Aldesleukin.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Aldesleukin.
DB06441,The risk or severity of bleeding can be increased when Cangrelor is combined with Aldesleukin.
DB08814,The risk or severity of bleeding can be increased when Triflusal is combined with Aldesleukin.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Aldesleukin.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Aldesleukin.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Aldesleukin.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Aldesleukin.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Aldesleukin.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Aldesleukin.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Aldesleukin.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Aldesleukin.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Aldesleukin.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Aldesleukin.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Aldesleukin.
DB12465,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ketanserin.
DB13400,The risk or severity of bleeding can be increased when Aldesleukin is combined with Linsidomine.
DB12092,The risk or severity of bleeding can be increased when Aldesleukin is combined with Naftopidil.
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Aldesleukin.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Aldesleukin.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Aldesleukin.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Aldesleukin.
DB08816,The risk or severity of bleeding can be increased when Ticagrelor is combined with Aldesleukin.
DB09236,Aldesleukin may increase the hypotensive activities of Lacidipine.
DB00898,Ethanol may increase the hypotensive activities of Aldesleukin.
DB11988,Ocrelizumab may increase the immunosuppressive activities of Aldesleukin.
DB13200,Aldesleukin may increase the myelosuppressive activities of Lipegfilgrastim.
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Aldesleukin.
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Aldesleukin.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Aldesleukin.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Aldesleukin.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Aldesleukin.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Aldesleukin.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Aldesleukin.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Aldesleukin.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Aldesleukin.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Aldesleukin.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Aldesleukin.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Aldesleukin.
DB01238,The metabolism of Aripiprazole can be decreased when combined with Aldesleukin.
DB14185,The metabolism of Aripiprazole lauroxil can be decreased when combined with Aldesleukin.
DB00039,The therapeutic efficacy of Palifermin can be decreased when used in combination with Aldesleukin.
DB00159,Icosapent may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00229,Cefotiam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00244,Mesalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00267,Cefmenoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00274,Cefmetazole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00282,Pamidronic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00300,Tenofovir disoproxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00369,Cidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00384,Triamterene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00430,Cefpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00438,Ceftazidime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00447,Loracarbef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00456,Cefalotin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00461,Nabumetone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00465,Ketorolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00469,Tenoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00482,Celecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00493,Cefotaxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00500,Tolmetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00529,Foscarnet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00533,Rofecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00554,Piroxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00567,Cephalexin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00573,Fenoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00577,Valaciclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00580,Valdecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00586,Diclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00605,Sulindac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00626,Bacitracin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00681,Amphotericin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00689,Cephaloglycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00712,Flurbiprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00718,Adefovir dipivoxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00738,Pentamidine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00742,Mannitol may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00749,Etodolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00784,Mefenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00787,Acyclovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00788,Naproxen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00812,Phenylbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00814,Meloxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00821,Carprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00833,Cefaclor may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00861,Diflunisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00903,Etacrynic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00923,Ceforanide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00936,Salicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00939,Meclofenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00945,Acetylsalicylic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00991,Oxaprozin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00999,Hydrochlorothiazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01009,Ketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01014,Balsalazide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01050,Ibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01066,Cefditoren may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01072,Atazanavir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01111,Colistimethate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01112,Cefuroxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01139,Cefapirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01140,Cefadroxil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01150,Cefprozil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01212,Ceftriaxone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01250,Olsalazine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01283,Lumiracoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01326,Cefamandole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01327,Cefazolin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01328,Cefonicid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01329,Cefoperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01330,Cefotetan may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01331,Cefoxitin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01332,Ceftizoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01333,Cefradine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01397,Magnesium salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01399,Salsalate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01401,Choline magnesium trisalicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01413,Cefepime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01414,Cefacetrile may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01415,Ceftibuten may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01416,Cefpodoxime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01419,Antrafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01424,Aminophenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01435,Antipyrine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01600,Tiaprofenic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01628,Etoricoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB02247,Hydrolyzed Cephalothin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB03450,Cephalothin Group may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB03585,Oxyphenbutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04552,Niflumic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04570,Latamoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04743,Nimesulide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04812,Benoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04817,Metamizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04828,Zomepirac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04918,Ceftobiprole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB05095,Cimicoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB06590,Ceftaroline fosamil may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB06725,Lornoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB06736,Aceclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB06737,Zaltoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB07402,Azapropazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB07477,Felbinac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08439,Parecoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08797,Salicylamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08940,Kebuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08942,Isoxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08951,Indoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08955,Ibuproxam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08976,Floctafenine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08981,Fenbufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08984,Etofenamate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08991,Epirizole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09008,Cefaloridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09062,Cefminox may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09084,Benzydamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09212,Loxoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09213,Dexibuprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09214,Dexketoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09215,Droxicam may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09216,Tolfenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09217,Firocoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09218,Clonixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09285,Morniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09295,Talniflumate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB09299,Tenofovir alafenamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11367,Cefroxadine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11455,Robenacoxib may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11518,Flunixin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11935,Flomoxef may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB12151,Brincidofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB12445,Nitroaspirin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB12545,Indobufen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13001,Tinoridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13167,Alclofenac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13217,Fentiazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13232,Suxibuzone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13266,Cefatrizine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13286,Bumadizone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13314,Alminoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13317,Flunoxaprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13364,Feprazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13371,Difenpiramide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13407,Nifenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13432,Lonazolac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13461,Cefcapene may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13470,Cefodizime may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13481,Tenidap may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13499,Cefsulodin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13501,Bendazac may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13504,Cefetamet may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13514,Pranoprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13524,Propyphenazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13527,Proglumetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13538,Guacetisal may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13544,Ethenzamide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13612,Carbaspirin calcium may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13629,Mofebutazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13638,Cefbuperazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13649,Proquazone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13657,Benorilate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13667,Cefozopran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13682,Cefpirome may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13722,Pirprofen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13778,Cefazedone may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13783,Acemetacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13821,Ceftezole may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13860,Imidazole salicylate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13868,Adefovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB14059,SC-236 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB14060,NS-398 may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB14126,Tenofovir may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB14713,Inotersen may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01438,Phenazopyridine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB15066,Givosiran may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01356,Lithium cation may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB14507,Lithium citrate may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00007,Leuprolide may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00014,Goserelin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00035,Desmopressin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00080,Aldesleukin may decrease the excretion rate of Daptomycin which could result in a higher serum level.
DB00158,Aldesleukin may decrease the excretion rate of Folic acid which could result in a higher serum level.
DB00165,Aldesleukin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
DB00176,Aldesleukin may decrease the excretion rate of Fluvoxamine which could result in a higher serum level.
DB00181,Aldesleukin may decrease the excretion rate of Baclofen which could result in a higher serum level.
DB00185,Aldesleukin may decrease the excretion rate of Cevimeline which could result in a higher serum level.
DB00190,Aldesleukin may decrease the excretion rate of Carbidopa which could result in a higher serum level.
DB00196,Aldesleukin may decrease the excretion rate of Fluconazole which could result in a higher serum level.
DB00198,Aldesleukin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
DB00200,Aldesleukin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
DB00206,Aldesleukin may decrease the excretion rate of Reserpine which could result in a higher serum level.
DB00213,Aldesleukin may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
DB00225,Aldesleukin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
DB00230,Aldesleukin may decrease the excretion rate of Pregabalin which could result in a higher serum level.
DB00231,Aldesleukin may decrease the excretion rate of Temazepam which could result in a higher serum level.
DB00235,Aldesleukin may decrease the excretion rate of Milrinone which could result in a higher serum level.
DB00243,Aldesleukin may decrease the excretion rate of Ranolazine which could result in a higher serum level.
DB00245,Aldesleukin may decrease the excretion rate of Benzatropine which could result in a higher serum level.
DB00254,Aldesleukin may decrease the excretion rate of Doxycycline which could result in a higher serum level.
DB00270,Aldesleukin may decrease the excretion rate of Isradipine which could result in a higher serum level.
DB00273,Aldesleukin may decrease the excretion rate of Topiramate which could result in a higher serum level.
DB00280,Aldesleukin may decrease the excretion rate of Disopyramide which could result in a higher serum level.
DB00284,Aldesleukin may decrease the excretion rate of Acarbose which could result in a higher serum level.
DB00285,Aldesleukin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.
DB00286,Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
DB00289,Aldesleukin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
DB00292,Aldesleukin may decrease the excretion rate of Etomidate which could result in a higher serum level.
DB00294,Aldesleukin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.
DB00296,Aldesleukin may decrease the excretion rate of Ropivacaine which could result in a higher serum level.
DB00303,Aldesleukin may decrease the excretion rate of Ertapenem which could result in a higher serum level.
DB00308,Aldesleukin may decrease the excretion rate of Ibutilide which could result in a higher serum level.
DB00319,Aldesleukin may decrease the excretion rate of Piperacillin which could result in a higher serum level.
DB00323,Aldesleukin may decrease the excretion rate of Tolcapone which could result in a higher serum level.
DB00325,Aldesleukin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.
DB00327,Aldesleukin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
DB00330,Aldesleukin may decrease the excretion rate of Ethambutol which could result in a higher serum level.
DB00331,Aldesleukin may decrease the excretion rate of Metformin which could result in a higher serum level.
DB00333,Aldesleukin may decrease the excretion rate of Methadone which could result in a higher serum level.
DB00339,Aldesleukin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
DB00341,Aldesleukin may decrease the excretion rate of Cetirizine which could result in a higher serum level.
DB00349,Aldesleukin may decrease the excretion rate of Clobazam which could result in a higher serum level.
DB00351,Aldesleukin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.
DB00355,Aldesleukin may decrease the excretion rate of Aztreonam which could result in a higher serum level.
DB00359,Aldesleukin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
DB00364,Aldesleukin may decrease the excretion rate of Sucralfate which could result in a higher serum level.
DB00372,Aldesleukin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.
DB00373,Aldesleukin may decrease the excretion rate of Timolol which could result in a higher serum level.
DB00377,Aldesleukin may decrease the excretion rate of Palonosetron which could result in a higher serum level.
DB00412,Aldesleukin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
DB00413,Aldesleukin may decrease the excretion rate of Pramipexole which could result in a higher serum level.
DB00415,Aldesleukin may decrease the excretion rate of Ampicillin which could result in a higher serum level.
DB00422,Aldesleukin may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
DB00435,Aldesleukin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.
DB00440,Aldesleukin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
DB00492,Aldesleukin may decrease the excretion rate of Fosinopril which could result in a higher serum level.
DB00499,Aldesleukin may decrease the excretion rate of Flutamide which could result in a higher serum level.
DB00535,Aldesleukin may decrease the excretion rate of Cefdinir which could result in a higher serum level.
DB00537,Aldesleukin may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
DB00548,Aldesleukin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.
DB00553,Aldesleukin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.
DB00555,Aldesleukin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
DB00558,Aldesleukin may decrease the excretion rate of Zanamivir which could result in a higher serum level.
DB00569,Aldesleukin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
DB00571,Aldesleukin may decrease the excretion rate of Propranolol which could result in a higher serum level.
DB00583,Aldesleukin may decrease the excretion rate of Levocarnitine which could result in a higher serum level.
DB00597,Aldesleukin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.
DB00598,Aldesleukin may decrease the excretion rate of Labetalol which could result in a higher serum level.
DB00603,Aldesleukin may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level.
DB00608,Aldesleukin may decrease the excretion rate of Chloroquine which could result in a higher serum level.
DB00612,Aldesleukin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
DB00624,Aldesleukin may decrease the excretion rate of Testosterone which could result in a higher serum level.
DB00628,Aldesleukin may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
DB00633,Aldesleukin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.
DB00651,Aldesleukin may decrease the excretion rate of Dyphylline which could result in a higher serum level.
DB00657,Aldesleukin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.
DB00660,Aldesleukin may decrease the excretion rate of Metaxalone which could result in a higher serum level.
DB00661,Aldesleukin may decrease the excretion rate of Verapamil which could result in a higher serum level.
DB00665,Aldesleukin may decrease the excretion rate of Nilutamide which could result in a higher serum level.
DB00669,Aldesleukin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
DB00672,Aldesleukin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
DB00690,Aldesleukin may decrease the excretion rate of Flurazepam which could result in a higher serum level.
DB00692,Aldesleukin may decrease the excretion rate of Phentolamine which could result in a higher serum level.
DB00698,Aldesleukin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
DB00706,Aldesleukin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
DB00709,Aldesleukin may decrease the excretion rate of Lamivudine which could result in a higher serum level.
DB00713,Aldesleukin may decrease the excretion rate of Oxacillin which could result in a higher serum level.
DB00716,Aldesleukin may decrease the excretion rate of Nedocromil which could result in a higher serum level.
DB00722,Aldesleukin may decrease the excretion rate of Lisinopril which could result in a higher serum level.
DB00730,Aldesleukin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.
DB00731,Aldesleukin may decrease the excretion rate of Nateglinide which could result in a higher serum level.
DB00733,Aldesleukin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.
DB00743,Aldesleukin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.
DB00759,Aldesleukin may decrease the excretion rate of Tetracycline which could result in a higher serum level.
DB00760,Aldesleukin may decrease the excretion rate of Meropenem which could result in a higher serum level.
DB00761,Aldesleukin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
DB00775,Aldesleukin may decrease the excretion rate of Tirofiban which could result in a higher serum level.
DB00782,Aldesleukin may decrease the excretion rate of Propantheline which could result in a higher serum level.
DB00783,Aldesleukin may decrease the excretion rate of Estradiol which could result in a higher serum level.
DB00789,Aldesleukin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.
DB00790,Aldesleukin may decrease the excretion rate of Perindopril which could result in a higher serum level.
DB00800,Aldesleukin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.
DB00804,Aldesleukin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
DB00806,Aldesleukin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
DB00811,Aldesleukin may decrease the excretion rate of Ribavirin which could result in a higher serum level.
DB00828,Aldesleukin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
DB00829,Aldesleukin may decrease the excretion rate of Diazepam which could result in a higher serum level.
DB00839,Aldesleukin may decrease the excretion rate of Tolazamide which could result in a higher serum level.
DB00841,Aldesleukin may decrease the excretion rate of Dobutamine which could result in a higher serum level.
DB00842,Aldesleukin may decrease the excretion rate of Oxazepam which could result in a higher serum level.
DB00863,Aldesleukin may decrease the excretion rate of Ranitidine which could result in a higher serum level.
DB00871,Aldesleukin may decrease the excretion rate of Terbutaline which could result in a higher serum level.
DB00894,Aldesleukin may decrease the excretion rate of Testolactone which could result in a higher serum level.
DB00900,Aldesleukin may decrease the excretion rate of Didanosine which could result in a higher serum level.
DB00911,Aldesleukin may decrease the excretion rate of Tinidazole which could result in a higher serum level.
DB00915,Aldesleukin may decrease the excretion rate of Amantadine which could result in a higher serum level.
DB00918,Aldesleukin may decrease the excretion rate of Almotriptan which could result in a higher serum level.
DB00934,Aldesleukin may decrease the excretion rate of Maprotiline which could result in a higher serum level.
DB00951,Aldesleukin may decrease the excretion rate of Isoniazid which could result in a higher serum level.
DB00953,Aldesleukin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
DB00960,Aldesleukin may decrease the excretion rate of Pindolol which could result in a higher serum level.
DB00961,Aldesleukin may decrease the excretion rate of Mepivacaine which could result in a higher serum level.
DB00962,Aldesleukin may decrease the excretion rate of Zaleplon which could result in a higher serum level.
DB00968,Aldesleukin may decrease the excretion rate of Methyldopa which could result in a higher serum level.
DB00980,Aldesleukin may decrease the excretion rate of Ramelteon which could result in a higher serum level.
DB00988,Aldesleukin may decrease the excretion rate of Dopamine which could result in a higher serum level.
DB00995,Aldesleukin may decrease the excretion rate of Auranofin which could result in a higher serum level.
DB01001,Aldesleukin may decrease the excretion rate of Salbutamol which could result in a higher serum level.
DB01002,Aldesleukin may decrease the excretion rate of Levobupivacaine which could result in a higher serum level.
DB01004,Aldesleukin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
DB01010,Aldesleukin may decrease the excretion rate of Edrophonium which could result in a higher serum level.
DB01011,Aldesleukin may decrease the excretion rate of Metyrapone which could result in a higher serum level.
DB01018,Aldesleukin may decrease the excretion rate of Guanfacine which could result in a higher serum level.
DB01020,Aldesleukin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.
DB01022,Aldesleukin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
DB01032,Aldesleukin may decrease the excretion rate of Probenecid which could result in a higher serum level.
DB01036,Aldesleukin may decrease the excretion rate of Tolterodine which could result in a higher serum level.
DB01043,Aldesleukin may decrease the excretion rate of Memantine which could result in a higher serum level.
DB01046,Aldesleukin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
DB01048,Aldesleukin may decrease the excretion rate of Abacavir which could result in a higher serum level.
DB01060,Aldesleukin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
DB01067,Aldesleukin may decrease the excretion rate of Glipizide which could result in a higher serum level.
DB01068,Aldesleukin may decrease the excretion rate of Clonazepam which could result in a higher serum level.
DB01069,Aldesleukin may decrease the excretion rate of Promethazine which could result in a higher serum level.
DB01093,Aldesleukin may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level.
DB01105,Aldesleukin may decrease the excretion rate of Sibutramine which could result in a higher serum level.
DB01115,Aldesleukin may decrease the excretion rate of Nifedipine which could result in a higher serum level.
DB01124,Aldesleukin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
DB01129,Aldesleukin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.
DB01133,Aldesleukin may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.
DB01135,Aldesleukin may decrease the excretion rate of Doxacurium which could result in a higher serum level.
DB01137,Aldesleukin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
DB01148,Aldesleukin may decrease the excretion rate of Flavoxate which could result in a higher serum level.
DB01149,Aldesleukin may decrease the excretion rate of Nefazodone which could result in a higher serum level.
DB01156,Aldesleukin may decrease the excretion rate of Bupropion which could result in a higher serum level.
DB01157,Aldesleukin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.
DB01170,Aldesleukin may decrease the excretion rate of Guanethidine which could result in a higher serum level.
DB01183,Aldesleukin may decrease the excretion rate of Naloxone which could result in a higher serum level.
DB01203,Aldesleukin may decrease the excretion rate of Nadolol which could result in a higher serum level.
DB01205,Aldesleukin may decrease the excretion rate of Flumazenil which could result in a higher serum level.
DB01213,Aldesleukin may decrease the excretion rate of Fomepizole which could result in a higher serum level.
DB01215,Aldesleukin may decrease the excretion rate of Estazolam which could result in a higher serum level.
DB01221,Aldesleukin may decrease the excretion rate of Ketamine which could result in a higher serum level.
DB01233,Aldesleukin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
DB01240,Aldesleukin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.
DB01241,Aldesleukin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
DB01261,Aldesleukin may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
DB01267,Aldesleukin may decrease the excretion rate of Paliperidone which could result in a higher serum level.
DB01273,Aldesleukin may decrease the excretion rate of Varenicline which could result in a higher serum level.
DB01274,Aldesleukin may decrease the excretion rate of Arformoterol which could result in a higher serum level.
DB01275,Aldesleukin may decrease the excretion rate of Hydralazine which could result in a higher serum level.
DB01359,Aldesleukin may decrease the excretion rate of Penbutolol which could result in a higher serum level.
DB01409,Aldesleukin may decrease the excretion rate of Tiotropium which could result in a higher serum level.
DB01420,Aldesleukin may decrease the excretion rate of Testosterone propionate which could result in a higher serum level.
DB01427,Aldesleukin may decrease the excretion rate of Amrinone which could result in a higher serum level.
DB01428,Aldesleukin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.
DB01550,Aldesleukin may decrease the excretion rate of Fenproporex which could result in a higher serum level.
DB01558,Aldesleukin may decrease the excretion rate of Bromazepam which could result in a higher serum level.
DB01563,Aldesleukin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.
DB01577,Aldesleukin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
DB01587,Aldesleukin may decrease the excretion rate of Ketazolam which could result in a higher serum level.
DB01610,Aldesleukin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
DB01638,Aldesleukin may decrease the excretion rate of Sorbitol which could result in a higher serum level.
DB01685,Aldesleukin may decrease the excretion rate of Topiroxostat which could result in a higher serum level.
DB04574,Aldesleukin may decrease the excretion rate of Estrone sulfate which could result in a higher serum level.
DB04871,Aldesleukin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.
DB04895,Aldesleukin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
DB04896,Aldesleukin may decrease the excretion rate of Milnacipran which could result in a higher serum level.
DB04920,Aldesleukin may decrease the excretion rate of Clevidipine which could result in a higher serum level.
DB04948,Aldesleukin may decrease the excretion rate of Lofexidine which could result in a higher serum level.
DB04953,Aldesleukin may decrease the excretion rate of Ezogabine which could result in a higher serum level.
DB05018,Aldesleukin may decrease the excretion rate of Migalastat which could result in a higher serum level.
DB05541,Aldesleukin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
DB06154,Aldesleukin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.
DB06186,Aldesleukin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
DB06196,Aldesleukin may decrease the excretion rate of Icatibant which could result in a higher serum level.
DB06203,Aldesleukin may decrease the excretion rate of Alogliptin which could result in a higher serum level.
DB06209,Aldesleukin may decrease the excretion rate of Prasugrel which could result in a higher serum level.
DB06211,Aldesleukin may decrease the excretion rate of Doripenem which could result in a higher serum level.
DB06230,Aldesleukin may decrease the excretion rate of Nalmefene which could result in a higher serum level.
DB06262,Aldesleukin may decrease the excretion rate of Droxidopa which could result in a higher serum level.
DB06282,Aldesleukin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
DB06335,Aldesleukin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
DB06402,Aldesleukin may decrease the excretion rate of Telavancin which could result in a higher serum level.
DB06623,Aldesleukin may decrease the excretion rate of Flupirtine which could result in a higher serum level.
DB06637,Aldesleukin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
DB06695,Aldesleukin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.
DB06700,Aldesleukin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
DB06702,Aldesleukin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
DB06705,Aldesleukin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.
DB06710,Aldesleukin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.
DB06767,Aldesleukin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.
DB06782,Aldesleukin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.
DB06796,Aldesleukin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.
DB06800,Aldesleukin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
DB06809,Aldesleukin may decrease the excretion rate of Plerixafor which could result in a higher serum level.
DB06823,Aldesleukin may decrease the excretion rate of Tiopronin which could result in a higher serum level.
DB06824,Aldesleukin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.
DB08824,Aldesleukin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.
DB08826,Aldesleukin may decrease the excretion rate of Deferiprone which could result in a higher serum level.
DB08840,Aldesleukin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.
DB08872,Aldesleukin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
DB08893,Aldesleukin may decrease the excretion rate of Mirabegron which could result in a higher serum level.
DB08897,Aldesleukin may decrease the excretion rate of Aclidinium which could result in a higher serum level.
DB08899,Aldesleukin may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
DB08900,Aldesleukin may decrease the excretion rate of Teduglutide which could result in a higher serum level.
DB08905,Aldesleukin may decrease the excretion rate of Formestane which could result in a higher serum level.
DB08909,Aldesleukin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.
DB08911,Aldesleukin may decrease the excretion rate of Trametinib which could result in a higher serum level.
DB08918,Aldesleukin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
DB08932,Aldesleukin may decrease the excretion rate of Macitentan which could result in a higher serum level.
DB08934,Aldesleukin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
DB08964,Aldesleukin may decrease the excretion rate of Gemeprost which could result in a higher serum level.
DB09027,Aldesleukin may decrease the excretion rate of Ledipasvir which could result in a higher serum level.
DB09050,Aldesleukin may decrease the excretion rate of Ceftolozane which could result in a higher serum level.
DB09066,Aldesleukin may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level.
DB09068,Aldesleukin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
DB09075,Aldesleukin may decrease the excretion rate of Edoxaban which could result in a higher serum level.
DB09081,Aldesleukin may decrease the excretion rate of Idebenone which could result in a higher serum level.
DB09089,Aldesleukin may decrease the excretion rate of Trimebutine which could result in a higher serum level.
DB09103,Aldesleukin may decrease the excretion rate of Ancestim which could result in a higher serum level.
DB09104,Aldesleukin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
DB09106,Aldesleukin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.
DB09111,Aldesleukin may decrease the excretion rate of Pentastarch which could result in a higher serum level.
DB09118,Aldesleukin may decrease the excretion rate of Stiripentol which could result in a higher serum level.
DB09121,Aldesleukin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.
DB09123,Aldesleukin may decrease the excretion rate of Dienogest which could result in a higher serum level.
DB09129,Aldesleukin may decrease the excretion rate of Chromic chloride which could result in a higher serum level.
DB09132,Aldesleukin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.
DB09133,Aldesleukin may decrease the excretion rate of Iothalamic acid which could result in a higher serum level.
DB09136,Aldesleukin may decrease the excretion rate of Isosulfan blue which could result in a higher serum level.
DB09137,Aldesleukin may decrease the excretion rate of Technetium Tc-99m mebrofenin which could result in a higher serum level.
DB09139,Aldesleukin may decrease the excretion rate of Technetium Tc-99m oxidronate which could result in a higher serum level.
DB09148,Aldesleukin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.
DB09149,Aldesleukin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.
DB09163,Aldesleukin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.
DB09165,Aldesleukin may decrease the excretion rate of Technetium Tc-99m pyrophosphate which could result in a higher serum level.
DB09185,Aldesleukin may decrease the excretion rate of Viloxazine which could result in a higher serum level.
DB09194,Aldesleukin may decrease the excretion rate of Etoperidone which could result in a higher serum level.
DB09195,Aldesleukin may decrease the excretion rate of Lorpiprazole which could result in a higher serum level.
DB09204,Aldesleukin may decrease the excretion rate of Arotinolol which could result in a higher serum level.
DB09205,Aldesleukin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.
DB09209,Aldesleukin may decrease the excretion rate of Pholcodine which could result in a higher serum level.
DB09210,Aldesleukin may decrease the excretion rate of Piracetam which could result in a higher serum level.
DB09219,Aldesleukin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.
DB09223,Aldesleukin may decrease the excretion rate of Blonanserin which could result in a higher serum level.
DB09224,Aldesleukin may decrease the excretion rate of Melperone which could result in a higher serum level.
DB09255,Aldesleukin may decrease the excretion rate of Dextran which could result in a higher serum level.
DB09256,Aldesleukin may decrease the excretion rate of Tegafur which could result in a higher serum level.
DB09257,Aldesleukin may decrease the excretion rate of Gimeracil which could result in a higher serum level.
DB09262,Aldesleukin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.
DB09264,Aldesleukin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.
DB09265,Aldesleukin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
DB09268,Aldesleukin may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level.
DB09276,Aldesleukin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.
DB09277,Aldesleukin may decrease the excretion rate of Choline C 11 which could result in a higher serum level.
DB09281,Aldesleukin may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level.
DB09292,Aldesleukin may decrease the excretion rate of Sacubitril which could result in a higher serum level.
DB09301,Aldesleukin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.
DB09317,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, A which could result in a higher serum level."
DB09318,"Aldesleukin may decrease the excretion rate of Synthetic Conjugated Estrogens, B which could result in a higher serum level."
DB09320,Aldesleukin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
DB09324,Aldesleukin may decrease the excretion rate of Sulbactam which could result in a higher serum level.
DB09325,Aldesleukin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.
DB09329,"Aldesleukin may decrease the excretion rate of Antihemophilic Factor (Recombinant), PEGylated which could result in a higher serum level."
DB09344,Aldesleukin may decrease the excretion rate of Invert sugar which could result in a higher serum level.
DB09357,Aldesleukin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.
DB09394,Aldesleukin may decrease the excretion rate of Phosphoric acid which could result in a higher serum level.
DB09395,Aldesleukin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.
DB09407,Aldesleukin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.
DB09472,Aldesleukin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.
DB09477,Aldesleukin may decrease the excretion rate of Enalaprilat which could result in a higher serum level.
DB09481,Aldesleukin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.
DB09488,Aldesleukin may decrease the excretion rate of Acrivastine which could result in a higher serum level.
DB09496,Aldesleukin may decrease the excretion rate of Octinoxate which could result in a higher serum level.
DB09502,Aldesleukin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.
DB09546,Aldesleukin may decrease the excretion rate of Iobenguane sulfate I-123 which could result in a higher serum level.
DB11077,Aldesleukin may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level.
DB11090,Aldesleukin may decrease the excretion rate of Potassium nitrate which could result in a higher serum level.
DB11098,Aldesleukin may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level.
DB11102,Aldesleukin may decrease the excretion rate of N-acetyltyrosine which could result in a higher serum level.
DB11114,Aldesleukin may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level.
DB11127,Aldesleukin may decrease the excretion rate of Selenious acid which could result in a higher serum level.
DB11130,Aldesleukin may decrease the excretion rate of Opium which could result in a higher serum level.
DB11135,Aldesleukin may decrease the excretion rate of Selenium which could result in a higher serum level.
DB11136,Aldesleukin may decrease the excretion rate of Chromium which could result in a higher serum level.
DB11145,Aldesleukin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.
DB11156,Aldesleukin may decrease the excretion rate of Pyrantel which could result in a higher serum level.
DB11164,Aldesleukin may decrease the excretion rate of Bicisate which could result in a higher serum level.
DB11251,Aldesleukin may decrease the excretion rate of Tocopherol which could result in a higher serum level.
DB11278,Aldesleukin may decrease the excretion rate of DL-Methylephedrine which could result in a higher serum level.
DB11328,Aldesleukin may decrease the excretion rate of Tetradecyl hydrogen sulfate (ester) which could result in a higher serum level.
DB11338,Aldesleukin may decrease the excretion rate of Clove oil which could result in a higher serum level.
DB11358,Aldesleukin may decrease the excretion rate of Evening primrose oil which could result in a higher serum level.
DB11364,Aldesleukin may decrease the excretion rate of Pidotimod which could result in a higher serum level.
DB11560,Aldesleukin may decrease the excretion rate of Lesinurad which could result in a higher serum level.
DB11577,Aldesleukin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.
DB11587,Aldesleukin may decrease the excretion rate of Etafedrine which could result in a higher serum level.
DB11598,Aldesleukin may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.
DB11642,Aldesleukin may decrease the excretion rate of Pitolisant which could result in a higher serum level.
DB11691,Aldesleukin may decrease the excretion rate of Naldemedine which could result in a higher serum level.
DB11699,Aldesleukin may decrease the excretion rate of Tropisetron which could result in a higher serum level.
DB11901,Aldesleukin may decrease the excretion rate of Apalutamide which could result in a higher serum level.
DB11915,Aldesleukin may decrease the excretion rate of Valbenazine which could result in a higher serum level.
DB11943,Aldesleukin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
DB11989,Aldesleukin may decrease the excretion rate of Benznidazole which could result in a higher serum level.
DB12007,Aldesleukin may decrease the excretion rate of Isoflavone which could result in a higher serum level.
DB12107,Aldesleukin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.
DB12161,Aldesleukin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
DB12278,Aldesleukin may decrease the excretion rate of Propiverine which could result in a higher serum level.
DB12783,Aldesleukin may decrease the excretion rate of Benserazide which could result in a higher serum level.
DB13025,Aldesleukin may decrease the excretion rate of Tiapride which could result in a higher serum level.
DB13139,Aldesleukin may decrease the excretion rate of Levosalbutamol which could result in a higher serum level.
DB13156,Aldesleukin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.
DB13178,Aldesleukin may decrease the excretion rate of Inositol which could result in a higher serum level.
DB13185,Aldesleukin may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level.
DB13191,Aldesleukin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.
DB13269,Aldesleukin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.
DB13293,Aldesleukin may decrease the excretion rate of Ipecac which could result in a higher serum level.
DB13595,Aldesleukin may decrease the excretion rate of Almasilate which could result in a higher serum level.
DB13873,Aldesleukin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.
DB13884,Aldesleukin may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.
DB13909,Aldesleukin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.
DB13943,Aldesleukin may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level.
DB13944,Aldesleukin may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level.
DB13946,Aldesleukin may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level.
DB13952,Aldesleukin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level.
DB13954,Aldesleukin may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level.
DB13955,Aldesleukin may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level.
DB13956,Aldesleukin may decrease the excretion rate of Estradiol valerate which could result in a higher serum level.
DB13967,Aldesleukin may decrease the excretion rate of Patent Blue which could result in a higher serum level.
DB14006,Aldesleukin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.
DB14007,Aldesleukin may decrease the excretion rate of Pentetic acid which could result in a higher serum level.
DB14498,Aldesleukin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.
DB14499,Aldesleukin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level.
DB14526,Aldesleukin may decrease the excretion rate of Chromic citrate which could result in a higher serum level.
DB14527,Aldesleukin may decrease the excretion rate of Chromic nitrate which could result in a higher serum level.
DB14528,Aldesleukin may decrease the excretion rate of Chromium gluconate which could result in a higher serum level.
DB14529,Aldesleukin may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level.
DB14530,Aldesleukin may decrease the excretion rate of Chromous sulfate which could result in a higher serum level.
DB14754,Aldesleukin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
DB06815,Aldesleukin may decrease the excretion rate of Pyrithione which could result in a higher serum level.
DB11121,Aldesleukin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.
DB11085,Aldesleukin may decrease the excretion rate of Resorcinol which could result in a higher serum level.
DB01224,Aldesleukin may decrease the excretion rate of Quetiapine which could result in a higher serum level.
DB00501,Aldesleukin may decrease the excretion rate of Cimetidine which could result in a higher serum level.
DB15593,Aldesleukin may decrease the excretion rate of Golodirsen which could result in a higher serum level.
DB00321,Aldesleukin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.
DB00458,Aldesleukin may decrease the excretion rate of Imipramine which could result in a higher serum level.
DB00490,Aldesleukin may decrease the excretion rate of Buspirone which could result in a higher serum level.
DB00820,Aldesleukin may decrease the excretion rate of Tadalafil which could result in a higher serum level.
DB01142,Aldesleukin may decrease the excretion rate of Doxepin which could result in a higher serum level.
DB00318,Aldesleukin may decrease the excretion rate of Codeine which could result in a higher serum level.
DB00879,Aldesleukin may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
DB00897,Aldesleukin may decrease the excretion rate of Triazolam which could result in a higher serum level.
DB06228,Aldesleukin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
DB08996,Aldesleukin may decrease the excretion rate of Dimetacrine which could result in a higher serum level.
DB14506,Aldesleukin may decrease the excretion rate of Lithium hydroxide which could result in a higher serum level.
DB00452,Framycetin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00479,Amikacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00684,Tobramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00798,Gentamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00955,Netilmicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB00994,Neomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01082,Streptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01172,Kanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB01421,Paromomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB03615,Ribostamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04263,Geneticin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04626,Apramycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04729,Gentamicin C1a may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB04808,Neamine may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB06696,Arbekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB08437,Puromycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11512,Dihydrostreptomycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB11520,Hygromycin B may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB12604,Sisomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13270,Dibekacin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13274,Micronomicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13540,Isepamicin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13673,Bekanamycin may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
DB13145,Aldesleukin may decrease the excretion rate of Nedaplatin which could result in a higher serum level.
DB00314,Aldesleukin may decrease the excretion rate of Capreomycin which could result in a higher serum level.
DB00390,Aldesleukin may decrease the excretion rate of Digoxin which could result in a higher serum level.
DB00512,Aldesleukin may decrease the excretion rate of Vancomycin which could result in a higher serum level.
DB00982,Aldesleukin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
DB01035,Aldesleukin may decrease the excretion rate of Procainamide which could result in a higher serum level.
DB12615,Aldesleukin may decrease the excretion rate of Plazomicin which could result in a higher serum level.
DB14509,Aldesleukin may decrease the excretion rate of Lithium carbonate which could result in a higher serum level.
DB00232,Aldesleukin may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00421,Aldesleukin may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.
DB00594,Aldesleukin may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.
DB00703,Aldesleukin may increase the excretion rate of Methazolamide which could result in a lower serum level and potentially a reduction in efficacy.
DB01144,Aldesleukin may increase the excretion rate of Diclofenamide which could result in a lower serum level and potentially a reduction in efficacy.
DB09125,Potassium citrate may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00562,Benzthiazide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13430,Mebutizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00214,Aldesleukin may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00310,Aldesleukin may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
DB00436,Aldesleukin may increase the excretion rate of Bendroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00606,Aldesleukin may increase the excretion rate of Cyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00774,Aldesleukin may increase the excretion rate of Hydroflumethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB00880,Aldesleukin may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01021,Aldesleukin may increase the excretion rate of Trichlormethiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB01119,Aldesleukin may increase the excretion rate of Diazoxide which could result in a lower serum level and potentially a reduction in efficacy.
DB01324,Aldesleukin may increase the excretion rate of Polythiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB04831,Aldesleukin may increase the excretion rate of Tienilic acid which could result in a lower serum level and potentially a reduction in efficacy.
DB12766,Aldesleukin may increase the excretion rate of Cicletanine which could result in a lower serum level and potentially a reduction in efficacy.
DB13532,Aldesleukin may increase the excretion rate of Cyclopenthiazide which could result in a lower serum level and potentially a reduction in efficacy.
DB13801,Aldesleukin may increase the excretion rate of Muzolimine which could result in a lower serum level and potentially a reduction in efficacy.
DB13803,Aldesleukin may increase the excretion rate of Xipamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00524,Aldesleukin may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
DB00695,Aldesleukin may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
DB00808,Aldesleukin may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
DB00887,Aldesleukin may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
DB00909,Aldesleukin may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
DB08907,Aldesleukin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
DB09338,Aldesleukin may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy.
DB00311,Ethoxzolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00819,Acetazolamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB01325,Quinethazone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB01412,Theobromine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB02925,Piretanide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB05034,Ularitide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB06370,Indisulam may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB08961,Azosemide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB09015,Canrenoic acid may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB09401,Isosorbide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB11827,Ertugliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB12221,Canrenone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB12670,Rolofylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB12704,Spiradoline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13284,Meticrane may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13316,Ibopamine may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13405,Mefruside may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13617,Clorexolone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13663,Clofenamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13708,Fenquizone may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13792,Clopamide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB13989,Epitizide may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB14018,Bromotheophylline may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB14500,Potassium may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB09235,Aldesleukin may increase the excretion rate of Efonidipine which could result in a lower serum level and potentially a reduction in efficacy.
DB06292,Dapagliflozin may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00700,Aldesleukin may increase the excretion rate of Eplerenone which could result in a lower serum level and potentially a reduction in efficacy.
DB00872,Aldesleukin may increase the excretion rate of Conivaptan which could result in a lower serum level and potentially a reduction in efficacy.
DB06212,Tolvaptan may increase the excretion rate of Aldesleukin which could result in a lower serum level and potentially a reduction in efficacy.
DB00228,The metabolism of Enflurane can be decreased when combined with Aldesleukin.
DB00347,The metabolism of Trimethadione can be decreased when combined with Aldesleukin.
DB00753,The metabolism of Isoflurane can be decreased when combined with Aldesleukin.
DB01028,The metabolism of Methoxyflurane can be decreased when combined with Aldesleukin.
DB01159,The metabolism of Halothane can be decreased when combined with Aldesleukin.
DB01236,The metabolism of Sevoflurane can be decreased when combined with Aldesleukin.
DB06712,The metabolism of Nilvadipine can be decreased when combined with Aldesleukin.
DB06728,The metabolism of Aniline can be decreased when combined with Aldesleukin.
DB06770,The metabolism of Benzyl alcohol can be decreased when combined with Aldesleukin.
DB00356,The metabolism of Chlorzoxazone can be decreased when combined with Aldesleukin.
DB00949,The metabolism of Felbamate can be decreased when combined with Aldesleukin.
DB01136,The metabolism of Carvedilol can be decreased when combined with Aldesleukin.
DB06119,The metabolism of Cenobamate can be decreased when combined with Aldesleukin.
DB00252,The metabolism of Phenytoin can be decreased when combined with Aldesleukin.
DB00593,The metabolism of Ethosuximide can be decreased when combined with Aldesleukin.
DB11689,The metabolism of Selumetinib can be decreased when combined with Aldesleukin.
DB00908,The metabolism of Quinidine can be decreased when combined with Aldesleukin.
DB00001,The risk or severity of bleeding can be increased when Lepirudin is combined with Aldesleukin.
DB00006,The risk or severity of bleeding can be increased when Bivalirudin is combined with Aldesleukin.
DB00009,The risk or severity of bleeding can be increased when Alteplase is combined with Aldesleukin.
DB00013,The risk or severity of bleeding can be increased when Urokinase is combined with Aldesleukin.
DB00015,The risk or severity of bleeding can be increased when Reteplase is combined with Aldesleukin.
DB00029,The risk or severity of bleeding can be increased when Anistreplase is combined with Aldesleukin.
DB00031,The risk or severity of bleeding can be increased when Tenecteplase is combined with Aldesleukin.
DB00055,The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Aldesleukin.
DB00266,The risk or severity of bleeding can be increased when Dicoumarol is combined with Aldesleukin.
DB00407,The risk or severity of bleeding can be increased when Ardeparin is combined with Aldesleukin.
DB00498,The risk or severity of bleeding can be increased when Phenindione is combined with Aldesleukin.
DB00686,The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Aldesleukin.
DB01109,The risk or severity of bleeding can be increased when Heparin is combined with Aldesleukin.
DB01225,The risk or severity of bleeding can be increased when Enoxaparin is combined with Aldesleukin.
DB04665,The risk or severity of bleeding can be increased when Coumarin is combined with Aldesleukin.
DB04898,The risk or severity of bleeding can be increased when Ximelagatran is combined with Aldesleukin.
DB04925,The risk or severity of bleeding can be increased when Desmoteplase is combined with Aldesleukin.
DB05099,The risk or severity of bleeding can be increased when Ancrod is combined with Aldesleukin.
DB05254,The risk or severity of bleeding can be increased when Fibrinolysin is combined with Aldesleukin.
DB06271,The risk or severity of bleeding can be increased when Sulodexide is combined with Aldesleukin.
DB06294,The risk or severity of bleeding can be increased when Semuloparin is combined with Aldesleukin.
DB06406,The risk or severity of bleeding can be increased when Idraparinux is combined with Aldesleukin.
DB06543,The risk or severity of bleeding can be increased when Astaxanthin is combined with Aldesleukin.
DB06635,The risk or severity of bleeding can be increased when Otamixaban is combined with Aldesleukin.
DB06679,The risk or severity of bleeding can be increased when Amediplase is combined with Aldesleukin.
DB06754,The risk or severity of bleeding can be increased when Danaparoid is combined with Aldesleukin.
DB06779,The risk or severity of bleeding can be increased when Dalteparin is combined with Aldesleukin.
DB06822,The risk or severity of bleeding can be increased when Tinzaparin is combined with Aldesleukin.
DB08813,The risk or severity of bleeding can be increased when Nadroparin is combined with Aldesleukin.
DB08994,The risk or severity of bleeding can be increased when Ditazole is combined with Aldesleukin.
DB09154,The risk or severity of bleeding can be increased when Sodium citrate is combined with Aldesleukin.
DB09258,The risk or severity of bleeding can be increased when Bemiparin is combined with Aldesleukin.
DB09259,The risk or severity of bleeding can be increased when Reviparin is combined with Aldesleukin.
DB09260,The risk or severity of bleeding can be increased when Parnaparin is combined with Aldesleukin.
DB09261,The risk or severity of bleeding can be increased when Certoparin is combined with Aldesleukin.
DB11095,The risk or severity of bleeding can be increased when Desirudin is combined with Aldesleukin.
DB11154,The risk or severity of bleeding can be increased when Zinc citrate is combined with Aldesleukin.
DB11166,The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Aldesleukin.
DB11312,The risk or severity of bleeding can be increased when Protein C is combined with Aldesleukin.
DB11984,The risk or severity of bleeding can be increased when Letaxaban is combined with Aldesleukin.
DB12289,The risk or severity of bleeding can be increased when Darexaban is combined with Aldesleukin.
DB12364,The risk or severity of bleeding can be increased when Betrixaban is combined with Aldesleukin.
DB12598,The risk or severity of bleeding can be increased when Nafamostat is combined with Aldesleukin.
DB12726,The risk or severity of bleeding can be increased when Monteplase is combined with Aldesleukin.
DB12831,The risk or severity of bleeding can be increased when Gabexate is combined with Aldesleukin.
DB13149,The risk or severity of bleeding can be increased when Protein S human is combined with Aldesleukin.
DB13199,The risk or severity of bleeding can be increased when Brinase is combined with Aldesleukin.
DB13451,The risk or severity of bleeding can be increased when Tioclomarol is combined with Aldesleukin.
DB13616,The risk or severity of bleeding can be increased when Melagatran is combined with Aldesleukin.
DB13646,The risk or severity of bleeding can be increased when Saruplase is combined with Aldesleukin.
DB14598,The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Aldesleukin.
DB14726,The risk or severity of bleeding can be increased when Dabigatran is combined with Aldesleukin.
DB07767,The risk or severity of bleeding can be increased when Aldesleukin is combined with Ferulic acid.
DB14094,The risk or severity of bleeding can be increased when Aldesleukin is combined with Tocopherylquinone.
DB00278,The risk or severity of bleeding can be increased when Argatroban is combined with Aldesleukin.
DB06605,The risk or severity of bleeding can be increased when Apixaban is combined with Aldesleukin.
DB08794,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Aldesleukin.
DB13347,The risk or severity of bleeding can be increased when Diphenadione is combined with Aldesleukin.
DB09042,The risk or severity of myelosuppression can be increased when Aldesleukin is combined with Tedizolid phosphate.
DB06480,The metabolism of Prucalopride can be decreased when combined with Aldesleukin.
DB00091,Aldesleukin may increase the immunosuppressive activities of Cyclosporine.
DB00115,The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Aldesleukin.
DB00017,The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Aldesleukin.
DB00024,The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Aldesleukin.
DB00066,The therapeutic efficacy of Follitropin can be decreased when used in combination with Aldesleukin.
DB00279,The therapeutic efficacy of Liothyronine can be decreased when used in combination with Aldesleukin.
DB00389,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Aldesleukin.
DB00451,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Aldesleukin.
DB00550,The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Aldesleukin.
DB00763,The therapeutic efficacy of Methimazole can be decreased when used in combination with Aldesleukin.
DB01583,The therapeutic efficacy of Liotrix can be decreased when used in combination with Aldesleukin.
DB03374,"The therapeutic efficacy of 3,5-Diiodotyrosine can be decreased when used in combination with Aldesleukin."
DB03604,The therapeutic efficacy of Tiratricol can be decreased when used in combination with Aldesleukin.
DB05084,The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Aldesleukin.
DB05829,The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Aldesleukin.
DB06285,The therapeutic efficacy of Teriparatide can be decreased when used in combination with Aldesleukin.
DB06715,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Aldesleukin.
DB07637,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Aldesleukin.
DB09100,"The therapeutic efficacy of Thyroid, porcine can be decreased when used in combination with Aldesleukin."
DB09418,The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Aldesleukin.
DB09421,The therapeutic efficacy of Protirelin can be decreased when used in combination with Aldesleukin.
DB12629,"The therapeutic efficacy of 3,5-diiodothyropropionic acid can be decreased when used in combination with Aldesleukin."
DB13644,The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Aldesleukin.
DB13742,The therapeutic efficacy of Elcatonin can be decreased when used in combination with Aldesleukin.
DB13804,The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Aldesleukin.
DB15263,The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Aldesleukin.
DB00437,The risk or severity of adverse effects can be increased when Allopurinol is combined with Aldesleukin.
DB00316,Aldesleukin may increase the hepatotoxic activities of Acetaminophen.
DB09288,Aldesleukin may increase the hepatotoxic activities of Propacetamol.
DB00212,Aldesleukin may increase the hypotensive activities of Remikiren.
DB00217,Aldesleukin may increase the hypotensive activities of Bethanidine.
DB00226,Aldesleukin may increase the hypotensive activities of Guanadrel.
DB00374,Aldesleukin may increase the hypotensive activities of Treprostinil.
DB00616,Aldesleukin may increase the hypotensive activities of Candoxatril.
DB00629,Aldesleukin may increase the hypotensive activities of Guanabenz.
DB00765,Aldesleukin may increase the hypotensive activities of Metyrosine.
DB00785,Aldesleukin may increase the hypotensive activities of Cryptenamine.
DB00866,Aldesleukin may increase the hypotensive activities of Alprenolol.
DB00886,Aldesleukin may increase the hypotensive activities of Omapatrilat.
DB01089,Aldesleukin may increase the hypotensive activities of Deserpidine.
DB01090,Aldesleukin may increase the hypotensive activities of Pentolinium.
DB01116,Aldesleukin may increase the hypotensive activities of Trimethaphan.
DB01180,Aldesleukin may increase the hypotensive activities of Rescinnamine.
DB01295,Aldesleukin may increase the hypotensive activities of Bevantolol.
DB01297,Aldesleukin may increase the hypotensive activities of Practolol.
DB01347,Aldesleukin may increase the hypotensive activities of Saprisartan.
DB01348,Aldesleukin may increase the hypotensive activities of Spirapril.
DB03322,Aldesleukin may increase the hypotensive activities of Dexpropranolol.
DB04840,Aldesleukin may increase the hypotensive activities of Debrisoquine.
DB04846,Aldesleukin may increase the hypotensive activities of Celiprolol.
DB06268,Aldesleukin may increase the hypotensive activities of Sitaxentan.
DB06445,Aldesleukin may increase the hypotensive activities of Diethylnorspermine.
DB08808,Aldesleukin may increase the hypotensive activities of Bupranolol.
DB08836,Aldesleukin may increase the hypotensive activities of Temocapril.
DB08952,Aldesleukin may increase the hypotensive activities of Indenolol.
DB08960,Aldesleukin may increase the hypotensive activities of Hexamethonium.
DB09206,Aldesleukin may increase the hypotensive activities of Trimazosin.
DB09363,Aldesleukin may increase the hypotensive activities of Rauwolfia serpentina root.
DB11720,Aldesleukin may increase the hypotensive activities of Angiotensin 1-7.
DB11738,Aldesleukin may increase the hypotensive activities of Rilmenidine.
DB11770,Aldesleukin may increase the hypotensive activities of Talinolol.
DB12054,Aldesleukin may increase the hypotensive activities of BQ-123.
DB12212,Aldesleukin may increase the hypotensive activities of Landiolol.
DB12661,Aldesleukin may increase the hypotensive activities of Urapidil.
DB12945,Aldesleukin may increase the hypotensive activities of Dihydralazine.
DB13166,Aldesleukin may increase the hypotensive activities of Zofenopril.
DB13211,Aldesleukin may increase the hypotensive activities of Guanoxan.
DB13312,Aldesleukin may increase the hypotensive activities of Delapril.
DB13374,Aldesleukin may increase the hypotensive activities of Vincamine.
DB13410,Aldesleukin may increase the hypotensive activities of Guanoxabenz.
DB13429,Aldesleukin may increase the hypotensive activities of Tolonidine.
DB13435,Aldesleukin may increase the hypotensive activities of Endralazine.
DB13443,Aldesleukin may increase the hypotensive activities of Esatenolol.
DB13452,Aldesleukin may increase the hypotensive activities of Cadralazine.
DB13508,Aldesleukin may increase the hypotensive activities of Cloranolol.
DB13575,Aldesleukin may increase the hypotensive activities of Bietaserpine.
DB13604,Aldesleukin may increase the hypotensive activities of Guanazodine.
DB13631,Aldesleukin may increase the hypotensive activities of Methoserpidine.
DB13757,Aldesleukin may increase the hypotensive activities of Epanolol.
DB13779,Aldesleukin may increase the hypotensive activities of Guanoclor.
DB13919,Aldesleukin may increase the hypotensive activities of Candesartan.
DB14125,Aldesleukin may increase the hypotensive activities of Benazeprilat.
DB14207,Aldesleukin may increase the hypotensive activities of Fosinoprilat.
DB14208,Aldesleukin may increase the hypotensive activities of Ramiprilat.
DB14213,Aldesleukin may increase the hypotensive activities of Perindoprilat.
DB14217,Aldesleukin may increase the hypotensive activities of Quinaprilat.
DB00559,Aldesleukin may increase the hypotensive activities of Bosentan.
DB01388,Aldesleukin may increase the hypotensive activities of Mibefradil.
DB06403,Aldesleukin may increase the hypotensive activities of Ambrisentan.
DB06762,Aldesleukin may increase the hypotensive activities of Pinacidil.
DB09238,Aldesleukin may increase the hypotensive activities of Manidipine.
DB09239,Aldesleukin may increase the hypotensive activities of Niguldipine.
DB11362,Aldesleukin may increase the hypotensive activities of Selexipag.
DB12093,Aldesleukin may increase the hypotensive activities of Tetrahydropalmatine.
DB14068,Aldesleukin may increase the hypotensive activities of Dexniguldipine.
DB14975,The serum concentration of Voxelotor can be increased when it is combined with Aldesleukin.
DB09237,The serum concentration of Levamlodipine can be increased when it is combined with Aldesleukin.
DB00193,The metabolism of Tramadol can be decreased when combined with Aldesleukin.
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Aldesleukin.
DB01601,The serum concentration of Aldesleukin can be increased when it is combined with Lopinavir.
DB00502,The serum concentration of Haloperidol can be increased when it is combined with Aldesleukin.
DB12530,The risk or severity of infection can be increased when Aldesleukin is combined with Inebilizumab.
DB00186,The metabolism of Lorazepam can be decreased when combined with Aldesleukin.
DB00208,The metabolism of Ticlopidine can be decreased when combined with Aldesleukin.
DB00264,The metabolism of Metoprolol can be decreased when combined with Aldesleukin.
DB00477,The metabolism of Chlorpromazine can be decreased when combined with Aldesleukin.
DB01039,The metabolism of Fenofibrate can be decreased when combined with Aldesleukin.
DB01431,The metabolism of Allylestrenol can be decreased when combined with Aldesleukin.
DB09071,The metabolism of Tasimelteon can be decreased when combined with Aldesleukin.
DB00191,The metabolism of Phentermine can be decreased when combined with Aldesleukin.
DB00207,The metabolism of Azithromycin can be decreased when combined with Aldesleukin.
DB00246,The metabolism of Ziprasidone can be decreased when combined with Aldesleukin.
DB00426,The metabolism of Famciclovir can be decreased when combined with Aldesleukin.
DB00433,The metabolism of Prochlorperazine can be decreased when combined with Aldesleukin.
DB00518,The metabolism of Albendazole can be decreased when combined with Aldesleukin.
DB00590,The metabolism of Doxazosin can be decreased when combined with Aldesleukin.
DB00717,The metabolism of Norethisterone can be decreased when combined with Aldesleukin.
DB01098,The metabolism of Rosuvastatin can be decreased when combined with Aldesleukin.
DB01323,The metabolism of St. John's Wort can be decreased when combined with Aldesleukin.
DB01395,The metabolism of Drospirenone can be decreased when combined with Aldesleukin.
DB01411,The metabolism of Pranlukast can be decreased when combined with Aldesleukin.
DB01624,The metabolism of Zuclopenthixol can be decreased when combined with Aldesleukin.
DB06201,The metabolism of Rufinamide can be decreased when combined with Aldesleukin.
DB06218,The metabolism of Lacosamide can be decreased when combined with Aldesleukin.
DB08882,The metabolism of Linagliptin can be decreased when combined with Aldesleukin.
DB09030,The metabolism of Vorapaxar can be decreased when combined with Aldesleukin.
DB09034,The metabolism of Suvorexant can be decreased when combined with Aldesleukin.
DB09048,The metabolism of Netupitant can be decreased when combined with Aldesleukin.
DB09079,The metabolism of Nintedanib can be decreased when combined with Aldesleukin.
DB09330,The metabolism of Osimertinib can be decreased when combined with Aldesleukin.
DB11094,The metabolism of Vitamin D can be decreased when combined with Aldesleukin.
DB11273,The metabolism of Dihydroergocornine can be decreased when combined with Aldesleukin.
DB11730,The metabolism of Ribociclib can be decreased when combined with Aldesleukin.
DB11952,The metabolism of Duvelisib can be decreased when combined with Aldesleukin.
DB12141,The metabolism of Gilteritinib can be decreased when combined with Aldesleukin.
DB12515,The metabolism of 9-aminocamptothecin can be decreased when combined with Aldesleukin.
DB12952,The metabolism of Methylprednisone can be decreased when combined with Aldesleukin.
DB13345,The metabolism of Dihydroergocristine can be decreased when combined with Aldesleukin.
DB13385,The metabolism of Dihydroergocryptine can be decreased when combined with Aldesleukin.
DB14009,The metabolism of Medical Cannabis can be decreased when combined with Aldesleukin.
DB00549,The metabolism of Zafirlukast can be decreased when combined with Aldesleukin.
DB15444,The metabolism of Elexacaftor can be decreased when combined with Aldesleukin.
DB12887,The metabolism of Tazemetostat can be decreased when combined with Aldesleukin.
DB06717,The metabolism of Fosaprepitant can be decreased when combined with Aldesleukin.
DB12825,The metabolism of Lefamulin can be decreased when combined with Aldesleukin.
DB01151,The metabolism of Desipramine can be decreased when combined with Aldesleukin.
DB00454,The metabolism of Meperidine can be decreased when combined with Aldesleukin.
DB00247,The metabolism of Methysergide can be decreased when combined with Aldesleukin.
DB00637,The metabolism of Astemizole can be decreased when combined with Aldesleukin.
DB08827,The metabolism of Lomitapide can be decreased when combined with Aldesleukin.
DB11742,The metabolism of Ebastine can be decreased when combined with Aldesleukin.
DB00188,The metabolism of Bortezomib can be decreased when combined with Aldesleukin.
DB00309,The metabolism of Vindesine can be decreased when combined with Aldesleukin.
DB00361,The metabolism of Vinorelbine can be decreased when combined with Aldesleukin.
DB00398,The metabolism of Sorafenib can be decreased when combined with Aldesleukin.
DB00444,The metabolism of Teniposide can be decreased when combined with Aldesleukin.
DB00541,The metabolism of Vincristine can be decreased when combined with Aldesleukin.
DB00563,The metabolism of Methotrexate can be decreased when combined with Aldesleukin.
DB00570,The metabolism of Vinblastine can be decreased when combined with Aldesleukin.
DB00619,The metabolism of Imatinib can be decreased when combined with Aldesleukin.
DB00694,The metabolism of Daunorubicin can be decreased when combined with Aldesleukin.
DB00773,The metabolism of Etoposide can be decreased when combined with Aldesleukin.
DB00987,The metabolism of Cytarabine can be decreased when combined with Aldesleukin.
DB00997,The metabolism of Doxorubicin can be decreased when combined with Aldesleukin.
DB01108,The metabolism of Trilostane can be decreased when combined with Aldesleukin.
DB01181,The metabolism of Ifosfamide can be decreased when combined with Aldesleukin.
DB01248,The metabolism of Docetaxel can be decreased when combined with Aldesleukin.
DB01268,The metabolism of Sunitinib can be decreased when combined with Aldesleukin.
DB04572,The metabolism of Thiotepa can be decreased when combined with Aldesleukin.
DB04845,The metabolism of Ixabepilone can be decreased when combined with Aldesleukin.
DB04868,The metabolism of Nilotinib can be decreased when combined with Aldesleukin.
DB05015,The metabolism of Belinostat can be decreased when combined with Aldesleukin.
DB05109,The metabolism of Trabectedin can be decreased when combined with Aldesleukin.
DB06589,The metabolism of Pazopanib can be decreased when combined with Aldesleukin.
DB06603,The metabolism of Panobinostat can be decreased when combined with Aldesleukin.
DB06616,The metabolism of Bosutinib can be decreased when combined with Aldesleukin.
DB08870,The metabolism of Brentuximab vedotin can be decreased when combined with Aldesleukin.
DB08877,The metabolism of Ruxolitinib can be decreased when combined with Aldesleukin.
DB08901,The metabolism of Ponatinib can be decreased when combined with Aldesleukin.
DB09054,The metabolism of Idelalisib can be decreased when combined with Aldesleukin.
DB09073,The metabolism of Palbociclib can be decreased when combined with Aldesleukin.
DB09570,The metabolism of Ixazomib can be decreased when combined with Aldesleukin.
DB00564,The metabolism of Carbamazepine can be decreased when combined with Aldesleukin.
DB00204,The metabolism of Dofetilide can be decreased when combined with Aldesleukin.
DB00277,The metabolism of Theophylline can be decreased when combined with Aldesleukin.
DB00342,The metabolism of Terfenadine can be decreased when combined with Aldesleukin.
DB00604,The metabolism of Cisapride can be decreased when combined with Aldesleukin.
DB00877,The metabolism of Sirolimus can be decreased when combined with Aldesleukin.
DB00946,The metabolism of Phenprocoumon can be decreased when combined with Aldesleukin.
DB01008,The metabolism of Busulfan can be decreased when combined with Aldesleukin.
DB01100,The metabolism of Pimozide can be decreased when combined with Aldesleukin.
DB01118,The metabolism of Amiodarone can be decreased when combined with Aldesleukin.
DB01223,The metabolism of Aminophylline can be decreased when combined with Aldesleukin.
DB01229,The metabolism of Paclitaxel can be decreased when combined with Aldesleukin.
DB01254,The metabolism of Dasatinib can be decreased when combined with Aldesleukin.
DB01320,The metabolism of Fosphenytoin can be decreased when combined with Aldesleukin.
DB01396,The metabolism of Digitoxin can be decreased when combined with Aldesleukin.
DB01590,The metabolism of Everolimus can be decreased when combined with Aldesleukin.
DB03410,The metabolism of 4-hydroxycoumarin can be decreased when combined with Aldesleukin.
DB04855,The metabolism of Dronedarone can be decreased when combined with Aldesleukin.
DB05239,The metabolism of Cobimetinib can be decreased when combined with Aldesleukin.
DB06287,The metabolism of Temsirolimus can be decreased when combined with Aldesleukin.
DB09063,The metabolism of Ceritinib can be decreased when combined with Aldesleukin.
DB09289,The metabolism of Tianeptine can be decreased when combined with Aldesleukin.
DB11633,The metabolism of Isavuconazole can be decreased when combined with Aldesleukin.
DB11963,The metabolism of Dacomitinib can be decreased when combined with Aldesleukin.
DB12015,The metabolism of Alpelisib can be decreased when combined with Aldesleukin.
DB13136,The metabolism of Fluindione can be decreased when combined with Aldesleukin.
DB13275,The metabolism of Clorindione can be decreased when combined with Aldesleukin.
DB00675,The metabolism of Tamoxifen can be decreased when combined with Aldesleukin.
DB05294,The metabolism of Vandetanib can be decreased when combined with Aldesleukin.
DB05812,The metabolism of Abiraterone can be decreased when combined with Aldesleukin.
DB08881,The metabolism of Vemurafenib can be decreased when combined with Aldesleukin.
DB11363,The metabolism of Alectinib can be decreased when combined with Aldesleukin.
DB11581,The metabolism of Venetoclax can be decreased when combined with Aldesleukin.
DB11641,The metabolism of Vinflunine can be decreased when combined with Aldesleukin.
DB11703,The metabolism of Acalabrutinib can be decreased when combined with Aldesleukin.
DB13874,The metabolism of Enasidenib can be decreased when combined with Aldesleukin.
DB15035,The metabolism of Zanubrutinib can be decreased when combined with Aldesleukin.
DB00248,The metabolism of Cabergoline can be decreased when combined with Aldesleukin.
DB00530,The metabolism of Erlotinib can be decreased when combined with Aldesleukin.
DB06595,The metabolism of Midostaurin can be decreased when combined with Aldesleukin.
DB06626,The metabolism of Axitinib can be decreased when combined with Aldesleukin.
DB08865,The metabolism of Crizotinib can be decreased when combined with Aldesleukin.
DB08912,The metabolism of Dabrafenib can be decreased when combined with Aldesleukin.
DB09143,The metabolism of Sonidegib can be decreased when combined with Aldesleukin.
DB11718,The metabolism of Encorafenib can be decreased when combined with Aldesleukin.
DB11828,The metabolism of Neratinib can be decreased when combined with Aldesleukin.
DB12147,The metabolism of Erdafitinib can be decreased when combined with Aldesleukin.
DB12267,The metabolism of Brigatinib can be decreased when combined with Aldesleukin.
DB12483,The metabolism of Copanlisib can be decreased when combined with Aldesleukin.
DB12978,The metabolism of Pexidartinib can be decreased when combined with Aldesleukin.
DB14568,The metabolism of Ivosidenib can be decreased when combined with Aldesleukin.
DB11986,The metabolism of Entrectinib can be decreased when combined with Aldesleukin.
DB00921,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
DB00366,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00470,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00450,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00956,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
DB00557,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00653,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Magnesium sulfate.
DB01403,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
DB00765,Botulinum Toxin Type B may increase the sedative activities of Metyrosine.
DB01017,Minocycline may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00370,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
DB00486,Nabilone may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB01173,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
DB09117,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
DB08883,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00413,Botulinum Toxin Type B may increase the sedative activities of Pramipexole.
DB00268,Botulinum Toxin Type B may increase the sedative activities of Ropinirole.
DB05271,Botulinum Toxin Type B may increase the sedative activities of Rotigotine.
DB06201,The risk or severity of adverse effects can be increased when Rufinamide is combined with Botulinum Toxin Type B.
DB09072,Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB09034,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
DB06204,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB01041,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
DB00425,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
DB00202,The therapeutic efficacy of Succinylcholine can be increased when used in combination with Botulinum Toxin Type B.
DB01245,The therapeutic efficacy of Decamethonium can be increased when used in combination with Botulinum Toxin Type B.
DB11156,The therapeutic efficacy of Pyrantel can be increased when used in combination with Botulinum Toxin Type B.
DB12989,The therapeutic efficacy of Neosaxitoxin can be increased when used in combination with Botulinum Toxin Type B.
DB00333,The risk or severity of adverse effects can be increased when Methadone is combined with Botulinum Toxin Type B.
DB00209,The risk or severity of adverse effects can be increased when Trospium is combined with Botulinum Toxin Type B.
DB00219,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Botulinum Toxin Type B.
DB00237,The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum Toxin Type B.
DB00241,The risk or severity of adverse effects can be increased when Butalbital is combined with Botulinum Toxin Type B.
DB00245,The risk or severity of adverse effects can be increased when Benzatropine is combined with Botulinum Toxin Type B.
DB00280,The risk or severity of adverse effects can be increased when Disopyramide is combined with Botulinum Toxin Type B.
DB00306,The risk or severity of adverse effects can be increased when Talbutal is combined with Botulinum Toxin Type B.
DB00312,The risk or severity of adverse effects can be increased when Pentobarbital is combined with Botulinum Toxin Type B.
DB00321,The risk or severity of adverse effects can be increased when Amitriptyline is combined with Botulinum Toxin Type B.
DB00332,The risk or severity of adverse effects can be increased when Ipratropium is combined with Botulinum Toxin Type B.
DB00334,The risk or severity of adverse effects can be increased when Olanzapine is combined with Botulinum Toxin Type B.
DB00340,The risk or severity of adverse effects can be increased when Metixene is combined with Botulinum Toxin Type B.
DB00342,The risk or severity of adverse effects can be increased when Terfenadine is combined with Botulinum Toxin Type B.
DB00354,The risk or severity of adverse effects can be increased when Buclizine is combined with Botulinum Toxin Type B.
DB00363,The risk or severity of adverse effects can be increased when Clozapine is combined with Botulinum Toxin Type B.
DB00376,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Botulinum Toxin Type B.
DB00383,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Botulinum Toxin Type B.
DB00387,The risk or severity of adverse effects can be increased when Procyclidine is combined with Botulinum Toxin Type B.
DB00392,The risk or severity of adverse effects can be increased when Profenamine is combined with Botulinum Toxin Type B.
DB00416,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Botulinum Toxin Type B.
DB00418,The risk or severity of adverse effects can be increased when Secobarbital is combined with Botulinum Toxin Type B.
DB00420,The risk or severity of adverse effects can be increased when Promazine is combined with Botulinum Toxin Type B.
DB00424,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Botulinum Toxin Type B.
DB00434,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Botulinum Toxin Type B.
DB00458,The risk or severity of adverse effects can be increased when Imipramine is combined with Botulinum Toxin Type B.
DB00462,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Botulinum Toxin Type B.
DB00463,The risk or severity of adverse effects can be increased when Metharbital is combined with Botulinum Toxin Type B.
DB00477,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Botulinum Toxin Type B.
DB00483,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Botulinum Toxin Type B.
DB00496,The risk or severity of adverse effects can be increased when Darifenacin is combined with Botulinum Toxin Type B.
DB00505,The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Botulinum Toxin Type B.
DB00508,The risk or severity of adverse effects can be increased when Triflupromazine is combined with Botulinum Toxin Type B.
DB00514,The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Botulinum Toxin Type B.
DB00517,The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Botulinum Toxin Type B.
DB00540,The risk or severity of adverse effects can be increased when Nortriptyline is combined with Botulinum Toxin Type B.
DB00543,The risk or severity of adverse effects can be increased when Amoxapine is combined with Botulinum Toxin Type B.
DB00555,The risk or severity of adverse effects can be increased when Lamotrigine is combined with Botulinum Toxin Type B.
DB00565,The risk or severity of adverse effects can be increased when Cisatracurium is combined with Botulinum Toxin Type B.
DB00572,The risk or severity of adverse effects can be increased when Atropine is combined with Botulinum Toxin Type B.
DB00599,The risk or severity of adverse effects can be increased when Thiopental is combined with Botulinum Toxin Type B.
DB00622,The risk or severity of adverse effects can be increased when Nicardipine is combined with Botulinum Toxin Type B.
DB00657,The risk or severity of adverse effects can be increased when Mecamylamine is combined with Botulinum Toxin Type B.
DB00670,The risk or severity of adverse effects can be increased when Pirenzepine is combined with Botulinum Toxin Type B.
DB00715,The risk or severity of adverse effects can be increased when Paroxetine is combined with Botulinum Toxin Type B.
DB00721,The risk or severity of adverse effects can be increased when Procaine is combined with Botulinum Toxin Type B.
DB00725,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Botulinum Toxin Type B.
DB00728,The risk or severity of adverse effects can be increased when Rocuronium is combined with Botulinum Toxin Type B.
DB00732,The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Botulinum Toxin Type B.
DB00747,The risk or severity of adverse effects can be increased when Scopolamine is combined with Botulinum Toxin Type B.
DB00753,The risk or severity of adverse effects can be increased when Isoflurane is combined with Botulinum Toxin Type B.
DB00767,The risk or severity of adverse effects can be increased when Benzquinamide is combined with Botulinum Toxin Type B.
DB00771,The risk or severity of adverse effects can be increased when Clidinium is combined with Botulinum Toxin Type B.
DB00777,The risk or severity of adverse effects can be increased when Propiomazine is combined with Botulinum Toxin Type B.
DB00782,The risk or severity of adverse effects can be increased when Propantheline is combined with Botulinum Toxin Type B.
DB00794,The risk or severity of adverse effects can be increased when Primidone is combined with Botulinum Toxin Type B.
DB00804,The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum Toxin Type B.
DB00810,The risk or severity of adverse effects can be increased when Biperiden is combined with Botulinum Toxin Type B.
DB00835,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Botulinum Toxin Type B.
DB00849,The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Botulinum Toxin Type B.
DB00875,The risk or severity of adverse effects can be increased when Flupentixol is combined with Botulinum Toxin Type B.
DB00907,The risk or severity of adverse effects can be increased when Cocaine is combined with Botulinum Toxin Type B.
DB00908,The risk or severity of adverse effects can be increased when Quinidine is combined with Botulinum Toxin Type B.
DB00915,The risk or severity of adverse effects can be increased when Amantadine is combined with Botulinum Toxin Type B.
DB00934,The risk or severity of adverse effects can be increased when Maprotiline is combined with Botulinum Toxin Type B.
DB00940,The risk or severity of adverse effects can be increased when Methantheline is combined with Botulinum Toxin Type B.
DB00941,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Botulinum Toxin Type B.
DB00942,The risk or severity of adverse effects can be increased when Cycrimine is combined with Botulinum Toxin Type B.
DB00967,The risk or severity of adverse effects can be increased when Desloratadine is combined with Botulinum Toxin Type B.
DB00986,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Botulinum Toxin Type B.
DB01036,The risk or severity of adverse effects can be increased when Tolterodine is combined with Botulinum Toxin Type B.
DB01062,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Botulinum Toxin Type B.
DB01069,The risk or severity of adverse effects can be increased when Promethazine is combined with Botulinum Toxin Type B.
DB01075,The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Botulinum Toxin Type B.
DB01090,The risk or severity of adverse effects can be increased when Pentolinium is combined with Botulinum Toxin Type B.
DB01116,The risk or severity of adverse effects can be increased when Trimethaphan is combined with Botulinum Toxin Type B.
DB01135,The risk or severity of adverse effects can be increased when Doxacurium is combined with Botulinum Toxin Type B.
DB01142,The risk or severity of adverse effects can be increased when Doxepin is combined with Botulinum Toxin Type B.
DB01148,The risk or severity of adverse effects can be increased when Flavoxate is combined with Botulinum Toxin Type B.
DB01151,The risk or severity of adverse effects can be increased when Desipramine is combined with Botulinum Toxin Type B.
DB01161,The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Botulinum Toxin Type B.
DB01174,The risk or severity of adverse effects can be increased when Phenobarbital is combined with Botulinum Toxin Type B.
DB01175,The risk or severity of adverse effects can be increased when Escitalopram is combined with Botulinum Toxin Type B.
DB01199,The risk or severity of adverse effects can be increased when Tubocurarine is combined with Botulinum Toxin Type B.
DB01224,The risk or severity of adverse effects can be increased when Quetiapine is combined with Botulinum Toxin Type B.
DB01226,The risk or severity of adverse effects can be increased when Mivacurium is combined with Botulinum Toxin Type B.
DB01227,The risk or severity of adverse effects can be increased when Levacetylmethadol is combined with Botulinum Toxin Type B.
DB01231,The risk or severity of adverse effects can be increased when Diphenidol is combined with Botulinum Toxin Type B.
DB01238,The risk or severity of adverse effects can be increased when Aripiprazole is combined with Botulinum Toxin Type B.
DB01239,The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Botulinum Toxin Type B.
DB01288,The risk or severity of adverse effects can be increased when Fenoterol is combined with Botulinum Toxin Type B.
DB01336,The risk or severity of adverse effects can be increased when Metocurine is combined with Botulinum Toxin Type B.
DB01337,The risk or severity of adverse effects can be increased when Pancuronium is combined with Botulinum Toxin Type B.
DB01338,The risk or severity of adverse effects can be increased when Pipecuronium is combined with Botulinum Toxin Type B.
DB01339,The risk or severity of adverse effects can be increased when Vecuronium is combined with Botulinum Toxin Type B.
DB01351,The risk or severity of adverse effects can be increased when Amobarbital is combined with Botulinum Toxin Type B.
DB01352,The risk or severity of adverse effects can be increased when Aprobarbital is combined with Botulinum Toxin Type B.
DB01353,The risk or severity of adverse effects can be increased when Butobarbital is combined with Botulinum Toxin Type B.
DB01354,The risk or severity of adverse effects can be increased when Heptabarbital is combined with Botulinum Toxin Type B.
DB01355,The risk or severity of adverse effects can be increased when Hexobarbital is combined with Botulinum Toxin Type B.
DB01409,The risk or severity of adverse effects can be increased when Tiotropium is combined with Botulinum Toxin Type B.
DB01483,The risk or severity of adverse effects can be increased when Barbital is combined with Botulinum Toxin Type B.
DB01496,"The risk or severity of adverse effects can be increased when Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione is combined with Botulinum Toxin Type B."
DB01591,The risk or severity of adverse effects can be increased when Solifenacin is combined with Botulinum Toxin Type B.
DB01625,The risk or severity of adverse effects can be increased when Isopropamide is combined with Botulinum Toxin Type B.
DB04834,The risk or severity of adverse effects can be increased when Rapacuronium is combined with Botulinum Toxin Type B.
DB04843,The risk or severity of adverse effects can be increased when Mepenzolate is combined with Botulinum Toxin Type B.
DB05710,The risk or severity of adverse effects can be increased when Gantacurium is combined with Botulinum Toxin Type B.
DB06153,The risk or severity of adverse effects can be increased when Pizotifen is combined with Botulinum Toxin Type B.
DB06702,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Botulinum Toxin Type B.
DB06787,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Botulinum Toxin Type B.
DB08801,The risk or severity of adverse effects can be increased when Dimetindene is combined with Botulinum Toxin Type B.
DB08838,The risk or severity of adverse effects can be increased when Agmatine is combined with Botulinum Toxin Type B.
DB08897,The risk or severity of adverse effects can be increased when Aclidinium is combined with Botulinum Toxin Type B.
DB08960,The risk or severity of adverse effects can be increased when Hexamethonium is combined with Botulinum Toxin Type B.
DB08997,The risk or severity of adverse effects can be increased when Dexetimide is combined with Botulinum Toxin Type B.
DB09007,The risk or severity of adverse effects can be increased when Chlorphenoxamine is combined with Botulinum Toxin Type B.
DB09023,The risk or severity of adverse effects can be increased when Benactyzine is combined with Botulinum Toxin Type B.
DB09076,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Botulinum Toxin Type B.
DB09089,The risk or severity of adverse effects can be increased when Trimebutine is combined with Botulinum Toxin Type B.
DB09167,The risk or severity of adverse effects can be increased when Dosulepin is combined with Botulinum Toxin Type B.
DB09262,The risk or severity of adverse effects can be increased when Imidafenacin is combined with Botulinum Toxin Type B.
DB09300,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Botulinum Toxin Type B.
DB11235,The risk or severity of adverse effects can be increased when Thonzylamine is combined with Botulinum Toxin Type B.
DB11315,The risk or severity of adverse effects can be increased when Methscopolamine is combined with Botulinum Toxin Type B.
DB11855,The risk or severity of adverse effects can be increased when Revefenacin is combined with Botulinum Toxin Type B.
DB12086,The risk or severity of adverse effects can be increased when Oxitropium is combined with Botulinum Toxin Type B.
DB12278,The risk or severity of adverse effects can be increased when Propiverine is combined with Botulinum Toxin Type B.
DB12526,The risk or severity of adverse effects can be increased when Batefenterol is combined with Botulinum Toxin Type B.
DB12554,The risk or severity of adverse effects can be increased when Mebeverine is combined with Botulinum Toxin Type B.
DB13252,The risk or severity of adverse effects can be increased when Tropatepine is combined with Botulinum Toxin Type B.
DB13254,The risk or severity of adverse effects can be increased when Prifinium is combined with Botulinum Toxin Type B.
DB13295,The risk or severity of adverse effects can be increased when Atracurium is combined with Botulinum Toxin Type B.
DB13351,The risk or severity of adverse effects can be increased when Piperidolate is combined with Botulinum Toxin Type B.
DB13369,The risk or severity of adverse effects can be increased when Benzilone is combined with Botulinum Toxin Type B.
DB13380,The risk or severity of adverse effects can be increased when Difemerine is combined with Botulinum Toxin Type B.
DB13413,The risk or severity of adverse effects can be increased when Phenglutarimide is combined with Botulinum Toxin Type B.
DB13448,The risk or severity of adverse effects can be increased when Mazaticol is combined with Botulinum Toxin Type B.
DB13468,The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Botulinum Toxin Type B.
DB13500,The risk or severity of adverse effects can be increased when Otilonium is combined with Botulinum Toxin Type B.
DB13505,The risk or severity of adverse effects can be increased when Emepronium is combined with Botulinum Toxin Type B.
DB13507,The risk or severity of adverse effects can be increased when Poldine is combined with Botulinum Toxin Type B.
DB13542,The risk or severity of adverse effects can be increased when Bevonium is combined with Botulinum Toxin Type B.
DB13581,The risk or severity of adverse effects can be increased when Rociverine is combined with Botulinum Toxin Type B.
DB13584,The risk or severity of adverse effects can be increased when Gallamine is combined with Botulinum Toxin Type B.
DB13619,The risk or severity of adverse effects can be increased when Bornaprine is combined with Botulinum Toxin Type B.
DB13636,The risk or severity of adverse effects can be increased when Etanautine is combined with Botulinum Toxin Type B.
DB13648,The risk or severity of adverse effects can be increased when Alcuronium is combined with Botulinum Toxin Type B.
DB13666,The risk or severity of adverse effects can be increased when Tiemonium iodide is combined with Botulinum Toxin Type B.
DB13678,The risk or severity of adverse effects can be increased when Dihexyverine is combined with Botulinum Toxin Type B.
DB13695,The risk or severity of adverse effects can be increased when Penthienate is combined with Botulinum Toxin Type B.
DB13720,The risk or severity of adverse effects can be increased when Diphemanil is combined with Botulinum Toxin Type B.
DB13738,The risk or severity of adverse effects can be increased when Camylofin is combined with Botulinum Toxin Type B.
DB13759,The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Botulinum Toxin Type B.
DB13769,The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Botulinum Toxin Type B.
DB13844,The risk or severity of adverse effects can be increased when Pipenzolate is combined with Botulinum Toxin Type B.
DB13850,The risk or severity of adverse effects can be increased when Timepidium is combined with Botulinum Toxin Type B.
DB00898,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
DB00972,Botulinum Toxin Type B may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
DB00484,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluvoxamine.
DB00215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Citalopram.
DB00476,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Duloxetine.
DB00656,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trazodone.
DB01104,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertraline.
DB01105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sibutramine.
DB01149,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefazodone.
DB04832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zimelidine.
DB04884,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dapoxetine.
DB04896,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Milnacipran.
DB06700,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desvenlafaxine.
DB06731,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Seproxetine.
DB08918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levomilnacipran.
DB08953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indalpine.
DB12693,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ritanserin.
DB13233,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alaproclate.
DB01198,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zopiclone.
DB00150,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tryptophan.
DB00181,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Baclofen.
DB00182,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amphetamine.
DB00186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorazepam.
DB00189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethchlorvynol.
DB00206,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reserpine.
DB00216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eletriptan.
DB00228,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Enflurane.
DB00231,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Temazepam.
DB00234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reboxetine.
DB00247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methysergide.
DB00248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cabergoline.
DB00252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenytoin.
DB00273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Topiramate.
DB00283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clemastine.
DB00285,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Venlafaxine.
DB00289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Atomoxetine.
DB00292,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etomidate.
DB00295,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Morphine.
DB00313,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valproic acid.
DB00315,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolmitriptan.
DB00318,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Codeine.
DB00320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroergotamine.
DB00323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolcapone.
DB00327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydromorphone.
DB00341,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cetirizine.
DB00344,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Protriptyline.
DB00347,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethadione.
DB00349,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clobazam.
DB00356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorzoxazone.
DB00371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meprobamate.
DB00372,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiethylperazine.
DB00377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Palonosetron.
DB00391,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulpiride.
DB00404,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprazolam.
DB00405,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexbrompheniramine.
DB00408,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loxapine.
DB00409,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remoxipride.
DB00423,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methocarbamol.
DB00427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triprolidine.
DB00433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prochlorperazine.
DB00454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meperidine.
DB00474,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methohexital.
DB00475,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlordiazepoxide.
DB00494,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Entacapone.
DB00497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxycodone.
DB00532,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenytoin.
DB00546,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adinazolam.
DB00564,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbamazepine.
DB00574,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenfluramine.
DB00579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mazindol.
DB00588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluticasone propionate.
DB00589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lisuride.
DB00593,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethosuximide.
DB00601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Linezolid.
DB00604,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cisapride.
DB00611,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butorphanol.
DB00614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Furazolidone.
DB00617,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paramethadione.
DB00623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluphenazine.
DB00625,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Efavirenz.
DB00628,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorazepic acid.
DB00633,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmedetomidine.
DB00645,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dyclonine.
DB00647,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextropropoxyphene.
DB00652,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pentazocine.
DB00660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metaxalone.
DB00662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimethobenzamide.
DB00669,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sumatriptan.
DB00679,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioridazine.
DB00680,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moricizine.
DB00683,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midazolam.
DB00690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flurazepam.
DB00696,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergotamine.
DB00697,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tizanidine.
DB00708,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sufentanil.
DB00714,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apomorphine.
DB00726,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trimipramine.
DB00734,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Risperidone.
DB00737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meclizine.
DB00740,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Riluzole.
DB00748,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbinoxamine.
DB00752,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tranylcypromine.
DB00754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethotoin.
DB00757,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dolasetron.
DB00776,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxcarbazepine.
DB00780,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenelzine.
DB00801,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halazepam.
DB00802,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfentanil.
DB00805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Minaprine.
DB00813,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fentanyl.
DB00818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propofol.
DB00819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetazolamide.
DB00829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diazepam.
DB00831,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluoperazine.
DB00832,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phensuximide.
DB00837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Progabide.
DB00842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam.
DB00843,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Donepezil.
DB00844,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nalbuphine.
DB00850,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine.
DB00854,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levorphanol.
DB00865,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzphetamine.
DB00866,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alprenolol.
DB00889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Granisetron.
DB00897,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triazolam.
DB00899,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remifentanil.
DB00904,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ondansetron.
DB00906,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiagabine.
DB00909,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zonisamide.
DB00918,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Almotriptan.
DB00933,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mesoridazine.
DB00937,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethylpropion.
DB00949,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Felbamate.
DB00952,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naratriptan.
DB00953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rizatriptan.
DB00960,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pindolol.
DB00962,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zaleplon.
DB00969,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alosetron.
DB00980,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramelteon.
DB00985,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimenhydrinate.
DB00996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin.
DB00998,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Frovatriptan.
DB01018,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Guanfacine.
DB01028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methoxyflurane.
DB01037,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Selegiline.
DB01049,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergoloid mesylate.
DB01063,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetophenazine.
DB01065,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melatonin.
DB01068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clonazepam.
DB01080,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vigabatrin.
DB01081,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diphenoxylate.
DB01100,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimozide.
DB01107,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methyprylon.
DB01114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorpheniramine.
DB01121,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenacemide.
DB01154,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiamylal.
DB01156,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bupropion.
DB01159,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Halothane.
DB01168,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Procarbazine.
DB01171,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moclobemide.
DB01176,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclizine.
DB01178,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlormezanone.
DB01186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pergolide.
DB01189,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desflurane.
DB01192,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxymorphone.
DB01200,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromocriptine.
DB01202,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levetiracetam.
DB01209,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dezocine.
DB01215,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Estazolam.
DB01221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketamine.
DB01235,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levodopa.
DB01236,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sevoflurane.
DB01242,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomipramine.
DB01246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alimemazine.
DB01247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Isocarboxazid.
DB01253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergometrine.
DB01267,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Paliperidone.
DB01320,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fosphenytoin.
DB01323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with St. John's Wort.
DB01356,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium cation.
DB01359,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penbutolol.
DB01367,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rasagiline.
DB01392,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Yohimbine.
DB01433,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methadyl acetate.
DB01437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Glutethimide.
DB01440,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with gamma-Hydroxybutyric acid.
DB01442,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MMDA.
DB01445,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bufotenine.
DB01450,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydroetorphine.
DB01452,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diamorphine.
DB01454,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Midomafetamine.
DB01463,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fencamfamin.
DB01466,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethylmorphine.
DB01472,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Methoxyamphetamine.
DB01484,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 4-Bromo-2,5-dimethoxyamphetamine."
DB01488,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimethyltryptamine.
DB01489,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Camazepam.
DB01495,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dichloralphenazone.
DB01497,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etorphine.
DB01501,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Difenoxin.
DB01509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tenamfetamine.
DB01511,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Delorazepam.
DB01529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextromoramide.
DB01531,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Desomorphine.
DB01534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorhexadol.
DB01535,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil.
DB01544,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunitrazepam.
DB01545,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethyl loflazepate.
DB01547,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Drotebanol.
DB01551,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydrocodeine.
DB01553,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cloxazolam.
DB01555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphacetylmethadol.
DB01558,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromazepam.
DB01559,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clotiazepam.
DB01560,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cathinone.
DB01563,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chloral hydrate.
DB01565,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dihydromorphine.
DB01567,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fludiazepam.
DB01577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metamfetamine.
DB01580,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxprenolol.
DB01587,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketazolam.
DB01588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prazepam.
DB01589,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quazepam.
DB01594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinolazepam.
DB01595,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrazepam.
DB01608,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Periciazine.
DB01614,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acepromazine.
DB01615,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aceprometazine.
DB01616,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alverine.
DB01618,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Molindone.
DB01621,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipotiazine.
DB01622,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thioproperazine.
DB01623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiothixene.
DB01624,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zuclopenthixol.
DB01626,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pargyline.
DB01954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Rolipram.
DB02207,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7-Nitroindazole.
DB02234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with S-Ethylisothiourea.
DB02852,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Domoic Acid.
DB02959,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxitriptan.
DB03575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phencyclidine.
DB04017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clorgiline.
DB04165,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valpromide.
DB04325,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenethylamine.
DB04599,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aniracetam.
DB04818,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproniazid.
DB04819,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methapyrilene.
DB04820,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nialamide.
DB04821,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nomifensine.
DB04827,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urethane.
DB04829,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lysergic acid diethylamide.
DB04833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methaqualone.
DB04836,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amineptine.
DB04841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flunarizine.
DB04842,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluspirilene.
DB04871,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lorcaserin.
DB04872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Osanetant.
DB04885,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cilansetron.
DB04888,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifeprunox.
DB04903,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pagoclone.
DB04908,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Flibanserin.
DB04917,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Renzapride.
DB04946,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iloperidone.
DB04953,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ezogabine.
DB05227,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with APD791.
DB05232,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrodotoxin.
DB05246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methsuximide.
DB05316,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pimavanserin.
DB05541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brivaracetam.
DB05542,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naronapride.
DB05562,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naluzotan.
DB05607,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with PRX-08066.
DB05687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with BL-1020.
DB06016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cariprazine.
DB06077,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lumateperone.
DB06109,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with YKP-1358.
DB06144,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sertindole.
DB06148,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mianserin.
DB06216,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Asenapine.
DB06218,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lacosamide.
DB06264,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tolperisone.
DB06282,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Levocetirizine.
DB06283,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ziconotide.
DB06288,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amisulpride.
DB06446,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dotarizine.
DB06458,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Remacemide.
DB06470,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clomethiazole.
DB06512,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deramciclane.
DB06527,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tramiprosate.
DB06529,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ocinaplon.
DB06554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gaboxadol.
DB06579,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Adipiplon.
DB06582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dextofisopam.
DB06594,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Agomelatine.
DB06654,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safinamide.
DB06660,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Saredutant.
DB06678,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esmirtazapine.
DB06684,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vilazodone.
DB06690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nitrous oxide.
DB06691,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mepyramine.
DB06701,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dexmethylphenidate.
DB06716,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fospropofol.
DB06738,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketobemidone.
DB06753,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Triclofos.
DB06770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzyl alcohol.
DB06797,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebutamate.
DB08059,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Wortmannin.
DB08329,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sulthiame.
DB08550,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline."
DB08810,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinitapride.
DB08811,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tofisopam.
DB08815,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lurasidone.
DB08839,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Serotonin.
DB08861,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with DPDPE.
DB08872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gabapentin enacarbil.
DB08892,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Arbaclofen Placarbil.
DB08910,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pomalidomide.
DB08922,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perospirone.
DB08927,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amperozide.
DB08954,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ifenprodil.
DB08986,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etifoxine.
DB08992,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eperisone.
DB08996,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dimetacrine.
DB09000,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyamemazine.
DB09001,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Barbexaclone.
DB09011,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Beclamide.
DB09014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Captodiame.
DB09016,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butriptyline.
DB09017,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brotizolam.
DB09021,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzoctamine.
DB09068,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vortioxetine.
DB09071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tasimelteon.
DB09118,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Stiripentol.
DB09119,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine acetate.
DB09128,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexpiprazole.
DB09166,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etizolam.
DB09174,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofentanil.
DB09184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Edivoxetine.
DB09185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Viloxazine.
DB09186,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nisoxetine.
DB09187,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lortalamine.
DB09190,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Talopram.
DB09194,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etoperidone.
DB09223,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Blonanserin.
DB09224,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melperone.
DB09225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zotepine.
DB09226,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brilaroxazine.
DB09241,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylene blue.
DB09243,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hydracarbazine.
DB09244,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pirlindole.
DB09245,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Toloxatone.
DB09246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benmoxin.
DB09247,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iproclozide.
DB09248,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebanazine.
DB09249,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Octamoxin.
DB09250,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheniprazine.
DB09251,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoxypropazine.
DB09252,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivhydrazine.
DB09253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Safrazine.
DB09254,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Caroxazone.
DB09286,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pipamperone.
DB09289,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tianeptine.
DB09290,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ramosetron.
DB09307,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaprotiline.
DB11130,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opium.
DB11371,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alfaxalone.
DB11376,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Azaperone.
DB11400,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doramectin.
DB11428,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medetomidine.
DB11477,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Xylazine.
DB11540,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propiopromazine.
DB11543,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Romifidine.
DB11549,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiletamine.
DB11552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tricaine.
DB11555,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Zolazepam.
DB11556,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Detomidine.
DB11582,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiocolchicoside.
DB11609,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Normethadone.
DB11664,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Psilocybin.
DB11675,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapride.
DB11686,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iferanserin.
DB11699,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tropisetron.
DB11755,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydrocannabivarin.
DB11859,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brexanolone.
DB11868,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Etiracetam.
DB11889,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lanicemine.
DB11957,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Idalopirdine.
DB12071,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vabicaserin.
DB12093,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrahydropalmatine.
DB12105,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imagabalin.
DB12110,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with m-Chlorophenylpiperazine.
DB12111,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MK-212.
DB12131,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinpocetine.
DB12163,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sarpogrelate.
DB12177,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eplivanserin.
DB12184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gepirone.
DB12229,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cerlapirdine.
DB12273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ecopipam.
DB12308,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltanolone.
DB12327,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Salvinorin A.
DB12338,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carisbamate.
DB12361,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piclozotan.
DB12395,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esreboxetine.
DB12401,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromperidol.
DB12427,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Orvepitant.
DB12465,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ketanserin.
DB12492,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Piritramide.
DB12518,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Raclopride.
DB12537,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benzodiazepine.
DB12576,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with AZD-3043.
DB12590,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Indiplon.
DB12661,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Urapidil.
DB12710,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perazine.
DB12725,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with TD-8954.
DB12833,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tandospirone.
DB12867,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Benperidol.
DB12883,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eltoprazine.
DB12930,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Opipramol.
DB12951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pivagabine.
DB12958,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Prothipendyl.
DB13014,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hypericin.
DB13025,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tiapride.
DB13082,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nefiracetam.
DB13099,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Valnoctamide.
DB13114,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Amitriptylinoxide.
DB13160,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Alphaprodine.
DB13213,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Butaperazine.
DB13219,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medifoxamine.
DB13221,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Apronalide.
DB13225,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dibenzepin.
DB13234,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Propanidid.
DB13246,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Quinupramine.
DB13253,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Proxibarbal.
DB13256,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clothiapine.
DB13273,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Sultopride.
DB13303,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Febarbamate.
DB13323,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trichloroethylene.
DB13324,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetrazepam.
DB13331,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrithyldione.
DB13335,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pinazepam.
DB13352,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Deanol.
DB13354,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenprobamate.
DB13357,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Styramate.
DB13362,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pheneturide.
DB13370,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bromisoval.
DB13377,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinbarbital.
DB13382,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Chlorproethazine.
DB13384,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Melitracen.
DB13396,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Neocitrullamon.
DB13402,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Acetylglycinamide chloral hydrate.
DB13403,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxypertine.
DB13411,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lofepramine.
DB13414,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fenyramidol.
DB13420,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiazinam.
DB13437,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Medazepam.
DB13455,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenibut.
DB13457,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxaflozane.
DB13478,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Meptazinol.
DB13496,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprindole.
DB13520,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Metergoline.
DB13522,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mebicar.
DB13523,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Veralipride.
DB13534,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Gedocarnil.
DB13541,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Iprazochrome.
DB13550,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bifemelane.
DB13552,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Trifluperidol.
DB13554,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Moperone.
DB13557,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Thiopropazate.
DB13572,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Emylcamate.
DB13577,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Allobarbital.
DB13588,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Naftidrofuryl.
DB13598,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Diethyl ether.
DB13601,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxiracetam.
DB13605,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenoperidine.
DB13606,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Phenazocine.
DB13623,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fabomotizole.
DB13642,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pridinol.
DB13643,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Loprazolam.
DB13662,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Hexapropymate.
DB13665,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fluanisone.
DB13676,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mosapramine.
DB13687,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Niaprazine.
DB13690,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinyl ether.
DB13733,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Methylpentynol.
DB13737,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclobarbital.
DB13745,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Fazadinium bromide.
DB13754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Mephenoxalone.
DB13770,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Vinylbital.
DB13782,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Imipramine oxide.
DB13784,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Dixyrazine.
DB13787,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tilidine.
DB13791,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Penfluridol.
DB13799,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ethadione.
DB13805,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Reposal.
DB13817,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carbromal.
DB13837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Doxefazepam.
DB13841,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Clopenthixol.
DB13872,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lormetazepam.
DB13875,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Harmaline.
DB13876,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Brofaromine.
DB13940,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 2,5-Dimethoxy-4-ethylthioamphetamine."
DB13948,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine."
DB13984,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopropane.
DB13993,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with MRK-409.
DB14010,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with 5-methoxy-N,N-dimethyltryptamine."
DB14028,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nordazepam.
DB14050,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cannabidivarin.
DB14185,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Aripiprazole lauroxil.
DB14509,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium carbonate.
DB14575,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Eslicarbazepine.
DB14651,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Perphenazine enanthate.
DB14672,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Oxazepam acetate.
DB14715,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cinazepam.
DB14718,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Pyrazolam.
DB14719,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Bentazepam.
DB14754,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Solriamfetol.
DB15203,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with JNJ-26489112.
DB15360,"The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Carfentanil, C-11."
DB11951,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lemborexant.
DB00230,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Pregabalin.
DB04948,The therapeutic efficacy of Botulinum Toxin Type B can be increased when used in combination with Lofexidine.
DB00083,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Botulinum toxin type A.
DB00184,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Nicotine.
DB08837,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Tetraethylammonium.
DB08999,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Cyclopentamine.
DB00091,The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum Toxin Type B.
DB00254,The risk or severity of adverse effects can be increased when Doxycycline is combined with Botulinum Toxin Type B.
DB00256,The risk or severity of adverse effects can be increased when Lymecycline is combined with Botulinum Toxin Type B.
DB00314,The risk or severity of adverse effects can be increased when Capreomycin is combined with Botulinum Toxin Type B.
DB00319,The risk or severity of adverse effects can be increased when Piperacillin is combined with Botulinum Toxin Type B.
DB00452,The risk or severity of adverse effects can be increased when Framycetin is combined with Botulinum Toxin Type B.
DB00453,The risk or severity of adverse effects can be increased when Clomocycline is combined with Botulinum Toxin Type B.
DB00468,The risk or severity of adverse effects can be increased when Quinine is combined with Botulinum Toxin Type B.
DB00512,The risk or severity of adverse effects can be increased when Vancomycin is combined with Botulinum Toxin Type B.
DB00560,The risk or severity of adverse effects can be increased when Tigecycline is combined with Botulinum Toxin Type B.
DB00595,The risk or severity of adverse effects can be increased when Oxytetracycline is combined with Botulinum Toxin Type B.
DB00608,The risk or severity of adverse effects can be increased when Chloroquine is combined with Botulinum Toxin Type B.
DB00618,The risk or severity of adverse effects can be increased when Demeclocycline is combined with Botulinum Toxin Type B.
DB00684,The risk or severity of adverse effects can be increased when Tobramycin is combined with Botulinum Toxin Type B.
DB00759,The risk or severity of adverse effects can be increased when Tetracycline is combined with Botulinum Toxin Type B.
DB00798,The risk or severity of adverse effects can be increased when Gentamicin is combined with Botulinum Toxin Type B.
DB00903,The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Botulinum Toxin Type B.
DB00931,The risk or severity of adverse effects can be increased when Metacycline is combined with Botulinum Toxin Type B.
DB00955,The risk or severity of adverse effects can be increased when Netilmicin is combined with Botulinum Toxin Type B.
DB00994,The risk or severity of adverse effects can be increased when Neomycin is combined with Botulinum Toxin Type B.
DB01035,The risk or severity of adverse effects can be increased when Procainamide is combined with Botulinum Toxin Type B.
DB01082,The risk or severity of adverse effects can be increased when Streptomycin is combined with Botulinum Toxin Type B.
DB01111,The risk or severity of adverse effects can be increased when Colistimethate is combined with Botulinum Toxin Type B.
DB01172,The risk or severity of adverse effects can be increased when Kanamycin is combined with Botulinum Toxin Type B.
DB01190,The risk or severity of adverse effects can be increased when Clindamycin is combined with Botulinum Toxin Type B.
DB01219,The risk or severity of adverse effects can be increased when Dantrolene is combined with Botulinum Toxin Type B.
DB01301,The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Botulinum Toxin Type B.
DB01377,The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Botulinum Toxin Type B.
DB01378,The risk or severity of adverse effects can be increased when Magnesium cation is combined with Botulinum Toxin Type B.
DB01421,The risk or severity of adverse effects can be increased when Paromomycin is combined with Botulinum Toxin Type B.
DB01627,The risk or severity of adverse effects can be increased when Lincomycin is combined with Botulinum Toxin Type B.
DB03615,The risk or severity of adverse effects can be increased when Ribostamycin is combined with Botulinum Toxin Type B.
DB04263,The risk or severity of adverse effects can be increased when Geneticin is combined with Botulinum Toxin Type B.
DB04626,The risk or severity of adverse effects can be increased when Apramycin is combined with Botulinum Toxin Type B.
DB04729,The risk or severity of adverse effects can be increased when Gentamicin C1a is combined with Botulinum Toxin Type B.
DB04808,The risk or severity of adverse effects can be increased when Neamine is combined with Botulinum Toxin Type B.
DB06696,The risk or severity of adverse effects can be increased when Arbekacin is combined with Botulinum Toxin Type B.
DB06827,The risk or severity of adverse effects can be increased when Viomycin is combined with Botulinum Toxin Type B.
DB08437,The risk or severity of adverse effects can be increased when Puromycin is combined with Botulinum Toxin Type B.
DB09104,The risk or severity of adverse effects can be increased when Magnesium hydroxide is combined with Botulinum Toxin Type B.
DB09281,The risk or severity of adverse effects can be increased when Magnesium trisilicate is combined with Botulinum Toxin Type B.
DB09407,The risk or severity of adverse effects can be increased when Magnesium chloride is combined with Botulinum Toxin Type B.
DB09409,The risk or severity of adverse effects can be increased when Magnesium acetate tetrahydrate is combined with Botulinum Toxin Type B.
DB09481,The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Botulinum Toxin Type B.
DB11110,The risk or severity of adverse effects can be increased when Magnesium citrate is combined with Botulinum Toxin Type B.
DB11189,The risk or severity of adverse effects can be increased when Magnesium glycinate is combined with Botulinum Toxin Type B.
DB11230,The risk or severity of adverse effects can be increased when Magnesium Aluminum Silicate is combined with Botulinum Toxin Type B.
DB11512,The risk or severity of adverse effects can be increased when Dihydrostreptomycin is combined with Botulinum Toxin Type B.
DB11520,The risk or severity of adverse effects can be increased when Hygromycin B is combined with Botulinum Toxin Type B.
DB12604,The risk or severity of adverse effects can be increased when Sisomicin is combined with Botulinum Toxin Type B.
DB12615,The risk or severity of adverse effects can be increased when Plazomicin is combined with Botulinum Toxin Type B.
DB13249,The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Botulinum Toxin Type B.
DB13264,The risk or severity of adverse effects can be increased when Penimepicycline is combined with Botulinum Toxin Type B.
DB13270,The risk or severity of adverse effects can be increased when Dibekacin is combined with Botulinum Toxin Type B.
DB13274,The risk or severity of adverse effects can be increased when Micronomicin is combined with Botulinum Toxin Type B.
DB13359,The risk or severity of adverse effects can be increased when Magnesium aspartate is combined with Botulinum Toxin Type B.
DB13540,The risk or severity of adverse effects can be increased when Isepamicin is combined with Botulinum Toxin Type B.
DB13673,The risk or severity of adverse effects can be increased when Bekanamycin is combined with Botulinum Toxin Type B.
DB13749,The risk or severity of adverse effects can be increased when Magnesium gluconate is combined with Botulinum Toxin Type B.
DB13786,The risk or severity of adverse effects can be increased when Magnesium orotate is combined with Botulinum Toxin Type B.
DB13862,The risk or severity of adverse effects can be increased when Magnesium phosphate is combined with Botulinum Toxin Type B.
DB13996,The risk or severity of adverse effects can be increased when Magnesium acetate is combined with Botulinum Toxin Type B.
DB05077,The risk or severity of adverse effects can be increased when SLV319 is combined with Botulinum Toxin Type B.
DB06155,The risk or severity of adverse effects can be increased when Rimonabant is combined with Botulinum Toxin Type B.
DB06624,The risk or severity of adverse effects can be increased when Taranabant is combined with Botulinum Toxin Type B.
DB09061,The risk or severity of adverse effects can be increased when Cannabidiol is combined with Botulinum Toxin Type B.
DB11903,The risk or severity of adverse effects can be increased when GW842166 is combined with Botulinum Toxin Type B.
DB12193,The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Botulinum Toxin Type B.
DB12649,The risk or severity of adverse effects can be increased when Ibipinabant is combined with Botulinum Toxin Type B.
DB13070,The risk or severity of adverse effects can be increased when Surinabant is combined with Botulinum Toxin Type B.
DB13950,The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Botulinum Toxin Type B.
DB14011,The risk or severity of adverse effects can be increased when Nabiximols is combined with Botulinum Toxin Type B.
DB14043,The risk or severity of adverse effects can be increased when Palmidrol is combined with Botulinum Toxin Type B.
DB14737,The risk or severity of adverse effects can be increased when Cannabinol is combined with Botulinum Toxin Type B.
DB11823,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Esketamine.
DB00395,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Botulinum Toxin Type B.
DB00704,The risk or severity of respiratory depression can be increased when Naltrexone is combined with Botulinum Toxin Type B.
DB01459,The risk or severity of respiratory depression can be increased when Bezitramide is combined with Botulinum Toxin Type B.
DB09272,The risk or severity of respiratory depression can be increased when Eluxadoline is combined with Botulinum Toxin Type B.
DB13454,The risk or severity of respiratory depression can be increased when Nicomorphine is combined with Botulinum Toxin Type B.
DB15465,The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Botulinum Toxin Type B.
DB00402,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Eszopiclone.
DB00575,The risk or severity of sedation can be increased when Clonidine is combined with Botulinum Toxin Type B.
DB00924,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Cyclobenzaprine.
DB01233,The risk or severity of sedation can be increased when Metoclopramide is combined with Botulinum Toxin Type B.
DB11732,The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lasmiditan.
DB00193,The risk or severity of CNS depression can be increased when Tramadol is combined with Botulinum Toxin Type B.
DB00246,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Botulinum Toxin Type B.
DB00502,The risk or severity of CNS depression can be increased when Botulinum Toxin Type B is combined with Haloperidol.
DB00472,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Botulinum Toxin Type B.
DB00408,The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine.
DB00255,Diethylstilbestrol may increase the thrombogenic activities of Omalizumab.
DB00269,Chlorotrianisene may increase the thrombogenic activities of Omalizumab.
DB00286,Conjugated estrogens may increase the thrombogenic activities of Omalizumab.
DB00655,Estrone may increase the thrombogenic activities of Omalizumab.
DB00783,Estradiol may increase the thrombogenic activities of Omalizumab.
DB00890,Dienestrol may increase the thrombogenic activities of Omalizumab.
DB00977,Ethinylestradiol may increase the thrombogenic activities of Omalizumab.
DB01357,Mestranol may increase the thrombogenic activities of Omalizumab.
DB04573,Estriol may increase the thrombogenic activities of Omalizumab.
DB04574,Estrone sulfate may increase the thrombogenic activities of Omalizumab.
DB04575,Quinestrol may increase the thrombogenic activities of Omalizumab.
DB07931,Hexestrol may increase the thrombogenic activities of Omalizumab.
DB09070,Tibolone may increase the thrombogenic activities of Omalizumab.
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Omalizumab."
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Omalizumab."
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Omalizumab.
DB09381,Esterified estrogens may increase the thrombogenic activities of Omalizumab.
DB11478,Zeranol may increase the thrombogenic activities of Omalizumab.
DB11674,Equol may increase the thrombogenic activities of Omalizumab.
DB12487,Promestriene may increase the thrombogenic activities of Omalizumab.
DB13143,Methallenestril may increase the thrombogenic activities of Omalizumab.
DB13386,Epimestrol may increase the thrombogenic activities of Omalizumab.
DB13418,Moxestrol may increase the thrombogenic activities of Omalizumab.
DB13952,Estradiol acetate may increase the thrombogenic activities of Omalizumab.
DB13953,Estradiol benzoate may increase the thrombogenic activities of Omalizumab.
DB13954,Estradiol cypionate may increase the thrombogenic activities of Omalizumab.
DB13956,Estradiol valerate may increase the thrombogenic activities of Omalizumab.
DB15334,Biochanin A may increase the thrombogenic activities of Omalizumab.
DB15335,Formononetin may increase the thrombogenic activities of Omalizumab.
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Omalizumab.
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Omalizumab.
DB00051,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.
DB00054,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.
DB00056,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gemtuzumab ozogamicin.
DB00057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indium In-111 satumomab pendetide.
DB00065,The risk or severity of adverse effects can be increased when Omalizumab is combined with Infliximab.
DB00072,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab.
DB00073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Omalizumab is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Omalizumab is combined with Muromonab.
DB00076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Digoxin Immune Fab (Ovine).
DB00078,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alemtuzumab.
DB00089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Capromab pendetide.
DB00095,The risk or severity of adverse effects can be increased when Omalizumab is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antithymocyte immunoglobulin (rabbit).
DB00108,The risk or severity of adverse effects can be increased when Omalizumab is combined with Natalizumab.
DB00110,The risk or severity of adverse effects can be increased when Omalizumab is combined with Palivizumab.
DB00111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab.
DB00113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Technetium Tc-99m arcitumomab.
DB01257,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eculizumab.
DB01269,The risk or severity of adverse effects can be increased when Omalizumab is combined with Panitumumab.
DB01270,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ranibizumab.
DB04901,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galiximab.
DB04949,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pexelizumab.
DB04956,The risk or severity of adverse effects can be increased when Omalizumab is combined with Afelimomab.
DB04958,The risk or severity of adverse effects can be increased when Omalizumab is combined with Epratuzumab.
DB04962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bectumomab.
DB04964,The risk or severity of adverse effects can be increased when Omalizumab is combined with Oregovomab.
DB04988,The risk or severity of adverse effects can be increased when Omalizumab is combined with IGN311.
DB05006,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adecatumumab.
DB05097,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab.
DB05101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Matuzumab.
DB05111,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fontolizumab.
DB05136,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bavituximab.
DB05139,The risk or severity of adverse effects can be increased when Omalizumab is combined with CR002.
DB05209,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozrolimupab.
DB05304,The risk or severity of adverse effects can be increased when Omalizumab is combined with Girentuximab.
DB05336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obiltoxaximab.
DB05405,The risk or severity of adverse effects can be increased when Omalizumab is combined with XTL-001.
DB05437,The risk or severity of adverse effects can be increased when Omalizumab is combined with NAV 1800.
DB05459,The risk or severity of adverse effects can be increased when Omalizumab is combined with Briakinumab.
DB05496,The risk or severity of adverse effects can be increased when Omalizumab is combined with Otelixizumab.
DB05545,The risk or severity of adverse effects can be increased when Omalizumab is combined with AMG 108.
DB05550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Iratumumab.
DB05555,The risk or severity of adverse effects can be increased when Omalizumab is combined with Enokizumab.
DB05578,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ramucirumab.
DB05595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Farletuzumab.
DB05656,The risk or severity of adverse effects can be increased when Omalizumab is combined with Veltuzumab.
DB05679,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ustekinumab.
DB05773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab emtansine.
DB05793,The risk or severity of adverse effects can be increased when Omalizumab is combined with PRO-542.
DB05797,The risk or severity of adverse effects can be increased when Omalizumab is combined with TNX-901.
DB05889,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin.
DB05892,The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624.
DB05915,The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029.
DB05916,The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011.
DB05941,The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab.
DB05996,The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin.
DB06043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.
DB06049,The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101.
DB06050,The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402.
DB06081,The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab.
DB06101,The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11.
DB06116,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab.
DB06162,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab.
DB06168,The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab.
DB06186,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.
DB06192,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab.
DB06241,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab.
DB06273,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.
DB06304,The risk or severity of adverse effects can be increased when Omalizumab is combined with BIIB015.
DB06305,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sonepcizumab.
DB06310,The risk or severity of adverse effects can be increased when Omalizumab is combined with Motavizumab.
DB06317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Elotuzumab.
DB06318,The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633.
DB06322,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carotuximab.
DB06324,The risk or severity of adverse effects can be increased when Omalizumab is combined with XmAb 2513.
DB06342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Coltuximab ravtansine.
DB06343,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teprotumumab.
DB06360,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lucatumumab.
DB06366,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pertuzumab.
DB06371,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siplizumab.
DB06467,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apolizumab.
DB06474,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sibrotuzumab.
DB06550,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bivatuzumab.
DB06557,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lerdelimumab.
DB06599,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lexatumumab.
DB06602,The risk or severity of adverse effects can be increased when Omalizumab is combined with Reslizumab.
DB06606,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teplizumab.
DB06607,The risk or severity of adverse effects can be increased when Omalizumab is combined with Catumaxomab.
DB06612,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mepolizumab.
DB06643,The risk or severity of adverse effects can be increased when Omalizumab is combined with Denosumab.
DB06647,The risk or severity of adverse effects can be increased when Omalizumab is combined with Volociximab.
DB06650,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab.
DB06674,The risk or severity of adverse effects can be increased when Omalizumab is combined with Golimumab.
DB08870,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.
DB08879,The risk or severity of adverse effects can be increased when Omalizumab is combined with Belimumab.
DB08902,The risk or severity of adverse effects can be increased when Omalizumab is combined with Raxibacumab.
DB08904,The risk or severity of adverse effects can be increased when Omalizumab is combined with Certolizumab pegol.
DB08935,The risk or severity of adverse effects can be increased when Omalizumab is combined with Obinutuzumab.
DB09029,The risk or severity of adverse effects can be increased when Omalizumab is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vedolizumab.
DB09035,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab.
DB09036,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siltuximab.
DB09037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pembrolizumab.
DB09045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dulaglutide.
DB09052,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blinatumomab.
DB09057,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anthrax immune globulin human.
DB09077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dinutuximab.
DB09105,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asfotase alfa.
DB09264,The risk or severity of adverse effects can be increased when Omalizumab is combined with Idarucizumab.
DB09302,The risk or severity of adverse effects can be increased when Omalizumab is combined with Alirocumab.
DB09303,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evolocumab.
DB09312,The risk or severity of adverse effects can be increased when Omalizumab is combined with Antilymphocyte immunoglobulin (horse).
DB09331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Daratumumab.
DB09559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Necitumumab.
DB11569,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ravulizumab.
DB11595,The risk or severity of adverse effects can be increased when Omalizumab is combined with Atezolizumab.
DB11604,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tetanus Immune Globulin.
DB11608,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eftrenonacog alfa.
DB11621,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human Varicella-Zoster Immune Globulin.
DB11646,The risk or severity of adverse effects can be increased when Omalizumab is combined with Conatumumab.
DB11657,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tabalumab.
DB11680,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ficlatuzumab.
DB11685,The risk or severity of adverse effects can be increased when Omalizumab is combined with Figitumumab.
DB11714,The risk or severity of adverse effects can be increased when Omalizumab is combined with Durvalumab.
DB11715,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bapineuzumab.
DB11731,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab mafodotin.
DB11746,The risk or severity of adverse effects can be increased when Omalizumab is combined with Onartuzumab.
DB11756,The risk or severity of adverse effects can be increased when Omalizumab is combined with Solanezumab.
DB11767,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sarilumab.
DB11771,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tremelimumab.
DB11776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sirukumab.
DB11826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lampalizumab.
DB11834,The risk or severity of adverse effects can be increased when Omalizumab is combined with Guselkumab.
DB11840,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalotuzumab.
DB11849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emibetuzumab.
DB11850,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ublituximab.
DB11856,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ligelizumab.
DB11857,The risk or severity of adverse effects can be increased when Omalizumab is combined with Seribantumab.
DB11862,The risk or severity of adverse effects can be increased when Omalizumab is combined with Landogrozumab.
DB11866,The risk or severity of adverse effects can be increased when Omalizumab is combined with Romosozumab.
DB11884,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vadastuximab Talirine.
DB11914,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab.
DB11930,The risk or severity of adverse effects can be increased when Omalizumab is combined with Varlilumab.
DB11945,The risk or severity of adverse effects can be increased when Omalizumab is combined with Avelumab.
DB11959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crenezumab.
DB11972,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rilotumumab.
DB11976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anifrolumab.
DB11988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ocrelizumab.
DB12023,The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab.
DB12034,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gantenerumab.
DB12053,The risk or severity of adverse effects can be increased when Omalizumab is combined with Visilizumab.
DB12077,The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab.
DB12089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorvotuzumab mertansine.
DB12090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Patritumab.
DB12102,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fulranumab.
DB12104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tarextumab.
DB12118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept.
DB12119,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab.
DB12142,The risk or severity of adverse effects can be increased when Omalizumab is combined with Duligotuzumab.
DB12152,The risk or severity of adverse effects can be increased when Omalizumab is combined with Simtuzumab.
DB12157,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fasinumab.
DB12159,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dupilumab.
DB12169,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tralokinumab.
DB12189,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etrolizumab.
DB12202,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zalutumumab.
DB12205,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ganitumab.
DB12213,The risk or severity of adverse effects can be increased when Omalizumab is combined with Etaracizumab.
DB12240,The risk or severity of adverse effects can be increased when Omalizumab is combined with Polatuzumab vedotin.
DB12246,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inclacumab.
DB12250,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cixutumumab.
DB12261,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ascrinvacumab.
DB12274,The risk or severity of adverse effects can be increased when Omalizumab is combined with Aducanumab.
DB12281,The risk or severity of adverse effects can be increased when Omalizumab is combined with Luspatercept.
DB12296,The risk or severity of adverse effects can be increased when Omalizumab is combined with GS-5745.
DB12317,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vanucizumab.
DB12331,The risk or severity of adverse effects can be increased when Omalizumab is combined with Labetuzumab govitecan.
DB12335,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tanezumab.
DB12342,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ensituximab.
DB12344,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fezakinumab.
DB12363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dusigitumab.
DB12396,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fresolimumab.
DB12413,The risk or severity of adverse effects can be increased when Omalizumab is combined with Indusatumab vedotin.
DB12456,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bococizumab.
DB12489,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mirvetuximab Soravtansine.
DB12498,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mogamulizumab.
DB12520,The risk or severity of adverse effects can be increased when Omalizumab is combined with Plozalizumab.
DB12530,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inebilizumab.
DB12534,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mavrilimumab.
DB12560,The risk or severity of adverse effects can be increased when Omalizumab is combined with Blosozumab.
DB12584,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimagrumab.
DB12589,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dacetuzumab.
DB12609,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tovetumab.
DB12683,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumretuzumab.
DB12698,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ibalizumab.
DB12701,The risk or severity of adverse effects can be increased when Omalizumab is combined with Intetumumab.
DB12718,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carlumab.
DB12734,The risk or severity of adverse effects can be increased when Omalizumab is combined with Demcizumab.
DB12773,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab.
DB12775,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abituzumab.
DB12797,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ecromeximab.
DB12807,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naptumomab Estafenatox.
DB12815,The risk or severity of adverse effects can be increased when Omalizumab is combined with Crotedumab.
DB12820,The risk or severity of adverse effects can be increased when Omalizumab is combined with Concizumab.
DB12826,The risk or severity of adverse effects can be increased when Omalizumab is combined with Depatuxizumab.
DB12844,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rontalizumab.
DB12845,The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab.
DB12849,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clazakizumab.
DB12891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ozanezumab.
DB12893,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sacituzumab govitecan.
DB12917,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bimekizumab.
DB12943,The risk or severity of adverse effects can be increased when Omalizumab is combined with Milatuzumab.
DB12976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Robatumumab.
DB13017,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rovalpituzumab Tesirine.
DB13037,The risk or severity of adverse effects can be increased when Omalizumab is combined with Namilumab.
DB13045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Racotumomab.
DB13073,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tregalizumab.
DB13127,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olokizumab.
DB13140,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bezlotoxumab.
DB13375,The risk or severity of adverse effects can be increased when Omalizumab is combined with Edrecolomab.
DB13535,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nebacumab.
DB13886,The risk or severity of adverse effects can be increased when Omalizumab is combined with Human cytomegalovirus immune globulin.
DB13923,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emicizumab.
DB13976,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sulesomab.
DB13979,The risk or severity of adverse effects can be increased when Omalizumab is combined with Besilesomab.
DB14004,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tildrakizumab.
DB14012,The risk or severity of adverse effects can be increased when Omalizumab is combined with Burosumab.
DB14039,The risk or severity of adverse effects can be increased when Omalizumab is combined with Erenumab.
DB14040,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eptinezumab.
DB14041,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fremanezumab.
DB14042,The risk or severity of adverse effects can be increased when Omalizumab is combined with Galcanezumab.
DB14211,The risk or severity of adverse effects can be increased when Omalizumab is combined with Fanolesomab.
DB14580,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lecanemab.
DB14597,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lanadelumab.
DB14707,The risk or severity of adverse effects can be increased when Omalizumab is combined with Cemiplimab.
DB14724,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Omalizumab is combined with Risankizumab.
DB14776,The risk or severity of adverse effects can be increased when Omalizumab is combined with Camrelizumab.
DB14778,The risk or severity of adverse effects can be increased when Omalizumab is combined with Setrusumab.
DB14784,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gancotamab.
DB14809,The risk or severity of adverse effects can be increased when Omalizumab is combined with Anetumab ravtansine.
DB14811,The risk or severity of adverse effects can be increased when Omalizumab is combined with Isatuximab.
DB14824,The risk or severity of adverse effects can be increased when Omalizumab is combined with Icrucumab.
DB14843,The risk or severity of adverse effects can be increased when Omalizumab is combined with Codrituzumab.
DB14864,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brolucizumab.
DB14871,The risk or severity of adverse effects can be increased when Omalizumab is combined with Xentuzumab.
DB14877,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lintuzumab.
DB14891,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vobarilizumab.
DB14897,The risk or severity of adverse effects can be increased when Omalizumab is combined with Parsatuzumab.
DB14905,The risk or severity of adverse effects can be increased when Omalizumab is combined with Emactuzumab.
DB14907,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bevacizumab zirconium Zr-89.
DB14908,The risk or severity of adverse effects can be increased when Omalizumab is combined with Refanezumab.
DB14919,The risk or severity of adverse effects can be increased when Omalizumab is combined with Rozanolixizumab.
DB14947,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bermekimab.
DB14952,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pamrevlumab.
DB14959,The risk or severity of adverse effects can be increased when Omalizumab is combined with Opicinumab.
DB14962,The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab deruxtecan.
DB14967,The risk or severity of adverse effects can be increased when Omalizumab is combined with Margetuximab.
DB14988,The risk or severity of adverse effects can be increased when Omalizumab is combined with Dalantercept.
DB14997,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pateclizumab.
DB15014,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gremubamab.
DB15022,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apomab.
DB15044,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tafasitamab.
DB15045,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipafricept.
DB15076,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abrilumab.
DB15089,The risk or severity of adverse effects can be increased when Omalizumab is combined with Frovocimab.
DB15090,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tezepelumab.
DB15101,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tigatuzumab.
DB15104,The risk or severity of adverse effects can be increased when Omalizumab is combined with Telisotuzumab vedotin.
DB15113,The risk or severity of adverse effects can be increased when Omalizumab is combined with Utomilumab.
DB15118,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zolbetuximab.
DB15135,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ponezumab.
DB15160,The risk or severity of adverse effects can be increased when Omalizumab is combined with Asunercept.
DB15172,The risk or severity of adverse effects can be increased when Omalizumab is combined with Suvratoxumab.
DB15225,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mitazalimab.
DB15252,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nemolizumab.
DB15253,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bleselumab.
DB15277,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gedivumab.
DB15336,The risk or severity of adverse effects can be increased when Omalizumab is combined with Valanafusp alfa.
DB15349,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sofituzumab vedotin.
DB15354,The risk or severity of adverse effects can be increased when Omalizumab is combined with Evinacumab.
DB15363,The risk or severity of adverse effects can be increased when Omalizumab is combined with Istiratumab.
DB15383,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pidilizumab.
DB15397,The risk or severity of adverse effects can be increased when Omalizumab is combined with GMA-161.
DB15409,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ladiratuzumab vedotin.
DB15415,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tomaralimab.
DB15428,The risk or severity of adverse effects can be increased when Omalizumab is combined with Vesencumab.
DB15432,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pinatuzumab vedotin.
DB15441,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lulizumab pegol.
DB15443,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lorukafusp alfa.
DB15453,The risk or severity of adverse effects can be increased when Omalizumab is combined with Naratuximab emtansine.
DB15559,The risk or severity of adverse effects can be increased when Omalizumab is combined with Zenocutuzumab.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Omalizumab."
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin lispro.
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin lispro.
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin lispro.
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin lispro.
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin lispro.
DB00412,The risk or severity of congestive heart failure can be increased when Insulin lispro is combined with Rosiglitazone.
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin lispro.
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin lispro.
DB00187,Esmolol may increase the hypoglycemic activities of Insulin lispro.
DB00218,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Moxifloxacin.
DB00365,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Grepafloxacin.
DB00467,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enoxacin.
DB00487,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pefloxacin.
DB00537,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ciprofloxacin.
DB00685,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Trovafloxacin.
DB00779,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nalidixic acid.
DB00817,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosoxacin.
DB00827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cinoxacin.
DB00978,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Lomefloxacin.
DB01044,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gatifloxacin.
DB01059,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Norfloxacin.
DB01137,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levofloxacin.
DB01155,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Gemifloxacin.
DB01165,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ofloxacin.
DB01208,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sparfloxacin.
DB01405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Temafloxacin.
DB04576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fleroxacin.
DB05488,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
DB06160,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Garenoxacin.
DB06600,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nemonoxacin.
DB08972,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Flumequine.
DB11404,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Enrofloxacin.
DB11443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Orbifloxacin.
DB11491,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sarafloxacin.
DB11511,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Difloxacin.
DB11774,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pazufloxacin.
DB11892,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Prulifloxacin.
DB11943,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Delafloxacin.
DB13261,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sitafloxacin.
DB13627,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxolinic acid.
DB13772,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rufloxacin.
DB13823,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pipemidic acid.
DB00232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methyclothiazide.
DB00310,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorthalidone.
DB00436,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Bendroflumethiazide.
DB00524,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Metolazone.
DB00562,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Benzthiazide.
DB00774,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroflumethiazide.
DB00808,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indapamide.
DB00880,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Polythiazide.
DB01325,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quinethazone.
DB13532,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyclopenthiazide.
DB13989,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epitizide.
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin lispro.
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin lispro.
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin lispro.
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin lispro.
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin lispro.
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin lispro.
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin lispro.
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin lispro.
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin lispro.
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin lispro.
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin lispro.
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin lispro.
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin lispro.
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin lispro.
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin lispro.
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin lispro.
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin lispro.
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin lispro.
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin lispro.
DB00007,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Leuprolide.
DB00014,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Goserelin.
DB00104,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Octreotide.
DB00220,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nelfinavir.
DB00224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Indinavir.
DB00246,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ziprasidone.
DB00294,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etonogestrel.
DB00304,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Desogestrel.
DB00334,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Olanzapine.
DB00351,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Megestrol acetate.
DB00363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Clozapine.
DB00367,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levonorgestrel.
DB00396,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Progesterone.
DB00477,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Chlorpromazine.
DB00502,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Haloperidol.
DB00503,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ritonavir.
DB00592,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Piperazine.
DB00603,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Medroxyprogesterone acetate.
DB00627,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Niacin.
DB00668,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Epinephrine.
DB00717,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norethisterone.
DB00734,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Risperidone.
DB00738,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pentamidine.
DB00823,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethynodiol diacetate.
DB00852,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pseudoephedrine.
DB00864,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tacrolimus.
DB00877,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Sirolimus.
DB00903,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Etacrynic acid.
DB00932,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Tipranavir.
DB00957,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Norgestimate.
DB00977,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ethinylestradiol.
DB01072,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Atazanavir.
DB01169,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Arsenic trioxide.
DB01224,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Quetiapine.
DB01232,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Saquinavir.
DB01238,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Aripiprazole.
DB01267,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Paliperidone.
DB01319,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Fosamprenavir.
DB01323,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with St. John's Wort.
DB01357,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Mestranol.
DB01363,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ephedra sinica root.
DB01395,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Drospirenone.
DB01403,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Methotrimeprazine.
DB01406,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Danazol.
DB01590,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Everolimus.
DB01601,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lopinavir.
DB01621,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pipotiazine.
DB02546,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Vorinostat.
DB04574,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Estrone sulfate.
DB04839,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Cyproterone acetate.
DB04868,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Nilotinib.
DB04946,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Iloperidone.
DB06216,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Asenapine.
DB06287,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Temsirolimus.
DB06663,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Pasireotide.
DB06719,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Buserelin.
DB06788,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Histrelin.
DB06789,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Hydroxyprogesterone caproate.
DB06791,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lanreotide.
DB06825,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Triptorelin.
DB08815,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Lurasidone.
DB08912,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dabrafenib.
DB09009,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Articaine.
DB09063,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Ceritinib.
DB09123,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Dienogest.
DB09128,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Brexpiprazole.
DB06343,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Teprotumumab.
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin lispro.
DB00624,Testosterone may increase the hypoglycemic activities of Insulin lispro.
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin lispro.
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin lispro.
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin lispro.
DB02901,Stanolone may increase the hypoglycemic activities of Insulin lispro.
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin lispro.
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin lispro.
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin lispro.
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin lispro.
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin lispro.
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin lispro.
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin lispro.
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin lispro.
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin lispro.
DB00215,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Citalopram.
DB00230,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Pregabalin.
DB00285,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Venlafaxine.
DB00328,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indomethacin.
DB01104,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sertraline.
DB01149,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nefazodone.
DB01175,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Escitalopram.
DB04832,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Zimelidine.
DB04884,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Dapoxetine.
DB04896,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Milnacipran.
DB06700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Desvenlafaxine.
DB08918,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Levomilnacipran.
DB08953,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Indalpine.
DB09270,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ubidecarenone.
DB12693,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ritanserin.
DB13233,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Alaproclate.
DB13358,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Cibenzoline.
DB14025,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Clinafloxacin.
DB09038,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Empagliflozin.
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin lispro.
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin lispro.
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin lispro.
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin lispro.
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin lispro.
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin lispro.
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin lispro.
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin lispro.
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin lispro.
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin lispro.
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin lispro.
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin lispro.
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin lispro.
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin lispro.
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin lispro.
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin lispro.
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin lispro.
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin lispro.
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin lispro.
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin lispro.
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin lispro.
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin lispro.
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin lispro.
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin lispro.
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin lispro.
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin lispro.
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin lispro.
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin lispro.
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin lispro.
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin lispro.
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin lispro.
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin lispro.
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin lispro.
DB01276,Exenatide may increase the hypoglycemic activities of Insulin lispro.
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin lispro.
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin lispro.
DB09265,Lixisenatide may increase the hypoglycemic activities of Insulin lispro.
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin lispro.
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin lispro.
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin lispro.
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin lispro.
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin lispro.
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin lispro.
DB01626,Pargyline may increase the hypoglycemic activities of Insulin lispro.
DB00805,Minaprine may increase the hypoglycemic activities of Insulin lispro.
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin lispro.
DB04820,Nialamide may increase the hypoglycemic activities of Insulin lispro.
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin lispro.
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin lispro.
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin lispro.
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin lispro.
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin lispro.
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin lispro.
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin lispro.
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin lispro.
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin lispro.
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin lispro.
DB09253,Safrazine may increase the hypoglycemic activities of Insulin lispro.
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin lispro.
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin lispro.
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin lispro."
DB13875,Harmaline may increase the hypoglycemic activities of Insulin lispro.
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin lispro.
DB00721,Procaine may increase the hypoglycemic activities of Insulin lispro.
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin lispro.
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin lispro.
DB00601,Linezolid may increase the hypoglycemic activities of Insulin lispro.
DB06654,Safinamide may increase the hypoglycemic activities of Insulin lispro.
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin lispro.
DB11827,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ertugliflozin.
DB00203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sildenafil.
DB00214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Torasemide.
DB00263,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfisoxazole.
DB00311,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Ethoxzolamide.
DB00359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadiazine.
DB00482,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celecoxib.
DB00559,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bosentan.
DB00576,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethizole.
DB00606,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cyclothiazide.
DB00664,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametopyrazine.
DB00669,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sumatriptan.
DB00695,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Furosemide.
DB00706,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tamsulosin.
DB00819,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetazolamide.
DB00887,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bumetanide.
DB00891,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfapyridine.
DB00909,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Zonisamide.
DB01015,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxazole.
DB01032,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Probenecid.
DB01098,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Rosuvastatin.
DB01119,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diazoxide.
DB01144,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Diclofenamide.
DB01264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Darunavir.
DB01298,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfacytine.
DB01299,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadoxine.
DB01382,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Glymidine.
DB01581,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamerazine.
DB01582,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethazine.
DB02925,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Piretanide.
DB04707,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxyfasudil.
DB06150,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadimethoxine.
DB06290,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Simeprevir.
DB06729,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaphenazole.
DB06821,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfameter.
DB07996,The therapeutic efficacy of Insulin lispro can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.
DB08162,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fasudil.
DB08798,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamoxole.
DB08881,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Vemurafenib.
DB08961,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Azosemide.
DB11389,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorsulon.
DB11461,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfachlorpyridazine.
DB11462,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaethoxypyridazine.
DB11463,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfanitran.
DB11464,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaquinoxaline.
DB12051,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Setrobuvir.
DB12921,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Chlorsulfaquinoxaline.
DB13214,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfadicramide.
DB13248,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phthalylsulfathiazole.
DB13283,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaisodimidine.
DB13284,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Meticrane.
DB13320,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaperin.
DB13405,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mefruside.
DB13430,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mebutizide.
DB13485,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfametomidine.
DB13547,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfatolamide.
DB13556,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamazone.
DB13580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Succinylsulfathiazole.
DB13617,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clorexolone.
DB13663,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clofenamide.
DB13699,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfathiourea.
DB13708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Fenquizone.
DB13726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfaguanidine.
DB13773,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Sulfamethoxypyridazine.
DB13792,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Clopamide.
DB13803,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Xipamide.
DB14033,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acetyl sulfisoxazole.
DB14708,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tosylchloramide.
DB00703,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Methazolamide.
DB06370,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indisulam.
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin lispro.
DB00184,The metabolism of Nicotine can be increased when combined with Insulin lispro.
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin lispro.
DB00201,The metabolism of Caffeine can be increased when combined with Insulin lispro.
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin lispro.
DB00262,The metabolism of Carmustine can be increased when combined with Insulin lispro.
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin lispro.
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin lispro.
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin lispro.
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin lispro.
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin lispro.
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin lispro.
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin lispro.
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin lispro.
DB00382,The metabolism of Tacrine can be increased when combined with Insulin lispro.
DB00384,The metabolism of Triamterene can be increased when combined with Insulin lispro.
DB00420,The metabolism of Promazine can be increased when combined with Insulin lispro.
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin lispro.
DB00442,The metabolism of Entecavir can be increased when combined with Insulin lispro.
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin lispro.
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin lispro.
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin lispro.
DB00499,The metabolism of Flutamide can be increased when combined with Insulin lispro.
DB00518,The metabolism of Albendazole can be increased when combined with Insulin lispro.
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin lispro.
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin lispro.
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin lispro.
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin lispro.
DB00619,The metabolism of Imatinib can be increased when combined with Insulin lispro.
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin lispro.
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin lispro.
DB00661,The metabolism of Verapamil can be increased when combined with Insulin lispro.
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin lispro.
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin lispro.
DB00740,The metabolism of Riluzole can be increased when combined with Insulin lispro.
DB00744,The metabolism of Zileuton can be increased when combined with Insulin lispro.
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin lispro.
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin lispro.
DB00788,The metabolism of Naproxen can be increased when combined with Insulin lispro.
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin lispro.
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin lispro.
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin lispro.
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin lispro.
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin lispro.
DB00898,The metabolism of Ethanol can be increased when combined with Insulin lispro.
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin lispro.
DB00969,The metabolism of Alosetron can be increased when combined with Insulin lispro.
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin lispro.
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin lispro.
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin lispro.
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin lispro.
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin lispro.
DB01037,The metabolism of Selegiline can be increased when combined with Insulin lispro.
DB01056,The metabolism of Tocainide can be increased when combined with Insulin lispro.
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin lispro.
DB01065,The metabolism of Melatonin can be increased when combined with Insulin lispro.
DB01087,The metabolism of Primaquine can be increased when combined with Insulin lispro.
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin lispro.
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin lispro.
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin lispro.
DB01184,The metabolism of Domperidone can be increased when combined with Insulin lispro.
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin lispro.
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin lispro.
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin lispro.
DB01412,The metabolism of Theobromine can be increased when combined with Insulin lispro.
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin lispro.
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin lispro.
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin lispro.
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin lispro.
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin lispro.
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin lispro.
DB01645,The metabolism of Genistein can be increased when combined with Insulin lispro.
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin lispro.
DB02134,The metabolism of Xanthine can be increased when combined with Insulin lispro.
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin lispro.
DB02568,The metabolism of Peldesine can be increased when combined with Insulin lispro.
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin lispro.
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin lispro.
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin lispro.
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin lispro.
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin lispro.
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin lispro.
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin lispro.
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin lispro.
DB05676,The metabolism of Apremilast can be increased when combined with Insulin lispro.
DB06148,The metabolism of Mianserin can be increased when combined with Insulin lispro.
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin lispro.
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin lispro.
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin lispro.
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin lispro.
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin lispro.
DB06626,The metabolism of Axitinib can be increased when combined with Insulin lispro.
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin lispro.
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin lispro.
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin lispro.
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin lispro.
DB08883,The metabolism of Perampanel can be increased when combined with Insulin lispro.
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin lispro.
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin lispro.
DB09225,The metabolism of Zotepine can be increased when combined with Insulin lispro.
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin lispro.
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin lispro.
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin lispro.
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin lispro.
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin lispro.
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin lispro.
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin lispro.
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin lispro.
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin lispro.
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin lispro.
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin lispro.
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin lispro.
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin lispro.
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin lispro.
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin lispro.
DB13573,The metabolism of Acefylline can be increased when combined with Insulin lispro.
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin lispro.
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin lispro.
DB13812,The metabolism of Bufylline can be increased when combined with Insulin lispro.
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin lispro.
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin lispro.
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin lispro.
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin lispro.
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin lispro.
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin lispro.
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin lispro.
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin lispro.
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin lispro.
DB00972,The metabolism of Azelastine can be increased when combined with Insulin lispro.
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin lispro.
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin lispro.
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin lispro.
DB01195,The metabolism of Flecainide can be increased when combined with Insulin lispro.
DB00783,The metabolism of Estradiol can be increased when combined with Insulin lispro.
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin lispro.
DB00458,The metabolism of Imipramine can be increased when combined with Insulin lispro.
DB01142,The metabolism of Doxepin can be increased when combined with Insulin lispro.
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin lispro.
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin lispro.
DB00575,The metabolism of Clonidine can be increased when combined with Insulin lispro.
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin lispro.
DB01151,The metabolism of Desipramine can be increased when combined with Insulin lispro.
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin lispro.
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin lispro.
DB00277,The metabolism of Theophylline can be increased when combined with Insulin lispro.
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin lispro.
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin lispro.
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin lispro.
DB00682,The metabolism of Warfarin can be increased when combined with Insulin lispro.
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin lispro.
DB00773,The metabolism of Etoposide can be increased when combined with Insulin lispro.
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin lispro.
DB01100,The metabolism of Pimozide can be increased when combined with Insulin lispro.
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin lispro.
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin lispro.
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin lispro.
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin lispro.
DB09256,The metabolism of Tegafur can be increased when combined with Insulin lispro.
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin lispro.
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin lispro.
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin lispro.
DB00047,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.
DB00071,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin pork.
DB00197,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Troglitazone.
DB00222,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glimepiride.
DB00280,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Disopyramide.
DB00284,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acarbose.
DB00414,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Acetohexamide.
DB00468,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Quinine.
DB00491,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Miglitol.
DB00672,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Chlorpropamide.
DB00731,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Nateglinide.
DB00834,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mifepristone.
DB00839,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolazamide.
DB00912,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Repaglinide.
DB00914,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Phenformin.
DB01016,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glyburide.
DB01067,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glipizide.
DB01120,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliclazide.
DB01124,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tolbutamide.
DB01200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Bromocriptine.
DB01251,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gliquidone.
DB01252,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mitiglinide.
DB01268,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sunitinib.
DB01277,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Mecasermin.
DB01289,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glisoxepide.
DB01306,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin aspart.
DB01307,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin detemir.
DB01309,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glulisine.
DB01700,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with AICA ribonucleotide.
DB04830,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Buformin.
DB04878,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Voglibose.
DB05115,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NN344.
DB05819,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with NBI-6024.
DB08962,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Glibornuride.
DB09022,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Benfluorex.
DB09198,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Lobeglitazone.
DB09199,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Netoglitazone.
DB09200,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Rivoglitazone.
DB09201,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ciglitazone.
DB09456,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin beef.
DB09564,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin degludec.
DB11567,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin peglispro.
DB11568,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin tregopil.
DB11698,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Ipragliflozin.
DB11780,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Allicin.
DB11824,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tofogliflozin.
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with 2,4-thiazolidinedione."
DB12713,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Sotagliflozin.
DB12781,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Balaglitazone.
DB12935,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Remogliflozin etabonate.
DB13406,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Carbutamide.
DB13446,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Guar gum.
DB13675,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Metahexamide.
DB14035,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Englitazone.
DB15171,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Tirzepatide.
DB15217,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Gastric inhibitory polypeptide.
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin lispro.
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin lispro.
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin lispro.
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin lispro.
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin lispro.
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin lispro.
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin lispro.
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin lispro.
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin lispro.
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin lispro.
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin lispro.
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin lispro.
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin lispro.
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin lispro.
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin lispro.
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin lispro.
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin lispro.
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin lispro.
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin lispro.
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin lispro.
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin lispro.
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin lispro.
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin lispro.
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin lispro.
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin lispro.
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin lispro.
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin lispro.
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin lispro.
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin lispro.
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin lispro.
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin lispro.
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin lispro.
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin lispro.
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin lispro.
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin lispro.
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin lispro.
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin lispro.
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin lispro.
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin lispro.
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin lispro.
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin lispro.
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin lispro.
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin lispro.
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin lispro.
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin lispro.
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin lispro.
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin lispro.
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin lispro.
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin lispro.
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin lispro.
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin lispro.
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin lispro.
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin lispro.
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin lispro.
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin lispro.
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin lispro.
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin lispro.
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin lispro.
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin lispro.
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin lispro.
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin lispro.
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin lispro.
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin lispro.
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin lispro.
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin lispro.
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin lispro.
DB00191,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Phentermine.
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin lispro.
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin lispro.
DB00279,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Liothyronine.
DB00331,The risk or severity of adverse effects can be increased when Insulin lispro is combined with Metformin.
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin lispro.
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin lispro.
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin lispro.
DB00181,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Baclofen.
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin lispro.
DB00196,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Fluconazole.
DB00040,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Glucagon.
DB00264,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Metoprolol.
DB00335,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Atenolol.
DB00373,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Timolol.
DB00598,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Labetalol.
DB00612,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bisoprolol.
DB00866,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Alprenolol.
DB00960,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Pindolol.
DB01193,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Acebutolol.
DB01203,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nadolol.
DB01295,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bevantolol.
DB01297,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Practolol.
DB01359,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Penbutolol.
DB01580,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Oxprenolol.
DB03322,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Dexpropranolol.
DB04846,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Celiprolol.
DB04861,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Nebivolol.
DB06726,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bufuralol.
DB08807,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bopindolol.
DB08808,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bupranolol.
DB08952,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Indenolol.
DB09013,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Befunolol.
DB09204,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Arotinolol.
DB09351,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Levobetaxolol.
DB11770,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Talinolol.
DB11785,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Anisodamine.
DB12212,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Landiolol.
DB12752,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Bucindolol.
DB13443,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Esatenolol.
DB13508,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Cloranolol.
DB13530,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Mepindolol.
DB13757,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Epanolol.
DB13775,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Tertatolol.
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin lispro.
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin lispro.
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin lispro.
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin lispro.
DB01611,The therapeutic efficacy of Insulin lispro can be increased when used in combination with Hydroxychloroquine.
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin lispro.
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin lispro.
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin lispro.
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin lispro.
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin lispro.
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin lispro.
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin lispro.
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin lispro.
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin lispro.
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin lispro.
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin lispro.
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin lispro.
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin lispro.
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin lispro.
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin lispro.
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin lispro.
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin lispro.
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin lispro.
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin lispro.
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin lispro.
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin lispro.
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin lispro.
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin lispro.
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin lispro.
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin lispro.
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin lispro.
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin lispro.
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin lispro.
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin lispro.
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin lispro.
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin lispro.
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin lispro.
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin lispro.
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin lispro.
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin lispro.
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin lispro.
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin lispro.
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin lispro.
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin lispro.
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin lispro.
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin lispro.
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin lispro.
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin lispro.
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin lispro.
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin lispro.
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin lispro.
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin lispro.
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin lispro.
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin lispro.
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin lispro.
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin lispro.
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin lispro.
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin lispro.
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin lispro.
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin lispro.
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin lispro.
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin lispro.
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin lispro.
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin lispro.
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin lispro.
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin lispro.
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin lispro.
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin lispro.
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin lispro.
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin lispro.
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin lispro.
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin lispro.
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin lispro.
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin lispro.
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin lispro.
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin lispro.
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin lispro.
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin lispro.
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin lispro.
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin lispro.
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin lispro.
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin lispro.
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin lispro.
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin lispro.
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin lispro.
DB00451,The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Levothyroxine.
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin lispro.
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin lispro.
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin lispro.
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin lispro."
DB06655,Liraglutide may increase the hypoglycemic activities of Insulin glargine.
DB09046,Metreleptin may increase the hypoglycemic activities of Insulin glargine.
DB00082,The risk or severity of hypoglycemia can be increased when Pegvisomant is combined with Insulin glargine.
DB01132,The risk or severity of adverse effects can be increased when Pioglitazone is combined with Insulin glargine.
DB01278,Pramlintide may increase the hypoglycemic activities of Insulin glargine.
DB00412,The risk or severity of congestive heart failure can be increased when Insulin glargine is combined with Rosiglitazone.
DB00166,The risk or severity of hypoglycemia can be increased when Lipoic acid is combined with Insulin glargine.
DB00974,Edetic acid may increase the hypoglycemic activities of Insulin glargine.
DB00187,Esmolol may increase the hypoglycemic activities of Insulin glargine.
DB01044,The therapeutic efficacy of Gatifloxacin can be increased when used in combination with Insulin glargine.
DB00218,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Moxifloxacin.
DB00467,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enoxacin.
DB00487,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pefloxacin.
DB00537,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ciprofloxacin.
DB00685,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Trovafloxacin.
DB00779,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nalidixic acid.
DB00817,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosoxacin.
DB00827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cinoxacin.
DB01059,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Norfloxacin.
DB01137,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levofloxacin.
DB01155,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Gemifloxacin.
DB01165,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ofloxacin.
DB01208,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sparfloxacin.
DB04576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fleroxacin.
DB05488,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Technetium Tc-99m ciprofloxacin.
DB06160,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Garenoxacin.
DB06600,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nemonoxacin.
DB08972,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Flumequine.
DB11404,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Enrofloxacin.
DB11443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Orbifloxacin.
DB11491,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sarafloxacin.
DB11511,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Difloxacin.
DB11774,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pazufloxacin.
DB11892,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Prulifloxacin.
DB11943,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Delafloxacin.
DB13261,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sitafloxacin.
DB13627,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxolinic acid.
DB13772,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rufloxacin.
DB13823,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pipemidic acid.
DB00232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methyclothiazide.
DB00310,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorthalidone.
DB00436,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bendroflumethiazide.
DB00524,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Metolazone.
DB00562,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Benzthiazide.
DB00774,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroflumethiazide.
DB00808,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indapamide.
DB00880,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Polythiazide.
DB01325,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quinethazone.
DB13532,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclopenthiazide.
DB13989,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epitizide.
DB00344,Protriptyline may decrease the hypoglycemic activities of Insulin glargine.
DB00543,Amoxapine may decrease the hypoglycemic activities of Insulin glargine.
DB00726,Trimipramine may decrease the hypoglycemic activities of Insulin glargine.
DB04836,Amineptine may decrease the hypoglycemic activities of Insulin glargine.
DB08996,Dimetacrine may decrease the hypoglycemic activities of Insulin glargine.
DB09016,Butriptyline may decrease the hypoglycemic activities of Insulin glargine.
DB09167,Dosulepin may decrease the hypoglycemic activities of Insulin glargine.
DB09289,Tianeptine may decrease the hypoglycemic activities of Insulin glargine.
DB09307,Oxaprotiline may decrease the hypoglycemic activities of Insulin glargine.
DB12930,Opipramol may decrease the hypoglycemic activities of Insulin glargine.
DB13114,Amitriptylinoxide may decrease the hypoglycemic activities of Insulin glargine.
DB13225,Dibenzepin may decrease the hypoglycemic activities of Insulin glargine.
DB13246,Quinupramine may decrease the hypoglycemic activities of Insulin glargine.
DB13384,Melitracen may decrease the hypoglycemic activities of Insulin glargine.
DB13411,Lofepramine may decrease the hypoglycemic activities of Insulin glargine.
DB13496,Iprindole may decrease the hypoglycemic activities of Insulin glargine.
DB13782,Imipramine oxide may decrease the hypoglycemic activities of Insulin glargine.
DB06292,Dapagliflozin may increase the hypoglycemic activities of Insulin glargine.
DB08907,Canagliflozin may increase the hypoglycemic activities of Insulin glargine.
DB00007,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Leuprolide.
DB00014,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Goserelin.
DB00104,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Octreotide.
DB00214,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Torasemide.
DB00220,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nelfinavir.
DB00224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Indinavir.
DB00246,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ziprasidone.
DB00294,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etonogestrel.
DB00304,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Desogestrel.
DB00334,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Olanzapine.
DB00351,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Megestrol acetate.
DB00363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Clozapine.
DB00367,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levonorgestrel.
DB00396,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Progesterone.
DB00477,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Chlorpromazine.
DB00502,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Haloperidol.
DB00503,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ritonavir.
DB00592,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Piperazine.
DB00603,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Medroxyprogesterone acetate.
DB00606,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyclothiazide.
DB00627,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Niacin.
DB00668,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Epinephrine.
DB00695,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Furosemide.
DB00717,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norethisterone.
DB00734,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Risperidone.
DB00738,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pentamidine.
DB00823,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethynodiol diacetate.
DB00852,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pseudoephedrine.
DB00864,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tacrolimus.
DB00877,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Sirolimus.
DB00887,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Bumetanide.
DB00903,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Etacrynic acid.
DB00932,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Tipranavir.
DB00957,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Norgestimate.
DB00977,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ethinylestradiol.
DB01072,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Atazanavir.
DB01119,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Diazoxide.
DB01169,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Arsenic trioxide.
DB01224,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Quetiapine.
DB01232,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Saquinavir.
DB01238,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Aripiprazole.
DB01264,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Darunavir.
DB01267,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Paliperidone.
DB01319,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Fosamprenavir.
DB01323,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with St. John's Wort.
DB01357,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mestranol.
DB01363,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ephedra sinica root.
DB01395,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Drospirenone.
DB01403,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Methotrimeprazine.
DB01406,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Danazol.
DB01590,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Everolimus.
DB01601,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lopinavir.
DB01621,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pipotiazine.
DB02546,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Vorinostat.
DB04574,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Estrone sulfate.
DB04839,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Cyproterone acetate.
DB04868,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Nilotinib.
DB04946,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Iloperidone.
DB06216,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Asenapine.
DB06287,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Temsirolimus.
DB06663,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Pasireotide.
DB06719,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Buserelin.
DB06788,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Histrelin.
DB06789,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Hydroxyprogesterone caproate.
DB06791,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lanreotide.
DB06825,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Triptorelin.
DB08815,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Lurasidone.
DB08912,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dabrafenib.
DB09009,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Articaine.
DB09063,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Ceritinib.
DB09123,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Dienogest.
DB09128,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Brexpiprazole.
DB13430,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Mebutizide.
DB06343,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Teprotumumab.
DB00621,Oxandrolone may increase the hypoglycemic activities of Insulin glargine.
DB00624,Testosterone may increase the hypoglycemic activities of Insulin glargine.
DB00984,Nandrolone phenpropionate may increase the hypoglycemic activities of Insulin glargine.
DB01185,Fluoxymesterone may increase the hypoglycemic activities of Insulin glargine.
DB01420,Testosterone propionate may increase the hypoglycemic activities of Insulin glargine.
DB02901,Stanolone may increase the hypoglycemic activities of Insulin glargine.
DB06412,Oxymetholone may increase the hypoglycemic activities of Insulin glargine.
DB06710,Methyltestosterone may increase the hypoglycemic activities of Insulin glargine.
DB06718,Stanozolol may increase the hypoglycemic activities of Insulin glargine.
DB08804,Nandrolone decanoate may increase the hypoglycemic activities of Insulin glargine.
DB12461,GLPG-0492 may increase the hypoglycemic activities of Insulin glargine.
DB13169,Nandrolone may increase the hypoglycemic activities of Insulin glargine.
DB13587,Mesterolone may increase the hypoglycemic activities of Insulin glargine.
DB13943,Testosterone cypionate may increase the hypoglycemic activities of Insulin glargine.
DB13944,Testosterone enanthate may increase the hypoglycemic activities of Insulin glargine.
DB00215,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Citalopram.
DB00230,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Pregabalin.
DB00285,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Venlafaxine.
DB00328,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indomethacin.
DB01104,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sertraline.
DB01149,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nefazodone.
DB01175,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Escitalopram.
DB04832,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Zimelidine.
DB04884,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Dapoxetine.
DB04896,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Milnacipran.
DB06700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Desvenlafaxine.
DB08918,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Levomilnacipran.
DB08953,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Indalpine.
DB09270,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ubidecarenone.
DB12693,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ritanserin.
DB13233,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Alaproclate.
DB13358,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Cibenzoline.
DB14025,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Clinafloxacin.
DB09038,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Empagliflozin.
DB00233,Aminosalicylic acid may increase the hypoglycemic activities of Insulin glargine.
DB00244,Mesalazine may increase the hypoglycemic activities of Insulin glargine.
DB00795,Sulfasalazine may increase the hypoglycemic activities of Insulin glargine.
DB00861,Diflunisal may increase the hypoglycemic activities of Insulin glargine.
DB00936,Salicylic acid may increase the hypoglycemic activities of Insulin glargine.
DB01014,Balsalazide may increase the hypoglycemic activities of Insulin glargine.
DB01250,Olsalazine may increase the hypoglycemic activities of Insulin glargine.
DB01294,Bismuth subsalicylate may increase the hypoglycemic activities of Insulin glargine.
DB06251,Dersalazine may increase the hypoglycemic activities of Insulin glargine.
DB06807,Phenyl aminosalicylate may increase the hypoglycemic activities of Insulin glargine.
DB09543,Methyl salicylate may increase the hypoglycemic activities of Insulin glargine.
DB11079,Trolamine salicylate may increase the hypoglycemic activities of Insulin glargine.
DB12445,Nitroaspirin may increase the hypoglycemic activities of Insulin glargine.
DB13509,Aloxiprin may increase the hypoglycemic activities of Insulin glargine.
DB13538,Guacetisal may increase the hypoglycemic activities of Insulin glargine.
DB13612,Carbaspirin calcium may increase the hypoglycemic activities of Insulin glargine.
DB14006,Choline salicylate may increase the hypoglycemic activities of Insulin glargine.
DB14026,Thiosalicylic acid may increase the hypoglycemic activities of Insulin glargine.
DB01261,Sitagliptin may increase the hypoglycemic activities of Insulin glargine.
DB04876,Vildagliptin may increase the hypoglycemic activities of Insulin glargine.
DB06011,AMG-222 may increase the hypoglycemic activities of Insulin glargine.
DB06127,Bisegliptin may increase the hypoglycemic activities of Insulin glargine.
DB06203,Alogliptin may increase the hypoglycemic activities of Insulin glargine.
DB06335,Saxagliptin may increase the hypoglycemic activities of Insulin glargine.
DB08382,Gosogliptin may increase the hypoglycemic activities of Insulin glargine.
DB08882,Linagliptin may increase the hypoglycemic activities of Insulin glargine.
DB11723,Dutogliptin may increase the hypoglycemic activities of Insulin glargine.
DB11950,Teneligliptin may increase the hypoglycemic activities of Insulin glargine.
DB11992,Omarigliptin may increase the hypoglycemic activities of Insulin glargine.
DB12268,Carmegliptin may increase the hypoglycemic activities of Insulin glargine.
DB12412,Gemigliptin may increase the hypoglycemic activities of Insulin glargine.
DB12417,Anagliptin may increase the hypoglycemic activities of Insulin glargine.
DB12625,Evogliptin may increase the hypoglycemic activities of Insulin glargine.
DB01276,Exenatide may increase the hypoglycemic activities of Insulin glargine.
DB09043,Albiglutide may increase the hypoglycemic activities of Insulin glargine.
DB09045,Dulaglutide may increase the hypoglycemic activities of Insulin glargine.
DB13928,Semaglutide may increase the hypoglycemic activities of Insulin glargine.
DB14027,Taspoglutide may increase the hypoglycemic activities of Insulin glargine.
DB00752,Tranylcypromine may increase the hypoglycemic activities of Insulin glargine.
DB00780,Phenelzine may increase the hypoglycemic activities of Insulin glargine.
DB01171,Moclobemide may increase the hypoglycemic activities of Insulin glargine.
DB01247,Isocarboxazid may increase the hypoglycemic activities of Insulin glargine.
DB01626,Pargyline may increase the hypoglycemic activities of Insulin glargine.
DB00805,Minaprine may increase the hypoglycemic activities of Insulin glargine.
DB04818,Iproniazid may increase the hypoglycemic activities of Insulin glargine.
DB04820,Nialamide may increase the hypoglycemic activities of Insulin glargine.
DB09244,Pirlindole may increase the hypoglycemic activities of Insulin glargine.
DB09245,Toloxatone may increase the hypoglycemic activities of Insulin glargine.
DB09243,Hydracarbazine may increase the hypoglycemic activities of Insulin glargine.
DB09241,Methylene blue may increase the hypoglycemic activities of Insulin glargine.
DB09246,Benmoxin may increase the hypoglycemic activities of Insulin glargine.
DB09248,Mebanazine may increase the hypoglycemic activities of Insulin glargine.
DB09249,Octamoxin may increase the hypoglycemic activities of Insulin glargine.
DB09250,Pheniprazine may increase the hypoglycemic activities of Insulin glargine.
DB09251,Phenoxypropazine may increase the hypoglycemic activities of Insulin glargine.
DB09252,Pivhydrazine may increase the hypoglycemic activities of Insulin glargine.
DB09253,Safrazine may increase the hypoglycemic activities of Insulin glargine.
DB09254,Caroxazone may increase the hypoglycemic activities of Insulin glargine.
DB00614,Furazolidone may increase the hypoglycemic activities of Insulin glargine.
DB08550,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Insulin glargine."
DB13875,Harmaline may increase the hypoglycemic activities of Insulin glargine.
DB13876,Brofaromine may increase the hypoglycemic activities of Insulin glargine.
DB00721,Procaine may increase the hypoglycemic activities of Insulin glargine.
DB00182,Amphetamine may increase the hypoglycemic activities of Insulin glargine.
DB01168,Procarbazine may increase the hypoglycemic activities of Insulin glargine.
DB00601,Linezolid may increase the hypoglycemic activities of Insulin glargine.
DB06654,Safinamide may increase the hypoglycemic activities of Insulin glargine.
DB04017,Clorgiline may increase the hypoglycemic activities of Insulin glargine.
DB11827,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ertugliflozin.
DB00203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sildenafil.
DB00263,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfisoxazole.
DB00311,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Ethoxzolamide.
DB00359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadiazine.
DB00482,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celecoxib.
DB00559,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bosentan.
DB00576,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethizole.
DB00664,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametopyrazine.
DB00669,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sumatriptan.
DB00706,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tamsulosin.
DB00819,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetazolamide.
DB00891,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfapyridine.
DB00909,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Zonisamide.
DB01015,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxazole.
DB01032,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Probenecid.
DB01144,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Diclofenamide.
DB01298,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfacytine.
DB01299,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadoxine.
DB01382,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Glymidine.
DB01581,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamerazine.
DB01582,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethazine.
DB02925,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Piretanide.
DB04707,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxyfasudil.
DB06150,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadimethoxine.
DB06290,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Simeprevir.
DB06729,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaphenazole.
DB06821,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfameter.
DB07996,The therapeutic efficacy of Insulin glargine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.
DB08162,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fasudil.
DB08798,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamoxole.
DB08881,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Vemurafenib.
DB08961,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Azosemide.
DB11389,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorsulon.
DB11461,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfachlorpyridazine.
DB11462,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaethoxypyridazine.
DB11463,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfanitran.
DB11464,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaquinoxaline.
DB12051,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Setrobuvir.
DB12921,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Chlorsulfaquinoxaline.
DB13214,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfadicramide.
DB13248,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phthalylsulfathiazole.
DB13283,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaisodimidine.
DB13284,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Meticrane.
DB13320,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaperin.
DB13405,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mefruside.
DB13485,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfametomidine.
DB13547,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfatolamide.
DB13556,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamazone.
DB13580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Succinylsulfathiazole.
DB13617,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clorexolone.
DB13663,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clofenamide.
DB13699,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfathiourea.
DB13708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Fenquizone.
DB13726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfaguanidine.
DB13773,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Sulfamethoxypyridazine.
DB13792,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Clopamide.
DB13803,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Xipamide.
DB14033,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acetyl sulfisoxazole.
DB14708,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tosylchloramide.
DB01098,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Rosuvastatin.
DB00703,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Methazolamide.
DB06370,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indisulam.
DB00176,The metabolism of Fluvoxamine can be increased when combined with Insulin glargine.
DB00184,The metabolism of Nicotine can be increased when combined with Insulin glargine.
DB00188,The metabolism of Bortezomib can be increased when combined with Insulin glargine.
DB00201,The metabolism of Caffeine can be increased when combined with Insulin glargine.
DB00261,The metabolism of Anagrelide can be increased when combined with Insulin glargine.
DB00262,The metabolism of Carmustine can be increased when combined with Insulin glargine.
DB00281,The metabolism of Lidocaine can be increased when combined with Insulin glargine.
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Insulin glargine.
DB00296,The metabolism of Ropivacaine can be increased when combined with Insulin glargine.
DB00315,The metabolism of Zolmitriptan can be increased when combined with Insulin glargine.
DB00316,The metabolism of Acetaminophen can be increased when combined with Insulin glargine.
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Insulin glargine.
DB00365,The metabolism of Grepafloxacin can be increased when combined with Insulin glargine.
DB00370,The metabolism of Mirtazapine can be increased when combined with Insulin glargine.
DB00379,The metabolism of Mexiletine can be increased when combined with Insulin glargine.
DB00382,The metabolism of Tacrine can be increased when combined with Insulin glargine.
DB00384,The metabolism of Triamterene can be increased when combined with Insulin glargine.
DB00420,The metabolism of Promazine can be increased when combined with Insulin glargine.
DB00425,The metabolism of Zolpidem can be increased when combined with Insulin glargine.
DB00442,The metabolism of Entecavir can be increased when combined with Insulin glargine.
DB00461,The metabolism of Nabumetone can be increased when combined with Insulin glargine.
DB00472,The metabolism of Fluoxetine can be increased when combined with Insulin glargine.
DB00476,The metabolism of Duloxetine can be increased when combined with Insulin glargine.
DB00499,The metabolism of Flutamide can be increased when combined with Insulin glargine.
DB00518,The metabolism of Albendazole can be increased when combined with Insulin glargine.
DB00533,The metabolism of Rofecoxib can be increased when combined with Insulin glargine.
DB00544,The metabolism of Fluorouracil can be increased when combined with Insulin glargine.
DB00568,The metabolism of Cinnarizine can be increased when combined with Insulin glargine.
DB00586,The metabolism of Diclofenac can be increased when combined with Insulin glargine.
DB00619,The metabolism of Imatinib can be increased when combined with Insulin glargine.
DB00629,The metabolism of Guanabenz can be increased when combined with Insulin glargine.
DB00642,The metabolism of Pemetrexed can be increased when combined with Insulin glargine.
DB00661,The metabolism of Verapamil can be increased when combined with Insulin glargine.
DB00715,The metabolism of Paroxetine can be increased when combined with Insulin glargine.
DB00730,The metabolism of Thiabendazole can be increased when combined with Insulin glargine.
DB00740,The metabolism of Riluzole can be increased when combined with Insulin glargine.
DB00744,The metabolism of Zileuton can be increased when combined with Insulin glargine.
DB00758,The metabolism of Clopidogrel can be increased when combined with Insulin glargine.
DB00787,The metabolism of Acyclovir can be increased when combined with Insulin glargine.
DB00788,The metabolism of Naproxen can be increased when combined with Insulin glargine.
DB00806,The metabolism of Pentoxifylline can be increased when combined with Insulin glargine.
DB00831,The metabolism of Trifluoperazine can be increased when combined with Insulin glargine.
DB00850,The metabolism of Perphenazine can be increased when combined with Insulin glargine.
DB00857,The metabolism of Terbinafine can be increased when combined with Insulin glargine.
DB00863,The metabolism of Ranitidine can be increased when combined with Insulin glargine.
DB00898,The metabolism of Ethanol can be increased when combined with Insulin glargine.
DB00934,The metabolism of Maprotiline can be increased when combined with Insulin glargine.
DB00969,The metabolism of Alosetron can be increased when combined with Insulin glargine.
DB00978,The metabolism of Lomefloxacin can be increased when combined with Insulin glargine.
DB00980,The metabolism of Ramelteon can be increased when combined with Insulin glargine.
DB00993,The metabolism of Azathioprine can be increased when combined with Insulin glargine.
DB00998,The metabolism of Frovatriptan can be increased when combined with Insulin glargine.
DB01002,The metabolism of Levobupivacaine can be increased when combined with Insulin glargine.
DB01012,The metabolism of Cinacalcet can be increased when combined with Insulin glargine.
DB01037,The metabolism of Selegiline can be increased when combined with Insulin glargine.
DB01056,The metabolism of Tocainide can be increased when combined with Insulin glargine.
DB01058,The metabolism of Praziquantel can be increased when combined with Insulin glargine.
DB01065,The metabolism of Melatonin can be increased when combined with Insulin glargine.
DB01087,The metabolism of Primaquine can be increased when combined with Insulin glargine.
DB01094,The metabolism of Hesperetin can be increased when combined with Insulin glargine.
DB01097,The metabolism of Leflunomide can be increased when combined with Insulin glargine.
DB01166,The metabolism of Cilostazol can be increased when combined with Insulin glargine.
DB01184,The metabolism of Domperidone can be increased when combined with Insulin glargine.
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Insulin glargine.
DB01303,The metabolism of Oxtriphylline can be increased when combined with Insulin glargine.
DB01367,The metabolism of Rasagiline can be increased when combined with Insulin glargine.
DB01405,The metabolism of Temafloxacin can be increased when combined with Insulin glargine.
DB01412,The metabolism of Theobromine can be increased when combined with Insulin glargine.
DB01424,The metabolism of Aminophenazone can be increased when combined with Insulin glargine.
DB01435,The metabolism of Antipyrine can be increased when combined with Insulin glargine.
DB01482,The metabolism of Fenethylline can be increased when combined with Insulin glargine.
DB01558,The metabolism of Bromazepam can be increased when combined with Insulin glargine.
DB01623,The metabolism of Thiothixene can be increased when combined with Insulin glargine.
DB01628,The metabolism of Etoricoxib can be increased when combined with Insulin glargine.
DB01645,The metabolism of Genistein can be increased when combined with Insulin glargine.
DB01667,The metabolism of 8-azaguanine can be increased when combined with Insulin glargine.
DB02134,The metabolism of Xanthine can be increased when combined with Insulin glargine.
DB02489,The metabolism of 9-Methylguanine can be increased when combined with Insulin glargine.
DB02568,The metabolism of Peldesine can be increased when combined with Insulin glargine.
DB02709,The metabolism of Resveratrol can be increased when combined with Insulin glargine.
DB03783,The metabolism of Phenacetin can be increased when combined with Insulin glargine.
DB04076,The metabolism of Hypoxanthine can be increased when combined with Insulin glargine.
DB04356,The metabolism of 9-Deazaguanine can be increased when combined with Insulin glargine.
DB04841,The metabolism of Flunarizine can be increased when combined with Insulin glargine.
DB04871,The metabolism of Lorcaserin can be increased when combined with Insulin glargine.
DB04948,The metabolism of Lofexidine can be increased when combined with Insulin glargine.
DB04951,The metabolism of Pirfenidone can be increased when combined with Insulin glargine.
DB05676,The metabolism of Apremilast can be increased when combined with Insulin glargine.
DB06148,The metabolism of Mianserin can be increased when combined with Insulin glargine.
DB06210,The metabolism of Eltrombopag can be increased when combined with Insulin glargine.
DB06235,The metabolism of Vadimezan can be increased when combined with Insulin glargine.
DB06479,The metabolism of Propentofylline can be increased when combined with Insulin glargine.
DB06589,The metabolism of Pazopanib can be increased when combined with Insulin glargine.
DB06594,The metabolism of Agomelatine can be increased when combined with Insulin glargine.
DB06626,The metabolism of Axitinib can be increased when combined with Insulin glargine.
DB06769,The metabolism of Bendamustine can be increased when combined with Insulin glargine.
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Insulin glargine.
DB06774,The metabolism of Capsaicin can be increased when combined with Insulin glargine.
DB08496,The metabolism of (R)-warfarin can be increased when combined with Insulin glargine.
DB08883,The metabolism of Perampanel can be increased when combined with Insulin glargine.
DB09071,The metabolism of Tasimelteon can be increased when combined with Insulin glargine.
DB09118,The metabolism of Stiripentol can be increased when combined with Insulin glargine.
DB09225,The metabolism of Zotepine can be increased when combined with Insulin glargine.
DB09273,The metabolism of Doxofylline can be increased when combined with Insulin glargine.
DB09288,The metabolism of Propacetamol can be increased when combined with Insulin glargine.
DB09290,The metabolism of Ramosetron can be increased when combined with Insulin glargine.
DB11919,The metabolism of 6-O-benzylguanine can be increased when combined with Insulin glargine.
DB11967,The metabolism of Binimetinib can be increased when combined with Insulin glargine.
DB12026,The metabolism of Voxilaprevir can be increased when combined with Insulin glargine.
DB12245,The metabolism of Triclabendazole can be increased when combined with Insulin glargine.
DB12332,The metabolism of Rucaparib can be increased when combined with Insulin glargine.
DB12406,The metabolism of Lisofylline can be increased when combined with Insulin glargine.
DB12531,The metabolism of Lobucavir can be increased when combined with Insulin glargine.
DB12926,The metabolism of Cafedrine can be increased when combined with Insulin glargine.
DB12927,The metabolism of Theodrenaline can be increased when combined with Insulin glargine.
DB12945,The metabolism of Dihydralazine can be increased when combined with Insulin glargine.
DB13203,The metabolism of Bamifylline can be increased when combined with Insulin glargine.
DB13449,The metabolism of Proxyphylline can be increased when combined with Insulin glargine.
DB13573,The metabolism of Acefylline can be increased when combined with Insulin glargine.
DB13592,The metabolism of Etamiphylline can be increased when combined with Insulin glargine.
DB13634,The metabolism of Pentifylline can be increased when combined with Insulin glargine.
DB13812,The metabolism of Bufylline can be increased when combined with Insulin glargine.
DB13952,The metabolism of Estradiol acetate can be increased when combined with Insulin glargine.
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Insulin glargine.
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Insulin glargine.
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Insulin glargine.
DB13956,The metabolism of Estradiol valerate can be increased when combined with Insulin glargine.
DB14018,The metabolism of Bromotheophylline can be increased when combined with Insulin glargine.
DB14132,The metabolism of 8-chlorotheophylline can be increased when combined with Insulin glargine.
DB01115,The metabolism of Nifedipine can be increased when combined with Insulin glargine.
DB11757,The metabolism of Istradefylline can be increased when combined with Insulin glargine.
DB00972,The metabolism of Azelastine can be increased when combined with Insulin glargine.
DB00625,The metabolism of Efavirenz can be increased when combined with Insulin glargine.
DB04889,The metabolism of Bicifadine can be increased when combined with Insulin glargine.
DB05708,The metabolism of GTS-21 can be increased when combined with Insulin glargine.
DB01195,The metabolism of Flecainide can be increased when combined with Insulin glargine.
DB00783,The metabolism of Estradiol can be increased when combined with Insulin glargine.
DB00321,The metabolism of Amitriptyline can be increased when combined with Insulin glargine.
DB00458,The metabolism of Imipramine can be increased when combined with Insulin glargine.
DB01142,The metabolism of Doxepin can be increased when combined with Insulin glargine.
DB00532,The metabolism of Mephenytoin can be increased when combined with Insulin glargine.
DB00540,The metabolism of Nortriptyline can be increased when combined with Insulin glargine.
DB00575,The metabolism of Clonidine can be increased when combined with Insulin glargine.
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Insulin glargine.
DB01151,The metabolism of Desipramine can be increased when combined with Insulin glargine.
DB01242,The metabolism of Clomipramine can be increased when combined with Insulin glargine.
DB11689,The metabolism of Selumetinib can be increased when combined with Insulin glargine.
DB00277,The metabolism of Theophylline can be increased when combined with Insulin glargine.
DB00398,The metabolism of Sorafenib can be increased when combined with Insulin glargine.
DB00530,The metabolism of Erlotinib can be increased when combined with Insulin glargine.
DB00564,The metabolism of Carbamazepine can be increased when combined with Insulin glargine.
DB00682,The metabolism of Warfarin can be increased when combined with Insulin glargine.
DB00697,The metabolism of Tizanidine can be increased when combined with Insulin glargine.
DB00773,The metabolism of Etoposide can be increased when combined with Insulin glargine.
DB00851,The metabolism of Dacarbazine can be increased when combined with Insulin glargine.
DB01100,The metabolism of Pimozide can be increased when combined with Insulin glargine.
DB01223,The metabolism of Aminophylline can be increased when combined with Insulin glargine.
DB01254,The metabolism of Dasatinib can be increased when combined with Insulin glargine.
DB01418,The metabolism of Acenocoumarol can be increased when combined with Insulin glargine.
DB08910,The metabolism of Pomalidomide can be increased when combined with Insulin glargine.
DB09256,The metabolism of Tegafur can be increased when combined with Insulin glargine.
DB13874,The metabolism of Enasidenib can be increased when combined with Insulin glargine.
DB00675,The metabolism of Tamoxifen can be increased when combined with Insulin glargine.
DB00030,The risk or severity of hypoglycemia can be increased when Insulin human is combined with Insulin glargine.
DB00046,The risk or severity of hypoglycemia can be increased when Insulin lispro is combined with Insulin glargine.
DB00071,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin pork.
DB00197,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Troglitazone.
DB00222,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glimepiride.
DB00280,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Disopyramide.
DB00284,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acarbose.
DB00414,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Acetohexamide.
DB00468,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Quinine.
DB00491,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Miglitol.
DB00672,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Chlorpropamide.
DB00731,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Nateglinide.
DB00834,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mifepristone.
DB00839,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolazamide.
DB00912,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Repaglinide.
DB00914,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Phenformin.
DB01016,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glyburide.
DB01067,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glipizide.
DB01120,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliclazide.
DB01124,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tolbutamide.
DB01200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Bromocriptine.
DB01251,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gliquidone.
DB01252,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mitiglinide.
DB01268,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sunitinib.
DB01277,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Mecasermin.
DB01289,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glisoxepide.
DB01306,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin aspart.
DB01307,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin detemir.
DB01309,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin glulisine.
DB01700,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with AICA ribonucleotide.
DB04830,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Buformin.
DB04878,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Voglibose.
DB05115,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NN344.
DB05819,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with NBI-6024.
DB08962,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Glibornuride.
DB09022,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Benfluorex.
DB09198,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Lobeglitazone.
DB09199,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Netoglitazone.
DB09200,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Rivoglitazone.
DB09201,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ciglitazone.
DB09456,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin beef.
DB09564,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin degludec.
DB11567,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin peglispro.
DB11568,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Insulin tregopil.
DB11698,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Ipragliflozin.
DB11780,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Allicin.
DB11824,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tofogliflozin.
DB11898,"The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with 2,4-thiazolidinedione."
DB12713,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Sotagliflozin.
DB12781,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Balaglitazone.
DB12935,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Remogliflozin etabonate.
DB13406,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Carbutamide.
DB13446,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Guar gum.
DB13675,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Metahexamide.
DB14035,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Englitazone.
DB15171,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Tirzepatide.
DB15217,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Gastric inhibitory polypeptide.
DB00270,The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glargine.
DB00343,The risk or severity of hypoglycemia can be increased when Diltiazem is combined with Insulin glargine.
DB00347,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Insulin glargine.
DB00381,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Insulin glargine.
DB00393,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Insulin glargine.
DB00401,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Insulin glargine.
DB00528,The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Insulin glargine.
DB00555,The risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Insulin glargine.
DB00593,The risk or severity of hypoglycemia can be increased when Ethosuximide is combined with Insulin glargine.
DB00622,The risk or severity of hypoglycemia can be increased when Nicardipine is combined with Insulin glargine.
DB00653,The risk or severity of hypoglycemia can be increased when Magnesium sulfate is combined with Insulin glargine.
DB00836,The risk or severity of hypoglycemia can be increased when Loperamide is combined with Insulin glargine.
DB01054,The risk or severity of hypoglycemia can be increased when Nitrendipine is combined with Insulin glargine.
DB01074,The risk or severity of hypoglycemia can be increased when Perhexiline is combined with Insulin glargine.
DB01244,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Insulin glargine.
DB01388,The risk or severity of hypoglycemia can be increased when Mibefradil is combined with Insulin glargine.
DB04743,The risk or severity of hypoglycemia can be increased when Nimesulide is combined with Insulin glargine.
DB04825,The risk or severity of hypoglycemia can be increased when Prenylamine is combined with Insulin glargine.
DB04838,The risk or severity of hypoglycemia can be increased when Cyclandelate is combined with Insulin glargine.
DB04842,The risk or severity of hypoglycemia can be increased when Fluspirilene is combined with Insulin glargine.
DB04920,The risk or severity of hypoglycemia can be increased when Clevidipine is combined with Insulin glargine.
DB05246,The risk or severity of hypoglycemia can be increased when Methsuximide is combined with Insulin glargine.
DB05885,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Insulin glargine.
DB06152,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Insulin glargine.
DB06283,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Insulin glargine.
DB06446,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Insulin glargine.
DB06694,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Insulin glargine.
DB06712,The risk or severity of hypoglycemia can be increased when Nilvadipine is combined with Insulin glargine.
DB07615,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Insulin glargine.
DB08838,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Insulin glargine.
DB08980,The risk or severity of hypoglycemia can be increased when Fendiline is combined with Insulin glargine.
DB08992,The risk or severity of hypoglycemia can be increased when Eperisone is combined with Insulin glargine.
DB09089,The risk or severity of hypoglycemia can be increased when Trimebutine is combined with Insulin glargine.
DB09090,The risk or severity of hypoglycemia can be increased when Pinaverium is combined with Insulin glargine.
DB09216,The risk or severity of hypoglycemia can be increased when Tolfenamic acid is combined with Insulin glargine.
DB09227,The risk or severity of hypoglycemia can be increased when Barnidipine is combined with Insulin glargine.
DB09229,The risk or severity of hypoglycemia can be increased when Aranidipine is combined with Insulin glargine.
DB09230,The risk or severity of hypoglycemia can be increased when Azelnidipine is combined with Insulin glargine.
DB09231,The risk or severity of hypoglycemia can be increased when Benidipine is combined with Insulin glargine.
DB09232,The risk or severity of hypoglycemia can be increased when Cilnidipine is combined with Insulin glargine.
DB09234,The risk or severity of hypoglycemia can be increased when Darodipine is combined with Insulin glargine.
DB09235,The risk or severity of hypoglycemia can be increased when Efonidipine is combined with Insulin glargine.
DB09236,The risk or severity of hypoglycemia can be increased when Lacidipine is combined with Insulin glargine.
DB09238,The risk or severity of hypoglycemia can be increased when Manidipine is combined with Insulin glargine.
DB09239,The risk or severity of hypoglycemia can be increased when Niguldipine is combined with Insulin glargine.
DB09240,The risk or severity of hypoglycemia can be increased when Niludipine is combined with Insulin glargine.
DB11960,The risk or severity of hypoglycemia can be increased when Carboxyamidotriazole is combined with Insulin glargine.
DB12092,The risk or severity of hypoglycemia can be increased when Naftopidil is combined with Insulin glargine.
DB12093,The risk or severity of hypoglycemia can be increased when Tetrahydropalmatine is combined with Insulin glargine.
DB12131,The risk or severity of hypoglycemia can be increased when Vinpocetine is combined with Insulin glargine.
DB12923,The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Insulin glargine.
DB13488,The risk or severity of hypoglycemia can be increased when Bencyclane is combined with Insulin glargine.
DB13500,The risk or severity of hypoglycemia can be increased when Otilonium is combined with Insulin glargine.
DB13725,The risk or severity of hypoglycemia can be increased when Terodiline is combined with Insulin glargine.
DB13766,The risk or severity of hypoglycemia can be increased when Lidoflazine is combined with Insulin glargine.
DB13791,The risk or severity of hypoglycemia can be increased when Penfluridol is combined with Insulin glargine.
DB13835,The risk or severity of hypoglycemia can be increased when Caroverine is combined with Insulin glargine.
DB13950,The risk or severity of hypoglycemia can be increased when WIN 55212-2 is combined with Insulin glargine.
DB13961,The risk or severity of hypoglycemia can be increased when Fish oil is combined with Insulin glargine.
DB14063,The risk or severity of hypoglycemia can be increased when Dexverapamil is combined with Insulin glargine.
DB14064,The risk or severity of hypoglycemia can be increased when Emopamil is combined with Insulin glargine.
DB14065,The risk or severity of hypoglycemia can be increased when Lomerizine is combined with Insulin glargine.
DB14066,The risk or severity of hypoglycemia can be increased when Tetrandrine is combined with Insulin glargine.
DB14068,The risk or severity of hypoglycemia can be increased when Dexniguldipine is combined with Insulin glargine.
DB01023,The risk or severity of hypoglycemia can be increased when Felodipine is combined with Insulin glargine.
DB01118,The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Insulin glargine.
DB00191,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Phentermine.
DB00268,The metabolism of Ropinirole can be increased when combined with Insulin glargine.
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Insulin glargine.
DB00279,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Liothyronine.
DB00331,The risk or severity of adverse effects can be increased when Insulin glargine is combined with Metformin.
DB00542,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Insulin glargine.
DB13946,The risk or severity of adverse effects can be increased when Testosterone undecanoate is combined with Insulin glargine.
DB00945,The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Insulin glargine.
DB00181,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Baclofen.
DB00489,The risk or severity of hypoglycemia can be increased when Sotalol is combined with Insulin glargine.
DB00196,The risk or severity of hypoglycemia can be increased when Insulin glargine is combined with Fluconazole.
DB00040,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Glucagon.
DB00264,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Metoprolol.
DB00335,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Atenolol.
DB00373,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Timolol.
DB00598,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Labetalol.
DB00612,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bisoprolol.
DB00866,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Alprenolol.
DB00960,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Pindolol.
DB01193,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Acebutolol.
DB01203,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nadolol.
DB01295,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bevantolol.
DB01297,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Practolol.
DB01359,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Penbutolol.
DB01580,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Oxprenolol.
DB03322,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Dexpropranolol.
DB04846,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Celiprolol.
DB04861,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Nebivolol.
DB06726,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bufuralol.
DB08807,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bopindolol.
DB08808,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bupranolol.
DB08952,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Indenolol.
DB09013,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Befunolol.
DB09204,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Arotinolol.
DB09351,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Levobetaxolol.
DB11770,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Talinolol.
DB11785,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Anisodamine.
DB12212,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Landiolol.
DB12752,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Bucindolol.
DB13443,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Esatenolol.
DB13508,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Cloranolol.
DB13530,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Mepindolol.
DB13757,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Epanolol.
DB13775,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Tertatolol.
DB00195,The therapeutic efficacy of Betaxolol can be increased when used in combination with Insulin glargine.
DB00571,The therapeutic efficacy of Propranolol can be increased when used in combination with Insulin glargine.
DB01136,The therapeutic efficacy of Carvedilol can be increased when used in combination with Insulin glargine.
DB01182,The therapeutic efficacy of Propafenone can be increased when used in combination with Insulin glargine.
DB01611,The therapeutic efficacy of Insulin glargine can be increased when used in combination with Hydroxychloroquine.
DB01233,The therapeutic efficacy of Metoclopramide can be increased when used in combination with Insulin glargine.
DB00394,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Insulin glargine.
DB00443,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Insulin glargine.
DB00620,The risk or severity of hyperglycemia can be increased when Triamcinolone is combined with Insulin glargine.
DB00635,The risk or severity of hyperglycemia can be increased when Prednisone is combined with Insulin glargine.
DB00687,The risk or severity of hyperglycemia can be increased when Fludrocortisone is combined with Insulin glargine.
DB00741,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Insulin glargine.
DB00764,The risk or severity of hyperglycemia can be increased when Mometasone is combined with Insulin glargine.
DB00860,The risk or severity of hyperglycemia can be increased when Prednisolone is combined with Insulin glargine.
DB00959,The risk or severity of hyperglycemia can be increased when Methylprednisolone is combined with Insulin glargine.
DB01234,The risk or severity of hyperglycemia can be increased when Dexamethasone is combined with Insulin glargine.
DB01285,The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Insulin glargine.
DB01380,The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Insulin glargine.
DB01384,The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Insulin glargine.
DB01410,The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Insulin glargine.
DB08906,The risk or severity of hyperglycemia can be increased when Fluticasone furoate is combined with Insulin glargine.
DB08970,The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Insulin glargine.
DB08971,The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Insulin glargine.
DB09383,The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Insulin glargine.
DB11487,The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Insulin glargine.
DB11750,The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Insulin glargine.
DB11921,The risk or severity of hyperglycemia can be increased when Deflazacort is combined with Insulin glargine.
DB13003,The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Insulin glargine.
DB13208,The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Insulin glargine.
DB13843,The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Insulin glargine.
DB13867,The risk or severity of hyperglycemia can be increased when Fluticasone is combined with Insulin glargine.
DB14512,The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Insulin glargine.
DB00180,The risk or severity of hyperglycemia can be increased when Flunisolide is combined with Insulin glargine.
DB01108,The risk or severity of hyperglycemia can be increased when Trilostane is combined with Insulin glargine.
DB01222,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin glargine.
DB04630,The risk or severity of hyperglycemia can be increased when Aldosterone is combined with Insulin glargine.
DB09378,The risk or severity of hyperglycemia can be increased when Fluprednisolone is combined with Insulin glargine.
DB11529,The risk or severity of hyperglycemia can be increased when Melengestrol is combined with Insulin glargine.
DB14681,The risk or severity of hyperglycemia can be increased when Cortisone is combined with Insulin glargine.
DB00223,The risk or severity of hyperglycemia can be increased when Diflorasone is combined with Insulin glargine.
DB00240,The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Insulin glargine.
DB00253,The risk or severity of hyperglycemia can be increased when Medrysone is combined with Insulin glargine.
DB00288,The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Insulin glargine.
DB00324,The risk or severity of hyperglycemia can be increased when Fluorometholone is combined with Insulin glargine.
DB00547,The risk or severity of hyperglycemia can be increased when Desoximetasone is combined with Insulin glargine.
DB00588,The risk or severity of hyperglycemia can be increased when Fluticasone propionate is combined with Insulin glargine.
DB00591,The risk or severity of hyperglycemia can be increased when Fluocinolone acetonide is combined with Insulin glargine.
DB00596,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Insulin glargine.
DB00663,The risk or severity of hyperglycemia can be increased when Flumethasone is combined with Insulin glargine.
DB00838,The risk or severity of hyperglycemia can be increased when Clocortolone is combined with Insulin glargine.
DB00846,The risk or severity of hyperglycemia can be increased when Flurandrenolide is combined with Insulin glargine.
DB14596,The risk or severity of hyperglycemia can be increased when Loteprednol etabonate is combined with Insulin glargine.
DB00896,The risk or severity of hyperglycemia can be increased when Rimexolone is combined with Insulin glargine.
DB01013,The risk or severity of hyperglycemia can be increased when Clobetasol propionate is combined with Insulin glargine.
DB01047,The risk or severity of hyperglycemia can be increased when Fluocinonide is combined with Insulin glargine.
DB01130,The risk or severity of hyperglycemia can be increased when Prednicarbate is combined with Insulin glargine.
DB01260,The risk or severity of hyperglycemia can be increased when Desonide is combined with Insulin glargine.
DB06781,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Insulin glargine.
DB06786,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Insulin glargine.
DB09091,The risk or severity of hyperglycemia can be increased when Tixocortol is combined with Insulin glargine.
DB09095,The risk or severity of hyperglycemia can be increased when Difluocortolone is combined with Insulin glargine.
DB13158,The risk or severity of hyperglycemia can be increased when Clobetasone is combined with Insulin glargine.
DB13223,The risk or severity of hyperglycemia can be increased when Fluocortin is combined with Insulin glargine.
DB13491,The risk or severity of hyperglycemia can be increased when Fluperolone is combined with Insulin glargine.
DB13664,The risk or severity of hyperglycemia can be increased when Formocortal is combined with Insulin glargine.
DB13728,The risk or severity of hyperglycemia can be increased when Halometasone is combined with Insulin glargine.
DB13856,The risk or severity of hyperglycemia can be increased when Fluclorolone is combined with Insulin glargine.
DB14538,The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Insulin glargine.
DB14539,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Insulin glargine.
DB14540,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Insulin glargine.
DB14541,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Insulin glargine.
DB14543,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Insulin glargine.
DB14544,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Insulin glargine.
DB14545,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Insulin glargine.
DB00873,The risk or severity of hyperglycemia can be increased when Loteprednol is combined with Insulin glargine.
DB14631,The risk or severity of hyperglycemia can be increased when Prednisolone phosphate is combined with Insulin glargine.
DB14633,The risk or severity of hyperglycemia can be increased when Prednisolone hemisuccinate is combined with Insulin glargine.
DB14634,The risk or severity of hyperglycemia can be increased when Fluprednidene acetate is combined with Insulin glargine.
DB14643,The risk or severity of hyperglycemia can be increased when Methylprednisolone aceponate is combined with Insulin glargine.
DB14644,The risk or severity of hyperglycemia can be increased when Methylprednisolone hemisuccinate is combined with Insulin glargine.
DB14646,The risk or severity of hyperglycemia can be increased when Prednisone acetate is combined with Insulin glargine.
DB14652,The risk or severity of hyperglycemia can be increased when Clocortolone acetate is combined with Insulin glargine.
DB14659,The risk or severity of hyperglycemia can be increased when Melengestrol acetate is combined with Insulin glargine.
DB14669,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Insulin glargine.
DB15566,The risk or severity of hyperglycemia can be increased when Prednisolone acetate is combined with Insulin glargine.
DB00451,The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Levothyroxine.
DB00024,Thyrotropin alfa may decrease the hypoglycemic activities of Insulin glargine.
DB01583,Liotrix may decrease the hypoglycemic activities of Insulin glargine.
DB03604,Tiratricol may decrease the hypoglycemic activities of Insulin glargine.
DB09100,"Thyroid, porcine may decrease the hypoglycemic activities of Insulin glargine."
DB00006,The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.
DB00054,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.
DB00266,The risk or severity of adverse effects can be increased when Dicoumarol is combined with Collagenase clostridium histolyticum.
DB00278,The risk or severity of adverse effects can be increased when Argatroban is combined with Collagenase clostridium histolyticum.
DB00407,The risk or severity of adverse effects can be increased when Ardeparin is combined with Collagenase clostridium histolyticum.
DB00498,The risk or severity of adverse effects can be increased when Phenindione is combined with Collagenase clostridium histolyticum.
DB00569,The risk or severity of adverse effects can be increased when Fondaparinux is combined with Collagenase clostridium histolyticum.
DB00682,The risk or severity of adverse effects can be increased when Warfarin is combined with Collagenase clostridium histolyticum.
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Collagenase clostridium histolyticum.
DB00946,The risk or severity of adverse effects can be increased when Phenprocoumon is combined with Collagenase clostridium histolyticum.
DB00974,The risk or severity of adverse effects can be increased when Edetic acid is combined with Collagenase clostridium histolyticum.
DB01109,The risk or severity of adverse effects can be increased when Heparin is combined with Collagenase clostridium histolyticum.
DB01225,The risk or severity of adverse effects can be increased when Enoxaparin is combined with Collagenase clostridium histolyticum.
DB01418,The risk or severity of adverse effects can be increased when Acenocoumarol is combined with Collagenase clostridium histolyticum.
DB04898,The risk or severity of adverse effects can be increased when Ximelagatran is combined with Collagenase clostridium histolyticum.
DB05099,The risk or severity of adverse effects can be increased when Ancrod is combined with Collagenase clostridium histolyticum.
DB06228,The risk or severity of adverse effects can be increased when Rivaroxaban is combined with Collagenase clostridium histolyticum.
DB06271,The risk or severity of adverse effects can be increased when Sulodexide is combined with Collagenase clostridium histolyticum.
DB06406,The risk or severity of adverse effects can be increased when Idraparinux is combined with Collagenase clostridium histolyticum.
DB06605,The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.
DB06635,The risk or severity of adverse effects can be increased when Otamixaban is combined with Collagenase clostridium histolyticum.
DB06695,The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Collagenase clostridium histolyticum.
DB06754,The risk or severity of adverse effects can be increased when Danaparoid is combined with Collagenase clostridium histolyticum.
DB06779,The risk or severity of adverse effects can be increased when Dalteparin is combined with Collagenase clostridium histolyticum.
DB07767,The risk or severity of adverse effects can be increased when Ferulic acid is combined with Collagenase clostridium histolyticum.
DB08794,The risk or severity of adverse effects can be increased when Ethyl biscoumacetate is combined with Collagenase clostridium histolyticum.
DB08813,The risk or severity of adverse effects can be increased when Nadroparin is combined with Collagenase clostridium histolyticum.
DB09075,The risk or severity of adverse effects can be increased when Edoxaban is combined with Collagenase clostridium histolyticum.
DB09255,The risk or severity of adverse effects can be increased when Dextran is combined with Collagenase clostridium histolyticum.
DB09259,The risk or severity of adverse effects can be increased when Reviparin is combined with Collagenase clostridium histolyticum.
DB09261,The risk or severity of adverse effects can be increased when Certoparin is combined with Collagenase clostridium histolyticum.
DB11095,The risk or severity of adverse effects can be increased when Desirudin is combined with Collagenase clostridium histolyticum.
DB11268,The risk or severity of adverse effects can be increased when Protocatechualdehyde is combined with Collagenase clostridium histolyticum.
DB11312,The risk or severity of adverse effects can be increased when Protein C is combined with Collagenase clostridium histolyticum.
DB11598,The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Collagenase clostridium histolyticum.
DB11984,The risk or severity of adverse effects can be increased when Letaxaban is combined with Collagenase clostridium histolyticum.
DB12289,The risk or severity of adverse effects can be increased when Darexaban is combined with Collagenase clostridium histolyticum.
DB12598,The risk or severity of adverse effects can be increased when Nafamostat is combined with Collagenase clostridium histolyticum.
DB12831,The risk or severity of adverse effects can be increased when Gabexate is combined with Collagenase clostridium histolyticum.
DB13124,The risk or severity of adverse effects can be increased when Troxerutin is combined with Collagenase clostridium histolyticum.
DB13136,The risk or severity of adverse effects can be increased when Fluindione is combined with Collagenase clostridium histolyticum.
DB13149,The risk or severity of adverse effects can be increased when Protein S human is combined with Collagenase clostridium histolyticum.
DB13616,The risk or severity of adverse effects can be increased when Melagatran is combined with Collagenase clostridium histolyticum.
DB09125,The risk or severity of adverse effects can be increased when Potassium citrate is combined with Collagenase clostridium histolyticum.
DB09154,The risk or severity of adverse effects can be increased when Sodium citrate is combined with Collagenase clostridium histolyticum.
DB00031,The risk or severity of adverse effects can be increased when Tenecteplase is combined with Collagenase clostridium histolyticum.
DB00055,The risk or severity of adverse effects can be increased when Drotrecogin alfa is combined with Collagenase clostridium histolyticum.
DB04932,The risk or severity of adverse effects can be increased when Defibrotide is combined with Collagenase clostridium histolyticum.
DB06822,The risk or severity of adverse effects can be increased when Tinzaparin is combined with Collagenase clostridium histolyticum.
DB13199,The risk or severity of adverse effects can be increased when Brinase is combined with Collagenase clostridium histolyticum.
DB13646,The risk or severity of adverse effects can be increased when Saruplase is combined with Collagenase clostridium histolyticum.
DB00086,The risk or severity of adverse effects can be increased when Streptokinase is combined with Collagenase clostridium histolyticum.
DB00945,The risk or severity of adverse effects can be increased when Acetylsalicylic acid is combined with Collagenase clostridium histolyticum.
DB04925,The risk or severity of adverse effects can be increased when Desmoteplase is combined with Collagenase clostridium histolyticum.
DB05254,The risk or severity of adverse effects can be increased when Fibrinolysin is combined with Collagenase clostridium histolyticum.
DB06543,The risk or severity of adverse effects can be increased when Astaxanthin is combined with Collagenase clostridium histolyticum.
DB00013,The risk or severity of adverse effects can be increased when Urokinase is combined with Collagenase clostridium histolyticum.
DB00975,The risk or severity of adverse effects can be increased when Dipyridamole is combined with Collagenase clostridium histolyticum.
DB01088,The risk or severity of adverse effects can be increased when Iloprost is combined with Collagenase clostridium histolyticum.
DB01240,The risk or severity of adverse effects can be increased when Epoprostenol is combined with Collagenase clostridium histolyticum.
DB05229,The risk or severity of adverse effects can be increased when Beraprost is combined with Collagenase clostridium histolyticum.
DB06209,The risk or severity of adverse effects can be increased when Prasugrel is combined with Collagenase clostridium histolyticum.
DB06441,The risk or severity of adverse effects can be increased when Cangrelor is combined with Collagenase clostridium histolyticum.
DB08814,The risk or severity of adverse effects can be increased when Triflusal is combined with Collagenase clostridium histolyticum.
DB08816,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Collagenase clostridium histolyticum.
DB08994,The risk or severity of adverse effects can be increased when Ditazole is combined with Collagenase clostridium histolyticum.
DB09030,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Collagenase clostridium histolyticum.
DB09258,The risk or severity of adverse effects can be increased when Bemiparin is combined with Collagenase clostridium histolyticum.
DB09260,The risk or severity of adverse effects can be increased when Parnaparin is combined with Collagenase clostridium histolyticum.
DB13275,The risk or severity of adverse effects can be increased when Clorindione is combined with Collagenase clostridium histolyticum.
DB13347,The risk or severity of adverse effects can be increased when Diphenadione is combined with Collagenase clostridium histolyticum.
DB13451,The risk or severity of adverse effects can be increased when Tioclomarol is combined with Collagenase clostridium histolyticum.
DB00001,The risk or severity of adverse effects can be increased when Lepirudin is combined with Collagenase clostridium histolyticum.
DB00009,The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.
DB00015,The risk or severity of adverse effects can be increased when Reteplase is combined with Collagenase clostridium histolyticum.
DB00029,The risk or severity of adverse effects can be increased when Anistreplase is combined with Collagenase clostridium histolyticum.
DB14094,The risk or severity of adverse effects can be increased when Tocopherylquinone is combined with Collagenase clostridium histolyticum.
DB06679,The risk or severity of adverse effects can be increased when Amediplase is combined with Collagenase clostridium histolyticum.
DB03410,The risk or severity of adverse effects can be increased when 4-hydroxycoumarin is combined with Collagenase clostridium histolyticum.
DB08496,The risk or severity of adverse effects can be increased when (R)-warfarin is combined with Collagenase clostridium histolyticum.
DB14055,The risk or severity of adverse effects can be increased when (S)-Warfarin is combined with Collagenase clostridium histolyticum.
DB12364,The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.
DB14598,The risk or severity of adverse effects can be increased when Edetate calcium disodium anhydrous is combined with Collagenase clostridium histolyticum.
DB11154,The risk or severity of adverse effects can be increased when Zinc citrate is combined with Collagenase clostridium histolyticum.
DB11166,The risk or severity of adverse effects can be increased when Antithrombin Alfa is combined with Collagenase clostridium histolyticum.
DB04665,The risk or severity of adverse effects can be increased when Coumarin is combined with Collagenase clostridium histolyticum.
DB14726,The risk or severity of adverse effects can be increased when Dabigatran is combined with Collagenase clostridium histolyticum.
DB06294,The risk or severity of adverse effects can be increased when Semuloparin is combined with Collagenase clostridium histolyticum.
DB12726,The risk or severity of adverse effects can be increased when Monteplase is combined with Collagenase clostridium histolyticum.
DB00232,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Methyclothiazide.
DB00436,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Bendroflumethiazide.
DB00562,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Benzthiazide.
DB00606,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclothiazide.
DB00774,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydroflumethiazide.
DB00880,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Chlorothiazide.
DB00999,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Hydrochlorothiazide.
DB01021,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Trichlormethiazide.
DB01324,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Polythiazide.
DB13430,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Mebutizide.
DB13532,The therapeutic efficacy of Rasburicase can be decreased when used in combination with Cyclopenthiazide.
DB01281,The risk or severity of infection can be increased when Adalimumab is combined with Abatacept.
DB00026,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anakinra.
DB06168,The risk or severity of infection and neutropenia can be increased when Adalimumab is combined with Canakinumab.
DB08904,The risk or severity of infection can be increased when Adalimumab is combined with Certolizumab pegol.
DB06643,The risk or severity of adverse effects can be increased when Denosumab is combined with Adalimumab.
DB00005,The risk or severity of adverse effects can be increased when Etanercept is combined with Adalimumab.
DB00008,The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Adalimumab.
DB00011,The risk or severity of adverse effects can be increased when Interferon alfa-n1 is combined with Adalimumab.
DB00018,The risk or severity of adverse effects can be increased when Interferon alfa-n3 is combined with Adalimumab.
DB00022,The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Adalimumab.
DB00033,The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Adalimumab.
DB00034,"The risk or severity of adverse effects can be increased when Interferon alfa-2a, Recombinant is combined with Adalimumab."
DB00041,The risk or severity of adverse effects can be increased when Aldesleukin is combined with Adalimumab.
DB00056,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemtuzumab ozogamicin.
DB00059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pegaspargase.
DB00068,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon beta-1b.
DB00069,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfacon-1.
DB00073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Adalimumab is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Adalimumab is combined with Muromonab.
DB00078,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibritumomab tiuxetan.
DB00081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tositumomab.
DB00087,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alemtuzumab.
DB00092,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alefacept.
DB00095,The risk or severity of adverse effects can be increased when Adalimumab is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antithymocyte immunoglobulin (rabbit).
DB00105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa-2b.
DB00111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab.
DB00120,The risk or severity of adverse effects can be increased when Adalimumab is combined with Phenylalanine.
DB00242,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cladribine.
DB00276,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amsacrine.
DB00290,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleomycin.
DB00291,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chlorambucil.
DB00293,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raltitrexed.
DB00305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitomycin.
DB00322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Floxuridine.
DB00352,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tioguanine.
DB00380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexrazoxane.
DB00428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Streptozocin.
DB00432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trifluridine.
DB00441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gemcitabine.
DB00445,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epirubicin.
DB00446,The risk or severity of adverse effects can be increased when Adalimumab is combined with Chloramphenicol.
DB00480,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lenalidomide.
DB00488,The risk or severity of adverse effects can be increased when Adalimumab is combined with Altretamine.
DB00515,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cisplatin.
DB00526,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oxaliplatin.
DB00550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Propylthiouracil.
DB00552,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pentostatin.
DB00601,The risk or severity of adverse effects can be increased when Adalimumab is combined with Linezolid.
DB00631,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clofarabine.
DB00763,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methimazole.
DB00795,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulfasalazine.
DB00853,The risk or severity of adverse effects can be increased when Adalimumab is combined with Temozolomide.
DB00859,The risk or severity of adverse effects can be increased when Adalimumab is combined with Penicillamine.
DB00888,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mechlorethamine.
DB00928,The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine.
DB00958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carboplatin.
DB00970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dactinomycin.
DB01005,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxyurea.
DB01024,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mycophenolic acid.
DB01030,The risk or severity of adverse effects can be increased when Adalimumab is combined with Topotecan.
DB01042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melphalan.
DB01073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludarabine.
DB01099,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flucytosine.
DB01168,The risk or severity of adverse effects can be increased when Adalimumab is combined with Procarbazine.
DB01169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Arsenic trioxide.
DB01204,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitoxantrone.
DB01206,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lomustine.
DB01257,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eculizumab.
DB01262,The risk or severity of adverse effects can be increased when Adalimumab is combined with Decitabine.
DB01280,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nelarabine.
DB01423,The risk or severity of adverse effects can be increased when Adalimumab is combined with Stepronin.
DB01816,The risk or severity of adverse effects can be increased when Adalimumab is combined with Castanospermine.
DB02546,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vorinostat.
DB02806,The risk or severity of adverse effects can be increased when Adalimumab is combined with 2-Methoxyethanol.
DB03523,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brequinar.
DB04956,The risk or severity of adverse effects can be increased when Adalimumab is combined with Afelimomab.
DB05258,The risk or severity of adverse effects can be increased when Adalimumab is combined with Interferon alfa.
DB05259,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glatiramer.
DB05260,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gallium nitrate.
DB05459,The risk or severity of adverse effects can be increased when Adalimumab is combined with Briakinumab.
DB05472,The risk or severity of adverse effects can be increased when Adalimumab is combined with omega interferon.
DB06612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab.
DB06662,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abetimus.
DB06674,The risk or severity of adverse effects can be increased when Adalimumab is combined with Golimumab.
DB06681,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belatacept.
DB06813,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pralatrexate.
DB08059,The risk or severity of adverse effects can be increased when Adalimumab is combined with Wortmannin.
DB08871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eribulin.
DB08879,The risk or severity of adverse effects can be increased when Adalimumab is combined with Belimumab.
DB08880,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teriflunomide.
DB08889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carfilzomib.
DB08908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dimethyl fumarate.
DB08935,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obinutuzumab.
DB09029,The risk or severity of adverse effects can be increased when Adalimumab is combined with Secukinumab.
DB09036,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siltuximab.
DB09052,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blinatumomab.
DB09077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dinutuximab.
DB09091,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tixocortol.
DB09122,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peginterferon beta-1a.
DB09312,The risk or severity of adverse effects can be increased when Adalimumab is combined with Antilymphocyte immunoglobulin (horse).
DB11466,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tepoxalin.
DB11569,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ravulizumab.
DB11616,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pirarubicin.
DB11693,The risk or severity of adverse effects can be increased when Adalimumab is combined with Voclosporin.
DB11708,The risk or severity of adverse effects can be increased when Adalimumab is combined with Peficitinib.
DB11767,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sarilumab.
DB11776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sirukumab.
DB11834,The risk or severity of adverse effects can be increased when Adalimumab is combined with Guselkumab.
DB11988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ocrelizumab.
DB12025,The risk or severity of adverse effects can be increased when Adalimumab is combined with Triptolide.
DB12612,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanimod.
DB12617,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mizoribine.
DB12692,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gusperimus.
DB12814,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cepeginterferon alfa-2B.
DB12902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trofosfamide.
DB12947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Doxifluridine.
DB12991,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deoxyspergualin.
DB12996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Acteoside.
DB13003,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortivazol.
DB13014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hypericin.
DB13068,The risk or severity of adverse effects can be increased when Adalimumab is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
DB13223,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortin.
DB13241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Begelomab.
DB13491,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluperolone.
DB13664,The risk or severity of adverse effects can be increased when Adalimumab is combined with Formocortal.
DB13728,The risk or severity of adverse effects can be increased when Adalimumab is combined with Halometasone.
DB13843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cloprednol.
DB13856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluclorolone.
DB14219,The risk or severity of adverse effects can be increased when Adalimumab is combined with Monomethyl fumarate.
DB14724,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Adalimumab is combined with Risankizumab.
DB14919,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozanolixizumab.
DB15253,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bleselumab.
DB00180,The risk or severity of adverse effects can be increased when Adalimumab is combined with Flunisolide.
DB00394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Beclomethasone dipropionate.
DB00443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Betamethasone.
DB00591,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocinolone acetonide.
DB00635,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisone.
DB00687,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fludrocortisone.
DB00764,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone.
DB00860,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednisolone.
DB00959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Methylprednisolone.
DB01196,The risk or severity of adverse effects can be increased when Adalimumab is combined with Estramustine.
DB01285,The risk or severity of adverse effects can be increased when Adalimumab is combined with Corticotropin.
DB01380,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cortisone acetate.
DB01384,The risk or severity of adverse effects can be increased when Adalimumab is combined with Paramethasone.
DB01611,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydroxychloroquine.
DB04630,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aldosterone.
DB08970,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednidene.
DB08971,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluocortolone.
DB09082,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vilanterol.
DB09378,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fluprednisolone.
DB09383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Meprednisone.
DB11487,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dexamethasone isonicotinate.
DB11529,The risk or severity of adverse effects can be increased when Adalimumab is combined with Melengestrol.
DB11750,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clobetasol.
DB11817,The risk or severity of adverse effects can be increased when Adalimumab is combined with Baricitinib.
DB11921,The risk or severity of adverse effects can be increased when Adalimumab is combined with Deflazacort.
DB13208,The risk or severity of adverse effects can be increased when Adalimumab is combined with Prednylidene.
DB14066,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetrandrine.
DB14512,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mometasone furoate.
DB14545,The risk or severity of adverse effects can be increased when Adalimumab is combined with Hydrocortisone succinate.
DB01222,The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.
DB01394,The risk or severity of adverse effects can be increased when Adalimumab is combined with Colchicine.
DB00108,The risk or severity of adverse effects can be increased when Adalimumab is combined with Natalizumab.
DB00337,The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Adalimumab.
DB06372,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilonacept.
DB01656,Adalimumab may increase the immunosuppressive activities of Roflumilast.
DB06688,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Adalimumab.
DB06273,Tocilizumab may increase the immunosuppressive activities of Adalimumab.
DB08895,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tofacitinib.
DB09033,The risk or severity of infection can be increased when Adalimumab is combined with Vedolizumab.
DB00065,Adalimumab may increase the immunosuppressive activities of Infliximab.
DB00682,The serum concentration of Warfarin can be decreased when it is combined with Adalimumab.
DB00091,The serum concentration of Cyclosporine can be decreased when it is combined with Adalimumab.
DB00651,The serum concentration of Dyphylline can be decreased when it is combined with Adalimumab.
DB01033,The serum concentration of Mercaptopurine can be decreased when it is combined with Adalimumab.
DB01978,"The serum concentration of 7,9-Dimethylguanine can be decreased when it is combined with Adalimumab."
DB02245,The serum concentration of 7-Deazaguanine can be decreased when it is combined with Adalimumab.
DB02377,The serum concentration of Guanine can be decreased when it is combined with Adalimumab.
DB06575,The serum concentration of Valomaciclovir can be decreased when it is combined with Adalimumab.
DB07954,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be decreased when it is combined with Adalimumab.
DB08844,The serum concentration of Uric acid can be decreased when it is combined with Adalimumab.
DB14029,The serum concentration of Furafylline can be decreased when it is combined with Adalimumab.
DB15122,The serum concentration of PCS-499 can be decreased when it is combined with Adalimumab.
DB00277,The serum concentration of Theophylline can be decreased when it is combined with Adalimumab.
DB01223,The serum concentration of Aminophylline can be decreased when it is combined with Adalimumab.
DB00201,The serum concentration of Caffeine can be decreased when it is combined with Adalimumab.
DB00806,The serum concentration of Pentoxifylline can be decreased when it is combined with Adalimumab.
DB01303,The serum concentration of Oxtriphylline can be decreased when it is combined with Adalimumab.
DB01412,The serum concentration of Theobromine can be decreased when it is combined with Adalimumab.
DB01482,The serum concentration of Fenethylline can be decreased when it is combined with Adalimumab.
DB01667,The serum concentration of 8-azaguanine can be decreased when it is combined with Adalimumab.
DB02134,The serum concentration of Xanthine can be decreased when it is combined with Adalimumab.
DB02489,The serum concentration of 9-Methylguanine can be decreased when it is combined with Adalimumab.
DB02568,The serum concentration of Peldesine can be decreased when it is combined with Adalimumab.
DB04076,The serum concentration of Hypoxanthine can be decreased when it is combined with Adalimumab.
DB04356,The serum concentration of 9-Deazaguanine can be decreased when it is combined with Adalimumab.
DB06479,The serum concentration of Propentofylline can be decreased when it is combined with Adalimumab.
DB09273,The serum concentration of Doxofylline can be decreased when it is combined with Adalimumab.
DB11919,The serum concentration of 6-O-benzylguanine can be decreased when it is combined with Adalimumab.
DB12406,The serum concentration of Lisofylline can be decreased when it is combined with Adalimumab.
DB12531,The serum concentration of Lobucavir can be decreased when it is combined with Adalimumab.
DB12926,The serum concentration of Cafedrine can be decreased when it is combined with Adalimumab.
DB12927,The serum concentration of Theodrenaline can be decreased when it is combined with Adalimumab.
DB13203,The serum concentration of Bamifylline can be decreased when it is combined with Adalimumab.
DB13449,The serum concentration of Proxyphylline can be decreased when it is combined with Adalimumab.
DB13573,The serum concentration of Acefylline can be decreased when it is combined with Adalimumab.
DB13592,The serum concentration of Etamiphylline can be decreased when it is combined with Adalimumab.
DB13634,The serum concentration of Pentifylline can be decreased when it is combined with Adalimumab.
DB13812,The serum concentration of Bufylline can be decreased when it is combined with Adalimumab.
DB14018,The serum concentration of Bromotheophylline can be decreased when it is combined with Adalimumab.
DB14132,The serum concentration of 8-chlorotheophylline can be decreased when it is combined with Adalimumab.
DB01015,The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Adalimumab.
DB00269,Chlorotrianisene may increase the thrombogenic activities of Adalimumab.
DB00655,Estrone may increase the thrombogenic activities of Adalimumab.
DB00890,Dienestrol may increase the thrombogenic activities of Adalimumab.
DB04573,Estriol may increase the thrombogenic activities of Adalimumab.
DB04575,Quinestrol may increase the thrombogenic activities of Adalimumab.
DB07931,Hexestrol may increase the thrombogenic activities of Adalimumab.
DB09070,Tibolone may increase the thrombogenic activities of Adalimumab.
DB09369,Polyestradiol phosphate may increase the thrombogenic activities of Adalimumab.
DB11478,Zeranol may increase the thrombogenic activities of Adalimumab.
DB11674,Equol may increase the thrombogenic activities of Adalimumab.
DB12487,Promestriene may increase the thrombogenic activities of Adalimumab.
DB13143,Methallenestril may increase the thrombogenic activities of Adalimumab.
DB13386,Epimestrol may increase the thrombogenic activities of Adalimumab.
DB13418,Moxestrol may increase the thrombogenic activities of Adalimumab.
DB15334,Biochanin A may increase the thrombogenic activities of Adalimumab.
DB15335,Formononetin may increase the thrombogenic activities of Adalimumab.
DB09317,"Synthetic Conjugated Estrogens, A may increase the thrombogenic activities of Adalimumab."
DB09318,"Synthetic Conjugated Estrogens, B may increase the thrombogenic activities of Adalimumab."
DB09381,Esterified estrogens may increase the thrombogenic activities of Adalimumab.
DB01097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leflunomide.
DB00072,Trastuzumab may increase the neutropenic activities of Adalimumab.
DB08868,Adalimumab may increase the immunosuppressive activities of Fingolimod.
DB00864,Tacrolimus may increase the immunosuppressive activities of Adalimumab.
DB04914,The therapeutic efficacy of G17DT can be decreased when used in combination with Adalimumab.
DB05144,The therapeutic efficacy of PEV3A can be decreased when used in combination with Adalimumab.
DB05325,The therapeutic efficacy of INGN 225 can be decreased when used in combination with Adalimumab.
DB05374,The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Adalimumab.
DB05440,The therapeutic efficacy of SRP 299 can be decreased when used in combination with Adalimumab.
DB05942,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Adalimumab.
DB06400,The therapeutic efficacy of Vitespen can be decreased when used in combination with Adalimumab.
DB06584,The therapeutic efficacy of TG4010 can be decreased when used in combination with Adalimumab.
DB09057,The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Adalimumab.
DB10062,"The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Adalimumab."
DB10076,The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.
DB10276,The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Adalimumab.
DB10283,"The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Adalimumab."
DB10342,The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Adalimumab.
DB10583,The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB10584,The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB10600,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB10769,The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB10794,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB10803,The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Adalimumab.
DB10989,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Adalimumab.
DB10990,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Adalimumab.
DB11038,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB11040,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB11041,The therapeutic efficacy of Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB11044,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB11603,The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Adalimumab.
DB11627,The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.
DB12568,The therapeutic efficacy of Tecemotide can be decreased when used in combination with Adalimumab.
DB14022,The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Adalimumab.
DB14384,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB14385,The therapeutic efficacy of Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB14394,The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Adalimumab.
DB14445,The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB14449,The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Adalimumab.
DB14619,The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB14620,The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Adalimumab.
DB14711,The therapeutic efficacy of Vaccinia virus strain new york city board of health live antigen can be decreased when used in combination with Adalimumab.
DB15274,The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Adalimumab.
DB15461,The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Adalimumab.
DB13924,The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Adalimumab.
DB15483,The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Adalimumab.
DB10317,The risk or severity of infection can be increased when Rubella virus vaccine is combined with Adalimumab.
DB10318,The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Adalimumab.
DB10343,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Adalimumab.
DB10804,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Adalimumab.
DB10805,The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Adalimumab.
DB11003,The risk or severity of infection can be increased when Anthrax vaccine is combined with Adalimumab.
DB11050,The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Adalimumab.
DB12386,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain danish 1331 live antigen is combined with Adalimumab.
DB12768,The risk or severity of infection can be increased when BCG vaccine is combined with Adalimumab.
DB14409,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Adalimumab.
DB14443,The risk or severity of infection can be increased when Vibrio cholerae CVD 103-HgR strain live antigen is combined with Adalimumab.
DB14685,The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Adalimumab.
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Adalimumab.
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Adalimumab.
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Adalimumab.
DB00054,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.
DB00057,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indium In-111 satumomab pendetide.
DB00076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Digoxin Immune Fab (Ovine).
DB00089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Capromab pendetide.
DB00110,The risk or severity of adverse effects can be increased when Adalimumab is combined with Palivizumab.
DB00113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Technetium Tc-99m arcitumomab.
DB01269,The risk or severity of adverse effects can be increased when Adalimumab is combined with Panitumumab.
DB01270,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ranibizumab.
DB04901,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galiximab.
DB04949,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pexelizumab.
DB04958,The risk or severity of adverse effects can be increased when Adalimumab is combined with Epratuzumab.
DB04962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bectumomab.
DB04964,The risk or severity of adverse effects can be increased when Adalimumab is combined with Oregovomab.
DB04988,The risk or severity of adverse effects can be increased when Adalimumab is combined with IGN311.
DB05006,The risk or severity of adverse effects can be increased when Adalimumab is combined with Adecatumumab.
DB05097,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab.
DB05101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Matuzumab.
DB05111,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fontolizumab.
DB05136,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bavituximab.
DB05139,The risk or severity of adverse effects can be increased when Adalimumab is combined with CR002.
DB05209,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rozrolimupab.
DB05304,The risk or severity of adverse effects can be increased when Adalimumab is combined with Girentuximab.
DB05336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Obiltoxaximab.
DB05405,The risk or severity of adverse effects can be increased when Adalimumab is combined with XTL-001.
DB05437,The risk or severity of adverse effects can be increased when Adalimumab is combined with NAV 1800.
DB05496,The risk or severity of adverse effects can be increased when Adalimumab is combined with Otelixizumab.
DB05545,The risk or severity of adverse effects can be increased when Adalimumab is combined with AMG 108.
DB05550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Iratumumab.
DB05555,The risk or severity of adverse effects can be increased when Adalimumab is combined with Enokizumab.
DB05578,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ramucirumab.
DB05595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Farletuzumab.
DB05656,The risk or severity of adverse effects can be increased when Adalimumab is combined with Veltuzumab.
DB05793,The risk or severity of adverse effects can be increased when Adalimumab is combined with PRO-542.
DB05797,The risk or severity of adverse effects can be increased when Adalimumab is combined with TNX-901.
DB05889,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inotuzumab ozogamicin.
DB05892,The risk or severity of adverse effects can be increased when Adalimumab is combined with RI 624.
DB05915,The risk or severity of adverse effects can be increased when Adalimumab is combined with MYO-029.
DB05916,The risk or severity of adverse effects can be increased when Adalimumab is combined with CT-011.
DB05941,The risk or severity of adverse effects can be increased when Adalimumab is combined with Leronlimab.
DB05996,The risk or severity of adverse effects can be increased when Adalimumab is combined with Glembatumumab vedotin.
DB06043,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olaratumab.
DB06049,The risk or severity of adverse effects can be increased when Adalimumab is combined with IPH 2101.
DB06050,The risk or severity of adverse effects can be increased when Adalimumab is combined with TB-402.
DB06081,The risk or severity of adverse effects can be increased when Adalimumab is combined with Caplacizumab.
DB06101,The risk or severity of adverse effects can be increased when Adalimumab is combined with IMC-1C11.
DB06116,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eldelumab.
DB06162,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumiliximab.
DB06186,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipilimumab.
DB06192,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nimotuzumab.
DB06241,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clenoliximab.
DB06304,The risk or severity of adverse effects can be increased when Adalimumab is combined with BIIB015.
DB06305,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sonepcizumab.
DB06310,The risk or severity of adverse effects can be increased when Adalimumab is combined with Motavizumab.
DB06317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Elotuzumab.
DB06318,The risk or severity of adverse effects can be increased when Adalimumab is combined with AVE9633.
DB06322,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carotuximab.
DB06324,The risk or severity of adverse effects can be increased when Adalimumab is combined with XmAb 2513.
DB06342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Coltuximab ravtansine.
DB06343,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teprotumumab.
DB06360,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lucatumumab.
DB06366,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pertuzumab.
DB06371,The risk or severity of adverse effects can be increased when Adalimumab is combined with Siplizumab.
DB06467,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apolizumab.
DB06474,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sibrotuzumab.
DB06550,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bivatuzumab.
DB06557,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lerdelimumab.
DB06599,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lexatumumab.
DB06602,The risk or severity of adverse effects can be increased when Adalimumab is combined with Reslizumab.
DB06606,The risk or severity of adverse effects can be increased when Adalimumab is combined with Teplizumab.
DB06607,The risk or severity of adverse effects can be increased when Adalimumab is combined with Catumaxomab.
DB06647,The risk or severity of adverse effects can be increased when Adalimumab is combined with Volociximab.
DB06650,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ofatumumab.
DB08902,The risk or severity of adverse effects can be increased when Adalimumab is combined with Raxibacumab.
DB09035,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nivolumab.
DB09037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pembrolizumab.
DB09045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dulaglutide.
DB09105,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asfotase alfa.
DB09264,The risk or severity of adverse effects can be increased when Adalimumab is combined with Idarucizumab.
DB09302,The risk or severity of adverse effects can be increased when Adalimumab is combined with Alirocumab.
DB09303,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evolocumab.
DB09331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Daratumumab.
DB09559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Necitumumab.
DB11595,The risk or severity of adverse effects can be increased when Adalimumab is combined with Atezolizumab.
DB11604,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tetanus Immune Globulin.
DB11608,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eftrenonacog alfa.
DB11621,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human Varicella-Zoster Immune Globulin.
DB11646,The risk or severity of adverse effects can be increased when Adalimumab is combined with Conatumumab.
DB11657,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tabalumab.
DB11680,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ficlatuzumab.
DB11685,The risk or severity of adverse effects can be increased when Adalimumab is combined with Figitumumab.
DB11714,The risk or severity of adverse effects can be increased when Adalimumab is combined with Durvalumab.
DB11715,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bapineuzumab.
DB11731,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab mafodotin.
DB11746,The risk or severity of adverse effects can be increased when Adalimumab is combined with Onartuzumab.
DB11756,The risk or severity of adverse effects can be increased when Adalimumab is combined with Solanezumab.
DB11771,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tremelimumab.
DB11826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lampalizumab.
DB11840,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalotuzumab.
DB11849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emibetuzumab.
DB11850,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ublituximab.
DB11856,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ligelizumab.
DB11857,The risk or severity of adverse effects can be increased when Adalimumab is combined with Seribantumab.
DB11862,The risk or severity of adverse effects can be increased when Adalimumab is combined with Landogrozumab.
DB11866,The risk or severity of adverse effects can be increased when Adalimumab is combined with Romosozumab.
DB11884,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vadastuximab Talirine.
DB11914,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lebrikizumab.
DB11930,The risk or severity of adverse effects can be increased when Adalimumab is combined with Varlilumab.
DB11945,The risk or severity of adverse effects can be increased when Adalimumab is combined with Avelumab.
DB11959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crenezumab.
DB11972,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rilotumumab.
DB11976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anifrolumab.
DB12023,The risk or severity of adverse effects can be increased when Adalimumab is combined with Benralizumab.
DB12034,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gantenerumab.
DB12053,The risk or severity of adverse effects can be increased when Adalimumab is combined with Visilizumab.
DB12077,The risk or severity of adverse effects can be increased when Adalimumab is combined with Urelumab.
DB12089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorvotuzumab mertansine.
DB12090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Patritumab.
DB12102,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fulranumab.
DB12104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tarextumab.
DB12118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sotatercept.
DB12119,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gevokizumab.
DB12142,The risk or severity of adverse effects can be increased when Adalimumab is combined with Duligotuzumab.
DB12152,The risk or severity of adverse effects can be increased when Adalimumab is combined with Simtuzumab.
DB12157,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fasinumab.
DB12159,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dupilumab.
DB12169,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tralokinumab.
DB12189,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etrolizumab.
DB12202,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zalutumumab.
DB12205,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ganitumab.
DB12213,The risk or severity of adverse effects can be increased when Adalimumab is combined with Etaracizumab.
DB12246,The risk or severity of adverse effects can be increased when Adalimumab is combined with Inclacumab.
DB12250,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cixutumumab.
DB12261,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ascrinvacumab.
DB12274,The risk or severity of adverse effects can be increased when Adalimumab is combined with Aducanumab.
DB12281,The risk or severity of adverse effects can be increased when Adalimumab is combined with Luspatercept.
DB12296,The risk or severity of adverse effects can be increased when Adalimumab is combined with GS-5745.
DB12317,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vanucizumab.
DB12331,The risk or severity of adverse effects can be increased when Adalimumab is combined with Labetuzumab govitecan.
DB12335,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tanezumab.
DB12342,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ensituximab.
DB12344,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fezakinumab.
DB12363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dusigitumab.
DB12396,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fresolimumab.
DB12413,The risk or severity of adverse effects can be increased when Adalimumab is combined with Indusatumab vedotin.
DB12456,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bococizumab.
DB12489,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mirvetuximab Soravtansine.
DB12498,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mogamulizumab.
DB12520,The risk or severity of adverse effects can be increased when Adalimumab is combined with Plozalizumab.
DB12534,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mavrilimumab.
DB12560,The risk or severity of adverse effects can be increased when Adalimumab is combined with Blosozumab.
DB12584,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimagrumab.
DB12589,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dacetuzumab.
DB12609,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tovetumab.
DB12683,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lumretuzumab.
DB12698,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ibalizumab.
DB12701,The risk or severity of adverse effects can be increased when Adalimumab is combined with Intetumumab.
DB12718,The risk or severity of adverse effects can be increased when Adalimumab is combined with Carlumab.
DB12734,The risk or severity of adverse effects can be increased when Adalimumab is combined with Demcizumab.
DB12773,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sifalimumab.
DB12775,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abituzumab.
DB12797,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ecromeximab.
DB12807,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naptumomab Estafenatox.
DB12815,The risk or severity of adverse effects can be increased when Adalimumab is combined with Crotedumab.
DB12820,The risk or severity of adverse effects can be increased when Adalimumab is combined with Concizumab.
DB12826,The risk or severity of adverse effects can be increased when Adalimumab is combined with Depatuxizumab.
DB12844,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rontalizumab.
DB12845,The risk or severity of adverse effects can be increased when Adalimumab is combined with Amatuximab.
DB12849,The risk or severity of adverse effects can be increased when Adalimumab is combined with Clazakizumab.
DB12891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ozanezumab.
DB12893,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sacituzumab govitecan.
DB12917,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bimekizumab.
DB12943,The risk or severity of adverse effects can be increased when Adalimumab is combined with Milatuzumab.
DB12976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Robatumumab.
DB13017,The risk or severity of adverse effects can be increased when Adalimumab is combined with Rovalpituzumab Tesirine.
DB13037,The risk or severity of adverse effects can be increased when Adalimumab is combined with Namilumab.
DB13045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Racotumomab.
DB13073,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tregalizumab.
DB13127,The risk or severity of adverse effects can be increased when Adalimumab is combined with Olokizumab.
DB13140,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bezlotoxumab.
DB13375,The risk or severity of adverse effects can be increased when Adalimumab is combined with Edrecolomab.
DB13535,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nebacumab.
DB13886,The risk or severity of adverse effects can be increased when Adalimumab is combined with Human cytomegalovirus immune globulin.
DB13923,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emicizumab.
DB13976,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sulesomab.
DB13979,The risk or severity of adverse effects can be increased when Adalimumab is combined with Besilesomab.
DB14012,The risk or severity of adverse effects can be increased when Adalimumab is combined with Burosumab.
DB14039,The risk or severity of adverse effects can be increased when Adalimumab is combined with Erenumab.
DB14040,The risk or severity of adverse effects can be increased when Adalimumab is combined with Eptinezumab.
DB14041,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fremanezumab.
DB14042,The risk or severity of adverse effects can be increased when Adalimumab is combined with Galcanezumab.
DB14211,The risk or severity of adverse effects can be increased when Adalimumab is combined with Fanolesomab.
DB14580,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lecanemab.
DB14597,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lanadelumab.
DB14707,The risk or severity of adverse effects can be increased when Adalimumab is combined with Cemiplimab.
DB14776,The risk or severity of adverse effects can be increased when Adalimumab is combined with Camrelizumab.
DB14778,The risk or severity of adverse effects can be increased when Adalimumab is combined with Setrusumab.
DB14784,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gancotamab.
DB14809,The risk or severity of adverse effects can be increased when Adalimumab is combined with Anetumab ravtansine.
DB14811,The risk or severity of adverse effects can be increased when Adalimumab is combined with Isatuximab.
DB14824,The risk or severity of adverse effects can be increased when Adalimumab is combined with Icrucumab.
DB14843,The risk or severity of adverse effects can be increased when Adalimumab is combined with Codrituzumab.
DB14864,The risk or severity of adverse effects can be increased when Adalimumab is combined with Brolucizumab.
DB14871,The risk or severity of adverse effects can be increased when Adalimumab is combined with Xentuzumab.
DB14877,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lintuzumab.
DB14891,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vobarilizumab.
DB14897,The risk or severity of adverse effects can be increased when Adalimumab is combined with Parsatuzumab.
DB14905,The risk or severity of adverse effects can be increased when Adalimumab is combined with Emactuzumab.
DB14907,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bevacizumab zirconium Zr-89.
DB14908,The risk or severity of adverse effects can be increased when Adalimumab is combined with Refanezumab.
DB14947,The risk or severity of adverse effects can be increased when Adalimumab is combined with Bermekimab.
DB14952,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pamrevlumab.
DB14959,The risk or severity of adverse effects can be increased when Adalimumab is combined with Opicinumab.
DB14962,The risk or severity of adverse effects can be increased when Adalimumab is combined with Trastuzumab deruxtecan.
DB14967,The risk or severity of adverse effects can be increased when Adalimumab is combined with Margetuximab.
DB14988,The risk or severity of adverse effects can be increased when Adalimumab is combined with Dalantercept.
DB14997,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pateclizumab.
DB15014,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gremubamab.
DB15022,The risk or severity of adverse effects can be increased when Adalimumab is combined with Apomab.
DB15044,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tafasitamab.
DB15045,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ipafricept.
DB15076,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abrilumab.
DB15089,The risk or severity of adverse effects can be increased when Adalimumab is combined with Frovocimab.
DB15090,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tezepelumab.
DB15101,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tigatuzumab.
DB15104,The risk or severity of adverse effects can be increased when Adalimumab is combined with Telisotuzumab vedotin.
DB15113,The risk or severity of adverse effects can be increased when Adalimumab is combined with Utomilumab.
DB15118,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zolbetuximab.
DB15135,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ponezumab.
DB15160,The risk or severity of adverse effects can be increased when Adalimumab is combined with Asunercept.
DB15172,The risk or severity of adverse effects can be increased when Adalimumab is combined with Suvratoxumab.
DB15225,The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitazalimab.
DB15252,The risk or severity of adverse effects can be increased when Adalimumab is combined with Nemolizumab.
DB15277,The risk or severity of adverse effects can be increased when Adalimumab is combined with Gedivumab.
DB15336,The risk or severity of adverse effects can be increased when Adalimumab is combined with Valanafusp alfa.
DB15349,The risk or severity of adverse effects can be increased when Adalimumab is combined with Sofituzumab vedotin.
DB15354,The risk or severity of adverse effects can be increased when Adalimumab is combined with Evinacumab.
DB15363,The risk or severity of adverse effects can be increased when Adalimumab is combined with Istiratumab.
DB15383,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pidilizumab.
DB15397,The risk or severity of adverse effects can be increased when Adalimumab is combined with GMA-161.
DB15409,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ladiratuzumab vedotin.
DB15415,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tomaralimab.
DB15428,The risk or severity of adverse effects can be increased when Adalimumab is combined with Vesencumab.
DB15432,The risk or severity of adverse effects can be increased when Adalimumab is combined with Pinatuzumab vedotin.
DB15441,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lulizumab pegol.
DB15443,The risk or severity of adverse effects can be increased when Adalimumab is combined with Lorukafusp alfa.
DB15453,The risk or severity of adverse effects can be increased when Adalimumab is combined with Naratuximab emtansine.
DB14004,The risk or severity of adverse effects can be increased when Adalimumab is combined with Tildrakizumab.
DB05679,The risk or severity of adverse effects can be increased when Adalimumab is combined with Ustekinumab.
DB12240,The risk or severity of adverse effects can be increased when Adalimumab is combined with Polatuzumab vedotin.
DB15559,The risk or severity of adverse effects can be increased when Adalimumab is combined with Zenocutuzumab.
DB00176,The metabolism of Fluvoxamine can be increased when combined with Adalimumab.
DB00195,The metabolism of Betaxolol can be increased when combined with Adalimumab.
DB00261,The metabolism of Anagrelide can be increased when combined with Adalimumab.
DB00262,The metabolism of Carmustine can be increased when combined with Adalimumab.
DB00268,The metabolism of Ropinirole can be increased when combined with Adalimumab.
DB00280,The metabolism of Disopyramide can be increased when combined with Adalimumab.
DB00286,The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.
DB00296,The metabolism of Ropivacaine can be increased when combined with Adalimumab.
DB00315,The metabolism of Zolmitriptan can be increased when combined with Adalimumab.
DB00316,The metabolism of Acetaminophen can be increased when combined with Adalimumab.
DB00334,The metabolism of Olanzapine can be increased when combined with Adalimumab.
DB00356,The metabolism of Chlorzoxazone can be increased when combined with Adalimumab.
DB00365,The metabolism of Grepafloxacin can be increased when combined with Adalimumab.
DB00370,The metabolism of Mirtazapine can be increased when combined with Adalimumab.
DB00379,The metabolism of Mexiletine can be increased when combined with Adalimumab.
DB00382,The metabolism of Tacrine can be increased when combined with Adalimumab.
DB00384,The metabolism of Triamterene can be increased when combined with Adalimumab.
DB00442,The metabolism of Entecavir can be increased when combined with Adalimumab.
DB00477,The metabolism of Chlorpromazine can be increased when combined with Adalimumab.
DB00518,The metabolism of Albendazole can be increased when combined with Adalimumab.
DB00544,The metabolism of Fluorouracil can be increased when combined with Adalimumab.
DB00629,The metabolism of Guanabenz can be increased when combined with Adalimumab.
DB00642,The metabolism of Pemetrexed can be increased when combined with Adalimumab.
DB00730,The metabolism of Thiabendazole can be increased when combined with Adalimumab.
DB00740,The metabolism of Riluzole can be increased when combined with Adalimumab.
DB00787,The metabolism of Acyclovir can be increased when combined with Adalimumab.
DB00831,The metabolism of Trifluoperazine can be increased when combined with Adalimumab.
DB00863,The metabolism of Ranitidine can be increased when combined with Adalimumab.
DB00898,The metabolism of Ethanol can be increased when combined with Adalimumab.
DB00934,The metabolism of Maprotiline can be increased when combined with Adalimumab.
DB00978,The metabolism of Lomefloxacin can be increased when combined with Adalimumab.
DB00993,The metabolism of Azathioprine can be increased when combined with Adalimumab.
DB00998,The metabolism of Frovatriptan can be increased when combined with Adalimumab.
DB01002,The metabolism of Levobupivacaine can be increased when combined with Adalimumab.
DB01012,The metabolism of Cinacalcet can be increased when combined with Adalimumab.
DB01056,The metabolism of Tocainide can be increased when combined with Adalimumab.
DB01087,The metabolism of Primaquine can be increased when combined with Adalimumab.
DB01094,The metabolism of Hesperetin can be increased when combined with Adalimumab.
DB01182,The metabolism of Propafenone can be increased when combined with Adalimumab.
DB01191,The metabolism of Dexfenfluramine can be increased when combined with Adalimumab.
DB01367,The metabolism of Rasagiline can be increased when combined with Adalimumab.
DB01405,The metabolism of Temafloxacin can be increased when combined with Adalimumab.
DB01558,The metabolism of Bromazepam can be increased when combined with Adalimumab.
DB01623,The metabolism of Thiothixene can be increased when combined with Adalimumab.
DB01645,The metabolism of Genistein can be increased when combined with Adalimumab.
DB02709,The metabolism of Resveratrol can be increased when combined with Adalimumab.
DB04871,The metabolism of Lorcaserin can be increased when combined with Adalimumab.
DB04948,The metabolism of Lofexidine can be increased when combined with Adalimumab.
DB04951,The metabolism of Pirfenidone can be increased when combined with Adalimumab.
DB06148,The metabolism of Mianserin can be increased when combined with Adalimumab.
DB06210,The metabolism of Eltrombopag can be increased when combined with Adalimumab.
DB06216,The metabolism of Asenapine can be increased when combined with Adalimumab.
DB06235,The metabolism of Vadimezan can be increased when combined with Adalimumab.
DB06594,The metabolism of Agomelatine can be increased when combined with Adalimumab.
DB06769,The metabolism of Bendamustine can be increased when combined with Adalimumab.
DB06770,The metabolism of Benzyl alcohol can be increased when combined with Adalimumab.
DB06774,The metabolism of Capsaicin can be increased when combined with Adalimumab.
DB08496,The metabolism of (R)-warfarin can be increased when combined with Adalimumab.
DB09071,The metabolism of Tasimelteon can be increased when combined with Adalimumab.
DB09118,The metabolism of Stiripentol can be increased when combined with Adalimumab.
DB09225,The metabolism of Zotepine can be increased when combined with Adalimumab.
DB09290,The metabolism of Ramosetron can be increased when combined with Adalimumab.
DB11967,The metabolism of Binimetinib can be increased when combined with Adalimumab.
DB12026,The metabolism of Voxilaprevir can be increased when combined with Adalimumab.
DB12245,The metabolism of Triclabendazole can be increased when combined with Adalimumab.
DB12332,The metabolism of Rucaparib can be increased when combined with Adalimumab.
DB12945,The metabolism of Dihydralazine can be increased when combined with Adalimumab.
DB11757,The metabolism of Istradefylline can be increased when combined with Adalimumab.
DB04889,The metabolism of Bicifadine can be increased when combined with Adalimumab.
DB05708,The metabolism of GTS-21 can be increased when combined with Adalimumab.
DB00977,The metabolism of Adalimumab can be increased when combined with Ethinylestradiol.
DB00425,The metabolism of Zolpidem can be increased when combined with Adalimumab.
DB00458,The metabolism of Imipramine can be increased when combined with Adalimumab.
DB00532,The metabolism of Mephenytoin can be increased when combined with Adalimumab.
DB00540,The metabolism of Nortriptyline can be increased when combined with Adalimumab.
DB00575,The metabolism of Clonidine can be increased when combined with Adalimumab.
DB00924,The metabolism of Cyclobenzaprine can be increased when combined with Adalimumab.
DB01242,The metabolism of Clomipramine can be increased when combined with Adalimumab.
DB11689,The metabolism of Selumetinib can be increased when combined with Adalimumab.
DB00564,The metabolism of Carbamazepine can be increased when combined with Adalimumab.
DB00697,The metabolism of Tizanidine can be increased when combined with Adalimumab.
DB01100,The metabolism of Pimozide can be increased when combined with Adalimumab.
DB01418,The metabolism of Acenocoumarol can be increased when combined with Adalimumab.
DB09256,The metabolism of Tegafur can be increased when combined with Adalimumab.
DB00851,The metabolism of Dacarbazine can be increased when combined with Adalimumab.
DB08910,The metabolism of Pomalidomide can be increased when combined with Adalimumab.
DB00238,The metabolism of Nevirapine can be increased when combined with Adalimumab.
DB00471,The metabolism of Montelukast can be increased when combined with Adalimumab.
DB00690,The metabolism of Flurazepam can be increased when combined with Adalimumab.
DB00916,The metabolism of Metronidazole can be increased when combined with Adalimumab.
DB00983,The metabolism of Formoterol can be increased when combined with Adalimumab.
DB01006,The metabolism of Letrozole can be increased when combined with Adalimumab.
DB01028,The metabolism of Methoxyflurane can be increased when combined with Adalimumab.
DB01159,The metabolism of Halothane can be increased when combined with Adalimumab.
DB01236,The metabolism of Sevoflurane can be increased when combined with Adalimumab.
DB01274,The metabolism of Arformoterol can be increased when combined with Adalimumab.
DB01544,The metabolism of Flunitrazepam can be increased when combined with Adalimumab.
DB06292,The metabolism of Dapagliflozin can be increased when combined with Adalimumab.
DB06470,The metabolism of Clomethiazole can be increased when combined with Adalimumab.
DB09068,The metabolism of Vortioxetine can be increased when combined with Adalimumab.
DB09327,The metabolism of Tegafur-uracil can be increased when combined with Adalimumab.
DB11586,The metabolism of Asunaprevir can be increased when combined with Adalimumab.
DB04977,The metabolism of Plitidepsin can be increased when combined with Adalimumab.
DB06119,The metabolism of Cenobamate can be increased when combined with Adalimumab.
DB00193,The metabolism of Tramadol can be increased when combined with Adalimumab.
DB00333,The metabolism of Methadone can be increased when combined with Adalimumab.
DB00349,The metabolism of Clobazam can be increased when combined with Adalimumab.
DB00625,The metabolism of Efavirenz can be increased when combined with Adalimumab.
DB00753,The metabolism of Isoflurane can be increased when combined with Adalimumab.
DB00818,The metabolism of Propofol can be increased when combined with Adalimumab.
DB00835,The metabolism of Brompheniramine can be increased when combined with Adalimumab.
DB00836,The metabolism of Loperamide can be increased when combined with Adalimumab.
DB00849,The metabolism of Methylphenobarbital can be increased when combined with Adalimumab.
DB00865,The metabolism of Benzphetamine can be increased when combined with Adalimumab.
DB01069,The metabolism of Promethazine can be increased when combined with Adalimumab.
DB01074,The metabolism of Perhexiline can be increased when combined with Adalimumab.
DB01221,The metabolism of Ketamine can be increased when combined with Adalimumab.
DB01466,The metabolism of Ethylmorphine can be increased when combined with Adalimumab.
DB01559,The metabolism of Clotiazepam can be increased when combined with Adalimumab.
DB04938,The metabolism of Ospemifene can be increased when combined with Adalimumab.
DB04975,The metabolism of Banoxantrone can be increased when combined with Adalimumab.
DB05541,The metabolism of Brivaracetam can be increased when combined with Adalimumab.
DB06176,The metabolism of Romidepsin can be increased when combined with Adalimumab.
DB06209,The metabolism of Prasugrel can be increased when combined with Adalimumab.
DB06697,The metabolism of Artemether can be increased when combined with Adalimumab.
DB06710,The metabolism of Methyltestosterone can be increased when combined with Adalimumab.
DB06738,The metabolism of Ketobemidone can be increased when combined with Adalimumab.
DB06739,The metabolism of Seratrodast can be increased when combined with Adalimumab.
DB11613,The metabolism of Velpatasvir can be increased when combined with Adalimumab.
DB13132,The metabolism of Artemisinin can be increased when combined with Adalimumab.
DB13943,The metabolism of Testosterone cypionate can be increased when combined with Adalimumab.
DB13944,The metabolism of Testosterone enanthate can be increased when combined with Adalimumab.
DB13946,The metabolism of Testosterone undecanoate can be increased when combined with Adalimumab.
DB01156,The metabolism of Bupropion can be increased when combined with Adalimumab.
DB00956,The metabolism of Hydrocodone can be increased when combined with Adalimumab.
DB14975,The metabolism of Voxelotor can be increased when combined with Adalimumab.
DB11837,The metabolism of Osilodrostat can be increased when combined with Adalimumab.
DB13384,The metabolism of Melitracen can be increased when combined with Adalimumab.
DB13411,The metabolism of Lofepramine can be increased when combined with Adalimumab.
DB00714,The metabolism of Apomorphine can be increased when combined with Adalimumab.
DB09167,The metabolism of Dosulepin can be increased when combined with Adalimumab.
DB00213,The metabolism of Pantoprazole can be increased when combined with Adalimumab.
DB00215,The metabolism of Citalopram can be increased when combined with Adalimumab.
DB00312,The metabolism of Pentobarbital can be increased when combined with Adalimumab.
DB00338,The metabolism of Omeprazole can be increased when combined with Adalimumab.
DB00347,The metabolism of Trimethadione can be increased when combined with Adalimumab.
DB00395,The metabolism of Carisoprodol can be increased when combined with Adalimumab.
DB00448,The metabolism of Lansoprazole can be increased when combined with Adalimumab.
DB00474,The metabolism of Methohexital can be increased when combined with Adalimumab.
DB00582,The metabolism of Voriconazole can be increased when combined with Adalimumab.
DB00679,The metabolism of Thioridazine can be increased when combined with Adalimumab.
DB00736,The metabolism of Esomeprazole can be increased when combined with Adalimumab.
DB00794,The metabolism of Primidone can be increased when combined with Adalimumab.
DB00909,The metabolism of Zonisamide can be increased when combined with Adalimumab.
DB01129,The metabolism of Rabeprazole can be increased when combined with Adalimumab.
DB01131,The metabolism of Proguanil can be increased when combined with Adalimumab.
DB01175,The metabolism of Escitalopram can be increased when combined with Adalimumab.
DB01259,The metabolism of Lapatinib can be increased when combined with Adalimumab.
DB01323,The metabolism of St. John's Wort can be increased when combined with Adalimumab.
DB01355,The metabolism of Hexobarbital can be increased when combined with Adalimumab.
DB01483,The metabolism of Barbital can be increased when combined with Adalimumab.
DB05246,The metabolism of Methsuximide can be increased when combined with Adalimumab.
DB05351,The metabolism of Dexlansoprazole can be increased when combined with Adalimumab.
DB06218,The metabolism of Lacosamide can be increased when combined with Adalimumab.
DB06414,The metabolism of Etravirine can be increased when combined with Adalimumab.
DB06605,The metabolism of Apixaban can be increased when combined with Adalimumab.
DB09166,The metabolism of Etizolam can be increased when combined with Adalimumab.
DB12130,The metabolism of Lorlatinib can be increased when combined with Adalimumab.
DB12474,The metabolism of Lynestrenol can be increased when combined with Adalimumab.
DB13762,The metabolism of Dexrabeprazole can be increased when combined with Adalimumab.
DB14055,The metabolism of (S)-Warfarin can be increased when combined with Adalimumab.
DB00715,The metabolism of Paroxetine can be increased when combined with Adalimumab.
DB12500,The metabolism of Fedratinib can be increased when combined with Adalimumab.
DB04861,The metabolism of Nebivolol can be increased when combined with Adalimumab.
DB06684,The metabolism of Vilazodone can be increased when combined with Adalimumab.
DB01104,The metabolism of Sertraline can be increased when combined with Adalimumab.
DB11823,The metabolism of Esketamine can be increased when combined with Adalimumab.
DB00252,The metabolism of Phenytoin can be increased when combined with Adalimumab.
DB00599,The metabolism of Thiopental can be increased when combined with Adalimumab.
DB01174,The metabolism of Phenobarbital can be increased when combined with Adalimumab.
DB01320,The metabolism of Fosphenytoin can be increased when combined with Adalimumab.
DB00613,The metabolism of Amodiaquine can be increased when combined with Adalimumab.
DB00799,The metabolism of Tazarotene can be increased when combined with Adalimumab.
DB05229,The metabolism of Beraprost can be increased when combined with Adalimumab.
DB06510,The metabolism of Muraglitazar can be increased when combined with Adalimumab.
DB09296,The metabolism of Ombitasvir can be increased when combined with Adalimumab.
DB01217,The metabolism of Anastrozole can be increased when combined with Adalimumab.
DB00255,The metabolism of Adalimumab can be increased when combined with Diethylstilbestrol.
DB00295,The metabolism of Morphine can be increased when combined with Adalimumab.
DB00359,The metabolism of Sulfadiazine can be increased when combined with Adalimumab.
DB00402,The metabolism of Eszopiclone can be increased when combined with Adalimumab.
DB00622,The metabolism of Nicardipine can be increased when combined with Adalimumab.
DB00912,The metabolism of Repaglinide can be increased when combined with Adalimumab.
DB01261,The metabolism of Sitagliptin can be increased when combined with Adalimumab.
DB06670,The metabolism of Odanacatib can be increased when combined with Adalimumab.
DB08502,The metabolism of Capravirine can be increased when combined with Adalimumab.
DB08931,The metabolism of Riociguat can be increased when combined with Adalimumab.
DB09198,The metabolism of Lobeglitazone can be increased when combined with Adalimumab.
DB09199,The metabolism of Netoglitazone can be increased when combined with Adalimumab.
DB09200,The metabolism of Rivoglitazone can be increased when combined with Adalimumab.
DB09201,The metabolism of Ciglitazone can be increased when combined with Adalimumab.
DB11362,The metabolism of Selexipag can be increased when combined with Adalimumab.
DB11901,The metabolism of Apalutamide can be increased when combined with Adalimumab.
DB11978,The metabolism of Glasdegib can be increased when combined with Adalimumab.
DB12781,The metabolism of Balaglitazone can be increased when combined with Adalimumab.
DB01132,The metabolism of Pioglitazone can be increased when combined with Adalimumab.
DB11652,The metabolism of Tucatinib can be increased when combined with Adalimumab.
DB00946,The metabolism of Phenprocoumon can be increased when combined with Adalimumab.
DB01229,The metabolism of Paclitaxel can be increased when combined with Adalimumab.
DB00177,The metabolism of Valsartan can be increased when combined with Adalimumab.
DB00184,The metabolism of Nicotine can be increased when combined with Adalimumab.
DB00197,The metabolism of Troglitazone can be increased when combined with Adalimumab.
DB00214,The metabolism of Torasemide can be increased when combined with Adalimumab.
DB00222,The metabolism of Glimepiride can be increased when combined with Adalimumab.
DB00285,The metabolism of Venlafaxine can be increased when combined with Adalimumab.
DB00304,The metabolism of Desogestrel can be increased when combined with Adalimumab.
DB00307,The metabolism of Bexarotene can be increased when combined with Adalimumab.
DB00327,The metabolism of Hydromorphone can be increased when combined with Adalimumab.
DB00328,The metabolism of Indomethacin can be increased when combined with Adalimumab.
DB00343,The metabolism of Diltiazem can be increased when combined with Adalimumab.
DB00374,The metabolism of Treprostinil can be increased when combined with Adalimumab.
DB00412,The metabolism of Rosiglitazone can be increased when combined with Adalimumab.
DB00414,The metabolism of Acetohexamide can be increased when combined with Adalimumab.
DB00420,The metabolism of Promazine can be increased when combined with Adalimumab.
DB00440,The metabolism of Trimethoprim can be increased when combined with Adalimumab.
DB00461,The metabolism of Nabumetone can be increased when combined with Adalimumab.
DB00468,The metabolism of Quinine can be increased when combined with Adalimumab.
DB00469,The metabolism of Tenoxicam can be increased when combined with Adalimumab.
DB00472,The metabolism of Fluoxetine can be increased when combined with Adalimumab.
DB00476,The metabolism of Duloxetine can be increased when combined with Adalimumab.
DB00482,The metabolism of Celecoxib can be increased when combined with Adalimumab.
DB00495,The metabolism of Zidovudine can be increased when combined with Adalimumab.
DB00502,The metabolism of Haloperidol can be increased when combined with Adalimumab.
DB00531,The metabolism of Cyclophosphamide can be increased when combined with Adalimumab.
DB00533,The metabolism of Rofecoxib can be increased when combined with Adalimumab.
DB00549,The metabolism of Zafirlukast can be increased when combined with Adalimumab.
DB00554,The metabolism of Piroxicam can be increased when combined with Adalimumab.
DB00559,The metabolism of Bosentan can be increased when combined with Adalimumab.
DB00568,The metabolism of Cinnarizine can be increased when combined with Adalimumab.
DB00580,The metabolism of Valdecoxib can be increased when combined with Adalimumab.
DB00586,The metabolism of Diclofenac can be increased when combined with Adalimumab.
DB00617,The metabolism of Paramethadione can be increased when combined with Adalimumab.
DB00661,The metabolism of Verapamil can be increased when combined with Adalimumab.
DB00672,The metabolism of Chlorpropamide can be increased when combined with Adalimumab.
DB00678,The metabolism of Losartan can be increased when combined with Adalimumab.
DB00701,The metabolism of Amprenavir can be increased when combined with Adalimumab.
DB00712,The metabolism of Flurbiprofen can be increased when combined with Adalimumab.
DB00731,The metabolism of Nateglinide can be increased when combined with Adalimumab.
DB00744,The metabolism of Zileuton can be increased when combined with Adalimumab.
DB00749,The metabolism of Etodolac can be increased when combined with Adalimumab.
DB00755,The metabolism of Tretinoin can be increased when combined with Adalimumab.
DB00758,The metabolism of Clopidogrel can be increased when combined with Adalimumab.
DB00783,The metabolism of Estradiol can be increased when combined with Adalimumab.
DB00784,The metabolism of Mefenamic acid can be increased when combined with Adalimumab.
DB00788,The metabolism of Naproxen can be increased when combined with Adalimumab.
DB00796,The metabolism of Candesartan cilexetil can be increased when combined with Adalimumab.
DB00812,The metabolism of Phenylbutazone can be increased when combined with Adalimumab.
DB00814,The metabolism of Meloxicam can be increased when combined with Adalimumab.
DB00839,The metabolism of Tolazamide can be increased when combined with Adalimumab.
DB00843,The metabolism of Donepezil can be increased when combined with Adalimumab.
DB00857,The metabolism of Terbinafine can be increased when combined with Adalimumab.
DB00904,The metabolism of Ondansetron can be increased when combined with Adalimumab.
DB00921,The metabolism of Buprenorphine can be increased when combined with Adalimumab.
DB00936,The metabolism of Salicylic acid can be increased when combined with Adalimumab.
DB00945,The metabolism of Acetylsalicylic acid can be increased when combined with Adalimumab.
DB00969,The metabolism of Alosetron can be increased when combined with Adalimumab.
DB00972,The metabolism of Azelastine can be increased when combined with Adalimumab.
DB00980,The metabolism of Ramelteon can be increased when combined with Adalimumab.
DB01016,The metabolism of Glyburide can be increased when combined with Adalimumab.
DB01029,The metabolism of Irbesartan can be increased when combined with Adalimumab.
DB01036,The metabolism of Tolterodine can be increased when combined with Adalimumab.
DB01037,The metabolism of Selegiline can be increased when combined with Adalimumab.
DB01041,The metabolism of Thalidomide can be increased when combined with Adalimumab.
DB01050,The metabolism of Ibuprofen can be increased when combined with Adalimumab.
DB01065,The metabolism of Melatonin can be increased when combined with Adalimumab.
DB01067,The metabolism of Glipizide can be increased when combined with Adalimumab.
DB01072,The metabolism of Atazanavir can be increased when combined with Adalimumab.
DB01075,The metabolism of Diphenhydramine can be increased when combined with Adalimumab.
DB01095,The metabolism of Fluvastatin can be increased when combined with Adalimumab.
DB01098,The metabolism of Rosuvastatin can be increased when combined with Adalimumab.
DB01120,The metabolism of Gliclazide can be increased when combined with Adalimumab.
DB01124,The metabolism of Tolbutamide can be increased when combined with Adalimumab.
DB01136,The metabolism of Carvedilol can be increased when combined with Adalimumab.
DB01154,The metabolism of Thiamylal can be increased when combined with Adalimumab.
DB01171,The metabolism of Moclobemide can be increased when combined with Adalimumab.
DB01177,The metabolism of Idarubicin can be increased when combined with Adalimumab.
DB01198,The metabolism of Zopiclone can be increased when combined with Adalimumab.
DB01251,The metabolism of Gliquidone can be increased when combined with Adalimumab.
DB01283,The metabolism of Lumiracoxib can be increased when combined with Adalimumab.
DB01289,The metabolism of Glisoxepide can be increased when combined with Adalimumab.
DB01357,The metabolism of Mestranol can be increased when combined with Adalimumab.
DB01424,The metabolism of Aminophenazone can be increased when combined with Adalimumab.
DB01435,The metabolism of Antipyrine can be increased when combined with Adalimumab.
DB01589,The metabolism of Quazepam can be increased when combined with Adalimumab.
DB01628,The metabolism of Etoricoxib can be increased when combined with Adalimumab.
DB03756,The metabolism of Doconexent can be increased when combined with Adalimumab.
DB03783,The metabolism of Phenacetin can be increased when combined with Adalimumab.
DB04557,The metabolism of Arachidonic Acid can be increased when combined with Adalimumab.
DB04574,The metabolism of Estrone sulfate can be increased when combined with Adalimumab.
DB04665,The metabolism of Coumarin can be increased when combined with Adalimumab.
DB04725,The metabolism of Licofelone can be increased when combined with Adalimumab.
DB04841,The metabolism of Flunarizine can be increased when combined with Adalimumab.
DB04898,The metabolism of Ximelagatran can be increased when combined with Adalimumab.
DB06204,The metabolism of Tapentadol can be increased when combined with Adalimumab.
DB06268,The metabolism of Sitaxentan can be increased when combined with Adalimumab.
DB06370,The metabolism of Indisulam can be increased when combined with Adalimumab.
DB06652,The metabolism of Vicriviroc can be increased when combined with Adalimumab.
DB06725,The metabolism of Lornoxicam can be increased when combined with Adalimumab.
DB06737,The metabolism of Zaltoprofen can be increased when combined with Adalimumab.
DB06803,The metabolism of Niclosamide can be increased when combined with Adalimumab.
DB07615,The metabolism of Tranilast can be increased when combined with Adalimumab.
DB08439,The metabolism of Parecoxib can be increased when combined with Adalimumab.
DB08828,The metabolism of Vismodegib can be increased when combined with Adalimumab.
DB08860,The metabolism of Pitavastatin can be increased when combined with Adalimumab.
DB08875,The metabolism of Cabozantinib can be increased when combined with Adalimumab.
DB08899,The metabolism of Enzalutamide can be increased when combined with Adalimumab.
DB08962,The metabolism of Glibornuride can be increased when combined with Adalimumab.
DB09048,The metabolism of Netupitant can be increased when combined with Adalimumab.
DB09061,The metabolism of Cannabidiol can be increased when combined with Adalimumab.
DB09080,The metabolism of Olodaterol can be increased when combined with Adalimumab.
DB09288,The metabolism of Propacetamol can be increased when combined with Adalimumab.
DB11560,The metabolism of Lesinurad can be increased when combined with Adalimumab.
DB11614,The metabolism of Rupatadine can be increased when combined with Adalimumab.
DB13406,The metabolism of Carbutamide can be increased when combined with Adalimumab.
DB13675,The metabolism of Metahexamide can be increased when combined with Adalimumab.
DB13919,The metabolism of Candesartan can be increased when combined with Adalimumab.
DB13941,The metabolism of Piperaquine can be increased when combined with Adalimumab.
DB13952,The metabolism of Estradiol acetate can be increased when combined with Adalimumab.
DB13953,The metabolism of Estradiol benzoate can be increased when combined with Adalimumab.
DB13954,The metabolism of Estradiol cypionate can be increased when combined with Adalimumab.
DB13955,The metabolism of Estradiol dienanthate can be increased when combined with Adalimumab.
DB13956,The metabolism of Estradiol valerate can be increased when combined with Adalimumab.
DB14009,The metabolism of Medical Cannabis can be increased when combined with Adalimumab.
DB14011,The metabolism of Nabiximols can be increased when combined with Adalimumab.
DB00829,The metabolism of Diazepam can be increased when combined with Adalimumab.
DB00514,The metabolism of Dextromethorphan can be increased when combined with Adalimumab.
DB00470,The metabolism of Dronabinol can be increased when combined with Adalimumab.
DB09213,The metabolism of Dexibuprofen can be increased when combined with Adalimumab.
DB00465,The metabolism of Ketorolac can be increased when combined with Adalimumab.
DB15233,The metabolism of Avapritinib can be increased when combined with Adalimumab.
DB00321,The metabolism of Amitriptyline can be increased when combined with Adalimumab.
DB01142,The metabolism of Doxepin can be increased when combined with Adalimumab.
DB00216,The metabolism of Eletriptan can be increased when combined with Adalimumab.
DB00404,The metabolism of Alprazolam can be increased when combined with Adalimumab.
DB00726,The metabolism of Trimipramine can be increased when combined with Adalimumab.
DB01101,The metabolism of Capecitabine can be increased when combined with Adalimumab.
DB00266,The metabolism of Dicoumarol can be increased when combined with Adalimumab.
DB00313,The metabolism of Valproic acid can be increased when combined with Adalimumab.
DB00908,The metabolism of Quinidine can be increased when combined with Adalimumab.
DB13136,The metabolism of Fluindione can be increased when combined with Adalimumab.
DB01224,The metabolism of Quetiapine can be increased when combined with Adalimumab.
DB00182,The metabolism of Amphetamine can be increased when combined with Adalimumab.
DB00187,The metabolism of Esmolol can be increased when combined with Adalimumab.
DB00245,The metabolism of Benzatropine can be increased when combined with Adalimumab.
DB00289,The metabolism of Atomoxetine can be increased when combined with Adalimumab.
DB00335,The metabolism of Atenolol can be increased when combined with Adalimumab.
DB00373,The metabolism of Timolol can be increased when combined with Adalimumab.
DB00409,The metabolism of Remoxipride can be increased when combined with Adalimumab.
DB00592,The metabolism of Piperazine can be increased when combined with Adalimumab.
DB00699,The metabolism of Nicergoline can be increased when combined with Adalimumab.
DB00737,The metabolism of Meclizine can be increased when combined with Adalimumab.
DB00805,The metabolism of Minaprine can be increased when combined with Adalimumab.
DB00866,The metabolism of Alprenolol can be increased when combined with Adalimumab.
DB00914,The metabolism of Phenformin can be increased when combined with Adalimumab.
DB00933,The metabolism of Mesoridazine can be increased when combined with Adalimumab.
DB00960,The metabolism of Pindolol can be increased when combined with Adalimumab.
DB01071,The metabolism of Mequitazine can be increased when combined with Adalimumab.
DB01079,The metabolism of Tegaserod can be increased when combined with Adalimumab.
DB01193,The metabolism of Acebutolol can be increased when combined with Adalimumab.
DB01203,The metabolism of Nadolol can be increased when combined with Adalimumab.
DB01228,The metabolism of Encainide can be increased when combined with Adalimumab.
DB01233,The metabolism of Metoclopramide can be increased when combined with Adalimumab.
DB01255,The metabolism of Lisdexamfetamine can be increased when combined with Adalimumab.
DB01295,The metabolism of Bevantolol can be increased when combined with Adalimumab.
DB01297,The metabolism of Practolol can be increased when combined with Adalimumab.
DB01359,The metabolism of Penbutolol can be increased when combined with Adalimumab.
DB01403,The metabolism of Methotrimeprazine can be increased when combined with Adalimumab.
DB01429,The metabolism of Aprindine can be increased when combined with Adalimumab.
DB01454,The metabolism of Midomafetamine can be increased when combined with Adalimumab.
DB01472,The metabolism of 4-Methoxyamphetamine can be increased when combined with Adalimumab.
DB01576,The metabolism of Dextroamphetamine can be increased when combined with Adalimumab.
DB01577,The metabolism of Metamfetamine can be increased when combined with Adalimumab.
DB01580,The metabolism of Oxprenolol can be increased when combined with Adalimumab.
DB04840,The metabolism of Debrisoquine can be increased when combined with Adalimumab.
DB04844,The metabolism of Tetrabenazine can be increased when combined with Adalimumab.
DB04846,The metabolism of Celiprolol can be increased when combined with Adalimumab.
DB06217,The metabolism of Vernakalant can be increased when combined with Adalimumab.
DB06506,The metabolism of Repinotan can be increased when combined with Adalimumab.
DB06608,The metabolism of Tafenoquine can be increased when combined with Adalimumab.
DB06678,The metabolism of Esmirtazapine can be increased when combined with Adalimumab.
DB06726,The metabolism of Bufuralol can be increased when combined with Adalimumab.
DB06727,The metabolism of Sparteine can be increased when combined with Adalimumab.
DB06735,The metabolism of Enclomiphene can be increased when combined with Adalimumab.
DB08807,The metabolism of Bopindolol can be increased when combined with Adalimumab.
DB08808,The metabolism of Bupranolol can be increased when combined with Adalimumab.
DB08952,The metabolism of Indenolol can be increased when combined with Adalimumab.
DB09013,The metabolism of Befunolol can be increased when combined with Adalimumab.
DB09076,The metabolism of Umeclidinium can be increased when combined with Adalimumab.
DB09204,The metabolism of Arotinolol can be increased when combined with Adalimumab.
DB09351,The metabolism of Levobetaxolol can be increased when combined with Adalimumab.
DB11770,The metabolism of Talinolol can be increased when combined with Adalimumab.
DB11785,The metabolism of Anisodamine can be increased when combined with Adalimumab.
DB11855,The metabolism of Revefenacin can be increased when combined with Adalimumab.
DB11979,The metabolism of Elagolix can be increased when combined with Adalimumab.
DB12070,The metabolism of Letermovir can be increased when combined with Adalimumab.
DB12212,The metabolism of Landiolol can be increased when combined with Adalimumab.
DB12752,The metabolism of Bucindolol can be increased when combined with Adalimumab.
DB13443,The metabolism of Esatenolol can be increased when combined with Adalimumab.
DB13508,The metabolism of Cloranolol can be increased when combined with Adalimumab.
DB13530,The metabolism of Mepindolol can be increased when combined with Adalimumab.
DB13679,The metabolism of Dexchlorpheniramine can be increased when combined with Adalimumab.
DB13757,The metabolism of Epanolol can be increased when combined with Adalimumab.
DB13775,The metabolism of Tertatolol can be increased when combined with Adalimumab.
DB00850,The metabolism of Perphenazine can be increased when combined with Adalimumab.
DB09173,The metabolism of Butyrfentanyl can be increased when combined with Adalimumab.
DB00281,The metabolism of Lidocaine can be increased when combined with Adalimumab.
DB00598,The metabolism of Labetalol can be increased when combined with Adalimumab.
DB14010,"The metabolism of 5-methoxy-N,N-dimethyltryptamine can be increased when combined with Adalimumab."
DB01410,The metabolism of Ciclesonide can be increased when combined with Adalimumab.
DB00918,The metabolism of Almotriptan can be increased when combined with Adalimumab.
DB08918,The metabolism of Levomilnacipran can be increased when combined with Adalimumab.
DB08922,The metabolism of Perospirone can be increased when combined with Adalimumab.
DB09183,The metabolism of Dasabuvir can be increased when combined with Adalimumab.
DB00185,The metabolism of Cevimeline can be increased when combined with Adalimumab.
DB00243,The metabolism of Ranolazine can be increased when combined with Adalimumab.
DB00297,The metabolism of Bupivacaine can be increased when combined with Adalimumab.
DB00318,The metabolism of Codeine can be increased when combined with Adalimumab.
DB00377,The metabolism of Palonosetron can be increased when combined with Adalimumab.
DB00589,The metabolism of Lisuride can be increased when combined with Adalimumab.
DB00647,The metabolism of Dextropropoxyphene can be increased when combined with Adalimumab.
DB00674,The metabolism of Galantamine can be increased when combined with Adalimumab.
DB00705,The metabolism of Delavirdine can be increased when combined with Adalimumab.
DB00706,The metabolism of Tamsulosin can be increased when combined with Adalimumab.
DB00757,The metabolism of Dolasetron can be increased when combined with Adalimumab.
DB01149,The metabolism of Nefazodone can be increased when combined with Adalimumab.
DB01192,The metabolism of Oxymorphone can be increased when combined with Adalimumab.
DB01244,The metabolism of Bepridil can be increased when combined with Adalimumab.
DB01392,The metabolism of Yohimbine can be increased when combined with Adalimumab.
DB01409,The metabolism of Tiotropium can be increased when combined with Adalimumab.
DB01551,The metabolism of Dihydrocodeine can be increased when combined with Adalimumab.
DB01591,The metabolism of Solifenacin can be increased when combined with Adalimumab.
DB01621,The metabolism of Pipotiazine can be increased when combined with Adalimumab.
DB02703,The metabolism of Fusidic acid can be increased when combined with Adalimumab.
DB04829,The metabolism of Lysergic acid diethylamide can be increased when combined with Adalimumab.
DB04884,The metabolism of Dapoxetine can be increased when combined with Adalimumab.
DB04905,The metabolism of Tesmilifene can be increased when combined with Adalimumab.
DB04920,The metabolism of Clevidipine can be increased when combined with Adalimumab.
DB05271,The metabolism of Rotigotine can be increased when combined with Adalimumab.
DB06016,The metabolism of Cariprazine can be increased when combined with Adalimumab.
DB06144,The metabolism of Sertindole can be increased when combined with Adalimumab.
DB06203,The metabolism of Alogliptin can be increased when combined with Adalimumab.
DB06702,The metabolism of Fesoterodine can be increased when combined with Adalimumab.
DB08893,The metabolism of Mirabegron can be increased when combined with Adalimumab.
DB09128,The metabolism of Brexpiprazole can be increased when combined with Adalimumab.
DB09195,The metabolism of Lorpiprazole can be increased when combined with Adalimumab.
DB09555,The metabolism of Dexchlorpheniramine maleate can be increased when combined with Adalimumab.
DB11130,The metabolism of Opium can be increased when combined with Adalimumab.
DB11642,The metabolism of Pitolisant can be increased when combined with Adalimumab.
DB13293,The metabolism of Ipecac can be increased when combined with Adalimumab.
DB00344,The metabolism of Protriptyline can be increased when combined with Adalimumab.
DB00496,The metabolism of Darifenacin can be increased when combined with Adalimumab.
DB00543,The metabolism of Amoxapine can be increased when combined with Adalimumab.
DB00932,The metabolism of Tipranavir can be increased when combined with Adalimumab.
DB09039,The metabolism of Eliglustat can be increased when combined with Adalimumab.
DB12930,The metabolism of Opipramol can be increased when combined with Adalimumab.
DB00489,The metabolism of Sotalol can be increased when combined with Adalimumab.
DB01035,The metabolism of Procainamide can be increased when combined with Adalimumab.
DB01195,The metabolism of Flecainide can be increased when combined with Adalimumab.
DB00228,The metabolism of Enflurane can be increased when combined with Adalimumab.
DB06712,The metabolism of Nilvadipine can be increased when combined with Adalimumab.
DB06728,The metabolism of Aniline can be increased when combined with Adalimumab.
DB00949,The metabolism of Felbamate can be increased when combined with Adalimumab.
DB00593,The metabolism of Ethosuximide can be increased when combined with Adalimumab.
DB00186,The metabolism of Lorazepam can be increased when combined with Adalimumab.
DB00191,The metabolism of Phentermine can be increased when combined with Adalimumab.
DB00207,The metabolism of Azithromycin can be increased when combined with Adalimumab.
DB00208,The metabolism of Ticlopidine can be increased when combined with Adalimumab.
DB00264,The metabolism of Metoprolol can be increased when combined with Adalimumab.
DB00426,The metabolism of Famciclovir can be increased when combined with Adalimumab.
DB00433,The metabolism of Prochlorperazine can be increased when combined with Adalimumab.
DB00567,The metabolism of Cephalexin can be increased when combined with Adalimumab.
DB00590,The metabolism of Doxazosin can be increased when combined with Adalimumab.
DB01039,The metabolism of Fenofibrate can be increased when combined with Adalimumab.
DB01395,The metabolism of Drospirenone can be increased when combined with Adalimumab.
DB01411,The metabolism of Pranlukast can be increased when combined with Adalimumab.
DB01431,The metabolism of Allylestrenol can be increased when combined with Adalimumab.
DB01624,The metabolism of Zuclopenthixol can be increased when combined with Adalimumab.
DB06201,The metabolism of Rufinamide can be increased when combined with Adalimumab.
DB06480,The metabolism of Prucalopride can be increased when combined with Adalimumab.
DB08882,The metabolism of Linagliptin can be increased when combined with Adalimumab.
DB09030,The metabolism of Vorapaxar can be increased when combined with Adalimumab.
DB09034,The metabolism of Suvorexant can be increased when combined with Adalimumab.
DB09079,The metabolism of Nintedanib can be increased when combined with Adalimumab.
DB09299,The metabolism of Tenofovir alafenamide can be increased when combined with Adalimumab.
DB09330,The metabolism of Osimertinib can be increased when combined with Adalimumab.
DB11094,The metabolism of Vitamin D can be increased when combined with Adalimumab.
DB11273,The metabolism of Dihydroergocornine can be increased when combined with Adalimumab.
DB11730,The metabolism of Ribociclib can be increased when combined with Adalimumab.
DB11952,The metabolism of Duvelisib can be increased when combined with Adalimumab.
DB12141,The metabolism of Gilteritinib can be increased when combined with Adalimumab.
DB12515,The metabolism of 9-aminocamptothecin can be increased when combined with Adalimumab.
DB12952,The metabolism of Methylprednisone can be increased when combined with Adalimumab.
DB13345,The metabolism of Dihydroergocristine can be increased when combined with Adalimumab.
DB13385,The metabolism of Dihydroergocryptine can be increased when combined with Adalimumab.
DB14126,The metabolism of Tenofovir can be increased when combined with Adalimumab.
DB15444,The metabolism of Elexacaftor can be increased when combined with Adalimumab.
DB06717,The metabolism of Fosaprepitant can be increased when combined with Adalimumab.
DB12825,The metabolism of Lefamulin can be increased when combined with Adalimumab.
DB12887,The metabolism of Tazemetostat can be increased when combined with Adalimumab.
DB00454,The metabolism of Meperidine can be increased when combined with Adalimumab.
DB01151,The metabolism of Desipramine can be increased when combined with Adalimumab.
DB12371,The metabolism of Siponimod can be increased when combined with Adalimumab.
DB00247,The metabolism of Methysergide can be increased when combined with Adalimumab.
DB08827,The metabolism of Lomitapide can be increased when combined with Adalimumab.
DB11742,The metabolism of Ebastine can be increased when combined with Adalimumab.
DB05015,The metabolism of Belinostat can be increased when combined with Adalimumab.
DB01118,The metabolism of Amiodarone can be increased when combined with Adalimumab.
DB00675,The metabolism of Tamoxifen can be increased when combined with Adalimumab.
DB00204,The metabolism of Dofetilide can be increased when combined with Adalimumab.
DB00342,The metabolism of Terfenadine can be increased when combined with Adalimumab.
DB00451,The metabolism of Levothyroxine can be increased when combined with Adalimumab.
DB00604,The metabolism of Cisapride can be increased when combined with Adalimumab.
DB00877,The metabolism of Sirolimus can be increased when combined with Adalimumab.
DB01008,The metabolism of Busulfan can be increased when combined with Adalimumab.
DB01254,The metabolism of Dasatinib can be increased when combined with Adalimumab.
DB01396,The metabolism of Digitoxin can be increased when combined with Adalimumab.
DB01590,The metabolism of Everolimus can be increased when combined with Adalimumab.
DB03410,The metabolism of 4-hydroxycoumarin can be increased when combined with Adalimumab.
DB04855,The metabolism of Dronedarone can be increased when combined with Adalimumab.
DB06287,The metabolism of Temsirolimus can be increased when combined with Adalimumab.
DB09053,The metabolism of Ibrutinib can be increased when combined with Adalimumab.
DB09289,The metabolism of Tianeptine can be increased when combined with Adalimumab.
DB11633,The metabolism of Isavuconazole can be increased when combined with Adalimumab.
DB13275,The metabolism of Clorindione can be increased when combined with Adalimumab.
DB00398,The metabolism of Sorafenib can be increased when combined with Adalimumab.
DB00444,The metabolism of Teniposide can be increased when combined with Adalimumab.
DB00530,The metabolism of Erlotinib can be increased when combined with Adalimumab.
DB00541,The metabolism of Vincristine can be increased when combined with Adalimumab.
DB00619,The metabolism of Imatinib can be increased when combined with Adalimumab.
DB00773,The metabolism of Etoposide can be increased when combined with Adalimumab.
DB01248,The metabolism of Docetaxel can be increased when combined with Adalimumab.
DB01268,The metabolism of Sunitinib can be increased when combined with Adalimumab.
DB06626,The metabolism of Axitinib can be increased when combined with Adalimumab.
DB08865,The metabolism of Crizotinib can be increased when combined with Adalimumab.
DB08901,The metabolism of Ponatinib can be increased when combined with Adalimumab.
DB12483,The metabolism of Copanlisib can be increased when combined with Adalimumab.
DB00188,The metabolism of Bortezomib can be increased when combined with Adalimumab.
DB00363,The metabolism of Clozapine can be increased when combined with Adalimumab.
DB01181,The metabolism of Ifosfamide can be increased when combined with Adalimumab.
DB05109,The metabolism of Trabectedin can be increased when combined with Adalimumab.
DB12147,The metabolism of Erdafitinib can be increased when combined with Adalimumab.
DB13874,The metabolism of Enasidenib can be increased when combined with Adalimumab.
DB06589,The metabolism of Pazopanib can be increased when combined with Adalimumab.
DB05239,The metabolism of Cobimetinib can be increased when combined with Adalimumab.
DB09063,The metabolism of Ceritinib can be increased when combined with Adalimumab.
DB11963,The metabolism of Dacomitinib can be increased when combined with Adalimumab.
DB12015,The metabolism of Alpelisib can be increased when combined with Adalimumab.
DB00309,The metabolism of Vindesine can be increased when combined with Adalimumab.
DB00361,The metabolism of Vinorelbine can be increased when combined with Adalimumab.
DB00570,The metabolism of Vinblastine can be increased when combined with Adalimumab.
DB00694,The metabolism of Daunorubicin can be increased when combined with Adalimumab.
DB00987,The metabolism of Cytarabine can be increased when combined with Adalimumab.
DB00997,The metabolism of Doxorubicin can be increased when combined with Adalimumab.
DB01108,The metabolism of Trilostane can be increased when combined with Adalimumab.
DB04572,The metabolism of Thiotepa can be increased when combined with Adalimumab.
DB04845,The metabolism of Ixabepilone can be increased when combined with Adalimumab.
DB04868,The metabolism of Nilotinib can be increased when combined with Adalimumab.
DB06603,The metabolism of Panobinostat can be increased when combined with Adalimumab.
DB06616,The metabolism of Bosutinib can be increased when combined with Adalimumab.
DB08870,The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.
DB08877,The metabolism of Ruxolitinib can be increased when combined with Adalimumab.
DB09073,The metabolism of Palbociclib can be increased when combined with Adalimumab.
DB08912,The metabolism of Dabrafenib can be increased when combined with Adalimumab.
DB12267,The metabolism of Brigatinib can be increased when combined with Adalimumab.
DB11718,The metabolism of Encorafenib can be increased when combined with Adalimumab.
DB00563,The metabolism of Methotrexate can be increased when combined with Adalimumab.
DB05294,The metabolism of Vandetanib can be increased when combined with Adalimumab.
DB05812,The metabolism of Abiraterone can be increased when combined with Adalimumab.
DB08881,The metabolism of Vemurafenib can be increased when combined with Adalimumab.
DB11363,The metabolism of Alectinib can be increased when combined with Adalimumab.
DB11581,The metabolism of Venetoclax can be increased when combined with Adalimumab.
DB11641,The metabolism of Vinflunine can be increased when combined with Adalimumab.
DB11703,The metabolism of Acalabrutinib can be increased when combined with Adalimumab.
DB15035,The metabolism of Zanubrutinib can be increased when combined with Adalimumab.
DB00248,The metabolism of Cabergoline can be increased when combined with Adalimumab.
DB06595,The metabolism of Midostaurin can be increased when combined with Adalimumab.
DB09143,The metabolism of Sonidegib can be increased when combined with Adalimumab.
DB11828,The metabolism of Neratinib can be increased when combined with Adalimumab.
DB11986,The metabolism of Entrectinib can be increased when combined with Adalimumab.
DB12978,The metabolism of Pexidartinib can be increased when combined with Adalimumab.
DB14568,The metabolism of Ivosidenib can be increased when combined with Adalimumab.
DB09054,The metabolism of Idelalisib can be increased when combined with Adalimumab.
DB09570,The metabolism of Ixazomib can be increased when combined with Adalimumab.
DB00199,The metabolism of Erythromycin can be increased when combined with Adalimumab.
DB00246,The metabolism of Ziprasidone can be increased when combined with Adalimumab.
DB00439,The metabolism of Cerivastatin can be increased when combined with Adalimumab.
DB00499,The metabolism of Flutamide can be increased when combined with Adalimumab.
DB00528,The metabolism of Lercanidipine can be increased when combined with Adalimumab.
DB00571,The metabolism of Propranolol can be increased when combined with Adalimumab.
DB00588,The metabolism of Fluticasone propionate can be increased when combined with Adalimumab.
DB00608,The metabolism of Chloroquine can be increased when combined with Adalimumab.
DB00688,The metabolism of Mycophenolate mofetil can be increased when combined with Adalimumab.
DB00717,The metabolism of Norethisterone can be increased when combined with Adalimumab.
DB00738,The metabolism of Pentamidine can be increased when combined with Adalimumab.
DB00741,The metabolism of Hydrocortisone can be increased when combined with Adalimumab.
DB00762,The metabolism of Irinotecan can be increased when combined with Adalimumab.
DB00822,The metabolism of Disulfiram can be increased when combined with Adalimumab.
DB00834,The metabolism of Mifepristone can be increased when combined with Adalimumab.
DB00938,The metabolism of Salmeterol can be increased when combined with Adalimumab.
DB00962,The metabolism of Zaleplon can be increased when combined with Adalimumab.
DB00976,The metabolism of Telithromycin can be increased when combined with Adalimumab.
DB01054,The metabolism of Nitrendipine can be increased when combined with Adalimumab.
DB01058,The metabolism of Praziquantel can be increased when combined with Adalimumab.
DB01062,The metabolism of Oxybutynin can be increased when combined with Adalimumab.
DB01076,The metabolism of Atorvastatin can be increased when combined with Adalimumab.
DB01103,The metabolism of Quinacrine can be increased when combined with Adalimumab.
DB01115,The metabolism of Nifedipine can be increased when combined with Adalimumab.
DB01126,The metabolism of Dutasteride can be increased when combined with Adalimumab.
DB01166,The metabolism of Cilostazol can be increased when combined with Adalimumab.
DB01184,The metabolism of Domperidone can be increased when combined with Adalimumab.
DB01211,The metabolism of Clarithromycin can be increased when combined with Adalimumab.
DB01216,The metabolism of Finasteride can be increased when combined with Adalimumab.
DB01218,The metabolism of Halofantrine can be increased when combined with Adalimumab.
DB05521,The metabolism of Telaprevir can be increased when combined with Adalimumab.
DB05773,The metabolism of Trastuzumab emtansine can be increased when combined with Adalimumab.
DB06267,The metabolism of Udenafil can be increased when combined with Adalimumab.
DB06335,The metabolism of Saxagliptin can be increased when combined with Adalimumab.
DB06403,The metabolism of Ambrisentan can be increased when combined with Adalimumab.
DB06419,The metabolism of Cethromycin can be increased when combined with Adalimumab.
DB06772,The metabolism of Cabazitaxel can be increased when combined with Adalimumab.
DB06789,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Adalimumab.
DB08820,The metabolism of Ivacaftor can be increased when combined with Adalimumab.
DB08873,The metabolism of Boceprevir can be increased when combined with Adalimumab.
DB08883,The metabolism of Perampanel can be increased when combined with Adalimumab.
DB08906,The metabolism of Fluticasone furoate can be increased when combined with Adalimumab.
DB09065,The metabolism of Cobicistat can be increased when combined with Adalimumab.
DB09074,The metabolism of Olaparib can be increased when combined with Adalimumab.
DB09102,The metabolism of Daclatasvir can be increased when combined with Adalimumab.
DB09231,The metabolism of Benidipine can be increased when combined with Adalimumab.
DB09297,The metabolism of Paritaprevir can be increased when combined with Adalimumab.
DB11574,The metabolism of Elbasvir can be increased when combined with Adalimumab.
DB11712,The metabolism of Tezacaftor can be increased when combined with Adalimumab.
DB11737,The metabolism of Icotinib can be increased when combined with Adalimumab.
DB12301,The metabolism of Doravirine can be increased when combined with Adalimumab.
DB13867,The metabolism of Fluticasone can be increased when combined with Adalimumab.
DB14538,The metabolism of Hydrocortisone aceponate can be increased when combined with Adalimumab.
DB14539,The metabolism of Hydrocortisone acetate can be increased when combined with Adalimumab.
DB14541,The metabolism of Hydrocortisone cypionate can be increased when combined with Adalimumab.
DB14542,The metabolism of Hydrocortisone phosphate can be increased when combined with Adalimumab.
DB00396,The metabolism of Progesterone can be increased when combined with Adalimumab.
DB04856,The metabolism of Dexloxiglumide can be increased when combined with Adalimumab.
DB04957,The metabolism of Azimilide can be increased when combined with Adalimumab.
DB00250,The metabolism of Dapsone can be increased when combined with Adalimumab.
DB00317,The metabolism of Gefitinib can be increased when combined with Adalimumab.
DB00367,The metabolism of Levonorgestrel can be increased when combined with Adalimumab.
DB00497,The metabolism of Oxycodone can be increased when combined with Adalimumab.
DB00620,The metabolism of Triamcinolone can be increased when combined with Adalimumab.
DB00624,The metabolism of Testosterone can be increased when combined with Adalimumab.
DB00656,The metabolism of Trazodone can be increased when combined with Adalimumab.
DB00734,The metabolism of Risperidone can be increased when combined with Adalimumab.
DB01114,The metabolism of Chlorpheniramine can be increased when combined with Adalimumab.
DB01238,The metabolism of Aripiprazole can be increased when combined with Adalimumab.
DB01267,The metabolism of Paliperidone can be increased when combined with Adalimumab.
DB04946,The metabolism of Iloperidone can be increased when combined with Adalimumab.
DB11915,The metabolism of Valbenazine can be increased when combined with Adalimumab.
DB12161,The metabolism of Deutetrabenazine can be increased when combined with Adalimumab.
DB14185,The metabolism of Aripiprazole lauroxil can be increased when combined with Adalimumab.
DB01234,The metabolism of Dexamethasone can be increased when combined with Adalimumab.
DB09237,The metabolism of Levamlodipine can be increased when combined with Adalimumab.
DB11951,The metabolism of Lemborexant can be increased when combined with Adalimumab.
DB00557,The metabolism of Hydroxyzine can be increased when combined with Adalimumab.
DB00203,The metabolism of Sildenafil can be increased when combined with Adalimumab.
DB00227,The metabolism of Lovastatin can be increased when combined with Adalimumab.
DB00490,The metabolism of Buspirone can be increased when combined with Adalimumab.
DB00641,The metabolism of Simvastatin can be increased when combined with Adalimumab.
DB00673,The metabolism of Aprepitant can be increased when combined with Adalimumab.
DB00820,The metabolism of Tadalafil can be increased when combined with Adalimumab.
DB00862,The metabolism of Vardenafil can be increased when combined with Adalimumab.
DB01190,The metabolism of Clindamycin can be increased when combined with Adalimumab.
DB00503,The metabolism of Ritonavir can be increased when combined with Adalimumab.
DB00224,The metabolism of Indinavir can be increased when combined with Adalimumab.
DB00401,The metabolism of Nisoldipine can be increased when combined with Adalimumab.
DB00637,The metabolism of Astemizole can be increased when combined with Adalimumab.
DB00683,The metabolism of Midazolam can be increased when combined with Adalimumab.
DB00700,The metabolism of Eplerenone can be increased when combined with Adalimumab.
DB00802,The metabolism of Alfentanil can be increased when combined with Adalimumab.
DB00813,The metabolism of Fentanyl can be increased when combined with Adalimumab.
DB00897,The metabolism of Triazolam can be increased when combined with Adalimumab.
DB01023,The metabolism of Felodipine can be increased when combined with Adalimumab.
DB01227,The metabolism of Levacetylmethadol can be increased when combined with Adalimumab.
DB01232,The metabolism of Saquinavir can be increased when combined with Adalimumab.
DB06228,The metabolism of Rivaroxaban can be increased when combined with Adalimumab.
DB05804,The metabolism of Prasterone sulfate can be increased when combined with Adalimumab.
DB05676,The therapeutic efficacy of Apremilast can be decreased when used in combination with Adalimumab.
DB15595,"The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Adalimumab."
DB14513,The serum concentration of Magnesium can be decreased when it is combined with Adalimumab.
DB01601,The serum concentration of Adalimumab can be increased when it is combined with Lopinavir.
DB12530,The risk or severity of infection can be increased when Adalimumab is combined with Inebilizumab.
DB00635,The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Somatotropin resulting in a loss in efficacy.
DB00255,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.
DB00269,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Chlorotrianisene.
DB00286,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.
DB00783,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol.
DB00977,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ethinylestradiol.
DB01357,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mestranol.
DB04573,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estriol.
DB04574,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estrone sulfate.
DB04575,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Quinestrol.
DB07931,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Hexestrol.
DB09070,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Tibolone.
DB09317,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, A."
DB09318,"The therapeutic efficacy of Somatotropin can be decreased when used in combination with Synthetic Conjugated Estrogens, B."
DB09369,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Polyestradiol phosphate.
DB09381,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Esterified estrogens.
DB11478,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Zeranol.
DB11674,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Equol.
DB12487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Promestriene.
DB13143,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methallenestril.
DB13386,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Epimestrol.
DB13418,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Moxestrol.
DB13952,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol acetate.
DB13956,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol valerate.
DB15334,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Biochanin A.
DB15335,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Formononetin.
DB01380,The serum concentration of the active metabolites of Cortisone acetate can be reduced when Cortisone acetate is used in combination with Somatotropin resulting in a loss in efficacy.
DB00007,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin."
DB00065,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Infliximab."
DB00080,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Daptomycin."
DB00091,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cyclosporine."
DB00175,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin."
DB00181,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Baclofen."
DB00203,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sildenafil."
DB00224,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Indinavir."
DB00227,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lovastatin."
DB00242,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cladribine."
DB00252,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin."
DB00282,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pamidronic acid."
DB00358,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mefloquine."
DB00382,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrine."
DB00389,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Carbimazole."
DB00439,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cerivastatin."
DB00440,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trimethoprim."
DB00471,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Montelukast."
DB00495,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine."
DB00501,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cimetidine."
DB00503,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ritonavir."
DB00528,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lercanidipine."
DB00537,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofloxacin."
DB00541,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Vincristine."
DB00550,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propylthiouracil."
DB00563,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methotrexate."
DB00584,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Enalapril."
DB00585,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nizatidine."
DB00602,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin."
DB00608,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Chloroquine."
DB00627,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin."
DB00630,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Alendronic acid."
DB00636,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibrate."
DB00641,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simvastatin."
DB00649,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine."
DB00666,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nafarelin."
DB00681,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amphotericin B."
DB00688,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mycophenolate mofetil."
DB00704,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Naltrexone."
DB00709,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine."
DB00710,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ibandronate."
DB00818,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propofol."
DB00857,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Terbinafine."
DB00859,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Penicillamine."
DB00863,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ranitidine."
DB00864,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrolimus."
DB00876,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Eprosartan."
DB00884,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Risedronic acid."
DB00887,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bumetanide."
DB00897,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Triazolam."
DB00898,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ethanol."
DB00938,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Salmeterol."
DB00951,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isoniazid."
DB00968,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methyldopa."
DB00982,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isotretinoin."
DB00987,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cytarabine."
DB01004,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir."
DB01006,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Letrozole."
DB01015,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sulfamethoxazole."
DB01017,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline."
DB01035,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procainamide."
DB01039,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate."
DB01059,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Norfloxacin."
DB01076,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Atorvastatin."
DB01088,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Iloprost."
DB01095,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fluvastatin."
DB01097,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Leflunomide."
DB01098,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Rosuvastatin."
DB01118,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone."
DB01165,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin."
DB01168,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procarbazine."
DB01197,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Captopril."
DB01229,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Paclitaxel."
DB01232,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Saquinavir."
DB01233,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Metoclopramide."
DB01234,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone."
DB01241,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil."
DB01248,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Docetaxel."
DB01393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bezafibrate."
DB01394,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Colchicine."
DB02703,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fusidic acid."
DB05109,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trabectedin."
DB06693,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mevastatin."
DB06817,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Raltegravir."
DB08860,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pitavastatin."
DB08983,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Etofibrate."
DB09055,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Acipimox."
DB09064,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofibrate."
DB09270,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone."
DB09289,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tianeptine."
DB12554,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mebeverine."
DB13293,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ipecac."
DB13393,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Emetine."
DB13433,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simfibrate."
DB13460,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ronifibrate."
DB13780,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Aluminium clofibrate."
DB13849,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibride."
DB13873,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibric acid."
DB13074,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Somatotropin.
DB00443,The therapeutic efficacy of Betamethasone can be decreased when used in combination with Somatotropin.
DB00620,The therapeutic efficacy of Triamcinolone can be decreased when used in combination with Somatotropin.
DB00253,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Medrysone.
DB00324,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluorometholone.
DB00394,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Beclomethasone dipropionate.
DB00764,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone.
DB00896,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Rimexolone.
DB01384,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Paramethasone.
DB01410,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ciclesonide.
DB08906,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.
DB08970,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene.
DB08971,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.
DB09383,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Meprednisone.
DB11487,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Dexamethasone isonicotinate.
DB11750,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clobetasol.
DB11921,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Deflazacort.
DB13003,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortivazol.
DB13208,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednylidene.
DB13728,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Halometasone.
DB13843,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cloprednol.
DB13867,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.
DB14512,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone furoate.
DB14631,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone phosphate.
DB14633,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisolone hemisuccinate.
DB14634,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene acetate.
DB14644,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Methylprednisolone hemisuccinate.
DB14646,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednisone acetate.
DB14652,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Clocortolone acetate.
DB14659,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Melengestrol acetate.
DB14669,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Betamethasone phosphate.
DB14681,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortisone.
DB06605,Apixaban may increase the anticoagulant activities of Abciximab.
DB06695,Dabigatran etexilate may increase the anticoagulant activities of Abciximab.
DB01254,The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Abciximab.
DB01609,The risk or severity of gastrointestinal bleeding can be increased when Abciximab is combined with Deferasirox.
DB09075,The risk or severity of bleeding can be increased when Edoxaban is combined with Abciximab.
DB09053,The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Abciximab.
DB06228,Abciximab may increase the anticoagulant activities of Rivaroxaban.
DB06206,The risk or severity of bleeding and hemorrhage can be increased when Abciximab is combined with Sugammadex.
DB09070,Tibolone may increase the anticoagulant activities of Abciximab.
DB00013,Urokinase may increase the anticoagulant activities of Abciximab.
DB09030,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Abciximab.
DB06692,The therapeutic efficacy of Abciximab can be decreased when used in combination with Aprotinin.
DB01586,The risk or severity of adverse effects can be increased when Abciximab is combined with Ursodeoxycholic acid.
DB02123,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycochenodeoxycholic Acid.
DB02659,The risk or severity of adverse effects can be increased when Abciximab is combined with Cholic Acid.
DB02691,The risk or severity of adverse effects can be increased when Abciximab is combined with Glycocholic acid.
DB03619,The risk or severity of adverse effects can be increased when Abciximab is combined with Deoxycholic acid.
DB04348,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurocholic acid.
DB05990,The risk or severity of adverse effects can be increased when Abciximab is combined with Obeticholic acid.
DB06777,The risk or severity of adverse effects can be increased when Abciximab is combined with Chenodeoxycholic acid.
DB08833,The risk or severity of adverse effects can be increased when Abciximab is combined with Taurochenodeoxycholic acid.
DB08834,The risk or severity of adverse effects can be increased when Abciximab is combined with Tauroursodeoxycholic acid.
DB08857,The risk or severity of adverse effects can be increased when Abciximab is combined with Bamet-UD2.
DB11622,The risk or severity of adverse effects can be increased when Abciximab is combined with Dehydrocholic acid.
DB11789,The risk or severity of adverse effects can be increased when Abciximab is combined with Hyodeoxycholic Acid.
DB01296,Glucosamine may increase the antiplatelet activities of Abciximab.
DB00078,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibritumomab tiuxetan.
DB08935,The risk or severity of adverse effects can be increased when Abciximab is combined with Obinutuzumab.
DB00932,Tipranavir may increase the antiplatelet activities of Abciximab.
DB00163,Vitamin E may increase the antiplatelet activities of Abciximab.
DB01381,The therapeutic efficacy of Abciximab can be increased when used in combination with Ginkgo biloba.
DB01181,The risk or severity of bleeding can be increased when Ifosfamide is combined with Abciximab.
DB00468,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinine.
DB00908,The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.
DB00675,The risk or severity of bleeding can be increased when Tamoxifen is combined with Abciximab.
DB00539,The risk or severity of bleeding can be increased when Toremifene is combined with Abciximab.
DB00806,The therapeutic efficacy of Abciximab can be increased when used in combination with Pentoxifylline.
DB00686,The risk or severity of adverse effects can be increased when Pentosan polysulfate is combined with Abciximab.
DB00583,The therapeutic efficacy of Abciximab can be increased when used in combination with Levocarnitine.
DB00655,Estrone may increase the thrombogenic activities of Abciximab.
DB00890,Dienestrol may increase the thrombogenic activities of Abciximab.
DB09255,Dextran may increase the anticoagulant activities of Abciximab.
DB00255,Diethylstilbestrol may decrease the anticoagulant activities of Abciximab.
DB00269,Chlorotrianisene may decrease the anticoagulant activities of Abciximab.
DB00286,Conjugated estrogens may decrease the anticoagulant activities of Abciximab.
DB00783,Estradiol may decrease the anticoagulant activities of Abciximab.
DB00977,Ethinylestradiol may decrease the anticoagulant activities of Abciximab.
DB01357,Mestranol may decrease the anticoagulant activities of Abciximab.
DB04573,Estriol may decrease the anticoagulant activities of Abciximab.
DB04574,Estrone sulfate may decrease the anticoagulant activities of Abciximab.
DB04575,Quinestrol may decrease the anticoagulant activities of Abciximab.
DB07931,Hexestrol may decrease the anticoagulant activities of Abciximab.
DB09317,"Synthetic Conjugated Estrogens, A may decrease the anticoagulant activities of Abciximab."
DB09318,"Synthetic Conjugated Estrogens, B may decrease the anticoagulant activities of Abciximab."
DB09369,Polyestradiol phosphate may decrease the anticoagulant activities of Abciximab.
DB09381,Esterified estrogens may decrease the anticoagulant activities of Abciximab.
DB11478,Zeranol may decrease the anticoagulant activities of Abciximab.
DB11674,Equol may decrease the anticoagulant activities of Abciximab.
DB12487,Promestriene may decrease the anticoagulant activities of Abciximab.
DB13143,Methallenestril may decrease the anticoagulant activities of Abciximab.
DB13386,Epimestrol may decrease the anticoagulant activities of Abciximab.
DB13418,Moxestrol may decrease the anticoagulant activities of Abciximab.
DB13952,Estradiol acetate may decrease the anticoagulant activities of Abciximab.
DB13953,Estradiol benzoate may decrease the anticoagulant activities of Abciximab.
DB13954,Estradiol cypionate may decrease the anticoagulant activities of Abciximab.
DB13956,Estradiol valerate may decrease the anticoagulant activities of Abciximab.
DB15334,Biochanin A may decrease the anticoagulant activities of Abciximab.
DB15335,Formononetin may decrease the anticoagulant activities of Abciximab.
DB00159,The risk or severity of bleeding and hemorrhage can be increased when Icosapent is combined with Abciximab.
DB00244,The risk or severity of bleeding and hemorrhage can be increased when Mesalazine is combined with Abciximab.
DB00328,The risk or severity of bleeding and hemorrhage can be increased when Indomethacin is combined with Abciximab.
DB00461,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Abciximab.
DB00465,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Abciximab.
DB00469,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Abciximab.
DB00482,The risk or severity of bleeding and hemorrhage can be increased when Celecoxib is combined with Abciximab.
DB00500,The risk or severity of bleeding and hemorrhage can be increased when Tolmetin is combined with Abciximab.
DB00533,The risk or severity of bleeding and hemorrhage can be increased when Rofecoxib is combined with Abciximab.
DB00554,The risk or severity of bleeding and hemorrhage can be increased when Piroxicam is combined with Abciximab.
DB00573,The risk or severity of bleeding and hemorrhage can be increased when Fenoprofen is combined with Abciximab.
DB00580,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Abciximab.
DB00586,The risk or severity of bleeding and hemorrhage can be increased when Diclofenac is combined with Abciximab.
DB00605,The risk or severity of bleeding and hemorrhage can be increased when Sulindac is combined with Abciximab.
DB00712,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen is combined with Abciximab.
DB00749,The risk or severity of bleeding and hemorrhage can be increased when Etodolac is combined with Abciximab.
DB00784,The risk or severity of bleeding and hemorrhage can be increased when Mefenamic acid is combined with Abciximab.
DB00788,The risk or severity of bleeding and hemorrhage can be increased when Naproxen is combined with Abciximab.
DB00795,The risk or severity of bleeding and hemorrhage can be increased when Sulfasalazine is combined with Abciximab.
DB00812,The risk or severity of bleeding and hemorrhage can be increased when Phenylbutazone is combined with Abciximab.
DB00814,The risk or severity of bleeding and hemorrhage can be increased when Meloxicam is combined with Abciximab.
DB00821,The risk or severity of bleeding and hemorrhage can be increased when Carprofen is combined with Abciximab.
DB00861,The risk or severity of bleeding and hemorrhage can be increased when Diflunisal is combined with Abciximab.
DB00936,The risk or severity of bleeding and hemorrhage can be increased when Salicylic acid is combined with Abciximab.
DB00939,The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Abciximab.
DB00991,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Abciximab.
DB01009,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Abciximab.
DB01014,The risk or severity of bleeding and hemorrhage can be increased when Balsalazide is combined with Abciximab.
DB01250,The risk or severity of bleeding and hemorrhage can be increased when Olsalazine is combined with Abciximab.
DB01283,The risk or severity of bleeding and hemorrhage can be increased when Lumiracoxib is combined with Abciximab.
DB01397,The risk or severity of bleeding and hemorrhage can be increased when Magnesium salicylate is combined with Abciximab.
DB01399,The risk or severity of bleeding and hemorrhage can be increased when Salsalate is combined with Abciximab.
DB01401,The risk or severity of bleeding and hemorrhage can be increased when Choline magnesium trisalicylate is combined with Abciximab.
DB01419,The risk or severity of bleeding and hemorrhage can be increased when Antrafenine is combined with Abciximab.
DB01424,The risk or severity of bleeding and hemorrhage can be increased when Aminophenazone is combined with Abciximab.
DB01435,The risk or severity of bleeding and hemorrhage can be increased when Antipyrine is combined with Abciximab.
DB01600,The risk or severity of bleeding and hemorrhage can be increased when Tiaprofenic acid is combined with Abciximab.
DB01628,The risk or severity of bleeding and hemorrhage can be increased when Etoricoxib is combined with Abciximab.
DB02224,The risk or severity of bleeding and hemorrhage can be increased when Taxifolin is combined with Abciximab.
DB03585,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Abciximab.
DB04552,The risk or severity of bleeding and hemorrhage can be increased when Niflumic acid is combined with Abciximab.
DB04725,The risk or severity of bleeding and hemorrhage can be increased when Licofelone is combined with Abciximab.
DB04812,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Abciximab.
DB04817,The risk or severity of bleeding and hemorrhage can be increased when Metamizole is combined with Abciximab.
DB04828,The risk or severity of bleeding and hemorrhage can be increased when Zomepirac is combined with Abciximab.
DB05095,The risk or severity of bleeding and hemorrhage can be increased when Cimicoxib is combined with Abciximab.
DB06725,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Abciximab.
DB06736,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Abciximab.
DB06737,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Abciximab.
DB07402,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Abciximab.
DB07477,The risk or severity of bleeding and hemorrhage can be increased when Felbinac is combined with Abciximab.
DB08439,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Abciximab.
DB08797,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Abciximab.
DB08940,The risk or severity of bleeding and hemorrhage can be increased when Kebuzone is combined with Abciximab.
DB08942,The risk or severity of bleeding and hemorrhage can be increased when Isoxicam is combined with Abciximab.
DB08951,The risk or severity of bleeding and hemorrhage can be increased when Indoprofen is combined with Abciximab.
DB08955,The risk or severity of bleeding and hemorrhage can be increased when Ibuproxam is combined with Abciximab.
DB08976,The risk or severity of bleeding and hemorrhage can be increased when Floctafenine is combined with Abciximab.
DB08981,The risk or severity of bleeding and hemorrhage can be increased when Fenbufen is combined with Abciximab.
DB08984,The risk or severity of bleeding and hemorrhage can be increased when Etofenamate is combined with Abciximab.
DB08991,The risk or severity of bleeding and hemorrhage can be increased when Epirizole is combined with Abciximab.
DB09084,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Abciximab.
DB09212,The risk or severity of bleeding and hemorrhage can be increased when Loxoprofen is combined with Abciximab.
DB09214,The risk or severity of bleeding and hemorrhage can be increased when Dexketoprofen is combined with Abciximab.
DB09215,The risk or severity of bleeding and hemorrhage can be increased when Droxicam is combined with Abciximab.
DB09216,The risk or severity of bleeding and hemorrhage can be increased when Tolfenamic acid is combined with Abciximab.
DB09217,The risk or severity of bleeding and hemorrhage can be increased when Firocoxib is combined with Abciximab.
DB09218,The risk or severity of bleeding and hemorrhage can be increased when Clonixin is combined with Abciximab.
DB09285,The risk or severity of bleeding and hemorrhage can be increased when Morniflumate is combined with Abciximab.
DB09288,The risk or severity of bleeding and hemorrhage can be increased when Propacetamol is combined with Abciximab.
DB09295,The risk or severity of bleeding and hemorrhage can be increased when Talniflumate is combined with Abciximab.
DB11455,The risk or severity of bleeding and hemorrhage can be increased when Robenacoxib is combined with Abciximab.
DB11466,The risk or severity of bleeding and hemorrhage can be increased when Tepoxalin is combined with Abciximab.
DB11518,The risk or severity of bleeding and hemorrhage can be increased when Flunixin is combined with Abciximab.
DB12399,The risk or severity of bleeding and hemorrhage can be increased when Polmacoxib is combined with Abciximab.
DB12480,The risk or severity of bleeding and hemorrhage can be increased when Betulinic Acid is combined with Abciximab.
DB12610,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Abciximab.
DB13001,The risk or severity of bleeding and hemorrhage can be increased when Tinoridine is combined with Abciximab.
DB13167,The risk or severity of bleeding and hemorrhage can be increased when Alclofenac is combined with Abciximab.
DB13217,The risk or severity of bleeding and hemorrhage can be increased when Fentiazac is combined with Abciximab.
DB13232,The risk or severity of bleeding and hemorrhage can be increased when Suxibuzone is combined with Abciximab.
DB13286,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Abciximab.
DB13314,The risk or severity of bleeding and hemorrhage can be increased when Alminoprofen is combined with Abciximab.
DB13317,The risk or severity of bleeding and hemorrhage can be increased when Flunoxaprofen is combined with Abciximab.
DB13364,The risk or severity of bleeding and hemorrhage can be increased when Feprazone is combined with Abciximab.
DB13371,The risk or severity of bleeding and hemorrhage can be increased when Difenpiramide is combined with Abciximab.
DB13407,The risk or severity of bleeding and hemorrhage can be increased when Nifenazone is combined with Abciximab.
DB13432,The risk or severity of bleeding and hemorrhage can be increased when Lonazolac is combined with Abciximab.
DB13481,The risk or severity of bleeding and hemorrhage can be increased when Tenidap is combined with Abciximab.
DB13501,The risk or severity of bleeding and hemorrhage can be increased when Bendazac is combined with Abciximab.
DB13514,The risk or severity of bleeding and hemorrhage can be increased when Pranoprofen is combined with Abciximab.
DB13524,The risk or severity of bleeding and hemorrhage can be increased when Propyphenazone is combined with Abciximab.
DB13527,The risk or severity of bleeding and hemorrhage can be increased when Proglumetacin is combined with Abciximab.
DB13538,The risk or severity of bleeding and hemorrhage can be increased when Guacetisal is combined with Abciximab.
DB13544,The risk or severity of bleeding and hemorrhage can be increased when Ethenzamide is combined with Abciximab.
DB13612,The risk or severity of bleeding and hemorrhage can be increased when Carbaspirin calcium is combined with Abciximab.
DB13629,The risk or severity of bleeding and hemorrhage can be increased when Mofebutazone is combined with Abciximab.
DB13649,The risk or severity of bleeding and hemorrhage can be increased when Proquazone is combined with Abciximab.
DB13657,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Abciximab.
DB13722,The risk or severity of bleeding and hemorrhage can be increased when Pirprofen is combined with Abciximab.
DB13860,The risk or severity of bleeding and hemorrhage can be increased when Imidazole salicylate is combined with Abciximab.
DB14059,The risk or severity of bleeding and hemorrhage can be increased when SC-236 is combined with Abciximab.
DB14060,The risk or severity of bleeding and hemorrhage can be increased when NS-398 is combined with Abciximab.
DB14938,The risk or severity of bleeding and hemorrhage can be increased when Flurbiprofen axetil is combined with Abciximab.
DB04865,The risk or severity of bleeding can be increased when Abciximab is combined with Omacetaxine mepesuccinate.
DB09211,The risk or severity of adverse effects can be increased when Limaprost is combined with Abciximab.
DB00048,The risk or severity of adverse effects can be increased when Abciximab is combined with Collagenase clostridium histolyticum.
DB11133,Omega-3 fatty acids may increase the antiplatelet activities of Abciximab.
DB00081,The risk or severity of adverse effects can be increased when Abciximab is combined with Tositumomab.
DB00389,Carbimazole may increase the anticoagulant activities of Abciximab.
DB00550,Propylthiouracil may increase the anticoagulant activities of Abciximab.
DB00763,Methimazole may increase the anticoagulant activities of Abciximab.
DB03374,"3,5-Diiodotyrosine may increase the anticoagulant activities of Abciximab."
DB06715,Potassium Iodide may increase the anticoagulant activities of Abciximab.
DB07637,Dibromotyrosine may increase the anticoagulant activities of Abciximab.
DB09418,Potassium perchlorate may increase the anticoagulant activities of Abciximab.
DB13644,Methylthiouracil may increase the anticoagulant activities of Abciximab.
DB13804,Benzylthiouracil may increase the anticoagulant activities of Abciximab.
DB00834,The therapeutic efficacy of Abciximab can be decreased when used in combination with Mifepristone.
DB04066,The therapeutic efficacy of Abciximab can be decreased when used in combination with p-Coumaric acid.
DB04682,The therapeutic efficacy of Abciximab can be decreased when used in combination with Octylphenoxy polyethoxyethanol.
DB05830,The therapeutic efficacy of Abciximab can be decreased when used in combination with Trestolone.
DB06266,The therapeutic efficacy of Abciximab can be decreased when used in combination with Lonidamine.
DB08867,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ulipristal.
DB09401,The therapeutic efficacy of Abciximab can be decreased when used in combination with Isosorbide.
DB11507,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cloprostenol.
DB12025,The therapeutic efficacy of Abciximab can be decreased when used in combination with Triptolide.
DB13044,The therapeutic efficacy of Abciximab can be decreased when used in combination with Gossypol.
DB13310,The therapeutic efficacy of Abciximab can be decreased when used in combination with Ormeloxifene.
DB00294,Etonogestrel may decrease the anticoagulant activities of Abciximab.
DB00304,Desogestrel may decrease the anticoagulant activities of Abciximab.
DB00351,Megestrol acetate may decrease the anticoagulant activities of Abciximab.
DB00367,Levonorgestrel may decrease the anticoagulant activities of Abciximab.
DB00378,Dydrogesterone may decrease the anticoagulant activities of Abciximab.
DB00396,Progesterone may decrease the anticoagulant activities of Abciximab.
DB00603,Medroxyprogesterone acetate may decrease the anticoagulant activities of Abciximab.
DB00717,Norethisterone may decrease the anticoagulant activities of Abciximab.
DB00823,Ethynodiol diacetate may decrease the anticoagulant activities of Abciximab.
DB00957,Norgestimate may decrease the anticoagulant activities of Abciximab.
DB01395,Drospirenone may decrease the anticoagulant activities of Abciximab.
DB01431,Allylestrenol may decrease the anticoagulant activities of Abciximab.
DB04839,Cyproterone acetate may decrease the anticoagulant activities of Abciximab.
DB06713,Norelgestromin may decrease the anticoagulant activities of Abciximab.
DB06730,Gestodene may decrease the anticoagulant activities of Abciximab.
DB06789,Hydroxyprogesterone caproate may decrease the anticoagulant activities of Abciximab.
DB09123,Dienogest may decrease the anticoagulant activities of Abciximab.
DB09124,Medrogestone may decrease the anticoagulant activities of Abciximab.
DB09371,Norethynodrel may decrease the anticoagulant activities of Abciximab.
DB09389,Norgestrel may decrease the anticoagulant activities of Abciximab.
DB11372,Altrenogest may decrease the anticoagulant activities of Abciximab.
DB11619,Gestrinone may decrease the anticoagulant activities of Abciximab.
DB11636,Nomegestrol may decrease the anticoagulant activities of Abciximab.
DB12474,Lynestrenol may decrease the anticoagulant activities of Abciximab.
DB13230,Gestonorone may decrease the anticoagulant activities of Abciximab.
DB13528,Chlormadinone may decrease the anticoagulant activities of Abciximab.
DB13533,Methylestrenolone may decrease the anticoagulant activities of Abciximab.
DB13563,Norgestrienone may decrease the anticoagulant activities of Abciximab.
DB13602,Promegestone may decrease the anticoagulant activities of Abciximab.
DB13685,Quingestanol may decrease the anticoagulant activities of Abciximab.
DB13857,Demegestone may decrease the anticoagulant activities of Abciximab.
DB13866,Etynodiol may decrease the anticoagulant activities of Abciximab.
DB13981,Nomegestrol acetate may decrease the anticoagulant activities of Abciximab.
DB14570,Hydroxyprogesterone may decrease the anticoagulant activities of Abciximab.
DB14678,Norethindrone enanthate may decrease the anticoagulant activities of Abciximab.
DB14679,Quingestanol acetate may decrease the anticoagulant activities of Abciximab.
DB00233,The risk or severity of bleeding can be increased when Aminosalicylic acid is combined with Abciximab.
DB01294,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Abciximab.
DB06251,The risk or severity of bleeding can be increased when Dersalazine is combined with Abciximab.
DB06807,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Abciximab.
DB09543,The risk or severity of bleeding can be increased when Methyl salicylate is combined with Abciximab.
DB11079,The risk or severity of bleeding can be increased when Trolamine salicylate is combined with Abciximab.
DB13509,The risk or severity of bleeding can be increased when Aloxiprin is combined with Abciximab.
DB14006,The risk or severity of bleeding can be increased when Choline salicylate is combined with Abciximab.
DB14026,The risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Abciximab.
DB00001,The risk or severity of bleeding can be increased when Abciximab is combined with Lepirudin.
DB00006,The risk or severity of bleeding can be increased when Abciximab is combined with Bivalirudin.
DB00009,The risk or severity of bleeding can be increased when Abciximab is combined with Alteplase.
DB00015,The risk or severity of bleeding can be increased when Abciximab is combined with Reteplase.
DB00029,The risk or severity of bleeding can be increased when Abciximab is combined with Anistreplase.
DB00031,The risk or severity of bleeding can be increased when Abciximab is combined with Tenecteplase.
DB00055,The risk or severity of bleeding can be increased when Abciximab is combined with Drotrecogin alfa.
DB00086,The risk or severity of bleeding can be increased when Abciximab is combined with Streptokinase.
DB00261,The risk or severity of bleeding can be increased when Abciximab is combined with Anagrelide.
DB00266,The risk or severity of bleeding can be increased when Abciximab is combined with Dicoumarol.
DB00278,The risk or severity of bleeding can be increased when Abciximab is combined with Argatroban.
DB00407,The risk or severity of bleeding can be increased when Abciximab is combined with Ardeparin.
DB00498,The risk or severity of bleeding can be increased when Abciximab is combined with Phenindione.
DB00569,The risk or severity of bleeding can be increased when Abciximab is combined with Fondaparinux.
DB00682,The risk or severity of bleeding can be increased when Abciximab is combined with Warfarin.
DB00946,The risk or severity of bleeding can be increased when Abciximab is combined with Phenprocoumon.
DB00975,The risk or severity of bleeding can be increased when Abciximab is combined with Dipyridamole.
DB01088,The risk or severity of bleeding can be increased when Abciximab is combined with Iloprost.
DB01109,The risk or severity of bleeding can be increased when Abciximab is combined with Heparin.
DB01225,The risk or severity of bleeding can be increased when Abciximab is combined with Enoxaparin.
DB01240,The risk or severity of bleeding can be increased when Abciximab is combined with Epoprostenol.
DB01418,The risk or severity of bleeding can be increased when Abciximab is combined with Acenocoumarol.
DB03410,The risk or severity of bleeding can be increased when Abciximab is combined with 4-hydroxycoumarin.
DB04665,The risk or severity of bleeding can be increased when Abciximab is combined with Coumarin.
DB04898,The risk or severity of bleeding can be increased when Abciximab is combined with Ximelagatran.
DB04925,The risk or severity of bleeding can be increased when Abciximab is combined with Desmoteplase.
DB04932,The risk or severity of bleeding can be increased when Abciximab is combined with Defibrotide.
DB05099,The risk or severity of bleeding can be increased when Abciximab is combined with Ancrod.
DB05229,The risk or severity of bleeding can be increased when Abciximab is combined with Beraprost.
DB05254,The risk or severity of bleeding can be increased when Abciximab is combined with Fibrinolysin.
DB06209,The risk or severity of bleeding can be increased when Abciximab is combined with Prasugrel.
DB06271,The risk or severity of bleeding can be increased when Abciximab is combined with Sulodexide.
DB06294,The risk or severity of bleeding can be increased when Abciximab is combined with Semuloparin.
DB06406,The risk or severity of bleeding can be increased when Abciximab is combined with Idraparinux.
DB06441,The risk or severity of bleeding can be increased when Abciximab is combined with Cangrelor.
DB06543,The risk or severity of bleeding can be increased when Abciximab is combined with Astaxanthin.
DB06635,The risk or severity of bleeding can be increased when Abciximab is combined with Otamixaban.
DB06679,The risk or severity of bleeding can be increased when Abciximab is combined with Amediplase.
DB06754,The risk or severity of bleeding can be increased when Abciximab is combined with Danaparoid.
DB06779,The risk or severity of bleeding can be increased when Abciximab is combined with Dalteparin.
DB06822,The risk or severity of bleeding can be increased when Abciximab is combined with Tinzaparin.
DB07767,The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid.
DB08496,The risk or severity of bleeding can be increased when Abciximab is combined with (R)-warfarin.
DB08794,The risk or severity of bleeding can be increased when Abciximab is combined with Ethyl biscoumacetate.
DB08813,The risk or severity of bleeding can be increased when Abciximab is combined with Nadroparin.
DB08814,The risk or severity of bleeding can be increased when Abciximab is combined with Triflusal.
DB08816,The risk or severity of bleeding can be increased when Abciximab is combined with Ticagrelor.
DB08994,The risk or severity of bleeding can be increased when Abciximab is combined with Ditazole.
DB09125,The risk or severity of bleeding can be increased when Abciximab is combined with Potassium citrate.
DB09154,The risk or severity of bleeding can be increased when Abciximab is combined with Sodium citrate.
DB09258,The risk or severity of bleeding can be increased when Abciximab is combined with Bemiparin.
DB09259,The risk or severity of bleeding can be increased when Abciximab is combined with Reviparin.
DB09260,The risk or severity of bleeding can be increased when Abciximab is combined with Parnaparin.
DB09261,The risk or severity of bleeding can be increased when Abciximab is combined with Certoparin.
DB11095,The risk or severity of bleeding can be increased when Abciximab is combined with Desirudin.
DB11154,The risk or severity of bleeding can be increased when Abciximab is combined with Zinc citrate.
DB11166,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin Alfa.
DB11312,The risk or severity of bleeding can be increased when Abciximab is combined with Protein C.
DB11598,The risk or severity of bleeding can be increased when Abciximab is combined with Antithrombin III human.
DB11984,The risk or severity of bleeding can be increased when Abciximab is combined with Letaxaban.
DB12289,The risk or severity of bleeding can be increased when Abciximab is combined with Darexaban.
DB12364,The risk or severity of bleeding can be increased when Abciximab is combined with Betrixaban.
DB12598,The risk or severity of bleeding can be increased when Abciximab is combined with Nafamostat.
DB12726,The risk or severity of bleeding can be increased when Abciximab is combined with Monteplase.
DB12831,The risk or severity of bleeding can be increased when Abciximab is combined with Gabexate.
DB13136,The risk or severity of bleeding can be increased when Abciximab is combined with Fluindione.
DB13149,The risk or severity of bleeding can be increased when Abciximab is combined with Protein S human.
DB13199,The risk or severity of bleeding can be increased when Abciximab is combined with Brinase.
DB13275,The risk or severity of bleeding can be increased when Abciximab is combined with Clorindione.
DB13347,The risk or severity of bleeding can be increased when Abciximab is combined with Diphenadione.
DB13451,The risk or severity of bleeding can be increased when Abciximab is combined with Tioclomarol.
DB13616,The risk or severity of bleeding can be increased when Abciximab is combined with Melagatran.
DB13646,The risk or severity of bleeding can be increased when Abciximab is combined with Saruplase.
DB14055,The risk or severity of bleeding can be increased when Abciximab is combined with (S)-Warfarin.
DB14094,The risk or severity of bleeding can be increased when Abciximab is combined with Tocopherylquinone.
DB14598,The risk or severity of bleeding can be increased when Abciximab is combined with Edetate calcium disodium anhydrous.
DB14726,The risk or severity of bleeding can be increased when Abciximab is combined with Dabigatran.
DB00063,The risk or severity of bleeding can be increased when Eptifibatide is combined with Abciximab.
DB00208,The risk or severity of bleeding can be increased when Ticlopidine is combined with Abciximab.
DB00758,The risk or severity of bleeding can be increased when Clopidogrel is combined with Abciximab.
DB00775,The risk or severity of bleeding can be increased when Tirofiban is combined with Abciximab.
DB01138,The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Abciximab.
DB01166,The risk or severity of bleeding can be increased when Cilostazol is combined with Abciximab.
DB01207,The risk or severity of bleeding can be increased when Ridogrel is combined with Abciximab.
DB01236,The risk or severity of bleeding can be increased when Sevoflurane is combined with Abciximab.
DB02709,The risk or severity of bleeding can be increased when Resveratrol is combined with Abciximab.
DB04743,The risk or severity of bleeding can be increased when Nimesulide is combined with Abciximab.
DB04905,The risk or severity of bleeding can be increased when Tesmilifene is combined with Abciximab.
DB05266,The risk or severity of bleeding can be increased when Ibudilast is combined with Abciximab.
DB05767,The risk or severity of bleeding can be increased when Andrographolide is combined with Abciximab.
DB06081,The risk or severity of bleeding can be increased when Caplacizumab is combined with Abciximab.
DB07615,The risk or severity of bleeding can be increased when Tranilast is combined with Abciximab.
DB08887,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Abciximab.
DB09283,The risk or severity of bleeding can be increased when Trapidil is combined with Abciximab.
DB12092,The risk or severity of bleeding can be increased when Naftopidil is combined with Abciximab.
DB12163,The risk or severity of bleeding can be increased when Sarpogrelate is combined with Abciximab.
DB12321,The risk or severity of bleeding can be increased when Ifetroban is combined with Abciximab.
DB12445,The risk or severity of bleeding can be increased when Nitroaspirin is combined with Abciximab.
DB12465,The risk or severity of bleeding can be increased when Ketanserin is combined with Abciximab.
DB12545,The risk or severity of bleeding can be increased when Indobufen is combined with Abciximab.
DB12749,The risk or severity of bleeding can be increased when Butylphthalide is combined with Abciximab.
DB12771,The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Abciximab.
DB13036,The risk or severity of bleeding can be increased when Ramatroban is combined with Abciximab.
DB13327,The risk or severity of bleeding can be increased when Picotamide is combined with Abciximab.
DB13367,The risk or severity of bleeding can be increased when Cloricromen is combined with Abciximab.
DB13400,The risk or severity of bleeding can be increased when Linsidomine is combined with Abciximab.
DB13510,The risk or severity of bleeding can be increased when Buflomedil is combined with Abciximab.
DB13929,The risk or severity of bleeding can be increased when Relcovaptan is combined with Abciximab.
DB00374,The risk or severity of adverse effects can be increased when Abciximab is combined with Treprostinil.
DB00008,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2a.
DB00011,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n1.
DB00018,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-n3.
DB00022,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon alfa-2b.
DB00033,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon gamma-1b.
DB00034,"The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2a, Recombinant."
DB00041,The risk or severity of bleeding can be increased when Abciximab is combined with Aldesleukin.
DB00068,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon beta-1b.
DB00069,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfacon-1.
DB00105,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa-2b.
DB00120,The risk or severity of bleeding can be increased when Abciximab is combined with Phenylalanine.
DB00188,The risk or severity of bleeding can be increased when Abciximab is combined with Bortezomib.
DB00242,The risk or severity of bleeding can be increased when Abciximab is combined with Cladribine.
DB00262,The risk or severity of bleeding can be increased when Abciximab is combined with Carmustine.
DB00276,The risk or severity of bleeding can be increased when Abciximab is combined with Amsacrine.
DB00291,The risk or severity of bleeding can be increased when Abciximab is combined with Chlorambucil.
DB00293,The risk or severity of bleeding can be increased when Abciximab is combined with Raltitrexed.
DB00305,The risk or severity of bleeding can be increased when Abciximab is combined with Mitomycin.
DB00307,The risk or severity of bleeding can be increased when Abciximab is combined with Bexarotene.
DB00309,The risk or severity of bleeding can be increased when Abciximab is combined with Vindesine.
DB00322,The risk or severity of bleeding can be increased when Abciximab is combined with Floxuridine.
DB00352,The risk or severity of bleeding can be increased when Abciximab is combined with Tioguanine.
DB00361,The risk or severity of bleeding can be increased when Abciximab is combined with Vinorelbine.
DB00380,The risk or severity of bleeding can be increased when Abciximab is combined with Dexrazoxane.
DB00398,The risk or severity of bleeding can be increased when Abciximab is combined with Sorafenib.
DB00428,The risk or severity of bleeding can be increased when Abciximab is combined with Streptozocin.
DB00441,The risk or severity of bleeding can be increased when Abciximab is combined with Gemcitabine.
DB00444,The risk or severity of bleeding can be increased when Abciximab is combined with Teniposide.
DB00445,The risk or severity of bleeding can be increased when Abciximab is combined with Epirubicin.
DB00446,The risk or severity of bleeding can be increased when Abciximab is combined with Chloramphenicol.
DB00480,The risk or severity of bleeding can be increased when Abciximab is combined with Lenalidomide.
DB00488,The risk or severity of bleeding can be increased when Abciximab is combined with Altretamine.
DB00495,The risk or severity of bleeding can be increased when Abciximab is combined with Zidovudine.
DB00515,The risk or severity of bleeding can be increased when Abciximab is combined with Cisplatin.
DB00526,The risk or severity of bleeding can be increased when Abciximab is combined with Oxaliplatin.
DB00531,The risk or severity of bleeding can be increased when Abciximab is combined with Cyclophosphamide.
DB00544,The risk or severity of bleeding can be increased when Abciximab is combined with Fluorouracil.
DB00552,The risk or severity of bleeding can be increased when Abciximab is combined with Pentostatin.
DB00563,The risk or severity of bleeding can be increased when Abciximab is combined with Methotrexate.
DB00564,The risk or severity of bleeding can be increased when Abciximab is combined with Carbamazepine.
DB00570,The risk or severity of bleeding can be increased when Abciximab is combined with Vinblastine.
DB00619,The risk or severity of bleeding can be increased when Abciximab is combined with Imatinib.
DB00631,The risk or severity of bleeding can be increased when Abciximab is combined with Clofarabine.
DB00642,The risk or severity of bleeding can be increased when Abciximab is combined with Pemetrexed.
DB00694,The risk or severity of bleeding can be increased when Abciximab is combined with Daunorubicin.
DB00762,The risk or severity of bleeding can be increased when Abciximab is combined with Irinotecan.
DB00773,The risk or severity of bleeding can be increased when Abciximab is combined with Etoposide.
DB00851,The risk or severity of bleeding can be increased when Abciximab is combined with Dacarbazine.
DB00853,The risk or severity of bleeding can be increased when Abciximab is combined with Temozolomide.
DB00859,The risk or severity of bleeding can be increased when Abciximab is combined with Penicillamine.
DB00864,The risk or severity of bleeding can be increased when Abciximab is combined with Tacrolimus.
DB00877,The risk or severity of bleeding can be increased when Abciximab is combined with Sirolimus.
DB00888,The risk or severity of bleeding can be increased when Abciximab is combined with Mechlorethamine.
DB00928,The risk or severity of bleeding can be increased when Abciximab is combined with Azacitidine.
DB00958,The risk or severity of bleeding can be increased when Abciximab is combined with Carboplatin.
DB00970,The risk or severity of bleeding can be increased when Abciximab is combined with Dactinomycin.
DB00987,The risk or severity of bleeding can be increased when Abciximab is combined with Cytarabine.
DB00997,The risk or severity of bleeding can be increased when Abciximab is combined with Doxorubicin.
DB01005,The risk or severity of bleeding can be increased when Abciximab is combined with Hydroxyurea.
DB01008,The risk or severity of bleeding can be increased when Abciximab is combined with Busulfan.
DB01030,The risk or severity of bleeding can be increased when Abciximab is combined with Topotecan.
DB01033,The risk or severity of bleeding can be increased when Abciximab is combined with Mercaptopurine.
DB01041,The risk or severity of bleeding can be increased when Abciximab is combined with Thalidomide.
DB01042,The risk or severity of bleeding can be increased when Abciximab is combined with Melphalan.
DB01073,The risk or severity of bleeding can be increased when Abciximab is combined with Fludarabine.
DB01099,The risk or severity of bleeding can be increased when Abciximab is combined with Flucytosine.
DB01101,The risk or severity of bleeding can be increased when Abciximab is combined with Capecitabine.
DB01169,The risk or severity of bleeding can be increased when Abciximab is combined with Arsenic trioxide.
DB01177,The risk or severity of bleeding can be increased when Abciximab is combined with Idarubicin.
DB01204,The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone.
DB01206,The risk or severity of bleeding can be increased when Abciximab is combined with Lomustine.
DB01229,The risk or severity of bleeding can be increased when Abciximab is combined with Paclitaxel.
DB01248,The risk or severity of bleeding can be increased when Abciximab is combined with Docetaxel.
DB01262,The risk or severity of bleeding can be increased when Abciximab is combined with Decitabine.
DB01280,The risk or severity of bleeding can be increased when Abciximab is combined with Nelarabine.
DB01590,The risk or severity of bleeding can be increased when Abciximab is combined with Everolimus.
DB02546,The risk or severity of bleeding can be increased when Abciximab is combined with Vorinostat.
DB04572,The risk or severity of bleeding can be increased when Abciximab is combined with Thiotepa.
DB04845,The risk or severity of bleeding can be increased when Abciximab is combined with Ixabepilone.
DB04868,The risk or severity of bleeding can be increased when Abciximab is combined with Nilotinib.
DB05015,The risk or severity of bleeding can be increased when Abciximab is combined with Belinostat.
DB05109,The risk or severity of bleeding can be increased when Abciximab is combined with Trabectedin.
DB05258,The risk or severity of bleeding can be increased when Abciximab is combined with Interferon alfa.
DB05472,The risk or severity of bleeding can be increased when Abciximab is combined with omega interferon.
DB06287,The risk or severity of bleeding can be increased when Abciximab is combined with Temsirolimus.
DB06616,The risk or severity of bleeding can be increased when Abciximab is combined with Bosutinib.
DB06769,The risk or severity of bleeding can be increased when Abciximab is combined with Bendamustine.
DB06772,The risk or severity of bleeding can be increased when Abciximab is combined with Cabazitaxel.
DB08871,The risk or severity of bleeding can be increased when Abciximab is combined with Eribulin.
DB08877,The risk or severity of bleeding can be increased when Abciximab is combined with Ruxolitinib.
DB08889,The risk or severity of bleeding can be increased when Abciximab is combined with Carfilzomib.
DB08895,The risk or severity of bleeding can be increased when Abciximab is combined with Tofacitinib.
DB08901,The risk or severity of bleeding can be increased when Abciximab is combined with Ponatinib.
DB08910,The risk or severity of bleeding can be increased when Abciximab is combined with Pomalidomide.
DB09042,The risk or severity of bleeding can be increased when Abciximab is combined with Tedizolid phosphate.
DB09073,The risk or severity of bleeding can be increased when Abciximab is combined with Palbociclib.
DB09074,The risk or severity of bleeding can be increased when Abciximab is combined with Olaparib.
DB09122,The risk or severity of bleeding can be increased when Abciximab is combined with Peginterferon beta-1a.
DB12814,The risk or severity of bleeding can be increased when Abciximab is combined with Cepeginterferon alfa-2B.
DB03404,Hemin may increase the anticoagulant activities of Abciximab.
DB13783,The risk or severity of bleeding and hemorrhage can be increased when Acemetacin is combined with Abciximab.
DB00624,Testosterone may increase the anticoagulant activities of Abciximab.
DB01420,Testosterone propionate may increase the anticoagulant activities of Abciximab.
DB01481,1-Testosterone may increase the anticoagulant activities of Abciximab.
DB01485,4-Hydroxytestosterone may increase the anticoagulant activities of Abciximab.
DB01510,Dehydrochloromethyltestosterone may increase the anticoagulant activities of Abciximab.
DB01541,Boldenone may increase the anticoagulant activities of Abciximab.
DB01543,18-methyl-19-nortestosterone may increase the anticoagulant activities of Abciximab.
DB01564,Calusterone may increase the anticoagulant activities of Abciximab.
DB01569,Formebolone may increase the anticoagulant activities of Abciximab.
DB01572,Methyl-1-testosterone may increase the anticoagulant activities of Abciximab.
DB02901,Stanolone may increase the anticoagulant activities of Abciximab.
DB07447,5beta-dihydrotestosterone may increase the anticoagulant activities of Abciximab.
DB08619,Testosterone succinate may increase the anticoagulant activities of Abciximab.
DB11429,Mibolerone may increase the anticoagulant activities of Abciximab.
DB13943,Testosterone cypionate may increase the anticoagulant activities of Abciximab.
DB13944,Testosterone enanthate may increase the anticoagulant activities of Abciximab.
DB13946,Testosterone undecanoate may increase the anticoagulant activities of Abciximab.
DB13947,Testosterone enantate benzilic acid hydrazone may increase the anticoagulant activities of Abciximab.
DB13951,Stanolone acetate may increase the anticoagulant activities of Abciximab.
DB13958,Trestolone acetate may increase the anticoagulant activities of Abciximab.
DB14093,"(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Abciximab."
DB14655,Drostanolone propionate may increase the anticoagulant activities of Abciximab.
DB11051,The risk or severity of adverse effects can be increased when Abciximab is combined with Azficel-T.
DB09568,The therapeutic efficacy of Abciximab can be increased when used in combination with Omega-3-carboxylic acids.
DB00002,The risk or severity of adverse effects can be increased when Cetuximab is combined with Abciximab.
DB00028,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Abciximab.
DB00043,The risk or severity of adverse effects can be increased when Omalizumab is combined with Abciximab.
DB00051,The risk or severity of adverse effects can be increased when Adalimumab is combined with Abciximab.
DB00056,The risk or severity of adverse effects can be increased when Abciximab is combined with Gemtuzumab ozogamicin.
DB00057,The risk or severity of adverse effects can be increased when Abciximab is combined with Indium In-111 satumomab pendetide.
DB00065,The risk or severity of adverse effects can be increased when Abciximab is combined with Infliximab.
DB00072,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab.
DB00073,The risk or severity of adverse effects can be increased when Abciximab is combined with Rituximab.
DB00074,The risk or severity of adverse effects can be increased when Abciximab is combined with Basiliximab.
DB00075,The risk or severity of adverse effects can be increased when Abciximab is combined with Muromonab.
DB00076,The risk or severity of adverse effects can be increased when Abciximab is combined with Digoxin Immune Fab (Ovine).
DB00087,The risk or severity of adverse effects can be increased when Abciximab is combined with Alemtuzumab.
DB00089,The risk or severity of adverse effects can be increased when Abciximab is combined with Capromab pendetide.
DB00095,The risk or severity of adverse effects can be increased when Abciximab is combined with Efalizumab.
DB00098,The risk or severity of adverse effects can be increased when Abciximab is combined with Antithymocyte immunoglobulin (rabbit).
DB00108,The risk or severity of adverse effects can be increased when Abciximab is combined with Natalizumab.
DB00110,The risk or severity of adverse effects can be increased when Abciximab is combined with Palivizumab.
DB00111,The risk or severity of adverse effects can be increased when Abciximab is combined with Daclizumab.
DB00112,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab.
DB00113,The risk or severity of adverse effects can be increased when Abciximab is combined with Technetium Tc-99m arcitumomab.
DB01257,The risk or severity of adverse effects can be increased when Abciximab is combined with Eculizumab.
DB01269,The risk or severity of adverse effects can be increased when Abciximab is combined with Panitumumab.
DB01270,The risk or severity of adverse effects can be increased when Abciximab is combined with Ranibizumab.
DB04901,The risk or severity of adverse effects can be increased when Abciximab is combined with Galiximab.
DB04949,The risk or severity of adverse effects can be increased when Abciximab is combined with Pexelizumab.
DB04956,The risk or severity of adverse effects can be increased when Abciximab is combined with Afelimomab.
DB04958,The risk or severity of adverse effects can be increased when Abciximab is combined with Epratuzumab.
DB04962,The risk or severity of adverse effects can be increased when Abciximab is combined with Bectumomab.
DB04964,The risk or severity of adverse effects can be increased when Abciximab is combined with Oregovomab.
DB04988,The risk or severity of adverse effects can be increased when Abciximab is combined with IGN311.
DB05006,The risk or severity of adverse effects can be increased when Abciximab is combined with Adecatumumab.
DB05097,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab.
DB05101,The risk or severity of adverse effects can be increased when Abciximab is combined with Matuzumab.
DB05111,The risk or severity of adverse effects can be increased when Abciximab is combined with Fontolizumab.
DB05136,The risk or severity of adverse effects can be increased when Abciximab is combined with Bavituximab.
DB05139,The risk or severity of adverse effects can be increased when Abciximab is combined with CR002.
DB05209,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozrolimupab.
DB05304,The risk or severity of adverse effects can be increased when Abciximab is combined with Girentuximab.
DB05336,The risk or severity of adverse effects can be increased when Abciximab is combined with Obiltoxaximab.
DB05405,The risk or severity of adverse effects can be increased when Abciximab is combined with XTL-001.
DB05437,The risk or severity of adverse effects can be increased when Abciximab is combined with NAV 1800.
DB05459,The risk or severity of adverse effects can be increased when Abciximab is combined with Briakinumab.
DB05496,The risk or severity of adverse effects can be increased when Abciximab is combined with Otelixizumab.
DB05545,The risk or severity of adverse effects can be increased when Abciximab is combined with AMG 108.
DB05550,The risk or severity of adverse effects can be increased when Abciximab is combined with Iratumumab.
DB05555,The risk or severity of adverse effects can be increased when Abciximab is combined with Enokizumab.
DB05578,The risk or severity of adverse effects can be increased when Abciximab is combined with Ramucirumab.
DB05595,The risk or severity of adverse effects can be increased when Abciximab is combined with Farletuzumab.
DB05656,The risk or severity of adverse effects can be increased when Abciximab is combined with Veltuzumab.
DB05679,The risk or severity of adverse effects can be increased when Abciximab is combined with Ustekinumab.
DB05773,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab emtansine.
DB05793,The risk or severity of adverse effects can be increased when Abciximab is combined with PRO-542.
DB05797,The risk or severity of adverse effects can be increased when Abciximab is combined with TNX-901.
DB05889,The risk or severity of adverse effects can be increased when Abciximab is combined with Inotuzumab ozogamicin.
DB05892,The risk or severity of adverse effects can be increased when Abciximab is combined with RI 624.
DB05915,The risk or severity of adverse effects can be increased when Abciximab is combined with MYO-029.
DB05916,The risk or severity of adverse effects can be increased when Abciximab is combined with CT-011.
DB05941,The risk or severity of adverse effects can be increased when Abciximab is combined with Leronlimab.
DB05996,The risk or severity of adverse effects can be increased when Abciximab is combined with Glembatumumab vedotin.
DB06043,The risk or severity of adverse effects can be increased when Abciximab is combined with Olaratumab.
DB06049,The risk or severity of adverse effects can be increased when Abciximab is combined with IPH 2101.
DB06050,The risk or severity of adverse effects can be increased when Abciximab is combined with TB-402.
DB06101,The risk or severity of adverse effects can be increased when Abciximab is combined with IMC-1C11.
DB06116,The risk or severity of adverse effects can be increased when Abciximab is combined with Eldelumab.
DB06162,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumiliximab.
DB06168,The risk or severity of adverse effects can be increased when Abciximab is combined with Canakinumab.
DB06186,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipilimumab.
DB06192,The risk or severity of adverse effects can be increased when Abciximab is combined with Nimotuzumab.
DB06241,The risk or severity of adverse effects can be increased when Abciximab is combined with Clenoliximab.
DB06273,The risk or severity of adverse effects can be increased when Abciximab is combined with Tocilizumab.
DB06304,The risk or severity of adverse effects can be increased when Abciximab is combined with BIIB015.
DB06305,The risk or severity of adverse effects can be increased when Abciximab is combined with Sonepcizumab.
DB06310,The risk or severity of adverse effects can be increased when Abciximab is combined with Motavizumab.
DB06317,The risk or severity of adverse effects can be increased when Abciximab is combined with Elotuzumab.
DB06318,The risk or severity of adverse effects can be increased when Abciximab is combined with AVE9633.
DB06322,The risk or severity of adverse effects can be increased when Abciximab is combined with Carotuximab.
DB06324,The risk or severity of adverse effects can be increased when Abciximab is combined with XmAb 2513.
DB06342,The risk or severity of adverse effects can be increased when Abciximab is combined with Coltuximab ravtansine.
DB06343,The risk or severity of adverse effects can be increased when Abciximab is combined with Teprotumumab.
DB06360,The risk or severity of adverse effects can be increased when Abciximab is combined with Lucatumumab.
DB06366,The risk or severity of adverse effects can be increased when Abciximab is combined with Pertuzumab.
DB06371,The risk or severity of adverse effects can be increased when Abciximab is combined with Siplizumab.
DB06467,The risk or severity of adverse effects can be increased when Abciximab is combined with Apolizumab.
DB06474,The risk or severity of adverse effects can be increased when Abciximab is combined with Sibrotuzumab.
DB06550,The risk or severity of adverse effects can be increased when Abciximab is combined with Bivatuzumab.
DB06557,The risk or severity of adverse effects can be increased when Abciximab is combined with Lerdelimumab.
DB06599,The risk or severity of adverse effects can be increased when Abciximab is combined with Lexatumumab.
DB06602,The risk or severity of adverse effects can be increased when Abciximab is combined with Reslizumab.
DB06606,The risk or severity of adverse effects can be increased when Abciximab is combined with Teplizumab.
DB06607,The risk or severity of adverse effects can be increased when Abciximab is combined with Catumaxomab.
DB06612,The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab.
DB06643,The risk or severity of adverse effects can be increased when Abciximab is combined with Denosumab.
DB06647,The risk or severity of adverse effects can be increased when Abciximab is combined with Volociximab.
DB06650,The risk or severity of adverse effects can be increased when Abciximab is combined with Ofatumumab.
DB06674,The risk or severity of adverse effects can be increased when Abciximab is combined with Golimumab.
DB08870,The risk or severity of adverse effects can be increased when Abciximab is combined with Brentuximab vedotin.
DB08879,The risk or severity of adverse effects can be increased when Abciximab is combined with Belimumab.
DB08902,The risk or severity of adverse effects can be increased when Abciximab is combined with Raxibacumab.
DB08904,The risk or severity of adverse effects can be increased when Abciximab is combined with Certolizumab pegol.
DB09029,The risk or severity of adverse effects can be increased when Abciximab is combined with Secukinumab.
DB09033,The risk or severity of adverse effects can be increased when Abciximab is combined with Vedolizumab.
DB09035,The risk or severity of adverse effects can be increased when Abciximab is combined with Nivolumab.
DB09036,The risk or severity of adverse effects can be increased when Abciximab is combined with Siltuximab.
DB09037,The risk or severity of adverse effects can be increased when Abciximab is combined with Pembrolizumab.
DB09045,The risk or severity of adverse effects can be increased when Abciximab is combined with Dulaglutide.
DB09052,The risk or severity of adverse effects can be increased when Abciximab is combined with Blinatumomab.
DB09057,The risk or severity of adverse effects can be increased when Abciximab is combined with Anthrax immune globulin human.
DB09077,The risk or severity of adverse effects can be increased when Abciximab is combined with Dinutuximab.
DB09105,The risk or severity of adverse effects can be increased when Abciximab is combined with Asfotase alfa.
DB09264,The risk or severity of adverse effects can be increased when Abciximab is combined with Idarucizumab.
DB09302,The risk or severity of adverse effects can be increased when Abciximab is combined with Alirocumab.
DB09303,The risk or severity of adverse effects can be increased when Abciximab is combined with Evolocumab.
DB09312,The risk or severity of adverse effects can be increased when Abciximab is combined with Antilymphocyte immunoglobulin (horse).
DB09331,The risk or severity of adverse effects can be increased when Abciximab is combined with Daratumumab.
DB09559,The risk or severity of adverse effects can be increased when Abciximab is combined with Necitumumab.
DB11569,The risk or severity of adverse effects can be increased when Abciximab is combined with Ixekizumab.
DB11580,The risk or severity of adverse effects can be increased when Abciximab is combined with Ravulizumab.
DB11595,The risk or severity of adverse effects can be increased when Abciximab is combined with Atezolizumab.
DB11604,The risk or severity of adverse effects can be increased when Abciximab is combined with Tetanus Immune Globulin.
DB11621,The risk or severity of adverse effects can be increased when Abciximab is combined with Human Varicella-Zoster Immune Globulin.
DB11646,The risk or severity of adverse effects can be increased when Abciximab is combined with Conatumumab.
DB11657,The risk or severity of adverse effects can be increased when Abciximab is combined with Tabalumab.
DB11680,The risk or severity of adverse effects can be increased when Abciximab is combined with Ficlatuzumab.
DB11685,The risk or severity of adverse effects can be increased when Abciximab is combined with Figitumumab.
DB11714,The risk or severity of adverse effects can be increased when Abciximab is combined with Durvalumab.
DB11715,The risk or severity of adverse effects can be increased when Abciximab is combined with Bapineuzumab.
DB11731,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab mafodotin.
DB11746,The risk or severity of adverse effects can be increased when Abciximab is combined with Onartuzumab.
DB11756,The risk or severity of adverse effects can be increased when Abciximab is combined with Solanezumab.
DB11767,The risk or severity of adverse effects can be increased when Abciximab is combined with Sarilumab.
DB11771,The risk or severity of adverse effects can be increased when Abciximab is combined with Tremelimumab.
DB11776,The risk or severity of adverse effects can be increased when Abciximab is combined with Brodalumab.
DB11803,The risk or severity of adverse effects can be increased when Abciximab is combined with Sirukumab.
DB11826,The risk or severity of adverse effects can be increased when Abciximab is combined with Lampalizumab.
DB11834,The risk or severity of adverse effects can be increased when Abciximab is combined with Guselkumab.
DB11840,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalotuzumab.
DB11849,The risk or severity of adverse effects can be increased when Abciximab is combined with Emibetuzumab.
DB11850,The risk or severity of adverse effects can be increased when Abciximab is combined with Ublituximab.
DB11856,The risk or severity of adverse effects can be increased when Abciximab is combined with Ligelizumab.
DB11857,The risk or severity of adverse effects can be increased when Abciximab is combined with Seribantumab.
DB11862,The risk or severity of adverse effects can be increased when Abciximab is combined with Landogrozumab.
DB11866,The risk or severity of adverse effects can be increased when Abciximab is combined with Romosozumab.
DB11884,The risk or severity of adverse effects can be increased when Abciximab is combined with Vadastuximab Talirine.
DB11914,The risk or severity of adverse effects can be increased when Abciximab is combined with Lebrikizumab.
DB11930,The risk or severity of adverse effects can be increased when Abciximab is combined with Varlilumab.
DB11945,The risk or severity of adverse effects can be increased when Abciximab is combined with Avelumab.
DB11959,The risk or severity of adverse effects can be increased when Abciximab is combined with Crenezumab.
DB11972,The risk or severity of adverse effects can be increased when Abciximab is combined with Rilotumumab.
DB11976,The risk or severity of adverse effects can be increased when Abciximab is combined with Anifrolumab.
DB11988,The risk or severity of adverse effects can be increased when Abciximab is combined with Ocrelizumab.
DB12023,The risk or severity of adverse effects can be increased when Abciximab is combined with Benralizumab.
DB12034,The risk or severity of adverse effects can be increased when Abciximab is combined with Gantenerumab.
DB12053,The risk or severity of adverse effects can be increased when Abciximab is combined with Visilizumab.
DB12077,The risk or severity of adverse effects can be increased when Abciximab is combined with Urelumab.
DB12089,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorvotuzumab mertansine.
DB12090,The risk or severity of adverse effects can be increased when Abciximab is combined with Patritumab.
DB12102,The risk or severity of adverse effects can be increased when Abciximab is combined with Fulranumab.
DB12104,The risk or severity of adverse effects can be increased when Abciximab is combined with Tarextumab.
DB12118,The risk or severity of adverse effects can be increased when Abciximab is combined with Sotatercept.
DB12119,The risk or severity of adverse effects can be increased when Abciximab is combined with Gevokizumab.
DB12142,The risk or severity of adverse effects can be increased when Abciximab is combined with Duligotuzumab.
DB12152,The risk or severity of adverse effects can be increased when Abciximab is combined with Simtuzumab.
DB12157,The risk or severity of adverse effects can be increased when Abciximab is combined with Fasinumab.
DB12159,The risk or severity of adverse effects can be increased when Abciximab is combined with Dupilumab.
DB12169,The risk or severity of adverse effects can be increased when Abciximab is combined with Tralokinumab.
DB12189,The risk or severity of adverse effects can be increased when Abciximab is combined with Etrolizumab.
DB12202,The risk or severity of adverse effects can be increased when Abciximab is combined with Zalutumumab.
DB12205,The risk or severity of adverse effects can be increased when Abciximab is combined with Ganitumab.
DB12213,The risk or severity of adverse effects can be increased when Abciximab is combined with Etaracizumab.
DB12240,The risk or severity of adverse effects can be increased when Abciximab is combined with Polatuzumab vedotin.
DB12246,The risk or severity of adverse effects can be increased when Abciximab is combined with Inclacumab.
DB12250,The risk or severity of adverse effects can be increased when Abciximab is combined with Cixutumumab.
DB12261,The risk or severity of adverse effects can be increased when Abciximab is combined with Ascrinvacumab.
DB12274,The risk or severity of adverse effects can be increased when Abciximab is combined with Aducanumab.
DB12281,The risk or severity of adverse effects can be increased when Abciximab is combined with Luspatercept.
DB12296,The risk or severity of adverse effects can be increased when Abciximab is combined with GS-5745.
DB12317,The risk or severity of adverse effects can be increased when Abciximab is combined with Vanucizumab.
DB12331,The risk or severity of adverse effects can be increased when Abciximab is combined with Labetuzumab govitecan.
DB12335,The risk or severity of adverse effects can be increased when Abciximab is combined with Tanezumab.
DB12342,The risk or severity of adverse effects can be increased when Abciximab is combined with Ensituximab.
DB12344,The risk or severity of adverse effects can be increased when Abciximab is combined with Fezakinumab.
DB12363,The risk or severity of adverse effects can be increased when Abciximab is combined with Dusigitumab.
DB12396,The risk or severity of adverse effects can be increased when Abciximab is combined with Fresolimumab.
DB12413,The risk or severity of adverse effects can be increased when Abciximab is combined with Indusatumab vedotin.
DB12456,The risk or severity of adverse effects can be increased when Abciximab is combined with Bococizumab.
DB12489,The risk or severity of adverse effects can be increased when Abciximab is combined with Mirvetuximab Soravtansine.
DB12498,The risk or severity of adverse effects can be increased when Abciximab is combined with Mogamulizumab.
DB12520,The risk or severity of adverse effects can be increased when Abciximab is combined with Plozalizumab.
DB12530,The risk or severity of adverse effects can be increased when Abciximab is combined with Inebilizumab.
DB12534,The risk or severity of adverse effects can be increased when Abciximab is combined with Mavrilimumab.
DB12560,The risk or severity of adverse effects can be increased when Abciximab is combined with Blosozumab.
DB12584,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimagrumab.
DB12589,The risk or severity of adverse effects can be increased when Abciximab is combined with Dacetuzumab.
DB12609,The risk or severity of adverse effects can be increased when Abciximab is combined with Tovetumab.
DB12683,The risk or severity of adverse effects can be increased when Abciximab is combined with Lumretuzumab.
DB12698,The risk or severity of adverse effects can be increased when Abciximab is combined with Ibalizumab.
DB12701,The risk or severity of adverse effects can be increased when Abciximab is combined with Intetumumab.
DB12718,The risk or severity of adverse effects can be increased when Abciximab is combined with Carlumab.
DB12734,The risk or severity of adverse effects can be increased when Abciximab is combined with Demcizumab.
DB12773,The risk or severity of adverse effects can be increased when Abciximab is combined with Sifalimumab.
DB12775,The risk or severity of adverse effects can be increased when Abciximab is combined with Abituzumab.
DB12797,The risk or severity of adverse effects can be increased when Abciximab is combined with Ecromeximab.
DB12807,The risk or severity of adverse effects can be increased when Abciximab is combined with Naptumomab Estafenatox.
DB12815,The risk or severity of adverse effects can be increased when Abciximab is combined with Crotedumab.
DB12820,The risk or severity of adverse effects can be increased when Abciximab is combined with Concizumab.
DB12826,The risk or severity of adverse effects can be increased when Abciximab is combined with Depatuxizumab.
DB12844,The risk or severity of adverse effects can be increased when Abciximab is combined with Rontalizumab.
DB12845,The risk or severity of adverse effects can be increased when Abciximab is combined with Amatuximab.
DB12849,The risk or severity of adverse effects can be increased when Abciximab is combined with Clazakizumab.
DB12891,The risk or severity of adverse effects can be increased when Abciximab is combined with Ozanezumab.
DB12893,The risk or severity of adverse effects can be increased when Abciximab is combined with Sacituzumab govitecan.
DB12917,The risk or severity of adverse effects can be increased when Abciximab is combined with Bimekizumab.
DB12943,The risk or severity of adverse effects can be increased when Abciximab is combined with Milatuzumab.
DB12976,The risk or severity of adverse effects can be increased when Abciximab is combined with Robatumumab.
DB13017,The risk or severity of adverse effects can be increased when Abciximab is combined with Rovalpituzumab Tesirine.
DB13037,The risk or severity of adverse effects can be increased when Abciximab is combined with Namilumab.
DB13045,The risk or severity of adverse effects can be increased when Abciximab is combined with Racotumomab.
DB13073,The risk or severity of adverse effects can be increased when Abciximab is combined with Tregalizumab.
DB13127,The risk or severity of adverse effects can be increased when Abciximab is combined with Olokizumab.
DB13140,The risk or severity of adverse effects can be increased when Abciximab is combined with Bezlotoxumab.
DB13375,The risk or severity of adverse effects can be increased when Abciximab is combined with Edrecolomab.
DB13535,The risk or severity of adverse effects can be increased when Abciximab is combined with Nebacumab.
DB13886,The risk or severity of adverse effects can be increased when Abciximab is combined with Human cytomegalovirus immune globulin.
DB13976,The risk or severity of adverse effects can be increased when Abciximab is combined with Sulesomab.
DB13979,The risk or severity of adverse effects can be increased when Abciximab is combined with Besilesomab.
DB14004,The risk or severity of adverse effects can be increased when Abciximab is combined with Tildrakizumab.
DB14012,The risk or severity of adverse effects can be increased when Abciximab is combined with Burosumab.
DB14039,The risk or severity of adverse effects can be increased when Abciximab is combined with Erenumab.
DB14040,The risk or severity of adverse effects can be increased when Abciximab is combined with Eptinezumab.
DB14041,The risk or severity of adverse effects can be increased when Abciximab is combined with Fremanezumab.
DB14042,The risk or severity of adverse effects can be increased when Abciximab is combined with Galcanezumab.
DB14211,The risk or severity of adverse effects can be increased when Abciximab is combined with Fanolesomab.
DB14580,The risk or severity of adverse effects can be increased when Abciximab is combined with Lecanemab.
DB14597,The risk or severity of adverse effects can be increased when Abciximab is combined with Lanadelumab.
DB14707,The risk or severity of adverse effects can be increased when Abciximab is combined with Cemiplimab.
DB14724,The risk or severity of adverse effects can be increased when Abciximab is combined with Emapalumab.
DB14762,The risk or severity of adverse effects can be increased when Abciximab is combined with Risankizumab.
DB14776,The risk or severity of adverse effects can be increased when Abciximab is combined with Camrelizumab.
DB14778,The risk or severity of adverse effects can be increased when Abciximab is combined with Setrusumab.
DB14784,The risk or severity of adverse effects can be increased when Abciximab is combined with Gancotamab.
DB14809,The risk or severity of adverse effects can be increased when Abciximab is combined with Anetumab ravtansine.
DB14811,The risk or severity of adverse effects can be increased when Abciximab is combined with Isatuximab.
DB14824,The risk or severity of adverse effects can be increased when Abciximab is combined with Icrucumab.
DB14843,The risk or severity of adverse effects can be increased when Abciximab is combined with Codrituzumab.
DB14864,The risk or severity of adverse effects can be increased when Abciximab is combined with Brolucizumab.
DB14871,The risk or severity of adverse effects can be increased when Abciximab is combined with Xentuzumab.
DB14877,The risk or severity of adverse effects can be increased when Abciximab is combined with Lintuzumab.
DB14891,The risk or severity of adverse effects can be increased when Abciximab is combined with Vobarilizumab.
DB14897,The risk or severity of adverse effects can be increased when Abciximab is combined with Parsatuzumab.
DB14905,The risk or severity of adverse effects can be increased when Abciximab is combined with Emactuzumab.
DB14907,The risk or severity of adverse effects can be increased when Abciximab is combined with Bevacizumab zirconium Zr-89.
DB14908,The risk or severity of adverse effects can be increased when Abciximab is combined with Refanezumab.
DB14919,The risk or severity of adverse effects can be increased when Abciximab is combined with Rozanolixizumab.
DB14947,The risk or severity of adverse effects can be increased when Abciximab is combined with Bermekimab.
DB14952,The risk or severity of adverse effects can be increased when Abciximab is combined with Pamrevlumab.
DB14959,The risk or severity of adverse effects can be increased when Abciximab is combined with Opicinumab.
DB14962,The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab deruxtecan.
DB14967,The risk or severity of adverse effects can be increased when Abciximab is combined with Margetuximab.
DB14988,The risk or severity of adverse effects can be increased when Abciximab is combined with Dalantercept.
DB14997,The risk or severity of adverse effects can be increased when Abciximab is combined with Pateclizumab.
DB15014,The risk or severity of adverse effects can be increased when Abciximab is combined with Gremubamab.
DB15022,The risk or severity of adverse effects can be increased when Abciximab is combined with Apomab.
DB15044,The risk or severity of adverse effects can be increased when Abciximab is combined with Tafasitamab.
DB15045,The risk or severity of adverse effects can be increased when Abciximab is combined with Ipafricept.
DB15076,The risk or severity of adverse effects can be increased when Abciximab is combined with Abrilumab.
DB15089,The risk or severity of adverse effects can be increased when Abciximab is combined with Frovocimab.
DB15090,The risk or severity of adverse effects can be increased when Abciximab is combined with Tezepelumab.
DB15101,The risk or severity of adverse effects can be increased when Abciximab is combined with Tigatuzumab.
DB15104,The risk or severity of adverse effects can be increased when Abciximab is combined with Telisotuzumab vedotin.
DB15113,The risk or severity of adverse effects can be increased when Abciximab is combined with Utomilumab.
DB15118,The risk or severity of adverse effects can be increased when Abciximab is combined with Zolbetuximab.
DB15135,The risk or severity of adverse effects can be increased when Abciximab is combined with Ponezumab.
DB15160,The risk or severity of adverse effects can be increased when Abciximab is combined with Asunercept.
DB15172,The risk or severity of adverse effects can be increased when Abciximab is combined with Suvratoxumab.
DB15225,The risk or severity of adverse effects can be increased when Abciximab is combined with Mitazalimab.
DB15252,The risk or severity of adverse effects can be increased when Abciximab is combined with Nemolizumab.
DB15253,The risk or severity of adverse effects can be increased when Abciximab is combined with Bleselumab.
DB15277,The risk or severity of adverse effects can be increased when Abciximab is combined with Gedivumab.
DB15336,The risk or severity of adverse effects can be increased when Abciximab is combined with Valanafusp alfa.
DB15349,The risk or severity of adverse effects can be increased when Abciximab is combined with Sofituzumab vedotin.
DB15354,The risk or severity of adverse effects can be increased when Abciximab is combined with Evinacumab.
DB15363,The risk or severity of adverse effects can be increased when Abciximab is combined with Istiratumab.
DB15383,The risk or severity of adverse effects can be increased when Abciximab is combined with Pidilizumab.
DB15397,The risk or severity of adverse effects can be increased when Abciximab is combined with GMA-161.
DB15409,The risk or severity of adverse effects can be increased when Abciximab is combined with Ladiratuzumab vedotin.
DB15415,The risk or severity of adverse effects can be increased when Abciximab is combined with Tomaralimab.
DB15428,The risk or severity of adverse effects can be increased when Abciximab is combined with Vesencumab.
DB15432,The risk or severity of adverse effects can be increased when Abciximab is combined with Pinatuzumab vedotin.
DB15441,The risk or severity of adverse effects can be increased when Abciximab is combined with Lulizumab pegol.
DB15443,The risk or severity of adverse effects can be increased when Abciximab is combined with Lorukafusp alfa.
DB15453,The risk or severity of adverse effects can be increased when Abciximab is combined with Naratuximab emtansine.
DB15559,The risk or severity of adverse effects can be increased when Abciximab is combined with Zenocutuzumab.
DB00258,The therapeutic efficacy of Calcium acetate can be decreased when used in combination with Abciximab.
DB01164,The therapeutic efficacy of Calcium chloride can be decreased when used in combination with Abciximab.
DB01373,The therapeutic efficacy of Calcium can be decreased when used in combination with Abciximab.
DB11126,The therapeutic efficacy of Calcium gluconate can be decreased when used in combination with Abciximab.
DB11608,The therapeutic efficacy of Eftrenonacog alfa can be decreased when used in combination with Abciximab.
DB13884,The therapeutic efficacy of Albutrepenonacog alfa can be decreased when used in combination with Abciximab.
DB13923,The therapeutic efficacy of Emicizumab can be decreased when used in combination with Abciximab.
DB14738,The therapeutic efficacy of Turoctocog alfa pegol can be decreased when used in combination with Abciximab.
DB00025,"The therapeutic efficacy of Antihemophilic factor, human recombinant can be decreased when used in combination with Abciximab."
DB00036,The therapeutic efficacy of Coagulation factor VIIa Recombinant Human can be decreased when used in combination with Abciximab.
DB00100,The therapeutic efficacy of Coagulation Factor IX (Recombinant) can be decreased when used in combination with Abciximab.
DB01783,The therapeutic efficacy of Pantothenic acid can be decreased when used in combination with Abciximab.
DB01942,The therapeutic efficacy of Formic acid can be decreased when used in combination with Abciximab.
DB02261,The therapeutic efficacy of Platelet Activating Factor can be decreased when used in combination with Abciximab.
DB06724,The therapeutic efficacy of Calcium carbonate can be decreased when used in combination with Abciximab.
DB09109,The therapeutic efficacy of Turoctocog alfa can be decreased when used in combination with Abciximab.
DB09222,The therapeutic efficacy of Fibrinogen human can be decreased when used in combination with Abciximab.
DB09310,The therapeutic efficacy of Catridecacog can be decreased when used in combination with Abciximab.
DB09329,"The therapeutic efficacy of Antihemophilic Factor (Recombinant), PEGylated can be decreased when used in combination with Abciximab."
DB11093,The therapeutic efficacy of Calcium citrate can be decreased when used in combination with Abciximab.
DB11168,The therapeutic efficacy of Calcium threonate can be decreased when used in combination with Abciximab.
DB11311,The therapeutic efficacy of Prothrombin can be decreased when used in combination with Abciximab.
DB11330,The therapeutic efficacy of Factor IX Complex (Human) can be decreased when used in combination with Abciximab.
DB11348,The therapeutic efficacy of Calcium Phosphate can be decreased when used in combination with Abciximab.
DB11606,The therapeutic efficacy of Susoctocog alfa can be decreased when used in combination with Abciximab.
DB11668,The therapeutic efficacy of Rusalatide acetate can be decreased when used in combination with Abciximab.
DB12409,The therapeutic efficacy of Vatreptacog alfa can be decreased when used in combination with Abciximab.
DB12909,The therapeutic efficacy of Factor XIII (human) can be decreased when used in combination with Abciximab.
DB13133,The therapeutic efficacy of Von Willebrand Factor Human can be decreased when used in combination with Abciximab.
DB13148,The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Abciximab.
DB13150,The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Abciximab.
DB13151,The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Abciximab.
DB13152,The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Abciximab.
DB13192,The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Abciximab.
DB13197,The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Abciximab.
DB13201,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Abciximab.
DB13933,The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Abciximab.
DB13999,The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Abciximab.
DB14473,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Abciximab.
DB14562,The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Abciximab.
DB14577,The therapeutic efficacy of Calcium cation can be decreased when used in combination with Abciximab.
DB14700,The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Abciximab.
DB06731,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Abciximab.
DB00176,The risk or severity of hemorrhage can be increased when Fluvoxamine is combined with Abciximab.
DB00215,The risk or severity of hemorrhage can be increased when Citalopram is combined with Abciximab.
DB00472,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Abciximab.
DB00476,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Abciximab.
DB00715,The risk or severity of hemorrhage can be increased when Paroxetine is combined with Abciximab.
DB01105,The risk or severity of hemorrhage can be increased when Sibutramine is combined with Abciximab.
DB01149,The risk or severity of hemorrhage can be increased when Nefazodone is combined with Abciximab.
DB04832,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Abciximab.
DB04884,The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Abciximab.
DB04896,The risk or severity of hemorrhage can be increased when Milnacipran is combined with Abciximab.
DB06700,The risk or severity of hemorrhage can be increased when Desvenlafaxine is combined with Abciximab.
DB08918,The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Abciximab.
DB08953,The risk or severity of hemorrhage can be increased when Indalpine is combined with Abciximab.
DB12693,The risk or severity of hemorrhage can be increased when Ritanserin is combined with Abciximab.
DB13233,The risk or severity of hemorrhage can be increased when Alaproclate is combined with Abciximab.
DB00285,Venlafaxine may increase the antiplatelet activities of Abciximab.
DB00182,The risk or severity of bleeding and hemorrhage can be increased when Amphetamine is combined with Abciximab.
DB00601,The risk or severity of bleeding and hemorrhage can be increased when Linezolid is combined with Abciximab.
DB00614,The risk or severity of bleeding and hemorrhage can be increased when Furazolidone is combined with Abciximab.
DB00721,The risk or severity of bleeding and hemorrhage can be increased when Procaine is combined with Abciximab.
DB00752,The risk or severity of bleeding and hemorrhage can be increased when Tranylcypromine is combined with Abciximab.
DB00780,The risk or severity of bleeding and hemorrhage can be increased when Phenelzine is combined with Abciximab.
DB00805,The risk or severity of bleeding and hemorrhage can be increased when Minaprine is combined with Abciximab.
DB01037,The risk or severity of bleeding and hemorrhage can be increased when Selegiline is combined with Abciximab.
DB01168,The risk or severity of bleeding and hemorrhage can be increased when Procarbazine is combined with Abciximab.
DB01171,The risk or severity of bleeding and hemorrhage can be increased when Moclobemide is combined with Abciximab.
DB01247,The risk or severity of bleeding and hemorrhage can be increased when Isocarboxazid is combined with Abciximab.
DB01367,The risk or severity of bleeding and hemorrhage can be increased when Rasagiline is combined with Abciximab.
DB01626,The risk or severity of bleeding and hemorrhage can be increased when Pargyline is combined with Abciximab.
DB04017,The risk or severity of bleeding and hemorrhage can be increased when Clorgiline is combined with Abciximab.
DB04818,The risk or severity of bleeding and hemorrhage can be increased when Iproniazid is combined with Abciximab.
DB04820,The risk or severity of bleeding and hemorrhage can be increased when Nialamide is combined with Abciximab.
DB06654,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Abciximab.
DB08550,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Abciximab."
DB09241,The risk or severity of bleeding and hemorrhage can be increased when Methylene blue is combined with Abciximab.
DB09243,The risk or severity of bleeding and hemorrhage can be increased when Hydracarbazine is combined with Abciximab.
DB09244,The risk or severity of bleeding and hemorrhage can be increased when Pirlindole is combined with Abciximab.
DB09245,The risk or severity of bleeding and hemorrhage can be increased when Toloxatone is combined with Abciximab.
DB09246,The risk or severity of bleeding and hemorrhage can be increased when Benmoxin is combined with Abciximab.
DB09248,The risk or severity of bleeding and hemorrhage can be increased when Mebanazine is combined with Abciximab.
DB09249,The risk or severity of bleeding and hemorrhage can be increased when Octamoxin is combined with Abciximab.
DB09250,The risk or severity of bleeding and hemorrhage can be increased when Pheniprazine is combined with Abciximab.
DB09251,The risk or severity of bleeding and hemorrhage can be increased when Phenoxypropazine is combined with Abciximab.
DB09252,The risk or severity of bleeding and hemorrhage can be increased when Pivhydrazine is combined with Abciximab.
DB09253,The risk or severity of bleeding and hemorrhage can be increased when Safrazine is combined with Abciximab.
DB09254,The risk or severity of bleeding and hemorrhage can be increased when Caroxazone is combined with Abciximab.
DB13875,The risk or severity of bleeding and hemorrhage can be increased when Harmaline is combined with Abciximab.
DB13876,The risk or severity of bleeding and hemorrhage can be increased when Brofaromine is combined with Abciximab.
DB00974,The risk or severity of bleeding can be increased when Abciximab is combined with Edetic acid.
DB11268,The risk or severity of bleeding can be increased when Abciximab is combined with Protocatechualdehyde.
DB13124,The risk or severity of bleeding can be increased when Abciximab is combined with Troxerutin.
DB00203,The risk or severity of hemorrhage can be increased when Abciximab is combined with Sildenafil.
DB00229,The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefotiam.
